,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-15,"October 01, 2004 -  September 30, 2005",The Effect of Phytochemicals on Biochemical Mechanisms Relevant to Carcinogenesi,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Sara  Bass



Henry  Ciolino; PhD



Christopher J Macdonald



Pawel  Sienkiewicz",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Brantley E, Patel V, Stinson SF, Trapani V, Hose CD, Ciolino HP, Yeh GC, Gutkind JS, Sausville EA, Loaiza-Pérez AI (2005). The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. Anticancer Drugs  16, 137-43.   https://doi.org/10.1097/00001813-200502000-00004




PubMed


 


PubMed ID 15655410
    
     


 



2.
Dennis PA, Van Waes C, Gutkind JS, Kellar KJ, Vinson C, Mukhin AG, Spitz MR, Bailey-Wilson JE, Yeh GC, Anderson LM, Wiest JS (2005). The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev  14, 764-7.   https://doi.org/10.1158/1055-9965.EPI-04-0652




PubMed



        
     
Free Article


 


PubMed ID 15824140
         Pubmed Central ID 3459058 


 



3.
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA (2004). Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther  3, 715-25.




PubMed


 


PubMed ID 15210858",https://intramural.nih.gov/search/searchview.taf?ipid=36988
1,BC000157-15,"October 01, 2004 -  September 30, 2005",Imidodipeptides and Amino Acid Metabolites in Cell Regulation and Carcinogenesis,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gregory L Borchert



Sandra D White



Steven  Donald



Yongmin  Liu



Ashley  Nick



Jui  Pandhare



Show all 8","Andy  Hu
(Biochemistry and Molecular Biology, U. of New Mexico School of Medicine)




Larry  Oberley
(Cancer Biology, U. of Iowa)




David  Valle
(Human Genetics and Pediatrics, Johns Hopkins University School of Medicine)","Kazimierz S Kasprzak; PhD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Phang J   (2004) The hyperprolinemias and hydroxyprolinemia, in Cecil Textbook of Medicine. Goldman L, Ausiello D, eds., Saunders (Philadelphia), pp. 1285.




 



2.
Dabrowski K, Terjesen BF, Zhang Y, Phang JM, Lee KJ (2005). A concept of dietary dipeptides: a step to resolve the problem of amino acid availability in the early life of vertebrates. J Exp Biol  208, 2885-94.   https://doi.org/10.1242/jeb.01689




PubMed


 


PubMed ID 16043593
    
     


 



3.
Hu CA, Donald SP, Yu J, Lin WW, Liu Z, Steel G, Obie C, Valle D, Phang JM (2007). Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis. Mol Cell Biochem  295, 85-92.   https://doi.org/10.1007/s11010-006-9276-6




PubMed


 


PubMed ID 16874462
    
     


 



4.
Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ, Oberley LW, Phang JM (2005). MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis  26, 1335-42.   https://doi.org/10.1093/carcin/bgi083




PubMed


 


PubMed ID 15817612
    
     


 



5.
Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM (2006). Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene  25, 5640-7.   https://doi.org/10.1038/sj.onc.1209564




PubMed


 


PubMed ID 16619034
    
     


 



6.
Miltyk W, Surazynski A, Kasprzak KS, Fivash MJ, Buzard GS, Phang JM (2005). Inhibition of prolidase activity by nickel causes decreased growth of proline auxotrophic CHO cells. J Cell Biochem  94, 1210-7.   https://doi.org/10.1002/jcb.20384




PubMed


 


PubMed ID 15696600
    
     


 



7.
Surazynski A, Liu Y, Miltyk W, Phang JM (2005). Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem  96, 1086-94.   https://doi.org/10.1002/jcb.20631




PubMed


 


PubMed ID 16167338",https://intramural.nih.gov/search/searchview.taf?ipid=36989
2,BC000189-12,"October 01, 2004 -  September 30, 2005",Dietary Regulation of BiochemicalMolecular Changes in Carcinogen Resistant Cells,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Sara  Bass



Henry  Ciolino; PhD



Christopher J Macdonald



Pawel  Sienkiewicz",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Brantley E, Patel V, Stinson SF, Trapani V, Hose CD, Ciolino HP, Yeh GC, Gutkind JS, Sausville EA, Loaiza-Pérez AI (2005). The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. Anticancer Drugs  16, 137-43.   https://doi.org/10.1097/00001813-200502000-00004




PubMed


 


PubMed ID 15655410
    
     


 



2.
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA (2004). Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther  3, 715-25.




PubMed


 


PubMed ID 15210858",https://intramural.nih.gov/search/searchview.taf?ipid=36990
3,BC003229-35,"October 01, 2004 -  September 30, 2005",T-Cell Antigen Recognition and Tumor Antigens,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Marco L Schito



Hiroshi  Yamaguchi","William E.  Biddison
(MOLECULAR IMMUNOLOGY SECTION, National Institute of Neurological Disorders and Stroke)




Esteban  Celis





Edward J.  Collins
(Microbiology and Immunology, Univ North Carolina, Chapel Hill)




Albert B.  DeLeo
(MOLECULAR IMMUNOLOGY SECTION, Pittsburgh Cancer Institute, Pathology)




Benjamin  Wizel
(University of Texas Health Center at Tyler)",NULL,NULL,"Ordered by publication type and then author name.



1.
Houtman JC, Higashimoto Y, Dimasi N, Cho S, Yamaguchi H, Bowden B, Regan C, Malchiodi EL, Mariuzza R, Schuck P, Appella E, Samelson LE (2004). Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences. Biochemistry  43, 4170-8.   https://doi.org/10.1021/bi0357311




PubMed


 


PubMed ID 15065860
    
     


 



2.
Lu J, Higashimoto Y, Appella E, Celis E (2004). Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses. J Immunol  172, 4575-82.   https://doi.org/10.4049/jimmunol.172.7.4575




PubMed


 


PubMed ID 15034075
    
     


 



3.
Pinchuk I, Starcher BC, Livingston B, Tvninnereim A, Wu S, Appella E, Sidney J, Sette A, Wizel B (2005). A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J Immunol  174, 5729-39.   https://doi.org/10.4049/jimmunol.174.9.5729




PubMed


 


PubMed ID 15843575
    
     


 



4.
Salvador JM, Mittelstadt PR, Guszczynski T, Copeland TD, Yamaguchi H, Appella E, Fornace AJ, Ashwell JD (2005). Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol  6, 390-5.   https://doi.org/10.1038/ni1177




PubMed


 


PubMed ID 15735648",https://intramural.nih.gov/search/searchview.taf?ipid=36991
4,BC004496-28,"October 01, 2004 -  September 30, 2005",Chromosomal Proteins and Chromosomal Functions,"Michael  Bustin; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Galina Ivanovna Belova



Srujana  Cherukuri



Yong-Chul  Kim



Frederic  Catez



Ella  Frolova; PhD



Takashi  Furusawa



Show all 8","Melinda K Duncan; PhD
(Biological Sciences, The University of Delaware)




Robert  Hock
(Wuerzburg U)




Hitoshi  Shirakawa
(Tohoku U)




Wendy  Weinberg
(FDA)","Thomas A Misteli; PhD (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)



Susan  Makem (National Cancer Institute)



Joram  Piatigorsky; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, West KL, Postnikov YV, Haines DC, Bustin M (2005). Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res  65, 6711-8.   https://doi.org/10.1158/0008-5472.CAN-05-0310




PubMed



        
     
Free Article


 


PubMed ID 16061652
         Pubmed Central ID 3714215 


 



2.
Bustin M, Catez F, Lim JH (2005). The dynamics of histone H1 function in chromatin. Mol Cell  17, 617-20.   https://doi.org/10.1016/j.molcel.2005.02.019




PubMed


 


PubMed ID 15749012
    
     


 



3.
Bustin M, Robinson RC, Friedman FK (2004). Immunochemical analysis of chromatin. Methods Enzymol  376, 209-20.   https://doi.org/10.1016/S0076-6879(03)76014-5




PubMed


 


PubMed ID 14975308
    
     


 



4.
Catez F, Yang H, Tracey KJ, Reeves R, Misteli T, Bustin M (2004). Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol  24, 4321-8.   https://doi.org/10.1128/mcb.24.10.4321-4328.2004




PubMed



        
     
Free Article


 


PubMed ID 15121851
         Pubmed Central ID 400478 


 



5.
Harrer M, Lührs H, Bustin M, Scheer U, Hock R (2004). Dynamic interaction of HMGA1a proteins with chromatin. J Cell Sci  117, 3459-71.   https://doi.org/10.1242/jcs.01160




PubMed


 


PubMed ID 15213251
    
     


 



6.
Lim a   (2005) Chromosomal Protein HMGN1 enhances the acetylation of lysine 14 in histone H3.  EMBO J, in press.




 



7.
Lim JH, Catez F, Birger Y, Postnikov YV, Bustin M (2004). Preparation and functional analysis of HMGN proteins. Methods Enzymol  375, 323-42.   https://doi.org/10.1016/s0076-6879(03)75021-6




PubMed


 


PubMed ID 14870676
    
     


 



8.
Lim JH, Catez F, Birger Y, West KL, Prymakowska-Bosak M, Postnikov YV, Bustin M (2004). Chromosomal protein HMGN1 modulates histone H3 phosphorylation. Mol Cell  15, 573-84.   https://doi.org/10.1016/j.molcel.2004.08.006




PubMed


 


PubMed ID 15327773
    
     


 



9.
Lim JH, West KL, Rubinstein Y, Bergel M, Postnikov YV, Bustin M (2005). Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3. EMBO J  24, 3038-48.   https://doi.org/10.1038/sj.emboj.7600768




PubMed



        
     
Free Article


 


PubMed ID 16096646
         Pubmed Central ID 1201349 


 



10.
Phair RD, Scaffidi P, Elbi C, Vecerová J, Dey A, Ozato K, Brown DT, Hager G, Bustin M, Misteli T (2004). Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol  24, 6393-402.   https://doi.org/10.1128/MCB.24.14.6393-6402.2004




PubMed



        
     
Free Article


 


PubMed ID 15226439
         Pubmed Central ID 434243 


 



11.
West KL, Castellini MA, Duncan MK, Bustin M (2004). Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1. Mol Cell Biol  24, 3747-56.   https://doi.org/10.1128/mcb.24.9.3747-3756.2004




PubMed



        
     
Free Article


 


PubMed ID 15082770
         Pubmed Central ID 387732",https://intramural.nih.gov/search/searchview.taf?ipid=36992
5,BC004504-33,"October 01, 2004 -  September 30, 2005",Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Joanna  Anders



Christophe  Cataisson



Christina K Cheng



Luowei  Li



Lisa A Nolan



Andrea J Pearson



Show all 9","Jiliang  Gao
(NIAID)




Steven  Ogbourne
(Peplin Biotech)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)




Peter  Welburn
(Peplin Biotech)","Kyung  Lee; PhD (National Cancer Institute)



Sergei A. Nedospasov; PhD, DSc (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)



Tadeusz P Guszczynski (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cataisson C, Pearson AJ, Torgerson S, Nedospasov SA, Yuspa SH (2005). Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo. J Immunol  174, 1686-92.   https://doi.org/10.4049/jimmunol.174.3.1686




PubMed


 


PubMed ID 15661932
    
     


 



2.
Glick AB, Yuspa SH (2005). Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol  15, 75-83.   https://doi.org/10.1016/j.semcancer.2004.08.008




PubMed


 


PubMed ID 15652452
    
     


 



3.
Repertinger SK, Campagnaro E, Fuhrman J, El-Abaseri T, Yuspa SH, Hansen LA (2004). EGFR enhances early healing after cutaneous incisional wounding. J Invest Dermatol  123, 982-9.   https://doi.org/10.1111/j.0022-202X.2004.23478.x




PubMed


 


PubMed ID 15482488",https://intramural.nih.gov/search/searchview.taf?ipid=36993
6,BC004517-29,"October 01, 2004 -  September 30, 2005",DNA Repair in Human Cancer-Prone Genetic Diseases,"Kenneth H Kraemer; MD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","John  Digiovanna



Kyu-Seon  Oh



Debra  Schmidt



Jennifer  Boyle



Jared Ravi Jagdeo



Carine  Nadem","Douglas  Brash
(Neurology, Yale Univ)




James  Cleaver
(Dermatology Department, University of California)




Steffen  Emmert





Engin  Gozukara
(Biochemistry Department, Inönü University Medical School)




Nicolaas  Jaspers
(Photon Medical Research Center, Erasmus University)




W.Clark  Lambert
(Human Genetics, NJ College of Medicine)


Show all 15","Margaret Anne Tucker (National Cancer Institute)



Thomas Dana Schneider; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Michael  Bustin; PhD (National Cancer Institute)



Jon  Vogel (National Cancer Institute)



Roxana  Moslehi (National Cancer Institute)","Yun  Wang (NIMH) 



Vilhelm A Bohr; MD, PhD (NIA) 



Raphael  Schiffmann; MD (NINDS) 



Ira W Levin; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S (2005). Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis  26, 1085-90.   https://doi.org/10.1093/carcin/bgi055




PubMed


 


PubMed ID 15731165
    
     


 



2.
Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Volkenandt M, Neumann C, Ziegler A, Kraemer KH, Reich K, Emmert S (2005). No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Hum Genet  13, 253-5.   https://doi.org/10.1038/sj.ejhg.5201296




PubMed


 


PubMed ID 15494739
    
     


 



3.
Bohr VA, Sander M, Kraemer KH (2005). Rare diseases provide rare insights into DNA repair pathways, TFIIH, aging and cancer center. DNA Repair (Amst)  4, 293-302.   https://doi.org/10.1016/j.dnarep.2004.09.010




PubMed


 


PubMed ID 15678607
    
     


 



4.
Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, Kraemer KH (2004). Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet  13, 343-52.   https://doi.org/10.1093/hmg/ddh026




PubMed


 


PubMed ID 14662655
    
     


 



5.
Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, DiGiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH (2006). Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis  27, 84-94.   https://doi.org/10.1093/carcin/bgi204




PubMed


 


PubMed ID 16081512
    
     


 



6.
Kraemer KH (2004). From proteomics to disease. Nat Genet  36, 677-8.   https://doi.org/10.1038/ng0704-677




PubMed


 


PubMed ID 15226750
    
     


 



7.
Kraemer KH, Bohr VA, DNA Repair Interest Group (2005). The DNA Repair Interest Group: a global village. DNA Repair (Amst)  4, 405-6.   https://doi.org/10.1016/j.dnarep.2005.01.002




PubMed


 


PubMed ID 15725621
    
     


 



8.
Liang C, Kraemer KH, Morris A, Schiffmann R, Price VH, Menefee E, DiGiovanna JJ (2005). Characterization of tiger-tail banding and hair shaft abnormalities in trichothiodystrophy. J Am Acad Dermatol  52, 224-32.   https://doi.org/10.1016/j.jaad.2004.09.013




PubMed


 


PubMed ID 15692466
    
     


 



9.
Takeuchi S, Zhang W, Wakamatsu K, Ito S, Hearing VJ, Kraemer KH, Brash DE (2004). Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A  101, 15076-81.   https://doi.org/10.1073/pnas.0403994101




PubMed



        
     
Free Article


 


PubMed ID 15477596
         Pubmed Central ID 524044 


 



10.
Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC (2004). Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes. Gene Ther  11, 1729-34.   https://doi.org/10.1038/sj.gt.3302344




PubMed


 


PubMed ID 15334113",https://intramural.nih.gov/search/searchview.taf?ipid=36994
7,BC004582-30,"October 01, 2004 -  September 30, 2005",Mechanisms of Transition Metal-Induced Carcinogenesis,"Kazimierz S Kasprzak; PhD, DSc",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Robert M Bare



Filip  Golebiowski



Monika  Kaczmarek



Aldona Aleksandra Karaczyn



Susan L North



Konstantin V Salnikow","Wojciech  Bal
(Biophysics, Polish Academy of Science)




Karol  Bialkowski
(Clinical Biochemistry, University Medical School)




Malgorzata  Jezowska-Bojczuk
(Chemistry, University of Wroclaw)




Bruick  Richard K.
(Department of Biochemistry, University of Texas Southwestern Medical Center)




Anatoly  Zhitkovich
(Department of Pathology and Laboratory Medicine, Brown University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36995
8,BC005051-02,"October 01, 2004 -  September 30, 2005",Signal Transduction Pathways of Transforming Growth Factor-beta,Anita B Roberts; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Stacey  Byfield



Angelina  Felici



Makiko  Fujii; MD, PhD



Anil  Kumar



Arany  Praveen



Christina  Stuelten



Show all 8","Akira  Ooshima
(Pathology, Wakayama Univ)




Neil Joseph Perkins; PhD





Shizuya  Saika
(Opthalmalogy, Wakayama Univ.)




Jens  Wurthner
(Pathology, Univ. Dusseldorf)","Angelo  Russo; MD, PhD (National Cancer Institute)



Rocky S Tuan; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J (2004). Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol  173, 2099-108.   https://doi.org/10.4049/jimmunol.173.3.2099




PubMed


 


PubMed ID 15265946
    
     


 



2.
Byfield SD, Roberts AB (2004). Lateral signaling enhances TGF-beta response complexity. Trends Cell Biol  14, 107-11.   https://doi.org/10.1016/j.tcb.2004.01.001




PubMed


 


PubMed ID 15055198
    
     


 



3.
DaCosta Byfield S, Major C, Laping NJ, Roberts AB (2004). SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol  65, 744-52.   https://doi.org/10.1124/mol.65.3.744




PubMed


 


PubMed ID 14978253
    
     


 



4.
Falanga V, Schrayer D, Cha J, Butmarc J, Carson P, Roberts AB, Kim SJ (2004). Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen  12, 320-6.   https://doi.org/10.1111/j.1067-1927.2004.012316.x




PubMed


 


PubMed ID 15225210
    
     


 



5.
Kamaraju AK, Roberts AB (2005). Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem  280, 1024-36.   https://doi.org/10.1074/jbc.M403960200




PubMed


 


PubMed ID 15520018
    
     


 



6.
Lyakh LA, Sanford M, Chekol S, Young HA, Roberts AB (2005). TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J Immunol  174, 2061-70.   https://doi.org/10.4049/jimmunol.174.4.2061




PubMed


 


PubMed ID 15699136
    
     


 



7.
Piek E, Van Dinther M, Parks WT, Sallee JM, Böttinger EP, Roberts AB, Ten Dijke P (2004). RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta. Biochem J  383, 187-99.   https://doi.org/10.1042/BJ20040774




PubMed



        
     
Free Article


 


PubMed ID 15239668
         Pubmed Central ID 1134058 


 



8.
Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Nakajima Y, Kao WW, Flanders KC, Roberts AB (2005). Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol  166, 1405-18.   https://doi.org/10.1016/S0002-9440(10)62358-9




PubMed



        
     
Free Article


 


PubMed ID 15855641
         Pubmed Central ID 1606395 


 



9.
Saika S, Ikeda K, Yamanaka O, Sato M, Muragaki Y, Ohnishi Y, Ooshima A, Nakajima Y, Namikawa K, Kiyama H, Flanders KC, Roberts AB (2004). Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest  84, 1259-70.   https://doi.org/10.1038/labinvest.3700151




PubMed


 


PubMed ID 15258599
    
     


 



10.
Saika S, Kono-Saika S, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Flanders KC, Yoo J, Anzano M, Liu CY, Kao WW, Roberts AB (2004). Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol  164, 651-63.   https://doi.org/10.1016/S0002-9440(10)63153-7




PubMed



        
     
Free Article


 


PubMed ID 14742269
         Pubmed Central ID 1602265 


 



11.
Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC, Roberts AB (2004). Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest  84, 1245-58.   https://doi.org/10.1038/labinvest.3700156




PubMed


 


PubMed ID 15273699
    
     


 



12.
Saika S, Yamanaka O, Ikeda K, Kim-Mitsuyama S, Flanders KC, Yoo J, Roberts AB, Nishikawa-Ishida I, Ohnishi Y, Muragaki Y, Ooshima A (2005). Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest  85, 838-50.   https://doi.org/10.1038/labinvest.3700294




PubMed


 


PubMed ID 15924151
    
     


 



13.
Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, Glick AB, Schäfer-Korting M, Roberts AB, Kleuser B (2004). Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem  279, 38471-9.   https://doi.org/10.1074/jbc.M313557200




PubMed


 


PubMed ID 15247277
    
     


 



14.
Sauer B, Vogler R, Zimmermann K, Fujii M, Anzano MB, Schäfer-Korting M, Roberts AB, Kleuser B (2004). Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis. J Invest Dermatol  123, 840-9.   https://doi.org/10.1111/j.0022-202X.2004.23458.x




PubMed


 


PubMed ID 15482469
    
     


 



15.
Stramer BM, Austin JS, Roberts AB, Fini ME (2005). Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J Cell Physiol  203, 226-32.   https://doi.org/10.1002/jcp.20215




PubMed


 


PubMed ID 15521071
    
     


 



16.
Stuelten CH, DaCosta Byfield S, Arany PR, Karpova TS, Stetler-Stevenson WG, Roberts AB (2005). Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci  118, 2143-53.   https://doi.org/10.1242/jcs.02334




PubMed


 


PubMed ID 15855236
    
     


 



17.
Tan NS, Michalik L, Di-Poï N, Ng CY, Mermod N, Roberts AB, Desvergne B, Wahli W (2004). Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO J  23, 4211-21.   https://doi.org/10.1038/sj.emboj.7600437




PubMed



        
     
Free Article


 


PubMed ID 15470497
         Pubmed Central ID 524401 


 



18.
Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB (2004). Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res  64, 4523-30.   https://doi.org/10.1158/0008-5472.CAN-04-0030




PubMed


 


PubMed ID 15231662
    
     


 



19.
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ (2004). Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med  351, 552-9.   https://doi.org/10.1056/NEJMoa031197




PubMed


 


PubMed ID 15295048
    
     


 



20.
Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, Sowers A, Mitchell JB, Roberts AB, Russo A (2004). Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem  279, 15167-76.   https://doi.org/10.1074/jbc.M309798200




PubMed


 


PubMed ID 14732719",https://intramural.nih.gov/search/searchview.taf?ipid=36977
9,BC005093-27,"October 01, 2004 -  September 30, 2005",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Lee F Dove



Sergey  Plisov



Nirmala D Sharma



Olga A Timofeeva



Honghe  Wang","Mark  de Caestecker
(Department of Medicine, Vanderbilt University)




Anton Marinus Jetten; PhD
(NIEHS)




Robert  Koesters","Mark B Lewandoski (National Cancer Institute)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF, Lewandoski M (2005). Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development  132, 3859-71.   https://doi.org/10.1242/dev.01945




PubMed


 


PubMed ID 16049111
    
     


 



2.
Plisov S, Tsang M, Shi G, Boyle S, Yoshino K, Dunwoodie SL, Dawid IB, Shioda T, Perantoni AO, de Caestecker MP (2005). Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning. J Am Soc Nephrol  16, 1632-44.   https://doi.org/10.1681/ASN.2004060476




PubMed


 


PubMed ID 15843474",https://intramural.nih.gov/search/searchview.taf?ipid=36997
10,BC005148-26,"October 01, 2004 -  September 30, 2005",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Sharon A Bargo



Aida  Cremesti



Sahlah  Lawson



David M Mccurdy



Ahmed M Raafat



Youping  Sun",NULL,David  Salomon; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36998
11,BC005177-25,"October 01, 2004 -  September 30, 2005",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Rao L Divi



Jessica  Ming



Ofelia  Olivero; PhD



Christine C Orozco



M. Margaret  Pratt



Paul  Sirajuddin",NULL,"Sanford Martin Dawsey; MD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, Adams ME, Nesel CJ, O'Neill JP, Abrams EJ, Poirier MC (2004). Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS  18, 1013-21.   https://doi.org/10.1097/00002030-200404300-00009




PubMed


 


PubMed ID 15096804
    
     


 



2.
Olivero OA, Tejera AM, Fernandez JJ, Taylor BJ, Das S, Divi RL, Poirier MC (2005). Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis  20, 139-46.   https://doi.org/10.1093/mutage/gei019




PubMed


 


PubMed ID 15784690
    
     


 



3.
Poirier MC (2004). Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer  4, 630-7.   https://doi.org/10.1038/nrc1410




PubMed


 


PubMed ID 15286742
    
     


 



4.
Schild LJ, Phillips DH, Osborne MR, Hewer A, Beland FA, Churchwell MI, Brown K, Gaskell M, Wright E, Poirier MC (2005). Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods. Mutagenesis  20, 115-24.   https://doi.org/10.1093/mutage/gei015




PubMed


 


PubMed ID 15755801",https://intramural.nih.gov/search/searchview.taf?ipid=36999
12,BC005216-34,"October 01, 2004 -  September 30, 2005",cAMP-Dependent Protein Kinase in Human Cancer: Basic Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI","Chris  Cheadle; PhD



Roosevelt B Hyman



Natalie  Johnson



Ji Hye Hye Lee



Maria V Nesterova



Feng  Wen","Sudhir  Agrawal
(Hybridon, Inc)




Claude  Malvy
(University of Paris)",Susan  Bates; MD (National Cancer Institute),"Kevin Graham Becker; BS, MAS, PhD (NIA)","Ordered by publication type and then author name.



1.
Cho-Chung Y   (2004) Antisense Protein Kinase A-RIalpha restores normal signal transduction signatures to inhibit tumor growth, in Cancer Drug Discovery and Development: Nucleic Acid Therapeutics in Cancer. Gewirtz A, ed., Humana Press (Totowa), pp. 199-212.",https://intramural.nih.gov/search/searchview.taf?ipid=37000
13,BC005254-24,"October 01, 2004 -  September 30, 2005",Regulation of HTLV-I Transcription,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Rebecca J Linton



Meisheng  Zhou",NULL,NULL,Vittorio  Sartorelli; MD (NIAMS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37001
14,BC005258-26,"October 01, 2004 -  September 30, 2005",Molecular Studies of Eukaryotic Gene Regulation,"Bruce  Paterson; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI","Muktadir S Hossain



Concetta  Lipardi



Qin  Wei",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37002
15,BC005263-24,"October 01, 2004 -  September 30, 2005",Eukaryotic Chromatin Structure and Gene Regulation,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Joseph W Landry



Edward E Luk



Manabu  Mizuguchi



Subhojit  Sen



Kyoko  Tomita



Paul  Wang



Show all 11","Ilaria  Rebay
(Biology, MIT)




Matthew  Voas
(Biology, MIT)",NULL,NULL,"Ordered by publication type and then author name.



1.
Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C (2004). ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science  303, 343-8.   https://doi.org/10.1126/science.1090701




PubMed


 


PubMed ID 14645854
    
     


 



2.
Schwanbeck R, Xiao H, Wu C (2004). Spatial contacts and nucleosome step movements induced by the NURF chromatin remodeling complex. J Biol Chem  279, 39933-41.   https://doi.org/10.1074/jbc.M406060200




PubMed


 


PubMed ID 15262970",https://intramural.nih.gov/search/searchview.taf?ipid=37003
16,BC005268-18,"October 01, 2004 -  September 30, 2005",Mechanism of Meiotic Recombination,"Michael Joseph Lichten; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI","Cyril  Buhler



David E Eyre



Robert A Shroff



Anuradha  Sourirajan



Tzuchen  (Carol)  Wu","Valérie  Borde
(Biology, Insitut Curie)




Alastair  Goldman
(University of Sheffield)




James  Haber





Douglas  Koshland
(Embryology, Carnegie Institution of Washington)




Alain  Nicolas





John  Petrini



Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Borde V, Lin W, Novikov E, Petrini JH, Lichten M, Nicolas A (2004). Association of Mre11p with double-strand break sites during yeast meiosis. Mol Cell  13, 389-401.   https://doi.org/10.1016/s1097-2765(04)00034-6




PubMed


 


PubMed ID 14967146
    
     


 



2.
Jessop L, Allers T, Lichten M (2005). Infrequent co-conversion of markers flanking a meiotic recombination initiation site in Saccharomyces cerevisiae. Genetics  169, 1353-67.   https://doi.org/10.1534/genetics.104.036509




PubMed



        
     
Free Article


 


PubMed ID 15654098
         Pubmed Central ID 1449552 


 



3.
Lichten M (2005). Rad50 connects by hook or by crook. Nat Struct Mol Biol  12, 392-3.   https://doi.org/10.1038/nsmb0505-392




PubMed


 


PubMed ID 15870729
    
     


 



4.
Schlecht HB, Lichten M, Goldman AS (2004). Compartmentalization of the yeast meiotic nucleus revealed by analysis of ectopic recombination. Genetics  168, 1189-203.   https://doi.org/10.1534/genetics.104.029157




PubMed



        
     
Free Article


 


PubMed ID 15579679
         Pubmed Central ID 1448799 


 



5.
Shroff R, Arbel-Eden A, Pilch D, Ira G, Bonner WM, Petrini JH, Haber JE, Lichten M (2004). Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr Biol  14, 1703-11.   https://doi.org/10.1016/j.cub.2004.09.047




PubMed



        
     
Free Article


 


PubMed ID 15458641
         Pubmed Central ID 4493763 


 



6.
Unal E, Arbel-Eden A, Sattler U, Shroff R, Lichten M, Haber JE, Koshland D (2004). DNA damage response pathway uses histone modification to assemble a double-strand break-specific cohesin domain. Mol Cell  16, 991-1002.   https://doi.org/10.1016/j.molcel.2004.11.027




PubMed


 


PubMed ID 15610741",https://intramural.nih.gov/search/searchview.taf?ipid=37005
17,BC005270-24,"October 01, 2004 -  September 30, 2005",Molecular Mechanism of Action of Phorbol Ester,"Peter  Blumberg; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Derek C Braun



Sung-Hee  Choi



Tetsurou  Ikeda



Noemi  Kedei



Jozsef  Lazar



Nancy E Lewin



Show all 11","Tamas  Biro
(Dept. of Physiology, University of Debrecen)




Chaya  Brodie; PhD
(Faculty of Life Science, Bar Ilan University)




Narender  Gavva
(Amgen)




Jose  Giner
(Dept. of Chemistry, State University of New York at Syracuse)




Sergio  Grinstein
(University of Toronto)




Marcelo G Kazanietz; PhD
(Pharmacology, University of Pennsylvania)


Show all 18","Victor  Marquez; PhD (National Cancer Institute)



Susan H Garfield (National Cancer Institute)



J. Frederic Mushinski; MD (National Cancer Institute)



Dean H. Hamer; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Joost J Oppenheim; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blumberg P, Kedei N, Lazar J, Pavlyukovets V, Pearce L   (2005) Insights into TRPV1 pharmacology provided by non-capsaicin ligands.  Prog Inflam Res, in press.




 



2.
Blumberg P, Peach M, Lewin N, Marquez V   (2005) Conformationally constrained analogues of DAG 25 Dissection of the functions of the sn-1 and sn-2 carbonyls in the binding of DAG-lactones to protein kinase C reveals the essential role of the sn-1 carbonyl at the lipid interface.  J Med Chem, in press.




 



3.
Brodie C, Steinhart R, Kazimirsky G, Rubinfeld H, Hyman T, Ayres JN, Hur GM, Toth A, Yang D, Garfield SH, Stone JC, Blumberg PM (2004). PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol  66, 76-84.   https://doi.org/10.1124/mol.66.1.76




PubMed


 


PubMed ID 15213298
    
     


 



4.
Duan D, Lewin NE, Sigano DM, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 21. A solid-phase method of synthesis of diacylglycerol lactones as a prelude to a combinatorial approach for the synthesis of protein kinase C isozyme-specific ligands. J Med Chem  47, 3248-54.   https://doi.org/10.1021/jm030610k




PubMed


 


PubMed ID 15163204
    
     


 



5.
Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ (2004). Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem  279, 20283-95.   https://doi.org/10.1074/jbc.M312577200




PubMed


 


PubMed ID 14996838
    
     


 



6.
Kang JH, Kim SY, Lee J, Marquez VE, Lewin NE, Pearce LV, Blumberg PM (2004). Macrocyclic diacylglycerol-bis-lactones as conformationally constrained analogues of diacylglycerol-lactones. Interactions with protein kinase C. J Med Chem  47, 4000-7.   https://doi.org/10.1021/jm0497747




PubMed


 


PubMed ID 15267238
    
     


 



7.
Kang JH, Siddiqui MA, Sigano DM, Krajewski K, Lewin NE, Pu Y, Blumberg PM, Lee J, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 24. Asymmetric synthesis of a chiral (R)-DAG-lactone template as a versatile precursor for highly functionalized DAG-lactones. Org Lett  6, 2413-6.   https://doi.org/10.1021/ol0492041




PubMed


 


PubMed ID 15228292
    
     


 



8.
Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM (2004). Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res  64, 3243-55.   https://doi.org/10.1158/0008-5472.can-03-3403




PubMed


 


PubMed ID 15126366
    
     


 



9.
Lázár J, Szabó T, Marincsák R, Kovács L, Blumberg PM, Bíró T (2004). Sensitization of recombinant vanilloid receptor-1 by various neurotrophic factors. Life Sci  75, 153-63.   https://doi.org/10.1016/j.lfs.2003.11.023




PubMed


 


PubMed ID 15120568
    
     


 



10.
Lee J, Kang SU, Choi HK, Lee J, Lim JO, Kil MJ, Jin MK, Kim KP, Sung JH, Chung SJ, Ha HJ, Kim YH, Pearce LV, Tran R, Lundberg DJ, Wang Y, Toth A, Blumberg PM (2004). Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity. Bioorg Med Chem Lett  14, 2291-7.   https://doi.org/10.1016/j.bmcl.2004.02.002




PubMed


 


PubMed ID 15081027
    
     


 



11.
Lee J, Kang SU, Lim JO, Choi HK, Jin MK, Toth A, Pearce LV, Tran R, Wang Y, Szabo T, Blumberg PM (2004). N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the ""C-Region"". Bioorg Med Chem  12, 371-85.   https://doi.org/10.1016/j.bmc.2003.10.047




PubMed


 


PubMed ID 14723956
    
     


 



12.
Lee J, Kim SY, Kang JH, Acs G, Acs P, Blumberg PM, Marquez VE (2004). Conformationally constrained diacylglycerol (DAG) analogs: 4-C-hydroxyethyl-5-O-acyl-2,3-dideoxy-D-glyceropentono-1,4-lactone analogs as protein kinase C (PKC) ligands. Eur J Med Chem  39, 69-77.   https://doi.org/10.1016/j.ejmech.2003.10.006




PubMed


 


PubMed ID 14987835
    
     


 



13.
Lee J, Kim SY, Lee J, Kang M, Kil MJ, Choi HK, Jin MK, Wang Y, Toth A, Pearce LV, Lundberg DJ, Tran R, Blumberg PM (2004). Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism. Bioorg Med Chem  12, 3411-20.   https://doi.org/10.1016/j.bmc.2004.04.040




PubMed


 


PubMed ID 15186827
    
     


 



14.
Lee J, Kim SY, Park S, Lim JO, Kim JM, Kang M, Lee J, Kang SU, Choi HK, Jin MK, Welter JD, Szabo T, Tran R, Pearce LV, Toth A, Blumberg PM (2004). Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding. Bioorg Med Chem  12, 1055-69.   https://doi.org/10.1016/j.bmc.2003.12.005




PubMed


 


PubMed ID 14980619
    
     


 



15.
Papp H, Czifra G, Bodó E, Lázár J, Kovács I, Aleksza M, Juhász I, Acs P, Sipka S, Kovács L, Blumberg PM, Bíró T (2004). Opposite roles of protein kinase C isoforms in proliferation, differentiation, apoptosis, and tumorigenicity of human HaCaT keratinocytes. Cell Mol Life Sci  61, 1095-105.   https://doi.org/10.1007/s00018-004-4014-2




PubMed


 


PubMed ID 15112056
    
     


 



16.
Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP, Blumberg PM (2004). Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Org Biomol Chem  2, 2281-6.   https://doi.org/10.1039/B404506H




PubMed


 


PubMed ID 15305207
    
     


 



17.
Pettit GR, Hoffmann H, Herald DL, Blumberg PM, Hamel E, Schmidt JM, Chang Y, Pettit RK, Lewin NE, Pearce LV (2004). Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine. J Med Chem  47, 1775-82.   https://doi.org/10.1021/jm030070r




PubMed


 


PubMed ID 15027869
    
     


 



18.
Pettit GR, Hoffmann H, Herald DL, McNulty J, Murphy A, Higgs KC, Hamel E, Lewin NE, Pearce LV, Blumberg PM, Pettit RK, Knight JC (2004). Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine. J Org Chem  69, 2251-6.   https://doi.org/10.1021/jo0300486




PubMed


 


PubMed ID 15049616
    
     


 



19.
Tóth A, Blumberg PM, Chen Z, Kozikowski AP (2004). Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population. Mol Pharmacol  65, 282-91.   https://doi.org/10.1124/mol.65.2.282




PubMed


 


PubMed ID 14742669
    
     


 



20.
Tamamura H, Sigano DM, Lewin NE, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 20. The search for an elusive binding site on protein kinase C through relocation of the carbonyl pharmacophore along the sn-1 side chain of 1,2-diacylglycerol lactones. J Med Chem  47, 644-55.   https://doi.org/10.1021/jm030454h




PubMed


 


PubMed ID 14736244
    
     


 



21.
Tamamura H, Sigano DM, Lewin NE, Peach ML, Nicklaus MC, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C). J Med Chem  47, 4858-64.   https://doi.org/10.1021/jm049723+




PubMed


 


PubMed ID 15369389
    
     


 



22.
Wang QJ, Lu G, Schlapkohl WA, Goerke A, Larsson C, Mischak H, Blumberg PM, Mushinski JF (2004). The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-delta and -epsilon. Mol Cancer Res  2, 129-40.




PubMed


 


PubMed ID 14985469
    
     


 



23.
Wang Y, Kedei N, Wang M, Wang QJ, Huppler AR, Toth A, Tran R, Blumberg PM (2004). Interaction between protein kinase Cmu and the vanilloid receptor type 1. J Biol Chem  279, 53674-82.   https://doi.org/10.1074/jbc.M410331200




PubMed


 


PubMed ID 15471852",https://intramural.nih.gov/search/searchview.taf?ipid=37006
18,BC005271-14,"October 01, 2004 -  September 30, 2005",Gene Regulation and Function: The B-ZIP Proteins,"Charles  Vinson; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Won-Jun  Oh



Vikas  Rishi



Julian  Rozenburg",NULL,Charlotte  Peterson (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Appierto V, Villani MG, Cavadini E, Lotan R, Vinson C, Formelli F (2004). Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death Differ  11, 270-9.   https://doi.org/10.1038/sj.cdd.4401349




PubMed


 


PubMed ID 14647238
    
     


 



2.
Bauer I, Hohl M, Al-Sarraj A, Vinson C, Thiel G (2005). Transcriptional activation of the Egr-1 gene mediated by tetradecanoylphorbol acetate and extracellular signal-regulated protein kinase. Arch Biochem Biophys  438, 36-52.   https://doi.org/10.1016/j.abb.2005.03.016




PubMed


 


PubMed ID 15910736
    
     


 



3.
Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res  64, 3849-54.   https://doi.org/10.1158/0008-5472.CAN-04-0322




PubMed


 


PubMed ID 15172993
    
     


 



4.
Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G (2004). Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A  101, 3258-63.   https://doi.org/10.1073/pnas.0308744101




PubMed



        
     
Free Article


 


PubMed ID 14978271
         Pubmed Central ID 365777 


 



5.
FitzGerald PC, Shlyakhtenko A, Mir AA, Vinson C (2004). Clustering of DNA sequences in human promoters. Genome Res  14, 1562-74.   https://doi.org/10.1101/gr.1953904




PubMed



        
     
Free Article


 


PubMed ID 15256515
         Pubmed Central ID 509265 


 



6.
Jeong MY, Kinugawa K, Vinson C, Long CS (2005). AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program. Circulation  111, 1645-51.   https://doi.org/10.1161/01.CIR.0000160367.99928.87




PubMed



        
     
Free Article


 


PubMed ID 15795322
         Pubmed Central ID 1201436 


 



7.
Rishi V, Gal J, Krylov D, Fridriksson J, Boysen MS, Mandrup S, Vinson C (2004). SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains: use of a dominant negative. J Biol Chem  279, 11863-74.   https://doi.org/10.1074/jbc.M308000200




PubMed


 


PubMed ID 14702347
    
     


 



8.
Rishi V, Potter T, Laudeman J, Reinhart R, Silvers T, Selby M, Stevenson T, Krosky P, Stephen AG, Acharya A, Moll J, Oh WJ, Scudiero D, Shoemaker RH, Vinson C (2005). A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal Biochem  340, 259-71.   https://doi.org/10.1016/j.ab.2005.02.012




PubMed


 


PubMed ID 15840499
    
     


 



9.
Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K (2005). Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy. FASEB J  19, 127-9.   https://doi.org/10.1096/fj.04-2183fje




PubMed


 


PubMed ID 15496495
    
     


 



10.
Thiel G, Al Sarraj J, Vinson C, Stefano L, Bach K (2005). Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. J Neurochem  92, 321-36.   https://doi.org/10.1111/j.1471-4159.2004.02882.x




PubMed


 


PubMed ID 15663480
    
     


 



11.
Vinson C (2005). A rationally designed small molecule that inhibits the HIF-1alpha-ARNT heterodimer from binding to DNA in vivo. Sci STKE  2005, pe23.   https://doi.org/10.1126/stke.2842005pe23




PubMed


 


PubMed ID 15900031
    
     


 



12.
Zhang JW, Klemm DJ, Vinson C, Lane MD (2004). Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem  279, 4471-8.   https://doi.org/10.1074/jbc.M311327200




PubMed


 


PubMed ID 14593102
    
     


 



13.
Zhang JW, Tang QQ, Vinson C, Lane MD (2004). Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A  101, 43-7.   https://doi.org/10.1073/pnas.0307229101




PubMed



        
     
Free Article


 


PubMed ID 14688407
         Pubmed Central ID 314135",https://intramural.nih.gov/search/searchview.taf?ipid=37007
19,BC005317-22,"October 01, 2004 -  September 30, 2005",Role of Selenium in Cancer and Health,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Aniruddha  Sengupta



Rajeev K Shrimali



Min-Hyuk  Yoo","Marla  Berry
(Molecular Biology, U of Hawaii)




Vadim  Gladyshev
(Biochem, U of NE)




Byeong Jae  Lee
(Molecular Biology and Genetics, Seoul National University)","Cindy D Davis (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hatfield D, Gladyshev V   (2005) Um34 in selenocysteine tRNA is required for the expression of stress-related selenoproteins in mammals, in Topics in Current Genetics. Grosjean H, ed., Springer-Verlag (Berlin-Heidelberg), pp. 431-438.




 



2.
Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, Gladyshev VN, Hatfield DL (2004). Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem  279, 8011-7.   https://doi.org/10.1074/jbc.M310470200




PubMed


 


PubMed ID 14660662
    
     


 



3.
Carlson BA, Xu XM, Gladyshev VN, Hatfield DL (2005). Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem  280, 5542-8.   https://doi.org/10.1074/jbc.M411725200




PubMed


 


PubMed ID 15611090
    
     


 



4.
Carlson BA, Xu XM, Kryukov GV, Rao M, Berry MJ, Gladyshev VN, Hatfield DL (2004). Identification and characterization of phosphoseryl-tRNA[Ser]Sec kinase. Proc Natl Acad Sci U S A  101, 12848-53.   https://doi.org/10.1073/pnas.0402636101




PubMed



        
     
Free Article


 


PubMed ID 15317934
         Pubmed Central ID 516484 


 



5.
Gladyshev VN, Kryukov GV, Fomenko DE, Hatfield DL (2004). Identification of trace element-containing proteins in genomic databases. Annu Rev Nutr  24, 579-96.   https://doi.org/10.1146/annurev.nutr.24.012003.132241




PubMed


 


PubMed ID 15189132
    
     


 



6.
Hatfield D, Calvisi D, Labunskyy V, Factor V, Carlson B, Fomenko D, Moustafa M, Gladyshev V   (2005) Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice.  Oncogene, in press.




 



7.
Jin JS, Baek S, Lee H, Oh MY, Koo YE, Shim MS, Kwon SY, Jeon I, Park SY, Baek K, Yoo MA, Hatfield DL, Lee BJ (2004). A DNA replication-related element downstream from the initiation site of Drosophila selenophosphate synthetase 2 gene is essential for its transcription. Nucleic Acids Res  32, 2482-93.   https://doi.org/10.1093/nar/gkh569




PubMed



        
     
Free Article


 


PubMed ID 15121905
         Pubmed Central ID 419457 


 



8.
Schweizer U, Streckfuss F, Pelt P, Carlson BA, Hatfield DL, Köhrle J, Schomburg L (2005). Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J  386, 221-6.   https://doi.org/10.1042/BJ20041973




PubMed



        
     
Free Article


 


PubMed ID 15638810
         Pubmed Central ID 1134785 


 



9.
Shrimali RK, Lobanov AV, Xu XM, Rao M, Carlson BA, Mahadeo DC, Parent CA, Gladyshev VN, Hatfield DL (2005). Selenocysteine tRNA identification in the model organisms Dictyostelium discoideum and Tetrahymena thermophila. Biochem Biophys Res Commun  329, 147-51.   https://doi.org/10.1016/j.bbrc.2005.01.120




PubMed


 


PubMed ID 15721286
    
     


 



10.
Su D, Novoselov SV, Sun QA, Moustafa ME, Zhou Y, Oko R, Hatfield DL, Gladyshev VN (2005). Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation. J Biol Chem  280, 26491-8.   https://doi.org/10.1074/jbc.M503638200




PubMed


 


PubMed ID 15901730",https://intramural.nih.gov/search/searchview.taf?ipid=37010
20,BC005318-23,"October 01, 2004 -  September 30, 2005",Structure-Function of Cytochrome P450,Fred  Friedman; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Allen  Markowitz; MEE (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37011
21,BC005352-23,"October 01, 2004 -  September 30, 2005",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Yuk Sing Robert Cheng



Janet R Fields



Ki Narm  Ko



Sean D Mccann



Yih-horng  Shiao



Cuiju  Wang",NULL,"Kazimierz S Kasprzak; PhD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Anderson LM (2004). Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies. Toxicol Appl Pharmacol  199, 85-90.   https://doi.org/10.1016/j.taap.2004.02.015




PubMed


 


PubMed ID 15313581
    
     


 



2.
Anderson LM (2004). Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination. Toxicol Appl Pharmacol  199, 162-74.   https://doi.org/10.1016/j.taap.2004.02.008




PubMed


 


PubMed ID 15313588
    
     


 



3.
Cheng RY, Birely LA, Lum NL, Perella CM, Cherry JM, Bhat NK, Kasprzak KS, Powell DA, Alvord WG, Anderson LM (2004). Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. J Mol Endocrinol  32, 257-78.   https://doi.org/10.1677/jme.0.0320257




PubMed


 


PubMed ID 14766007
    
     


 



4.
Cheng RY, Hockman T, Crawford E, Anderson LM, Shiao YH (2004). Epigenetic and gene expression changes related to transgenerational carcinogenesis. Mol Carcinog  40, 1-11.   https://doi.org/10.1002/mc.20022




PubMed


 


PubMed ID 15108325
    
     


 



5.
Shiao YH, Crawford EB, Anderson LM, Patel P, Ko K (2005). Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure. Toxicol Appl Pharmacol  205, 290-6.   https://doi.org/10.1016/j.taap.2004.10.017




PubMed


 


PubMed ID 15922014
    
     


 



6.
Souliotis VL, Sfikakis PP, Anderson LM, Kyrtopoulos SA (2004). Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexity. Mutat Res  568, 155-70.   https://doi.org/10.1016/j.mrfmmm.2004.07.009




PubMed


 


PubMed ID 15542103",https://intramural.nih.gov/search/searchview.taf?ipid=37012
22,BC005367-22,"October 01, 2004 -  September 30, 2005",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Valerie A Beason



Meredith Ann Brown



Carlos Antonio Driscoll; PhD



Warren  Johnson



Bailey D Kessing



Shujin  Luo



Show all 14","Agostinho  Antunes; PhD





Christine  Breitenmoser-Wursten
(IUCN/SSC Cat Specialist Group, KORA)




Laurence  Frank
(Museum of Vert. Zoology, University of California)




Todd  Fuller
(Dept. of Forestry & Wildlife Management, University of Massachusetts)




Darrell  Land
(Researcher, FLA Fish & Wildlife Conserv. Comm.)




David  MacDonald
(Wildlife Conserv. Research Unit)


Show all 10",NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, Antunes A, Luo S, Menninger J, Nash W, Johnson W   (2005) Evolutionary analysis of a large mtDNA translocation (numt) into the nuclear genome of the Panthera genus species.  Gene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37013
23,BC005385-22,"October 01, 2004 -  September 30, 2005","The Development of the Domestic Cat, IFelis catusI, as an Animal Model for Genet",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Victor A David



Yasuko  Ishida



Valerie A Beason



Carlos Antonio Driscoll; PhD



Meghan S Kessler



Janice S Martenson



Show all 13","John  Butler
(Biotechnology Div., Nat'l. Bureau of Standards)




John  Fyfe
(Michigan State U.)




Steven  Hannah
(Nestle Purina PetCare Co.)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)",Robert H Stephens (National Cancer Institute),Alejandro Alberto Schaffer; PhD (NLM),"Ordered by publication type and then author name.



1.
He Q, Lowrie C, Shelton GD, Castellani RJ, Menotti-Raymond M, Murphy W, O'Brien SJ, Swanson WF, Fyfe JC (2005). Inherited motor neuron disease in domestic cats: a model of spinal muscular atrophy. Pediatr Res  57, 324-30.   https://doi.org/10.1203/01.PDR.0000153625.46892.6F




PubMed


 


PubMed ID 15635053
    
     


 



2.
O'Brien S, David V, Wachter L, Butler J   (2005) An STR forensic typing system for genetic individualization of domestic cat (Felis catus) samples.  J. Forensic Science, in press.




 



3.
Schmidt-Küntzel A, Eizirik E, O'Brien SJ, Menotti-Raymond M (2005). Tyrosinase and tyrosinase related protein 1 alleles specify domestic cat coat color phenotypes of the albino and brown loci. J Hered  96, 289-301.   https://doi.org/10.1093/jhered/esi066




PubMed


 


PubMed ID 15858157",https://intramural.nih.gov/search/searchview.taf?ipid=37015
24,BC005389-22,"October 01, 2004 -  September 30, 2005",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Janice S Martenson



Katherine  Pelican



David  Wildt



Polina  Perelman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M, Lorneli H, Nagy A, McLaughlin K, Scholer H, Tomilin A   (2004) Oct4 is required for primordial germ cell survival.  EMBO Reports, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37016
25,BC005399-22,"October 01, 2004 -  September 30, 2005",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Richard J Calvert



Yuk Sing Robert Cheng



Janet R Fields



Laura  Fornwald



Keith D Kikawa



Malgorzata  Romanowska



Show all 7",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dennis PA, Van Waes C, Gutkind JS, Kellar KJ, Vinson C, Mukhin AG, Spitz MR, Bailey-Wilson JE, Yeh GC, Anderson LM, Wiest JS (2005). The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev  14, 764-7.   https://doi.org/10.1158/1055-9965.EPI-04-0652




PubMed



        
     
Free Article


 


PubMed ID 15824140
         Pubmed Central ID 3459058 


 



2.
Maciag A, Anderson LM (2005). Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis. Exp Lung Res  31, 83-104.   https://doi.org/10.1080/01902140490495048




PubMed


 


PubMed ID 15765920
    
     


 



3.
Maciag A, Sithanandam G, Anderson LM (2004). Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells. Carcinogenesis  25, 2231-7.   https://doi.org/10.1093/carcin/bgh245




PubMed


 


PubMed ID 15284181
    
     


 



4.
Sithanandam G, Fornwald LW, Fields J, Anderson LM (2005). Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene  24, 1847-59.   https://doi.org/10.1038/sj.onc.1208381




PubMed


 


PubMed ID 15688028
    
     


 



5.
Sithanandam G, Smith GT, Fields JR, Fornwald LW, Anderson LM (2005). Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1. Am J Respir Cell Mol Biol  33, 490-9.   https://doi.org/10.1165/rcmb.2005-0049OC




PubMed



        
     
Free Article


 


PubMed ID 16055672
         Pubmed Central ID 2715357 


 



6.
Vucenik I, Ramakrishna G, Tantivejkul K, Anderson LM, Ramljak D (2005). Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat  91, 35-45.   https://doi.org/10.1007/s10549-004-6456-5




PubMed


 


PubMed ID 15868430",https://intramural.nih.gov/search/searchview.taf?ipid=37017
26,BC005445-21,"October 01, 2004 -  September 30, 2005",Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Joanna  Anders



Christina K Cheng



Nicholas A Frost



Michael  Gerdes



Arash  Koochek



Ulrike F Lichti; PhD



Show all 8","Robert  Eisenman
(Fred Hutchinson Cancer Research Center)




Adam  Glick; PhD
(NCI)




Dennis  Roop; PhD
(Department of Dermatogy and Cell Biology, Baylor College of Medicine)




Yuzuru  Shiio
(Institute of Systems Biology)","Charles  Vinson; PhD (National Cancer Institute)



Miriam Christine Poirier; PhD (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)



James  McMahon; PhD (National Cancer Institute)","Joseph A Mindell; BS, MD, PhD (NINDS)","Ordered by publication type and then author name.



1.
Suh KS, Mutoh M, Gerdes M, Crutchley JM, Mutoh T, Edwards LE, Dumont RA, Sodha P, Cheng C, Glick A, Yuspa SH (2005). Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res  65, 562-71.




PubMed


 


PubMed ID 15695400
    
     


 



2.
Suh KS, Mutoh M, Nagashima K, Fernandez-Salas E, Edwards LE, Hayes DD, Crutchley JM, Marin KG, Dumont RA, Levy JM, Cheng C, Garfield S, Yuspa SH (2004). The organellular chloride channel protein CLIC4/mtCLIC translocates to the nucleus in response to cellular stress and accelerates apoptosis. J Biol Chem  279, 4632-41.   https://doi.org/10.1074/jbc.M311632200




PubMed


 


PubMed ID 14610078
    
     


 



3.
Suh KS, Yuspa SH (2005). Intracellular chloride channels: critical mediators of cell viability and potential targets for cancer therapy. Curr Pharm Des  11, 2753-64.   https://doi.org/10.2174/1381612054546806




PubMed


 


PubMed ID 16101453
    
     


 



4.
Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH (2004). Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis  25, 1771-8.   https://doi.org/10.1093/carcin/bgh170




PubMed


 


PubMed ID 15105299",https://intramural.nih.gov/search/searchview.taf?ipid=37018
27,BC005450-22,"October 01, 2004 -  September 30, 2005",Chromatin Structure and Gene Expression,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anindya P Hendarwanto



Tom  Johnson



Sam  John



Akhilesh Kumar Nagaich



Yi  Qui



Malgorzata  Wiench",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Dohoney KM, Guillerm C, Whiteford C, Elbi C, Lambert PF, Hager GL, Brady JN (2004). Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene  23, 49-57.   https://doi.org/10.1038/sj.onc.1207005




PubMed


 


PubMed ID 14712210
    
     


 



2.
Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, Ryan XP, Magiatis P, Polychronopoulos P, Greengard P, Skaltsounis L, Meijer L (2004). Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene  23, 4400-12.   https://doi.org/10.1038/sj.onc.1207535




PubMed


 


PubMed ID 15077192
    
     


 



3.
Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, Klokk TI, Hammarstrom C, Troen G, Svindland A, Hager GL, Saatcioglu F (2005). Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene  24, 4934-45.   https://doi.org/10.1038/sj.onc.1208677




PubMed


 


PubMed ID 15897894
    
     


 



4.
Nagaich AK, Hager GL (2004). UV laser cross-linking: a real-time assay to study dynamic protein/DNA interactions during chromatin remodeling. Sci STKE  2004, pl13.   https://doi.org/10.1126/stke.2562004pl13




PubMed


 


PubMed ID 15507594
    
     


 



5.
Nagaich AK, Rayasam GV, Martinez ED, Becker M, Qiu Y, Johnson TA, Elbi C, Fletcher TM, John S, Hager GL (2004). Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci  1024, 213-20.   https://doi.org/10.1196/annals.1321.002




PubMed


 


PubMed ID 15265783
    
     


 



6.
Nagaich AK, Walker DA, Wolford R, Hager GL (2004). Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell  14, 163-74.   https://doi.org/10.1016/s1097-2765(04)00178-9




PubMed


 


PubMed ID 15099516
    
     


 



7.
Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL (2005). Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol  25, 2406-18.   https://doi.org/10.1128/MCB.25.6.2406-2418.2005




PubMed



        
     
Free Article


 


PubMed ID 15743833
         Pubmed Central ID 1061598 


 



8.
Robertson AK, Geiman TM, Sankpal UT, Hager GL, Robertson KD (2004). Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro. Biochem Biophys Res Commun  322, 110-8.   https://doi.org/10.1016/j.bbrc.2004.07.083




PubMed


 


PubMed ID 15313181",https://intramural.nih.gov/search/searchview.taf?ipid=37019
28,BC005453-21,"October 01, 2004 -  September 30, 2005",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Joe W Grisham



Jeonghoon  Heo



Tanya N Hoang



Ju-Seog  Lee; PhD



Show all 9","Peter  Nagy
(Pathology, Sammelweiss University)




Aranzazu  Sanchez Munoz
(Dept. Biochemistry and Molecular Biology, Compluense University)",Valentina  Factor (Cellular and Molecular Biology Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37020
29,BC005480-20,"October 01, 2004 -  September 30, 2005",Molecular Epidemiology and Molecular Carcinogenesis of Human Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Sharon R Pine



Masahiro  Seike



Masataka  Taga



Elise Dawn Bowman



Nobutoshi  Hagiwara



Weidong  Jiang



Show all 16","M.  Rusin
(Maria-Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland, Institute of Oncology)




W.D.  Travis
(Memorial Sloan Kettering)




K.  Vahakangas
(University of Oulo)",NULL,NULL,"Ordered by publication type and then author name.



1.
Harris C, Hussain S, Caron C, Hainaut P   (2004) TP53 Mutation Spectra and Load: A Tool for Generating Hypotheses on the Etiology of Cancer, in Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology. Buffler P, Rice J, Baan R, Bird M, Boffetta P, eds., IARC (Lyon), pp. 247-270.




 



2.
Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC (2005). Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res  11, 232-41.




PubMed


 


PubMed ID 15671551
    
     


 



3.
Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A (2005). Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis  26, 1368-73.   https://doi.org/10.1093/carcin/bgi085




PubMed


 


PubMed ID 15802297
    
     


 



4.
He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC (2004). Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol  35, 1196-209.   https://doi.org/10.1016/j.humpath.2004.06.014




PubMed


 


PubMed ID 15492986
    
     


 



5.
Marrogi AJ, Mechanic LE, Welsh JA, Bowman ED, Khan MA, Enewold L, Shields PG, Harris CC (2005). TP53 mutation spectrum in lung cancer is not different in women and men. Cancer Epidemiol Biomarkers Prev  14, 1031-3.   https://doi.org/10.1158/1055-9965.EPI-04-0640




PubMed


 


PubMed ID 15824188
    
     


 



6.
Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC (2005). Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis  26, 597-604.   https://doi.org/10.1093/carcin/bgh344




PubMed


 


PubMed ID 15564288
    
     


 



7.
Yang SH, Mechanic LE, Yang P, Landi MT, Bowman ED, Wampfler J, Meerzaman D, Hong KM, Mann F, Dracheva T, Fukuoka J, Travis W, Caporaso NE, Harris CC, Jen J (2005). Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res  11, 2106-10.   https://doi.org/10.1158/1078-0432.CCR-04-1853




PubMed


 


PubMed ID 15788655",https://intramural.nih.gov/search/searchview.taf?ipid=37021
30,BC005482-20,"October 01, 2004 -  September 30, 2005",Regulation of papillomavirus gene expression,"Carl C Baker; MD, PhD",NULL,"Laboratory of Cellular Oncology, NCI","Janet M Dipasquale



Jesse F Quintero","Mariano  Garcia-Blanco
(Intronn, Inc.)




M.  Puttaraju
(Intronn, Inc.)",Kenneth H Kraemer; MD (National Cancer Institute),"Lloyd George Mitchell; MD (NHLBI) 



Wendy  Weinberg (OD)","Ordered by publication type and then author name.



1.
Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, DiGiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH (2006). Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis  27, 84-94.   https://doi.org/10.1093/carcin/bgi204




PubMed


 


PubMed ID 16081512
    
     


 



2.
King KE, Ponnamperuma RM, Gerdes MJ, Tokino T, Yamashita T, Baker CC, Weinberg WC (2006). Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis  27, 53-63.   https://doi.org/10.1093/carcin/bgi200




PubMed


 


PubMed ID 16081516",https://intramural.nih.gov/search/searchview.taf?ipid=37022
31,BC005488-20,"October 01, 2004 -  September 30, 2005",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Lamia Ilham Benbrahim-Tallaa; PhD



Ryan James Cooper



Jean-Francois L Coppin



Robert A Goyer



Elaine  Leslie



Wei  Qu; PhD



Show all 8","Min Ling  Chen
(Guiyang Medical College)




David L Miller





Mukta  Webber
(Michigan State University)","Larry K Keefer; PhD (National Cancer Institute)



Jerrold M Ward; DVM, PhD (National Cancer Institute)



Bhalchandra A Diwan; PhD (National Cancer Institute)



Kazimierz S Kasprzak; PhD, DSc (National Cancer Institute)","Colin F Chignell; PhD (NIEHS) 



Jau Shyong  Hong; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP (2004). Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis  25, 1779-86.   https://doi.org/10.1093/carcin/bgh161




PubMed


 


PubMed ID 15073043
    
     


 



2.
Goyer RA, Liu J, Waalkes MP (2004). Cadmium and cancer of prostate and testis. Biometals  17, 555-8.   https://doi.org/10.1023/b:biom.0000045738.59708.20




PubMed


 


PubMed ID 15688863
    
     


 



3.
He YY, Huang JL, Sik RH, Liu J, Waalkes MP, Chignell CF (2004). Expression profiling of human keratinocyte response to ultraviolet A: implications in apoptosis. J Invest Dermatol  122, 533-43.   https://doi.org/10.1046/j.0022-202X.2003.22123.x




PubMed


 


PubMed ID 15009741
    
     


 



4.
Jiang JG, Tang JB, Chen CL, Liu BX, Fu XN, Zhu ZH, Qu W, Cianflone K, Waalkes MP, Wang DW (2004). Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas. World J Gastroenterol  10, 2168-73.   https://doi.org/10.3748/wjg.v10.i15.2168




PubMed



        
     
Free Article


 


PubMed ID 15259059
         Pubmed Central ID 4724986 


 



5.
Jiang Y, Liu J, Waalkes M, Kang YJ (2004). Changes in the gene expression associated with carbon tetrachloride-induced liver fibrosis persist after cessation of dosing in mice. Toxicol Sci  79, 404-10.   https://doi.org/10.1093/toxsci/kfh120




PubMed


 


PubMed ID 15056808
    
     


 



6.
Kowara R, Salnikow K, Diwan BA, Bare RM, Waalkes MP, Kasprzak KS (2004). Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas. Mol Cell Biochem  255, 195-202.   https://doi.org/10.1023/b:mcbi.0000007275.22785.91




PubMed


 


PubMed ID 14971660
    
     


 



7.
Lang JY, Chen H, Zhou J, Zhang YX, Zhang XW, Li MH, Lin LP, Zhang JS, Waalkes MP, Ding J (2005). Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway. Clin Cancer Res  11, 3455-64.   https://doi.org/10.1158/1078-0432.CCR-04-2026




PubMed


 


PubMed ID 15867248
    
     


 



8.
Leslie EM, Haimeur A, Waalkes MP (2004). Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem  279, 32700-8.   https://doi.org/10.1074/jbc.M404912200




PubMed


 


PubMed ID 15161912
    
     


 



9.
Liu J, Li C, Qu W, Leslie E, Bonifant CL, Buzard GS, Saavedra JE, Keefer LK, Waalkes MP (2004). Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol Cancer Ther  3, 709-14.




PubMed


 


PubMed ID 15210857
    
     


 



10.
Liu J, Qu W, Saavedra JE, Waalkes MP (2004). The nitric oxide donor, O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO), protects against cadmium-induced hepatotoxicity in mice. J Pharmacol Exp Ther  310, 18-24.   https://doi.org/10.1124/jpet.103.065003




PubMed


 


PubMed ID 15010501
    
     


 



11.
Liu J, Waalkes M (2005). Focal adhesion kinase as a potential target in arsenic toxicity. Toxicol Sci  84, 212-3.   https://doi.org/10.1093/toxsci/kfi111




PubMed


 


PubMed ID 15834968
    
     


 



12.
Liu J, Waalkes MP (2005). Nitric oxide and chemically induced hepatotoxicity: beneficial effects of the liver-selective nitric oxide donor, V-PYRRO/NO. Toxicology  208, 289-97.   https://doi.org/10.1016/j.tox.2004.11.017




PubMed


 


PubMed ID 15691592
    
     


 



13.
Liu J, Walker N, Waalkes MP (2004). Hybridization buffer systems impact the quality of filter array data. J Pharmacol Toxicol Methods  50, 67-71.   https://doi.org/10.1016/j.vascn.2004.02.001




PubMed


 


PubMed ID 15233970
    
     


 



14.
Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP (2004). Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci  77, 249-57.   https://doi.org/10.1093/toxsci/kfh055




PubMed


 


PubMed ID 14691202
    
     


 



15.
Pi J, He Y, Bortner C, Huang J, Liu J, Zhou T, Qu W, North SL, Kasprzak KS, Diwan BA, Chignell CF, Waalkes MP (2005). Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int J Cancer  116, 20-6.   https://doi.org/10.1002/ijc.20990




PubMed


 


PubMed ID 15756686
    
     


 



16.
Pi J, Yamauchi H, Sun G, Yoshida T, Aikawa H, Fujimoto W, Iso H, Cui R, Waalkes MP, Kumagai Y (2005). Vascular dysfunction in patients with chronic arsenosis can be reversed by reduction of arsenic exposure. Environ Health Perspect  113, 339-41.   https://doi.org/10.1289/ehp.7471




PubMed



        
     
Free Article


 


PubMed ID 15743725
         Pubmed Central ID 1253762 


 



17.
Qu W, Diwan BA, Reece JM, Bortner CD, Pi J, Liu J, Waalkes MP (2005). Cadmium-induced malignant transformation in rat liver cells: role of aberrant oncogene expression and minimal role of oxidative stress. Int J Cancer  114, 346-55.   https://doi.org/10.1002/ijc.20736




PubMed


 


PubMed ID 15551354
    
     


 



18.
Qu W, Liu J, Fuquay R, Shimoda R, Sakurai T, Saavedra JE, Keefer LK, Waalkes MP (2005). The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level. Nitric Oxide  12, 114-20.   https://doi.org/10.1016/j.niox.2005.01.005




PubMed


 


PubMed ID 15740985
    
     


 



19.
Sakurai T, Kojima C, Ochiai M, Ohta T, Sakurai MH, Waalkes MP, Fujiwara K (2004). Cellular glutathione prevents cytolethality of monomethylarsonic acid. Toxicol Appl Pharmacol  195, 129-41.   https://doi.org/10.1016/j.taap.2003.11.022




PubMed


 


PubMed ID 14998680
    
     


 



20.
Sakurai T, Ochiai M, Kojima C, Ohta T, Sakurai MH, Takada NO, Qu W, Waalkes MP, Fujiwara K (2004). Role of glutathione in dimethylarsinic acid-induced apoptosis. Toxicol Appl Pharmacol  198, 354-65.   https://doi.org/10.1016/j.taap.2003.10.015




PubMed


 


PubMed ID 15276415
    
     


 



21.
Shimada H, Takamure Y, Shimada A, Yasutake A, Waalkes MP, Imamura Y (2004). Strain differences of cadmium-induced hepatotoxicity in Wistar-Imamichi and Fischer 344 rats: involvement of cadmium accumulation. Toxicology  203, 189-97.   https://doi.org/10.1016/j.tox.2004.06.012




PubMed


 


PubMed ID 15363594
    
     


 



22.
Stauber AJ, Brown-Borg H, Liu J, Waalkes MP, Laughter A, Staben RA, Coley JC, Swanson C, Voss KA, Kopchick JJ, Corton JC (2005). Constitutive expression of peroxisome proliferator-activated receptor alpha-regulated genes in dwarf mice. Mol Pharmacol  67, 681-94.   https://doi.org/10.1124/mol.104.007278




PubMed


 


PubMed ID 15576629
    
     


 



23.
Waalkes M, Lamar P, Tokar E, Rivette A, DeOcampo D, Prozialeck W, Webber M   (2004) Human prostate cell lines mimic heterogeneity of cadherin expression in human prostate cancer.  UroOncology  pp.




 



24.
Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, Cheng ML, Diwan BA (2004). Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst  96, 466-74.   https://doi.org/10.1093/jnci/djh070




PubMed


 


PubMed ID 15026472
    
     


 



25.
Waalkes MP, Liu J, Goyer RA, Diwan BA (2004). Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Res  64, 7766-72.   https://doi.org/10.1158/0008-5472.CAN-04-2220




PubMed


 


PubMed ID 15520181
    
     


 



26.
Waalkes MP, Liu J, Kasprzak KS, Diwan BA (2004). Minimal influence of metallothionein over-expression on nickel carcinogenesis in mice. Toxicol Lett  153, 357-64.   https://doi.org/10.1016/j.toxlet.2004.06.003




PubMed


 


PubMed ID 15454311
    
     


 



27.
Waalkes MP, Liu J, Ward JM, Diwan BA (2004). Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol  198, 377-84.   https://doi.org/10.1016/j.taap.2003.10.028




PubMed


 


PubMed ID 15276417
    
     


 



28.
Waalkes MP, Liu J, Ward JM, Diwan BA (2004). Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology  198, 31-8.   https://doi.org/10.1016/j.tox.2004.01.017




PubMed


 


PubMed ID 15138027
    
     


 



29.
Waalkes MP, Ward JM, Diwan BA (2004). Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis  25, 133-41.   https://doi.org/10.1093/carcin/bgg181




PubMed


 


PubMed ID 14514661
    
     


 



30.
Wang AG, Xia T, Yuan J, Yu RA, Yang KD, Chen XM, Qu W, Waalkes MP (2004). Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro. Food Chem Toxicol  42, 1647-53.   https://doi.org/10.1016/j.fct.2004.05.010




PubMed


 


PubMed ID 15304311
    
     


 



31.
Xie Y, Liu J, Liu Y, Klaassen CD, Waalkes MP (2004). Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice. Mol Cell Biochem  255, 11-8.   https://doi.org/10.1023/b:mcbi.0000007256.44450.8c




PubMed


 


PubMed ID 14971641
    
     


 



32.
Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR (2004). Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect  112, 1255-63.   https://doi.org/10.1289/txg.7152




PubMed



        
     
Free Article


 


PubMed ID 15345372
         Pubmed Central ID 1277119 


 



33.
Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP (2004). Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol Appl Pharmacol  198, 291-6.   https://doi.org/10.1016/j.taap.2003.10.021




PubMed


 


PubMed ID 15276408
    
     


 



34.
Zhou T, Jia X, Chapin RE, Maronpot RR, Harris MW, Liu J, Waalkes MP, Eddy EM (2004). Cadmium at a non-toxic dose alters gene expression in mouse testes. Toxicol Lett  154, 191-200.   https://doi.org/10.1016/j.toxlet.2004.07.015




PubMed


 


PubMed ID 15501611",https://intramural.nih.gov/search/searchview.taf?ipid=37023
32,BC005522-18,"October 01, 2004 -  September 30, 2005",Role of Thyroid-Specific Enhancer-Binding Protein in Development and Homeostasis,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Sayuri  Hoshi



Reiko  Kuratoni",NULL,NULL,"Jerrold M Ward; DVM, PhD (NIAID)","Ordered by publication type and then author name.



1.
Daugherty BL, Mateescu M, Patel AS, Wade K, Kimura S, Gonzales LW, Guttentag S, Ballard PL, Koval M (2004). Developmental regulation of claudin localization by fetal alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol  287, L1266-73.   https://doi.org/10.1152/ajplung.00423.2003




PubMed


 


PubMed ID 15347569
    
     


 



2.
Kusakabe T, Kawaguchi A, Kawaguchi R, Feigenbaum L, Kimura S (2004). Thyrocyte-specific expression of Cre recombinase in transgenic mice. Genesis  39, 212-6.   https://doi.org/10.1002/gene.20043




PubMed


 


PubMed ID 15282748
    
     


 



3.
Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, Puelles L, Minoo P (2004). In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice. Gene  331, 73-82.   https://doi.org/10.1016/j.gene.2004.01.026




PubMed


 


PubMed ID 15094193
    
     


 



4.
Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, Arra C, Mansouri A, Kimura S, Di Lauro R, De Felice M (2004). An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol  276, 464-75.   https://doi.org/10.1016/j.ydbio.2004.08.048




PubMed


 


PubMed ID 15581879
    
     


 



5.
Shima Y, Zubair M, Ishihara S, Shinohara Y, Oka S, Kimura S, Okamoto S, Minokoshi Y, Suita S, Morohashi K (2005). Ventromedial hypothalamic nucleus-specific enhancer of Ad4BP/SF-1 gene. Mol Endocrinol  19, 2812-23.   https://doi.org/10.1210/me.2004-0431




PubMed


 


PubMed ID 15994202
    
     


 



6.
Ward JM, Nikolov NP, Tschetter JR, Kopp JB, Gonzalez FJ, Kimura S, Siegel RM (2004). Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice. Toxicol Pathol  32, 710-8.   https://doi.org/10.1080/01926230490885706




PubMed


 


PubMed ID 15580705",https://intramural.nih.gov/search/searchview.taf?ipid=37024
33,BC005536-19,"October 01, 2004 -  September 30, 2005",Basic and Applied Studies in Development of an AIDS Vaccine,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Mary K Aldrich



Thorsten  Demberg



Ruth  Florese



Megan Joy Heath



Rachmat  Hidajat



Jennifer Ruth Kalman



Show all 12","Susan  Barnett
(Chiron Corporation)




Barbara  Ensoli
(Istituto Superiore di Sanita)




Norman  Letvin
(Beth Israel Deaconess Medical Center)




David C.  Montefiori
(Duke University Medical Center)




Krishna K.  Murthy
(Southwest foundation for Biomedical Research)




Keith A.  Reimann
(Beth Israel Deaconess Medical Center)


Show all 9","William Gregory Alvord (Office Of The Director)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Gary J Nabel; MD, PhD (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)",George J Grimes (CC),"Ordered by publication type and then author name.



1.
Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M (2005). Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol  174, 2185-9.   https://doi.org/10.4049/jimmunol.174.4.2185




PubMed


 


PubMed ID 15699150
    
     


 



2.
Malkevitch N, Rohne D, Pinczewski J, Aldrich K, Kalyanaraman VS, Letvin NL, Robert-Guroff M (2004). Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques. AIDS Res Hum Retroviruses  20, 235-44.   https://doi.org/10.1089/088922204773004969




PubMed


 


PubMed ID 15018712
    
     


 



3.
Malkevitch NV, Robert-Guroff M (2004). A call for replicating vector prime-protein boost strategies in HIV vaccine design. Expert Rev Vaccines  3, S105-17.   https://doi.org/10.1586/14760584.3.4.s105




PubMed


 


PubMed ID 15285710
    
     


 



4.
Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M (2004). Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol  78, 2212-21.   https://doi.org/10.1128/jvi.78.5.2212-2221.2004




PubMed



        
     
Free Article


 


PubMed ID 14963117
         Pubmed Central ID 369221 


 



5.
Peng B, Wang LR, Gómez-Román VR, Davis-Warren A, Montefiori DC, Kalyanaraman VS, Venzon D, Zhao J, Kan E, Rowell TJ, Murthy KK, Srivastava I, Barnett SW, Robert-Guroff M (2005). Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies. J Virol  79, 10200-9.   https://doi.org/10.1128/JVI.79.16.10200-10209.2005




PubMed



        
     
Free Article


 


PubMed ID 16051813
         Pubmed Central ID 1182659 


 



6.
Pinczewski J, Zhao J, Malkevitch N, Patterson LJ, Aldrich K, Alvord WG, Robert-Guroff M (2005). Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE. Viral Immunol  18, 236-43.   https://doi.org/10.1089/vim.2005.18.236




PubMed


 


PubMed ID 15802969
    
     


 



7.
Robert-Guroff M, Peng B, Nan X   (2004) Live adenovirus recombinants as vaccine vectors.  New Generation Vaccines, 3rd Edition  pp.




 



8.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN (2005). DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol  79, 8480-92.   https://doi.org/10.1128/JVI.79.13.8480-8492.2005




PubMed



        
     
Free Article


 


PubMed ID 15956591
         Pubmed Central ID 1143718 


 



9.
Zhao J, Voltan R, Peng B, Davis-Warren A, Kalyanaraman VS, Alvord WG, Aldrich K, Bernasconi D, Buttò S, Cafaro A, Ensoli B, Robert-Guroff M (2005). Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. Virology  342, 1-12.   https://doi.org/10.1016/j.virol.2005.07.016




PubMed


 


PubMed ID 16109434",https://intramural.nih.gov/search/searchview.taf?ipid=37025
34,BC005548-18,"October 01, 2004 -  September 30, 2005",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,NULL,"Laboratory of Cell Biology, NCI","Hiroki  Inoue



Xiu-Fen  Liu



Razi  Raziuddin



Xiaozhen  Xie",NULL,Kyung  Lee; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Miki T   (2005) Involvement of Rho GTPases in cell division, in Signal Transduction of Cell Division. Miki T, ed., Research Signpost (Kerala), pp. 263-284.




 



2.
Miki T, Abe M, Inoue H, L-R Y, Veenstra T, Kang Y, Lee K   (2006) Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase.  Oncogene, in press.




 



3.
Miki T, Tatsumoto T, Lee K   (2006) Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.  Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37026
35,BC005553-36,"October 01, 2004 -  September 30, 2005",Biology of plasma cell tumor development,Stuart  Rudikoff; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mary E Heller



Janet  Pumphrey



Ya-Wei  Qiang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Qiang YW, Rudikoff S (2004). Wnt signaling in B and T lymphocytes. Front Biosci  9, 1000-10.   https://doi.org/10.2741/1309




PubMed


 


PubMed ID 14766426
    
     


 



2.
Qiang YW, Yao L, Tosato G, Rudikoff S (2004). Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood  103, 301-8.   https://doi.org/10.1182/blood-2003-06-2066




PubMed


 


PubMed ID 14504085",https://intramural.nih.gov/search/searchview.taf?ipid=37027
36,BC005561-18,"October 01, 2004 -  September 30, 2005",Liver-Enriched Transcription Factors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Sarbani  Giri



Shinji  Ito



Insook  Kim



Kristopher W Krausz



Xiaochao  Ma



Keiichirou  Morimura



Show all 9",NULL,"Jerrold M Ward; DVM, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res  64, 3849-54.   https://doi.org/10.1158/0008-5472.CAN-04-0322




PubMed


 


PubMed ID 15172993
    
     


 



2.
Gonzalez FJ (2005). Getting fat: two new players in molecular adipogenesis. Cell Metab  1, 85-6.   https://doi.org/10.1016/j.cmet.2005.01.004




PubMed


 


PubMed ID 16054047
    
     


 



3.
Guo GL, Moffit JS, Nicol CJ, Ward JM, Aleksunes LA, Slitt AL, Kliewer SA, Manautou JE, Gonzalez FJ (2004). Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci  82, 374-80.   https://doi.org/10.1093/toxsci/kfh286




PubMed


 


PubMed ID 15456926
    
     


 



4.
Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ (2004). Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem  279, 44740-8.   https://doi.org/10.1074/jbc.M405177200




PubMed


 


PubMed ID 15292250
    
     


 



5.
Kamiya A, Gonzalez FJ (2004). TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices. Hepatology  40, 527-36.   https://doi.org/10.1002/hep.20362




PubMed


 


PubMed ID 15349890
    
     


 



6.
Kamiya A, Inoue Y, Kodama T, Gonzalez FJ (2004). Hepatocyte nuclear factors 1alpha and 4alpha control expression of proline oxidase in adult liver. FEBS Lett  578, 63-8.   https://doi.org/10.1016/j.febslet.2004.10.070




PubMed


 


PubMed ID 15581617
    
     


 



7.
Matsusue K, Gavrilova O, Lambert G, Brewer HB, Ward JM, Inoue Y, LeRoith D, Gonzalez FJ (2004). Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol Endocrinol  18, 2751-64.   https://doi.org/10.1210/me.2004-0213




PubMed


 


PubMed ID 15319454",https://intramural.nih.gov/search/searchview.taf?ipid=37028
37,BC005562-18,"October 01, 2004 -  September 30, 2005",Xenobiotic-Metabolizing Enzymes,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Sarbani  Giri



Kristopher W Krausz



Xiaochao  Ma



Keiichirou  Morimura



Yatrik  Shah



Qian  Yang



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cheung C, Yu AM, Ward JM, Krausz KW, Akiyama TE, Feigenbaum L, Gonzalez FJ (2005). The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug Metab Dispos  33, 449-57.   https://doi.org/10.1124/dmd.104.002402




PubMed


 


PubMed ID 15576447
    
     


 



2.
Gonzalez FJ (2005). Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res  569, 101-10.   https://doi.org/10.1016/j.mrfmmm.2004.04.021




PubMed


 


PubMed ID 15603755
    
     


 



3.
Gonzalez FJ (2006). Role of beta-catenin in the adult liver. Hepatology  43, 650-3.   https://doi.org/10.1002/hep.21154




PubMed



        
     
Free Article


 


PubMed ID 16557535
         Pubmed Central ID 1440290 


 



4.
Ma X, Idle JR, Krausz KW, Gonzalez FJ (2005). Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos  33, 489-94.   https://doi.org/10.1124/dmd.104.002410




PubMed


 


PubMed ID 15616152
    
     


 



5.
Miksys SL, Cheung C, Gonzalez FJ, Tyndale RF (2005). Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model. Drug Metab Dispos  33, 1495-502.   https://doi.org/10.1124/dmd.105.005488




PubMed


 


PubMed ID 16033950
    
     


 



6.
Yu AM, Fukamachi K, Krausz KW, Cheung C, Gonzalez FJ (2005). Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology  146, 2911-9.   https://doi.org/10.1210/en.2004-1248




PubMed


 


PubMed ID 15817670
    
     


 



7.
Zhen Y, Slanar O, Krausz KW, Chen C, Slavík J, McPhail KL, Zabriskie TM, Perlík F, Gonzalez FJ, Idle JR (2006). 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio. Drug Metab Dispos  34, 1563-74.   https://doi.org/10.1124/dmd.105.008920




PubMed



        
     
Free Article


 


PubMed ID 16782768
         Pubmed Central ID 1553181",https://intramural.nih.gov/search/searchview.taf?ipid=37029
38,BC005596-36,"October 01, 2004 -  September 30, 2005",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,NULL,"Laboratory of Genetics, NCI","Gary M Jones



Elizabeth B Mushinski



Joseph P Nale",NULL,John J Letterio; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Potter M   (2004) Plasmacytoma models in mice In Bergsagel PL and Kuehl WM (eds).  Biology of Myeloma, Humana Press, Totowa, NJ, In Press .




 



2.
Potter M, Shaffer A, Kim J, duBois W, Staudt L, Janz S   (2005) Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice.  Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37030
39,BC005597-16,"October 01, 2004 -  September 30, 2005",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,"Michael  Maurizi; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Sarada  Viswanathan



Mark A Lies



Agnieszka  Szyk



Yang  Zhang","Bijan  Ahvazi; PhD
(NIAMS)




Ann  Ginsburg; PhD
(NHLBI)




Alasdair C Steven; PhD
(NIAMS)",NULL,NULL,"Ordered by publication type and then author name.



1.
Maurizi M, Dimitrova M, Ginsburg A   (2005) : Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX.  J. Biol. Chem.  pp.




 



2.
Maurizi M, Melnikov F, Rotanova E, Gustchina V, Wlodawer R   (2005) Crystal structure of the N-terminal domain of E coli Lon protease.  Protein Sci.  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37031
40,BC005598-16,"October 01, 2004 -  September 30, 2005",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Adorjan  Aszalos



Carol O Cardarelli



Benjamin F Chu



Kimberly L Jackson



Chava  Kimchi-Sarfaty



Joseph A Ludwig



Show all 13","Jacob  Hochman
(Institute of Medical Chemistry, Hebrew University)




Chava  Kimchi-Sarfaty
(Dept. of Cell and Animal Biology, FDA)




Ariella  Oppenheim; PhD
(Hebrew University-Hadassah Medical School)




Balazs  Sarkady
(Semmelweis Medical University)",Vincent J. Hearing; PhD (National Cancer Institute),"Kevin G Chen; MD (NINDS) 



Henry M. Fales; PhD (NHLBI) 



Richard D Leapman; PhD (OD)","Ordered by publication type and then author name.



1.
Annereau JP, Szakács G, Tucker CJ, Arciello A, Cardarelli C, Collins J, Grissom S, Zeeberg BR, Reinhold W, Weinstein JN, Pommier Y, Paules RS, Gottesman MM (2004). Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol  66, 1397-405.   https://doi.org/10.1124/mol.104.005009




PubMed


 


PubMed ID 15342794
    
     


 



2.
Liang XJ, Shen DW, Chen KG, Wincovitch SM, Garfield SH, Gottesman MM (2005). Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum. J Cell Physiol  202, 635-41.   https://doi.org/10.1002/jcp.20253




PubMed


 


PubMed ID 15546142
    
     


 



3.
Liang XJ, Shen DW, Gottesman MM (2004). Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells. Mol Pharmacol  65, 1217-24.   https://doi.org/10.1124/mol.65.5.1217




PubMed


 


PubMed ID 15102950
    
     


 



4.
Shen DW, Liang XJ, Gawinowicz MA, Gottesman MM (2004). Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Mol Pharmacol  66, 789-93.   https://doi.org/10.1124/mol.66.4.




PubMed


 


PubMed ID 15385639
    
     


 



5.
Shen DW, Su A, Liang XJ, Pai-Panandiker A, Gottesman MM (2004). Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells. Br J Cancer  91, 270-6.   https://doi.org/10.1038/sj.bjc.6601956




PubMed



        
     
Free Article


 


PubMed ID 15199393
         Pubmed Central ID 2409801 


 



6.
Szakács G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN, Gottesman MM (2004). Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell  6, 129-37.   https://doi.org/10.1016/j.ccr.2004.06.026




PubMed


 


PubMed ID 15324696",https://intramural.nih.gov/search/searchview.taf?ipid=37032
41,BC005599-15,"October 01, 2004 -  September 30, 2005","Tumor Suppressor Protein, p53","Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Jeong Kyu Bang



Oleg  Demidov



Toshiaki  Hara



Lisa Marie Jenkins



Sharlyn  Mazur; PhD



Giuseppina  Minopoli



Show all 9","Carl W.  Anderson
(Biology Dept., Brookhaven National Laboratory)




Dmitry  Bulavin





Larry  Donehower
(Baylor College of Medicine, Mol. Virol. & Microbiol)




Yang  Xu
( Biology Dept, University of California, San Diego)",Maria  Miller (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol  7, 165-71.   https://doi.org/10.1038/ncb1211




PubMed


 


PubMed ID 15619621
    
     


 



2.
Vidal B, Parra M, Jardí M, Saito S, Appella E, Muñoz-Cánoves P (2005). The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Thromb Haemost  93, 584-91.   https://doi.org/10.1160/TH04-10-0644




PubMed


 


PubMed ID 15735814
    
     


 



3.
Yamaguchi H, Minopoli G, Demidov ON, Chatterjee DK, Anderson CW, Durell SR, Appella E (2005). Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. Biochemistry  44, 5285-94.   https://doi.org/10.1021/bi0476634




PubMed


 


PubMed ID 15807522",https://intramural.nih.gov/search/searchview.taf?ipid=37033
42,BC005617-17,"October 01, 2004 -  September 30, 2005",Molecular mechanisms of resistance to TGF-beta signaling,Seong-Jin  Kim; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Kim G Baik



Yo-Han  Cho



Amy  Hobbie



Suntaek  Hong



Wook  Jin



Ki-Yong  Kim



Show all 9","Yung-Jue  Bang
(Cancer Research Institute, Seoul National University School of Medicine)




Kyeong Sook  Choi
(Institute for Medical Sciences, Ajou University School of Medicine)




Sanford  Markowitz
(Ireland Cancer Center, Case Western Reserve University School of Medicine)




Joseph  Murray
(Department of Gastroenterology, Mayo Clinic)




Paul S.  Oh
(Department of Physiology and Functional Genomics, University of Florida College of Medicine)




Poul  Sorensen
(Department of Pathology and Pediatrics, University British Columbia)",Steven  Libutti; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Birchenall-Roberts MC, Fu T, Bang OS, Dambach M, Resau JH, Sadowski CL, Bertolette DC, Lee HJ, Kim SJ, Ruscetti FW (2004). Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways. J Biol Chem  279, 25605-13.   https://doi.org/10.1074/jbc.M402790200




PubMed


 


PubMed ID 15066998
    
     


 



2.
Falanga V, Schrayer D, Cha J, Butmarc J, Carson P, Roberts AB, Kim SJ (2004). Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen  12, 320-6.   https://doi.org/10.1111/j.1067-1927.2004.012316.x




PubMed


 


PubMed ID 15225210
    
     


 



3.
Han SU, Kim HT, Seong DH, Kim YS, Park YS, Bang YJ, Yang HK, Kim SJ (2004). Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene  23, 1333-41.   https://doi.org/10.1038/sj.onc.1207259




PubMed


 


PubMed ID 14647420
    
     


 



4.
Ju EM, Choi KC, Hong SH, Lee CH, Kim BC, Kim SJ, Kim IH, Park SH (2005). Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt. Biochem Biophys Res Commun  328, 1170-81.   https://doi.org/10.1016/j.bbrc.2005.01.078




PubMed


 


PubMed ID 15708000
    
     


 



5.
Kibler KV, Miyazato A, Yedavalli VS, Dayton AI, Jacobs BL, Dapolito G, Kim SJ, Jeang KT (2004). Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. J Biol Chem  279, 49055-63.   https://doi.org/10.1074/jbc.M403394200




PubMed


 


PubMed ID 15371436
    
     


 



6.
Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ (2004). Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol  24, 2251-62.   https://doi.org/10.1128/mcb.24.6.2251-2262.2004




PubMed



        
     
Free Article


 


PubMed ID 14993265
         Pubmed Central ID 355855 


 



7.
Kim BC, van Gelder H, Kim TA, Lee HJ, Baik KG, Chun HH, Lee DA, Choi KS, Kim SJ (2004). Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. J Biol Chem  279, 28458-65.   https://doi.org/10.1074/jbc.M313277200




PubMed


 


PubMed ID 15107418
    
     


 



8.
Kim IY, Kim MM, Kim SJ (2005). Transforming growth factor-beta : biology and clinical relevance. J Biochem Mol Biol  38, 1-8.   https://doi.org/10.5483/bmbrep.2005.38.1.001




PubMed


 


PubMed ID 15715939
    
     


 



9.
Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim SJ, Morton RA (2004). Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene  23, 7651-9.   https://doi.org/10.1038/sj.onc.1207924




PubMed


 


PubMed ID 15354178
    
     


 



10.
Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ (2004). Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res  64, 7355-60.   https://doi.org/10.1158/0008-5472.CAN-04-0154




PubMed


 


PubMed ID 15492256
    
     


 



11.
Kim KY, Kim BC, Xu Z, Kim SJ (2004). Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells. J Biol Chem  279, 29478-84.   https://doi.org/10.1074/jbc.M313947200




PubMed


 


PubMed ID 15069087
    
     


 



12.
Lannon CL, Martin MJ, Tognon CE, Jin W, Kim SJ, Sorensen PH (2004). A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation. J Biol Chem  279, 6225-34.   https://doi.org/10.1074/jbc.M307388200




PubMed


 


PubMed ID 14668342
    
     


 



13.
Lee HJ, Lee JK, Miyake S, Kim SJ (2004). A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes. J Biol Chem  279, 2666-72.   https://doi.org/10.1074/jbc.M310591200




PubMed


 


PubMed ID 14612439
    
     


 



14.
Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T, Gress RE (2004). Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res  64, 6524-9.   https://doi.org/10.1158/0008-5472.CAN-04-0896




PubMed


 


PubMed ID 15374963
    
     


 



15.
Minguillón J, Morancho B, Kim SJ, López-Botet M, Aramburu J (2005). Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. J Leukoc Biol  77, 748-58.   https://doi.org/10.1189/jlb.0904503




PubMed


 


PubMed ID 15716327
    
     


 



16.
Park S, Lee YJ, Lee HJ, Seki T, Hong KH, Park J, Beppu H, Lim IK, Yoon JW, Li E, Kim SJ, Oh SP (2004). B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol  24, 10256-62.   https://doi.org/10.1128/MCB.24.23.10256-10262.2004




PubMed



        
     
Free Article


 


PubMed ID 15542835
         Pubmed Central ID 529031 


 



17.
Park SS, Eom YW, Kim EH, Lee JH, Min DS, Kim S, Kim SJ, Choi KS (2004). Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosis. Oncogene  23, 6272-81.   https://doi.org/10.1038/sj.onc.1207856




PubMed


 


PubMed ID 15208664
    
     


 



18.
Yoo BM, Oh TY, Kim YB, Yeo M, Lee JS, Surh YJ, Ahn BO, Kim WH, Sohn S, Kim JH, Hahm KB   (2005) Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model.  Pancreatology 5:165-76.




PubMed


 


PubMed ID 15849487
    
     


 



19.
Zhang Q, Rubenstein JN, Jang TL, Pins M, Javonovic B, Yang X, Kim SJ, Park I, Lee C (2005). Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). Mol Endocrinol  19, 2390-9.   https://doi.org/10.1210/me.2005-0096




PubMed


 


PubMed ID 15905358
    
     


 



20.
Zhang Q, Yang X, Pins M, Javonovic B, Kuzel T, Kim SJ, Parijs LV, Greenberg NM, Liu V, Guo Y, Lee C (2005). Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res  65, 1761-9.   https://doi.org/10.1158/0008-5472.CAN-04-3169




PubMed


 


PubMed ID 15753372",https://intramural.nih.gov/search/searchview.taf?ipid=37034
43,BC005643-15,"October 01, 2004 -  September 30, 2005",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI","Anjan  Guhathakurta; MSc, MTech",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37036
44,BC005645-16,"October 01, 2004 -  September 30, 2005",T-cell Transformation by Oncoviruses,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Vibeke  Andresen



Miroslav  Dundr



Risaku  Fukumoto



Jake R Fullen



Robyn  Parks



Valerio William Valeri","Patrick  Green
(Ohio State University)




Michael  Lairmore
(Ohio State University)","David  Derse; PhD (National Cancer Institute)



Larry  Samelson (National Cancer Institute)



Thomas A Misteli; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37037
45,BC005652-15,"October 01, 2004 -  September 30, 2005",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Bernard C Gerrard



Michael J Malasky



Mary  Mcnally



Shawn R Palmer



Julie  Sawitzke



Stefan Alexandrov Stefanov



Show all 12","Samuel  Broder
(Celera)




James  Lupski
(Baylor University)




Kenneth  Offitt
(Sloan Kettering)




Robert D Wells",NULL,NULL,"Ordered by publication type and then author name.



1.
Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D (2004). Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun  5, 505-12.   https://doi.org/10.1038/sj.gene.6364118




PubMed


 


PubMed ID 15306845
    
     


 



2.
Clark VJ, Dean M (2004). Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum Genomics  1, 255-73.   https://doi.org/10.1186/1479-7364-1-4-255




PubMed



        
     
Free Article


 


PubMed ID 15588486
         Pubmed Central ID 3525265 


 



3.
Dean M, Fivash M, Moody M, Lung M, Guo X, Stanbridge E, Voevoda M, Kashuba V, Zabarovsky E, Qian C, Godbole S, Tean B, Lerman M   (2004) Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p213: prevalence in Asian populations and analysis of assocaiation with nasopharyngeal cancer.  Mol. Cell Probes  pp.




 



4.
Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K (2004). Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res  64, 8891-900.   https://doi.org/10.1158/0008-5472.CAN-04-1256




PubMed


 


PubMed ID 15604249
    
     


 



5.
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, et al. [2 more authors] (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A  102, 7227-32.   https://doi.org/10.1073/pnas.0501536102




PubMed



        
     
Free Article


 


PubMed ID 15870199
         Pubmed Central ID 1088171 


 



6.
Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M, AMD Clinical Study Group (2006). Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med  38, 592-604.




PubMed



        
     
Free Article


 


PubMed ID 17438673
         Pubmed Central ID 1905836 


 



7.
Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, Hou LF, Berndt SI, Yadavalli S, Johnson CC, Hayes RB (2005). Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev  14, 152-7.




PubMed


 


PubMed ID 15668489
    
     


 



8.
Landi MT, Goldstein AM, Tsang S, Munroe D, Modi W, Ter-Minassian M, Steighner R, Dean M, Metheny N, Staats B, Agatep R, Hogg D, Calista D (2004). Genetic susceptibility in familial melanoma from northeastern Italy. J Med Genet  41, 557-66.   https://doi.org/10.1136/jmg.2003.016907




PubMed



        
     
Free Article


 


PubMed ID 15235029
         Pubmed Central ID 1735833 


 



9.
Ng D, Stavrou T, Liu L, Taylor MD, Gold B, Dean M, Kelley MJ, Dubovsky EC, Vezina G, Nicholson HS, Byrne J, Rutka JT, Hogg D, Reaman GH, Goldstein AM (2005). Retrospective family study of childhood medulloblastoma. Am J Med Genet A  134, 399-403.   https://doi.org/10.1002/ajmg.a.30653




PubMed


 


PubMed ID 15759260
    
     


 



10.
Song B, Gold B, O'Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M, Sodroski J (2005). The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol  79, 6111-21.   https://doi.org/10.1128/JVI.79.10.6111-6121.2005




PubMed



        
     
Free Article


 


PubMed ID 15857996
         Pubmed Central ID 1091705 


 



11.
Yang XR, Wacholder S, Xu Z, Dean M, Clark V, Gold B, Brown LM, Stone BJ, Fraumeni JF, Caporaso NE (2004). CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett  214, 197-204.   https://doi.org/10.1016/j.canlet.2004.06.040




PubMed


 


PubMed ID 15363546",https://intramural.nih.gov/search/searchview.taf?ipid=36978
46,BC005657-16,"October 01, 2004 -  September 30, 2005",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Joan L Cmarik



Charlotte A Hanson



Gordon R Macpherson



Tanya M Obreiter



Delores M Thompson","Mary  Carrington
(IRSP, SAIC-Frederick)




Paul  Hoffman
(University of Florida)




Marcel  Leist
(Dept. of Neuroscience and Neurology, H. Lundbeck A/S)




Michiaki  Masuda
(Dokkyo University, Japan)




Susan  Wilt
(VAMC, Bronx)","Michael I Lerman; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nishigaki K, Hanson C, Thompson D, Yugawa T, Ruscetti S (2005). Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells. J Virol  79, 12752-62.   https://doi.org/10.1128/JVI.79.20.12752-12762.2005




PubMed



        
     
Free Article


 


PubMed ID 16188978
         Pubmed Central ID 1235824 


 



2.
Rulli K, Yugawa T, Hanson C, Thompson D, Ruscetti S, Nishigaki K (2004). Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation. J Virol  78, 4573-81.   https://doi.org/10.1128/jvi.78.9.4573-4581.2004




PubMed



        
     
Free Article


 


PubMed ID 15078939
         Pubmed Central ID 387688",https://intramural.nih.gov/search/searchview.taf?ipid=37038
47,BC005673-15,"October 01, 2004 -  September 30, 2005",Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therap,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Michael Louis Citro



Keith M Davies



Frank  Derosa



Paul J Donovan



Michael M Goodblatt



Joseph A. Hrabie; PhD



Show all 12","Christian  Bogdan
(Universitat Freiburg, Institut fur Medizinische Mikrobiologie und Hygiene)




Scott  Bohle
(Department of Chemistry, McGill University)




Jeffrey  Deschamps
(Lab for the Structure of Matter, Naval Research Laboratory)




George J Grimes





Joseph  Ivanic
(Adv. Biomed. Computing Center, SAIC)




Mark  Meyerhoff
(Department of Chemistry, University of Michigan)


Show all 10","Michael  Waalkes; PhD (National Cancer Institute)



Jie  Liu (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



David Anderson Wink (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Keefer L   (2005) Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): Emerging commercial opportunities.  Current Topics Med Chem  pp.




 



2.
Keefer L, Citro M, Chmurny G   (2005) Carbon-bound diazeniumdiolates from the reaction of nitric oxide with amidines.  J Org Chem, in press.




 



3.
Keefer L, Fox S, Roman J, Issaq H, Falk R, Saavedra J, Ziegler R   (2005) Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry.  Anal Chem, in press.




 



4.
Keefer L, Katori T, Torres C, Thomas L, Ridnour L, McLendon W, Dutton A, Champion H, Mancardi D, Tocchetti C, Saavedra J, Houk K, Fukuto J, Kass D, Paolocci N, Wink D   (2005) Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo.  J Med Chem, in press.




 



5.
Keefer L, Saavedra J, Buzard G, Hood B, Conrads T, Veenstra T   (2005) Deamidation of peptides in aerobic nitric oxide solution by a nitrosative pathway.  Nitric Oxide: Biol Chem, in press.




 



6.
Keefer L, Saavedra J, Davies K, Citro M, Powell D, Grimes G, Potti G   (2005) Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug.  J Pharm Sci, in press.




 



7.
Qu W, Liu J, Fuquay R, Shimoda R, Sakurai T, Saavedra JE, Keefer LK, Waalkes MP (2005). The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level. Nitric Oxide  12, 114-20.   https://doi.org/10.1016/j.niox.2005.01.005




PubMed


 


PubMed ID 15740985
    
     


 



8.
Saavedra JE, Bohle DS, Smith KN, George C, Deschamps JR, Parrish D, Ivanic J, Wang YN, Citro ML, Keefer LK (2004). Chemistry of the diazeniumdiolates. O- versus N-alkylation of the RNH[N(O)NO](-) ion. J Am Chem Soc  126, 12880-7.   https://doi.org/10.1021/ja031538i




PubMed


 


PubMed ID 15469285
    
     


 



9.
Wang YN, Bohle DS, Bonifant CL, Chmurny GN, Collins JR, Davies KM, Deschamps J, Flippen-Anderson JL, Keefer LK, Klose JR, Saavedra JE, Waterhouse DJ, Ivanic J (2005). Chemistry of the diazeniumdiolates: Z right harpoon over left harpoon E isomerism. J Am Chem Soc  127, 5388-95.   https://doi.org/10.1021/ja042258l




PubMed


 


PubMed ID 15826177
    
     


 



10.
Hrabie JA, Keefer LA (submitted in 2005) Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates. Patents issued: 7,928,079 (US in 2011); 2006309212 (AU in 2012); 2,628,055 (CA in 2014). Patents pending: 06826062.9 (EP application); PCT/US2006/040456 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37039
48,BC005681-15,"October 01, 2004 -  September 30, 2005",Approaches to Gene Mapping Development and Applications,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Holli B Hutcheson



Bailey D Kessing



Michael J Malasky



Janice S Martenson



Mary  Mcnally



Shawn R Palmer



Show all 10",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, Hattangadi N, Lane B, Lohmueller K, Hafler D, Oksenberg J, Hauser S, Smith M, Altshuler D, Daly M, Reich D   (2004) Methods for high density admixture mapping of disease genes.  Am. J. Hum. Gen.  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37040
49,BC005688-15,"October 01, 2004 -  September 30, 2005",Preventive and therapeutic T cell vaccines to mitigate HIV-1 replication; Preven,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Janos  Nacsa



Robyn  Parks



Wen-Po  Tsai



Monica  Vaccari



Jean-Michel  Heraud","Michael R Betts





Mike  Bray
(NIAID)




Scott  Cairns
(NIAID)




Mark  Connors; MD





Daniel C Douek; MD





Hana  Golding
(FDA)


Show all 21","Crystal L. Mackall; MD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



Marjorie  Robert-Guroff; PhD (National Cancer Institute)","Vanessa  Hirsch (NIAID) 



Nancy R Miller (NIAID)","Ordered by publication type and then author name.



1.
Edghill-Smith Y, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J, King LR, Robert-Guroff M, Hryniewicz A, Venzon D, Meseda C, Weir J, Nalca A, Livingston V, Wells J, Lewis MG, Huggins J, Zwiers SH, Golding H, Franchini G (2005). Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis  191, 372-81.   https://doi.org/10.1086/427265




PubMed


 


PubMed ID 15633096
    
     


 



2.
Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, Reimann KA, Franchini G (2005). Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med  11, 740-7.   https://doi.org/10.1038/nm1261




PubMed


 


PubMed ID 15951823
    
     


 



3.
Nacsa J, Edghill-Smith Y, Tsai WP, Venzon D, Tryniszewska E, Hryniewicz A, Moniuszko M, Kinter A, Smith KA, Franchini G (2005). Contrasting effects of low-dose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251. J Immunol  174, 1913-21.   https://doi.org/10.4049/jimmunol.174.4.1913




PubMed


 


PubMed ID 15699118",https://intramural.nih.gov/search/searchview.taf?ipid=37041
50,BC005691-14,"October 01, 2004 -  September 30, 2005",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Kathleen M Dohoney



Michael  Radonovich",NULL,"Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)","Jay H Chung; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Brady J, Jeong S, Jeong J, Chung J   (2005) Human T-Cell leukemia virus type I Tax attenuates γ-irradiation induced apoptosis through physical interaction with Chk2.  Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37042
51,BC005708-14,"October 01, 2004 -  September 30, 2005",Xenobiotic Receptors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Sarbani  Giri



Shinji  Ito



Insook  Kim



Kristopher W Krausz



Xiaochao  Ma



Keiichirou  Morimura



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res  64, 3849-54.   https://doi.org/10.1158/0008-5472.CAN-04-0322




PubMed


 


PubMed ID 15172993
    
     


 



2.
Guo GL, Santamarina-Fojo S, Akiyama TE, Amar MJ, Paigen BJ, Brewer B, Gonzalez FJ (2006). Effects of FXR in foam-cell formation and atherosclerosis development. Biochim Biophys Acta  1761, 1401-9.   https://doi.org/10.1016/j.bbalip.2006.09.018




PubMed



        
     
Free Article


 


PubMed ID 17110163
         Pubmed Central ID 1751860 


 



3.
Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ (2007). Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis  28, 940-6.   https://doi.org/10.1093/carcin/bgl249




PubMed



        
     
Free Article


 


PubMed ID 17183066
         Pubmed Central ID 1858639 


 



4.
Nicol CJ, Adachi M, Akiyama TE, Gonzalez FJ (2005). PPARgamma in endothelial cells influences high fat diet-induced hypertension. Am J Hypertens  18, 549-56.   https://doi.org/10.1016/j.amjhyper.2004.10.032




PubMed


 


PubMed ID 15831367
    
     


 



5.
Peters JM, Cheung C, Gonzalez FJ (2005). Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? J Mol Med (Berl)  83, 774-85.   https://doi.org/10.1007/s00109-005-0678-9




PubMed


 


PubMed ID 15976920
    
     


 



6.
Yim SH, Shah Y, Tomita S, Morris HD, Gavrilova O, Lambert G, Ward JM, Gonzalez FJ (2006). Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice. Hepatology  44, 550-60.   https://doi.org/10.1002/hep.21284




PubMed



        
     
Free Article


 


PubMed ID 16941684
         Pubmed Central ID 1559728",https://intramural.nih.gov/search/searchview.taf?ipid=37043
52,BC005725-13,"October 01, 2004 -  September 30, 2005",ABC Transporters in Human Disease and Multidrug Resistance,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Elena  Postnikova



Stefan Alexandrov Stefanov



Zhang-Qun  Chen



Julie A Costantino



Bernard C Gerrard



Mark  Scally



Show all 9",NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)","Alan T Remaley; MD, PhD (CC)","Ordered by publication type and then author name.



1.
Annilo T, Dean M (2004). Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics  84, 34-46.   https://doi.org/10.1016/j.ygeno.2004.02.010




PubMed


 


PubMed ID 15203202
    
     


 



2.
Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM (2005). ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med  172, 1026-31.   https://doi.org/10.1164/rccm.200503-504OC




PubMed



        
     
Free Article


 


PubMed ID 15976379
         Pubmed Central ID 1403838 


 



3.
Chen ZQ, Annilo T, Shulenin S, Dean M (2004). Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse Chromosome 7F3. Mamm Genome  15, 335-43.   https://doi.org/10.1007/s00335-004-2281-8




PubMed


 


PubMed ID 15170222
    
     


 



4.
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, et al. [2 more authors] (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A  102, 7227-32.   https://doi.org/10.1073/pnas.0501536102




PubMed



        
     
Free Article


 


PubMed ID 15870199
         Pubmed Central ID 1088171 


 



5.
Ogino S, Wilson R, Gold B, Hawley P, Grody W   (2004) Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.  Genet. Med  pp.




 



6.
Polgar O, Robey RW, Morisaki K, Dean M, Michejda C, Sauna ZE, Ambudkar SV, Tarasova N, Bates SE (2004). Mutational analysis of ABCG2: role of the GXXXG motif. Biochemistry  43, 9448-56.   https://doi.org/10.1021/bi0497953




PubMed


 


PubMed ID 15260487
    
     


 



7.
Potocnik U, Ferkolj I, Glavac D, Dean M (2004). Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun  5, 530-9.   https://doi.org/10.1038/sj.gene.6364123




PubMed


 


PubMed ID 15505619
    
     


 



8.
Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M (2004). ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med  350, 1296-303.   https://doi.org/10.1056/NEJMoa032178




PubMed


 


PubMed ID 15044640
    
     


 



9.
Tarnay JN, Szeri F, Iliás A, Annilo T, Sung C, Le Saux O, Váradi A, Dean M, Boyd CD, Robinow S (2004). The dMRP/CG6214 gene of Drosophila is evolutionarily and functionally related to the human multidrug resistance-associated protein family. Insect Mol Biol  13, 539-48.   https://doi.org/10.1111/j.0962-1075.2004.00512.x




PubMed


 


PubMed ID 15373810",https://intramural.nih.gov/search/searchview.taf?ipid=36979
53,BC005740-13,"October 01, 2004 -  September 30, 2005",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Dalit  Barkan



Jung-Im  Huh



Zi-yao  Liu



Quang T Nguyen



Ting-Hu  Qiu



Mark  Hoenerhoff; DVM, PhD



Show all 7","Maarten  Bosland
(NYU)




Alfonso  Calvo
(University of Pamplona)




Ann  Chambers
(London Regional Cancer Center)




Chuxia  Deng; PhD
(NIDDK)




Hynda K Kleinman; PhD
(NIDCR)




Eva  Lee
(UC Irvine)


Show all 7","Karl Thomas Ried; MD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)



Ilona  Linnoila; MD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Dolph Lee Hatfield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Green J   (2005) Breast cancer: insights from DNA microarrays, in Drug Resistance in Malignant Disease. Teicher B, ed., Humana Press (NJ), in press.




 



2.
Green J, Montagna C, Ried T   (2004) Mammary Gland Cancer, in Mouse Models of Human Cancer. Holland E, ed., Wiley (NY), pp. 103-131.




 



3.
Green J, Steele V, You M   (2005) potential use of transgenic mice in chemoprevention studies, in Cancer Chemoprevention. Humana Press (NJ), in press.




 



4.
Calvo A, Gonzalez-Moreno O, Yoon CY, Huh JI, Desai K, Nguyen QT, Green JE (2005). Prostate cancer and the genomic revolution: Advances using microarray analyses. Mutat Res  576, 66-79.   https://doi.org/10.1016/j.mrfmmm.2004.08.019




PubMed


 


PubMed ID 15950992
    
     


 



5.
Come SE, Buzdar AU, Arteaga CL, Bissell MJ, Brown MA, Ellis MJ, Goss PE, Green JE, Ingle JN, Lee AV, Medina D, Nicholson RI, Santen RJ, Schiff R, Hart CS (2004). Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement. Clin Cancer Res  10, 327S-330S.   https://doi.org/10.1158/1078-0432.ccr-031213




PubMed


 


PubMed ID 14734487
    
     


 



6.
Desai KV, Michalowska AM, Kondaiah P, Ward JM, Shih JH, Green JE (2004). Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Mol Endocrinol  18, 2895-907.   https://doi.org/10.1210/me.2004-0033




PubMed


 


PubMed ID 15358834
    
     


 



7.
Green J, Calvo A, Joshi B, Abasolo I, Wang A, Montuenga L, Puri R   (2006) Gene expression profiling identifities IL-3 receptor alpha2 chani as a therapeutic target in prostate tumor cells over-expression adrenomedullin.  Int. J. Cancer .




 



8.
Green JE, Desai K, Ye Y, Kavanaugh C, Calvo A, Huh JI (2004). Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy. Clin Cancer Res  10, 385S-90S.   https://doi.org/10.1158/1078-0432.ccr-031201




PubMed


 


PubMed ID 14734496
    
     


 



9.
Green JE, Desai KV, Ye Y, Kavanaugh C, Calvo A, Huh JI (2004). Application of gene expression profiling for validating models of human breast cancer. Toxicol Pathol  32 Suppl 1, 84-9.   https://doi.org/10.1080/01926230490424897




PubMed


 


PubMed ID 15209407
    
     


 



10.
Green JE, Hudson T (2005). The promise of genetically engineered mice for cancer prevention studies. Nat Rev Cancer  5, 184-98.   https://doi.org/10.1038/nrc1565




PubMed


 


PubMed ID 15738982
    
     


 



11.
Gupta V, Carey JL, Kawakubo H, Muzikansky A, Green JE, Donahoe PK, MacLaughlin DT, Maheswaran S (2005). Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. Proc Natl Acad Sci U S A  102, 3219-24.   https://doi.org/10.1073/pnas.0409709102




PubMed



        
     
Free Article


 


PubMed ID 15728372
         Pubmed Central ID 552936 


 



12.
Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE (2005). Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene  24, 790-800.   https://doi.org/10.1038/sj.onc.1208221




PubMed


 


PubMed ID 15592523
    
     


 



13.
Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S (2004). Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene  23, 8310-9.   https://doi.org/10.1038/sj.onc.1208008




PubMed


 


PubMed ID 15378000
    
     


 



14.
Moody TW, Dudek J, Zakowicz H, Walters J, Jensen RT, Petricoin E, Couldrey C, Green JE (2004). VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice. Life Sci  74, 1345-57.   https://doi.org/10.1016/j.lfs.2003.07.043




PubMed


 


PubMed ID 14706566
    
     


 



15.
Petersen D, Chandramouli GV, Geoghegan J, Hilburn J, Paarlberg J, Kim CH, Munroe D, Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki ES (2005). Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics  6, 63.   https://doi.org/10.1186/1471-2164-6-63




PubMed



        
     
Free Article


 


PubMed ID 15876355
         Pubmed Central ID 1140753 


 



16.
Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET (2004). Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res  64, 5973-81.   https://doi.org/10.1158/0008-5472.CAN-04-0242




PubMed


 


PubMed ID 15342376
    
     


 



17.
Shih JH, Michalowska AM, Dobbin K, Ye Y, Qiu TH, Green JE (2004). Effects of pooling mRNA in microarray class comparisons. Bioinformatics  20, 3318-25.   https://doi.org/10.1093/bioinformatics/bth391




PubMed


 


PubMed ID 15247103
    
     


 



18.
Utomo A, Jiang X, Furuta S, Yun J, Levin DS, Wang YC, Desai KV, Green JE, Chen PL, Lee WH (2004). Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J Biol Chem  279, 43522-9.   https://doi.org/10.1074/jbc.M407141200




PubMed


 


PubMed ID 15294905
    
     


 



19.
Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG, Swanson SM (2005). Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology  146, 5188-96.   https://doi.org/10.1210/en.2005-0607




PubMed


 


PubMed ID 16141391
    
     


 



20.
Ye Y, Qiu TH, Kavanaugh C, Green JE (2004). Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling. Breast Dis  19, 69-82.   https://doi.org/10.3233/bd-2004-19109




PubMed


 


PubMed ID 15687699",https://intramural.nih.gov/search/searchview.taf?ipid=37044
54,BC005748-13,"October 01, 2004 -  September 30, 2005",Acquisition of Genomic Alterations During Mammary Gland Cancer Induction in Rats,Elizabeth  Snyderwine; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Kara R Jones



Andriana  Papaconstantinou



Cunping  Qiu



Ilanchezhian  Shanmugam



Minshu R Yu","Herman  Schut
(Dept. Pathol., Med College of Ohio)




Liang  Shan",Insa S Schroeder (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Papaconstantinou AD, Shanmugam I, Shan L, Schroeder IS, Qiu C, Yu M, Snyderwine EG (2006). Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene. Int J Cancer  118, 17-24.   https://doi.org/10.1002/ijc.21247




PubMed


 


PubMed ID 16003757
    
     


 



2.
Shan L, Yu M, Schut HA, Snyderwine EG (2004). Susceptibility of rats to mammary gland carcinogenesis by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) varies with age and is associated with the induction of differential gene expression. Am J Pathol  165, 191-202.   https://doi.org/10.1016/S0002-9440(10)63288-9




PubMed



        
     
Free Article


 


PubMed ID 15215175
         Pubmed Central ID 1618529",https://intramural.nih.gov/search/searchview.taf?ipid=37047
55,BC005753-13,"October 01, 2004 -  September 30, 2005",HIV Tat Transcriptional Activation,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Meisheng  Zhou,"Fatah  Kashanchi
(Department of Biochemistry, George Washington University Medical School)




Ajit  Kumar
(Dept. of Biochemistry, George Washington University Medical School)




Nekhai  Sergei
(Center for Sickle Cell Disease, Howard University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37048
56,BC005785-11,"October 01, 2004 -  September 30, 2005",TGF-betas in breast cancer progression,"Lalage  Wakefield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Mi-Jin  Kang



Ethan  Kohn



Jeong-Seok  Nam



Binwu  Tang



Naomi  Yoo



Catherine  Hooke","Erwin  Bottinger
(Dept. of Medicine, Mount Sinai School of Medicine)




Scott  Lonning
(Gene Therapy, Genzyme Corp.)




Fred  Miller; MD
(Food and Drug Administration)




Jan  Pinkas
(PreClinical Tumor Biology, Genzyme Corp.)","Miriam R Anver (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37049
57,BC005793-11,"October 01, 2004 -  September 30, 2005",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Marshonna J Forgues



Mi Jung  Lim



Wei  Wang; PhD



Chuan-Ging  Wu



Anuradha Samantha Budhu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Budhu AS, Wang XW (2005). Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1. Cell Cycle  4, 1510-4.   https://doi.org/10.4161/cc.4.11.2187




PubMed



        
     
Free Article


 


PubMed ID 16294017
         Pubmed Central ID 1402358 


 



2.
Lim MJ, Wang XW (2006). Nucleophosmin and human cancer. Cancer Detect Prev  30, 481-90.   https://doi.org/10.1016/j.cdp.2006.10.008




PubMed



        
     
Free Article


 


PubMed ID 17113241
         Pubmed Central ID 1853269 


 



3.
Wang W, Budhu A, Forgues M, Wang XW (2005). Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol  7, 823-30.   https://doi.org/10.1038/ncb1282




PubMed


 


PubMed ID 16041368
    
     


 



4.
Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A, Hamburger AW (2005). The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci U S A  102, 9890-5.   https://doi.org/10.1073/pnas.0503829102




PubMed



        
     
Free Article


 


PubMed ID 15994225
         Pubmed Central ID 1175001",https://intramural.nih.gov/search/searchview.taf?ipid=37051
58,BC005795-11,"October 01, 2004 -  September 30, 2005",p53 Tumor Suppressor Pathway,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Yalda  Afshar



Kaori  Fujita



Sharon R Pine



Masahiro  Seike



Motoko  Unoki



John  Bradsher



Show all 15","J.  Egly
(Universite Louis Pasteur, Strasbourg, France)




I.  Hickson
(Imperial Cancer Research Fund Laboratories, Oxford, UK)




V.  Rotter
(Weizman Institute of Science)




M.  Rusin
(Maria-Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland, Institute of Oncology)




J.  Yokota
(National Cancer Center Research Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hofseth LJ, Hussain SP, Harris CC (2004). p53: 25 years after its discovery. Trends Pharmacol Sci  25, 177-81.   https://doi.org/10.1016/j.tips.2004.02.009




PubMed


 


PubMed ID 15116721
    
     


 



2.
Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X, Kalis M, Kogan I, Buganim Y, Goldfinger N, Ginsberg D, Harris CC, Domany E, Rotter V (2005). Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res  65, 4530-43.   https://doi.org/10.1158/0008-5472.CAN-04-3880




PubMed


 


PubMed ID 15930270
    
     


 



3.
Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, Kumamoto K, Wincovitch S, Garfield SH, McMenamin M, Nagashima M, Grossman SR, Appella E, Harris CC (2005). ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol  25, 6639-48.   https://doi.org/10.1128/MCB.25.15.6639-6648.2005




PubMed



        
     
Free Article


 


PubMed ID 16024799
         Pubmed Central ID 1190357 


 



4.
Sengupta S, Harris CC (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol  6, 44-55.   https://doi.org/10.1038/nrm1546




PubMed


 


PubMed ID 15688066
    
     


 



5.
Sengupta S, Robles AI, Linke SP, Sinogeeva NI, Zhang R, Pedeux R, Ward IM, Celeste A, Nussenzweig A, Chen J, Halazonetis TD, Harris CC (2004). Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol  166, 801-13.   https://doi.org/10.1083/jcb.200405128




PubMed



        
     
Free Article


 


PubMed ID 15364958
         Pubmed Central ID 2172115 


 



6.
Sengupta S, Shimamoto A, Koshiji M, Pedeux R, Rusin M, Spillare EA, Shen JC, Huang LE, Lindor NM, Furuichi Y, Harris CC (2005). Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene  24, 1738-48.   https://doi.org/10.1038/sj.onc.1208380




PubMed


 


PubMed ID 15674334
    
     


 



7.
Sommers JA, Sharma S, Doherty KM, Karmakar P, Yang Q, Kenny MK, Harris CC, Brosh RM (2005). p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res  65, 1223-33.   https://doi.org/10.1158/0008-5472.CAN-03-0231




PubMed


 


PubMed ID 15735006
    
     


 



8.
Spillare EA, Wang XW, von Kobbe C, Bohr VA, Hickson ID, Harris CC (2006). Redundancy of DNA helicases in p53-mediated apoptosis. Oncogene  25, 2119-23.   https://doi.org/10.1038/sj.onc.1209242




PubMed



        
     
Free Article


 


PubMed ID 16288211
         Pubmed Central ID 1420682 


 



9.
Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC (2005). The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res  65, 10255-64.   https://doi.org/10.1158/0008-5472.CAN-05-1714




PubMed



        
     
Free Article


 


PubMed ID 16288013
         Pubmed Central ID 1421332 


 



10.
Yang Q, Zhang R, Wang XW, Linke SP, Sengupta S, Hickson ID, Pedrazzi G, Perrera C, Stagljar I, Littman SJ, Modrich P, Harris CC (2004). The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase. Oncogene  23, 3749-56.   https://doi.org/10.1038/sj.onc.1207462




PubMed


 


PubMed ID 15064730
    
     


 



11.
Yang Q, Zheng YL, Harris CC (2005). POT1 and TRF2 cooperate to maintain telomeric integrity. Mol Cell Biol  25, 1070-80.   https://doi.org/10.1128/MCB.25.3.1070-1080.2005




PubMed



        
     
Free Article


 


PubMed ID 15657433
         Pubmed Central ID 544002 


 



12.
Zhang R, Sengupta S, Yang Q, Linke SP, Yanaihara N, Bradsher J, Blais V, McGowan CH, Harris CC (2005). BLM helicase facilitates Mus81 endonuclease activity in human cells. Cancer Res  65, 2526-31.   https://doi.org/10.1158/0008-5472.CAN-04-2421




PubMed


 


PubMed ID 15805243",https://intramural.nih.gov/search/searchview.taf?ipid=37052
59,BC005800-11,"October 01, 2004 -  September 30, 2005",Discovering Disease Susceptibility Genes in African Americans,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Yvette  Berthier-Schaad



Joanne  Clarke



Kristine C Cruz



Taras K Oleksyk



Mary A Thompson



Ann  Truelove



Show all 7","Lind  Kao
(Johns Hopkins University)




Mike  Klag
(Johns Hopkins University)




Nick  Patterson
(Broad Institute/MIT)




David  Reich
(Harvard University)




David  Thomas
(Johns Hopkins University)",NULL,Jeffrey Burnett Kopp; MD (NIDDK),"Ordered by publication type and then author name.



1.
Smith MW, O'Brien SJ (2005). Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet  6, 623-32.   https://doi.org/10.1038/nrg1657




PubMed


 


PubMed ID 16012528
    
     


 



2.
Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, et al. [7 more authors] (2004). A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet  74, 1001-13.   https://doi.org/10.1086/420856




PubMed



        
     
Free Article


 


PubMed ID 15088270
         Pubmed Central ID 1181963",https://intramural.nih.gov/search/searchview.taf?ipid=37053
60,BC006140-29,"October 01, 2004 -  September 30, 2005",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,"William M Bonner; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Asako  Nakamura



Christophe  Redon



Olga A Sedelnikova; PhD","David  Brenner
(Columbia University)




Olga  Kovalchuk
(Department of Biological Sciences, University of Lethbridge)




Igor  Panyutin
(NUCLEAR MEDICINE DEPT, CC)","Nicolae C Popescu; PhD (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bonner W, Pilch D   (2004) Genetic analysis of Saccharomyces cerevisiae H2A serine 129 mutant suggests a functional relationship between H2A and the sister chromatid cohesion partners Csm3-Tof1 for the repair of Topoisomerase I-induced DNA damage.  Genetics, in press.




 



2.
Bonner W, Sedelnikova O, Redon C, Pilch D, Sinogeeva N, Shroff R, Lichten M   (2006) Techniques for γ-H2AX detection.  Methods in Enzymology, in press.




 



3.
Bonner W, Smilenov L, Hall E, Panyutin I, Sedelnikova O   (2005) Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts.  Oncogene, in press.




 



4.
Bonner WM (2004). Phenomena leading to cell survival values which deviate from linear-quadratic models. Mutat Res  568, 33-9.   https://doi.org/10.1016/j.mrfmmm.2004.06.044




PubMed


 


PubMed ID 15530537
    
     


 



5.
Pilch DR, Redon C, Sedelnikova OA, Bonner WM (2004). Two-dimensional gel analysis of histones and other H2AX-related methods. Methods Enzymol  375, 76-88.   https://doi.org/10.1016/s0076-6879(03)75005-8




PubMed


 


PubMed ID 14870660
    
     


 



6.
Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC (2004). Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol  6, 168-70.   https://doi.org/10.1038/ncb1095




PubMed


 


PubMed ID 14755273
    
     


 



7.
Sedelnikova OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG (2004). Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells. Int J Radiat Biol  80, 927-31.   https://doi.org/10.1080/09553000400017648




PubMed


 


PubMed ID 15764404
    
     


 



8.
Shroff R, Arbel-Eden A, Pilch D, Ira G, Bonner WM, Petrini JH, Haber JE, Lichten M (2004). Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr Biol  14, 1703-11.   https://doi.org/10.1016/j.cub.2004.09.047




PubMed



        
     
Free Article


 


PubMed ID 15458641
         Pubmed Central ID 4493763",https://intramural.nih.gov/search/searchview.taf?ipid=37054
61,BC006150-24,"October 01, 2004 -  September 30, 2005","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs","Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Keli  Agama



Smitha  Antony



Andrew  Jobson



Christophe  Marchand



Ling-Hua  Meng



Ze-Hong  Miao



Show all 9",NULL,"Kenneth H Kraemer; MD (National Cancer Institute)



Dominic  Scudiero (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aladjem MI, Pasa S, Parodi S, Weinstein JN, Pommier Y, Kohn KW (2004). Molecular interaction maps--a diagrammatic graphical language for bioregulatory networks. Sci STKE  2004, pe8.   https://doi.org/10.1126/stke.2222004pe8




PubMed


 


PubMed ID 14997004
    
     


 



2.
Antony S, Kohlhagen G, Agama K, Jayaraman M, Cao S, Durrani FA, Rustum YM, Cushman M, Pommier Y (2005). Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Mol Pharmacol  67, 523-30.   https://doi.org/10.1124/mol.104.003889




PubMed


 


PubMed ID 15531731
    
     


 



3.
Farrell N, Povirk LF, Dange Y, DeMasters G, Gupta MS, Kohlhagen G, Khan QA, Pommier Y, Gewirtz DA (2004). Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells. Biochem Pharmacol  68, 857-66.   https://doi.org/10.1016/j.bcp.2004.05.023




PubMed


 


PubMed ID 15294448
    
     


 



4.
Kohn KW, Pommier Y (2005). Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem Biophys Res Commun  331, 816-27.   https://doi.org/10.1016/j.bbrc.2005.03.186




PubMed


 


PubMed ID 15865937
    
     


 



5.
Kohn KW, Riss J, Aprelikova O, Weinstein JN, Pommier Y, Barrett JC (2004). Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Mol Biol Cell  15, 3042-52.   https://doi.org/10.1091/mbc.e03-12-0897




PubMed



        
     
Free Article


 


PubMed ID 15107465
         Pubmed Central ID 452562 


 



6.
Liao ZY, Sordet O, Zhang HL, Kohlhagen G, Antony S, Gmeiner WH, Pommier Y (2005). A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes. Cancer Res  65, 4844-51.   https://doi.org/10.1158/0008-5472.CAN-04-1302




PubMed


 


PubMed ID 15930305
    
     


 



7.
Meng LH, Kohlhagen G, Liao ZY, Antony S, Sausville E, Pommier Y (2005). DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells. Cancer Res  65, 5337-43.   https://doi.org/10.1158/0008-5472.CAN-05-0003




PubMed


 


PubMed ID 15958581
    
     


 



8.
Meng LH, Zhang H, Hayward L, Takemura H, Shao RG, Pommier Y (2004). Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res  64, 9086-92.   https://doi.org/10.1158/0008-5472.CAN-04-0313




PubMed


 


PubMed ID 15604277
    
     


 



9.
Mertins SD, Myers TG, Holbeck SL, Medina-Perez W, Wang E, Kohlhagen G, Pommier Y, Bates SE (2004). In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity. Mol Cancer Ther  3, 849-60.




PubMed


 


PubMed ID 15252146
    
     


 



10.
Pommier Y, Antony S, Kohlhagen S, Meng L, Agama K, Stinson S, Sausville E   (2005) Antitumor drug candidate 2-(4-amino-3-methylphenyl0-5-fluorobenzothiazole induces single-strand breaks and DNA-protein crosslinks in sensitive MCF-7 breast cancer cells.  Cancer Chemotherapy Pharmacol.  pp.




 



11.
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene  23, 2934-49.   https://doi.org/10.1038/sj.onc.1207515




PubMed


 


PubMed ID 15077155
    
     


 



12.
Pommier Y, Sordet O, Rao VA, Zhang H, Kohn KW (2005). Targeting chk2 kinase: molecular interaction maps and therapeutic rationale. Curr Pharm Des  11, 2855-72.   https://doi.org/10.2174/1381612054546716




PubMed


 


PubMed ID 16101442
    
     


 



13.
Shao RG, Cao CX, Pommier Y (2004). Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells. Acta Pharmacol Sin  25, 756-62.




PubMed


 


PubMed ID 15169628
    
     


 



14.
Sordet O, Khan QA, Plo I, Pourquier P, Urasaki Y, Yoshida A, Antony S, Kohlhagen G, Solary E, Saparbaev M, Laval J, Pommier Y (2004). Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals. J Biol Chem  279, 50499-504.   https://doi.org/10.1074/jbc.M410277200




PubMed


 


PubMed ID 15448130
    
     


 



15.
Sordet O, Khan QA, Pommier Y (2004). Apoptotic topoisomerase I-DNA complexes induced by oxygen radicals and mitochondrial dysfunction. Cell Cycle  3, 1095-7.




PubMed


 


PubMed ID 15326388
    
     


 



16.
Sordet O, Liao Z, Liu H, Antony S, Stevens EV, Kohlhagen G, Fu H, Pommier Y (2004). Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis. J Biol Chem  279, 33968-75.   https://doi.org/10.1074/jbc.M404620200




PubMed


 


PubMed ID 15178684
    
     


 



17.
Xiao X, Miao ZH, Antony S, Pommier Y, Cushman M (2005). Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines. Bioorg Med Chem Lett  15, 2795-8.   https://doi.org/10.1016/j.bmcl.2005.03.101




PubMed


 


PubMed ID 15911256
    
     


 



18.
Pommier Y, Cardellina J, Currens M, Jobson A, Scudiero D, Shoemaker R (submitted in 2005) Use Of Chk2 Kinase Inhibitors For Cancer Treatment. Patents issued: 602006040537 (DE in 2014); 1912635 (EP in 2014); 1912635 (FR in 2014); 1912635 (GB in 2014); 8,912,214 (US in 2015); 2617150 (CA in 2016). Patents pending: 2006275679 (AU application); PCT/US2006/029401 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37055
62,BC006161-22,"October 01, 2004 -  September 30, 2005",DNA Topoisomerases as Target of Action of Anticancer Drugs,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Keli  Agama



Smitha  Antony



Andrew  Jobson



Ze-Hong  Miao



Jennifer A Seiler



Olivier  Sordet



Show all 7","Mark  Cushman
(Medicinal Chemistry, Purdue University)




Michael  Gamcsik
(Duke Comprehensive Cancer Center)




Anna  Granda
(University of Barcelona)




Donald  Jerina
(NIDDKD)




Peter  Muncon
(CIT)",Susan  Bates; MD (National Cancer Institute),"Howard A. Nash; MD, PhD (NIMH)","Ordered by publication type and then author name.



1.
Aladjem MI, Pasa S, Parodi S, Weinstein JN, Pommier Y, Kohn KW (2004). Molecular interaction maps--a diagrammatic graphical language for bioregulatory networks. Sci STKE  2004, pe8.   https://doi.org/10.1126/stke.2222004pe8




PubMed


 


PubMed ID 14997004
    
     


 



2.
Annereau JP, Szakács G, Tucker CJ, Arciello A, Cardarelli C, Collins J, Grissom S, Zeeberg BR, Reinhold W, Weinstein JN, Pommier Y, Paules RS, Gottesman MM (2004). Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol  66, 1397-405.   https://doi.org/10.1124/mol.104.005009




PubMed


 


PubMed ID 15342794
    
     


 



3.
Antony S, Arimondo PB, Sun JS, Pommier Y (2004). Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures. Nucleic Acids Res  32, 5163-73.   https://doi.org/10.1093/nar/gkh847




PubMed



        
     
Free Article


 


PubMed ID 15469908
         Pubmed Central ID 521660 


 



4.
Antony S, Kohlhagen G, Agama K, Jayaraman M, Cao S, Durrani FA, Rustum YM, Cushman M, Pommier Y (2005). Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Mol Pharmacol  67, 523-30.   https://doi.org/10.1124/mol.104.003889




PubMed


 


PubMed ID 15531731
    
     


 



5.
Arimondo PB, Laco GS, Thomas CJ, Halby L, Pez D, Schmitt P, Boutorine A, Garestier T, Pommier Y, Hecht SM, Sun JS, Bailly C (2005). Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotides. Biochemistry  44, 4171-80.   https://doi.org/10.1021/bi048031k




PubMed


 


PubMed ID 15766244
    
     


 



6.
Bates SE, Medina-Pérez WY, Kohlhagen G, Antony S, Nadjem T, Robey RW, Pommier Y (2004). ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins. J Pharmacol Exp Ther  310, 836-42.   https://doi.org/10.1124/jpet.103.063149




PubMed


 


PubMed ID 15075385
    
     


 



7.
Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F, Orsetti B, Scheffer GL, Ychou M, Khan QA, Pommier Y, Pau B, Martineau P, Del Rio M (2004). ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer  109, 848-54.   https://doi.org/10.1002/ijc.20032




PubMed


 


PubMed ID 15027118
    
     


 



8.
Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, Stewart L, Redinbo MR (2004). Mechanisms of camptothecin resistance by human topoisomerase I mutations. J Mol Biol  339, 773-84.   https://doi.org/10.1016/j.jmb.2004.03.077




PubMed


 


PubMed ID 15165849
    
     


 



9.
Ioanoviciu A, Antony S, Pommier Y, Staker BL, Stewart L, Cushman M (2005). Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. J Med Chem  48, 4803-14.   https://doi.org/10.1021/jm050076b




PubMed


 


PubMed ID 16033260
    
     


 



10.
Kohn KW, Riss J, Aprelikova O, Weinstein JN, Pommier Y, Barrett JC (2004). Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Mol Biol Cell  15, 3042-52.   https://doi.org/10.1091/mbc.e03-12-0897




PubMed



        
     
Free Article


 


PubMed ID 15107465
         Pubmed Central ID 452562 


 



11.
Laco GS, Du W, Kohlhagen G, Sayer JM, Jerina DM, Burke TG, Curran DP, Pommier Y (2004). Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies. Bioorg Med Chem  12, 5225-35.   https://doi.org/10.1016/j.bmc.2004.06.046




PubMed


 


PubMed ID 15351405
    
     


 



12.
Morrell A, Antony S, Kohlhagen G, Pommier Y, Cushman M (2004). Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Bioorg Med Chem Lett  14, 3659-63.   https://doi.org/10.1016/j.bmcl.2004.05.022




PubMed


 


PubMed ID 15203138
    
     


 



13.
Pommier Y (2004). Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem Anticancer Agents  4, 429-34.   https://doi.org/10.2174/1568011043352777




PubMed


 


PubMed ID 15379698
    
     


 



14.
Pommier Y, Cherfils J (2005). Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. Trends Pharmacol Sci  26, 138-45.   https://doi.org/10.1016/j.tips.2005.01.008




PubMed


 


PubMed ID 15749159
    
     


 



15.
Pommier Y, Fan A, Meng L, Doe C, North H   (2005) Phosphorylation of BLM, dissociation from topoisomerase IIIalpha and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.  Mol. Cell. Biol.  pp.




 



16.
Pommier Y, Marchand C (2005). Interfacial inhibitors of protein-nucleic acid interactions. Curr Med Chem Anticancer Agents  5, 421-9.   https://doi.org/10.2174/1568011054222337




PubMed


 


PubMed ID 16101492
    
     


 



17.
Pommier Y, Sordet O, Rao VA, Zhang H, Kohn KW (2005). Targeting chk2 kinase: molecular interaction maps and therapeutic rationale. Curr Pharm Des  11, 2855-72.   https://doi.org/10.2174/1381612054546716




PubMed


 


PubMed ID 16101442
    
     


 



18.
Rapisarda A, Uranchimeg B, Sordet O, Pommier Y, Shoemaker RH, Melillo G (2004). Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res  64, 1475-82.   https://doi.org/10.1158/0008-5472.can-03-3139




PubMed


 


PubMed ID 14983893
    
     


 



19.
Shao RG, Cao CX, Pommier Y (2004). Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells. Acta Pharmacol Sin  25, 756-62.




PubMed


 


PubMed ID 15169628
    
     


 



20.
Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L, Burgin AB (2005). Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J Med Chem  48, 2336-45.   https://doi.org/10.1021/jm049146p




PubMed


 


PubMed ID 15801827
    
     


 



21.
Xiao X, Antony S, Kohlhagen G, Pommier Y, Cushman M (2004). Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors. Bioorg Med Chem  12, 5147-60.   https://doi.org/10.1016/j.bmc.2004.07.027




PubMed


 


PubMed ID 15351398
    
     


 



22.
Xiao X, Antony S, Pommier Y, Cushman M (2005). On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex. J Med Chem  48, 3231-8.   https://doi.org/10.1021/jm050017y




PubMed


 


PubMed ID 15857129
    
     


 



23.
Xiao X, Miao ZH, Antony S, Pommier Y, Cushman M (2005). Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines. Bioorg Med Chem Lett  15, 2795-8.   https://doi.org/10.1016/j.bmcl.2005.03.101




PubMed


 


PubMed ID 15911256
    
     


 



24.
Yu D, Khan E, Khaleque MA, Lee J, Laco G, Kohlhagen G, Kharbanda S, Cheng YC, Pommier Y, Bharti A (2004). Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity. J Biol Chem  279, 51851-61.   https://doi.org/10.1074/jbc.M404396200




PubMed


 


PubMed ID 15448168
    
     


 



25.
Zhang H, Meng LH, Zimonjic DB, Popescu NC, Pommier Y (2004). Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases. Nucleic Acids Res  32, 2087-92.   https://doi.org/10.1093/nar/gkh525




PubMed



        
     
Free Article


 


PubMed ID 15096574
         Pubmed Central ID 407812",https://intramural.nih.gov/search/searchview.taf?ipid=37056
63,BC006173-20,"October 01, 2004 -  September 30, 2005",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Maria J Gonzalez-Moa,"Jan  Balzarini; PhD
(Rega Institute, Katholieke University Leuven)




Hiroaki  Mitsuya",Stephen H Hughes; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Boyer PL, Julias JG, Marquez VE, Hughes SH (2005). Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases. J Mol Biol  345, 441-50.   https://doi.org/10.1016/j.jmb.2004.10.021




PubMed


 


PubMed ID 15581889
    
     


 



2.
Siddiqui MA, Hughes SH, Boyer PL, Mitsuya H, Van QN, George C, Sarafinanos SG, Marquez VE (2004). A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides. J Med Chem  47, 5041-8.   https://doi.org/10.1021/jm049550o




PubMed


 


PubMed ID 15456247",https://intramural.nih.gov/search/searchview.taf?ipid=37057
64,BC006174-20,"October 01, 2004 -  September 30, 2005",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Pamela L Russ,"Riad  Agbaria
(School of Pharmacy, Ben-Gurion University, Israel)




Alexander  MacKerell
(University of Maryland)




Martin  Maier
(ISIS Pharmaceuticals, Inc.)",Joseph John Barchi (National Cancer Institute),"Kenneth A Jacobson; BA, MS, PhD (NIDDK) 



Christophe K Tseng (NIAID) 



Adriaan  Bax; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Boyer PL, Julias JG, Marquez VE, Hughes SH (2005). Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases. J Mol Biol  345, 441-50.   https://doi.org/10.1016/j.jmb.2004.10.021




PubMed


 


PubMed ID 15581889
    
     


 



2.
Horton JR, Ratner G, Banavali NK, Huang N, Choi Y, Maier MA, Marquez VE, MacKerell AD, Cheng X (2004). Caught in the act: visualization of an intermediate in the DNA base-flipping pathway induced by HhaI methyltransferase. Nucleic Acids Res  32, 3877-86.   https://doi.org/10.1093/nar/gkh701




PubMed



        
     
Free Article


 


PubMed ID 15273274
         Pubmed Central ID 506793 


 



3.
Huleihel M, Talishanisky M, Ford H, Marquez VE, Kelley JA, Johns DG, Agbaria R (2005). Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture. Int J Antimicrob Agents  25, 427-32.   https://doi.org/10.1016/j.ijantimicag.2005.01.013




PubMed


 


PubMed ID 15848299
    
     


 



4.
Joshi BV, Moon HR, Fettinger JC, Marquez VE, Jacobson KA (2005). A new synthetic route to (North)-methanocarba nucleosides designed as A3 adenosine receptor agonists. J Org Chem  70, 439-47.   https://doi.org/10.1021/jo0487606




PubMed


 


PubMed ID 15651784
    
     


 



5.
Maier MA, Choi Y, Gaus H, Barchi JJ, Marquez VE, Manoharan M (2004). Synthesis and characterization of oligonucleotides containing conformationally constrained bicyclo[3.1.0]hexane pseudosugar analogs. Nucleic Acids Res  32, 3642-50.   https://doi.org/10.1093/nar/gkh667




PubMed



        
     
Free Article


 


PubMed ID 15247346
         Pubmed Central ID 484163 


 



6.
Marquez V   (2004) Chemcial and biological consequences of locking the conformation of nucleosides at the two antipodal extremes of the pseudorotational cycle.  Nucleic Acids Symposium Series  pp.




 



7.
Marquez VE, Ben-Kasus T, Barchi JJ, Green KM, Nicklaus MC, Agbaria R (2004). Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker. J Am Chem Soc  126, 543-9.   https://doi.org/10.1021/ja037929e




PubMed


 


PubMed ID 14719951
    
     


 



8.
Schelling P, Claus MT, Johner R, Marquez VE, Schulz GE, Scapozza L (2004). Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells. J Biol Chem  279, 32832-8.   https://doi.org/10.1074/jbc.M313343200




PubMed


 


PubMed ID 15163659
    
     


 



9.
Sun G, Voigt JH, Filippov IV, Marquez VE, Nicklaus MC (2004). PROSIT: pseudo-rotational online service and interactive tool, applied to a conformational survey of nucleosides and nucleotides. J Chem Inf Comput Sci  44, 1752-62.   https://doi.org/10.1021/ci049881+




PubMed


 


PubMed ID 15446834
    
     


 



10.
Wu Z, Maderia M, Barchi JJ, Marquez VE, Bax A (2005). Changes in DNA bending induced by restricting nucleotide ring pucker studied by weak alignment NMR spectroscopy. Proc Natl Acad Sci U S A  102, 24-8.   https://doi.org/10.1073/pnas.0408498102




PubMed



        
     
Free Article


 


PubMed ID 15618396
         Pubmed Central ID 544063 


 



11.
Tseng CK, Marquez VK (submitted in 2005) North-2' Deoxy-methanocarbathymidines As Antiviral Agents Against Poxviruses. Patents issued: 1898935 (FR in 2012); 1898935 (GB in 2012); 1898935 (IT in 2012); 1898935 (DE in 2012); 1898935 (EP in 2012). Patent pending: 11/920,881 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=37058
65,BC006176-20,"October 01, 2004 -  September 30, 2005",Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Dehui  Duan



Ji-Hye  Kang



Dina M Sigano","Peter  Jones
(USC)




Allen  Yang
(Norris Comprehensive Cancer Center, USC)","Peter  Blumberg; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA, Agbaria R (2005). Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol  70, 121-33.   https://doi.org/10.1016/j.bcp.2005.04.010




PubMed


 


PubMed ID 15885659
    
     


 



2.
Borchers CH, Marquez VE, Schroeder GK, Short SA, Snider MJ, Speir JP, Wolfenden R (2004). Fourier transform ion cyclotron resonance MS reveals the presence of a water molecule in an enzyme transition-state analogue complex. Proc Natl Acad Sci U S A  101, 15341-5.   https://doi.org/10.1073/pnas.0406781101




PubMed



        
     
Free Article


 


PubMed ID 15494437
         Pubmed Central ID 524446 


 



3.
Cheng JC, Weisenberger DJ, Gonzales FA, Liang G, Xu GL, Hu YG, Marquez VE, Jones PA (2004). Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Mol Cell Biol  24, 1270-8.   https://doi.org/10.1128/mcb.24.3.1270-1278.2004




PubMed



        
     
Free Article


 


PubMed ID 14729971
         Pubmed Central ID 321446 


 



4.
Cheng JC, Yoo CB, Weisenberger DJ, Chuang J, Wozniak C, Liang G, Marquez VE, Greer S, Orntoft TF, Thykjaer T, Jones PA (2004). Preferential response of cancer cells to zebularine. Cancer Cell  6, 151-8.   https://doi.org/10.1016/j.ccr.2004.06.023




PubMed


 


PubMed ID 15324698
    
     


 



5.
Duan D, Lewin NE, Sigano DM, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 21. A solid-phase method of synthesis of diacylglycerol lactones as a prelude to a combinatorial approach for the synthesis of protein kinase C isozyme-specific ligands. J Med Chem  47, 3248-54.   https://doi.org/10.1021/jm030610k




PubMed


 


PubMed ID 15163204
    
     


 



6.
Jørgensen R, Merrill AR, Yates SP, Marquez VE, Schwan AL, Boesen T, Andersen GR (2005). Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Nature  436, 979-84.   https://doi.org/10.1038/nature03871




PubMed


 


PubMed ID 16107839
    
     


 



7.
Kang JH, Kim SY, Lee J, Marquez VE, Lewin NE, Pearce LV, Blumberg PM (2004). Macrocyclic diacylglycerol-bis-lactones as conformationally constrained analogues of diacylglycerol-lactones. Interactions with protein kinase C. J Med Chem  47, 4000-7.   https://doi.org/10.1021/jm0497747




PubMed


 


PubMed ID 15267238
    
     


 



8.
Kang JH, Siddiqui MA, Sigano DM, Krajewski K, Lewin NE, Pu Y, Blumberg PM, Lee J, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 24. Asymmetric synthesis of a chiral (R)-DAG-lactone template as a versatile precursor for highly functionalized DAG-lactones. Org Lett  6, 2413-6.   https://doi.org/10.1021/ol0492041




PubMed


 


PubMed ID 15228292
    
     


 



9.
Lee J, Kim SY, Kang JH, Acs G, Acs P, Blumberg PM, Marquez VE (2004). Conformationally constrained diacylglycerol (DAG) analogs: 4-C-hydroxyethyl-5-O-acyl-2,3-dideoxy-D-glyceropentono-1,4-lactone analogs as protein kinase C (PKC) ligands. Eur J Med Chem  39, 69-77.   https://doi.org/10.1016/j.ejmech.2003.10.006




PubMed


 


PubMed ID 14987835
    
     


 



10.
Lemaire M, Momparler LF, Bernstein ML, Marquez VE, Momparler RL (2005). Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia. Anticancer Drugs  16, 301-8.   https://doi.org/10.1097/00001813-200503000-00009




PubMed


 


PubMed ID 15711182
    
     


 



11.
Malolanarasimhan K, Lai CC, Kelley JA, Iaccarino L, Reynolds D, Young HA, Marquez VE (2005). Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe. Bioorg Med Chem  13, 2717-22.   https://doi.org/10.1016/j.bmc.2005.02.035




PubMed


 


PubMed ID 15781383
    
     


 



12.
Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA, Farrar WL (2004). Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res  64, 3465-73.   https://doi.org/10.1158/0008-5472.CAN-03-3970




PubMed


 


PubMed ID 15150099
    
     


 



13.
Pu Y, Perry NA, Yang D, Lewin NE, Kedei N, Braun DC, Choi SH, Blumberg PM, Garfield SH, Stone JC, Duan D, Marquez VE (2005). A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha. J Biol Chem  280, 27329-38.   https://doi.org/10.1074/jbc.M414132200




PubMed


 


PubMed ID 15923197
    
     


 



14.
Tamamura H, Sigano DM, Lewin NE, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol. 20. The search for an elusive binding site on protein kinase C through relocation of the carbonyl pharmacophore along the sn-1 side chain of 1,2-diacylglycerol lactones. J Med Chem  47, 644-55.   https://doi.org/10.1021/jm030454h




PubMed


 


PubMed ID 14736244
    
     


 



15.
Tamamura H, Sigano DM, Lewin NE, Peach ML, Nicklaus MC, Blumberg PM, Marquez VE (2004). Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C). J Med Chem  47, 4858-64.   https://doi.org/10.1021/jm049723+




PubMed


 


PubMed ID 15369389
    
     


 



16.
Vives M, Eritja R, Tauler R, Marquez VE, Gargallo R (2004). Synthesis, stability, and protonation studies of a self-complementary dodecamer containing the modified nucleoside 2'-deoxyzebularine. Biopolymers  73, 27-43.   https://doi.org/10.1002/bip.10515




PubMed


 


PubMed ID 14691937",https://intramural.nih.gov/search/searchview.taf?ipid=37059
66,BC006177-20,"October 01, 2004 -  September 30, 2005",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Christopher Cong Lai,"Riad  Agbaria
(Human Genetics Institute, Ben-Gurion University, Israel)




Jerry M.  Collins
(Center for Drug Evaluation Research, Food and Drug Administration)","Lawrence R Phillips (National Cancer Institute)



Sherman  Stinson (National Cancer Institute)



William  Farrar (National Cancer Institute)



David R Hodge (National Cancer Institute)



De  Yang (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA, Agbaria R (2005). Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol  70, 121-33.   https://doi.org/10.1016/j.bcp.2005.04.010




PubMed


 


PubMed ID 15885659
    
     


 



2.
Huleihel M, Talishanisky M, Ford H, Marquez VE, Kelley JA, Johns DG, Agbaria R (2005). Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture. Int J Antimicrob Agents  25, 427-32.   https://doi.org/10.1016/j.ijantimicag.2005.01.013




PubMed


 


PubMed ID 15848299
    
     


 



3.
Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA, Farrar WL (2004). Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res  64, 3465-73.   https://doi.org/10.1158/0008-5472.CAN-03-3970




PubMed


 


PubMed ID 15150099",https://intramural.nih.gov/search/searchview.taf?ipid=37060
67,BC006178-20,"October 01, 2004 -  September 30, 2005",Applications of New Mass Spectral Techniques,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Christopher Cong Lai,NULL,"Kirk R Gustafson; PhD (National Cancer Institute)



Lawrence R Phillips (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Malolanarasimhan K, Lai CC, Kelley JA, Iaccarino L, Reynolds D, Young HA, Marquez VE (2005). Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe. Bioorg Med Chem  13, 2717-22.   https://doi.org/10.1016/j.bmc.2005.02.035




PubMed


 


PubMed ID 15781383
    
     


 



2.
Milanowski DJ, Gustafson KR, Kelley JA, McMahon JB (2004). Caulibugulones A-F, novel cytotoxic isoquinoline quinones and iminoquinones from the marine bryozoan Caulibugula intermis. J Nat Prod  67, 70-3.   https://doi.org/10.1021/np030378l




PubMed


 


PubMed ID 14738389
    
     


 



3.
Shi ZD, Wei CQ, Lee K, Liu H, Zhang M, Araki T, Roberts LR, Worthy KM, Fisher RJ, Neel BG, Kelley JA, Yang D, Burke TR (2004). Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands. J Med Chem  47, 2166-9.   https://doi.org/10.1021/jm030510e




PubMed


 


PubMed ID 15056012",https://intramural.nih.gov/search/searchview.taf?ipid=37061
68,BC006192-17,"October 01, 2004 -  September 30, 2005",Investigations on the integrated behavior of molecular regulatory networks that,"Kurt  Kohn; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","David  Kane



Sohyoung  Kim



William Curtis Reinhold



Margot  Sunshine",NULL,"Yves  Pommier; PhD (National Cancer Institute)



Silvio  Parodi (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Joseph  Riss; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aladjem MI, Pasa S, Parodi S, Weinstein JN, Pommier Y, Kohn KW (2004). Molecular interaction maps--a diagrammatic graphical language for bioregulatory networks. Sci STKE  2004, pe8.   https://doi.org/10.1126/stke.2222004pe8




PubMed


 


PubMed ID 14997004
    
     


 



2.
Kohn K   (2005) Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage.  Biochem Biophys Research Comm  pp.




 



3.
Kohn KW, Riss J, Aprelikova O, Weinstein JN, Pommier Y, Barrett JC (2004). Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Mol Biol Cell  15, 3042-52.   https://doi.org/10.1091/mbc.e03-12-0897




PubMed



        
     
Free Article


 


PubMed ID 15107465
         Pubmed Central ID 452562 


 



4.
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene  23, 2934-49.   https://doi.org/10.1038/sj.onc.1207515




PubMed


 


PubMed ID 15077155",https://intramural.nih.gov/search/searchview.taf?ipid=37062
69,BC006198-16,"October 01, 2004 -  September 30, 2005",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anticancer Agents,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Won-Jun  Choi



Kyeong  Lee; PhD



Fa  Liu



Sachindra S Patil



Zhendan  Shi; PhD","David  Austin
(Dept. of Chemistry, Yale University)




Fuyuhiko  Inagaki
(Graduate School of Pharmaceutical Sciences, Hokkaido University)




Morag  Park
(Dept. Biochemistry and Oncology, McGill University)




Robert  Ulrich
(Molecular Immunology, USAMRIID)




Dajun  Yang
(School of Medicine, Univ. of Michigan)




Zhong-Yin  Zhang
(Dept. Pharmacology, Albert Einstein Medical School)","William Marston Linehan; MD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)



Christoph  Rader; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Burke T, Choi W, Shi Z, Karki R, Worthy K, Bindu L, Nicklaus M, Waugh D, Fisher R   (2006) Application of phenylphosphate mimetics to the design and synthesis of olefin metathesis-derived Grb2 SH2 domain-binding macrocycles, in Understanding Biology Using Peptides, in press.




 



2.
Burke T, Dharmawardana P, Giubellino E, Worthy K, Bindu L, Fisher R   (2006) Synthesis and use of C-terminally biotinylated peptidomimetics with high Grb2 SH2 domain-binding affinity, in Understanding Biology Using Peptides, in press.




 



3.
Burke T, Kang U, Karki R, Worthy K, Bindu L, Chertov O, Esposito D, Frank P, Gillette W, Nicklaus M, Hartley J, Fisher R   (2005) Synthesis and application of novel phosphotyrosyl mimetics to Grb2 SH2 domain-binding inhibitors, in Peptide Science 2004. Shimohigashi Y, ed., The Japanese Peptide Society (Osaka), pp. 397-400.




 



4.
Burke T   (2004) A one-step synthesis of N-Fmoc-4-O[O',-di-tert-butyl-2-(2-fluoromalonyl)]-L-tyrosine from commercially-available starting material.  Tetrahedron Lett  pp.




 



5.
Burke T   (2004) Enantioselective synthesis of ureapeptoid-containing macrocycles.  Synlett  pp.




 



6.
Burke T   (2006) Development of Grb2 SH2 domain signaling antagonists: A potential new class of antiproliferative agents.  Int J Pept Res Therap  pp.




 



7.
Burke T, Gao Y, Phan J, Liang J, Zhang Z, Waugh D   (2004) Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase as potential leads for therapeutic development against plague.  Peptide Revolution: Genomics, Proteomics and Therapeutics  pp.




 



8.
Burke T, Gao Y, Zhang Z   (2004) Enantioselective synthesis of (S)-3-carboxy-4 ((carboxy)difluoromethyl)phenylalanine in protected form and incorporation into a PTP-1B-directed tripeptide.  Chem. Biodiversity  pp.




 



9.
Burke T, Kang S, Liu H, Zhang M, Yang D, Deschamps J   (2004) Synthesis of alpha, alpha-disubstituted 4-phosphonophenylalanine analogues as conformationally-constrained phosphotyrosyl mimetics.  Tetrahedron  pp.




 



10.
Burke T, Karki R, Worthy K, Bindu L, Nicklaus M, Fisher R   (2005) Utilization of a Common Pathway for the Synthesis of High Affinity Macrocyclic Grb2 SH2 Domain-Binding Peptide Mimetics That Differ in the Configuration at One Ring Junction.  Chem Biodivers  pp.




 



11.
Burke T, Lee K   (2005) Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenyalanine (F2Pmp) into signal transduction-directed peptides.  from Methods in Molecular Biology: Peptide Synthesis and Applications  pp.




 



12.
Burke T, Liu H, Zhang M, Yang D   (2004) Synthesis of the first alpha-fluorophosphotyrosyl mimetic.  Synth Comm  pp.




 



13.
Burke T, Wei Q, Lee K, Liu H, Zhang M, Vasselli J, Bottaro D, Linehan W, Yang D   (2004) Macrocyclization in the design of tetra-peptide mimetics that display potent inhibition of Grb2 SH2 domain binding in whole cell systems.  Peptide Revolution: Genomics, Proteomics and Therapeutics  pp.




 



14.
Choi WJ, Shi ZD, Worthy KM, Bindu L, Karki RG, Nicklaus MC, Fisher RJ, Burke TR (2006). Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles. Bioorg Med Chem Lett  16, 5265-9.   https://doi.org/10.1016/j.bmcl.2006.08.004




PubMed



        
     
Free Article


 


PubMed ID 16908148
         Pubmed Central ID 1624856 


 



15.
Kang SU, Shi ZD, Worthy KM, Bindu LK, Dharmawardana PG, Choyke SJ, Bottaro DP, Fisher RJ, Burke TR (2005). Examination of phosphoryl-mimicking functionalities within a macrocyclic Grb2 SH2 domain-binding platform. J Med Chem  48, 3945-8.   https://doi.org/10.1021/jm050059m




PubMed


 


PubMed ID 15943469
    
     


 



16.
Oishi S, Karki RG, Kang SU, Wang X, Worthy KM, Bindu LK, Nicklaus MC, Fisher RJ, Burke TR (2005). Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. J Med Chem  48, 764-72.   https://doi.org/10.1021/jm0492709




PubMed


 


PubMed ID 15689160
    
     


 



17.
Oishi S, Karki RG, Shi ZD, Worthy KM, Bindu L, Chertov O, Esposito D, Frank P, Gillette WK, Maderia M, Hartley J, Nicklaus MC, Barchi JJ, Fisher RJ, Burke TR (2005). Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic. Bioorg Med Chem  13, 2431-8.   https://doi.org/10.1016/j.bmc.2005.01.052




PubMed


 


PubMed ID 15755645
    
     


 



18.
Oishi S, Shi ZD, Worthy KM, Bindu LK, Fisher RJ, Burke TR (2005). Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles. Chembiochem  6, 668-74.   https://doi.org/10.1002/cbic.200400298




PubMed


 


PubMed ID 15719347
    
     


 



19.
Shi ZD, Karki RG, Oishi S, Worthy KM, Bindu LK, Dharmawardana PG, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2005). Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic. Bioorg Med Chem Lett  15, 1385-8.   https://doi.org/10.1016/j.bmcl.2005.01.017




PubMed


 


PubMed ID 15713392
    
     


 



20.
Shi ZD, Lee K, Wei CQ, Roberts LR, Worthy KM, Fisher RJ, Burke TR (2004). Synthesis of a 5-methylindolyl-containing macrocycle that displays ultrapotent Grb2 SH2 domain-binding affinity. J Med Chem  47, 788-91.   https://doi.org/10.1021/jm030440b




PubMed


 


PubMed ID 14761181
    
     


 



21.
Shi ZD, Liu H, Zhang M, Worthy KM, Bindu L, Yang D, Fisher RJ, Burke TR (2005). Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity. Bioorg Med Chem  13, 4200-8.   https://doi.org/10.1016/j.bmc.2005.04.028




PubMed


 


PubMed ID 15893931
    
     


 



22.
Shi ZD, Wei CQ, Lee K, Liu H, Zhang M, Araki T, Roberts LR, Worthy KM, Fisher RJ, Neel BG, Kelley JA, Yang D, Burke TR (2004). Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands. J Med Chem  47, 2166-9.   https://doi.org/10.1021/jm030510e




PubMed


 


PubMed ID 15056012
    
     


 



23.
Soriano JV, Liu N, Gao Y, Yao ZJ, Ishibashi T, Underhill C, Burke TR, Bottaro DP (2004). Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists. Mol Cancer Ther  3, 1289-99.




PubMed


 


PubMed ID 15486196
    
     


 



24.
Valizadeh M, Schenk G, Nash K, Oddie GW, Guddat LW, Hume DA, de Jersey J, Burke TR, Hamilton S (2004). Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases. Arch Biochem Biophys  424, 154-62.   https://doi.org/10.1016/j.abb.2004.01.008




PubMed


 


PubMed ID 15047187",https://intramural.nih.gov/search/searchview.taf?ipid=37063
70,BC007333-14,"October 01, 2004 -  September 30, 2005",Pharmacology of HIV Viral DNA & Retroviral Integrases,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Christophe  Marchand,NULL,"Vinay K Pathak; PhD (National Cancer Institute)



Peter P Roller; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cline MJ, Gale RP, Stiehm ER, Opelz G, Young LS, Feig SA, Fahey JL   (1975) Bone marrow transplantation in man.  Ann Intern Med 83:691-708.




PubMed


 


PubMed ID 937
    
     


 



2.
Di Santo R, Costi R, Artico M, Ragno R, Greco G, Novellino E, Marchand C, Pommier Y (2005). Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. Farmaco  60, 409-17.   https://doi.org/10.1016/j.farmac.2005.03.008




PubMed


 


PubMed ID 15910813
    
     


 



3.
Johnson AA, Marchand C, Pommier Y (2004). HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial. Curr Top Med Chem  4, 1059-77.   https://doi.org/10.2174/1568026043388394




PubMed


 


PubMed ID 15193139
    
     


 



4.
Johnson AA, Sayer JM, Yagi H, Kalena GP, Amin R, Jerina DM, Pommier Y (2004). Position-specific suppression and enhancement of HIV-1 integrase reactions by minor groove benzo[a]pyrene diol epoxide deoxyguanine adducts: implications for molecular interactions between integrase and substrates. J Biol Chem  279, 7947-55.   https://doi.org/10.1074/jbc.M311263200




PubMed


 


PubMed ID 14627697
    
     


 



5.
Pommier Y, Johnson AA, Marchand C (2005). Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov  4, 236-48.   https://doi.org/10.1038/nrd1660




PubMed


 


PubMed ID 15729361
    
     


 



6.
Pommier Y, Marchand C (2005). Interfacial inhibitors of protein-nucleic acid interactions. Curr Med Chem Anticancer Agents  5, 421-9.   https://doi.org/10.2174/1568011054222337




PubMed


 


PubMed ID 16101492
    
     


 



7.
Svarovskaia ES, Barr R, Zhang X, Pais GC, Marchand C, Pommier Y, Burke TR, Pathak VK (2004). Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol  78, 3210-22.   https://doi.org/10.1128/jvi.78.7.3210-3222.2004




PubMed



        
     
Free Article


 


PubMed ID 15016842
         Pubmed Central ID 371038 


 



8.
Zhang X, Marchand C, Pommier Y, Burke TR (2004). Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes. Bioorg Med Chem Lett  14, 1205-7.   https://doi.org/10.1016/j.bmcl.2003.12.064




PubMed


 


PubMed ID 14980666",https://intramural.nih.gov/search/searchview.taf?ipid=37065
71,BC007349-13,"October 01, 2004 -  September 30, 2005",New Strategies for Cancer Drug Discovery:  Integrative Pharmacogenomics and Phar,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI","Hong  Cao



David  Kane



Sudarshan  Narasimhan



Ike  Nnabugwu



Mark  Reimers



William Curtis Reinhold



Show all 11","Joe  Gray
(UCSF Cancer Center)




John  Grefenstette
(Bioinformatics and Compuational BIology, George Mason University)




Emanuel  Petricoin
(FDA)




Harold  Riethman
(Wistar Inst)




Michael  Stratton
(Molec and Cell Oncogenesis Program, Wellcome Trust Sanger Inst)




Daniel D Von hoff



Show all 7","Mirit I Aladjem; PhD (National Cancer Institute)



Natasha  Caplen (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)



Ernest S Kawasaki (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL (2005). Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health. J Immunother  28, 79-119.   https://doi.org/10.1097/01.cji.0000154251.20125.2e




PubMed


 


PubMed ID 15725954
    
     


 



2.
Reimers M, Weinstein JN (2005). Quality assessment of microarrays: visualization of spatial artifacts and quantitation of regional biases. BMC Bioinformatics  6, 166.   https://doi.org/10.1186/1471-2105-6-166




PubMed



        
     
Free Article


 


PubMed ID 15992406
         Pubmed Central ID 1189079 


 



3.
Ule J, Ule A, Spencer J, Williams A, Hu JS, Cline M, Wang H, Clark T, Fraser C, Ruggiu M, Zeeberg BR, Kane D, Weinstein JN, Blume J, Darnell RB (2005). Nova regulates brain-specific splicing to shape the synapse. Nat Genet  37, 844-52.   https://doi.org/10.1038/ng1610




PubMed


 


PubMed ID 16041372
    
     


 



4.
Weinstein J   (2005) Biomarkers in cancer staging, prognosis, and treatment selection.  Nature Reviews Cancer, in press.




 



5.
Weinstein J, Chin K, Lababidi S, Reinhold W, Kuo W, Gwadry F, Ajay K, Fridlyand H, Jain J, Collins A, Nishizuka C, Tonon S, Roschke G, Gehlhaus A, Kirsch K, Scudiero I, Reimers D, Gray M   (2005) Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.  Molecular Cancer Therapeutics, in press.




 



6.
Weinstein J, Farrell N, Ortuzar W, Tanimura H, Myers T   (2005) Identification of non-cross-resisant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.  Molec. Pharmacol, in press.




 



7.
Weinstein J, Gadisetti D, Geoghegan C, Hilburn J, Paarlberg J, Kim J, Munroe C, Gangi D, Han L, Puri J, Staudt R, Barrett J, Green J, Kawasaki J   (2005) Three microarray platforms: An analysis of their concordance in profiling gene expression.  BMC Genomics, in press.




 



8.
Weinstein J, Lababidi S, Tonon G, Gehlhaus K, Kirsch I   (2005) Chromosomal 'state' as a potential target for cancer therapy.  Proc. Natl. Acad. Sci. U.S.A.  pp.




 



9.
Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN (2005). High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics  6, 168.   https://doi.org/10.1186/1471-2105-6-168




PubMed



        
     
Free Article


 


PubMed ID 15998470
         Pubmed Central ID 1190154",https://intramural.nih.gov/search/searchview.taf?ipid=37066
72,BC007354-12,"October 01, 2004 -  September 30, 2005",Peptide-based Inhibitors of HDM2 Protein and Integrase,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Sheng  Jiang



Krzysztof A Krajewski","Robert B  Dickson
(Georgetown University Medical Center, Lombardi Cancer Center)




Shaomeng  Wang
(Dept. of Internal Medicine and Medicinal Chemistry, University of Michigan)","Christophe  Marchand (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Koehler NK, Yang CY, Varady J, Lu Y, Wu XW, Liu M, Yin D, Bartels M, Xu BY, Roller PP, Long YQ, Li P, Kattah M, Cohn ML, Moran K, Tilley E, Richert JR, Wang S (2004). Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein. J Med Chem  47, 4989-97.   https://doi.org/10.1021/jm030362s




PubMed


 


PubMed ID 15456243
    
     


 



2.
Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP (2004). Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin. Bioorg Med Chem Lett  14, 5595-8.   https://doi.org/10.1016/j.bmcl.2004.08.061




PubMed


 


PubMed ID 15482931
    
     


 



3.
Nikolovska-Coleska Z, Wang R, Fang X, Pan H, Tomita Y, Li P, Roller PP, Krajewski K, Saito NG, Stuckey JA, Wang S (2004). Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Anal Biochem  332, 261-73.   https://doi.org/10.1016/j.ab.2004.05.055




PubMed


 


PubMed ID 15325294
    
     


 



4.
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D, Wang S (2004). Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem  47, 2430-40.   https://doi.org/10.1021/jm030420+




PubMed


 


PubMed ID 15115387
    
     


 



5.
Roller P, Nikolovska-Coleska Z, Wang S   (2004) Solution conformation of wild-type and mutated Bak BH3 peptides via dynamical conformational sampling and implication to their binding to antiapoptotic Bcl-2 proteins.  J Phys Chem B  pp.




 



6.
Song YL, Roller PP, Long YQ (2004). Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity. Bioorg Med Chem Lett  14, 3205-8.   https://doi.org/10.1016/j.bmcl.2004.03.103




PubMed


 


PubMed ID 15149676
    
     


 



7.
Sun H, Nikolovska-Coleska Z, Chen J, Yang CY, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S (2005). Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics. Bioorg Med Chem Lett  15, 793-7.   https://doi.org/10.1016/j.bmcl.2004.11.008




PubMed


 


PubMed ID 15664859
    
     


 



8.
Sun H, Nikolovska-Coleska Z, Yang CY, Xu L, Liu M, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S (2004). Structure-based design of potent, conformationally constrained Smac mimetics. J Am Chem Soc  126, 16686-7.   https://doi.org/10.1021/ja047438+




PubMed


 


PubMed ID 15612682
    
     


 



9.
Sun H, Nikolovska-Coleska Z, Yang CY, Xu L, Tomita Y, Krajewski K, Roller PP, Wang S (2004). Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. J Med Chem  47, 4147-50.   https://doi.org/10.1021/jm0499108




PubMed


 


PubMed ID 15293984",https://intramural.nih.gov/search/searchview.taf?ipid=37067
73,BC007363-11,"October 01, 2004 -  September 30, 2005",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Fa  Liu



Sachindra S Patil","Eric  DeClercq
(Rega Institute)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Nouri  Neamati
(NCI)","Yves  Pommier; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Burke T, Tang Y, Nicklaus M   (2005) Model of full-lenght HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.  J Computer-Aided Mol Design  pp.




 



2.
Shkriabai N, Patil SS, Hess S, Budihas SR, Craigie R, Burke TR, Le Grice SF, Kvaratskhelia M (2004). Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. Proc Natl Acad Sci U S A  101, 6894-9.   https://doi.org/10.1073/pnas.0400873101




PubMed



        
     
Free Article


 


PubMed ID 15118107
         Pubmed Central ID 406438 


 



3.
Svarovskaia ES, Barr R, Zhang X, Pais GC, Marchand C, Pommier Y, Burke TR, Pathak VK (2004). Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol  78, 3210-22.   https://doi.org/10.1128/jvi.78.7.3210-3222.2004




PubMed



        
     
Free Article


 


PubMed ID 15016842
         Pubmed Central ID 371038 


 



4.
Zhang X, Marchand C, Pommier Y, Burke TR (2004). Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes. Bioorg Med Chem Lett  14, 1205-7.   https://doi.org/10.1016/j.bmcl.2003.12.064




PubMed


 


PubMed ID 14980666",https://intramural.nih.gov/search/searchview.taf?ipid=37068
74,BC007365-11,"October 01, 2004 -  September 30, 2005",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Sanita  Bharti



Fanny  Campa



Vi Luan  Ha



Ruibai  Luo



Zhongzhen  Nie



Hye-Young  Yoon



Show all 7",NULL,NULL,"Juan S Bonifacino; PhD (NICHD) 



Henry M. Fales; PhD (NHLBI) 



Emily S Boja; PhD (NHLBI) 



Jenny E Hinshaw; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Che MM, Boja ES, Yoon HY, Gruschus J, Jaffe H, Stauffer S, Schuck P, Fales HM, Randazzo PA (2005). Regulation of ASAP1 by phospholipids is dependent on the interface between the PH and Arf GAP domains. Cell Signal  17, 1276-88.   https://doi.org/10.1016/j.cellsig.2005.01.007




PubMed


 


PubMed ID 16038802
    
     


 



2.
I ST, Nie Z, Stewart A, Najdovska M, Hall NE, He H, Randazzo PA, Lock P (2004). ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. J Cell Sci  117, 6071-84.   https://doi.org/10.1242/jcs.01526




PubMed


 


PubMed ID 15546919
    
     


 



3.
Kowanetz K, Husnjak K, Hller D, Kowanetz M, Soubeyran P, Hirsch D, Schmidt MH, Pavelic K, De Camilli P, Randazzo PA, Dikic I   (2004) CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.  Mol Biol Cell 15:3155-66.




PubMed



        
     
Free Article


 


PubMed ID 15090612
         Pubmed Central ID 452573 


 



4.
Nie Z, Fei J, Premont RT, Randazzo PA (2005). The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. J Cell Sci  118, 3555-66.   https://doi.org/10.1242/jcs.02486




PubMed


 


PubMed ID 16079295
    
     


 



5.
Randazzo PA, Hirsch DS (2004). Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling. Cell Signal  16, 401-13.   https://doi.org/10.1016/j.cellsig.2003.09.012




PubMed


 


PubMed ID 14709330
    
     


 



6.
Yoon HY, Jacques K, Nealon B, Stauffer S, Premont RT, Randazzo PA (2004). Differences between AGAP1, ASAP1 and Arf GAP1 in substrate recognition: interaction with the N-terminus of Arf1. Cell Signal  16, 1033-44.   https://doi.org/10.1016/j.cellsig.2004.02.008




PubMed


 


PubMed ID 15212764",https://intramural.nih.gov/search/searchview.taf?ipid=37069
75,BC008000-35,"October 01, 2004 -  September 30, 2005",Regulation of EGFR Gene Activity,Alfred Charles Johnson; PhD,NULL,"Laboratory of Molecular Biology, NCI","Hideo  Ohtsuka



Jennifer D Rieker","Hassan  Ashtorab
(Howard University)




Anping  Chen
(Louisiana State University-Shreveport)




Hirotaka  Nishi
(Tokyo Medical University)",Marjorie  Robert-Guroff; PhD (National Cancer Institute),"Kuan-Teh  Jeang; PhD, MD (NIAID)","Ordered by publication type and then author name.



1.
Johnson A   (2005) Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.  Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37070
76,BC008226-29,"October 01, 2004 -  September 30, 2005",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Renqin  Duan



Jessica M Faupel-Badger



Erika P Ginsburg



Anita  Goldhar



Matthew J Meyer



Julia E Reid



Show all 8","Mikiko  Asai-Sato
(Maternal and Neonate Center, Yokohama City University School of Medicine)




Patricia  Berg
(George Washington University)




Charles  Brooks
(Department of Veterinary Biosciences, Ohio State University)




Russell  Hovey
(Department of Animal Science, University of Vermont)




John P. Lydon; PhD
(Department of Molecular and Cellular Biology, Baylor College of Medicine)




Christopher  Ormandy
(Cancer Research Program, Garvan Institute of Medical Research)


Show all 8","Jennifer  Eng Wong (National Cancer Institute)



Sheila Ann Prindiville (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Asai-Sato M, Nagashima Y, Miyagi E, Sato K, Ohta I, Vonderhaar BK, Hirahara F (2005). Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment. Int J Cancer  115, 539-44.   https://doi.org/10.1002/ijc.20810




PubMed


 


PubMed ID 15700312
    
     


 



2.
Bianco C, Strizzi L, Ebert A, Chang C, Rehman A, Normanno N, Guedez L, Salloum R, Ginsburg E, Sun Y, Khan N, Hirota M, Wallace-Jones B, Wechselberger C, Vonderhaar BK, Tosato G, Stetler-Stevenson WG, Sanicola M, Salomon DS (2005). Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst  97, 132-41.   https://doi.org/10.1093/jnci/dji011




PubMed


 


PubMed ID 15657343
    
     


 



3.
Goldhar AS, Vonderhaar BK, Trott JF, Hovey RC (2005). Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol Cell Endocrinol  232, 9-19.   https://doi.org/10.1016/j.mce.2005.01.005




PubMed


 


PubMed ID 15737464
    
     


 



4.
Hovey RC, Asai-Sato M, Warri A, Terry-Koroma B, Colyn N, Ginsburg E, Vonderhaar BK (2005). Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod  72, 423-35.   https://doi.org/10.1095/biolreprod.104.029769




PubMed


 


PubMed ID 15470002
    
     


 



5.
Tan D, Johnson DA, Wu W, Zeng L, Chen YH, Chen WY, Vonderhaar BK, Walker AM (2005). Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells. Mol Endocrinol  19, 1291-303.   https://doi.org/10.1210/me.2004-0304




PubMed


 


PubMed ID 15695371
    
     


 



6.
Wu W, Ginsburg E, Vonderhaar BK, Walker AM (2005). S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Res  65, 7509-15.   https://doi.org/10.1158/0008-5472.CAN-04-3350




PubMed


 


PubMed ID 16103106",https://intramural.nih.gov/search/searchview.taf?ipid=37071
77,BC008281-23,"October 01, 2004 -  September 30, 2005",Protein kinase A and Human Cancer: Translational Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI","Chris  Cheadle; PhD



Roosevelt B Hyman



Natalie  Johnson



Ji Hye Hye Lee



Maria V Nesterova



Feng  Wen",NULL,Susan  Bates; MD (National Cancer Institute),"Kevin Graham Becker; BS, MAS, PhD (NIA) 



Constantine Argyrios Stratakis; MD, DSc (NICHD)","Ordered by publication type and then author name.



1.
Cho-Chung YS (2005). DNA drug design for cancer therapy. Curr Pharm Des  11, 2811-23.   https://doi.org/10.2174/1381612054546770




PubMed


 


PubMed ID 16101439",https://intramural.nih.gov/search/searchview.taf?ipid=37072
78,BC008303-33,"October 01, 2004 -  September 30, 2005",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Christine M Close



Antony  Dimitrov



Catherine M Finnegan



Himanshu  Garg



Danielle L Guiffre



Amy L Jacobs



Show all 14","Javad  Aman
(Medicine, USAMRID)




Robert W Doms; MD, PhD
(Microbiology, University of Pennsylvania)




Alfredo  Garzino-Demo
(Pediatrics, Cell & Neurobiology Childrens Hospital, IHV)




Robert  Hogan
(Image Analysis Lab,Research Technology Program, University of Georgia)




James  Hoxie
(CFAR, UPenn)




Robert I. Lehrer; MD
(David Geffen School of Medicine, UCLA)


Show all 13","Vineet Narain KewalRamani; PhD (National Cancer Institute)



Sriram  Subrimanian (National Cancer Institute)



Marius  Clore; MD, PhD (National Cancer Institute)



Ji Ming  Wang; MD, PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R (2004). Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci U S A  101, 15452-7.   https://doi.org/10.1073/pnas.0402874101




PubMed



        
     
Free Article


 


PubMed ID 15489273
         Pubmed Central ID 524434 


 



2.
Gallo SA, Clore GM, Louis JM, Bewley CA, Blumenthal R (2004). Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. Biochemistry  43, 8230-3.   https://doi.org/10.1021/bi049957v




PubMed


 


PubMed ID 15209519
    
     


 



3.
Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R (2004). The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors. J Mol Biol  340, 9-14.   https://doi.org/10.1016/j.jmb.2004.04.027




PubMed


 


PubMed ID 15184018
    
     


 



4.
Gerber D, Pritsker M, Gunther-Ausborn S, Johnson B, Blumenthal R, Shai Y (2004). Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex. J Biol Chem  279, 48224-30.   https://doi.org/10.1074/jbc.M403436200




PubMed


 


PubMed ID 15339935
    
     


 



5.
Puri A, Rawat SS, Lin HM, Finnegan CM, Mikovits J, Ruscetti FW, Blumenthal R (2004). An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells. AIDS  18, 849-58.   https://doi.org/10.1097/00002030-200404090-00002




PubMed


 


PubMed ID 15060432
    
     


 



6.
Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A (2004). Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology  318, 55-65.   https://doi.org/10.1016/j.virol.2003.08.042




PubMed


 


PubMed ID 14972535
    
     


 



7.
Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A (2004). Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J Virol  78, 7360-8.   https://doi.org/10.1128/JVI.78.14.7360-7368.2004




PubMed



        
     
Free Article


 


PubMed ID 15220409
         Pubmed Central ID 434090 


 



8.
Ray PE, Soler-García AA, Xu L, Soderland C, Blumenthal R, Puri A (2005). Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism. Pediatr Nephrol  20, 1401-9.   https://doi.org/10.1007/s00467-005-1950-5




PubMed


 


PubMed ID 16047221
    
     


 



9.
Shnaper S, Sackett K, Gallo SA, Blumenthal R, Shai Y (2004). The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively. J Biol Chem  279, 18526-34.   https://doi.org/10.1074/jbc.M304950200




PubMed


 


PubMed ID 14981088
    
     


 



10.
Viard M, Parolini I, Rawat SS, Fecchi K, Sargiacomo M, Puri A, Blumenthal R (2004). The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J  20, 213-22.   https://doi.org/10.1023/B:GLYC.0000024253.48791.d9




PubMed


 


PubMed ID 15090735",https://intramural.nih.gov/search/searchview.taf?ipid=37073
79,BC008363-23,"October 01, 2004 -  September 30, 2005",Membrane Protein Modeling,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI","Ramesh S Sarathi



Yinon  Shafrir","Steffen  Hering
(Institut für Pharmakologie und Toxikologie, Universität Wien)




Li  Ronald
(Johns Hopkins University)




Sergei  Sukharev; PhD
(Department of Biology, University of Maryland)




Gea-Ny  Tseng
(Biology, Virginia Commonwealth University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Guy H   (2005) Glutamate-activated Channels, in Bacterial Ion Channels and Their Eukaryotic Homologs. Kubalski A, Martinac B, eds., ASM Press (Washington, D.C.), pp. 83-96.




 



2.
Guy H   (2005) Inward Rectifier K+ Channels, in Bacterial Ion Channels and Their Eukaryotic Homologs. Kubalski A, Martinac B, eds., ASM Press (Washington, D.C.), pp. 123-132.




 



3.
Guy H   (2005) Voltage-gated K+ channels, in Bacterial Ion Channels and Their Eukaryotic Homologs. Kubalski A, Martinac B, eds., ASM Press (Washington, D.C.), pp. 97-122.




 



4.
Guy H, Anishkin A, Chiang C, Betanzos M   (2005) MscL, a Bacterial Mechanosensitive Channel, in Bacterial Ion Channels and Their Eukaryotic Homologs. Kubalski A, Martinac B, eds., ASM Press (Washington, D.C.), pp. 259-290.




 



5.
Guy HR (2005). Transmembrane interactions of alpha/beta integrin signaling. Structure  13, 683-4.   https://doi.org/10.1016/j.str.2005.04.004




PubMed


 


PubMed ID 15893656
    
     


 



6.
Tseng GN, Guy HR (2005). Structure-function studies of the outer mouth and voltage sensor domain of hERG. Novartis Found Symp  266, 19-35; discussion 35-45.




PubMed


 


PubMed ID 16050260",https://intramural.nih.gov/search/searchview.taf?ipid=37074
80,BC008371-22,"October 01, 2004 -  September 30, 2005",DNA Deformations and Interactions with Transcription Factors,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Timofey  Spiridonov



Michael Ye Tolstorukov



Feng  Cui",NULL,Curtis  Harris; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37075
81,BC008382-22,"October 01, 2004 -  September 30, 2005",Computer Analysis of Nucleic Acid Structure,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Javed M Aman



Eckart  Bindewald



Ethan S Bromberg-Martin



Steven J Cole



Alan H Gee



Calvin P Grunewald



Show all 10","Donald  Atha
(Biotechnology Division, National Institutes of Standards and Technology)




John  Casey
(Microbiology and Immunology, Georgetown University)




Gregory  Chirikjian
(Mechanical Engineering, Johns Hopkins University)




John  Grefenstette
(Bioinformatics and Compuational BIology, George Mason University)




Hugo  Martinez
(Consultant, SAIC)




Nagarajan  Pattabiraman
(Oncology, Georgetown University)


Show all 7","Carmen  Allegra; PhD (National Cancer Institute)



Nancy H Colburn; PhD (National Cancer Institute)","Jack A Ragheb (NEI) 



John T Patton; BS, PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37077
82,BC008396-17,"October 01, 2004 -  September 30, 2005",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Zehua  Chen



Ilya  Lyakhov



Danielle  Needle","Paul
 Paul  Anagnostopoulos
(windfall.com)




Harald  Hess
(HHMI, Janelia Farm Campus)




Brent M Jewett





Michael Y Levashov





Karen A Lewis





Eric  Miller; PhD
(Department of Microbiology, North Carolina Sate University)


Show all 10","Robert J Fisher (National Cancer Institute)



Nancy H Colburn; PhD (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)",James R Ellis; PhD (OD),"Ordered by publication type and then author name.



1.
Schneider T   (2004) Dictionary of Bioinformatics and Computational Biology.  book: John M. Hancock and Marketa J. Zvelebil (eds), John Wiley and Sons, Inc 0-471-43622-4  pp.




 



2.
Schneider T   (2004) Molecular Computing Elements: Gates and Flip-Flop.  United States Patent 6,774,222  pp.




 



3.
Schneider TD (2006). Twenty Years of Delila and Molecular Information Theory: The Altenberg-Austin Workshop in Theoretical Biology Biological Information, Beyond Metaphor: Causality, Explanation, and Unification Altenberg, Austria, 11-14 July 2002. Biol Theory  1, 250-260.   https://doi.org/10.1162/biot.2006.1.3.250




PubMed



        
     
Free Article


 


PubMed ID 18084638
         Pubmed Central ID 2139980 


 



4.
Schneider TD, Lyakhov ID, Needle DD (submitted in 2005) Probe For Nucleic Acid Sequencing And Methods Of Use (medusa). Patents issued: 1960550 (FR in 2010); 1960550 (GB in 2010); 602006016984 (DE in 2010); 1960550 (EP in 2010); 7,871,777 (US in 2011). Patents pending: 10176710.1 (EP application); 2008-545768 (JP application); 12/980,802 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=37078
83,BC008579-12,"October 01, 2004 -  September 30, 2005",Functional Analysis of Cancer Genes from Human Chromosome 3p,"Michael I Lerman; MD, PhD",NULL,"Basic Research Laboratory, NCI","Tiziana  Cavinato



Fuh-Mei  Duh



Laura  Geil



Sergey  Ivanov



Alla  Ivanova



Igor  Kuzmin



Show all 7","Debora  Angeloni
(Scuola Superiore Sant'Anna and IFC-CNR)




Charles  Buys
(Genetics, University of Groningen)




Terrance  Johns
(Ludwig Institute for Cancer Research)




Frances  Jurnak
(UCI)




George  Klein
(MTC, Karolinska Institute)




Shu  Liao
(Pathology, UCI)


Show all 12","Lino  Tessarollo (National Cancer Institute)



Stephen K Anderson; PhD (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kuzmin I, Geil L, Gibson L, Cavinato T, Loukinov D, Lobanenkov V, Lerman MI (2005). Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter. J Mol Biol  346, 411-22.   https://doi.org/10.1016/j.jmb.2004.11.066




PubMed


 


PubMed ID 15670593
    
     


 



2.
Lerman M, Minna J   (2005) Chromosome 3 abnormalities in lung cancer.  Lung cancer: principles and practice  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37080
84,BC008710-27,"October 01, 2004 -  September 30, 2005",Molecular Chaperones and DNA Replication,"Sue H Wickner; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Jeremy G Bird



Matthew R Chenoweth; BA



Shannon M Doyle



Joel R Hoskins",NULL,Susan  Gottesman; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chae C, Sharma S, Hoskins JR, Wickner S   (2004) CbpA, a DnaJ homolog, is a DnaK co-chaperone, and its activity is modulated by CbpM.  J Biol Chem 279:33147-53.




PubMed


 


PubMed ID 15184371
    
     


 



2.
McKenney S   (2004) Chaperones, Molecular.  Encyclopedia of Biological Chemistry  pp.




 



3.
McKenney S, Hoskins R   (2005) Binding and Degradation of heterodimeric substrates by ClpAP and ClpXP.  J. Biol. Chem  pp.




 



4.
Sharma S, Sathyanarayana BK, Bird JG, Hoskins JR, Lee B, Wickner S (2004). Plasmid P1 RepA is homologous to the F plasmid RepE class of initiators. J Biol Chem  279, 6027-34.   https://doi.org/10.1074/jbc.M310917200




PubMed


 


PubMed ID 14634015",https://intramural.nih.gov/search/searchview.taf?ipid=36980
85,BC008714-28,"October 01, 2004 -  September 30, 2005",Bacterial Functions Involved in Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Jihane N Benhammou



Alexandre  Bougdour



Maude  Guillier



Nadim  Majdalani



Colleen A Mccullen



Karl  Thompson



Show all 8",NULL,"Michael  Maurizi; PhD (National Cancer Institute)



Sue H Wickner; PhD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)



Stephen H Leppla; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Christensen SK, Maenhaut-Michel G, Mine N, Gottesman S, Gerdes K, Van Melderen L (2004). Overproduction of the Lon protease triggers inhibition of translation in Escherichia coli: involvement of the yefM-yoeB toxin-antitoxin system. Mol Microbiol  51, 1705-17.   https://doi.org/10.1046/j.1365-2958.2003.03941.x




PubMed


 


PubMed ID 15009896
    
     


 



2.
Gottesman S   (2004) Involvement of a novel transcriptional activator and small RNA in post-transcriptional regulation of the glucose phosphoenolpyruvate phosphotransferase system.  Molecular Microbiology  pp.




 



3.
Gottesman S   (2004) The small RNA regulators of Escherichia coli: Roles and mechanisms.  Annual Rev. Microbiology  pp.




 



4.
Gottesman S (2005). Micros for microbes: non-coding regulatory RNAs in bacteria. Trends Genet  21, 399-404.   https://doi.org/10.1016/j.tig.2005.05.008




PubMed


 


PubMed ID 15913835
    
     


 



5.
Gottesman S, Heck M, Stout V   (2005) Role of RcsF in signaling to the Rcs phosphorelay pathway in Escherichia coli.  J. Bacteriology, in press.




 



6.
Gottesman S, Vanderpool C   (2005) Effect of RyhB small RNA on global iron use in Escherichia coli.  J. Bacteriology, in press.




 



7.
Majdalani N, Vanderpool CK, Gottesman S (2005). Bacterial small RNA regulators. Crit Rev Biochem Mol Biol  40, 93-113.   https://doi.org/10.1080/10409230590918702




PubMed


 


PubMed ID 15814430
    
     


 



8.
Munavar H, Zhou Y, Gottesman S (2005). Analysis of the Escherichia coli Alp phenotype: heat shock induction in ssrA mutants. J Bacteriol  187, 4739-51.   https://doi.org/10.1128/JB.187.14.4739-4751.2005




PubMed



        
     
Free Article


 


PubMed ID 15995188
         Pubmed Central ID 1169506 


 



9.
Vanderpool CK, Gottesman S (2005). Noncoding RNAs at the membrane. Nat Struct Mol Biol  12, 285-6.   https://doi.org/10.1038/nsmb0405-285




PubMed


 


PubMed ID 15809646
    
     


 



10.
Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, Vasil ML (2004). Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. Proc Natl Acad Sci U S A  101, 9792-7.   https://doi.org/10.1073/pnas.0403423101




PubMed



        
     
Free Article


 


PubMed ID 15210934
         Pubmed Central ID 470753",https://intramural.nih.gov/search/searchview.taf?ipid=37081
86,BC008727-27,"October 01, 2004 -  September 30, 2005",Gene Expression and Signal Transduction in Transformation and Differentiation,J. Frederic Mushinski; MD,NULL,"Laboratory of Genetics, NCI","Shalu  Gupta



Gibran  Holmes



James D Owens



Walter A Schlapkohl



Hongyang  Wang



Ki-Hwan  Kim","Michael  Kracht
(Biochemistry Department, Medizinische Hochschule Hannover)




Sabine  Mai
(Genomic Centre for Cancer Research and Diagnosis, University of Manitoba)




Harald  Mischak
(Abteilung Nephrologie, Medizinische Hochschule Hannover)




Larisa Y  Romanova
(MGH Dept. of Radiation Oncology, Harvard Medical School)




Qiming Jane  Wang
(Department of Pharmacology, University of Pittsburgh)","Jane Beth Trepel (National Cancer Institute)



Siegfried  Janz; MD, DSc (National Cancer Institute)



Michael  Potter; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Mushinski J, Kim J, Mousses S, Kallioniemi O, Kim J, Kim S, Lee B, Schaefer O, Trepel J   (2005) Microarrays as a Tool for Anti-Cancer Drug Development in Genetic and Proteomic Applications in Toxicity Testing, in Methods in Pharmacology and Toxicology,. Cunningham M, ed.,  The Humana Press Inc., in press.




 



2.
Mushinski J, Guffei A, Fest T   (2004) -Myc deregulation promotes a complex network of genomic instability.  Hormonal Carcinogenesis  pp.




 



3.
Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S (2005). Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res  65, 1306-15.   https://doi.org/10.1158/0008-5472.CAN-04-0268




PubMed


 


PubMed ID 15735016
    
     


 



4.
Romanova LY, Hashimoto S, Chay KO, Blagosklonny MV, Sabe H, Mushinski JF (2004). Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive. J Cell Sci  117, 3759-68.   https://doi.org/10.1242/jcs.01206




PubMed


 


PubMed ID 15252114
    
     


 



5.
Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M (2005). Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes. J Biol Chem  280, 27728-41.   https://doi.org/10.1074/jbc.M411657200




PubMed


 


PubMed ID 15837794
    
     


 



6.
Wang QJ, Lu G, Schlapkohl WA, Goerke A, Larsson C, Mischak H, Blumberg PM, Mushinski JF (2004). The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-delta and -epsilon. Mol Cancer Res  2, 129-40.




PubMed


 


PubMed ID 14985469",https://intramural.nih.gov/search/searchview.taf?ipid=37082
87,BC008751-25,"October 01, 2004 -  September 30, 2005",Regulation of Gene Transcription,"Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Colette  Burger



Sang Jun  Lee



Amos  Oppenheim



Fusheng  Guo; PhD



Sudeshna  Kar



Dale  Lewis; PhD



Show all 9",NULL,Victor  Zhurkin; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Roy S, Dimitriadis EK, Kar S, Geanacopoulos M, Lewis MS, Adhya S (2005). Gal repressor-operator-HU ternary complex: pathway of repressosome formation. Biochemistry  44, 5373-80.   https://doi.org/10.1021/bi047720t




PubMed


 


PubMed ID 15807530
    
     


 



2.
Semsey S, Virnik K, Adhya S (2005). A gamut of loops: meandering DNA. Trends Biochem Sci  30, 334-41.   https://doi.org/10.1016/j.tibs.2005.04.009




PubMed


 


PubMed ID 15950878
    
     


 



3.
Svenningsen SL, Costantino N, Court DL, Adhya S (2005). On the role of Cro in lambda prophage induction. Proc Natl Acad Sci U S A  102, 4465-9.   https://doi.org/10.1073/pnas.0409839102




PubMed



        
     
Free Article


 


PubMed ID 15728734
         Pubmed Central ID 555511 


 



4.
Tolstorukov MY, Virnik KM, Adhya S, Zhurkin VB (2005). A-tract clusters may facilitate DNA packaging in bacterial nucleoid. Nucleic Acids Res  33, 3907-18.   https://doi.org/10.1093/nar/gki699




PubMed



        
     
Free Article


 


PubMed ID 16024741
         Pubmed Central ID 1176013",https://intramural.nih.gov/search/searchview.taf?ipid=37083
88,BC008752-25,"October 01, 2004 -  September 30, 2005",Thyroid Hormone Receptors in Health and Disease,"Sheueyann  Cheng; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Osamu  Araki



Fumihiko  Furuya



Yasuhito  Kato



Caroline S Kim



Patrick  O'Shea



Hao  Ying



Show all 7","Reed  Larsen
(Brigham and Women's Hospital)




Bert  O'Malley
(Baylor College of Medicine)




Matthew D Ringel; MD
(Lab. of Molec. Endocrinol., Washington Hospital Center)




Graham  Williams
(Imperial College London, UK)




Mark  Willingham
(Wake Forest University School of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cheng S   (2005) An unliganded thyroid hormone nuclear beta receptor induces pituitary tumors.  Frontiers in Science, in press.




 



2.
Cheng S, Furuya F, Willingham M, O'Malley W   (2005) Dual functions of the steroid hormone receptor coactivator-3 in modulating resistance to thyroid hormone.  Mol Cel Biol, in press.




 



3.
Cheng SY (2005). Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Steroids  70, 450-4.   https://doi.org/10.1016/j.steroids.2005.02.003




PubMed


 


PubMed ID 15862829
    
     


 



4.
Cheng SY (2005). Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol Metab  16, 176-82.   https://doi.org/10.1016/j.tem.2005.03.008




PubMed


 


PubMed ID 15860414
    
     


 



5.
Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY (2005). An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol  25, 124-35.   https://doi.org/10.1128/MCB.25.1.124-135.2005




PubMed



        
     
Free Article


 


PubMed ID 15601836
         Pubmed Central ID 538780 


 



6.
Kim CS, Vasko VV, Kato Y, Kruhlak M, Saji M, Cheng SY, Ringel MD (2005). AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology  146, 4456-63.   https://doi.org/10.1210/en.2005-0172




PubMed


 


PubMed ID 16002527
    
     


 



7.
O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR (2005). Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Mol Endocrinol  19, 3045-59.   https://doi.org/10.1210/me.2005-0224




PubMed


 


PubMed ID 16051666
    
     


 



8.
Siesser WB, Cheng SY, McDonald MP (2005). Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse. Psychopharmacology (Berl)  181, 653-63.   https://doi.org/10.1007/s00213-005-0024-5




PubMed


 


PubMed ID 15983791
    
     


 



9.
Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, Harney JW, Cheng SY, Larsen PR, Bianco AC (2005). Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology  146, 1568-75.   https://doi.org/10.1210/en.2004-1392




PubMed


 


PubMed ID 15591136
    
     


 



10.
Zimonjic DB, Kato Y, Ying H, Popescu NC, Cheng SY (2005). Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice. Cancer Genet Cytogenet  161, 104-9.   https://doi.org/10.1016/j.cancergencyto.2005.02.007




PubMed


 


PubMed ID 16102579",https://intramural.nih.gov/search/searchview.taf?ipid=37084
89,BC008753-23,"October 01, 2004 -  September 30, 2005",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Richard A Beers



Tapan K Bera



Xing  Du



Mitchell  Ho



Tomoko  Ise



Satoshi  Nagata; PhD



Show all 9","Darell  Bigner
(Department of Pathology, Duke University Medical Center)




Giuliana  Salvatore
(Universita degli Studi di Napoli)","David J Fitzgerald; PhD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Bang S, Nagata S, Onda M, Kreitman RJ, Pastan I (2005). HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity. Clin Cancer Res  11, 1545-50.   https://doi.org/10.1158/1078-0432.CCR-04-1939




PubMed


 


PubMed ID 15746059
    
     


 



2.
Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang QC, Pastan I, Peschel C, Licht T (2004). Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood  103, 2718-26.   https://doi.org/10.1182/blood-2003-04-1317




PubMed


 


PubMed ID 14525789
    
     


 



3.
FitzGerald DJ, Kreitman R, Wilson W, Squires D, Pastan I (2004). Recombinant immunotoxins for treating cancer. Int J Med Microbiol  293, 577-82.   https://doi.org/10.1078/1438-4221-00302




PubMed


 


PubMed ID 15149034
    
     


 



4.
Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I (2005). Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Clin Cancer Res  11, 3814-20.   https://doi.org/10.1158/1078-0432.CCR-04-2304




PubMed


 


PubMed ID 15897581
    
     


 



5.
Ho M, Kreitman RJ, Onda M, Pastan I (2005). In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin. J Biol Chem  280, 607-17.   https://doi.org/10.1074/jbc.M409783200




PubMed


 


PubMed ID 15491997
    
     


 



6.
Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I, Nagata S (2005). Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin Cancer Res  11, 87-96.




PubMed


 


PubMed ID 15671532
    
     


 



7.
Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I (2005). Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol  16, 1013-23.   https://doi.org/10.1681/ASN.2004080720




PubMed


 


PubMed ID 15758046
    
     


 



8.
Nagata S, Ise T, Onda M, Nakamura K, Ho M, Raubitschek A, Pastan IH (2005). Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy. Proc Natl Acad Sci U S A  102, 7946-51.   https://doi.org/10.1073/pnas.0502975102




PubMed



        
     
Free Article


 


PubMed ID 15905329
         Pubmed Central ID 1142388 


 



9.
Oh S, Terabe M, Pendleton CD, Bhattacharyya A, Bera TK, Epel M, Reiter Y, Phillips J, Linehan WM, Kasten-Sportes C, Pastan I, Berzofsky JA (2004). Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Res  64, 2610-8.   https://doi.org/10.1158/0008-5472.can-03-2183




PubMed


 


PubMed ID 15059918
    
     


 



10.
Onda M, Bruland ØS, Pastan I (2005). TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma. Clin Orthop Relat Res   142-8  https://doi.org/10.1097/01.blo.0000137544.30200.b6




PubMed


 


PubMed ID 15662316
    
     


 



11.
Onda M, Wang QC, Guo HF, Cheung NK, Pastan I (2004). In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer Res  64, 1419-24.   https://doi.org/10.1158/0008-5472.can-03-0570




PubMed


 


PubMed ID 14973056
    
     


 



12.
Pastan I (2005). An NIH career: from bedside to basic research and back. J Biol Chem  280, 18553-7.   https://doi.org/10.1074/jbc.X500002200




PubMed


 


PubMed ID 15797860
    
     


 



13.
Pastan I, Beers R, Bera TK (2004). Recombinant immunotoxins in the treatment of cancer. Methods Mol Biol  248, 503-18.   https://doi.org/10.1385/1-59259-666-5:503




PubMed


 


PubMed ID 14970517
    
     


 



14.
Pastan I, Kreitman R, Willingham M   (2005) Localization of mesothelin in epithelial ovarian cancer.  Appl. Immunohistochem. Mol. Morphol, in press.




 



15.
Pastan I, Palena C, Arlen P, Hassan R, Schlom J, Tsang K   (2005) Identification of novel human cytotoxic T lymphocyte epitopes and their agonist epitopes of mesothelin.  Clin. Cancer Res, in press.




 



16.
Pastan I, Willingham M, Nagata S, Bera T, Beers R, Hassan R, Kreitman R   (2005) New monoclonal antibodies to mesothelin useful for immunohistochemistry, FACS, Western Blotting and ELISA.  Clin. Cancer Res, in press.




 



17.
Sato N, Hassan R, Axworthy D, Wong K, Theodore L, Lin Y, Park L, Brechbiel M, Paik C, Carrasquillo J   (2005) Prepared radioimmunotherapy of mesothelin expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.  J. Nucl. Med, in press.




 



18.
Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR (2004). Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38. Clin Cancer Res  10, 7079-87.   https://doi.org/10.1158/1078-0432.CCR-04-0587




PubMed


 


PubMed ID 15501988
    
     


 



19.
Yao Z, Zhang M, Garmestani K, Axworthy DB, Mallett RW, Fritzberg AR, Theodore LJ, Plascjak PS, Eckelman WC, Waldmann TA, Pastan I, Paik CH, Brechbiel MW, Carrasquillo JA (2004). Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N"",N""'-tetraacetic acid-biotin. Clin Cancer Res  10, 3137-46.   https://doi.org/10.1158/1078-0432.ccr-03-0171




PubMed


 


PubMed ID 15131055
    
     


 



20.
Pastan IH, Fitzgerald DH, Kreitman RH, Lee BH, Nagata SH, Onda MH (submitted in 2005) Mutated Pseudomonas Exotoxins With Reduced Antigenicity. Patents issued: 1910407 (CH in 2011); 1910407 (DE in 2011); 1910407 (EP in 2011); 1910407 (ES in 2011); 1910407 (FR in 2011); 1910407 (GB in 2011); 1910407 (IT in 2011); 2006275865 (AU in 2013); 2311854 (CH in 2013); 2311854 (DE in 2013); 2311854 (EP in 2013); 2311854 (ES in 2013); 2311854 (FR in 2013); 2311854 (GB in 2013); 2311854 (IT in 2013); 8,907,060 (US in 2015); 2014208269 (AU in 2016); 602006047581 (DE in 2016); 2332970 (EP in 2016); 2332970 (ES in 2016); 2332970 (FR in 2016); 2332970 (GB in 2016); 233970 (IT in 2016); 2616987 (CA in 2017); 2016202754 (AU in 2018); 3006458 (BE in 2018); 3006457 (BE in 2018); 602006054213 (DE in 2018); 602006054212 (DE in 2018); 3006457 (EP in 2018); 3006458 (EP in 2018); 2660026 (ES in 2018); 2659039 (ES in 2018); 3006458 (FR in 2018); 3006457 (FR in 2018); 3006458 (GB in 2018); 3006457 (GB in 2018); 3006458 (IE in 2018); 3006457 (IE in 2018); 3006458 (AT in 2018); 3006457 (AT in 2018); 3006458 (IT in 2018); 3006457 (IT in 2018); 3006458 (NL in 2018); 3006457 (NL in 2018); 3006458 (PL in 2018); 3006457 (PL in 2018). Patents pending: 2012216642 (AU application); 2941466 (CA application); 15191388.6 (EP application); PCT/US2006/028986 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37085
90,BC008756-18,"October 01, 2004 -  September 30, 2005",Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Linan  Ha



Takeshi  Ichikawa



Chamelli  Jhappan; PhD



Richard D Sharp



Yanlin  Yu



Muhammad R Zaidi","Boris  Bastian
(UCSF)




Dot  Bennett
(St. George's Hospital Medical School)




Shelley  Berger
(Wistar Institute)




Lynda  Chin
(Harvard Medical School)




Edward  De Fabo
(GWU)




Ron  DePinho
(Dana Farber, Harvard)


Show all 8","Lee Jay Helman; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Thomas J Hornyak (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37086
91,BC008757-18,"October 01, 2004 -  September 30, 2005",Bio-Therapies for the Treatment of Cancer and Infectious Disease,"David J Fitzgerald; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Victoria M Addis



Roy  Irving



Diana  Pastrana



Robert J Sarnovsky



Victoria  Chen","Gujon  Bu
(Washington Universitiy)




Marian  Mckee
(NCI)




Randall  Mrsny
(Trinity Biosystems)","Ira H Pastan; MD (National Cancer Institute)



Susan  Gottesman; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)",Eric N. Johnson; PhD (NIAID),"Ordered by publication type and then author name.



1.
FitzGerald D, Tham D, Feng W, Huang F, Embaie S, Liu K, Dean D, Hertle R, Mrsny R   (2005) An intranasal immunization strategy to impede pilin-mediated binding of P aeruginosa to airway epithelial cells.  Infection and Immunity, in press.




 



2.
Kreitman RJ, Squires DR, Stetler-Stevenson M, Noel P, FitzGerald DJ, Wilson WH, Pastan I (2005). Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. J Clin Oncol  23, 6719-29.   https://doi.org/10.1200/JCO.2005.11.437




PubMed


 


PubMed ID 16061911
    
     


 



3.
Pastrana DV, Hanson AJ, Knisely J, Bu G, Fitzgerald DJ (2005). LRP 1 B functions as a receptor for Pseudomonas exotoxin. Biochim Biophys Acta  1741, 234-9.   https://doi.org/10.1016/j.bbadis.2005.06.007




PubMed


 


PubMed ID 16095885
    
     


 



4.
Pastan IH, Fitzgerald DH, Kreitman RH, Lee BH, Nagata SH, Onda MH (submitted in 2005) Mutated Pseudomonas Exotoxins With Reduced Antigenicity. Patents issued: 1910407 (CH in 2011); 1910407 (DE in 2011); 1910407 (EP in 2011); 1910407 (ES in 2011); 1910407 (FR in 2011); 1910407 (GB in 2011); 1910407 (IT in 2011); 2006275865 (AU in 2013); 2311854 (CH in 2013); 2311854 (DE in 2013); 2311854 (EP in 2013); 2311854 (ES in 2013); 2311854 (FR in 2013); 2311854 (GB in 2013); 2311854 (IT in 2013); 8,907,060 (US in 2015); 2014208269 (AU in 2016); 602006047581 (DE in 2016); 2332970 (EP in 2016); 2332970 (ES in 2016); 2332970 (FR in 2016); 2332970 (GB in 2016); 233970 (IT in 2016); 2616987 (CA in 2017); 2016202754 (AU in 2018); 3006458 (BE in 2018); 3006457 (BE in 2018); 602006054213 (DE in 2018); 602006054212 (DE in 2018); 3006457 (EP in 2018); 3006458 (EP in 2018); 2660026 (ES in 2018); 2659039 (ES in 2018); 3006458 (FR in 2018); 3006457 (FR in 2018); 3006458 (GB in 2018); 3006457 (GB in 2018); 3006458 (IE in 2018); 3006457 (IE in 2018); 3006458 (AT in 2018); 3006457 (AT in 2018); 3006458 (IT in 2018); 3006457 (IT in 2018); 3006458 (NL in 2018); 3006457 (NL in 2018); 3006458 (PL in 2018); 3006457 (PL in 2018). Patents pending: 2012216642 (AU application); 2941466 (CA application); 15191388.6 (EP application); PCT/US2006/028986 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37087
92,BC008759-14,"October 01, 2004 -  September 30, 2005",Molecular Modeling and Bioinformatics,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Nalin  Goonesekere



Yoonsoo  Hahn



Changhoon  Kim



Bangalore K Sathyanarayana



Chin-Hsien  Tai



James J Vincent","Jean  Garnier; PhD





Jean-Francois  Gibrat; PhD
(Mathematique Informatique et Genome, Institut National de la Recherche Agronomique)




Giuseppe  Graziano","Ira H Pastan; MD (National Cancer Institute)



Sue H Wickner; PhD (DNA Molecular Biology Section)



Sankar  Adhya; PhD (National Cancer Institute)



Peter Jonathan Munson; BA, MA, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee B   (2005) On the intactness of hydrogen bonds around nonpolar solutes dissolved in water.  Journal of Physical Chemistry B  pp.




 



2.
Lee B, Bera T, Pastan I   (2005) Duplication and Extensive Remodeling Shaped POTE Family Genes Encoding Proteins Containing Ankyrin Repeat and Coiled Coil Domains.  Gene, in press.




 



3.
Lee B, Lee B   (2005) Evaluation of Domain Prediction in CASP6.  Proteins, in press.




 



4.
Lee B, Tai C, Sathyanarayana B   (2005) Assessment of CASP6 Predictions for New and Nearly New Fold Targets.  Proteins, in press.




 



5.
Lee B, Tai C, Wang G, Ezkurdia I, López G, Valencia A, Dunbrack R   (2005) Domain Definition and Target Classification for CASP6.  Proteins, in press.




 



6.
Pastan IH, Fitzgerald DH, Kreitman RH, Lee BH, Nagata SH, Onda MH (submitted in 2005) Mutated Pseudomonas Exotoxins With Reduced Antigenicity. Patents issued: 1910407 (CH in 2011); 1910407 (DE in 2011); 1910407 (EP in 2011); 1910407 (ES in 2011); 1910407 (FR in 2011); 1910407 (GB in 2011); 1910407 (IT in 2011); 2006275865 (AU in 2013); 2311854 (CH in 2013); 2311854 (DE in 2013); 2311854 (EP in 2013); 2311854 (ES in 2013); 2311854 (FR in 2013); 2311854 (GB in 2013); 2311854 (IT in 2013); 8,907,060 (US in 2015); 2014208269 (AU in 2016); 602006047581 (DE in 2016); 2332970 (EP in 2016); 2332970 (ES in 2016); 2332970 (FR in 2016); 2332970 (GB in 2016); 233970 (IT in 2016); 2616987 (CA in 2017); 2016202754 (AU in 2018); 3006458 (BE in 2018); 3006457 (BE in 2018); 602006054213 (DE in 2018); 602006054212 (DE in 2018); 3006457 (EP in 2018); 3006458 (EP in 2018); 2660026 (ES in 2018); 2659039 (ES in 2018); 3006458 (FR in 2018); 3006457 (FR in 2018); 3006458 (GB in 2018); 3006457 (GB in 2018); 3006458 (IE in 2018); 3006457 (IE in 2018); 3006458 (AT in 2018); 3006457 (AT in 2018); 3006458 (IT in 2018); 3006457 (IT in 2018); 3006458 (NL in 2018); 3006457 (NL in 2018); 3006458 (PL in 2018); 3006457 (PL in 2018). Patents pending: 2012216642 (AU application); 2941466 (CA application); 15191388.6 (EP application); PCT/US2006/028986 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37089
93,BC008905-24,"October 01, 2004 -  September 30, 2005",Tumor gene expression in vitro and in vivo,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Laura  Asnaghi



Richard B Braverman



Alex  Papageorge



Xiaolan  Qian; MD, PhD



William C Vass",NULL,"James G McNally; PhD (National Cancer Institute)



Paul A Randazzo; MD, PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW (2005). Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet  37, 1055-62.   https://doi.org/10.1038/ng1635




PubMed



        
     
Free Article


 


PubMed ID 16142231
         Pubmed Central ID 2140048 


 



2.
Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J  23, 1739-48.   https://doi.org/10.1038/sj.emboj.7600136




PubMed



        
     
Free Article


 


PubMed ID 15057284
         Pubmed Central ID 394229",https://intramural.nih.gov/search/searchview.taf?ipid=37090
94,BC008952-19,"October 01, 2004 -  September 30, 2005",Oncogenes and tumor suppressors in murine acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Juraj  Bies



Richard P Koller



Jan  Markus



Michael  Rosu-Myles



Thomas  Paul","Lucio  Castillo
(Program in Gene Function and Expression, University of Massachusetts)




Hiroaki  Honda
(Developmental Biology, Hiroshima University)




Christopher  Klug
(Department of Microbiology, University of Alabama)




Michele  Le Beau
(Department of Medicine, University of Chicago)




Thirman  Michael
(Department of Medicine, University of Chicago)




Janet  Rowley
(Department of Medicine, University of Chicago)


Show all 7","John J Letterio; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Peter D Aplan; MD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37091
95,BC009003-23,"October 01, 2004 -  September 30, 2005",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Shin  Hamada



Mario  Mancino



Kazuhide  Watanabe",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bianco C, Normanno N, Salomon DS, Ciardiello F (2004). Role of the cripto (EGF-CFC) family in embryogenesis and cancer. Growth Factors  22, 133-9.   https://doi.org/10.1080/08977190410001723290




PubMed


 


PubMed ID 15518236
    
     


 



2.
Bianco C, Strizzi L, Ebert A, Chang C, Rehman A, Normanno N, Guedez L, Salloum R, Ginsburg E, Sun Y, Khan N, Hirota M, Wallace-Jones B, Wechselberger C, Vonderhaar BK, Tosato G, Stetler-Stevenson WG, Sanicola M, Salomon DS (2005). Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst  97, 132-41.   https://doi.org/10.1093/jnci/dji011




PubMed


 


PubMed ID 15657343
    
     


 



3.
Bianco C, Strizzi L, Normanno N, Khan N, Salomon DS (2005). Cripto-1: an oncofetal gene with many faces. Curr Top Dev Biol  67, 85-133.   https://doi.org/10.1016/S0070-2153(05)67003-2




PubMed


 


PubMed ID 15949532
    
     


 



4.
Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, Caponigro F, Salomon DS (2005). The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets  6, 243-57.   https://doi.org/10.2174/1389450053765879




PubMed


 


PubMed ID 15857286
    
     


 



5.
Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS (2005). Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am J Pathol  167, 585-97.   https://doi.org/10.1016/S0002-9440(10)63000-3




PubMed



        
     
Free Article


 


PubMed ID 16049342
         Pubmed Central ID 1603555 


 



6.
Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS (2005). Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene  24, 4094-105.   https://doi.org/10.1038/sj.onc.1208417




PubMed


 


PubMed ID 15897912",https://intramural.nih.gov/search/searchview.taf?ipid=37092
96,BC009029-13,"October 01, 2004 -  September 30, 2005",Mechanisms of CTL-Mediated Antitumor Activity In Vivo in Mouse Models of Active,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Kristy M Greeneltch



Monika  Schneider



Trina J Stewart



Jenny  Bai",NULL,"James W Hodge; PhD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Jeffrey  Schlom; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Abrams S, Schlom J   (2005) Vaccines and Immunostimulants, in Cancer Medicine. Holland J, FreiIII E, eds., B.C. Decker (Ontario), in press.




 



2.
Abrams SI (2004). Regulation of tumor progression by anti-neoplastic T cell responses. Cancer Biol Ther  3, 140-6.   https://doi.org/10.4161/cbt.3.2.758




PubMed


 


PubMed ID 14739786
    
     


 



3.
Abrams SI (2005). Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response. Front Biosci  10, 809-21.   https://doi.org/10.2741/1575




PubMed


 


PubMed ID 15569621
    
     


 



4.
Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW (2004). External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res  64, 4328-37.   https://doi.org/10.1158/0008-5472.CAN-04-0073




PubMed


 


PubMed ID 15205348",https://intramural.nih.gov/search/searchview.taf?ipid=37093
97,BC009052-16,"October 01, 2004 -  September 30, 2005",Papillomavirus Virion Proteins and Vaccines,"John  Schiller; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Christopher  Buck



Patricia  Day; PhD



Jeffrey  Roberts



Cynthia D Thompson","Neil  Christensen
(Penn State)




Joakim  Diller
(University of Malmo)




David  Morgan
(University of South Florida)




Denise  Nardelli-Haefliger
(Centre Hospitalier Universitaire Vaudois)




Richard  Roden
(Johns Hopkins University)




Martin  Sapp
(University of Mainz)","Douglas  Lowy; MD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004). Efficient intracellular assembly of papillomaviral vectors. J Virol  78, 751-7.   https://doi.org/10.1128/jvi.78.2.751-757.2004




PubMed



        
     
Free Article


 


PubMed ID 14694107
         Pubmed Central ID 368835 


 



2.
Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005). Maturation of papillomavirus capsids. J Virol  79, 2839-46.   https://doi.org/10.1128/JVI.79.5.2839-2846.2005




PubMed



        
     
Free Article


 


PubMed ID 15709003
         Pubmed Central ID 548454 


 



3.
Chackerian B, Briglio L, Albert PS, Lowy DR, Schiller JT (2004). Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J Virol  78, 4037-47.   https://doi.org/10.1128/jvi.78.8.4037-4047.2004




PubMed



        
     
Free Article


 


PubMed ID 15047820
         Pubmed Central ID 374281 


 



4.
Day PM, Baker CC, Lowy DR, Schiller JT (2004). Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A  101, 14252-7.   https://doi.org/10.1073/pnas.0404229101




PubMed



        
     
Free Article


 


PubMed ID 15383670
         Pubmed Central ID 521143 


 



5.
Lenz P, Lowy DR, Schiller JT (2005). Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells. Eur J Immunol  35, 1548-56.   https://doi.org/10.1002/eji.200425547




PubMed


 


PubMed ID 15832296
    
     


 



6.
Nardelli-Haefliger D, Lurati F, Wirthner D, Spertini F, Schiller JT, Lowy DR, Ponci F, De Grandi P (2005). Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Vaccine  23, 3634-41.   https://doi.org/10.1016/j.vaccine.2005.02.019




PubMed


 


PubMed ID 15882523
    
     


 



7.
Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Krüger Kjaer S, Lowy DR, Schiller JT (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology  321, 205-16.   https://doi.org/10.1016/j.virol.2003.12.027




PubMed


 


PubMed ID 15051381
    
     


 



8.
Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, Culp TD, Christensen ND, Lowy DR, Schiller JT, Roden RB (2005). Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology  337, 365-72.   https://doi.org/10.1016/j.virol.2005.04.011




PubMed


 


PubMed ID 15885736
    
     


 



9.
Pinto LA, Castle PE, Roden RB, Harro CD, Lowy DR, Schiller JT, Wallace D, Williams M, Kopp W, Frazer IH, Berzofsky JA, Hildesheim A (2005). HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine  23, 3555-64.   https://doi.org/10.1016/j.vaccine.2005.01.146




PubMed


 


PubMed ID 15855014
    
     


 



10.
Schiller JT, Davies P (2004). Delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol  2, 343-7.   https://doi.org/10.1038/nrmicro867




PubMed


 


PubMed ID 15031733
    
     


 



11.
Schiller J, Gambhira R, Lowy D, Pastrana D, Roden R (submitted in 2005) Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies. Patents issued: 200680011079 (CN in 2013); 2006210792 (AU in 2013); 5224821 (JP in 2013); 8,404,244 (US in 2013); 263255 (IN in 2015); 9,388,221 (US in 2016); 2,596,698 (CA in 2017); 1853307 (DE in 2017); 1853307 (EP in 2017); 1853307 (FR in 2017); 1853307 (GB in 2017). Patent pending: PI0607097-3 (BR application).",https://intramural.nih.gov/search/searchview.taf?ipid=37094
98,BC009100-20,"October 01, 2004 -  September 30, 2005",Melanoma and Melanogenesis,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI","Barbara  Bellei



Werner F Berens



Toshihiko  Hoashi



Elodie  Le Pape



Yoshinori  Miyamura



Francois  Rouzaud



Show all 9","Ettore  Appella; MD
(NCI)




Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)




Donald  Hunt
(Department of Chemistry, University of Minnesota)




Shosuke  Ito
(Department of Chemistry, Fujita Health University)




M. Lynn  Lamoreux
(Department of Animal Sciences, Texas A & M University)




Jean Marie  Naeyaert
(Department of Dermatology, Gent University)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Ando H, Watabe H, Valencia JC, Yasumoto K, Furumura M, Funasaka Y, Oka M, Ichihashi M, Hearing VJ (2004). Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function. J Biol Chem  279, 15427-33.   https://doi.org/10.1074/jbc.M313701200




PubMed


 


PubMed ID 14739285
    
     


 



2.
Chen KG, Szakács G, Annereau JP, Rouzaud F, Liang XJ, Valencia JC, Nagineni CN, Hooks JJ, Hearing VJ, Gottesman MM (2005). Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res  18, 102-12.   https://doi.org/10.1111/j.1600-0749.2005.00214.x




PubMed



        
     
Free Article


 


PubMed ID 15760339
         Pubmed Central ID 3915408 


 



3.
Costin GE, Valencia JC, Wakamatsu K, Ito S, Solano F, Milac AL, Vieira WD, Yamaguchi Y, Rouzaud F, Petrescu AJ, Lamoreux ML, Hearing VJ (2005). Mutations in dopachrome tautomerase (Dct) affect eumelanin/pheomelanin synthesis, but do not affect intracellular trafficking of the mutant protein. Biochem J  391, 249-59.   https://doi.org/10.1042/BJ20042070




PubMed



        
     
Free Article


 


PubMed ID 15960609
         Pubmed Central ID 1276922 


 



4.
Costin GE, Vieira WD, Valencia JC, Rouzaud F, Lamoreux ML, Hearing VJ (2004). Immortalization of mouse melanocytes carrying mutations in various pigmentation genes. Anal Biochem  335, 171-4.   https://doi.org/10.1016/j.ab.2004.07.035




PubMed


 


PubMed ID 15519586
    
     


 



5.
Greggio E, Bergantino E, Carter D, Ahmad R, Costin GE, Hearing VJ, Clarimon J, Singleton A, Eerola J, Hellström O, Tienari PJ, Miller DW, Beilina A, Bubacco L, Cookson MR (2005). Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease. J Neurochem  93, 246-56.   https://doi.org/10.1111/j.1471-4159.2005.03019.x




PubMed


 


PubMed ID 15773923
    
     


 



6.
Hearing VJ (2005). Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci  37, 3-14.   https://doi.org/10.1016/j.jdermsci.2004.08.014




PubMed


 


PubMed ID 15619429
    
     


 



7.
Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ (2005). MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem  280, 14006-16.   https://doi.org/10.1074/jbc.M413692200




PubMed


 


PubMed ID 15695812
    
     


 



8.
Kageyama A, Oka M, Okada T, Nakamura S, Ueyama T, Saito N, Hearing VJ, Ichihashi M, Nishigori C (2004). Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase. J Biol Chem  279, 27774-80.   https://doi.org/10.1074/jbc.M401786200




PubMed


 


PubMed ID 15067002
    
     


 



9.
Rouzaud F, Hearing VJ (2005). Regulatory elements of the melanocortin 1 receptor. Peptides  26, 1858-70.   https://doi.org/10.1016/j.peptides.2004.11.041




PubMed


 


PubMed ID 16005546
    
     


 



10.
Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res  571, 133-52.   https://doi.org/10.1016/j.mrfmmm.2004.09.014




PubMed


 


PubMed ID 15748644
    
     


 



11.
Tadokoro T, Yamaguchi Y, Batzer J, Coelho SG, Zmudzka BZ, Miller SA, Wolber R, Beer JZ, Hearing VJ (2005). Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol  124, 1326-32.   https://doi.org/10.1111/j.0022-202X.2005.23760.x




PubMed


 


PubMed ID 15955111
    
     


 



12.
Takeuchi S, Zhang W, Wakamatsu K, Ito S, Hearing VJ, Kraemer KH, Brash DE (2004). Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A  101, 15076-81.   https://doi.org/10.1073/pnas.0403994101




PubMed



        
     
Free Article


 


PubMed ID 15477596
         Pubmed Central ID 524044 


 



13.
Watabe H, Valencia JC, Yasumoto K, Kushimoto T, Ando H, Muller J, Vieira WD, Mizoguchi M, Appella E, Hearing VJ (2004). Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J Biol Chem  279, 7971-81.   https://doi.org/10.1074/jbc.M309714200




PubMed


 


PubMed ID 14634018
    
     


 



14.
Yamaguchi Y, Itami S, Watabe H, Yasumoto K, Abdel-Malek ZA, Kubo T, Rouzaud F, Tanemura A, Yoshikawa K, Hearing VJ (2004). Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol  165, 275-85.   https://doi.org/10.1083/jcb.200311122




PubMed



        
     
Free Article


 


PubMed ID 15117970
         Pubmed Central ID 2172049 


 



15.
Yamaguchi Y, Yoshida S, Sumikawa Y, Kubo T, Hosokawa K, Ozawa K, Hearing VJ, Yoshikawa K, Itami S (2004). Rapid healing of intractable diabetic foot ulcers with exposed bones following a novel therapy of exposing bone marrow cells and then grafting epidermal sheets. Br J Dermatol  151, 1019-28.   https://doi.org/10.1111/j.1365-2133.2004.06170.x




PubMed


 


PubMed ID 15541080
    
     


 



16.
Yasumoto K, Watabe H, Valencia JC, Kushimoto T, Kobayashi T, Appella E, Hearing VJ (2004). Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment. J Biol Chem  279, 28330-8.   https://doi.org/10.1074/jbc.M401269200




PubMed


 


PubMed ID 15096515",https://intramural.nih.gov/search/searchview.taf?ipid=37095
99,BC009101-13,"October 01, 2004 -  September 30, 2005",Design of Antiviral Drugs Effective Against the HIV-1 Virus,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Toshiaki  Hara



Lisa Marie Jenkins



Marco L Schito","Simon  Barratt-Boyes
(Dept. of Infectious Diseases and Microbiology, University of Pittsburgh)




Robert  Buckheit Jr.
(President and Chief Scientific Officer, ImQuest BioSciences, Inc.)




David  Ott
(SAIC-Frederick)




Robin  Shattock; PhD
(St George's Hospital Medical School)




James  Turpin
(Prevention Sciences Branch, National Institute of Allergy and Infectious Diseases)",NULL,John K. Inman; PhD (NIAID),"Ordered by publication type and then author name.



1.
Jenkins LM, Byrd JC, Hara T, Srivastava P, Mazur SJ, Stahl SJ, Inman JK, Appella E, Omichinski JG, Legault P (2005). Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters. J Med Chem  48, 2847-58.   https://doi.org/10.1021/jm0492195




PubMed


 


PubMed ID 15828823
    
     


 



2.
Srivastava P, Schito M, Fattah RJ, Hara T, Hartman T, Buckheit RW, Turpin JA, Inman JK, Appella E (2004). Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorg Med Chem  12, 6437-50.   https://doi.org/10.1016/j.bmc.2004.09.032




PubMed


 


PubMed ID 15556761",https://intramural.nih.gov/search/searchview.taf?ipid=37096
100,BC009247-25,"October 01, 2004 -  September 30, 2005",Natural Cell-Mediated Immunity Mechanism of Lysis,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Meagan T Horner



Anna T Mason



John W Wine



Robin T Winkler Pickett","Stephen K Anderson; PhD

(Frederick, MD 21702-1201)




Michael  Bennett
(Dept. of Pathology, University of Texas Southwestern Medical Center)




Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)




Wayne M. Yokoyama; MD
(Rheumatology Division, Washington University)","Howard A Young; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)



Deborah L Hodge (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Ortaldo JR, Winkler-Pickett RT, Bere EW, Watanabe M, Murphy WJ, Wiltrout RH (2005). In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells. J Immunol  175, 693-9.   https://doi.org/10.4049/jimmunol.175.2.693




PubMed


 


PubMed ID 16002664
    
     


 



2.
Ortaldo JR, Young HA (2005). Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol  42, 445-50.   https://doi.org/10.1016/j.molimm.2004.07.024




PubMed


 


PubMed ID 15607796
    
     


 



3.
Ortaldo JR, Young HA, Winkler-Pickett RT, Bere EW, Murphy WJ, Wiltrout RH (2004). Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol  172, 943-53.   https://doi.org/10.4049/jimmunol.172.2.943




PubMed


 


PubMed ID 14707067",https://intramural.nih.gov/search/searchview.taf?ipid=37097
101,BC009251-35,"October 01, 2004 -  September 30, 2005",Mechanism of Lymphocyte-Mediated Cytotoxicity,Pierre A. Henkart; PhD,NULL,"Experimental Immunology Branch, NCI","Marta Liliana Catalfamo; PhD



Charles R Mainhart",NULL,Wei  Xiao (Lymphocyte Cytotoxicity Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37098
102,BC009254-31,"October 01, 2004 -  September 30, 2005",Innate Immunity,David M Segal; PhD,NULL,"Experimental Immunology Branch, NCI",Alessandra  Mazzoni,NULL,NULL,"Joseph  Shiloach; PhD (NIDDK) 



David R Davies; PhD (NIDDK) 



David Harvey Margulies; MD, PhD (NIAID) 



Reuben P Siraganian; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR (2005). The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A  102, 10976-80.   https://doi.org/10.1073/pnas.0505077102




PubMed



        
     
Free Article


 


PubMed ID 16043704
         Pubmed Central ID 1182468 


 



2.
Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, Dileepan KN, Segal DM (2004). A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J Biol Chem  279, 34698-704.   https://doi.org/10.1074/jbc.M405444200




PubMed


 


PubMed ID 15175334
    
     


 



3.
Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM (2004). TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol  173, 1179-83.   https://doi.org/10.4049/jimmunol.173.2.1179




PubMed



        
     
Free Article


 


PubMed ID 15240708
         Pubmed Central ID 2757936 


 



4.
Mazzoni A, Segal DM (2004). Controlling the Toll road to dendritic cell polarization. J Leukoc Biol  75, 721-30.   https://doi.org/10.1189/jlb.1003482




PubMed


 


PubMed ID 14726500",https://intramural.nih.gov/search/searchview.taf?ipid=37099
103,BC009255-30,"October 01, 2004 -  September 30, 2005",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI","Anthony J Adams



Larry  Granger



Don  Plugge",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36981
104,BC009256-23,"October 01, 2004 -  September 30, 2005",Natural Cell-Mediated Immunity: Biology and Regulation of CD3- LGL,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Meagan T Horner



Anna T Mason



John W Wine



Robin T Winkler Pickett","Julia  Albright
(George Washington University)




Stephen K Anderson; PhD

(Frederick, MD 21702-1201)




Michael  Bennett
(Dept. of Pathology, University of Texas Southwestern Medical Center)




Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)","Howard A Young; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Albright JW, Bream JH, Bere EW, Young HA, Winkler-Pickett R, Ortaldo JR (2004). Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2. Exp Gerontol  39, 73-82.   https://doi.org/10.1016/j.exger.2003.09.017




PubMed


 


PubMed ID 14724067
    
     


 



2.
Brehm MA, Daniels KA, Ortaldo JR, Welsh RM (2005). Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo. J Immunol  174, 6663-71.   https://doi.org/10.4049/jimmunol.174.11.6663




PubMed


 


PubMed ID 15905505
    
     


 



3.
Zhang X, Rodriguez-Galán MC, Subleski JJ, Ortaldo JR, Hodge DL, Wang JM, Shimozato O, Reynolds DA, Young HA (2004). Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. Blood  104, 3276-84.   https://doi.org/10.1182/blood-2004-02-0664




PubMed


 


PubMed ID 15265789",https://intramural.nih.gov/search/searchview.taf?ipid=37100
105,BC009257-30,"October 01, 2004 -  September 30, 2005",Mechanisms of Cellular Immune Responses,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Yin  Liu



Ruchika  Nijhara



Natalya  Belkina","Francis  Barr
(Department of Cell Biology, Max-Planck-Institute of Biochemistry)




Dominic  Esposito
(Protein Expression Laboratory, SAIC-Frederick)




Michelle  Gignac
(Image Analysis Laboratory, SAIC-Frederick)




James  Hartley
(Protein Expression Laboratory, SAIC-Frederick)




Peter  Hordijk
(Department of Experimental Immunohematology, Sanquin Research at CLB)




Peter  Parker



Show all 7",Michael John Kruhlak; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Anderson AO, Shaw S   (2005) Conduit for privileged communications in the lymph node.  Immunity 22:3-5.




PubMed


 


PubMed ID 15664153
    
     


 



2.
Fujii K, Zhu G, Liu Y, Hallam J, Chen L, Herrero J, Shaw S   (2004) Kinase peptide specificity: improved determination and relevance to protein phosphorylation.  Proc Natl Acad Sci U S A 101:13744-9.




PubMed



        
     
Free Article


 


PubMed ID 15356339
         Pubmed Central ID 518827 


 



3.
Nijhara R, van Hennik PB, Gignac ML, Kruhlak MJ, Hordijk PL, Delon J, Shaw S   (2004) Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes.  J Immunol 173:4985-93.




PubMed


 


PubMed ID 15470041
    
     


 



4.
Salganik MP, Hardie DL, Swart B, Dandie GW, Zola H, Shaw S, Shapiro H, Tinckam K, Milford EL, Wand MP   (2005) Detecting antibodies with similar reactivity patterns in the HLDA8 blind panel of flow cytometry data.  J Immunol Methods 305:67-74.




PubMed


 


PubMed ID 16129446
    
     


 



5.
Shaw J, Erlandsen S, Kruhlak M   (2005) Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells.  Immunology, in press.




 



6.
Zhu G, Fujii K, Belkina N, Liu Y, James M, Herrero J, Shaw S (2005). Exceptional disfavor for proline at the P + 1 position among AGC and CAMK kinases establishes reciprocal specificity between them and the proline-directed kinases. J Biol Chem  280, 10743-8.   https://doi.org/10.1074/jbc.M413159200




PubMed


 


PubMed ID 15647260
    
     


 



7.
Zhu G, Fujii K, Liu Y, Codrea V, Herrero J, Shaw S (2005). A single pair of acidic residues in the kinase major groove mediates strong substrate preference for P-2 or P-5 arginine in the AGC, CAMK, and STE kinase families. J Biol Chem  280, 36372-9.   https://doi.org/10.1074/jbc.M505031200




PubMed


 


PubMed ID 16131491
    
     


 



8.
Zhu G, Liu Y, Shaw S (2005). Protein kinase specificity. A strategic collaboration between kinase peptide specificity and substrate recruitment. Cell Cycle  4, 52-6.   https://doi.org/10.4161/cc.4.1.1353




PubMed


 


PubMed ID 15655379",https://intramural.nih.gov/search/searchview.taf?ipid=37101
106,BC009264-22,"October 01, 2004 -  September 30, 2005",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Maria  Birchenall-Roberts



Tao  Fu



Yi  Huang



Cari  Sadowski","Stephen  Bartelmez
(Stem Cell Biology, VIA-Cell-Singapore)




Lisbeth  Welniak
(Microbilogy-Immunology, Univ. Nevada-Reno)","Anita B Roberts; PhD (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Birchenall-Roberts MC, Fu T, Bang OS, Dambach M, Resau JH, Sadowski CL, Bertolette DC, Lee HJ, Kim SJ, Ruscetti FW (2004). Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways. J Biol Chem  279, 25605-13.   https://doi.org/10.1074/jbc.M402790200




PubMed


 


PubMed ID 15066998
    
     


 



2.
Ruscetti F   (2004) Cell cycle control and checkpoints in Hematopoietic Stem Cells.  Handbook of Stem Cells  pp.




 



3.
Ruscetti FW, Akel S, Bartelmez SH (2005). Autocrine transforming growth factor-beta regulation of hematopoiesis: many outcomes that depend on the context. Oncogene  24, 5751-63.   https://doi.org/10.1038/sj.onc.1208921




PubMed


 


PubMed ID 16123808",https://intramural.nih.gov/search/searchview.taf?ipid=37103
107,BC009265-23,"October 01, 2004 -  September 30, 2005",Analysis of the T Cell Repertoire,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Joanne  Lumsden



Melanie S Vacchio; PhD



Joy A Williams",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Vacchio MS, Hodes RJ (2005). Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J Immunol  174, 4657-61.   https://doi.org/10.4049/jimmunol.174.8.4657




PubMed


 


PubMed ID 15814689
    
     


 



2.
Vacchio MS, Williams JA, Hodes RJ (2005). A novel role for CD28 in thymic selection: elimination of CD28/B7 interactions increases positive selection. Eur J Immunol  35, 418-27.   https://doi.org/10.1002/eji.200424918




PubMed


 


PubMed ID 15657954",https://intramural.nih.gov/search/searchview.taf?ipid=37104
108,BC009266-23,"October 01, 2004 -  September 30, 2005",T Cell Regulation of B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Joanne  Lumsden,NULL,NULL,"Edward E Max (OD) 



Patricia J Gearhart; PhD (NIA) 



Herbert Carpenter Morse; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37105
109,BC009267-23,"October 01, 2004 -  September 30, 2005",Immune ProtectionDysregulation in HIVAIDS,"Gene  Shearer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Adriano  Boasso



Andrew W Hardy



Jean-Philippe  Herbeuval","Jan  Andersson
(Medicine, Karolinska Institutet)




Claire  Chougnet
(CHRF, Children's Hospital)




Matthew  Dolan
(AIDS, Wilford Hall Med Inst)




Dietmar  Fuchs
(Univ of Innsbruck)




David  Graham
(Johns Hopkins University)




Eric  Rosenberg
(Harvard University)


Show all 7","Jeffrey D Lifson; MD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)","Jean Charles  Grivel; PhD (NICHD) 



Richard T Wyatt; PhD (NIAID)","Ordered by publication type and then author name.



1.
Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM (2005). Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood  105, 1574-81.   https://doi.org/10.1182/blood-2004-06-2089




PubMed


 


PubMed ID 15466932
    
     


 



2.
Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, Dolan MJ, Chougnet C, Lifson JD, Shearer GM (2005). TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood  105, 2458-64.   https://doi.org/10.1182/blood-2004-08-3058




PubMed


 


PubMed ID 15585654
    
     


 



3.
Herbeuval JP, Grivel JC, Boasso A, Hardy AW, Chougnet C, Dolan MJ, Yagita H, Lifson JD, Shearer GM (2005). CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood  106, 3524-31.   https://doi.org/10.1182/blood-2005-03-1243




PubMed



        
     
Free Article


 


PubMed ID 16046522
         Pubmed Central ID 1895067 


 



4.
Rugeles MT, Shearer GM (2004). Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol  25, 348-52.   https://doi.org/10.1016/j.it.2004.04.007




PubMed


 


PubMed ID 15207501
    
     


 



5.
Shearer G, Hardy A, Boasso A, Stephanie A, Dolan M   (2005) Regulation of TRAIL on Primary CD4+ T Cells by HIV-1: Role of Type I Interferon-producing Plasmacytoid Dendritic Cells.  PNAS, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37106
110,BC009273-18,"October 01, 2004 -  September 30, 2005",T Cell Differentiation and Repertoire Selection,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Stanley  Adoro



Amala Shenai Alag



Oyvind  Dahle



Terry I Guinter



Jung-Hyun  Park



Sophia D Sarafova



Show all 8",NULL,Bosselut  Remy (National Cancer Institute),"Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Erman B, Guinter TI, Singer A (2004). Defined alphabeta T cell receptors with distinct ligand specificities do not require those ligands to signal double negative thymocyte differentiation. J Exp Med  199, 1719-24.   https://doi.org/10.1084/jem.20032204




PubMed



        
     
Free Article


 


PubMed ID 15210747
         Pubmed Central ID 2212817 


 



2.
Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A (2004). Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity  21, 289-302.   https://doi.org/10.1016/j.immuni.2004.07.016




PubMed


 


PubMed ID 15308108
    
     


 



3.
Sarafova SD, Erman B, Yu Q, Van Laethem F, Guinter T, Sharrow SO, Feigenbaum L, Wildt KF, Ellmeier W, Singer A (2005). Modulation of coreceptor transcription during positive selection dictates lineage fate independently of TCR/coreceptor specificity. Immunity  23, 75-87.   https://doi.org/10.1016/j.immuni.2005.05.011




PubMed


 


PubMed ID 16039581
    
     


 



4.
Singer A, Bosselut R (2004). CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv Immunol  83, 91-131.   https://doi.org/10.1016/S0065-2776(04)83003-7




PubMed


 


PubMed ID 15135629
    
     


 



5.
Tai X, Cowan M, Feigenbaum L, Singer A (2005). CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol  6, 152-62.   https://doi.org/10.1038/ni1160




PubMed


 


PubMed ID 15640801
    
     


 



6.
Yu Q, Erman B, Park JH, Feigenbaum L, Singer A (2004). IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med  200, 797-803.   https://doi.org/10.1084/jem.20032183




PubMed



        
     
Free Article


 


PubMed ID 15365098
         Pubmed Central ID 2211960",https://intramural.nih.gov/search/searchview.taf?ipid=37107
111,BC009279-20,"October 01, 2004 -  September 30, 2005",Regulation of Expression of MHC Class I Genes,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Shankar  Iyer



Aparna  Kotekar



Jocelyn D Weissman",NULL,"Kenneth  Buetow; PhD (National Cancer Institute)



Maxwell P Lee; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Grassadonia A, Tinari N, Fiorentino B, Suzuki K, Nakazato M, De Tursi M, Giuliani C, Napolitano G, Singer DS, Iacobelli S, Kohn LD (2004). The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. Endocrinology  145, 4728-36.   https://doi.org/10.1210/en.2004-0506




PubMed


 


PubMed ID 15231701
    
     


 



2.
Howcroft TK, Weissman JD, Gegonne A, Singer DS (2005). A T lymphocyte-specific transcription complex containing RUNX1 activates MHC class I expression. J Immunol  174, 2106-15.   https://doi.org/10.4049/jimmunol.174.4.2106




PubMed


 


PubMed ID 15699141
    
     


 



3.
Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS (2005). ATG deserts define a novel core promoter subclass. Genome Res  15, 1189-97.   https://doi.org/10.1101/gr.3873705




PubMed



        
     
Free Article


 


PubMed ID 16109972
         Pubmed Central ID 1199533 


 



4.
Singer D, Lovchik J, Zinger H   (2004) MHC Class I Expression Regulates Susceptibility to Spontaneous Autoimmune Disease in (NZBxNZW)F1 Mice.  Lupus .",https://intramural.nih.gov/search/searchview.taf?ipid=37108
112,BC009281-19,"October 01, 2004 -  September 30, 2005",Receptor Mediated T and B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Haifeng  Song



Karen  Hathcock",NULL,NULL,"Reuben P Siraganian; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Chiang YJ, Sommers CL, Jordan MS, Gu H, Samelson LE, Koretzky GA, Hodes RJ (2004). Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice. J Exp Med  200, 25-34.   https://doi.org/10.1084/jem.20040262




PubMed



        
     
Free Article


 


PubMed ID 15238603
         Pubmed Central ID 2213313 


 



2.
Williams JA, Hathcock KS, Klug D, Harada Y, Choudhury B, Allison JP, Abe R, Hodes RJ (2005). Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint. J Immunol  175, 4199-207.   https://doi.org/10.4049/jimmunol.175.7.4199




PubMed



        
     
Free Article


 


PubMed ID 16177059
         Pubmed Central ID 1343453 


 



3.
Zhang J, Chiang YJ, Hodes RJ, Siraganian RP (2004). Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J Immunol  173, 1811-8.   https://doi.org/10.4049/jimmunol.173.3.1811




PubMed


 


PubMed ID 15265912",https://intramural.nih.gov/search/searchview.taf?ipid=37109
113,BC009283-21,"October 01, 2004 -  September 30, 2005",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,"Howard A Young; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Matthew D Buschman



Deborah L Hodge



Della A Reynolds



Michael E Sanford","Thomas  Aune
(Vanderbilt Univ.)




Rivkah  Gonsky
(UCLA)




Lisa  Hensley; PhD
(FDA)




Michael  Tovey
(Andre Lwoff Institute)




Ricky  Ullrich
(USAMRIID)




Kelly  Warfield
(USAMRIID)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37110
114,BC009285-19,"October 01, 2004 -  September 30, 2005",Responses of MHC Class I Genes to Exogeneous Stimuli,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Helit  Cohen



Aparna  Kotekar



Jocelyn D Weissman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Grassadonia A, Tinari N, Fiorentino B, Suzuki K, Nakazato M, De Tursi M, Giuliani C, Napolitano G, Singer DS, Iacobelli S, Kohn LD (2004). The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. Endocrinology  145, 4728-36.   https://doi.org/10.1210/en.2004-0506




PubMed


 


PubMed ID 15231701
    
     


 



2.
Howcroft TK, Weissman JD, Gegonne A, Singer DS (2005). A T lymphocyte-specific transcription complex containing RUNX1 activates MHC class I expression. J Immunol  174, 2106-15.   https://doi.org/10.4049/jimmunol.174.4.2106




PubMed


 


PubMed ID 15699141
    
     


 



3.
Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS (2005). ATG deserts define a novel core promoter subclass. Genome Res  15, 1189-97.   https://doi.org/10.1101/gr.3873705




PubMed



        
     
Free Article


 


PubMed ID 16109972
         Pubmed Central ID 1199533 


 



4.
Singer D, Lovchik J, Zinger H   (2004) MHC Class I Expression Regulates Susceptibility to Spontaneous Autoimmune Disease in (NZBxNZW)F1 Mice.  Lupus .",https://intramural.nih.gov/search/searchview.taf?ipid=37111
115,BC009287-21,"October 01, 2004 -  September 30, 2005",Cytokines and T Cell Development,"Scott K Durum; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Benyam  Asefa



Qiong  Jiang



Annette R Khaled



Wenqing  Li



Renata I Mazzucchelli","V.  Boneto
(Mario Negri)




Igal  Gery; PhD
(NEI)




Annette  Khaled
(University of Central Florida)




Joseph  Kovacs
(NIAID)




A.  Leviton
(Harvard)




B.  Rich
(Harvard)


Show all 8","Tad  Guszczynski (National Cancer Institute)



Terry D Copeland (National Cancer Institute)



Toshiyuki E Mori (National Cancer Institute)



Albert J Fornace; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)



Terry J Fry (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Durum S, Aiello Q, Klarmann B, Keller K   (2005) Retroviral transduction of IL-7Ra into IL-7Ra-/- bone marrow stem cells: Correction of lymphoid deficiency and induction of neutrophilia.  Gene Ther, in press.




 



2.
Durum S, Dammann O   (2005) The adaptive immune response in neonatal cerebral white matter damage.  Annals of Neurology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37112
116,BC009290-20,"October 01, 2004 -  September 30, 2005",T Cell Activation and Apoptosis,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Dietrich B Conze



Bei  Dong



Yasemin G Isgor



Ludmila  Jirmanova



Peter  Mercado



Paul  Mittelstadt; PhD



Show all 9",NULL,NULL,"David Harvey Margulies; MD, PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37113
117,BC009297-14,"October 01, 2004 -  September 30, 2005",SENP1 and SUMO in mouse development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Meropi  Athanasiou



Allison  Galica



Amit  Kumar; PhD



Prashant  Sharma","Oskar  Fernandez-Capetillo
(Pharmacology, Spanish National Cancer Center)




Shigeki  Miyamoto
(University of Wisconsin)




Andrew  Sharrocks
(University of Manchester)",NULL,NULL,"Ordered by publication type and then author name.



1.
Yamada S, Nakajima H, Kuehn MR (2004). Novel testis- and embryo-specific isoforms of the phosphofructokinase-1 muscle type gene. Biochem Biophys Res Commun  316, 580-7.   https://doi.org/10.1016/j.bbrc.2004.02.089




PubMed


 


PubMed ID 15020257
    
     


 



2.
Yamaguchi T, Sharma P, Athanasiou M, Kumar A, Yamada S, Kuehn MR (2005). Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. Mol Cell Biol  25, 5171-82.   https://doi.org/10.1128/MCB.25.12.5171-5182.2005




PubMed



        
     
Free Article


 


PubMed ID 15923632
         Pubmed Central ID 1140580",https://intramural.nih.gov/search/searchview.taf?ipid=37114
118,BC009304-11,"October 01, 2004 -  September 30, 2005",Structure-Function of Galactosyltransferase sub-family members and Design of Nov,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Velavan  Ramasamy",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Qasba PK, Ramakrishnan B, Boeggeman E (2005). Substrate-induced conformational changes in glycosyltransferases. Trends Biochem Sci  30, 53-62.   https://doi.org/10.1016/j.tibs.2004.11.005




PubMed


 


PubMed ID 15653326
    
     


 



2.
Ramakrishnan B, Boeggeman E, Qasba PK (2005). Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Biochemistry  44, 3202-10.   https://doi.org/10.1021/bi0479454




PubMed


 


PubMed ID 15736931",https://intramural.nih.gov/search/searchview.taf?ipid=37115
119,BC009349-17,"October 01, 2004 -  September 30, 2005",Cloning and Characterization of Protein Tyrosine Kinases Involved in Leukocyte A,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Anthony V Washington,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
McVicar D, Mikhael A, Taylor L, Musso T   (2004) Complex regulation of the Csk homologous kinase (Chk) by IL-4 family cytokines and IFN-γ in human peripheral blood monocytes.  Mol Immunol .",https://intramural.nih.gov/search/searchview.taf?ipid=37117
120,BC009369-15,"October 01, 2004 -  September 30, 2005",Consequences of Chemokine-Receptor Interactions with Chemokines and Chemokine Mi,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Xin  Chen



Hui-Fang  Dong



Takeo  Edamatsu



Ping  Gao



Kahori  Kurosaka



Ruth  Neta



Show all 8","Michael  Caterina
(Department of Chemistry and Chemical Biology, Johns Hopkins University School of Medicine)




Olivera J Finn





Terry  Krakauer; PhD
(USAMRID)




Thomas  Rogers
( Department of Microbiology and Immunology, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine)




Kevin  Tracey
(Ctr Patient Oriented Res, North Shore-Long Island Jewish Res Inst)




David  Wade
(Rutgers University)",Qian  Chen (Office Of The Director),"Paul Hunter Plotz; MD (NIAMS) 



Rachel R Caspi; PhD (NEI) 



Susan  Pierce; PhD (NIAID) 



Helene Fischer Rosenberg; PhD, MD (NIAID)","Ordered by publication type and then author name.



1.
Carlos CA, Dong HF, Howard OM, Oppenheim JJ, Hanisch FG, Finn OJ (2005). Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol  175, 1628-35.   https://doi.org/10.4049/jimmunol.175.3.1628




PubMed


 


PubMed ID 16034102
    
     


 



2.
Chen X, Murakami T, Oppenheim JJ, Howard OM (2005). Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood  106, 2409-16.   https://doi.org/10.1182/blood-2005-03-0854




PubMed



        
     
Free Article


 


PubMed ID 15956285
         Pubmed Central ID 1569904 


 



3.
Chen X, Oppenheim JJ, Howard OM (2005). BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. J Leukoc Biol  78, 114-21.   https://doi.org/10.1189/jlb.0604341




PubMed


 


PubMed ID 15845645
    
     


 



4.
Gao P, Wange RL, Zhang N, Oppenheim JJ, Howard OM (2005). Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN. Blood  106, 2619-26.   https://doi.org/10.1182/blood-2004-08-3362




PubMed



        
     
Free Article


 


PubMed ID 15994292
         Pubmed Central ID 1895312 


 



5.
Howard OM, Dong HF, Su SB, Caspi RR, Chen X, Plotz P, Oppenheim JJ (2005). Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood  105, 4207-14.   https://doi.org/10.1182/blood-2004-07-2697




PubMed



        
     
Free Article


 


PubMed ID 15713799
         Pubmed Central ID 1895027 


 



6.
Jiao X, Zhang N, Xu X, Oppenheim JJ, Jin T (2005). Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling. Mol Cell Biol  25, 5752-62.   https://doi.org/10.1128/MCB.25.13.5752-5762.2005




PubMed



        
     
Free Article


 


PubMed ID 15964828
         Pubmed Central ID 1156970 


 



7.
Krakauer T, Chen X, Howard OM, Young HA (2005). Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol  27, 53-66.   https://doi.org/10.1081/iph-51294




PubMed


 


PubMed ID 15803859
    
     


 



8.
Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D (2005). Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol  174, 6257-65.   https://doi.org/10.4049/jimmunol.174.10.6257




PubMed


 


PubMed ID 15879124
    
     


 



9.
Oppenheim JJ, Dong HF, Plotz P, Caspi RR, Dykstra M, Pierce S, Martin R, Carlos C, Finn O, Koul O, Howard OM (2005). Autoantigens act as tissue-specific chemoattractants. J Leukoc Biol  77, 854-61.   https://doi.org/10.1189/jlb.1004623




PubMed


 


PubMed ID 15917448
    
     


 



10.
Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005). Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res  65, 1433-41.   https://doi.org/10.1158/0008-5472.CAN-04-1163




PubMed


 


PubMed ID 15735031
    
     


 



11.
Zhang N, Inan S, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ (2005). A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A  102, 4536-41.   https://doi.org/10.1073/pnas.0406030102




PubMed



        
     
Free Article


 


PubMed ID 15764707
         Pubmed Central ID 555471",https://intramural.nih.gov/search/searchview.taf?ipid=37118
121,BC009371-14,"October 01, 2004 -  September 30, 2005",Role of Lymphotoxin and TNF in the development and maintenance of lymphoid tissu,"Sergei A. Nedospasov; PhD, DSc",NULL,"Basic Research Laboratory, NCI","Sergei I Grivennikov



Dmitry  Liepinsh



Ludmila  Drutskaya","Adriano  Aguzzi
(Institute of Neuropathology, University Hospital Zutich)




Dmitry  Kuprash
(Laboratory of Molecular Immunology, Engelhardt Institute of Molecular Biology)




John  Ryan
(Biology, Virginia Commonwealth University)




Rolf  Zinkernagel
(Dept. Pathol., Inst. Exptl. Immunol., University Hospital Zurich)","Jonathan  Keller; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Förster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA (2005). Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity  22, 93-104.   https://doi.org/10.1016/j.immuni.2004.11.016




PubMed


 


PubMed ID 15664162
    
     


 



2.
Kuprash DV, Tumanov AV, Liepinsh DJ, Koroleva EP, Drutskaya MS, Kruglov AA, Shakhov AN, Southon E, Murphy WJ, Tessarollo L, Grivennikov SI, Nedospasov SA (2005). Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur J Immunol  35, 1592-600.   https://doi.org/10.1002/eji.200526119




PubMed


 


PubMed ID 15832287
    
     


 



3.
Shakhov AN, Rybtsov S, Tumanov AV, Shulenin S, Dean M, Kuprash DV, Nedospasov SA (2004). SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling. Eur J Immunol  34, 494-503.   https://doi.org/10.1002/eji.200324590




PubMed


 


PubMed ID 14768054
    
     


 



4.
Tumanov AV, Kuprash DV, Mach JA, Nedospasov SA, Chervonsky AV (2004). Lymphotoxin and TNF produced by B cells are dispensable for maintenance of the follicle-associated epithelium but are required for development of lymphoid follicles in the Peyer's patches. J Immunol  173, 86-91.   https://doi.org/10.4049/jimmunol.173.1.86




PubMed


 


PubMed ID 15210762",https://intramural.nih.gov/search/searchview.taf?ipid=37119
122,BC009392-12,"October 01, 2004 -  September 30, 2005",Determining the Fate of Transmembrane Proteins,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Bo  Chen



Mickael M Cohen



Andrew  Fotia



Jane P Jensen



Zlatka  Kostova-Lenard



Jennifer B Mariano



Show all 8",NULL,"Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



Ira  Daar; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fang S, Weissman AM (2004). A field guide to ubiquitylation. Cell Mol Life Sci  61, 1546-61.   https://doi.org/10.1007/s00018-004-4129-5




PubMed


 


PubMed ID 15224180
    
     


 



2.
Häkli M, Lorick KL, Weissman AM, Jänne OA, Palvimo JJ (2004). Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity. FEBS Lett  560, 56-62.   https://doi.org/10.1016/S0014-5793(04)00070-5




PubMed


 


PubMed ID 14987998",https://intramural.nih.gov/search/searchview.taf?ipid=36960
123,BC009404-11,"October 01, 2004 -  September 30, 2005",Protein Trafficking in Lymphocytes,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Anita C Hohenstein



Neil J Poloso



Niti  Puri



Even  Walseng","Oddmund  Bakke
(Biology, Univ. of Oslo)




Sidney  Whiteheart
(Molecular and Cellular Biochemistry, University of Kentucky)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37120
124,BC009405-11,"October 01, 2004 -  September 30, 2005",Regulation of Lymphocyte Proliferation and Replicative Capacity,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Karen  Hathcock



Xinglei  Shen



Haifeng  Song","Rafi  Ahmed; PhD
(Emory Vacine Center, Emory University)




Judy  Campisi","Karl Thomas Ried; MD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",Peter E Lipsky; MD (NIAMS),"Ordered by publication type and then author name.



1.
Chiang YJ, Hemann MT, Hathcock KS, Tessarollo L, Feigenbaum L, Hahn WC, Hodes RJ (2004). Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol Cell Biol  24, 7024-31.   https://doi.org/10.1128/MCB.24.16.7024-7031.2004




PubMed



        
     
Free Article


 


PubMed ID 15282303
         Pubmed Central ID 479722 


 



2.
Chiang YJ, Kim SH, Tessarollo L, Campisi J, Hodes RJ (2004). Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol Cell Biol  24, 6631-4.   https://doi.org/10.1128/MCB.24.15.6631-6634.2004




PubMed



        
     
Free Article


 


PubMed ID 15254230
         Pubmed Central ID 444850 


 



3.
Hathcock KS, Jeffrey Chiang Y, Hodes RJ (2005). In vivo regulation of telomerase activity and telomere length. Immunol Rev  205, 104-13.   https://doi.org/10.1111/j.0105-2896.2005.00267.x




PubMed


 


PubMed ID 15882348",https://intramural.nih.gov/search/searchview.taf?ipid=37121
125,BC010001-10,"October 01, 2004 -  September 30, 2005",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Kevin J Anthony



John  Gooya



Kimberly D Klarmann",NULL,"Peter F Johnson; PhD (National Cancer Institute)



Neal G Copeland; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Asefa B, Klarmann KD, Copeland NG, Gilbert DJ, Jenkins NA, Keller JR (2004). The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis  32, 155-67.   https://doi.org/10.1016/j.bcmd.2003.10.002




PubMed


 


PubMed ID 14757431
    
     


 



2.
Dermott JM, Gooya JM, Asefa B, Weiler SR, Smith M, Keller JR (2004). Inhibition of growth by p205: a nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation. Stem Cells  22, 832-48.   https://doi.org/10.1634/stemcells.22-5-832




PubMed


 


PubMed ID 15342947
    
     


 



3.
Heath V, Suh HC, Holman M, Renn K, Gooya JM, Parkin S, Klarmann KD, Ortiz M, Johnson P, Keller J (2004). C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood  104, 1639-47.   https://doi.org/10.1182/blood-2003-11-3963




PubMed


 


PubMed ID 15073037
    
     


 



4.
Jiang Q, Li WQ, Hofmeister RR, Young HA, Hodge DR, Keller JR, Khaled AR, Durum SK (2004). Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol  24, 6501-13.   https://doi.org/10.1128/MCB.24.14.6501-6513.2004




PubMed



        
     
Free Article


 


PubMed ID 15226449
         Pubmed Central ID 434255 


 



5.
Keller J, Winterstein D, Pfeffer K, Neubauer H, Linnekin D   (2004) JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to SCF.  Exp. Hema  pp.




 



6.
Leeanansaksiri W, Wang H, Gooya JM, Renn K, Abshari M, Tsai S, Keller JR (2005). IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development. J Immunol  174, 7014-21.   https://doi.org/10.4049/jimmunol.174.11.7014




PubMed


 


PubMed ID 15905544
    
     


 



7.
Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK (2004). Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem  279, 29160-6.   https://doi.org/10.1074/jbc.M401656200




PubMed


 


PubMed ID 15123689",https://intramural.nih.gov/search/searchview.taf?ipid=37122
126,BC010003-10,"October 01, 2004 -  September 30, 2005",Retrovirus Gene Regulation: HTLV-1 Transmission of Replication,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI","Shawn A Hill



Grace  Jividen



Yunjeong  Kim



Michael S Mitchell



Gerald L Princler



Ashley  Richardson","Charles  Bangham
(Immunology, Imperial College of Medicine,)




Nathaniel  Landau
(Infectious Disease Laboratory, Salk Institute for Biological Studies)




Suzy  Shuker
(Department of Chemistry, Georgia Institute of Technology)","Genoveffa  Franchini; MD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37123
127,BC010005-10,"October 01, 2004 -  September 30, 2005",The Role of IApcI and beta-Catenin in Cell Regulation and Carcinogenesis,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gregory L Borchert



Yongmin  Liu",NULL,Gregory  Buzard; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37125
128,BC010006-10,"October 01, 2004 -  September 30, 2005",Developmental Signal Transduction in Xenopus Oocytes and Embryos,"Ira  Daar; PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Yong-Sik  Bong



Hyun-Shik  Lee



Seung-Kiel  Park



Kathleen T Soria","Sally  Moody
(Anatomy and Cell Biology, George washington University)




Tony  Pawson
(Molecular Biology and Cancer, Samuel Lunenfeld Research Institute)","Allan M Weissman; MD (National Cancer Institute)



Deborah K Morrison (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37126
129,BC010008-10,"October 01, 2004 -  September 30, 2005",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Genetics, NCI","Valery  Bliskovsky; PhD



Kathleen L Kiernan



Richard C Robinson



Shuling  Zhang; MD, PhD",NULL,"Douglas  Lowy; MD (National Cancer Institute)



Nancy  Jenkins-Copeland; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Neal G Copeland; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Mock B, Ramsay S, Bliskovsky V, Zhang K, Shi W, DuBois W   (2005) Strategies for dissecting complex traits associated with cancer: lessons from plasma cell tumors, in AACR Education Book 2005. AACR (Philadelphia), pp. 273-276.",https://intramural.nih.gov/search/searchview.taf?ipid=37128
130,BC010012-10,"October 01, 2004 -  September 30, 2005",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Alan  Brooks



Teresa  Ramirez



Anil  Shanker","Mark  Smyth
(Cancer Immunolgy Program, Peter MacCallum Research Institute)




Hideo  Yagita
(Immunology, Juntendo University)",John R Ortaldo; PhD (National Cancer Institute),William T Murphy (OD),"Ordered by publication type and then author name.



1.
Brooks AD, Sayers TJ (2005). Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunol Immunother  54, 499-505.   https://doi.org/10.1007/s00262-004-0595-8




PubMed


 


PubMed ID 15614529
    
     


 



2.
Sayers T   (2004) Reduction of the anti-apoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL-apoptosis.  Cancer Immunol Immunother .




 



3.
Sayers T   (2004) TNF-related apoptosis inducing ligand (TRAIL): Combination with proteasome inhibition for anticancer therapy.  Proteasome Inhibition in Cancer Therapy. Ed. J Adams,  pp.




 



4.
Sedelies KA, Sayers TJ, Edwards KM, Chen W, Pellicci DG, Godfrey DI, Trapani JA (2004). Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J Biol Chem  279, 26581-7.   https://doi.org/10.1074/jbc.M312481200




PubMed


 


PubMed ID 15069086
    
     


 



5.
Shafer-Weaver KA, Sayers T, Kuhns DB, Strobl SL, Burkett MW, Baseler M, Malyguine A (2004). Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay. J Transl Med  2, 31.   https://doi.org/10.1186/1479-5876-2-31




PubMed



        
     
Free Article


 


PubMed ID 15380049
         Pubmed Central ID 522821 


 



6.
Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y (2004). NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med  200, 1325-35.   https://doi.org/10.1084/jem.20041522




PubMed



        
     
Free Article


 


PubMed ID 15545356
         Pubmed Central ID 2211920 


 



7.
Sun K, Welniak LA, Panoskaltsis-Mortari A, O'Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ (2004). Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proc Natl Acad Sci U S A  101, 8120-5.   https://doi.org/10.1073/pnas.0401563101




PubMed



        
     
Free Article


 


PubMed ID 15148407
         Pubmed Central ID 419567 


 



8.
Sun K, Wilkins DE, Anver MR, Sayers TJ, Panoskaltsis-Mortari A, Blazar BR, Welniak LA, Murphy WJ (2005). Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood  106, 3293-9.   https://doi.org/10.1182/blood-2004-11-4526




PubMed



        
     
Free Article


 


PubMed ID 15961519
         Pubmed Central ID 1895334 


 



9.
Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, Tanner JE, Sayers TJ, Seki N, Okumura K, Yagita H, Smyth MJ (2004). Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med  199, 437-48.   https://doi.org/10.1084/jem.20031457




PubMed



        
     
Free Article


 


PubMed ID 14769851
         Pubmed Central ID 2211825",https://intramural.nih.gov/search/searchview.taf?ipid=37129
131,BC010013-10,"October 01, 2004 -  September 30, 2005",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Gareth E Davies



Veronique  Pascal



Michael J Stulberg



Paul  Wright","Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)




Jeffrey  Miller
(Division of Hematology, Oncology, and Transplantation, University of Minnesota)","Michael I Lerman; MD, PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP (2005). Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun  6, 481-92.   https://doi.org/10.1038/sj.gene.6364232




PubMed


 


PubMed ID 15931229
    
     


 



2.
Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK (2005). Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun  6, 71-83.   https://doi.org/10.1038/sj.gene.6364154




PubMed


 


PubMed ID 15674375
    
     


 



3.
Makrigiannis AP, Rousselle E, Anderson SK (2004). Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J Immunol  172, 1414-25.   https://doi.org/10.4049/jimmunol.172.3.1414




PubMed


 


PubMed ID 14734717
    
     


 



4.
Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK (2004). Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity  21, 55-66.   https://doi.org/10.1016/j.immuni.2004.06.005




PubMed


 


PubMed ID 15345220",https://intramural.nih.gov/search/searchview.taf?ipid=37130
132,BC010014-10,"October 01, 2004 -  September 30, 2005",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI","Theresa M Geiman



Anja  Schmidtmann



Sichuan  Xi



Heming  Zhu","Rabindranath  de la Fuente





Ina  Dobrinski





David  Munroe
(SAIC)




Rolf  Ohlsson; PhD
(Department of Animal Development and Genetics, Uppsala University)",Sandra  Ruscetti; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37131
133,BC010015-10,"October 01, 2004 -  September 30, 2005",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Nancy M Dunlop



Wang-Hua  Gong",NULL,"Keqiang  Chen (Laboratory of Molecular Immunoregulation)



Joost J Oppenheim; MD (National Cancer Institute)



Sergei A. Nedospasov; PhD, DSc (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)",Thomas F Rogers (NIAID),"Ordered by publication type and then author name.



1.
Biragyn A, Ruffini PA, Coscia M, Harvey LK, Neelapu SS, Baskar S, Wang JM, Kwak LW (2004). Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo. Blood  104, 1961-9.   https://doi.org/10.1182/blood-2004-02-0637




PubMed


 


PubMed ID 15191951
    
     


 



2.
Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R (2004). Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci U S A  101, 15452-7.   https://doi.org/10.1073/pnas.0402874101




PubMed



        
     
Free Article


 


PubMed ID 15489273
         Pubmed Central ID 524434 


 



3.
Hu J, Li G, Tong Y, Li Y, Zhou G, He X, Xie P, Wang JM, Sun Q (2005). Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity. Int Immunopharmacol  5, 971-80.   https://doi.org/10.1016/j.intimp.2005.01.011




PubMed


 


PubMed ID 15829413
    
     


 



4.
Iribarren P, Zhou Y, Hu J, Le Y, Wang JM (2005). Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol Res  31, 165-76.   https://doi.org/10.1385/IR:31:3:165




PubMed


 


PubMed ID 15888909
    
     


 



5.
Le Y, Iribarren P, Gong W, Cui Y, Zhang X, Wang JM (2004). TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J Immunol  173, 962-8.   https://doi.org/10.4049/jimmunol.173.2.962




PubMed


 


PubMed ID 15240683
    
     


 



6.
Le Y, Iribarren P, Zhou Y, Gong W, Hu J, Zhang X, Wang JM (2004). Silencing the formylpeptide receptor FPR by short-interfering RNA. Mol Pharmacol  66, 1022-8.   https://doi.org/10.1124/mol.104.001982




PubMed


 


PubMed ID 15258259
    
     


 



7.
Le Y, Ye RD, Gong W, Li J, Iribarren P, Wang JM (2005). Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J  272, 769-78.   https://doi.org/10.1111/j.1742-4658.2004.04514.x




PubMed


 


PubMed ID 15670157
    
     


 



8.
Partida-Sánchez S, Iribarren P, Moreno-García ME, Gao JL, Murphy PM, Oppenheimer N, Wang JM, Lund FE (2004). Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol  172, 1896-906.   https://doi.org/10.4049/jimmunol.172.3.1896




PubMed


 


PubMed ID 14734775
    
     


 



9.
Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A (2004). Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology  318, 55-65.   https://doi.org/10.1016/j.virol.2003.08.042




PubMed


 


PubMed ID 14972535
    
     


 



10.
Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A (2004). Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J Virol  78, 7360-8.   https://doi.org/10.1128/JVI.78.14.7360-7368.2004




PubMed



        
     
Free Article


 


PubMed ID 15220409
         Pubmed Central ID 434090 


 



11.
Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005). Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res  65, 1433-41.   https://doi.org/10.1158/0008-5472.CAN-04-1163




PubMed


 


PubMed ID 15735031
    
     


 



12.
Sun R, Iribarren P, Zhang N, Zhou Y, Gong W, Cho EH, Lockett S, Chertov O, Bednar F, Rogers TJ, Oppenheim JJ, Wang JM (2004). Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol  173, 428-36.   https://doi.org/10.4049/jimmunol.173.1.428




PubMed


 


PubMed ID 15210802
    
     


 



13.
Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM (2004). Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol  172, 7078-85.   https://doi.org/10.4049/jimmunol.172.11.7078




PubMed


 


PubMed ID 15153530
    
     


 



14.
Zhang N, Inan S, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ (2005). A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A  102, 4536-41.   https://doi.org/10.1073/pnas.0406030102




PubMed



        
     
Free Article


 


PubMed ID 15764707
         Pubmed Central ID 555471 


 



15.
Zhang X, Rodriguez-Galán MC, Subleski JJ, Ortaldo JR, Hodge DL, Wang JM, Shimozato O, Reynolds DA, Young HA (2004). Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. Blood  104, 3276-84.   https://doi.org/10.1182/blood-2004-02-0664




PubMed


 


PubMed ID 15265789
    
     


 



16.
Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM (2005). Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst  97, 823-35.   https://doi.org/10.1093/jnci/dji142




PubMed


 


PubMed ID 15928303",https://intramural.nih.gov/search/searchview.taf?ipid=37132
134,BC010017-10,"October 01, 2004 -  September 30, 2005","The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di","Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Catherine  Bair



Rotem  Edgar



Michael  Mckinstry



Amos  Oppenheim",NULL,Dean H. Hamer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Adhya S, Black L, Friedman D, Hatfull G, Kreuzer K, Merril C, Oppenheim A, Rohwer F, Young R (2005). 2004 ASM Conference on the New Phage Biology: the 'Phage Summit'. Mol Microbiol  55, 1300-14.   https://doi.org/10.1111/j.1365-2958.2005.04509.x




PubMed


 


PubMed ID 15720541
    
     


 



2.
Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, Fekete RA, Kar S, Adhya S, Hamer DH (2005). Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci U S A  102, 11993-8.   https://doi.org/10.1073/pnas.0504881102




PubMed



        
     
Free Article


 


PubMed ID 16040799
         Pubmed Central ID 1189328 


 



3.
Scholl D, Adhya S, Merril C (2005). Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl Environ Microbiol  71, 4872-4.   https://doi.org/10.1128/AEM.71.8.4872-4874.2005




PubMed



        
     
Free Article


 


PubMed ID 16085886
         Pubmed Central ID 1183359 


 



4.
Scholl D, Kieleczawa J, Kemp P, Rush J, Richardson CC, Merril C, Adhya S, Molineux IJ (2004). Genomic analysis of bacteriophages SP6 and K1-5, an estranged subgroup of the T7 supergroup. J Mol Biol  335, 1151-71.   https://doi.org/10.1016/j.jmb.2003.11.035




PubMed


 


PubMed ID 14729334
    
     


 



5.
Vitiello CL, Merril CR, Adhya S (2005). An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res  114, 101-3.   https://doi.org/10.1016/j.virusres.2005.05.014




PubMed


 


PubMed ID 16055223",https://intramural.nih.gov/search/searchview.taf?ipid=37133
135,BC010020-10,"October 01, 2004 -  September 30, 2005",Clinical Trials with Immunotoxins,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Mitchell  Ho



Satoshi  Nagata; PhD



Dawn A Walker",NULL,"David J Fitzgerald; PhD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hassan R, Bera T, Pastan I (2004). Mesothelin: a new target for immunotherapy. Clin Cancer Res  10, 3937-42.   https://doi.org/10.1158/1078-0432.CCR-03-0801




PubMed


 


PubMed ID 15217923
    
     


 



2.
Hassan R, Williams-Gould J, Watson T, Pai-Scherf L, Pastan I (2004). Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1. Clin Cancer Res  10, 16-8.   https://doi.org/10.1158/1078-0432.ccr-1160-3




PubMed


 


PubMed ID 14734446
    
     


 



3.
Pastan I, Kreitman R, Willingham M   (2005) Localization of mesothelin in epithelial ovarian cancer.  Appl. Immunohistochem. Mol. Morphol, in press.




 



4.
Pastan I, Squires D, Stetler-Stevenson M, Noel P, FitzGerald D, Wilson W   (2005) Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies.  J. Clin. Oncol, in press.




 



5.
Sampson JH, Reardon DA, Friedman AH, Friedman HS, Coleman RE, McLendon RE, Pastan I, Bigner DD (2005). Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study. Neuro Oncol  7, 90-6.   https://doi.org/10.1215/S1152851703000589




PubMed



        
     
Free Article


 


PubMed ID 15701286
         Pubmed Central ID 1871629",https://intramural.nih.gov/search/searchview.taf?ipid=37134
136,BC010021-10,"October 01, 2004 -  September 30, 2005",Biology of Mammary Gland Development and Tumorigenesis,"Gilbert  Smith; PhD



IRP Faculty Profile",NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Brian  Booth



Corinne A Boulanger-Espeut



David L Mack",NULL,Karen  Hathcock (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Boulanger CA, Wagner KU, Smith GH (2005). Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene  24, 552-60.   https://doi.org/10.1038/sj.onc.1208185




PubMed


 


PubMed ID 15580303
    
     


 



2.
Clarke RB, Smith GH (2005). Stem cells and tissue homeostasis in mammary glands. J Mammary Gland Biol Neoplasia  10, 1-3.   https://doi.org/10.1007/s10911-005-2535-4




PubMed


 


PubMed ID 15886881
    
     


 



3.
Lowther W, Wiley K, Smith GH, Callahan R (2005). A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol  79, 10093-6.   https://doi.org/10.1128/JVI.79.15.10093-10096.2005




PubMed



        
     
Free Article


 


PubMed ID 16014973
         Pubmed Central ID 1181551 


 



4.
Smith GH (2005). Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development  132, 681-7.   https://doi.org/10.1242/dev.01609




PubMed


 


PubMed ID 15647322
    
     


 



5.
Triplett AA, Sakamoto K, Matulka LA, Shen L, Smith GH, Wagner KU (2005). Expression of the whey acidic protein (Wap) is necessary for adequate nourishment of the offspring but not functional differentiation of mammary epithelial cells. Genesis  43, 1-11.   https://doi.org/10.1002/gene.20149




PubMed


 


PubMed ID 16106354
    
     


 



6.
Wagner KU, Smith GH (2005). Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia  10, 25-36.   https://doi.org/10.1007/s10911-005-2538-1




PubMed


 


PubMed ID 15886884",https://intramural.nih.gov/search/searchview.taf?ipid=37135
137,BC010022-10,"October 01, 2004 -  September 30, 2005",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Elizabeth  Binns-Roemer



Zheng-Mei  Liu



Louise  Mckenzie



Yu-Chun  Zhou



Mary A Thompson



Michael E Weedon



Show all 9","Sudha  Iyengar
(Department of Epidemiology and Statistics, Case Western University)




Paul  Kimmel
(Division of Renal Diseases and Hypertension, George Washington University Medical Center)




Andrey  Shaw
(Dept. of Immunology and Pathology, Washington University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37136
138,BC010024-10,"October 01, 2004 -  September 30, 2005",c-IMycI-induced B cell and plasma cell neoplasms in mice,"Siegfried  Janz; MD, DSc",Beverly  Mock; PhD,"Laboratory of Genetics, NCI","Seung-Tae  Chung



Ki-Hwan  Kim



Makiko  Takizawa



Seong-Su  Han","John  Shaughnessy
(Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences)




Brian  Van Ness
(University of Minnesota, Department of Genetics and Cell Biology)","Karl Thomas Ried; MD (National Cancer Institute)



Walter M Kuehl; MD, PhD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Charles  Rabkin (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)",Herbert Carpenter Morse; MD (NIAID),"Ordered by publication type and then author name.



1.
Cheung WC, Kim JS, Linden M, Peng L, Van Ness B, Polakiewicz RD, Janz S (2004). Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J Clin Invest  113, 1763-73.   https://doi.org/10.1172/JCI20369




PubMed



        
     
Free Article


 


PubMed ID 15199411
         Pubmed Central ID 420503 


 



2.
Felix K, Gerstmeier S, Kyriakopoulos A, Howard OM, Dong HF, Eckhaus M, Behne D, Bornkamm GW, Janz S (2004). Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res  64, 2910-7.   https://doi.org/10.1158/0008-5472.can-03-2672




PubMed


 


PubMed ID 15087411
    
     


 



3.
McNeil N, Kim JS, Ried T, Janz S (2005). Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation. Genes Chromosomes Cancer  43, 137-46.   https://doi.org/10.1002/gcc.20172




PubMed


 


PubMed ID 15751044
    
     


 



4.
Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S (2005). Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res  65, 1306-15.   https://doi.org/10.1158/0008-5472.CAN-04-0268




PubMed


 


PubMed ID 15735016
    
     


 



5.
Silva S, Wiener F, Klein G, Janz S (2005). Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations. Genes Chromosomes Cancer  42, 416-26.   https://doi.org/10.1002/gcc.20149




PubMed


 


PubMed ID 15645495",https://intramural.nih.gov/search/searchview.taf?ipid=37137
139,BC010025-10,"October 01, 2004 -  September 30, 2005",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Alyson R Baker



Arindam  Dhar



Glenn  Hegamyer



Jing  Hu



Connie P Matthews","G. Timothy  Bowden
(Arizona Cancer Center)




Powel  Brown
(Baylor Breast Center, Baylor College of Medicine)




Raymond  Reeves
(Washington State University)




Linda  Resar
(Johns Hopkins)




Thomas  Weber
(Pediatric Hematology, Pacific Northwest National Laboratory)","Thomas  Conrads (National Cancer Institute)



George R.  Beck, Jr. (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37138
140,BC010026-10,"October 01, 2004 -  September 30, 2005",Genes Differentially Expressed During Tumor Promotion and Progression,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Arti  Santhanam



Alyson R Baker



Glenn  Hegamyer



Aaron P Jansen","Heike  Allgayer
(University of Munich)




Stephen J.  Lockett
(SAIC-Frederick)




William  Merrick
(Biochemistry, Case Western Reserve University)




Robert  Rhoads
(LSU Shreveport)




Nahum  Sonenberg
(McGill University)","Alexander  Wlodawer; PhD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Timothy  Clair; MS (National Cancer Institute)



George R.  Beck, Jr. (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37139
141,BC010027-11,"October 01, 2004 -  September 30, 2005",Function of Steroid Receptors in Subcellular Compartments,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anindya P Hendarwanto



Sam  John



Ty Cole Voss



Malgorzata  Wiench","Doug  Auld; PhD
(Pharmacopeia, Inc)




John A Beutler
(NCI)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cremazy FG, Manders EM, Bastiaens PI, Kramer G, Hager GL, van Munster EB, Verschure PJ, Gadella TJ, van Driel R (2005). Imaging in situ protein-DNA interactions in the cell nucleus using FRET-FLIM. Exp Cell Res  309, 390-6.   https://doi.org/10.1016/j.yexcr.2005.06.007




PubMed


 


PubMed ID 16040027
    
     


 



2.
Martinez ED, Rayasam GV, Dull AB, Walker DA, Hager GL (2005). An estrogen receptor chimera senses ligands by nuclear translocation. J Steroid Biochem Mol Biol  97, 307-21.   https://doi.org/10.1016/j.jsbmb.2005.06.033




PubMed


 


PubMed ID 16162406",https://intramural.nih.gov/search/searchview.taf?ipid=37140
142,BC010029-10,"October 01, 2004 -  September 30, 2005",Involvement of Valosin-Containing Protein in Ubiquitin-Proteasome Mediated Degra,Chou-Chi  Li; PhD,NULL,"Laboratory of Cancer Prevention, NCI",NULL,"Virginia  Kimonis
(Div. Genetics & Metabolism, Harvard University)




Cecile  Pickart
(Molecular Microbiology, Johns Hopkins University)




Xiaodong  Zhang
(Biological Sciences, Imperial College of London)",NULL,NULL,"Ordered by publication type and then author name.



1.
Wang Q, Song C, Li CC (2004). Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol  146, 44-57.   https://doi.org/10.1016/j.jsb.2003.11.014




PubMed


 


PubMed ID 15037236
    
     


 



2.
Yang Y, Li CC, Weissman AM (2004). Regulating the p53 system through ubiquitination. Oncogene  23, 2096-106.   https://doi.org/10.1038/sj.onc.1207411




PubMed


 


PubMed ID 15021897",https://intramural.nih.gov/search/searchview.taf?ipid=37141
143,BC010030-10,"October 01, 2004 -  September 30, 2005",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"Suresh V Ambudkar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Anna Maria Calcagno



Saibal  Dey



John E Golin



In Wha  Kim



Zuben  Sauna; PhD



Suneet  Shukla","Margery  Barrand
(Pharamacology, University of Cambridge)




Stephen  Hladky
(Pharmacology, University of Cambridge)




Pornngarm  Limtrakul
(Department of Biochemistry, Chiang Mai University)




Rajendra  Prasad
(Membrane Biology Laboratory, Jawaharlal Nehru University)",Susan  Bates; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ambudkar SV, Sauna ZE, Gottesman MM, Szakacs G (2005). A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci  26, 385-7.   https://doi.org/10.1016/j.tips.2005.06.001




PubMed



        
     
Free Article


 


PubMed ID 15978680
         Pubmed Central ID 1350964 


 



2.
Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P (2004). Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol  68, 2043-52.   https://doi.org/10.1016/j.bcp.2004.07.009




PubMed


 


PubMed ID 15476675
    
     


 



3.
Hanson L, May L, Tuma P, Keeven J, Mehl P, Ferenz M, Ambudkar SV, Golin J (2005). The role of hydrogen bond acceptor groups in the interaction of substrates with Pdr5p, a major yeast drug transporter. Biochemistry  44, 9703-13.   https://doi.org/10.1021/bi0502994




PubMed


 


PubMed ID 16008355
    
     


 



4.
Jiang Y, Bhattacharjee H, Zhou T, Rosen BP, Ambudkar SV, Sauna ZE (2005). Nonequivalence of the nucleotide binding domains of the ArsA ATPase. J Biol Chem  280, 9921-6.   https://doi.org/10.1074/jbc.M413391200




PubMed


 


PubMed ID 15637064
    
     


 



5.
Sauna ZE, Nandigama K, Ambudkar SV (2004). Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state. J Biol Chem  279, 48855-64.   https://doi.org/10.1074/jbc.M408849200




PubMed


 


PubMed ID 15364914
    
     


 



6.
Singh BB, Lockwich TP, Bandyopadhyay BC, Liu X, Bollimuntha S, Brazer SC, Combs C, Das S, Leenders AG, Sheng ZH, Knepper MA, Ambudkar SV, Ambudkar IS (2004). VAMP2-dependent exocytosis regulates plasma membrane insertion of TRPC3 channels and contributes to agonist-stimulated Ca2+ influx. Mol Cell  15, 635-46.   https://doi.org/10.1016/j.molcel.2004.07.010




PubMed


 


PubMed ID 15327778
    
     


 



7.
Wu CP, Klokouzas A, Hladky SB, Ambudkar SV, Barrand MA (2005). Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem Pharmacol  70, 500-10.   https://doi.org/10.1016/j.bcp.2005.05.022




PubMed



        
     
Free Article


 


PubMed ID 16004972
         Pubmed Central ID 1356667",https://intramural.nih.gov/search/searchview.taf?ipid=37142
144,BC010033-10,"October 01, 2004 -  September 30, 2005",Inflammation and  Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Mark E Bernard



Hideaki  Shiga



Jane J Sohn



Elise Dawn Bowman



Weidong  Jiang



Irfan  Shaikh



Show all 12","T. R Billiar
(University of Pittsburg)




R. N.  DuBois
(Vanderbilt University)




V.  Rotter
(Weizman Institute of Science)",David Anderson Wink (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Harris C, Sawa T, Hussain S   (2004) Inducible nitric oxide synthase as a target for chemoprevention, in Cancer Chemoprevention Vol. 1: Promising Cancer Chemopreventive Agents. Kelloff G, Hawk E, Sigman C, eds., The Humana Press (Totowa, NJ), pp. 133-151.




 



2.
Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC (2004). Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis  25, 2467-72.   https://doi.org/10.1093/carcin/bgh260




PubMed


 


PubMed ID 15308583
    
     


 



3.
Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S, Harris CC (2006). Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer  118, 1790-7.   https://doi.org/10.1002/ijc.21523




PubMed



        
     
Free Article


 


PubMed ID 16217767
         Pubmed Central ID 1451415 


 



4.
Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, Hofseth LJ, Moake M, Nagashima M, Forrester KS, Harris CC (2004). p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res  64, 2350-6.   https://doi.org/10.1158/0008-5472.can-2287-2




PubMed


 


PubMed ID 15059885
    
     


 



5.
Hussain SP, Trivers GE, Hofseth LJ, He P, Shaikh I, Mechanic LE, Doja S, Jiang W, Subleski J, Shorts L, Haines D, Laubach VE, Wiltrout RH, Djurickovic D, Harris CC (2004). Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res  64, 6849-53.   https://doi.org/10.1158/0008-5472.CAN-04-2201




PubMed


 


PubMed ID 15466171",https://intramural.nih.gov/search/searchview.taf?ipid=37143
145,BC010036-10,"October 01, 2004 -  September 30, 2005",Comparative functional genomics approach to identify best-fit models to study hu,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Elizabeth A Conner



Cedric  Coulouarn



Joe W Grisham



Jeonghoon  Heo



Pal  Kaposi-Novak



Sara  Ladu



Show all 10","Marcello  Arsura
(Department of Pharmacology &Therapeutic, University of Tennessee)




Jan  Reddy
(Dpt. Pathology, Northwestern University)",Valentina  Factor (Cellular and Molecular Biology Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37144
146,BC010037-10,"October 01, 2004 -  September 30, 2005",Mechanisms of Mammary Gland Carcinogenesis of Heterocyclic amines,Elizabeth  Snyderwine; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Kara R Jones



Andriana  Papaconstantinou



Cunping  Qiu



Minshu R Yu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Qiu C, Shan L, Yu M, Snyderwine EG (2005). Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis  26, 763-9.   https://doi.org/10.1093/carcin/bgi013




PubMed


 


PubMed ID 15637090
    
     


 



2.
Shan L, Yu M, Clark BD, Snyderwine EG (2004). Possible role of Stat5a in rat mammary gland carcinogenesis. Breast Cancer Res Treat  88, 263-72.   https://doi.org/10.1007/s10549-004-0805-2




PubMed


 


PubMed ID 15609129
    
     


 



3.
Shan L, Yu M, Snyderwine EG (2005). Gene expression profiling of chemically induced rat mammary gland cancer. Carcinogenesis  26, 503-9.   https://doi.org/10.1093/carcin/bgh330




PubMed


 


PubMed ID 15528215",https://intramural.nih.gov/search/searchview.taf?ipid=37145
147,BC010038-10,"October 01, 2004 -  September 30, 2005",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Ming  Guan



Veronika  Ullmannova



Xiaoling  Zhou



Drazen  Zimonjic; PhD","Steve  Goodison
(Department of Pathology, University of Florida)




Hector  Martinez-Valdez
(Department of Immunology, University of Texas - MD Anderson Cancer Center)




Guo-Ping  Shi
(Department of Medicine, Harvard University - Harvard Medical School)","Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Sheueyann  Cheng; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Durkin ME, Avner MR, Huh CG, Yuan BZ, Thorgeirsson SS, Popescu NC (2005). DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett  579, 1191-6.   https://doi.org/10.1016/j.febslet.2004.12.090




PubMed


 


PubMed ID 15710412
    
     


 



2.
Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, Urquidi V (2005). The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res  65, 6042-53.   https://doi.org/10.1158/0008-5472.CAN-04-3043




PubMed



        
     
Free Article


 


PubMed ID 16024604
         Pubmed Central ID 1360170 


 



3.
Kaur GP, Reddy DE, Zimonjic DB, de Riel JK, Athwal RS   (2005) Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells.  Oncogene 24:47-54.




PubMed


 


PubMed ID 15558027
    
     


 



4.
Sims-Mourtada JC, Bruce S, McKeller MR, Rangel R, Guzman-Rojas L, Cain K, Lopez C, Zimonjic DB, Popescu NC, Gordon J, Wilkinson MF, Martinez-Valdez H (2005). The human AKNA gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and polyadenylation. DNA Cell Biol  24, 325-38.   https://doi.org/10.1089/dna.2005.24.325




PubMed


 


PubMed ID 15869410
    
     


 



5.
Zimonjic DB, Kato Y, Ying H, Popescu NC, Cheng SY (2005). Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice. Cancer Genet Cytogenet  161, 104-9.   https://doi.org/10.1016/j.cancergencyto.2005.02.007




PubMed


 


PubMed ID 16102579
    
     


 



6.
Zimonjic DB, Liu J, Xu WH, Zhou X, Popescu NC, Shi GP (2005). Assignment of murine placental cathepsin R to mouse chromosome bands 13B2-B3 by fluorescence in situ hybridization. Cytogenet Genome Res  111, 96.   https://doi.org/10.1159/000085679




PubMed


 


PubMed ID 16097084",https://intramural.nih.gov/search/searchview.taf?ipid=37146
148,BC010041-10,"October 01, 2004 -  September 30, 2005","Oligosaccharide Inhibitor Interactions with beta-1,4-Galactosyltransferase-1",Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Velavan  Ramasamy",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37147
149,BC010251-10,"October 01, 2004 -  September 30, 2005",Secreted Frizzled-Related Proteins and Wnt Signaling,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Michal  Barshishat-Kupper



William G Taylor



David K Woods



Zong Fang  Xi","A.  Clark





M.  Gillespie
(St. Vincents Institute of Medical Research)




Paul  Marker
(University of Minnesota Cancer Center)




Bart  Williams; PhD
(NCI)","Alan O Perantoni; PhD (National Cancer Institute)



Stuart  Rudikoff; PhD (National Cancer Institute)



Terence P Yamaguchi; PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)",Alan Robert Kimmel; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Chuman Y, Uren A, Cahill J, Regan C, Wolf V, Kay BK, Rubin JS (2004). Identification of a peptide binding motif for secreted frizzled-related protein-1. Peptides  25, 1831-8.   https://doi.org/10.1016/j.peptides.2004.07.010




PubMed


 


PubMed ID 15501513
    
     


 



2.
Endo Y, Wolf V, Muraiso K, Kamijo K, Soon L, Uren A, Barshishat-Küpper M, Rubin JS (2005). Wnt-3a-dependent cell motility involves RhoA activation and is specifically regulated by dishevelled-2. J Biol Chem  280, 777-86.   https://doi.org/10.1074/jbc.M406391200




PubMed


 


PubMed ID 15509575
    
     


 



3.
Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT (2004). Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res  19, 1873-81.   https://doi.org/10.1359/JBMR.040807




PubMed


 


PubMed ID 15476588
    
     


 



4.
Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J, Rudikoff S (2005). Wnts induce migration and invasion of myeloma plasma cells. Blood  106, 1786-93.   https://doi.org/10.1182/blood-2005-01-0049




PubMed



        
     
Free Article


 


PubMed ID 15886323
         Pubmed Central ID 1895227 


 



5.
Uren A, Wolf V, Sun YF, Azari A, Rubin JS, Toretsky JA (2004). Wnt/Frizzled signaling in Ewing sarcoma. Pediatr Blood Cancer  43, 243-9.   https://doi.org/10.1002/pbc.20124




PubMed


 


PubMed ID 15266408",https://intramural.nih.gov/search/searchview.taf?ipid=37150
150,BC010252-10,"October 01, 2004 -  September 30, 2005",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Yi  Huang



Kathryn  Jones; PhD



Cari  Sadowski","Steve  Baylin





Judy  Mikovits
(Biosource, Immunassay R&D)




Candace  Pert





Michael  Ruff
(Georgetown University School of Medicine)","Robert  Blumenthal; PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC, Ruscetti FW (2005). Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. J Immunol  174, 4262-70.   https://doi.org/10.4049/jimmunol.174.7.4262




PubMed


 


PubMed ID 15778389
    
     


 



2.
Polianova MT, Ruscetti FW, Pert CB, Ruff MR (2005). Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA). Antiviral Res  67, 83-92.   https://doi.org/10.1016/j.antiviral.2005.03.007




PubMed


 


PubMed ID 16002156
    
     


 



3.
Puri A, Rawat SS, Lin HM, Finnegan CM, Mikovits J, Ruscetti FW, Blumenthal R (2004). An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells. AIDS  18, 849-58.   https://doi.org/10.1097/00002030-200404090-00002




PubMed


 


PubMed ID 15060432
    
     


 



4.
Ruscetti F, Mikovits J, Nilsson G, Schatter E, Key M, Petrow-Sadowski C   (2004) Alterations in mast cell function and survival following invitro infection with human immunodeficiency Virus-1 thorugh CXCR4.  Cellular Immunol. .




 



5.
Ruscetti F, Petrow-Sadowski C, Huang Y, Bertolette D   (2005) Heparan Sulfate Proteoglycans mediate Attachment and Entry of HTLV-1 virions into CD4+ T cells.  J. of Virology, in press.




 



6.
Ruscetti F, Rauch D, Jones K, Ratner L   (2004) Cholesterol-dependence of HTLV-I infection.  AIDS Research and Human Retroviruses .




 



7.
Ruscetti F, Rawat S, Puri A, Wang J   (2004) Ceramide: a novel target for antiviral therapy.  Proc. Natl. Acad. Sci. (USA) .",https://intramural.nih.gov/search/searchview.taf?ipid=37151
151,BC010253-10,"October 01, 2004 -  September 30, 2005",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI","David R Hodge



Elaine M Hurt



Han-Jong  Kim



Nima  Sharifi



Suneethe  Thomas



Xiaohu  Zhang",NULL,"Eltore  Appella (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Farrar W, Hurt M   (2005) Inflammation, Cancer and STAT transcription factors: The overlapping molecular mechanisms of inflammation and Cancer.  Eur. J. Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37152
152,BC010256-10,"October 01, 2004 -  September 30, 2005",Analysis of the function of the nodal gene during embryonic development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Allison  Galica



George T Lezin","Martina  Brueckner
(Yale University)




Xin-Yuan  Fu
(Yale University)",Mark B Lewandoski (National Cancer Institute),Amit  Kumar; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37153
153,BC010257-10,"October 01, 2004 -  September 30, 2005",Ligand-receptor-antibody interactions in transmembrane signaling,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Samitabh  Chakraborti



Vidita  Choudhry



Yang  Feng



Prabakaran  Ponraj



Igor A Sidorov



Bang K Vu



Show all 9","Carl  Barrett
(Novartis)




Christopher  Broder
(Immunology and Microbiology, USUHS)




Dennis  Burton; PhD
(Scripps Research Institute)




Hana  Golding
(Retrovirus Research, FDA)




Gerald  Quinnan
(Medicine, USUHS)","Robert  Blumenthal; PhD (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Dean H. Hamer; PhD (National Cancer Institute)",Peter D Kwong; PhD (NIAID),"Ordered by publication type and then author name.



1.
Zhang MY, Choudhry V, Sidorov IA, Tenev V, Vu BK, Choudhary A, Lu H, Stiegler GM, Katinger HW, Jiang S, Broder CC, Dimitrov DS (2006). Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. J Immunol Methods  317, 21-30.   https://doi.org/10.1016/j.jim.2006.09.016




PubMed



        
     
Free Article


 


PubMed ID 17078964
         Pubmed Central ID 1805821 


 



2.
Dimitrov DS, Broder CS, Zhongyu ZS (submitted in 2005) Human Monoclonal Antibodies Against Hendra And Nipah Viruses. Patents issued: 1861424 (BE in 2011); 1861424 (CH in 2011); 1861424 (DK in 2011); 1861424 (EP in 2011); 1861424 (ES in 2011); 1861424 (FR in 2011); 1861424 (GB in 2011); 1861424 (IT in 2011); 1861424 (NL in 2011); 7,988,971 (US in 2011); 8,313,746 (US in 2013); 2012200557 (AU in 2014); 2336174 (EP in 2015); 8,858,938 (US in 2015); 2005333155 (AU in 2015). Patents pending: 2014200581 (AU application); 13/671,721 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=37154
154,BC010258-09,"October 01, 2004 -  September 30, 2005",Molecular mechanisms regulating the transition from innate to adaptive immunity,Teizo  Yoshimura; PhD,NULL,"Laboratory of Molecular Immunoregulation, NCI",Munehisa  Takahashi,"Michel  Faure
(Research, SUGEN, Inc.)




Akihiro  Matsukawa
(Department of Pathology, Experimental Medicine, School of Medicine, Kumamoto University)




Wataru  Matsuyama
(Department of Internal Medicine, Kagoshima University)","Cheryl Ann Winkler (Laboratory of Genomic Diversity)



Lino  Tessarollo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calvo CF, Amigou E, Tencé M, Yoshimura T, Glowinski J (2005). Albumin stimulates monocyte chemotactic protein-1 expression in rat embryonic mixed brain cells. J Neurosci Res  80, 707-14.   https://doi.org/10.1002/jnr.20511




PubMed


 


PubMed ID 15880558
    
     


 



2.
Cho H, Lasco TM, Allen SS, Yoshimura T, McMurray DN (2005). Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun  73, 1367-76.   https://doi.org/10.1128/IAI.73.3.1367-1376.2005




PubMed



        
     
Free Article


 


PubMed ID 15731034
         Pubmed Central ID 1064954 


 



3.
Matsuyama W, Watanabe M, Shirahama Y, Oonakahara K, Higashimoto I, Yoshimura T, Osame M, Arimura K (2005). Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis. J Immunol  174, 6490-8.   https://doi.org/10.4049/jimmunol.174.10.6490




PubMed


 


PubMed ID 15879152
    
     


 



4.
Yoshimura T, Matsuyama W, Kamohara H (2005). Discoidin domain receptor 1: a new class of receptor regulating leukocyte-collagen interaction. Immunol Res  31, 219-30.   https://doi.org/10.1385/IR:31:3:219




PubMed


 


PubMed ID 15888913",https://intramural.nih.gov/search/searchview.taf?ipid=37155
155,BC010262-09,"October 01, 2004 -  September 30, 2005",Molecular Genetics of the MHC,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Xiaojiang  Gao



Yalun  Liu



Maureen P Martin



Darlene M Marti



Amy E Poisson","Stephan  Beck
(Sanger Centre)




Richard  Single
(University of Vermont)",NULL,NULL,"Ordered by publication type and then author name.



1.
Carrington M, Cullen M (2004). Justified chauvinism: advances in defining meiotic recombination through sperm typing. Trends Genet  20, 196-205.   https://doi.org/10.1016/j.tig.2004.02.006




PubMed


 


PubMed ID 15041174
    
     


 



2.
Gourraud PA, Mano S, Barnetche T, Carrington M, Inoko H, Cambon-Thomsen A (2004). Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis. Tissue Antigens  64, 543-55.   https://doi.org/10.1111/j.1399-0039.2004.00317.x




PubMed


 


PubMed ID 15496197
    
     


 



3.
Malkki M, Single R, Carrington M, Thomson G, Petersdorf E (2005). MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens  66, 114-24.   https://doi.org/10.1111/j.1399-0039.2005.00453.x




PubMed


 


PubMed ID 16029431",https://intramural.nih.gov/search/searchview.taf?ipid=37156
156,BC010263-09,"October 01, 2004 -  September 30, 2005",Comparative Feline Genomics:  High-Throughput BACPAC Contig Mapping of the Major,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Thomas  Beck



Emily L Howe



Katherine M Kelley



Lisa  Maslan



Joan C Menninger



Nicholas  Pinkin



Show all 10","Pieter  deJong
(CHORI)




William  Nash
(H & W Sytogenetics Service)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37157
157,BC010265-09,"October 01, 2004 -  September 30, 2005",Developing the Feline Radiation Hybrid Map,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Nicole J Crumpler



Victor A David



Joan C Menninger



Alfred L Roca



Emma  Teeling



Janice S Martenson",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37158
158,BC010269-09,"October 01, 2004 -  September 30, 2005",Effects of genetic variation on infectious disease,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Megan E Boon



Xiaojiang  Gao



Yalun  Liu



Darlene M Marti



Maureen P Martin



Alexander D Mcaskill



Show all 7","Salim  Khakoo
(University Medicine, University of Southhampton)




Howard  Strickler
(Albert Einstein College of Medicine)




Amalio  Telenti
(University Hospital of Lausanne)




Chloe  Thio
(University Medicine, Johns Hopkins University)




David  Thomas
(Johns Hopkins University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A (2005). Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med  201, 1069-75.   https://doi.org/10.1084/jem.20042158




PubMed



        
     
Free Article


 


PubMed ID 15809352
         Pubmed Central ID 2213116 


 



2.
Dong HF, Wigmore K, Carrington MN, Dean M, Turpin JA, Howard OM (2005). Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5. Genes Immun  6, 609-19.   https://doi.org/10.1038/sj.gene.6364247




PubMed



        
     
Free Article


 


PubMed ID 16015368
         Pubmed Central ID 1369982 


 



3.
Martin MP, Carrington M (2005). Immunogenetics of viral infections. Curr Opin Immunol  17, 510-6.   https://doi.org/10.1016/j.coi.2005.07.012




PubMed


 


PubMed ID 16084708",https://intramural.nih.gov/search/searchview.taf?ipid=37159
159,BC010270-09,"October 01, 2004 -  September 30, 2005",High-Throughput Genotyping for Genetic Epidemiology,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Yvette  Berthier-Schaad



Joanne  Clarke



Kristine C Cruz



Holli B Hutcheson



Michael J Malasky



Mary  Mcnally



Show all 9","David  Altshuler
(Massachusetts Institute of Technology)




Francisco  De La Vega
(Applied Biosystems)




Dennis  Gilbert
(Applied Biosystems)




Michael  Klag
(Johns Hopkins University)




Young Mei  Liu
(Johns Hopkins University)




David  Reich
(Harvard University)


Show all 9",NULL,"Lev G Goldfarb; MD, PhD (NINDS)","Ordered by publication type and then author name.



1.
Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA (2004). Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet  41, 421-4.   https://doi.org/10.1136/jmg.2004.019349




PubMed



        
     
Free Article


 


PubMed ID 15173226
         Pubmed Central ID 1735800 


 



2.
Liu Y, Berthier-Schaad Y, Fink NE, Fallin MD, Tracy RP, Klag MJ, Smith MW, Coresh J (2005). Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort. Am J Kidney Dis  46, 78-85.   https://doi.org/10.1053/j.ajkd.2005.03.008




PubMed


 


PubMed ID 15983960
    
     


 



3.
Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2005). Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun  6, 347-57.   https://doi.org/10.1038/sj.gene.6364188




PubMed


 


PubMed ID 15815689
    
     


 



4.
Shrestha S, Smith MW, Beaty TH, Strathdee SA (2005). Theory and methodology for utilizing genes as biomarkers to determine potential biological mixtures. Ann Epidemiol  15, 29-38.   https://doi.org/10.1016/j.annepidem.2004.05.006




PubMed


 


PubMed ID 15571991
    
     


 



5.
Silverberg MJ, Smith MW, Chmiel JS, Detels R, Margolick JB, Rinaldo CR, O'Brien SJ, Muñoz A (2004). Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants. Am J Epidemiol  159, 232-41.   https://doi.org/10.1093/aje/kwh036




PubMed


 


PubMed ID 14742283
    
     


 



6.
Smith M, Strathdee S, Broman K   (2005) Unknown biological mixtures evaluation using STR analytical quantification.  Electrophoresis, in press.




 



7.
Smith M, Strathdee S, Galai N, Oleksyk T, Fallin D, Mehta S, Schaid D, Vlahov D, O'Brien S   (2005) Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection.  Journal of Infectious Diseases, in press.




 



8.
Smith MW, O'Brien SJ (2005). Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet  6, 623-32.   https://doi.org/10.1038/nrg1657




PubMed


 


PubMed ID 16012528",https://intramural.nih.gov/search/searchview.taf?ipid=37160
160,BC010271-09,"October 01, 2004 -  September 30, 2005","Identification of Genes Involved in HIV-1AIDS, HBV and HCV",Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Yvette  Berthier-Schaad



Kristine C Cruz



Taras K Oleksyk



Sadeep  Shrestha



Ann  Truelove","Sharyne M.  Donfield
(Rho Incorporated)




Gregory D.  Kirk
(Department of Epidemiology, Johns Hopkins University)




Steffanie  Strathdee
(Univeristy of California, San Diego)




Chloe L.  Thio
(Department of Medicine, Johns Hopkins University)




David L.  Thomas
(Department of Epidemiology, Johns Hopkins University)




David  Vlahov
(New York Academy of Medicine)",Michael  Dean; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Smith M, Strathdee S, Broman K   (2005) Unknown biological mixtures evaluation using STR analytical quantification.  Electrophoresis, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37161
161,BC010272-09,"October 01, 2004 -  September 30, 2005",Facilitating Access to Information on Human Proteins and Their Phosphorylation,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Natalya  Belkina,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fujii K, Zhu G, Liu Y, Hallam J, Chen L, Herrero J, Shaw S   (2004) Kinase peptide specificity: improved determination and relevance to protein phosphorylation.  Proc Natl Acad Sci U S A 101:13744-9.




PubMed



        
     
Free Article


 


PubMed ID 15356339
         Pubmed Central ID 518827 


 



2.
Zhu G, Liu Y, Shaw S (2005). Protein kinase specificity. A strategic collaboration between kinase peptide specificity and substrate recruitment. Cell Cycle  4, 52-6.   https://doi.org/10.4161/cc.4.1.1353




PubMed


 


PubMed ID 15655379",https://intramural.nih.gov/search/searchview.taf?ipid=37162
162,BC010275-08,"October 01, 2004 -  September 30, 2005",Neuronal Cell Death Regulation in Drosophila,"Florence M Davidson; MS, PhD, BA",NULL,"Laboratory of Biochemistry, NCI","Sarah  Baxley



Moyi  Li



Robert  Padilla



Nadia  Urban",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37163
163,BC010276-08,"October 01, 2004 -  September 30, 2005",Protein Folding Mechanism,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI","Hangiao  Feng



Ngoc-Diep  Vu



Zheng  Zhou","Feng  Gai
(Department of Chemistry, University of Pennsylvania)




Lewis  Kay
(Department of Biochemistry, University of Toronto)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bai Y   (2005) Protein folding pathways studied by pulsed- and native-state hydrogen exchange.  Chem Rev, in press.




 



2.
Feng H, Zhou Z, Bai Y (2005). A protein folding pathway with multiple folding intermediates at atomic resolution. Proc Natl Acad Sci U S A  102, 5026-31.   https://doi.org/10.1073/pnas.0501372102




PubMed



        
     
Free Article


 


PubMed ID 15793003
         Pubmed Central ID 555603",https://intramural.nih.gov/search/searchview.taf?ipid=37164
164,BC010277-08,"October 01, 2004 -  September 30, 2005",Mechanisms of Chromosome Maintenance in Bacteria,"Dhruba K Chattoraj; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI","Richard Alfred Fekete



Debasish  Pal



Preeti  Srivastava



Tatiana B Venkova-Canova",NULL,NULL,Paul F Morrison; PhD (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37165
165,BC010278-08,"October 01, 2004 -  September 30, 2005",Imaging cellular assemblies with three-dimensional electron microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Alberto  Bartesaghi



Adam  Bennett



David  Germain



Lisa M. Hartnell



Jurgen A Heymann



Teruhisa  Hirai



Show all 11","Ben  Lich
(FEI Inc.)




Robert  Morrison
(GATAN Inc.)




Peter  Peters
(Netherlands Cancer Institute)




Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)","Robert  Blumenthal; PhD (National Cancer Institute)



Deb  Chatterjee (National Cancer Institute)



Richard D Leapman; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bartesaghi A, Sapiro G, Subramaniam S (2005). An energy-based three-dimensional segmentation approach for the quantitative interpretation of electron tomograms. IEEE Trans Image Process  14, 1314-23.   https://doi.org/10.1109/tip.2005.852467




PubMed



        
     
Free Article


 


PubMed ID 16190467
         Pubmed Central ID 1698959 


 



2.
Hirai T, Subramaniam S (2004). Structure and transport mechanism of the bacterial oxalate transporter OxlT. Biophys J  87, 3600-7.   https://doi.org/10.1529/biophysj.104.049320




PubMed



        
     
Free Article


 


PubMed ID 15339805
         Pubmed Central ID 1304825 


 



3.
Lefman J, Zhang P, Hirai T, Weis RM, Juliani J, Bliss D, Kessel M, Bos E, Peters PJ, Subramaniam S (2004). Three-dimensional electron microscopic imaging of membrane invaginations in Escherichia coli overproducing the chemotaxis receptor Tsr. J Bacteriol  186, 5052-61.   https://doi.org/10.1128/JB.186.15.5052-5061.2004




PubMed



        
     
Free Article


 


PubMed ID 15262942
         Pubmed Central ID 451663 


 



4.
Subramaniam S (2005). Bridging the imaging gap: visualizing subcellular architecture with electron tomography. Curr Opin Microbiol  8, 316-22.   https://doi.org/10.1016/j.mib.2005.04.012




PubMed



        
     
Free Article


 


PubMed ID 15939356
         Pubmed Central ID 1647296 


 



5.
Subramaniam S, Milne JL (2004). Three-dimensional electron microscopy at molecular resolution. Annu Rev Biophys Biomol Struct  33, 141-55.   https://doi.org/10.1146/annurev.biophys.33.110502.140339




PubMed


 


PubMed ID 15139808
    
     


 



6.
Zhang P, Bos E, Heymann J, Gnaegi H, Kessel M, Peters PJ, Subramaniam S (2004). Direct visualization of receptor arrays in frozen-hydrated sections and plunge-frozen specimens of E. coli engineered to overproduce the chemotaxis receptor Tsr. J Microsc  216, 76-83.   https://doi.org/10.1111/j.0022-2720.2004.01395.x




PubMed


 


PubMed ID 15369487
    
     


 



7.
Zhang P, Land W, Lee S, Juliani J, Lefman J, Smith SR, Germain D, Kessel M, Leapman R, Rouault TA, Subramaniam S (2005). Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J Struct Biol  150, 144-53.   https://doi.org/10.1016/j.jsb.2005.01.007




PubMed



        
     
Free Article


 


PubMed ID 15866737
         Pubmed Central ID 1698958 


 



8.
Subramanian S, Devasahayam N, Koscielniak J, Krishna M, Mitchell J (submitted in 2005) Fast Electron Paramagnetic Resonance Imaging (epri) Using Cw Cpr Spectrometer With Sinusoidal Rapid-scan And Digital Signal Processing. Patent issued: 8,269,496 (US in 2012).",https://intramural.nih.gov/search/searchview.taf?ipid=37166
166,BC010279-08,"October 01, 2004 -  September 30, 2005",Interaction of Progesterone Receptor with Chromatin,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anne  Gussow



Angeliki  Magklara",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37167
167,BC010283-08,"October 01, 2004 -  September 30, 2005",DNA Repair,"Andre A Nussenzweig; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Arkady  Celeste



Hua Tang (Henry)  Chen



Simone  Difilippantonio



Alicia  Lee



Maria Elsa  Callen Moreu",NULL,Shyam K Sharan (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Couëdel C, Mills KD, Barchi M, Shen L, Olshen A, Johnson RD, Nussenzweig A, Essers J, Kanaar R, Li GC, Alt FW, Jasin M (2004). Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells. Genes Dev  18, 1293-304.   https://doi.org/10.1101/gad.1209204




PubMed



        
     
Free Article


 


PubMed ID 15175261
         Pubmed Central ID 420355 


 



2.
Daniel R, Ramcharan J, Rogakou E, Taganov KD, Greger JG, Bonner W, Nussenzweig A, Katz RA, Skalka AM (2004). Histone H2AX is phosphorylated at sites of retroviral DNA integration but is dispensable for postintegration repair. J Biol Chem  279, 45810-4.   https://doi.org/10.1074/jbc.M407886200




PubMed


 


PubMed ID 15308627
    
     


 



3.
Difilippantonio S, Celeste A, Fernandez-Capetillo O, Chen HT, Reina San Martin B, Van Laethem F, Yang YP, Petukhova GV, Eckhaus M, Feigenbaum L, Manova K, Kruhlak M, Camerini-Otero RD, Sharan S, Nussenzweig M, Nussenzweig A (2005). Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol  7, 675-85.   https://doi.org/10.1038/ncb1270




PubMed


 


PubMed ID 15965469
    
     


 



4.
Dmitrieva NI, Celeste A, Nussenzweig A, Burg MB (2005). Ku86 preserves chromatin integrity in cells adapted to high NaCl. Proc Natl Acad Sci U S A  102, 10730-5.   https://doi.org/10.1073/pnas.0504870102




PubMed



        
     
Free Article


 


PubMed ID 16027367
         Pubmed Central ID 1180807 


 



5.
Fernandez-Capetillo O, Allis CD, Nussenzweig A (2004). Phosphorylation of histone H2B at DNA double-strand breaks. J Exp Med  199, 1671-7.   https://doi.org/10.1084/jem.20032247




PubMed



        
     
Free Article


 


PubMed ID 15197225
         Pubmed Central ID 2212807 


 



6.
Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004). H2AX: the histone guardian of the genome. DNA Repair (Amst)  3, 959-67.   https://doi.org/10.1016/j.dnarep.2004.03.024




PubMed


 


PubMed ID 15279782
    
     


 



7.
Fernandez-Capetillo O, Nussenzweig A (2004). Aging counts on chromosomes. Nat Genet  36, 672-4.   https://doi.org/10.1038/ng0704-672




PubMed


 


PubMed ID 15226747
    
     


 



8.
Fernandez-Capetillo O, Nussenzweig A (2004). Linking histone deacetylation with the repair of DNA breaks. Proc Natl Acad Sci U S A  101, 1427-8.   https://doi.org/10.1073/pnas.0307342101




PubMed



        
     
Free Article


 


PubMed ID 14757822
         Pubmed Central ID 341727 


 



9.
Lan L, Nakajima S, Komatsu K, Nussenzweig A, Shimamoto A, Oshima J, Yasui A (2005). Accumulation of Werner protein at DNA double-strand breaks in human cells. J Cell Sci  118, 4153-62.   https://doi.org/10.1242/jcs.02544




PubMed


 


PubMed ID 16141234
    
     


 



10.
Lee AC, Fernandez-Capetillo O, Pisupati V, Jackson SP, Nussenzweig A (2005). Specific association of mouse MDC1/NFBD1 with NBS1 at sites of DNA-damage. Cell Cycle  4, 177-82.   https://doi.org/10.4161/cc.4.1.1354




PubMed


 


PubMed ID 15611643
    
     


 



11.
Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, Honjo T, Nussenzweig A, Nussenzweig MC (2004). AID is required for c-myc/IgH chromosome translocations in vivo. Cell  118, 431-8.   https://doi.org/10.1016/j.cell.2004.08.006




PubMed


 


PubMed ID 15315756
    
     


 



12.
Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S (2005). Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci U S A  102, 1590-5.   https://doi.org/10.1073/pnas.0406289102




PubMed



        
     
Free Article


 


PubMed ID 15668392
         Pubmed Central ID 547831 


 



13.
Sengupta S, Robles AI, Linke SP, Sinogeeva NI, Zhang R, Pedeux R, Ward IM, Celeste A, Nussenzweig A, Chen J, Halazonetis TD, Harris CC (2004). Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol  166, 801-13.   https://doi.org/10.1083/jcb.200405128




PubMed



        
     
Free Article


 


PubMed ID 15364958
         Pubmed Central ID 2172115 


 



14.
Turner JM, Mahadevaiah SK, Fernandez-Capetillo O, Nussenzweig A, Xu X, Deng CX, Burgoyne PS (2005). Silencing of unsynapsed meiotic chromosomes in the mouse. Nat Genet  37, 41-7.   https://doi.org/10.1038/ng1484




PubMed


 


PubMed ID 15580272
    
     


 



15.
Ward IM, Reina-San-Martin B, Olaru A, Minn K, Tamada K, Lau JS, Cascalho M, Chen L, Nussenzweig A, Livak F, Nussenzweig MC, Chen J (2004). 53BP1 is required for class switch recombination. J Cell Biol  165, 459-64.   https://doi.org/10.1083/jcb.200403021




PubMed



        
     
Free Article


 


PubMed ID 15159415
         Pubmed Central ID 2172356",https://intramural.nih.gov/search/searchview.taf?ipid=37168
168,BC010289-08,"October 01, 2004 -  September 30, 2005",Chromatin Targets of Cyclic Nucleotide Signaling Pathways,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Erin  Bressler



Rebecca C Chiffer



Sara K Snyder","Jackie  Dudley; PhD
(University of Texas)




Hans-Gottfried  Genieser
(BIOLOG Life Science Institute)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37173
169,BC010292-07,"October 01, 2004 -  September 30, 2005",Enzymes and Substrates of the Ubiquitin Conjugating System,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Mickael M Cohen



Andrew  Fotia



Michael  Glickman



Jane P Jensen



Jirouta  Kitagaki



Yien-Che  Tsai



Show all 7",NULL,"Michael Robert Kuehn; PhD (National Cancer Institute)



Robert Andrew Byrd (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)












Karen H Vousden  (Regulation of Cell Growth Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Davydov IV, Woods D, Safiran YJ, Oberoi P, Fearnhead HO, Fang S, Jensen JP, Weissman AM, Kenten JH, Vousden KH (2004). Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2. J Biomol Screen  9, 695-703.   https://doi.org/10.1177/1087057104267956




PubMed


 


PubMed ID 15634796
    
     


 



2.
Megumi Y, Miyauchi Y, Sakurai H, Nobeyama H, Lorick K, Nakamura E, Chiba T, Tanaka K, Weissman AM, Kirisako T, Ogawa O, Iwai K (2005). Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex. Genes Cells  10, 679-91.   https://doi.org/10.1111/j.1365-2443.2005.00869.x




PubMed


 


PubMed ID 15966899
    
     


 



3.
Yang Y, Li CC, Weissman AM (2004). Regulating the p53 system through ubiquitination. Oncogene  23, 2096-106.   https://doi.org/10.1038/sj.onc.1207411




PubMed


 


PubMed ID 15021897
    
     


 



4.
Yang Y, Ludwig RL, Jensen JP, Pierre SA, Medaglia MV, Davydov IV, Safiran YJ, Oberoi P, Kenten JH, Phillips AC, Weissman AM, Vousden KH (2005). Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell  7, 547-59.   https://doi.org/10.1016/j.ccr.2005.04.029




PubMed


 


PubMed ID 15950904
    
     


 



5.
Yang Y, Jensen J, Weissman A (submitted in 2005) Inhibitors Of Ubiquitin E1. Patent issued: 8,242,160 (US in 2012). Patents pending: 13/547,417 (US application); PCT/US2006/045032 (PC application); 12/154,156 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36961
170,BC010297-08,"October 01, 2004 -  September 30, 2005",Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Ping  An; PhD



Elizabeth  Binns-Roemer



Zheng-Mei  Liu



Louise  Mckenzie



Yu-Chun  Zhou



Bailey D Kessing



Show all 7","David  Altshuler
(Massachusetts Institute of Technology)




Richard  D'Aquila
(Broad Institute, Vanderbilt University School of Medicine)




Eric  Lander
(MIT)




George  Nelson
(Basic Research Division, SAIC-Frederick)




Amalio  Telenti
(University Hospital of Lausanne)",NULL,NULL,"Ordered by publication type and then author name.



1.
Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D (2005). The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. J Acquir Immune Defic Syndr  38, 584-9.   https://doi.org/10.1097/01.qai.0000134741.49208.03




PubMed


 


PubMed ID 15793370
    
     


 



2.
Song B, Gold B, O'Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M, Sodroski J (2005). The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol  79, 6111-21.   https://doi.org/10.1128/JVI.79.10.6111-6121.2005




PubMed



        
     
Free Article


 


PubMed ID 15857996
         Pubmed Central ID 1091705 


 



3.
Winkler C, Lynn H, Donfield S, Lail A, O'Brien S, Huang W   (2005) Stromal cell-derived factor-1 genotype, co-receptor tropism and human immunodeficiency virus type 1 progression.  Journal of Virology, in press.




 



4.
Winkler C, Sabeti P, Hutcheson H, Fry B, Schaffner S, Bakker P, Varilly P, Palma A, Roy J, Cooper R, Zeng Y, The G, Lander E, O'Brien S, Altshuler D   (2005) Searching for signals of evolutionary selection in 168 genes related to immune function.  Human Genetics, in press.




 



5.
Winkler C, Scott K, Goedert J, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien S   (2005) Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study.  Genes and Immunity, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37174
171,BC010298-08,"October 01, 2004 -  September 30, 2005",Gene Discovery,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Richard A Beers



Tapan K Bera



Sudipto  Das



Satoshi  Nagata; PhD



Ashley  Saint Fleur



Laiman  Xiang",NULL,"Byungkook  Lee; PhD (National Cancer Institute)



James J Vincent (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pastan I, Egland K, Lee B   (2005) Identification of novel cancer target antigens utilizing EST and genome sequence databases, in The Oncogenomics Handbook. LaRochelle W, Skimkets R, eds., The Humana Press (Totowa, NJ), pp. 31-42.




 



2.
Bera TK, Das S, Maeda H, Beers R, Wolfgang CD, Kumar V, Hahn Y, Lee B, Pastan I (2004). NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate. Proc Natl Acad Sci U S A  101, 3059-64.   https://doi.org/10.1073/pnas.0308746101




PubMed



        
     
Free Article


 


PubMed ID 14981236
         Pubmed Central ID 365744 


 



3.
Bera TK, Huynh N, Maeda H, Sathyanarayana BK, Lee B, Pastan I (2004). Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths. Gene  337, 45-53.   https://doi.org/10.1016/j.gene.2004.05.009




PubMed


 


PubMed ID 15276201
    
     


 



4.
Hahn Y, Bera TK, Gehlhaus K, Kirsch IR, Pastan IH, Lee B (2004). Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Proc Natl Acad Sci U S A  101, 13257-61.   https://doi.org/10.1073/pnas.0405490101




PubMed



        
     
Free Article


 


PubMed ID 15326299
         Pubmed Central ID 516526 


 



5.
Maeda H, Nagata S, Wolfgang CD, Bratthauer GL, Bera TK, Pastan I (2004). The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria. J Biol Chem  279, 24561-8.   https://doi.org/10.1074/jbc.M402492200




PubMed


 


PubMed ID 15150260
    
     


 



6.
Pastan I, Bera T, Lee B   (2005) Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.  Gene, in press.




 



7.
Soler-García AA, Maitra R, Kumar V, Ise T, Nagata S, Beers R, Bera TK, Pastan I (2005). The PATE gene is expressed in the accessory tissues of the human male genital tract and encodes a secreted sperm-associated protein. Reproduction  129, 515-24.   https://doi.org/10.1530/rep.1.00576




PubMed


 


PubMed ID 15798027",https://intramural.nih.gov/search/searchview.taf?ipid=37175
172,BC010300-08,"October 01, 2004 -  September 30, 2005",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Laurel Anne Hughes



Sara E Reynolds



Rebecca L Schubert



Anthony V Washington



Gillian C Whittaker","Edward  Cho
(Image Analysis Laboratory, National Cancer Institite)




Mary  Nakamura
(Laboratoire d'Hematologie, UCSF)




Alan  Nurden
(INSERM)




Weiguo  Zhang
(NICHHD)","Stephen K Anderson; PhD (National Cancer Institute)



Jacek Tadeusz Lubkowski (National Cancer Institute)","Ivo  Francischetti; MD, PhD (NIAID) 



Paul E Love; MD, PhD (NICHD) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
McVicar D, Mikhael A, Taylor L, Musso T   (2004) Complex regulation of the Csk homologous kinase (Chk) by IL-4 family cytokines and IFN-γ in human peripheral blood monocytes.  Mol Immunol .




 



2.
McVicar D, Schubert R, Quigley L, Disipio T, Feltz R, Cho E   (2004) TREM Family Member, TLT-1, Is Found Exclusively in the Alpha Granules of Megakaryocytes and Platelets.  Blood .",https://intramural.nih.gov/search/searchview.taf?ipid=37176
173,BC010301-08,"October 01, 2004 -  September 30, 2005",Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal,"Robert J Kreitman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Evgeny  Arons



Kit S Beane



Karen  Bergeron



Barbara  Debrah



Linda  Ellison-Dejewski



Inger M Margulies","Harry  Findleyl
(Emory University School of Medicine)




Arthur  Frankel
(Wake Forest University)




Shoji  Hirashima
(Daiichi)




Kakushi  Matsushita
(1st Department of Internal Medicine, Kagoshima University, Japan)




Giuliana  Salvatore
(Universita degli Studi di Napoli)




Mark  Willingham
(Wake Forest University School of Medicine)","Ira H Pastan; MD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)



Byungkook  Lee; PhD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)","Pierre  Noel (CC) 



Margaret E Rick; MD (CC) 



Jorge A Carrasquillo; MD (CC) 



George J Grimes (CC)","Ordered by publication type and then author name.



1.
Pastan IH, Fitzgerald DH, Kreitman RH, Lee BH, Nagata SH, Onda MH (submitted in 2005) Mutated Pseudomonas Exotoxins With Reduced Antigenicity. Patents issued: 1910407 (CH in 2011); 1910407 (DE in 2011); 1910407 (EP in 2011); 1910407 (ES in 2011); 1910407 (FR in 2011); 1910407 (GB in 2011); 1910407 (IT in 2011); 2006275865 (AU in 2013); 2311854 (CH in 2013); 2311854 (DE in 2013); 2311854 (EP in 2013); 2311854 (ES in 2013); 2311854 (FR in 2013); 2311854 (GB in 2013); 2311854 (IT in 2013); 8,907,060 (US in 2015); 2014208269 (AU in 2016); 602006047581 (DE in 2016); 2332970 (EP in 2016); 2332970 (ES in 2016); 2332970 (FR in 2016); 2332970 (GB in 2016); 233970 (IT in 2016); 2616987 (CA in 2017); 2016202754 (AU in 2018); 3006458 (BE in 2018); 3006457 (BE in 2018); 602006054213 (DE in 2018); 602006054212 (DE in 2018); 3006457 (EP in 2018); 3006458 (EP in 2018); 2660026 (ES in 2018); 2659039 (ES in 2018); 3006458 (FR in 2018); 3006457 (FR in 2018); 3006458 (GB in 2018); 3006457 (GB in 2018); 3006458 (IE in 2018); 3006457 (IE in 2018); 3006458 (AT in 2018); 3006457 (AT in 2018); 3006458 (IT in 2018); 3006457 (IT in 2018); 3006458 (NL in 2018); 3006457 (NL in 2018); 3006458 (PL in 2018); 3006457 (PL in 2018). Patents pending: 2012216642 (AU application); 2941466 (CA application); 15191388.6 (EP application); PCT/US2006/028986 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37177
174,BC010303-07,"October 01, 2004 -  September 30, 2005",MicroArray Explorer for the data mining of expression profiles of DNA microarray,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Gregory  Thornwall,"Gregory  Alvord
(Data Management Services)




Jai A Evans





Lothar  Hennighausen; PhD
(NIDDK)




Mariusz  Lubomirski
(HHS, CSS/DMS-Frederick)




Shyam  Sundaram
(HHS, SRA/BIAMAS/CIT)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37178
175,BC010304-07,"October 01, 2004 -  September 30, 2005",Biochemical Basis of T Cell Activation,"Lawrence Elliot Samelson; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mira  Barda-Saad



Brent C Bowden



Alex  Braiman



Jordan M Gurson



Jon  Houtman



Connie  Sommers; PhD



Show all 9","Ruedi  Aebersold
(Institute for Systems Biology)




Roy  Mariuzza
(University of Maryland)




Julian  Watts
(Institute for Systems Biology)",NULL,"Paul E Love; MD, PhD (NICHD) 



Peter W Schuck; PhD (OD)","Ordered by publication type and then author name.



1.
Barda-Saad M, Braiman A, Titerence R, Bunnell SC, Barr VA, Samelson LE (2005). Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat Immunol  6, 80-9.   https://doi.org/10.1038/ni1143




PubMed


 


PubMed ID 15558067
    
     


 



2.
Chiang YJ, Sommers CL, Jordan MS, Gu H, Samelson LE, Koretzky GA, Hodes RJ (2004). Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice. J Exp Med  200, 25-34.   https://doi.org/10.1084/jem.20040262




PubMed



        
     
Free Article


 


PubMed ID 15238603
         Pubmed Central ID 2213313 


 



3.
Cho S, Velikovsky CA, Swaminathan CP, Houtman JC, Samelson LE, Mariuzza RA (2004). Structural basis for differential recognition of tyrosine-phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads. EMBO J  23, 1441-51.   https://doi.org/10.1038/sj.emboj.7600168




PubMed



        
     
Free Article


 


PubMed ID 15029250
         Pubmed Central ID 391073 


 



4.
Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, Eng JK, Aderem A, Boyle R, Brunner E, Donohoe S, Fausto N, Hafen E, Hood L, Katze MG, Kennedy KA, Kregenow F, Lee H, Lin B, Martin D, Ranish JA, Rawlings DJ, Samelson LE, Shiio Y, Watts JD, Wollscheid B, et al. [6 more authors] (2005). Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol  6, R9.   https://doi.org/10.1186/gb-2004-6-1-r9




PubMed



        
     
Free Article


 


PubMed ID 15642101
         Pubmed Central ID 549070 


 



5.
Houtman JC, Higashimoto Y, Dimasi N, Cho S, Yamaguchi H, Bowden B, Regan C, Malchiodi EL, Mariuzza R, Schuck P, Appella E, Samelson LE (2004). Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences. Biochemistry  43, 4170-8.   https://doi.org/10.1021/bi0357311




PubMed


 


PubMed ID 15065860
    
     


 



6.
Houtman JC, Houghtling RA, Barda-Saad M, Toda Y, Samelson LE (2005). Early phosphorylation kinetics of proteins involved in proximal TCR-mediated signaling pathways. J Immunol  175, 2449-58.   https://doi.org/10.4049/jimmunol.175.4.2449




PubMed



        
     
Free Article


 


PubMed ID 16081816
         Pubmed Central ID 1414060 


 



7.
Singer AL, Bunnell SC, Obstfeld AE, Jordan MS, Wu JN, Myung PS, Samelson LE, Koretzky GA (2004). Roles of the proline-rich domain in SLP-76 subcellular localization and T cell function. J Biol Chem  279, 15481-90.   https://doi.org/10.1074/jbc.M313339200




PubMed


 


PubMed ID 14722089
    
     


 



8.
Sommers CL, Lee J, Steiner KL, Gurson JM, Depersis CL, El-Khoury D, Fuller CL, Shores EW, Love PE, Samelson LE (2005). Mutation of the phospholipase C-gamma1-binding site of LAT affects both positive and negative thymocyte selection. J Exp Med  201, 1125-34.   https://doi.org/10.1084/jem.20041869




PubMed



        
     
Free Article


 


PubMed ID 15795236
         Pubmed Central ID 1538971 


 



9.
Sommers CL, Samelson LE, Love PE (2004). LAT: a T lymphocyte adapter protein that couples the antigen receptor to downstream signaling pathways. Bioessays  26, 61-7.   https://doi.org/10.1002/bies.10384




PubMed


 


PubMed ID 14696041
    
     


 



10.
Tkaczyk C, Horejsi V, Iwaki S, Draber P, Samelson LE, Satterthwaite AB, Nahm DH, Metcalfe DD, Gilfillan AM (2004). NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation. Blood  104, 207-14.   https://doi.org/10.1182/blood-2003-08-2769




PubMed


 


PubMed ID 15010370
    
     


 



11.
Wilson BS, Steinberg SL, Liederman K, Pfeiffer JR, Surviladze Z, Zhang J, Samelson LE, Yang LH, Kotula PG, Oliver JM (2004). Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol Biol Cell  15, 2580-92.   https://doi.org/10.1091/mbc.e03-08-0574




PubMed



        
     
Free Article


 


PubMed ID 15034144
         Pubmed Central ID 420084",https://intramural.nih.gov/search/searchview.taf?ipid=37179
176,BC010305-07,"October 01, 2004 -  September 30, 2005",Genetic effects of the MHC and KIR locus on autoimmune disease and cancer,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Megan E Boon



Xiaojiang  Gao



Yalun  Liu



Darlene M Marti



Maureen P Martin



Alexander D Mcaskill



Show all 7","James  Elder
(University of Michigan)




Dafna  Gladman
(University of Toronto)




Rajan  Nair
(University of Michigan)




John  Rioux
(MIT)




Katherine  Siminovitch
(Department of Medicine, University of Toronto)




John  Trowsdale
(Department of Medicine, University of Cambridge)","Allan  Hildesheim; PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A (2005). Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med  201, 1069-75.   https://doi.org/10.1084/jem.20042158




PubMed



        
     
Free Article


 


PubMed ID 15809352
         Pubmed Central ID 2213116 


 



2.
Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A (2004). Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med  200, 957-65.   https://doi.org/10.1084/jem.20041214




PubMed



        
     
Free Article


 


PubMed ID 15477349
         Pubmed Central ID 2211839 


 



3.
Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M (2004). Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol  173, 4273-6.   https://doi.org/10.4049/jimmunol.173.7.4273




PubMed


 


PubMed ID 15383555",https://intramural.nih.gov/search/searchview.taf?ipid=37183
177,BC010306-07,"October 01, 2004 -  September 30, 2005",Identification of Needle Sharing: A Risk Factor for Viral Infection,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Joanne  Clarke



Sadeep  Shrestha","Terri  Beaty
(Biostatistics, Johns Hopkins University)




Karl  Broman
(University of Michigan)




Steffanie  Strathdee
(University of California, San Diego)




David  Vlahov
(New York Academy of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Smith M, Strathdee S, Broman K   (2005) Unknown biological mixtures evaluation using STR analytical quantification.  Electrophoresis, in press.




 



2.
Smith M, Strathdee S, Galai N, Oleksyk T, Fallin D, Mehta S, Schaid D, Vlahov D, O'Brien S   (2005) Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection.  Journal of Infectious Diseases, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37184
178,BC010307-06,"October 01, 2004 -  September 30, 2005",Cell Growth Control In Vivo by CEBPbeta and CEBPdelta,"Gisela Esta Sterneck; PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Snehalata Anil Pawar



A-Mei  Huang



Shikha  Sharan","Lane  Christenson
(Center for Research on Reproduction and Women's Health, University of Pennsylvania)




Vadivel  Ganapathy
(Department of Biochemistry and Molecular Biology, Medical College of Georgia)




Lothar  Hennighausen; PhD
(NIDDK)




Zdenek  Kleibl
(Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)




Jan  McAllister
(Department of Cellular and Molecular Physiology, Pennsylviana State University College of Medicine)




Robert  Smart
(Department of Environmental and Molecular Toxicology, NCSU)


Show all 7","Ruth  Pfeiffer; PhD (National Cancer Institute)



Lisa M Gangi (National Cancer Institute)



Mark  Raffeld; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Huang AM, Montagna C, Sharan S, Ni Y, Ried T, Sterneck E (2004). Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene  23, 1549-57.   https://doi.org/10.1038/sj.onc.1207285




PubMed


 


PubMed ID 14716301
    
     


 



2.
Sterneck E, Zhu S, Ramirez A, Jorcano JL, Smart RC (2006). Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene  25, 1272-1276.   https://doi.org/10.1038/sj.onc.1209144




PubMed



        
     
Free Article


 


PubMed ID 16205634
         Pubmed Central ID 3773579 


 



3.
Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang AM, Sterneck E (2005). C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development  132, 4675-85.   https://doi.org/10.1242/dev.02050




PubMed


 


PubMed ID 16192306
    
     


 



4.
Thangaraju M, Sharan S, Sterneck E (2004). Comparison of mammary gland involution between 129S1 and C57BL/6 inbred mouse strains: differential regulation of Bcl2a1, Trp53, Cebpb, and Cebpd expression. Oncogene  23, 2548-53.   https://doi.org/10.1038/sj.onc.1207363




PubMed


 


PubMed ID 14981542",https://intramural.nih.gov/search/searchview.taf?ipid=36982
179,BC010308-07,"October 01, 2004 -  September 30, 2005",In vivo Imaging Analysis of SteroidNuclear Receptor Function,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anindya P Hendarwanto



Sam  John



Tom  Johnson



Ty Cole Voss



Malgorzata  Wiench","Don  DeFranco
(Pharmacology, Univ of Pittsburgh)




Dean  Edwards
(Pharmacology, Univ Colorado Hlth Sciences Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Elbi C, Walker DA, Romero G, Sullivan WP, Toft DO, Hager GL, DeFranco DB (2004). Molecular chaperones function as steroid receptor nuclear mobility factors. Proc Natl Acad Sci U S A  101, 2876-81.   https://doi.org/10.1073/pnas.0400116101




PubMed



        
     
Free Article


 


PubMed ID 14978266
         Pubmed Central ID 365713 


 



2.
Hager GL, Nagaich AK, Johnson TA, Walker DA, John S (2004). Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta  1677, 46-51.   https://doi.org/10.1016/j.bbaexp.2003.09.016




PubMed


 


PubMed ID 15020044
    
     


 



3.
Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL (2005). Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol  25, 2406-18.   https://doi.org/10.1128/MCB.25.6.2406-2418.2005




PubMed



        
     
Free Article


 


PubMed ID 15743833
         Pubmed Central ID 1061598 


 



4.
Stavreva DA, Müller WG, Hager GL, Smith CL, McNally JG (2004). Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol  24, 2682-97.   https://doi.org/10.1128/mcb.24.7.2682-2697.2004




PubMed



        
     
Free Article


 


PubMed ID 15024059
         Pubmed Central ID 371101",https://intramural.nih.gov/search/searchview.taf?ipid=37185
180,BC010309-07,"October 01, 2004 -  September 30, 2005",Nuclear Architecture and Disease,"Thomas A Misteli; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Stan  Gorski



Stephen A Mabon



Manjari  Mazumdar



Karen J Meaburn



Eran  Meshorer



Paola  Scaffidi



Show all 8","David  Brown
(University of Mississippi)




Susan  Gasser
(FMI)




Tina  Izard
(St. Jude's Research Hospital)","Michael  Bustin; PhD (National Cancer Institute)



Sushil Gopal Rane; MS, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Becker M, Becker A, Miyara F, Han Z, Kihara M, Brown DT, Hager GL, Latham K, Adashi EY, Misteli T (2005). Differential in vivo binding dynamics of somatic and oocyte-specific linker histones in oocytes and during ES cell nuclear transfer. Mol Biol Cell  16, 3887-95.   https://doi.org/10.1091/mbc.e05-04-0350




PubMed



        
     
Free Article


 


PubMed ID 15944219
         Pubmed Central ID 1182324 


 



2.
Brown DT, Izard T, Misteli T (2006). Mapping the interaction surface of linker histone H1(0) with the nucleosome of native chromatin in vivo. Nat Struct Mol Biol  13, 250-5.   https://doi.org/10.1038/nsmb1050




PubMed



        
     
Free Article


 


PubMed ID 16462749
         Pubmed Central ID 1868459 


 



3.
Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL, Misteli T (2006). Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A  103, 10271-10276.   https://doi.org/10.1073/pnas.0601058103




PubMed



        
     
Free Article


 


PubMed ID 16801550
         Pubmed Central ID 1502447 


 



4.
Mabon SA, Misteli T (2005). Differential recruitment of pre-mRNA splicing factors to alternatively spliced transcripts in vivo. PLoS Biol  3, e374.   https://doi.org/10.1371/journal.pbio.0030374




PubMed



        
     
Free Article


 


PubMed ID 16231974
         Pubmed Central ID 1262628 


 



5.
McNairn AJ, Okuno Y, Misteli T, Gilbert DM (2005). Chinese hamster ORC subunits dynamically associate with chromatin throughout the cell-cycle. Exp Cell Res  308, 345-56.   https://doi.org/10.1016/j.yexcr.2005.05.009




PubMed



        
     
Free Article


 


PubMed ID 15950218
         Pubmed Central ID 1350721 


 



6.
Misteli T (2004). Spatial positioning; a new dimension in genome function. Cell  119, 153-6.   https://doi.org/10.1016/j.cell.2004.09.035




PubMed


 


PubMed ID 15479633
    
     


 



7.
Scaffidi P, Misteli T (2005). Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med  11, 440-5.   https://doi.org/10.1038/nm1204




PubMed



        
     
Free Article


 


PubMed ID 15750600
         Pubmed Central ID 1351119",https://intramural.nih.gov/search/searchview.taf?ipid=37186
181,BC010312-07,"October 01, 2004 -  September 30, 2005",Analysis of cellular gene expression in HPV infection and cervical cancer,"Carl C Baker; MD, PhD",NULL,"Laboratory of Cellular Oncology, NCI","Astrid C Baege



Janet M Dipasquale



Jesse F Quintero",NULL,"Sophia S Wang; PhD (National Cancer Institute)



Mark  Schiffman; MD (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Seong-Jin  Kim; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J, Schlegel R (2005). The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem  280, 10807-16.   https://doi.org/10.1074/jbc.M410343200




PubMed


 


PubMed ID 15655249
    
     


 



2.
Wang SS, Dasgupta A, Sherman ME, Walker JL, Gold MA, Zuna R, Sakoda L, Wacholder S, Schiffman M, Baker CC (2005). Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol  14, 59-64.   https://doi.org/10.1097/01.pas.0000162754.45908.d4




PubMed


 


PubMed ID 15905687",https://intramural.nih.gov/search/searchview.taf?ipid=37188
182,BC010313-07,"October 01, 2004 -  September 30, 2005",Molecular profiling of human hepatocellular cancer,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Hu-Liang  Jia



Mi Jung  Lim



Vivian A Takafuji



Chuan-Ging  Wu



Show all 8","Lun-Xiu  Qin
(Liver Cancer Institute)




Zhao-You  Tang
(Liver Cancer Institute)","Richard  Simon (National Cancer Institute)



Yidong  Chen; PhD (National Cancer Institute)",Larry W Fisher; PhD (NIDCR),"Ordered by publication type and then author name.



1.
Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW (2005). The molecular signature of metastases of human hepatocellular carcinoma. Oncology  69 Suppl 1, 23-7.   https://doi.org/10.1159/000086628




PubMed


 


PubMed ID 16210873
    
     


 



2.
Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, Wang XW (2004). Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology  39, 518-27.   https://doi.org/10.1002/hep.20053




PubMed


 


PubMed ID 14768006",https://intramural.nih.gov/search/searchview.taf?ipid=37189
183,BC010317-07,"October 01, 2004 -  September 30, 2005",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Randall C Johnson



Holli B Hutcheson



George  Nelson



Sher L Hendrickson



Bailey D Kessing



James  Lautenberger; PhD



Show all 15",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S   (2004) Human Genes that limit AIDS.  Nature Genetics  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37190
184,BC010319-07,"October 01, 2004 -  September 30, 2005",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Courtni Edna Allen



Lothar  Esser



Xiu-Gong  Gao



Jichun  Ma",NULL,Michael Marc Gottesman; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Esser L, Quinn B, Li YF, Zhang M, Elberry M, Yu L, Yu CA, Xia D (2004). Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex. J Mol Biol  341, 281-302.   https://doi.org/10.1016/j.jmb.2004.05.065




PubMed


 


PubMed ID 15312779
    
     


 



2.
Gong X, Yu L, Xia D, Yu CA (2005). Evidence for electron equilibrium between the two hemes bL in the dimeric cytochrome bc1 complex. J Biol Chem  280, 9251-7.   https://doi.org/10.1074/jbc.M409994200




PubMed


 


PubMed ID 15615714
    
     


 



3.
Gurung B, Yu L, Xia D, Yu CA (2005). The iron-sulfur cluster of the Rieske iron-sulfur protein functions as a proton-exiting gate in the cytochrome bc(1) complex. J Biol Chem  280, 24895-902.   https://doi.org/10.1074/jbc.M503319200




PubMed


 


PubMed ID 15878858",https://intramural.nih.gov/search/searchview.taf?ipid=37193
185,BC010326-06,"October 01, 2004 -  September 30, 2005",Structural Chemistry of Biomolecular Systems and Structure-Based Drug Design,"Xinhua  Ji; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Jianhua  Gan



Gary X Shaw



Chao  Tu","Shivendra  Singh
(Pharmacology, U of Pittsburgh)




Kenneth  Tew
(Pharmacology, Fox Chase Cancer Center)




Honggao  Yan





Piotr  Zimniak
(University of Arkansas for Medical Sciences)",NULL,NULL,"Ordered by publication type and then author name.



1.
Blaszczyk J, Shi G, Li Y, Yan H, Ji X (2004). Reaction trajectory of pyrophosphoryl transfer catalyzed by 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. Structure  12, 467-75.   https://doi.org/10.1016/j.str.2004.02.003




PubMed


 


PubMed ID 15016362
    
     


 



2.
Findlay VJ, Townsend DM, Saavedra JE, Buzard GS, Citro ML, Keefer LK, Ji X, Tew KD (2004). Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol Pharmacol  65, 1070-9.   https://doi.org/10.1124/mol.65.5.1070




PubMed


 


PubMed ID 15102935
    
     


 



3.
Gan J, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2005). Intermediate states of ribonuclease III in complex with double-stranded RNA. Structure  13, 1435-42.   https://doi.org/10.1016/j.str.2005.06.014




PubMed


 


PubMed ID 16216575
    
     


 



4.
Hansen AM, Gu Y, Li M, Andrykovitch M, Waugh DS, Jin DJ, Ji X (2005). Structural basis for the function of stringent starvation protein a as a transcription factor. J Biol Chem  280, 17380-91.   https://doi.org/10.1074/jbc.M501444200




PubMed


 


PubMed ID 15735307",https://intramural.nih.gov/search/searchview.taf?ipid=37194
186,BC010328-06,"October 01, 2004 -  September 30, 2005",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,"Peter F Johnson; PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Carlton J Briggs



Fatima D Jones



Sook  Lee



Mary Jesse Lueben



Radek  Malik



Nancy C Martin



Show all 8","Dhan  Kalvakolanu
(Greenbaum Cancer Center, Dept. of Microbiology and Immunology, U. of Maryland School of Medicine)




Julien  Sage
(Departments of Pediatrics and Genetics, Stanford University School of Medicine)




Richard  Schwartz
(Department of Microbiology and Molecular Genetics, Michigan State University)




Robert  Smart
(Department of Environmental and Molecular Toxicology, North Carolina State University)","Stephen D Hursting; PhD, MPH (National Cancer Institute)



Jonathan  Keller; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Maria  Miller (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Burkart AD, Mukherjee A, Sterneck E, Johnson PF, Mayo KE (2005). Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta. Endocrinology  146, 1909-21.   https://doi.org/10.1210/en.2004-0842




PubMed


 


PubMed ID 15650079
    
     


 



2.
Colangelo AM, Mallei A, Johnson PF, Mocchetti I (2004). Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res Mol Brain Res  124, 97-104.   https://doi.org/10.1016/j.molbrainres.2004.01.011




PubMed


 


PubMed ID 15135217
    
     


 



3.
Heath V, Suh HC, Holman M, Renn K, Gooya JM, Parkin S, Klarmann KD, Ortiz M, Johnson P, Keller J (2004). C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood  104, 1639-47.   https://doi.org/10.1182/blood-2003-11-3963




PubMed


 


PubMed ID 15073037
    
     


 



4.
Johnson P, Sebastian T, Kaldis P, Copeland T, Zhu S, Smart R   (2004) Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.  Mol Cell Biol .




 



5.
Johnson PF (2005). Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci  118, 2545-55.   https://doi.org/10.1242/jcs.02459




PubMed


 


PubMed ID 15944395
    
     


 



6.
Roy SK, Shuman JD, Platanias LC, Shapiro PS, Reddy SP, Johnson PF, Kalvakolanu DV (2005). A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}. J Biol Chem  280, 24462-71.   https://doi.org/10.1074/jbc.M413661200




PubMed


 


PubMed ID 15878863
    
     


 



7.
Sebastian T, Malik R, Thomas S, Sage J, Johnson PF (2005). C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J  24, 3301-12.   https://doi.org/10.1038/sj.emboj.7600789




PubMed



        
     
Free Article


 


PubMed ID 16107878
         Pubmed Central ID 1224679 


 



8.
Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF (2004). BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem  279, 49995-50003.   https://doi.org/10.1074/jbc.M404246200




PubMed


 


PubMed ID 15465827
    
     


 



9.
Wessells J, Yakar S, Johnson PF (2004). Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells. Mol Cell Biol  24, 3238-50.   https://doi.org/10.1128/mcb.24.8.3238-3250.2004




PubMed



        
     
Free Article


 


PubMed ID 15060147
         Pubmed Central ID 381667",https://intramural.nih.gov/search/searchview.taf?ipid=37195
187,BC010329-06,"October 01, 2004 -  September 30, 2005",Regulation of Ras-Dependent Signal Transduction Pathways,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Junghwa  Lim



Melissa M Mckay","Kun Ping  Lu
(Harvard Institutes of Medicine)




John  Scott; PhD
(Biochem, Trinity Coll)




Timothy  Veenstra
(Cancer Biology Program, SAIC)","Ira  Daar; PhD (National Cancer Institute)



Terry D Copeland (National Cancer Institute)",Brian W Howell; PhD (NINDS),"Ordered by publication type and then author name.



1.
Morrison D   (2005) Ras and the Raf-MEK-ERK Cascade, in Ras GTPases. Der C, ed., Kluwer Academic Publishers (Norwell), in press.




 



2.
Dougherty MK, Müller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK (2005). Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell  17, 215-24.   https://doi.org/10.1016/j.molcel.2004.11.055




PubMed


 


PubMed ID 15664191
    
     


 



3.
Dougherty MK, Morrison DK (2004). Unlocking the code of 14-3-3. J Cell Sci  117, 1875-84.   https://doi.org/10.1242/jcs.01171




PubMed


 


PubMed ID 15090593
    
     


 



4.
Morrison D, Daar I   (2005) KSR regulation of the Raf-MEK-ERK Cascade.  Methods Enzymol, in press.




 



5.
Morrison DK (2004). Cancer: enzymes play molecular tag. Nature  428, 813-5.   https://doi.org/10.1038/428813a




PubMed


 


PubMed ID 15103362
    
     


 



6.
Murakami MS, Moody SA, Daar IO, Morrison DK (2004). Morphogenesis during Xenopus gastrulation requires Wee1-mediated inhibition of cell proliferation. Development  131, 571-80.   https://doi.org/10.1242/dev.00971




PubMed


 


PubMed ID 14711880
    
     


 



7.
Ory S, Morrison DK (2004). Signal transduction: implications for Ras-dependent ERK signaling. Curr Biol  14, R277-8.   https://doi.org/10.1016/j.cub.2004.03.023




PubMed


 


PubMed ID 15062121
    
     


 



8.
Weber HO, Ludwig RL, Morrison D, Kotlyarov A, Gaestel M, Vousden KH (2005). HDM2 phosphorylation by MAPKAP kinase 2. Oncogene  24, 1965-72.   https://doi.org/10.1038/sj.onc.1208389




PubMed


 


PubMed ID 15688025",https://intramural.nih.gov/search/searchview.taf?ipid=37196
188,BC010331-06,"October 01, 2004 -  September 30, 2005",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI",NULL,"Usha  Acharya
(Program in Gene Function and Expression, University of Massachusetts, Worcester)




Pedro  Labarca
(Arturo Prat 514, Centro de Estudios Cientificos)




Alfred  Merrill, Jr.
(School of Biology, Georgia Institute of Technology)","Lino  Tessarollo (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Acharya U, Acharya JK (2005). Enzymes of sphingolipid metabolism in Drosophila melanogaster. Cell Mol Life Sci  62, 128-42.   https://doi.org/10.1007/s00018-004-4254-1




PubMed


 


PubMed ID 15666085
    
     


 



2.
Acharya U, Mowen MB, Nagashima K, Acharya JK (2004). Ceramidase expression facilitates membrane turnover and endocytosis of rhodopsin in photoreceptors. Proc Natl Acad Sci U S A  101, 1922-6.   https://doi.org/10.1073/pnas.0308693100




PubMed



        
     
Free Article


 


PubMed ID 14769922
         Pubmed Central ID 357028",https://intramural.nih.gov/search/searchview.taf?ipid=37197
189,BC010333-06,"October 01, 2004 -  September 30, 2005",The Segregation of Bacterial Chromosomes to Daughter Cells,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD



Alena V Dabrazhynetskaya



Lucretia D Reaves



Brenda L Youngren",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37199
190,BC010334-06,"October 01, 2004 -  September 30, 2005",Posttranscriptional control of gene expression,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Irina V Tretyakova



Andrei S Zolotukhin","Elisa  Izaurralde
(European Molecular Biology Laboratory)




Marta  Marthas
(University of California, Davis, California Regional Primate Center)




Ruth  Ruprecht
(Dana-Farber Cancer Institute)",NULL,Nancy R Miller (NIAID),"Ordered by publication type and then author name.



1.
Tan W, Zolotukhin AS, Tretyakova I, Bear J, Lindtner S, Smulevitch SV, Felber BK (2005). Identification and characterization of the mouse nuclear export factor (Nxf) family members. Nucleic Acids Res  33, 3855-65.   https://doi.org/10.1093/nar/gki706




PubMed



        
     
Free Article


 


PubMed ID 16027110
         Pubmed Central ID 1175460",https://intramural.nih.gov/search/searchview.taf?ipid=37200
191,BC010336-06,"October 01, 2004 -  September 30, 2005",Genetic Networks and Red-mediated Recombination,"Donald L Court; PhD



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Teresa L Baker



Nina C Costantino



Simanti  Datta



James A Sawitzke



Lynn C Thomason","Gloria  Culver
(Biochemistry, biophysics, and Molecular Biology, Iowa State University)




Santanu  Dasgupta
(Cell and Molecular Biology, University of Uppsala)




David  Friedman
(Microbiology & Immunology, Michigan University)




Max  Gottesman
(Institute of Cancer Research, Columbia University)




Gerald  Koudelka
(Biological Sciences, SUNY Buffalo)




Roger  McMacken
(Biochemistry & Molecular Biology, Johns Hopkins)


Show all 8","Neal G Copeland; PhD (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Mikhail V Kashlev (National Cancer Institute)



Sankar  Adhya; PhD (National Cancer Institute)



Dhruba K Chattoraj; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",Nancy L Jenkins (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37202
192,BC010337-06,"October 01, 2004 -  September 30, 2005",Identification of protein factors and pathways leading to establishment and main,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Lucyna E Lubkowska,"Blaine  Bartholomew
(Southern Illinois University)




Carlos  Bustamante
(University of California, Berkeley)




Brad  Cairns
(Oncological Sciences, University of Utah School of Medicine)




Michelle  Wang
(Cornell University)",Jeffrey N Strathern (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kireeva ML, Hancock B, Cremona GH, Walter W, Studitsky VM, Kashlev M (2005). Nature of the nucleosomal barrier to RNA polymerase II. Mol Cell  18, 97-108.   https://doi.org/10.1016/j.molcel.2005.02.027




PubMed


 


PubMed ID 15808512
    
     


 



2.
Studitsky VM, Walter W, Kireeva M, Kashlev M, Felsenfeld G (2004). Chromatin remodeling by RNA polymerases. Trends Biochem Sci  29, 127-35.   https://doi.org/10.1016/j.tibs.2004.01.003




PubMed


 


PubMed ID 15003270",https://intramural.nih.gov/search/searchview.taf?ipid=37203
193,BC010338-06,"October 01, 2004 -  September 30, 2005",The Role of Fgf Signaling in Vertebrate Development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Cindy  Elder



Nakisha D Moore



Samuel T Waters



Catherine P Wilson",NULL,Alan O Perantoni; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37204
194,BC010339-06,"October 01, 2004 -  September 30, 2005",The Role of Rx in the Adult Retina,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Cindy  Elder



Catherine P Wilson",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37205
195,BC010340-06,"October 01, 2004 -  September 30, 2005",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Arun  Dakshinamurthy



Sharon P Moore



Karen Marie Stefanisko",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37206
196,BC010341-06,"October 01, 2004 -  September 30, 2005",Protein Expression and Purification in the Fast Lane,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Brian P Austin



Sreedevi  Nallamsetty","Gaetano  Montelione
(Northeast Structural Genomics Consortium, CABM, Rutgers University)




Jozsef  Tozser",NULL,NULL,"Ordered by publication type and then author name.



1.
Nallamsetty S, Kapust RB, Tözsér J, Cherry S, Tropea JE, Copeland TD, Waugh DS (2004). Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro. Protein Expr Purif  38, 108-15.   https://doi.org/10.1016/j.pep.2004.08.016




PubMed


 


PubMed ID 15477088
    
     


 



2.
Tözsér J, Tropea JE, Cherry S, Bagossi P, Copeland TD, Wlodawer A, Waugh DS (2005). Comparison of the substrate specificity of two potyvirus proteases. FEBS J  272, 514-23.   https://doi.org/10.1111/j.1742-4658.2004.04493.x




PubMed


 


PubMed ID 15654889
    
     


 



3.
Waugh D   (2005) Solubility enhancing proteins MBP and NusA play a passive role during the folding of their fusion partners.  Prot. Expr. Purif, in press.




 



4.
Waugh D, Cherry S, Nallamsetty S, Bignon C   (2005) A generic method for the production of recombinant proteins in Escherichia coli using a dual His6-MBP affinity tag.  Methods Mol. Biol. .




 



5.
Waugh DS (2005). Making the most of affinity tags. Trends Biotechnol  23, 316-20.   https://doi.org/10.1016/j.tibtech.2005.03.012




PubMed


 


PubMed ID 15922084",https://intramural.nih.gov/search/searchview.taf?ipid=37207
197,BC010342-06,"October 01, 2004 -  September 30, 2005",Structural Proteomics of the Yersinia Yop Virulon,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI",Brian P Austin,"Gregory  Plano; PhD
(Microbiology and Immunology, University of Miami School of Medicine)




Kurt  Schesser
(Microbiology and Immunology, University of Miami School of Medicine)




Robert  Ulrich
(Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Derewenda U, Mateja A, Devedjiev Y, Routzahn KM, Evdokimov AG, Derewenda ZS, Waugh DS (2004). The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure  12, 301-6.   https://doi.org/10.1016/j.str.2004.01.010




PubMed


 


PubMed ID 14962390
    
     


 



2.
Schubot FD, Cherry S, Austin BP, Tropea JE, Waugh DS (2005). Crystal structure of the protease-resistant core domain of Yersinia pestis virulence factor YopR. Protein Sci  14, 1679-83.   https://doi.org/10.1110/ps.051446405




PubMed



        
     
Free Article


 


PubMed ID 15930010
         Pubmed Central ID 2253397 


 



3.
Schubot FD, Jackson MW, Penrose KJ, Cherry S, Tropea JE, Plano GV, Waugh DS (2005). Three-dimensional structure of a macromolecular assembly that regulates type III secretion in Yersinia pestis. J Mol Biol  346, 1147-61.   https://doi.org/10.1016/j.jmb.2004.12.036




PubMed


 


PubMed ID 15701523
    
     


 



4.
Schubot FD, Waugh DS (2004). A pivotal role for reductive methylation in the de novo crystallization of a ternary complex composed of Yersinia pestis virulence factors YopN, SycN and YscB. Acta Crystallogr D Biol Crystallogr  60, 1981-6.   https://doi.org/10.1107/S0907444904023005




PubMed


 


PubMed ID 15502305
    
     


 



5.
Swietnicki W, O'Brien S, Holman K, Cherry S, Brueggemann E, Tropea JE, Hines HB, Waugh DS, Ulrich RG (2004). Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry. J Biol Chem  279, 38693-700.   https://doi.org/10.1074/jbc.M405217200




PubMed


 


PubMed ID 15213222
    
     


 



6.
Waugh D, Boovanahalli S, Nam K, Kang S, Lee M, Phan J, Zhang D, Lee K, Burke T   (2005) Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.  Bioorg. Med. Chem. Lett, in press.




 



7.
Waugh D, Schubot F, Plano G   (2005) Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion.  Mol. Microbiol, in press.




 



8.
Waugh D, Tropea E   (2004) Structure of the Yersinia pestis type III secretion chaperone SycH in complex with a stable fragment of YscM2.  Acta Crystallogr. D .",https://intramural.nih.gov/search/searchview.taf?ipid=37208
198,BC010343-06,"October 01, 2004 -  September 30, 2005","Transcription Through Nucleosomes in Vitro by E. coli RNA polymerase, RNA Polyme","Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Maria L Kireeva



Lucyna E Lubkowska","Blaine  Bartholomew
(Southern Illinois University)




Zach  Burton
(Michigan State University)




Peter  Geiduschek
(University of California, San Diego)




George  Kassavetis
(University of California, San Diego)




Vasily  Studitsky
(Department of Pharmacology, University of Medicine and Dentistry of New Jersey)




Michelle  Wang
(Cornell University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Kireeva ML, Hancock B, Cremona GH, Walter W, Studitsky VM, Kashlev M (2005). Nature of the nucleosomal barrier to RNA polymerase II. Mol Cell  18, 97-108.   https://doi.org/10.1016/j.molcel.2005.02.027




PubMed


 


PubMed ID 15808512
    
     


 



2.
Studitsky VM, Walter W, Kireeva M, Kashlev M, Felsenfeld G (2004). Chromatin remodeling by RNA polymerases. Trends Biochem Sci  29, 127-35.   https://doi.org/10.1016/j.tibs.2004.01.003




PubMed


 


PubMed ID 15003270",https://intramural.nih.gov/search/searchview.taf?ipid=37209
199,BC010345-06,"October 01, 2004 -  September 30, 2005",The Role of Wnt Genes in Vertebrate Development and Cancer,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","William C Dunty



Jaime  Greear",NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37210
200,BC010346-06,"October 01, 2004 -  September 30, 2005",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Amanda S Altieri; PhD



Ranabir  Das



Vadim  Gaponenko



Hana  Krizova



Jess R Li



Robert L Mcfeeters



Show all 7","Ermanno  Gherardi
(Growth Factors Group, MRC)




Warren J Leonard; MD
(NHLBI)




Raj  Puri; MD, PhD
(CBER, FDA)




Kurt  Zilm
(Chemistry, Yale University)","Donald L Court; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Allan M Weissman; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37211
201,BC010347-06,"October 01, 2004 -  September 30, 2005",Design of Drugs Against Cancer and Viral Diseases,Christopher J Michejda; PhD,NULL,"Structural Biophysics Laboratory, NCI","Giulio A Amadei



Carolyn F Cohran



Marcin Daniel Dyba



David W Farnsworth



Humcha  Hariprakasha



Gillian  Hussey



Show all 12","Edward  Arnold
(BIOCHEMISTRY, Rutgers University)




Brian  Carr
(SURGERY, University of Pittsburgh)




William  Jorgensen
(CHEMISTRY, Yale University)




Sid  Kar
(SURGERY, University of Pittsburgh)","Stephen H Hughes; PhD (National Cancer Institute)



Paul L Boyer (National Cancer Institute)



John G Julias (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Michejda C, Cholody W, Monks A, Woynarowska B   (2005) WMC79, a potent agent against colon cancer, induces apoptosis by a p53-dependent pathway.  Molec. Cancer Therapeutics, in press.




 



2.
Michejda C, Kosakowska-Cholody H, Hariprakasha M   (2005) A new synthetic agent with potent but selective cytotoxic activity against cancer.  J.Med.Chem  pp.




 



3.
Michejda C, Robey R, Morisaki K, Dean M, Sauna Z, Ambudkar V, Tarasova N, Bates S   (2004) Mutational analysis of ABSG2: Role of the GXXXG motif.  Biochemistry  pp.




 



4.
Michejda C, Salinas R, Neal B, Kosakowska-Cholody T, Waters S, Herman T, Woynarowski J, Woynarowska B   (2004) Caspase-mediated apoptosis and caspase-independant cell death induced by irofulven in prostate cancer cells.  Molec. Cancer Therapeutics  pp.




 



5.
Michejda C, Seth R, Tarasov S, Kosakowska-Cholody T, Hrycyna C, Gottesman M   (2005) Transmembrane Inhibitors of P-glycoprotein, an ABC Transporter.  J. Med.Chem  pp.




 



6.
Michejda C, Szekely Z, Conrads T, Veenstra T, Barchi J, Zhang O, Koch K   (2004) An anti-proliferative factor from interstitial cystitis patients is a novel frizzled-8 protein-related sialoglycopeptide.  Proc. Natl. Acad, Sciences (USA)  pp.




 



7.
Michejda C, Tarasova G, Moody N   (2004) Development of VIP-ellipticine conjugates.  Regulatory Peptides  pp.




 



8.
Michejda C, Tarasova N   (2004) Small molecuale toxins targeting tumor receptors.  Current Pharmaceutical Design  pp.




 



9.
Michejda C, Tarasova N, Kosakowska-Cholody T, Hamel E   (2005) Tetra and pentapeptide derivatives of hemiasterlin Synthesis and activity studies.  Understanding Biology Using Peptides, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37212
202,BC010348-06,"October 01, 2004 -  September 30, 2005",Protein Structure,"Alexander  Wlodawer; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Diogo R Demartini



Alla E Gustchina



Maria E Miller



Sergei V Pletnev



Alexander S Zdanov



Natasza Ewa Ziolkowska","Ben  Dunn
(Biochem. & Mol. Biol., University of Florida)




John  Elder
(The Scripps Research Institute)




Witold  Filipowicz
(Friedrich Miescher-Institut)




Jonathan  Leis
(Northwestern University School of Medicine)




Toru  Nakayama
(Biomolecular Engineering, Tohoku University)




Kohei  Oda
(Dept. Applied Biology, Kyoto Inst. of Technology)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Botos I, Melnikov EE, Cherry S, Khalatova AG, Rasulova FS, Tropea JE, Maurizi MR, Rotanova TV, Gustchina A, Wlodawer A (2004). Crystal structure of the AAA+ alpha domain of E. coli Lon protease at 1.9A resolution. J Struct Biol  146, 113-22.   https://doi.org/10.1016/j.jsb.2003.09.003




PubMed


 


PubMed ID 15037242
    
     


 



2.
Botos I, Melnikov EE, Cherry S, Kozlov S, Makhovskaya OV, Tropea JE, Gustchina A, Rotanova TV, Wlodawer A (2005). Atomic-resolution crystal structure of the proteolytic domain of Archaeoglobus fulgidus lon reveals the conformational variability in the active sites of lon proteases. J Mol Biol  351, 144-57.   https://doi.org/10.1016/j.jmb.2005.06.008




PubMed


 


PubMed ID 16002085
    
     


 



3.
Botos I, Melnikov EE, Cherry S, Tropea JE, Khalatova AG, Rasulova F, Dauter Z, Maurizi MR, Rotanova TV, Wlodawer A, Gustchina A (2004). The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J Biol Chem  279, 8140-8.   https://doi.org/10.1074/jbc.M312243200




PubMed


 


PubMed ID 14665623
    
     


 



4.
Botos I, Wlodawer A (2005). Proteins that bind high-mannose sugars of the HIV envelope. Prog Biophys Mol Biol  88, 233-82.   https://doi.org/10.1016/j.pbiomolbio.2004.05.001




PubMed


 


PubMed ID 15572157
    
     


 



5.
Brik A, Alexandratos J, Lin YC, Elder JH, Olson AJ, Wlodawer A, Goodsell DS, Wong CH (2005). 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Chembiochem  6, 1167-9.   https://doi.org/10.1002/cbic.200500101




PubMed


 


PubMed ID 15934050
    
     


 



6.
Chang C, Plückthun A, Wlodawer A (2004). Crystal structure of a truncated version of the phage lambda protein gpD. Proteins  57, 866-8.   https://doi.org/10.1002/prot.20254




PubMed


 


PubMed ID 15317025
    
     


 



7.
Dauter Z, Botos I, LaRonde-LeBlanc N, Wlodawer A (2005). Pathological crystallography: case studies of several unusual macromolecular crystals. Acta Crystallogr D Biol Crystallogr  61, 967-75.   https://doi.org/10.1107/S0907444905011285




PubMed


 


PubMed ID 15983420
    
     


 



8.
Forrer P, Chang C, Ott D, Wlodawer A, Plückthun A (2004). Kinetic stability and crystal structure of the viral capsid protein SHP. J Mol Biol  344, 179-93.   https://doi.org/10.1016/j.jmb.2004.09.030




PubMed


 


PubMed ID 15504410
    
     


 



9.
Gustchina A, Li M, Wünschmann S, Chapman MD, Pomés A, Wlodawer A (2005). Crystal structure of cockroach allergen Bla g 2, an unusual zinc binding aspartic protease with a novel mode of self-inhibition. J Mol Biol  348, 433-44.   https://doi.org/10.1016/j.jmb.2005.02.062




PubMed


 


PubMed ID 15811379
    
     


 



10.
LaRonde-LeBlanc N, Guszczynski T, Copeland T, Wlodawer A (2005). Autophosphorylation of Archaeoglobus fulgidus Rio2 and crystal structures of its nucleotide-metal ion complexes. FEBS J  272, 2800-10.   https://doi.org/10.1111/j.1742-4658.2005.04702.x




PubMed


 


PubMed ID 15943813
    
     


 



11.
Laronde-Leblanc N, Guszczynski T, Copeland T, Wlodawer A (2005). Structure and activity of the atypical serine kinase Rio1. FEBS J  272, 3698-713.   https://doi.org/10.1111/j.1742-4658.2005.04796.x




PubMed


 


PubMed ID 16008568
    
     


 



12.
LaRonde-LeBlanc N, Wlodawer A (2004). Crystal structure of A. fulgidus Rio2 defines a new family of serine protein kinases. Structure  12, 1585-94.   https://doi.org/10.1016/j.str.2004.06.016




PubMed


 


PubMed ID 15341724
    
     


 



13.
Pletnev S, Magracheva E, Wlodawer A, Zdanov A (2005). A model of the ternary complex of interleukin-10 with its soluble receptors. BMC Struct Biol  5, 10.   https://doi.org/10.1186/1472-6807-5-10




PubMed



        
     
Free Article


 


PubMed ID 15985167
         Pubmed Central ID 1192808 


 



14.
Prasanna MD, Vondrasek J, Wlodawer A, Bhat TN (2005). Application of InChI to curate, index, and query 3-D structures. Proteins  60, 1-4.   https://doi.org/10.1002/prot.20469




PubMed


 


PubMed ID 15861385
    
     


 



15.
Rotanova TV, Melnikov EE, Khalatova AG, Makhovskaya OV, Botos I, Wlodawer A, Gustchina A (2004). Classification of ATP-dependent proteases Lon and comparison of the active sites of their proteolytic domains. Eur J Biochem  271, 4865-71.   https://doi.org/10.1111/j.1432-1033.2004.04452.x




PubMed


 


PubMed ID 15606774
    
     


 



16.
Tözsér J, Tropea JE, Cherry S, Bagossi P, Copeland TD, Wlodawer A, Waugh DS (2005). Comparison of the substrate specificity of two potyvirus proteases. FEBS J  272, 514-23.   https://doi.org/10.1111/j.1742-4658.2004.04493.x




PubMed


 


PubMed ID 15654889
    
     


 



17.
Wlodawer A (2004). How to kill an enzyme (in more ways than one). Structure  12, 1117-9.   https://doi.org/10.1016/j.str.2004.06.003




PubMed


 


PubMed ID 15242582
    
     


 



18.
Wlodawer A, Li M, Gustchina A, Oyama H, Oda K, Beyer BB, Clemente J, Dunn BM (2004). Two inhibitor molecules bound in the active site of Pseudomonas sedolisin: a model for the bi-product complex following cleavage of a peptide substrate. Biochem Biophys Res Commun  314, 638-45.   https://doi.org/10.1016/j.bbrc.2003.12.130




PubMed


 


PubMed ID 14733955
    
     


 



19.
Wlodawer A, Li M, Gustchina A, Tsuruoka N, Ashida M, Minakata H, Oyama H, Oda K, Nishino T, Nakayama T (2004). Crystallographic and biochemical investigations of kumamolisin-As, a serine-carboxyl peptidase with collagenase activity. J Biol Chem  279, 21500-10.   https://doi.org/10.1074/jbc.M401141200




PubMed


 


PubMed ID 15014068
    
     


 



20.
Yusof AM, Hu NJ, Wlodawer A, Hofmann A (2005). Structural evidence for variable oligomerization of the N-terminal domain of cyclase-associated protein (CAP). Proteins  58, 255-62.   https://doi.org/10.1002/prot.20314




PubMed


 


PubMed ID 15558566
    
     


 



21.
Zakowicz H, Yang HS, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn NH (2005). Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA  11, 261-74.   https://doi.org/10.1261/rna.7191905




PubMed



        
     
Free Article


 


PubMed ID 15661843
         Pubmed Central ID 1370716",https://intramural.nih.gov/search/searchview.taf?ipid=37213
203,BC010349-06,"October 01, 2004 -  September 30, 2005",Genomic Imprinting in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Lidia F Hernandez



Serguei V Kozlov",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fan T, Hagan JP, Kozlov SV, Stewart CL, Muegge K (2005). Lsh controls silencing of the imprinted Cdkn1c gene. Development  132, 635-44.   https://doi.org/10.1242/dev.01612




PubMed


 


PubMed ID 15647320
    
     


 



2.
Hagan JP, Kozlov SV, Chiang Y, Sewell L, Stewart CL (2004). Intraspecific mating with CzechII/Ei mice rescue lethality associated with loss of function mutations of the imprinted genes, Igf2r and Cdkn1c. Genomics  84, 836-43.   https://doi.org/10.1016/j.ygeno.2004.07.007




PubMed


 


PubMed ID 15475262",https://intramural.nih.gov/search/searchview.taf?ipid=37214
204,BC010350-06,"October 01, 2004 -  September 30, 2005",Prevention of AIDS,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Candido  Alicea; PhD



Jenifer L Bear



Rashmi  Jalah



Viraj M Kulkarni","Marta  Marthas
(University of California, Davis, California Regional Primate Center)




David C Montefiori; PhD
(Department of Surgery, NIAID)




Frank  Park
(Louisiana State University Health Sciences Center)




Ruth  Ruprecht
(Dana-Farber Cancer Institute)




David  Weiner
(University of Pennsylvania)","George N Pavlakis; MD, PhD (National Cancer Institute)



Marjorie  Robert-Guroff; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB (2005). Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol  175, 112-23.   https://doi.org/10.4049/jimmunol.175.1.112




PubMed


 


PubMed ID 15972637
    
     


 



2.
Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB (2004). Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model. Vaccine  22, 1782-90.   https://doi.org/10.1016/j.vaccine.2004.01.037




PubMed


 


PubMed ID 15068862
    
     


 



3.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN (2005). DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol  79, 8480-92.   https://doi.org/10.1128/JVI.79.13.8480-8492.2005




PubMed



        
     
Free Article


 


PubMed ID 15956591
         Pubmed Central ID 1143718 


 



4.
Felber BK, Pavlakis GK (submitted in 2005) Codon Optimized Il-15 And Il-15r-alpha Gene Expression In Mammalian Cells. Patents issued: 200780003101 (CN in 2012); 295870 (MX in 2012); 569541 (NZ in 2012); 192730 (IL in 2013); 596494 (NZ in 2014); 2007207785 (AU in 2014); 5709356 (JP in 2015); ZL 201210119 (CN in 2016); 9,303,080 (US in 2016); 2013203171 (AU in 2016); 221384 (IL in 2017); 28163 (IN in 2017); 9,725,492 (US in 2017); 6289099 (JP in 2018); 9,790,261 (US in 2018). Patents pending: 2016216577 (AU application); PI0707106-0 (BR application); 2636111 (CA application); 07716564.5 (EP application); 11154217.1 (EP application); MX/A/2012/001670 (MX application); 15/728,455 (US application).




 



5.
Felber BK, Pavlakis GK, Rosati MK (submitted in 2005) Improved Il-12 For Expression In Mammalian Cells. Patent issued: 7,833,754 (US in 2011).",https://intramural.nih.gov/search/searchview.taf?ipid=37215
205,BC010376-06,"October 01, 2004 -  September 30, 2005",Leukemia Inhibitory Factor and Embryo Development,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianbo  Hu,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hondo E, Stewart CL (2005). Profiling gene expression in growth-arrested mouse embryos in diapause. Genome Biol  6, 202.   https://doi.org/10.1186/gb-2004-6-1-202




PubMed



        
     
Free Article


 


PubMed ID 15642106
         Pubmed Central ID 549055 


 



2.
Rodriguez CI, Cheng JG, Liu L, Stewart CL (2004). Cochlin, a secreted von Willebrand factor type a domain-containing factor, is regulated by leukemia inhibitory factor in the uterus at the time of embryo implantation. Endocrinology  145, 1410-8.   https://doi.org/10.1210/en.2003-1361




PubMed


 


PubMed ID 14657014
    
     


 



3.
Weber MA, Schnyder-Candrian S, Schnyder B, Quesniaux V, Poli V, Stewart CL, Ryffel B (2005). Endogenous leukemia inhibitory factor attenuates endotoxin response. Lab Invest  85, 276-84.   https://doi.org/10.1038/labinvest.3700216




PubMed


 


PubMed ID 15702085",https://intramural.nih.gov/search/searchview.taf?ipid=37216
206,BC010377-06,"October 01, 2004 -  September 30, 2005","The Nuclear Envelope in Development, Disease and Ageing",Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Leonid  Belayev



Tatiana Vilenskaya Cohen



Lidia F Hernandez



Ourania  Kosti



Serguei V Kozlov



Teresa L Sullivan","Brian  Burke
(Cell Biology, University of Florida)




Roland  Foisner
(Cell Biology, Vienna Biocenter)




Larry  Gerace
(Scripps Institute)




Richard  Lee
(Cardiovascular Division, Brigham and Womens Hospital Harvard)",Thomas A Misteli; PhD (National Cancer Institute),Kenneth R. Boheler; PhD (NIA),"Ordered by publication type and then author name.



1.
Croft DR, Coleman ML, Li S, Robertson D, Sullivan T, Stewart CL, Olson MF (2005). Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol  168, 245-55.   https://doi.org/10.1083/jcb.200409049




PubMed



        
     
Free Article


 


PubMed ID 15657395
         Pubmed Central ID 2171584 


 



2.
Fong LG, Ng JK, Meta M, Coté N, Yang SH, Stewart CL, Sullivan T, Burghardt A, Majumdar S, Reue K, Bergo MO, Young SG (2004). Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci U S A  101, 18111-6.   https://doi.org/10.1073/pnas.0408558102




PubMed



        
     
Free Article


 


PubMed ID 15608054
         Pubmed Central ID 536056 


 



3.
Johnson BR, Nitta RT, Frock RL, Mounkes L, Barbie DA, Stewart CL, Harlow E, Kennedy BK (2004). A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A  101, 9677-82.   https://doi.org/10.1073/pnas.0403250101




PubMed



        
     
Free Article


 


PubMed ID 15210943
         Pubmed Central ID 470734 


 



4.
Kozlov S, Mounkes L, Cutler D, Sullivan T, Hernandez L, Levy N, Rottman J, Stewart CL (2005). Mutations in the mouse Lmna gene causing progeria, muscular dystrophy and cardiomyopathy. Novartis Found Symp  264, 246-58; discussion 258-63.




PubMed


 


PubMed ID 15773758
    
     


 



5.
Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL, Lee RT (2005). Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol  170, 781-91.   https://doi.org/10.1083/jcb.200502148




PubMed



        
     
Free Article


 


PubMed ID 16115958
         Pubmed Central ID 2171355 


 



6.
Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT (2004). Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest  113, 370-8.   https://doi.org/10.1172/JCI19670




PubMed



        
     
Free Article


 


PubMed ID 14755334
         Pubmed Central ID 324542 


 



7.
Mounkes L, Stewart CL (2004). Structural organization and functions of the nucleus in development, aging, and disease. Curr Top Dev Biol  61, 191-228.   https://doi.org/10.1016/S0070-2153(04)61008-8




PubMed


 


PubMed ID 15350402
    
     


 



8.
Mounkes LC, Kozlov SV, Rottman JN, Stewart CL (2005). Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet  14, 2167-80.   https://doi.org/10.1093/hmg/ddi221




PubMed


 


PubMed ID 15972724
    
     


 



9.
Vaidya SV, Stepp SE, McNerney ME, Lee JK, Bennett M, Lee KM, Stewart CL, Kumar V, Mathew PA (2005). Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J Immunol  174, 800-7.   https://doi.org/10.4049/jimmunol.174.2.800




PubMed


 


PubMed ID 15634901
    
     


 



10.
Varela I, Cadiñanos J, Pendás AM, Gutiérrez-Fernández A, Folgueras AR, Sánchez LM, Zhou Z, Rodríguez FJ, Stewart CL, Vega JA, Tryggvason K, Freije JM, López-Otín C (2005). Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature  437, 564-8.   https://doi.org/10.1038/nature04019




PubMed


 


PubMed ID 16079796",https://intramural.nih.gov/search/searchview.taf?ipid=37217
207,BC010378-06,"October 01, 2004 -  September 30, 2005",Macromolecular Crystallography Research with Synchrotron Radiation,"Zbigniew  Dauter



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Robert P Jedrzejczak



Elzbieta  Nowak","Mariusz  Jaskolski





Andrzej  Joachimiak
(Biosciences, Argonne Natl. Lab.)




Wladek  Minor





George  Sheldrick",Alexander  Wlodawer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Banumathi S, Zwart PH, Ramagopal UA, Dauter M, Dauter Z (2004). Structural effects of radiation damage and its potential for phasing. Acta Crystallogr D Biol Crystallogr  60, 1085-93.   https://doi.org/10.1107/S0907444904007917




PubMed


 


PubMed ID 15159568
    
     


 



2.
Botos I, Melnikov EE, Cherry S, Tropea JE, Khalatova AG, Rasulova F, Dauter Z, Maurizi MR, Rotanova TV, Wlodawer A, Gustchina A (2004). The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J Biol Chem  279, 8140-8.   https://doi.org/10.1074/jbc.M312243200




PubMed


 


PubMed ID 14665623
    
     


 



3.
Dauter Z (2004). Phasing in iodine for structure determination. Nat Biotechnol  22, 1239-40.   https://doi.org/10.1038/nbt1004-1239




PubMed


 


PubMed ID 15470459
    
     


 



4.
Dauter Z (2005). Efficient use of synchrotron radiation for macromolecular diffraction data collection. Prog Biophys Mol Biol  89, 153-72.   https://doi.org/10.1016/j.pbiomolbio.2004.09.004




PubMed


 


PubMed ID 15910916
    
     


 



5.
Dauter Z, Botos I, LaRonde-LeBlanc N, Wlodawer A (2005). Pathological crystallography: case studies of several unusual macromolecular crystals. Acta Crystallogr D Biol Crystallogr  61, 967-75.   https://doi.org/10.1107/S0907444905011285




PubMed


 


PubMed ID 15983420
    
     


 



6.
Davies GJ, Brzozowski AM, Dauter Z, Rasmussen MD, Borchert TV, Wilson KS (2005). Structure of a Bacillus halmapalus family 13 alpha-amylase, BHA, in complex with an acarbose-derived nonasaccharide at 2.1 A resolution. Acta Crystallogr D Biol Crystallogr  61, 190-3.   https://doi.org/10.1107/S0907444904027118




PubMed


 


PubMed ID 15681870
    
     


 



7.
Derewenda U, Oleksy A, Stevenson AS, Korczynska J, Dauter Z, Somlyo AP, Otlewski J, Somlyo AV, Derewenda ZS (2004). The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle. Structure  12, 1955-65.   https://doi.org/10.1016/j.str.2004.09.003




PubMed


 


PubMed ID 15530360
    
     


 



8.
Janda I, Devedjiev Y, Derewenda U, Dauter Z, Bielnicki J, Cooper DR, Graf PC, Joachimiak A, Jakob U, Derewenda ZS (2004). The crystal structure of the reduced, Zn2+-bound form of the B. subtilis Hsp33 chaperone and its implications for the activation mechanism. Structure  12, 1901-7.   https://doi.org/10.1016/j.str.2004.08.003




PubMed



        
     
Free Article


 


PubMed ID 15458638
         Pubmed Central ID 3691021 


 



9.
Saikrishnan K, Manjunath GP, Singh P, Jeyakanthan J, Dauter Z, Sekar K, Muniyappa K, Vijayan M (2005). Structure of Mycobacterium smegmatis single-stranded DNA-binding protein and a comparative study involving homologus SSBs: biological implications of structural plasticity and variability in quaternary association. Acta Crystallogr D Biol Crystallogr  61, 1140-8.   https://doi.org/10.1107/S0907444905016896




PubMed


 


PubMed ID 16041080
    
     


 



10.
Sekar K, Rajakannan V, Velmurugan D, Yamane T, Thirumurugan R, Dauter M, Dauter Z (2004). A redetermination of the structure of the triple mutant (K53,56,120M) of phospholipase A2 at 1.6 A resolution using sulfur-SAS at 1.54 A wavelength. Acta Crystallogr D Biol Crystallogr  60, 1586-90.   https://doi.org/10.1107/S090744490401697X




PubMed


 


PubMed ID 15333929
    
     


 



11.
Serganov A, Keiper S, Malinina L, Tereshko V, Skripkin E, Höbartner C, Polonskaia A, Phan AT, Wombacher R, Micura R, Dauter Z, Jäschke A, Patel DJ (2005). Structural basis for Diels-Alder ribozyme-catalyzed carbon-carbon bond formation. Nat Struct Mol Biol  12, 218-24.   https://doi.org/10.1038/nsmb906




PubMed



        
     
Free Article


 


PubMed ID 15723077
         Pubmed Central ID 4692364 


 



12.
Sevcík J, Dauter Z, Wilson KS (2004). Crystal structure reveals two alternative conformations in the active site of ribonuclease Sa2. Acta Crystallogr D Biol Crystallogr  60, 1198-204.   https://doi.org/10.1107/S0907444904009035




PubMed


 


PubMed ID 15213380
    
     


 



13.
Singh DD, Saikrishnan K, Kumar P, Dauter Z, Sekar K, Surolia A, Vijayan M (2004). Purification, crystallization and preliminary X-ray structure analysis of the banana lectin from Musa paradisiaca. Acta Crystallogr D Biol Crystallogr  60, 2104-6.   https://doi.org/10.1107/S0907444904024114




PubMed


 


PubMed ID 15502341
    
     


 



14.
Teplyakov A, Pullalarevu S, Obmolova G, Doseeva V, Galkin A, Herzberg O, Dauter M, Dauter Z, Gilliland GL (2004). Crystal structure of the YffB protein from Pseudomonas aeruginosa suggests a glutathione-dependent thiol reductase function. BMC Struct Biol  4, 5.   https://doi.org/10.1186/1472-6807-4-5




PubMed



        
     
Free Article


 


PubMed ID 15102337
         Pubmed Central ID 387831 


 



15.
Yuan YR, Pei Y, Ma JB, Kuryavyi V, Zhadina M, Meister G, Chen HY, Dauter Z, Tuschl T, Patel DJ (2005). Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol Cell  19, 405-19.   https://doi.org/10.1016/j.molcel.2005.07.011




PubMed



        
     
Free Article


 


PubMed ID 16061186
         Pubmed Central ID 4689305 


 



16.
Zwart PH, Banumathi S, Dauter M, Dauter Z (2004). Radiation-damage-induced phasing with anomalous scattering: substructure solution and phasing. Acta Crystallogr D Biol Crystallogr  60, 1958-63.   https://doi.org/10.1107/S0907444904021730




PubMed


 


PubMed ID 15502302",https://intramural.nih.gov/search/searchview.taf?ipid=37218
208,BC010379-06,"October 01, 2004 -  September 30, 2005",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Nucleic Acid NMR Section, NCI",Donghan  Lee,"Karen  Beemon





Dudley  Strickland; PhD
(American Red Cross)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cabello-Villegas J, Giles KE, Soto AM, Yu P, Mougin A, Beemon KL, Wang YX (2004). Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor. RNA  10, 1388-98.   https://doi.org/10.1261/rna.7020804




PubMed



        
     
Free Article


 


PubMed ID 15317975
         Pubmed Central ID 1370626 


 



2.
Walsh JD, Kuszweski J, Wang YX (2005). Determining a helical protein structure using peptide pixels. J Magn Reson  177, 155-9.   https://doi.org/10.1016/j.jmr.2005.06.014




PubMed


 


PubMed ID 16084744
    
     


 



3.
Walsh JD, Wang YX (2005). Periodicity, planarity, residual dipolar coupling, and structures. J Magn Reson  174, 152-62.   https://doi.org/10.1016/j.jmr.2005.01.018




PubMed


 


PubMed ID 15809182
    
     


 



4.
Wu Y, Migliorini M, Walsh J, Yu P, Strickland DK, Wang YX (2004). NMR structural studies of domain 1 of receptor-associated protein. J Biomol NMR  29, 271-9.   https://doi.org/10.1023/B:JNMR.0000032507.96325.6d




PubMed


 


PubMed ID 15213425",https://intramural.nih.gov/search/searchview.taf?ipid=37219
209,BC010380-06,"October 01, 2004 -  September 30, 2005",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Gustavo S Santoyo Pizano



Deanna R Gotte



Alison J Rattray



Brenda K Shafer","Susan  Eshleman; MD, PhD
(Department of Pathology, Johns Hopkins School of Medicine)




Reuben  Harris
(Biochemistry, University of Minnesota)




James  Hicks
(Cancer Genetics, Cold Spring Harbor Laboratory)




Susanna  Lewis
(Medical Genetics, Hospital for Sick Children)




John W Mellors","Stephen H Hughes; PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH (2005). Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis  192, 24-9.   https://doi.org/10.1086/430742




PubMed


 


PubMed ID 15942890
    
     


 



2.
Malagon F, Tong AH, Shafer BK, Strathern JN (2004). Genetic interactions of DST1 in Saccharomyces cerevisiae suggest a role of TFIIS in the initiation-elongation transition. Genetics  166, 1215-27.   https://doi.org/10.1534/genetics.166.3.1215




PubMed



        
     
Free Article


 


PubMed ID 15082542
         Pubmed Central ID 1470799 


 



3.
Rattray AJ, Shafer BK, Neelam B, Strathern JN (2005). A mechanism of palindromic gene amplification in Saccharomyces cerevisiae. Genes Dev  19, 1390-9.   https://doi.org/10.1101/gad.1315805




PubMed



        
     
Free Article


 


PubMed ID 15937224
         Pubmed Central ID 1142561",https://intramural.nih.gov/search/searchview.taf?ipid=37220
210,BC010381-06,"October 01, 2004 -  September 30, 2005",Studies on Silencing,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Deepak  Sidhu



Michael J Bonaduce



Gurjeet  Singh",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Klar A   (2004) An epigenetic hypothesis for brain laterality, handedness, and psychosis development.  Cold Spring Harbor Symp. Quant. Biol.  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37221
211,BC010382-06,"October 01, 2004 -  September 30, 2005",Chemotherapy Adjuvants,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Sahar  Javanmard



Magdalena Katarzyna Krajewska



Gary T Pauly","Leonard  Erickson
(Oncology, Indiana University Cancer Center)




Henry  Friedman
(Oncology, Duke University Medical Center)




Anthony  Pegg
(Department of Physiology, Penn State College of Medicine)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37222
212,BC010385-06,"October 01, 2004 -  September 30, 2005",Studies on Imat1I Imprinting,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Michael J Bonaduce



Bum-Soo  Lee",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37224
213,BC010386-06,"October 01, 2004 -  September 30, 2005",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Deepak  Sidhu



Athanasios  Armakolas",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Klar A   (2004) A genetic mechanism implicates chromosome 11 in schizophrenia bipolar diseases.  Genetics  pp.




 



2.
Klar A   (2004) Response to Commentary on Klar.  Genetics  pp.




 



3.
Klar A   (2005) A 1927 study supports a current genetic model for inheritance of human scalp hair-whorl orientation and hand-use preference.  Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37225
214,BC010387-06,"October 01, 2004 -  September 30, 2005",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Sergey  Kuznetsov



Subha  Philip



Prajakta A Varadkar","Pegg  Anthony
(Department of Cellular and Molecular Physiology,  Pennsylvania State University College of Medicine,)




Peter  Donovan
( Stem Cell Program, Institute for Cell Engineering)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37226
215,BC010390-06,"October 01, 2004 -  September 30, 2005",Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Paola  Caprari



Laura  Carim



Vincenzo  Coppola



Mary Ellen  Palko



Sudhirkumar U Yanpallewar","Colin  Fletcher
(Novartis Research Institute)




Bernd  Fritzsch
(Biomedical Sciences, Creighton University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Akassoglou K, Malester B, Xu J, Tessarollo L, Rosenbluth J, Chao MV (2004). Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc Natl Acad Sci U S A  101, 5075-80.   https://doi.org/10.1073/pnas.0401030101




PubMed



        
     
Free Article


 


PubMed ID 15051870
         Pubmed Central ID 387376 


 



2.
Coppola V, Barrick CA, Southon EA, Celeste A, Wang K, Chen B, Haddad el-B, Yin J, Nussenzweig A, Subramaniam A, Tessarollo L (2004). Ablation of TrkA function in the immune system causes B cell abnormalities. Development  131, 5185-95.   https://doi.org/10.1242/dev.01383




PubMed


 


PubMed ID 15459109
    
     


 



3.
Coppola V, Tessarollo L (2004). Control of hyperphagia prevents obesity in BDNF heterozygous mice. Neuroreport  15, 2665-8.   https://doi.org/10.1097/00001756-200412030-00022




PubMed


 


PubMed ID 15570174
    
     


 



4.
Fritzsch B, Tessarollo L, Coppola E, Reichardt LF (2004). Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance. Prog Brain Res  146, 265-78.   https://doi.org/10.1016/S0079-6123(03)46017-2




PubMed


 


PubMed ID 14699969
    
     


 



5.
Sedý J, Szeder V, Walro JM, Ren ZG, Nanka O, Tessarollo L, Sieber-Blum M, Grim M, Kucera J (2004). Pacinian corpuscle development involves multiple Trk signaling pathways. Dev Dyn  231, 551-63.   https://doi.org/10.1002/dvdy.20156




PubMed


 


PubMed ID 15376326
    
     


 



6.
Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM (2004). Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J Neurosci Methods  140, 81-92.   https://doi.org/10.1016/j.jneumeth.2004.03.026




PubMed


 


PubMed ID 15589338
    
     


 



7.
Tessarollo L, Coppola V, Fritzsch B (2004). NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J Neurosci  24, 2575-84.   https://doi.org/10.1523/JNEUROSCI.5514-03.2004




PubMed



        
     
Free Article


 


PubMed ID 15014133
         Pubmed Central ID 3901528",https://intramural.nih.gov/search/searchview.taf?ipid=37227
216,BC010391-06,"October 01, 2004 -  September 30, 2005",Role of Trk receptors in the development and function of non-neuronal structures,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Paola  Caprari



Vincenzo  Coppola



Mary Ellen  Palko",NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37228
217,BC010392-06,"October 01, 2004 -  September 30, 2005",Myeloid Leukemia: Disease Gene Identification and Mouse Model Development,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Keiko  Akagi



Linda S Cleveland



Utpal P Dave



Yang  Du



Dubravka  Kufrin



Tami L Thomae



Show all 8","Philippe  Gros
(McGill University)




Takuro  Nakamura
(Dept. of Biochemistry, The Cancer Institute)","Jonathan  Keller; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Copeland N, Xiao -, Fan K, Poholek A, Jenkins N, Perkins A   (2005) Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.  Blood, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37229
218,BC010393-06,"October 01, 2004 -  September 30, 2005",Development of New Genetic Tools,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Keiko  Akagi



Linda S Cleveland



Utpal P Dave



Yang  Du



Dubravka  Kufrin



Karen M Mann



Show all 8",NULL,Donald L Court; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37230
219,BC010394-06,"October 01, 2004 -  September 30, 2005",A Genetic Approach to the Study of Vesicle Transport in the Mouse,Nancy  Jenkins-Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Adam J Dupuy



Michael B Mann



Lydia  Matesic



Rivka A Rachel; MD, PhD",NULL,NULL,John A Hammer; PhD (NHLBI),"Ordered by publication type and then author name.



1.
O'Sullivan TN, Wu XS, Rachel RA, Huang JD, Swing DA, Matesic LE, Hammer JA, Copeland NG, Jenkins NA (2004). dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice. Proc Natl Acad Sci U S A  101, 16831-6.   https://doi.org/10.1073/pnas.0407339101




PubMed



        
     
Free Article


 


PubMed ID 15550542
         Pubmed Central ID 534743 


 



2.
Tyska MJ, Mackey AT, Huang JD, Copeland NG, Jenkins NA, Mooseker MS   (2005) Myosin-1a is critical for normal brush border structure and composition.  Mol Biol Cell 16:2443-57.




PubMed



        
     
Free Article


 


PubMed ID 15758024
         Pubmed Central ID 1087248",https://intramural.nih.gov/search/searchview.taf?ipid=37231
220,BC010397-06,"October 01, 2004 -  September 30, 2005",Pathogenic mechanisms of HIV,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Vainav Vikram Patel



Antonio L Valentin","Mario  Roederer; PhD





Ralf  Schneider
(GSF-National Research Center for Environment and Health)","Tomoshige  Kino; MD, PhD (National Cancer Institute)



Dean H. Hamer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Daelemans D, Costes SV, Lockett S, Pavlakis GN (2005). Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol Cell Biol  25, 728-39.   https://doi.org/10.1128/MCB.25.2.728-739.2005




PubMed



        
     
Free Article


 


PubMed ID 15632073
         Pubmed Central ID 543413 


 



2.
Daelemans D, Pannecouque C, Pavlakis GN, Tabarrini O, De Clercq E (2005). A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. Mol Pharmacol  67, 1574-80.   https://doi.org/10.1124/mol.104.010249




PubMed


 


PubMed ID 15728798
    
     


 



3.
Kino T, Gragerov A, Valentin A, Tsopanomihalou M, Ilyina-Gragerova G, Erwin-Cohen R, Chrousos GP, Pavlakis GN (2005). Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol  79, 2780-7.   https://doi.org/10.1128/JVI.79.5.2780-2787.2005




PubMed



        
     
Free Article


 


PubMed ID 15708996
         Pubmed Central ID 548435 


 



4.
Kino T, Pavlakis GN (2004). Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA Cell Biol  23, 193-205.   https://doi.org/10.1089/104454904773819789




PubMed


 


PubMed ID 15142377
    
     


 



5.
Lindtner S, Zolotukhin AS, Uranishi H, Bear J, Kulkarni V, Smulevitch S, Samiotaki M, Panayotou G, Felber BK, Pavlakis GN (2006). RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem  281, 36915-28.   https://doi.org/10.1074/jbc.M608745200




PubMed


 


PubMed ID 17001072
    
     


 



6.
Lueders KK, De Rosa SC, Valentin A, Pavlakis GN, Roederer M, Hamer DH (2004). A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types. AIDS Res Hum Retroviruses  20, 145-50.   https://doi.org/10.1089/088922204773004851




PubMed


 


PubMed ID 15018701
    
     


 



7.
Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK (2006). RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology  3, 6.   https://doi.org/10.1186/1742-4690-3-6




PubMed



        
     
Free Article


 


PubMed ID 16412225
         Pubmed Central ID 1363727 


 



8.
Smulevitch S, Michalowski D, Zolotukhin AS, Schneider R, Bear J, Roth P, Pavlakis GN, Felber BK (2005). Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome. J Virol  79, 2356-65.   https://doi.org/10.1128/JVI.79.4.2356-2365.2005




PubMed



        
     
Free Article


 


PubMed ID 15681436
         Pubmed Central ID 546579",https://intramural.nih.gov/search/searchview.taf?ipid=37232
221,BC010399-06,"October 01, 2004 -  September 30, 2005",NMR Group Project: Biophysical Studies of Oligonucleotides Containing Conformati,"Joseph John Barchi



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Melissa A Maderia,"Susan  Krueger
(Center for Neutron Research, National Institute for Standards and Technology)




Alex  Mackerell
(School of Pharmacy, University of Maryland, Baltimore)




Justin  Wu
(Biochemistry, Ohio State University)",NULL,Adriaan  Bax; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Maier MA, Choi Y, Gaus H, Barchi JJ, Marquez VE, Manoharan M (2004). Synthesis and characterization of oligonucleotides containing conformationally constrained bicyclo[3.1.0]hexane pseudosugar analogs. Nucleic Acids Res  32, 3642-50.   https://doi.org/10.1093/nar/gkh667




PubMed



        
     
Free Article


 


PubMed ID 15247346
         Pubmed Central ID 484163 


 



2.
Wu Z, Maderia M, Barchi JJ, Marquez VE, Bax A (2005). Changes in DNA bending induced by restricting nucleotide ring pucker studied by weak alignment NMR spectroscopy. Proc Natl Acad Sci U S A  102, 24-8.   https://doi.org/10.1073/pnas.0408498102




PubMed



        
     
Free Article


 


PubMed ID 15618396
         Pubmed Central ID 544063",https://intramural.nih.gov/search/searchview.taf?ipid=37233
222,BC010411-06,"October 01, 2004 -  September 30, 2005",Initiation of DNA replication in Mammalian Cells,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Haiqing  Fu



Tsutomu  Shimura



Chiimei (Cindy) L Tseng



Lixin  Wang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Aladjem MI, Fu HI, Tseng CI, Wang LI (submitted in 2005) Use Of Replicators To Prevent Gene Silencing. Patent issued: 8,716,021 (US in 2014). Patent pending: PCT/US2006/034812 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=37234
223,BC010412-06,"October 01, 2004 -  September 30, 2005",Structural Analysis of Macromolecular Complexes by High Resolution Electron Micr,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI","Mario J Borgnia; PhD



Dan  Shi","David  Grahame
(USUHS)




Richard  Perham",NULL,NULL,"Ordered by publication type and then author name.



1.
Milne J   (2004) Three-dimensional electron microscopy at molecular resolution.  Ann. Rev. Biophys. Biomol. Struct.  pp.




 



2.
Milne J, Shi D, Zhang P   (2004) Visualization of alpha-helical features in a density map constructed using 9 molecular images of the 18 MDa icosahedral core of pyruvate dehydrogenase.  J. Struct. Biol  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37235
224,BC010413-05,"October 01, 2004 -  September 30, 2005",Comparative Analysis of Cancer-Associated Genes and Development of a Gene Delive,"Vladimir L Larionov; PhD, DSc",James Carl Barrett; PhD,"Laboratory of Biosystems and Cancer, NCI","Keith  Collins



Jung-Hyun  Kim



Natalay  Kouprina



Hiroshi  Masumoto



Vladimir  Noskov; PhD","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Jeffrey  Trent; PhD
(Translational Genomic)




Christopher  Walsh
(Howard Hughes Medical Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Larionov V, Kouprina N, Barrett J, Jurka J   (2004) Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition.  Human Molecular Genetics  pp.




 



2.
Larionov V, Okamoto Y, Noskov V, Kim J, Leem S, Barrett J, Masumoto H   (2005) Rapid generation of long synthetic centromeric tandem repeats for analysis in human artificial chromosome formation.  Nucleic Acids Research  pp.




 



3.
Larionov V, Pavlicek A, Collins N, Nakano M, Noskov V, Ohzeki J, Mochida G, Risinger J, Goldsmitt P, Gunsior M, Solomon G, Gersch W, Kim J, Barrett J, Walsh C, Jurka J, Masumoto H   (2005) The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein.  Human Molecular Genetics  pp.




 



4.
Larionov V, Pavlicek A, Noskov V, Solomon S, Otstot J, Isaacs C, Trent J, Barrett J, Jurka J   (2005) Dynamic Structure of the SPANX Gene Cluster Mapped to the Prostate Cancer Susceptibility Locus HPCX at Xq27.  Genome Research  pp.




 



5.
Larionov VL, Barrett JL, Earnshaw WL, Gassman RL, Kandels-lewis SL, Kouprina NL, Masumoto HL, Nakano ML, Noskov VL (submitted in 2005) Rapid Generation Of Long Synthetic Centromeric Tandem Repeats For Mammalian Artificial Chromosome Formation. Patents issued: 2006235356 (AU in 2012); 1866442 (EP in 2015); 9,139,849 (US in 2015). Patents pending: PCT/US2006/013362 (PC application); 2616085 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=36983
225,BC010417-06,"October 01, 2004 -  September 30, 2005","Cell Senescence, Carcinogenesis, and Aging",James Carl Barrett; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI","Olga  Aprelikova; PhD



Kristin  Bauer



Izumi  Horikawa



Jackie Ann Lavigne



Theresa  Lopez



Larry  Maxwell



Show all 11","Angelo  De Marzo
(John Hopkins)




William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Jeffrey  Kent
(Translational Genomics Research Institute)




Bertram  Opalka
(University of Essen)




Mitsuo  Oshimura
(Tottori University)




Takeki  Tsutsui
(Nippon Dental University of Tokyo)","Stephen D Hursting; PhD, MPH (National Cancer Institute)



Albert J Fornace; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)



Eric  Huang; MD (National Cancer Institute)



Victor  Zhurkin; PhD (National Cancer Institute)","Victor  Lobanenkov (NIAID) 



Mark Paul Mattson; PhD (NIA)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37238
226,BC010418-06,"October 01, 2004 -  September 30, 2005",Signaling events regulating chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Anna  Bagorda



Frank I Comer



Paul W Kriebel



Dana C Mahadeo",NULL,NULL,Alan Robert Kimmel; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Brzostowski JA, Parent CA, Kimmel AR (2004). A G alpha-dependent pathway that antagonizes multiple chemoattractant responses that regulate directional cell movement. Genes Dev  18, 805-15.   https://doi.org/10.1101/gad.1173404




PubMed



        
     
Free Article


 


PubMed ID 15059962
         Pubmed Central ID 387420 


 



2.
Comer FI, Lippincott CK, Masbad JJ, Parent CA (2005). The PI3K-mediated activation of CRAC independently regulates adenylyl cyclase activation and chemotaxis. Curr Biol  15, 134-9.   https://doi.org/10.1016/j.cub.2005.01.007




PubMed


 


PubMed ID 15668169
    
     


 



3.
Kimmel AR, Parent CA, Gough NR (2004). Teaching resources. Spatial and temporal dynamics of signaling components involved in the control of chemotaxis in Dictyostelium discoideum. Sci STKE  2004, tr3.   https://doi.org/10.1126/stke.2342004tr3




PubMed


 


PubMed ID 15161990
    
     


 



4.
Kriebel PW, Parent CA (2004). Adenylyl cyclase expression and regulation during the differentiation of Dictyostelium discoideum. IUBMB Life  56, 541-6.   https://doi.org/10.1080/15216540400013887




PubMed


 


PubMed ID 15590560
    
     


 



5.
Lee S, Comer FI, Sasaki A, McLeod IX, Duong Y, Okumura K, Yates JR, Parent CA, Firtel RA (2005). TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol Biol Cell  16, 4572-83.   https://doi.org/10.1091/mbc.e05-04-0342




PubMed



        
     
Free Article


 


PubMed ID 16079174
         Pubmed Central ID 1237065 


 



6.
Parent CA (2004). Making all the right moves: chemotaxis in neutrophils and Dictyostelium. Curr Opin Cell Biol  16, 4-13.   https://doi.org/10.1016/j.ceb.2003.11.008




PubMed


 


PubMed ID 15037299
    
     


 



7.
Shrimali RK, Lobanov AV, Xu XM, Rao M, Carlson BA, Mahadeo DC, Parent CA, Gladyshev VN, Hatfield DL (2005). Selenocysteine tRNA identification in the model organisms Dictyostelium discoideum and Tetrahymena thermophila. Biochem Biophys Res Commun  329, 147-51.   https://doi.org/10.1016/j.bbrc.2005.01.120




PubMed


 


PubMed ID 15721286",https://intramural.nih.gov/search/searchview.taf?ipid=37239
227,BC010419-06,"October 01, 2004 -  September 30, 2005",Molecular Mechanisms of TGF-beta Signaling Pathway,"Ying  Zhang



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Chaoyang  Jin



Caroline  Millet



Tyjen Lan Tsai



Motozo  Yamashita



Yu-an  Yang",NULL,"Chuxia  Deng; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



Michael Robert Kuehn; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB (2004). Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res  64, 4523-30.   https://doi.org/10.1158/0008-5472.CAN-04-0030




PubMed


 


PubMed ID 15231662
    
     


 



2.
Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE (2005). Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell  121, 101-13.   https://doi.org/10.1016/j.cell.2005.01.035




PubMed



        
     
Free Article


 


PubMed ID 15820682
         Pubmed Central ID 3314294",https://intramural.nih.gov/search/searchview.taf?ipid=37240
228,BC010424-06,"October 01, 2004 -  September 30, 2005",Hypoxia and Tumorigenesis,Eric  Huang; MD,Curtis  Harris; MD,"Laboratory of Human Carcinogenesis, NCI","Minori  Koshiji



Melissa S Samons



Kin Wah  To","Olivier  Bernard
(Hopital Necker, INSERM)




Hani  El-Gabalawy
(Arthritis Center, University of Manitoba)




Adrian L.  Harris
(Weatherall Institute of Molecular Medicine, Oxford University)




Paul  Modrich
(Biochemistry, Duke University Medical Center)




Jong-Wan  Park
(Department of Pharmacology, Seoul National University)




Peter  Ratcliffe
(Herny Wellcome Building of Genomic Medicine, Oxford University)",NULL,NULL,"Ordered by publication type and then author name.



1.
To KK, Huang LE (2005). Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J Biol Chem  280, 38102-7.   https://doi.org/10.1074/jbc.M504342200




PubMed



        
     
Free Article


 


PubMed ID 16157596
         Pubmed Central ID 1307502",https://intramural.nih.gov/search/searchview.taf?ipid=37241
229,BC010425-06,"October 01, 2004 -  September 30, 2005",Human T-Cell Responses to Tumor Antigens,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Patricia K Beetham



Claudia Mercedes Palena



Kwong Yok Tsang



Junko  Yokokawa","Fiorella  Guadagni
(Pathology, Regina Elena Cancer Institute)




John  Marshall





Michael G Morse





Mario  Roselli
(Oncology, Tor Vergata)",William Laurence Dahut; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL, Todd N, Lieberman R, Steinberg SM, Morin S, Bastian A, Marte J, Tsang KY, Beetham P, Grosenbach DW, Schlom J, Dahut W (2005). Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer. J Urol  174, 539-46.   https://doi.org/10.1097/01.ju.0000165159.33772.5b




PubMed


 


PubMed ID 16006888
    
     


 



2.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



3.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J (2005). Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol  23, 720-31.   https://doi.org/10.1200/JCO.2005.10.206




PubMed


 


PubMed ID 15613691
    
     


 



4.
Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK (2005). Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res  11, 3017-24.   https://doi.org/10.1158/1078-0432.CCR-04-2172




PubMed


 


PubMed ID 15837756
    
     


 



5.
Palena C, Foon KA, Panicali D, Yafal AG, Chinsangaram J, Hodge JW, Schlom J, Tsang KY (2005). Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules. Blood  106, 3515-23.   https://doi.org/10.1182/blood-2005-03-1214




PubMed



        
     
Free Article


 


PubMed ID 16081691
         Pubmed Central ID 1895050 


 



6.
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY (2005). Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. Clin Cancer Res  11, 6342-51.   https://doi.org/10.1158/1078-0432.CCR-05-0596




PubMed



        
     
Free Article


 


PubMed ID 16144939
         Pubmed Central ID 1351144 


 



7.
Panicali DL, Gritz LL, Hodge JL, Mazzara GL, Schlom JL, Tsang KL (submitted in 2005) System For Treating And Preventing Breast Cancer. Patents issued: 2004289340 (AU in 2011); 4995575 (JP in 2012); 1694364 (BE in 2014); 1694364 (CH in 2014); 1694364 (DE in 2014); 1694364 (AT in 2014); 1694364 (DK in 2014); 1694364 (EP in 2014); 1694364 (ES in 2014); 1694364 (FR in 2014); 1694364 (GB in 2014); 1694364 (IT in 2014); 1694364 (NL in 2014); 1694364 (SE in 2014); 8,933,041 (US in 2015); 2545164 (CA in 2017). Patents pending: 11009923.1 (EP application); 07101411.2 (HK application); 2011-179768 (JP application); PCT/US2004/037810 (PC application).




 



8.
Schlom J, Gritz L, Hodge J, Mazzara G, Panicali D, Tsang K (submitted in 2005) Custom Vectors For Treating And Preventing Pancreatic Cancer. Patents issued: 2004289368 (AU in 2011); 5285855 (JP in 2013); 8,901,093 (US in 2015); 1687322 (BE in 2017); 2545183 (CA in 2017); 1687322 (CH in 2017); 1687322 (DE in 2017); 1687322 (DK in 2017); 1687322 (EP in 2017); 1687322 (ES in 2017); 1687322 (FR in 2017); 1687322 (GB in 2017); 1687322 (IT in 2017); 1687322 (NL in 2017); 1687322 (SE in 2017); 1687322 (AT in 2017). Patents pending: PCT/US2004/38643 (PC application); 14/556,897 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=37242
230,BC010427-06,"October 01, 2004 -  September 30, 2005",Mechanism of Human T-Cell Activation,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Patricia K Beetham



Claudia Mercedes Palena



Kwong Yok Tsang



Sixun  Yang



Junko  Yokokawa",NULL,"Ira H Pastan; MD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Mitchell  Ho (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, Kaufman HL (2006). 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines. Vaccine  24, 4975-86.   https://doi.org/10.1016/j.vaccine.2006.03.042




PubMed



        
     
Free Article


 


PubMed ID 16621183
         Pubmed Central ID 1865095 


 



2.
Palena C, Foon KA, Panicali D, Yafal AG, Chinsangaram J, Hodge JW, Schlom J, Tsang KY (2005). Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules. Blood  106, 3515-23.   https://doi.org/10.1182/blood-2005-03-1214




PubMed



        
     
Free Article


 


PubMed ID 16081691
         Pubmed Central ID 1895050 


 



3.
Schlom J, Palena C, Arlen P, Hassan R, Pastan I, Tsang K   (2005) Identification of novel human cytotoxic T lymphocyte epitopes and their agonist epitopes of mesothelin.  Clin Cancer Res, in press.




 



4.
Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J (2005). Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res  11, 1597-607.   https://doi.org/10.1158/1078-0432.CCR-04-1609




PubMed


 


PubMed ID 15746065
    
     


 



5.
Yang S, Tsang KY, Schlom J (2005). Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells. Clin Cancer Res  11, 5603-15.   https://doi.org/10.1158/1078-0432.CCR-05-0670




PubMed



        
     
Free Article


 


PubMed ID 16061879
         Pubmed Central ID 1351007 


 



6.
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY (2005). Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. Clin Cancer Res  11, 6342-51.   https://doi.org/10.1158/1078-0432.CCR-05-0596




PubMed



        
     
Free Article


 


PubMed ID 16144939
         Pubmed Central ID 1351144",https://intramural.nih.gov/search/searchview.taf?ipid=37244
231,BC010428-06,"October 01, 2004 -  September 30, 2005",Cytokines as Biologic Adjuvants,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Kenneth W Hance



Connie Jo Rogers



David A Zaharoff",NULL,"Stephen D Hursting; PhD, MPH (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J (2005). Multiple costimulatory modalities enhance CTL avidity. J Immunol  174, 5994-6004.   https://doi.org/10.4049/jimmunol.174.10.5994




PubMed



        
     
Free Article


 


PubMed ID 15879092
         Pubmed Central ID 1924685 


 



2.
Reali E, Canter D, Zeytin H, Schlom J, Greiner JW (2005). Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms. Vaccine  23, 2909-21.   https://doi.org/10.1016/j.vaccine.2004.11.060




PubMed


 


PubMed ID 15780740
    
     


 



3.
Yang S, Tsang KY, Schlom J (2005). Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells. Clin Cancer Res  11, 5603-15.   https://doi.org/10.1158/1078-0432.CCR-05-0670




PubMed



        
     
Free Article


 


PubMed ID 16061879
         Pubmed Central ID 1351007",https://intramural.nih.gov/search/searchview.taf?ipid=37245
232,BC010429-06,"October 01, 2004 -  September 30, 2005",Novel Recombinant Immunoglobulin Forms for Cancer Therapy and Diagnosis,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Roberto  De Pascalis



Noreen R Gonzales McCurdy; PhD



Syed V. S. Kashmiri; PhD",NULL,NULL,Peter W Schuck; PhD (OD),"Ordered by publication type and then author name.



1.
Gonzales NR, De Pascalis R, Schlom J, Kashmiri SV (2005). Minimizing the immunogenicity of antibodies for clinical application. Tumour Biol  26, 31-43.   https://doi.org/10.1159/000084184




PubMed


 


PubMed ID 15741769
    
     


 



2.
Gonzales NR, Padlan EA, De Pascalis R, Schuck P, Schlom J, Kashmiri SV (2004). SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity. Mol Immunol  41, 863-72.   https://doi.org/10.1016/j.molimm.2004.03.041




PubMed


 


PubMed ID 15261458
    
     


 



3.
Kashmiri SV, De Pascalis R, Gonzales NR, Schlom J (2005). SDR grafting--a new approach to antibody humanization. Methods  36, 25-34.   https://doi.org/10.1016/j.ymeth.2005.01.003




PubMed


 


PubMed ID 15848072
    
     


 



4.
Milenic D, Garmestani K, Dadachova E, Chappell L, Albert P, Hill D, Schlom J, Brechbiel M (2004). Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother Radiopharm  19, 135-47.   https://doi.org/10.1089/108497804323071904




PubMed


 


PubMed ID 15186593",https://intramural.nih.gov/search/searchview.taf?ipid=37246
233,BC010431-06,"October 01, 2004 -  September 30, 2005",Metastasis Suppressor Genes For Prostate Cancer,James Carl Barrett; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",John I Risinger; PhD,"Zheng  Cui
(Wake Forest University School of Medicine, Winston-Salem, NC)




Michael  Sporn
(Dartmouth Medical School)




Yuxin  Yin
(Department of Radiation Oncology, Columbia University)","Albert J Fornace; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)



Eric  Huang; MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Peter  Nissley; PhD (National Cancer Institute)",Victor  Lobanenkov (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37247
234,BC010435-05,"October 01, 2004 -  September 30, 2005",Developmental Therapeutics,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI","Sherry M Yang



Diana A Nguyen",NULL,"Suparna B Wedam (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



Janice Maria Walshe (National Cancer Institute)



Jennifer A Low (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Swain S   (2005) Hormonal therapy for breast cancer, in Cancer Chemotherapy and Biotherapy, 4th ed. Chabner B, Longo D, eds., Lippincott Williams and Wilkins (Philadelphia), in press.




 



2.
Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM (2005). Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer. J Clin Oncol  23, 2726-34.   https://doi.org/10.1200/JCO.2005.10.024




PubMed


 


PubMed ID 15837987
    
     


 



3.
Swain S   (2005) Development of novel therapeutic agents to evade the mechanisms of multidrug resistance (MDR).  Semin Oncol, in press.




 



4.
Swain S, Simon S, Tan A, Nguyen D   (2005) Gene expression patterns and changes pre- and post-erlotinib treatment in patients with metastatic breast cancer.  Clin Cancer Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37248
235,BC010439-04,"October 01, 2004 -  September 30, 2005",Maryland Breast Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Brenda Jean Boersma-Maland



Tiffany Marie Howe","Dong  Lee
(Pathology and Laboratory Medicine, Baltimore Veteran Affairs Hospital)




Harry  Yfantis
(Department of Pathology, University of Maryland)","Stephen J Chanock; MD, PhD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37180
236,BC010440-04,"October 01, 2004 -  September 30, 2005","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Gunasakaran  Kannan



Buyong  Ma



Yongping  Pan



Chung  Tsai



Hui-Hsu (Gavin)  Tsai



David  Zanuy","Hadar  Benyamini





Angel  Garcia
(T10, Los Alamos National Laboratory)




Edud  Gazit





Gnana  Gnanakaran
(T10, Los Alamos National Laboratory)




Nurit  Haspel
(Computer Science, Tel Aviv University)




Yuval  Inbar
(Computer Science Dept., Tel Aviv University)


Show all 11",NULL,NULL,"Ordered by publication type and then author name.



1.
Gunasekaran K, Nussinov R (2004). Modulating functional loop movements: the role of highly conserved residues in the correlated loop motions. Chembiochem  5, 224-30.   https://doi.org/10.1002/cbic.200300732




PubMed


 


PubMed ID 14760744
    
     


 



2.
Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R (2005). A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. J Mol Biol  345, 1213-27.   https://doi.org/10.1016/j.jmb.2004.11.002




PubMed


 


PubMed ID 15644216
    
     


 



3.
Liu J, Pan Y, Ma B, Nussinov R (2006). ""Similarity trap"" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains. Structure  14, 1811-21.   https://doi.org/10.1016/j.str.2006.10.009




PubMed



        
     
Free Article


 


PubMed ID 17161371
         Pubmed Central ID 2429992 


 



4.
Pan Y, Ma B, Nussinov R (2005). CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible. J Mol Biol  350, 514-27.   https://doi.org/10.1016/j.jmb.2005.05.009




PubMed


 


PubMed ID 15946678
    
     


 



5.
Pan Y, Ma B, Venkataraghavan RB, Levine AJ, Nussinov R (2005). In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1. Biochemistry  44, 1423-32.   https://doi.org/10.1021/bi047845y




PubMed


 


PubMed ID 15683227
    
     


 



6.
Tsai HH, Reches M, Tsai CJ, Gunasekaran K, Gazit E, Nussinov R (2005). Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. Proc Natl Acad Sci U S A  102, 8174-9.   https://doi.org/10.1073/pnas.0408653102




PubMed



        
     
Free Article


 


PubMed ID 15923262
         Pubmed Central ID 1149403",https://intramural.nih.gov/search/searchview.taf?ipid=37181
237,BC010441-04,"October 01, 2004 -  September 30, 2005",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Gunasakaran  Kannan



Buyong  Ma



Yongping  Pan



Chung  Tsai","Oranit  Dror
(Tel Aviv University)




Dina  Duhovny
(Computer Science Dept., Tel Aviv University)




Inbar  Gihon-Cohen
(Computer Science Dept., Tel Aviv University)




Attila  Gursoy
(Computer Science Dept., Koc University)




Turkan  Haliloglu





Inbal  Halperin



Show all 20",NULL,NULL,"Ordered by publication type and then author name.



1.
Haliloglu T, Keskin O, Ma B, Nussinov R (2005). How similar are protein folding and protein binding nuclei? Examination of vibrational motions of energy hot spots and conserved residues. Biophys J  88, 1552-9.   https://doi.org/10.1529/biophysj.104.051342




PubMed



        
     
Free Article


 


PubMed ID 15596504
         Pubmed Central ID 1305212 


 



2.
Keskin O, Ma B, Nussinov R (2005). Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues. J Mol Biol  345, 1281-94.   https://doi.org/10.1016/j.jmb.2004.10.077




PubMed


 


PubMed ID 15644221
    
     


 



3.
Keskin O, Nussinov R (2005). Favorable scaffolds: proteins with different sequence, structure and function may associate in similar ways. Protein Eng Des Sel  18, 11-24.   https://doi.org/10.1093/protein/gzh095




PubMed


 


PubMed ID 15790576
    
     


 



4.
Liu J, Pan Y, Ma B, Nussinov R (2006). ""Similarity trap"" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains. Structure  14, 1811-21.   https://doi.org/10.1016/j.str.2006.10.009




PubMed



        
     
Free Article


 


PubMed ID 17161371
         Pubmed Central ID 2429992 


 



5.
Ma B, Pan Y, Gunasekaran K, Venkataraghavan RB, Levine AJ, Nussinov R (2005). Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface. Proc Natl Acad Sci U S A  102, 3988-93.   https://doi.org/10.1073/pnas.0500215102




PubMed



        
     
Free Article


 


PubMed ID 15738397
         Pubmed Central ID 554805",https://intramural.nih.gov/search/searchview.taf?ipid=37182
238,BC010442-04,"October 01, 2004 -  September 30, 2005",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Buyong  Ma



Chung  Tsai","Oranit  Dror
(Tel Aviv University)




Attila  Gursoy
(Computer Science Dept., Koc University)




Inbal  Halperin





Nurit  Haspel
(Computer Science, Tel Aviv University)




Yuval  Inbar
(Computer Science Dept., Tel Aviv University)




Ozlem  Keskin
(College of Engineering, Koc University)


Show all 13",NULL,NULL,"Ordered by publication type and then author name.



1.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ (2005). Prediction of multimolecular assemblies by multiple docking. J Mol Biol  349, 435-47.   https://doi.org/10.1016/j.jmb.2005.03.039




PubMed


 


PubMed ID 15890207
    
     


 



2.
Inbar Y, Schneidman-Duhovny D, Halperin I, Oron A, Nussinov R, Wolfson HJ (2005). Approaching the CAPRI challenge with an efficient geometry-based docking. Proteins  60, 217-23.   https://doi.org/10.1002/prot.20561




PubMed


 


PubMed ID 15981251
    
     


 



3.
Nussinov R, Wolfson H   (2005) Multiple Docking for Protein Structure Prediction.  International Journal of Robotics Research  pp.




 



4.
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005). Geometry-based flexible and symmetric protein docking. Proteins  60, 224-31.   https://doi.org/10.1002/prot.20562




PubMed


 


PubMed ID 15981269
    
     


 



5.
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005). PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res  33, W363-7.   https://doi.org/10.1093/nar/gki481




PubMed



        
     
Free Article


 


PubMed ID 15980490
         Pubmed Central ID 1160241 


 



6.
Shulman-Peleg A, Nussinov R, Wolfson HJ (2005). SiteEngines: recognition and comparison of binding sites and protein-protein interfaces. Nucleic Acids Res  33, W337-41.   https://doi.org/10.1093/nar/gki482




PubMed



        
     
Free Article


 


PubMed ID 15980484
         Pubmed Central ID 1160242 


 



7.
Wolfson HJ, Shatsky M, Schneidman-Duhovny D, Dror O, Shulman-Peleg A, Ma B, Nussinov R (2005). From structure to function: methods and applications. Curr Protein Pept Sci  6, 171-83.   https://doi.org/10.2174/1389203053545435




PubMed


 


PubMed ID 15853653",https://intramural.nih.gov/search/searchview.taf?ipid=37187
239,BC010446-04,"October 01, 2004 -  September 30, 2005",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Xiaolin  Bi



Min  Gong



Xiao-Feng  Zheng",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37192
240,BC010447-03,"October 01, 2004 -  September 30, 2005",Cell Cycle and Cancer,"Sushil Gopal Rane; MS, PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Wan  Jiao



Ji Hyeon  Lee



Huei-Min  Lin",NULL,"Anita B Roberts; PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Jiao W, Lin HM, Timmons J, Nagaich AK, Ng SW, Misteli T, Rane SG (2005). E2F-dependent repression of topoisomerase II regulates heterochromatin formation and apoptosis in cells with melanoma-prone mutation. Cancer Res  65, 4067-77.   https://doi.org/10.1158/0008-5472.CAN-04-3999




PubMed


 


PubMed ID 15899796",https://intramural.nih.gov/search/searchview.taf?ipid=36987
241,BC010448-04,"October 01, 2004 -  September 30, 2005",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI",Zhihong  Shan,NULL,"Nicolae C Popescu; PhD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37249
242,BC010449-04,"October 01, 2004 -  September 30, 2005",Role of Uteroglobin-Related Protein (UGRP) 1 in Lung Inflammation,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Reiko  Kuratoni



Takeshi  Tomita",NULL,Howard A Young; PhD (National Cancer Institute),Raymond  Donnelly (OD),"Ordered by publication type and then author name.



1.
Chiba Y, Kusakabe T, Kimura S (2004). Decreased expression of uteroglobin-related protein 1 in inflamed mouse airways is mediated by IL-9. Am J Physiol Lung Cell Mol Physiol  287, L1193-8.   https://doi.org/10.1152/ajplung.00263.2004




PubMed


 


PubMed ID 15531759
    
     


 



2.
Chiba Y, Srisodsai A, Supavilai P, Kimura S (2005). Interleukin-5 reduces the expression of uteroglobin-related protein (UGRP) 1 gene in allergic airway inflammation. Immunol Lett  97, 123-9.   https://doi.org/10.1016/j.imlet.2004.10.013




PubMed



        
     
Free Article


 


PubMed ID 15626484
         Pubmed Central ID 1343456 


 



3.
Srisodsai A, Kurotani R, Chiba Y, Sheikh F, Young HA, Donnelly RP, Kimura S (2004). Interleukin-10 induces uteroglobin-related protein (UGRP) 1 gene expression in lung epithelial cells through homeodomain transcription factor T/EBP/NKX2.1. J Biol Chem  279, 54358-68.   https://doi.org/10.1074/jbc.M405331200




PubMed


 


PubMed ID 15485815
    
     


 



4.
Yamada A, Kimura S (2005). Induction of uteroglobin-related protein 2 (Ugrp2) expression by EGF and TGFalpha. FEBS Lett  579, 2221-5.   https://doi.org/10.1016/j.febslet.2005.03.017




PubMed



        
     
Free Article


 


PubMed ID 15811345
         Pubmed Central ID 1343457 


 



5.
Yamada A, Sheikh F, Niimi T, DeMayo FJ, Keegan AD, Donnelly RP, Kimura S (2005). Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13. J Immunol  175, 5708-15.   https://doi.org/10.4049/jimmunol.175.9.5708




PubMed



        
     
Free Article


 


PubMed ID 16237061
         Pubmed Central ID 1364478",https://intramural.nih.gov/search/searchview.taf?ipid=37250
243,BC010450-04,"October 01, 2004 -  September 30, 2005",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Joell J Gills



Courtney A Granville



Wei  Han



Junji  Tsurutani



Noel Andrew Warfel



Chunyu  Zhang",NULL,William D Figg; PharmD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Dennis P   (2004) The development of phosphatidylinositol ether lipid analogues (PIAs) as inhibitors of the serine/threonine kinase, Akt.  Expert Opinion in Experimental Drugs  pp.




 



2.
Dennis P, Brognard J, Petukov P, Zhang C, Tsurutani J, Granville C, Jung M, West K, Kozikowski A   (2004) Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues.  Cancer Research  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37251
244,BC010451-04,"October 01, 2004 -  September 30, 2005",NMR Group Project: Preparation and Properties of Novel Multivalent Nanoparticles,"Joseph John Barchi



IRP Faculty Profile",Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Celeste A Constantine



Serge A Svarovsky","Vadislav  Glinskii
(Biochemistry, University of Missouri)




Kate  Rittenhouse-Olson
(Biotechnical and Clinical Laboratory Science, University of Buffalo)","Kent W Hunter; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41953
245,BC010453-04,"October 01, 2004 -  September 30, 2005",Identify SNPs and Polymorphisms that are Important in the Development of Prostat,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Haiqing  Li



Matthew G Permenter



Douglas K Price



Nicola F Smith","Bennett  Charlie





Scott  Lippman
(MD Anderson)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Figg W, Chau C, Price D   (2005) Mechanisms of disease: polymorphisms of androgen regulatory genes in the development of prostate cancer.  Nature Clin Pract Urol  pp.




 



2.
Figg W, Permenter M, Steinberg S, Dahut W, Price D   (2005) Mutation of the hypoxia inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.  Cancer Biol Ther, in press.




 



3.
Sissung TM, Mross K, Steinberg SM, Behringer D, Figg WD, Sparreboom A, Mielke S (2006). Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia. Eur J Cancer  42, 2893-6.   https://doi.org/10.1016/j.ejca.2006.06.017




PubMed



        
     
Free Article


 


PubMed ID 16950614
         Pubmed Central ID 1647318",https://intramural.nih.gov/search/searchview.taf?ipid=37252
246,BC010455-04,"October 01, 2004 -  September 30, 2005",The Role of Wnts in the Formation of the Vertebrate Body Plan,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Kristin K Biris



William C Dunty



Jaime  Greear



Masaaki  Nakaya",NULL,Mark B Lewandoski (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37253
247,BC010458-04,"October 01, 2004 -  September 30, 2005",Molecular Genetic Basis for Gynecologic Neoplasias,James Carl Barrett; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI","Larry  Maxwell



John I Risinger; PhD","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Takeki  Tsutsui
(Nippon Dental University of Tokyo)",Peter  Nissley; PhD (National Cancer Institute),Victor  Lobanenkov (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37254
248,BC010459-04,"October 01, 2004 -  September 30, 2005",Gene Methylation in Prostate Cancer,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",Elyse  Walk,"Luis  Guarda





Rebecca  Moroose





Judd  Moul





Keith  O'Reilly





David  Ward
(Pathology, Madigan Army Medical Center)","Joseph A Tangrea (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37255
249,BC010465-02,"October 01, 2004 -  September 30, 2005",Protemics bioinformatics tools,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Gregory  Thornwall,"Gregory  Alvord
(Data Management Services)




Jai A Evans





Howard  Gutstein
(UT-MD Anderson Cancer Center)




Mark A Knepper; PhD, MD
(NHLBI)




Djamel None Medjahed





Carl  Merrill
(NIMH)


Show all 8",Scott E McNeil (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36968
250,BC010468-03,"October 01, 2004 -  September 30, 2005",The Role of Cytopathology in Biomedical Research,"Andrea  Abati; BS, MD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Keith R Brosky



Dana K Erickson



Patricia A Fetsch



Anna-Maria  Wilder",NULL,"Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



James Chung-Yin Yang; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Monica C Skarulis; MD (National Cancer Institute)



David  Danforth (National Cancer Institute)",Francesco M. Marincola; MD (CC),"Ordered by publication type and then author name.



1.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



2.
Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, Mittal K, Bates SE (2006). Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett  235, 84-92.   https://doi.org/10.1016/j.canlet.2005.04.024




PubMed


 


PubMed ID 15990223
    
     


 



3.
Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005). High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood  105, 496-502.   https://doi.org/10.1182/blood-2004-05-1982




PubMed


 


PubMed ID 15358629
    
     


 



4.
Mattu R, Sorbara L, Filie AC, Little R, Wilson W, Raffeld M, Abati A (2004). Utilization of polymerase chain reaction on archival cytologic material: a comparison with fresh material with special emphasis on cerebrospinal fluids. Mod Pathol  17, 1295-301.   https://doi.org/10.1038/modpathol.3800185




PubMed


 


PubMed ID 15195110
    
     


 



5.
Nagorsen D, Fetsch PA, Abati A, Marincola FM, Panelli MC (2005). Degree of CD14 expression in melanoma infiltrating mononuclear phagocytes. J Dermatol Sci  37, 52-4.   https://doi.org/10.1016/j.jdermsci.2004.09.007




PubMed


 


PubMed ID 15619435",https://intramural.nih.gov/search/searchview.taf?ipid=37256
251,BC010469-03,"October 01, 2004 -  September 30, 2005",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Development Program, NCI","John A Beutler



Heidi  Bokesch



Laura  Cartner



Joseph  Collins



Angie  Dull



Richard W Fuller



Show all 21",NULL,"Scott K Durum; PhD (National Cancer Institute)



Gordon Lee Hager; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Peter  Nissley; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



Allan M Weissman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Budihas SR, Gorshkova I, Gaidamakov S, Wamiru A, Bona MK, Parniak MA, Crouch RJ, McMahon JB, Beutler JA, Le Grice SF (2005). Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Nucleic Acids Res  33, 1249-56.   https://doi.org/10.1093/nar/gki268




PubMed



        
     
Free Article


 


PubMed ID 15741178
         Pubmed Central ID 552956 


 



2.
Calis I, Kirmizibekmez H, Beutler J, Donmez F, Yalcin E, Kilic M, Ozalp M, Ruedi P, Tasdemir D   (2005) Secondary metabolites of Phlomis viscosa and their biological activities.  Turkish J. Chem.  pp.




 



3.
Chen B, Colgrave ML, Daly NL, Rosengren KJ, Gustafson KR, Craik DJ   (2005) Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.  J Biol Chem 280:22395-405.




PubMed


 


PubMed ID 15824119
    
     


 



4.
Koltay A, Daly N, Gustafson K, Craik D   (2005) Structure of Circulin B and Implications for Antimicrobial Activity of the Cyclotides.  Int. J. Peptide Res. Therapeut.  pp.




 



5.
Martinez E, Rayasam G, Dull A, Walker D, Hager G   (2005) An estrogen receptor chimera senses ligands by nuclear translocation.  Steroid Biochemistry and Molecular Biology, in press.




 



6.
McMahon J, O'Keefe B, Botos I, Wlodawer A   (2005) Overexpression and purification of Scytovirin, a potent novel anti-HIV protein from the cultured cyanobacterium scytonema varium.  Rec. Prot. Exp. Pur, in press.




 



7.
Mori T, O'Keefe BR, Sowder RC, Bringans S, Gardella R, Berg S, Cochran P, Turpin JA, Buckheit RW, McMahon JB, Boyd MR (2005). Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem  280, 9345-53.   https://doi.org/10.1074/jbc.M411122200




PubMed


 


PubMed ID 15613479
    
     


 



8.
Neighbors JD, Beutler JA, Wiemer DF (2005). Synthesis of nonracemic 3-deoxyschweinfurthin B. J Org Chem  70, 925-31.   https://doi.org/10.1021/jo048444r




PubMed


 


PubMed ID 15675850
    
     


 



9.
Oku N, Krishnamoorthy R, Benson AG, Ferguson RL, Lipton MA, Phillips LR, Gustafson KR, McMahon JB (2005). Complete stereochemistry of neamphamide A and absolute configuration of the beta-methoxytyrosine residue in papuamide B. J Org Chem  70, 6842-7.   https://doi.org/10.1021/jo0508853




PubMed



        
     
Free Article


 


PubMed ID 16095304
         Pubmed Central ID 1513540 


 



10.
Witvrouw M, Fikkert V, Hantson A, Pannecouque C, O'keefe BR, McMahon J, Stamatatos L, de Clercq E, Bolmstedt A (2005). Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J Virol  79, 7777-84.   https://doi.org/10.1128/JVI.79.12.7777-7784.2005




PubMed



        
     
Free Article


 


PubMed ID 15919930
         Pubmed Central ID 1143621 


 



11.
O'Keefe BR, Byrd RR, McMahon JR, Xiong CR (submitted in 2005) Scytovirin Domain 1 Related Polypeptides. Patents issued: 1891094 (FR in 2010); 1891094 (GB in 2010); 1891094 (IE in 2010); 602006014140 (DE in 2010); 1891094 (EP in 2010); 8,067,530 (US in 2012); 8,481,255 (US in 2013).",https://intramural.nih.gov/search/searchview.taf?ipid=37307
252,BC010470-03,"October 01, 2004 -  September 30, 2005",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Richard Phillip Finney



Michael N Edmonson



William L Rowe



Peisen  Zhang","Richard A. Gibbs; PhD
(Molecular and Human Genetics, Baylor College of Medicine)




Brian  Osborne
(Cognia Corporation)




Huitao  Sheng
(Columbia University)




David  Wheeler
(Baylor)




Imtiaz  Yakub
(Baylor)",Carl F Schaefer (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37259
253,BC010472-03,"October 01, 2004 -  September 30, 2005",High-Density Marker Studies Near Founder BRCA12 Mutations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Lutecia  Pereira



Marbin A Pineda","Andrew  Collins
(Human Genetics Division, University of Southampton)




Nathan  Ellis





Ken  Offit
(Memorial Sloan-Kettering Cancer Center)




Jinghui  Zhang
(NIC-LPG)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37306
254,BC010474-03,"October 01, 2004 -  September 30, 2005",Signal Transduction Mechanisms of Type I IFNs,Ana M Gamero,"Robert  Wiltrout; PhD 
 


Howard A Young; PhD","Laboratory of Experimental Immunology, NCI","Stephen G Maher



Ana L Romero



Anthony J Scarzello","Ray  Donnelly
(FDA)




Andrew  Larner
(Immunology, Cleveland Clinic Foundation)




Doug  Leaman
(University of Toledo)




Richard A Lempicki; PhD
(SAIC)","John R Ortaldo; PhD (National Cancer Institute)



Terry D Copeland (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37266
255,BC010476-03,"October 01, 2004 -  September 30, 2005",Time Domian Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Fuminori  Hyodo



Atsuka  Matsumoto



Sankaran  Subramanian; MD",NULL,NULL,"Thomas J Pohida; MS (CIT) 



Randall Harrison Pursley; MS (CIT) 



Calvin A Johnson; PhD (CIT)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37286
256,BC010477-03,"October 01, 2004 -  September 30, 2005",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Yukihiro  Hama



Fuminori  Hyodo



Atsuka  Matsumoto



Sankaran  Subramanian; MD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Matsumoto S, Utsumi H, Aravalluvan T, Matsumoto K, Matsumoto A, Devasahayam N, Sowers AL, Mitchell JB, Subramanian S, Krishna MC (2005). Influence of proton T1 on oxymetry using Overhauser enhanced magnetic resonance imaging. Magn Reson Med  54, 213-7.   https://doi.org/10.1002/mrm.20564




PubMed


 


PubMed ID 15968662
    
     


 



2.
Subramanian S, Matsumoto K, Mitchell JB, Krishna MC (2004). Radio frequency continuous-wave and time-domain EPR imaging and Overhauser-enhanced magnetic resonance imaging of small animals: instrumental developments and comparison of relative merits for functional imaging. NMR Biomed  17, 263-94.   https://doi.org/10.1002/nbm.897




PubMed


 


PubMed ID 15366027",https://intramural.nih.gov/search/searchview.taf?ipid=37284
257,BC010478-03,"October 01, 2004 -  September 30, 2005",Continuous Wave Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Yukihiro  Hama



Fuminori  Hyodo



Atsuka  Matsumoto



Sankaran  Subramanian; MD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Durairaj DC, Krishna MC, Murugesan R   (2004) Integration of color and boundary information for improved region of interest identification in electron magnetic resonance images.  Comput Med Imaging Graph 28:445-52.




PubMed


 


PubMed ID 15541951
    
     


 



2.
Matsumoto K, English S, Yoo J, Yamada K, Devasahayam N, Cook JA, Mitchell JB, Subramanian S, Krishna MC (2004). Pharmacokinetics of a triarylmethyl-type paramagnetic spin probe used in EPR oximetry. Magn Reson Med  52, 885-92.   https://doi.org/10.1002/mrm.20222




PubMed


 


PubMed ID 15389949
    
     


 



3.
Subramanian S, Devasahayam N, Koscielniak J, Krishna M, Mitchell J, Pohida T, Pursley R, Salem G (submitted in 2005) Fast Electron Paramagnetic Resonance Imaging (epri) In The Cw Epr Mode Using Rapid-scan In The Presence Of Rotating Gradients And Direct Detection With Transmit/receive & Data Processing In A Digital Signal Processing Platform. Patent issued: 8,242,778 (US in 2012). Patent pending: 12/564,006 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=37285
258,BC010479-03,"October 01, 2004 -  September 30, 2005",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Ganesh  Diwakar



Deming  Zhang","David  Dolan
(Otolaryngology, The University of Michigan)




Yehoash  Raphael; PhD
(Department of Otolaryngology, University of Michigan)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hornyak T, Wallace J, Zhang D, Diwakar G, Jiao Z   (2005) Altered Melanocyte Differentiation and Retinal Pigmented Epithelium Transdifferentiation Induced by Mash1 Expression in Pigment Cell Precursors.  Journal of Investigative Dermatology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37271
259,BC010481-03,"October 01, 2004 -  September 30, 2005",Structure and Function of HIV-1 Reverse Transcriptase,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Paul L Boyer



Kevin W Chang



Linda L Dunn



Andrea L Ferris



John G Julias



Stanislaw J Kaczmarczyk



Show all 10","Edward  Arnold
(BIOCHEMISTRY, Rutgers University)




Maxine  Linial
(University of Washington)




Michael  Parniak; PhD
(Department of Medicine, McGill University)","Victor  Marquez; PhD (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)",Donald M Jerina; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH (2004). Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision. J Virol  78, 9987-97.   https://doi.org/10.1128/JVI.78.18.9987-9997.2004




PubMed



        
     
Free Article


 


PubMed ID 15331732
         Pubmed Central ID 515022 


 



2.
Boyer PL, Julias JG, Marquez VE, Hughes SH (2005). Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases. J Mol Biol  345, 441-50.   https://doi.org/10.1016/j.jmb.2004.10.021




PubMed


 


PubMed ID 15581889
    
     


 



3.
Boyer PL, Stenbak CR, Clark PK, Linial ML, Hughes SH (2004). Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase. J Virol  78, 6112-21.   https://doi.org/10.1128/JVI.78.12.6112-6121.2004




PubMed



        
     
Free Article


 


PubMed ID 15163704
         Pubmed Central ID 416499 


 



4.
Das K, Clark AD, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Béthune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, Arnold E (2004). Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J Med Chem  47, 2550-60.   https://doi.org/10.1021/jm030558s




PubMed


 


PubMed ID 15115397
    
     


 



5.
Das K, Lewi PJ, Hughes SH, Arnold E (2005). Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog Biophys Mol Biol  88, 209-31.   https://doi.org/10.1016/j.pbiomolbio.2004.07.001




PubMed


 


PubMed ID 15572156
    
     


 



6.
Hughes S   (2005) Wiggling and jiggling can increase the effectiveness of AIDS drugs.  Frontiers Sci  pp.




 



7.
Janssen PA, Lewi PJ, Arnold E, Daeyaert F, de Jonge M, Heeres J, Koymans L, Vinkers M, Guillemont J, Pasquier E, Kukla M, Ludovici D, Andries K, de Béthune MP, Pauwels R, Das K, Clark AD, Frenkel YV, Hughes SH, Medaer B, De Knaep F, Bohets H, De Clerck F, Lampo A, Williams P, et al. [1 more author] (2005). In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J Med Chem  48, 1901-9.   https://doi.org/10.1021/jm040840e




PubMed


 


PubMed ID 15771434
    
     


 



8.
Peletskaya EN, Kogon AA, Tuske S, Arnold E, Hughes SH (2004). Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. J Virol  78, 3387-97.   https://doi.org/10.1128/jvi.78.7.3387-3397.2004




PubMed



        
     
Free Article


 


PubMed ID 15016861
         Pubmed Central ID 371094 


 



9.
Sarafianos SG, Das K, Hughes SH, Arnold E (2004). Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol  14, 716-30.   https://doi.org/10.1016/j.sbi.2004.10.013




PubMed


 


PubMed ID 15582396
    
     


 



10.
Sarafianos SG, Hughes SH, Arnold E (2004). Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs. Int J Biochem Cell Biol  36, 1706-15.   https://doi.org/10.1016/j.biocel.2004.02.027




PubMed


 


PubMed ID 15183339
    
     


 



11.
Siddiqui MA, Hughes SH, Boyer PL, Mitsuya H, Van QN, George C, Sarafinanos SG, Marquez VE (2004). A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides. J Med Chem  47, 5041-8.   https://doi.org/10.1021/jm049550o




PubMed


 


PubMed ID 15456247
    
     


 



12.
Sismour AM, Lutz S, Park JH, Lutz MJ, Boyer PL, Hughes SH, Benner SA (2004). PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1. Nucleic Acids Res  32, 728-35.   https://doi.org/10.1093/nar/gkh241




PubMed



        
     
Free Article


 


PubMed ID 14757837
         Pubmed Central ID 373358 


 



13.
Tuske S, Sarafianos SG, Clark AD, Ding J, Naeger LK, White KL, Miller MD, Gibbs CS, Boyer PL, Clark P, Wang G, Gaffney BL, Jones RA, Jerina DM, Hughes SH, Arnold E (2004). Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol  11, 469-74.   https://doi.org/10.1038/nsmb760




PubMed


 


PubMed ID 15107837",https://intramural.nih.gov/search/searchview.taf?ipid=37276
260,BC010482-03,"October 01, 2004 -  September 30, 2005",Retroviral Replication and Vector Design,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Paul L Boyer



Kevin W Chang



Linda L Dunn



Andrea L Ferris



John G Julias



Stanislaw J Kaczmarczyk



Show all 10","John  Coffin
(Tufts University School of Medicine)




Jerry  Dodgson
(Michigan State University)




Mark  Federspiel
(Mayo Clinic)




John  Young","Terence P Yamaguchi; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN (2004). In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J Virol  78, 13553-61.   https://doi.org/10.1128/JVI.78.24.13553-13561.2004




PubMed



        
     
Free Article


 


PubMed ID 15564466
         Pubmed Central ID 533891 


 



2.
Chang KW, Barsov EV, Ferris AL, Hughes SH (2005). Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors. J Virol  79, 10258-67.   https://doi.org/10.1128/JVI.79.16.10258-10267.2005




PubMed



        
     
Free Article


 


PubMed ID 16051819
         Pubmed Central ID 1182669 


 



3.
Hughes SH (2004). The RCAS vector system. Folia Biol (Praha)  50, 107-19.




PubMed


 


PubMed ID 15373344
    
     


 



4.
Julias JG, Boyer PL, McWilliams MJ, Alvord WG, Hughes SH (2004). Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis. Virology  322, 13-21.   https://doi.org/10.1016/j.virol.2004.01.004




PubMed


 


PubMed ID 15063112
    
     


 



5.
Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH (2004). Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage. J Virol  78, 13315-24.   https://doi.org/10.1128/JVI.78.23.13315-13324.2004




PubMed



        
     
Free Article


 


PubMed ID 15542682
         Pubmed Central ID 524982 


 



6.
Kvaratskhelia M, Clark PK, Hess S, Melder DC, Federspiel MJ, Hughes SH (2004). Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry. Virology  326, 171-81.   https://doi.org/10.1016/j.virol.2004.05.020




PubMed


 


PubMed ID 15262505",https://intramural.nih.gov/search/searchview.taf?ipid=37275
261,BC010483-03,"October 01, 2004 -  September 30, 2005",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Janine P Stevens",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37302
262,BC010484-03,"October 01, 2004 -  September 30, 2005",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Michael G Cullen



Steven  Seaman",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37303
263,BC010485-03,"October 01, 2004 -  September 30, 2005",Mechanism of DC-SIGNMediated Transmission of HIV,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Zandrea  Ambrose



Kyeongeun  Lee



Taichiro  Takemura","Simonetta  Di Fabio





Laura  Kiessling
(University of Wisconsin-Madison)




Derya  Unutmaz
(Vanderbilt University)




Li  Wu","Alan  Rein; PhD (National Cancer Institute)



Denise  Whitby (National Cancer Institute)



Ligia  Pinto (Cell Mediated Immunity Section)",NULL,"Ordered by publication type and then author name.



1.
VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D (2005). Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. J Virol  79, 11598-606.   https://doi.org/10.1128/JVI.79.18.11598-11606.2005




PubMed



        
     
Free Article


 


PubMed ID 16140737
         Pubmed Central ID 1212620 


 



2.
Wu L, Martin TD, Carrington M, KewalRamani VN (2004). Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology  318, 17-23.   https://doi.org/10.1016/j.virol.2003.09.028




PubMed


 


PubMed ID 14972530
    
     


 



3.
Wu L, Martin TD, Han YC, Breun SK, KewalRamani VN (2004). Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology  1, 14.   https://doi.org/10.1186/1742-4690-1-14




PubMed



        
     
Free Article


 


PubMed ID 15222882
         Pubmed Central ID 446230",https://intramural.nih.gov/search/searchview.taf?ipid=37281
264,BC010486-03,"October 01, 2004 -  September 30, 2005",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37304
265,BC010487-03,"October 01, 2004 -  September 30, 2005",Postentry Factors That Positively or Negatively Impact HIVSIV Replication,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Zandrea  Ambrose



Kyeongeun  Lee



Taichiro  Takemura","Dan  Littman
(New York University Medical Center)




Derya  Unutmaz
(Vanderbilt University)",Stephen H Hughes; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Baumann JG, Unutmaz D, Miller MD, Breun SK, Grill SM, Mirro J, Littman DR, Rein A, KewalRamani VN (2004). Murine T cells potently restrict human immunodeficiency virus infection. J Virol  78, 12537-47.   https://doi.org/10.1128/JVI.78.22.12537-12547.2004




PubMed



        
     
Free Article


 


PubMed ID 15507641
         Pubmed Central ID 525105 


 



2.
Lee K, KewalRamani VN (2004). In defense of the cell: TRIM5alpha interception of mammalian retroviruses. Proc Natl Acad Sci U S A  101, 10496-7.   https://doi.org/10.1073/pnas.0404066101




PubMed



        
     
Free Article


 


PubMed ID 15252204
         Pubmed Central ID 489964",https://intramural.nih.gov/search/searchview.taf?ipid=37282
266,BC010488-03,"October 01, 2004 -  September 30, 2005",Development of a Macaque Model to Evaluate HIV-1 Nonnucleoside Reverse Transcrip,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Zandrea  Ambrose



Kyeongeun  Lee



Taichiro  Takemura","Shiu-Lok  Hu
(National Primate Research Center, University of Washington)




Jason  Kimata
(Southwest Foundation)




John W Mellors","Stephen H Hughes; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37283
267,BC010492-03,"October 01, 2004 -  September 30, 2005",Modified Nucleosides as Probes of Replication Complexes,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Arkadiusz  Bibillo



Marion Karla Bona; PhD



Chandravanu  Dash



Bridget  Dixon



George J Klarmann



Victoria  Mcparland



Show all 10","Mary  Barkley
(Case Western Reserve University)




John  Marino
(National Institute of Standards and Technology, CARB)




Vinayaka  Prasad
(Albert Einstein University)","Victor  Marquez; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bibillo A, Lener D, Klarmann GJ, Le Grice SF (2005). Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase. Nucleic Acids Res  33, 171-81.   https://doi.org/10.1093/nar/gki150




PubMed



        
     
Free Article


 


PubMed ID 15647500
         Pubmed Central ID 546138 


 



2.
Bibillo A, Lener D, Tewari A, Le Grice SF (2005). Interaction of the Ty3 reverse transcriptase thumb subdomain with template-primer. J Biol Chem  280, 30282-90.   https://doi.org/10.1074/jbc.M502457200




PubMed


 


PubMed ID 15944162
    
     


 



3.
Dash C, Rausch JW, Le Grice SF (2004). Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract. Nucleic Acids Res  32, 1539-47.   https://doi.org/10.1093/nar/gkh307




PubMed



        
     
Free Article


 


PubMed ID 15004241
         Pubmed Central ID 390295 


 



4.
Dash C, Yi-Brunozzi HY, Le Grice SF (2004). Two modes of HIV-1 polypurine tract cleavage are affected by introducing locked nucleic acid analogs into the (-) DNA template. J Biol Chem  279, 37095-102.   https://doi.org/10.1074/jbc.M403306200




PubMed


 


PubMed ID 15220330
    
     


 



5.
Rausch JW, Le Grice SF (2004). 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol  36, 1752-66.   https://doi.org/10.1016/j.biocel.2004.02.016




PubMed


 


PubMed ID 15183342
    
     


 



6.
Yi-Brunozzi HY, Brabazon DM, Lener D, Le Grice SF, Marino JP (2005). A ribose sugar conformational switch in the LTR-retrotransposon Ty3 polypurine tract-containing RNA/DNA hybrid. J Am Chem Soc  127, 16344-5.   https://doi.org/10.1021/ja0534203




PubMed



        
     
Free Article


 


PubMed ID 16305191
         Pubmed Central ID 1350914 


 



7.
Yi-Brunozzi HY, Le Grice SF (2005). Investigating HIV-1 polypurine tract geometry via targeted insertion of abasic lesions in the (-)-DNA template and (+)-RNA primer. J Biol Chem  280, 20154-62.   https://doi.org/10.1074/jbc.M411228200




PubMed


 


PubMed ID 15778225",https://intramural.nih.gov/search/searchview.taf?ipid=37289
268,BC010493-03,"October 01, 2004 -  September 30, 2005",High-Resolution Protein and Nucleic Acid Footprinting,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Arkadiusz  Bibillo



Marion Karla Bona; PhD



Chandravanu  Dash



Bridget  Dixon



George J Klarmann



Victoria  Mcparland



Show all 10","Samson  Chow
(University of California at Los Angeles)




Daniele  Fabris
(University of Maryland Baltimore County)",NULL,NULL,"Ordered by publication type and then author name.



1.
Miller JT, Khvorova A, Scaringe SA, Le Grice SF (2004). Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res  32, 4687-95.   https://doi.org/10.1093/nar/gkh813




PubMed



        
     
Free Article


 


PubMed ID 15342789
         Pubmed Central ID 516074 


 



2.
Shkriabai N, Patil SS, Hess S, Budihas SR, Craigie R, Burke TR, Le Grice SF, Kvaratskhelia M (2004). Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. Proc Natl Acad Sci U S A  101, 6894-9.   https://doi.org/10.1073/pnas.0400873101




PubMed



        
     
Free Article


 


PubMed ID 15118107
         Pubmed Central ID 406438 


 



3.
Williams KL, Zhang Y, Shkriabai N, Karki RG, Nicklaus MC, Kotrikadze N, Hess S, Le Grice SF, Craigie R, Pathak VK, Kvaratskhelia M (2005). Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J Biol Chem  280, 7949-55.   https://doi.org/10.1074/jbc.M413579200




PubMed


 


PubMed ID 15615720",https://intramural.nih.gov/search/searchview.taf?ipid=37290
269,BC010494-03,"October 01, 2004 -  September 30, 2005",HIV-1 RNase H as a Therapeutic Target,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Arkadiusz  Bibillo



Marion Karla Bona; PhD



Chandravanu  Dash



Bridget  Dixon



George J Klarmann



Victoria  Mcparland



Show all 10","Matthias  Götte
(McGill University AIDS Centre)




Michael  Parniak; PhD
(Department of Medicine, McGill University)","John A Beutler (National Cancer Institute)



Robert Joseph Crouch; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",Peter W Schuck; PhD (OD),"Ordered by publication type and then author name.



1.
Budihas SR, Gorshkova I, Gaidamakov S, Wamiru A, Bona MK, Parniak MA, Crouch RJ, McMahon JB, Beutler JA, Le Grice SF (2005). Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Nucleic Acids Res  33, 1249-56.   https://doi.org/10.1093/nar/gki268




PubMed



        
     
Free Article


 


PubMed ID 15741178
         Pubmed Central ID 552956 


 



2.
Chan KC, Budihas SR, Le Grice SF, Parniak MA, Crouch RJ, Gaidamakov SA, Isaaq HJ, Wamiru A, McMahon JB, Beutler JA (2004). A capillary electrophoretic assay for ribonuclease H activity. Anal Biochem  331, 296-302.   https://doi.org/10.1016/j.ab.2004.05.017




PubMed


 


PubMed ID 15265735",https://intramural.nih.gov/search/searchview.taf?ipid=37287
270,BC010495-03,"October 01, 2004 -  September 30, 2005",Unnatural Amino Acids as Probes of RT Structure and Function,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Arkadiusz  Bibillo



Marion Karla Bona; PhD



Chandravanu  Dash



Bridget  Dixon



George J Klarmann



Victoria  Mcparland



Show all 10","Matthias  Götte
(McGill University AIDS Centre)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)","Deb  Chatterjee (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)",Jay Robert Knutson; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Klarmann GJ, Eisenhauer BM, Zhang Y, Sitaraman K, Chatterjee DK, Hecht SM, Le Grice SF (2004). Site- and subunit-specific incorporation of unnatural amino acids into HIV-1 reverse transcriptase. Protein Expr Purif  38, 37-44.   https://doi.org/10.1016/j.pep.2004.07.019




PubMed


 


PubMed ID 15477080
    
     


 



2.
Sitaraman K, Esposito D, Klarmann G, Le Grice SF, Hartley JL, Chatterjee DK (2004). A novel cell-free protein synthesis system. J Biotechnol  110, 257-63.   https://doi.org/10.1016/j.jbiotec.2004.02.014




PubMed


 


PubMed ID 15163516",https://intramural.nih.gov/search/searchview.taf?ipid=37288
271,BC010496-03,"October 01, 2004 -  September 30, 2005",Molecular genetics of the KIR gene complex,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Megan E Boon



Yalun  Liu



Maureen P Martin



Darlene M Marti



Amy E Poisson","Stephan  Beck
(Sanger Centre)




Judith  Kidd
(Yale University)




Kenneth  Kidd
(Yale University)




Richard  Single
(Medical Biostatistics, University of Vermont)




Judith  Torimiro
(Johns Hopkins School of Public Health)




John  Trowsdale
(University of Cambridge)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37260
272,BC010499-03,"October 01, 2004 -  September 30, 2005",Maryland Prostate Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe,NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37257
273,BC010500-03,"October 01, 2004 -  September 30, 2005",The Molecular Profile of Inflammatory Breast Cancer,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",Brenda Jean Boersma-Maland,NULL,Mark  Reimers (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37258
274,BC010504-03,"October 01, 2004 -  September 30, 2005",Genetic Recombination in Retroviruses,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Vitaly P Boyko



Jianbo  Chen



Mario  Chin



William W Fu



Kazushi  Motomura



Olga A Nikolaitchik",NULL,"Vinay K Pathak; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Rhodes TD, Hu WS (2005). Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells. J Virol  79, 9337-40.   https://doi.org/10.1128/JVI.79.14.9337-9340.2005




PubMed



        
     
Free Article


 


PubMed ID 15994830
         Pubmed Central ID 1168728 


 



2.
Chin MP, Rhodes TD, Chen J, Fu W, Hu WS (2005). Identification of a major restriction in HIV-1 intersubtype recombination. Proc Natl Acad Sci U S A  102, 9002-7.   https://doi.org/10.1073/pnas.0502522102




PubMed



        
     
Free Article


 


PubMed ID 15956186
         Pubmed Central ID 1157039 


 



3.
Rhodes TD, Nikolaitchik O, Chen J, Powell D, Hu WS (2005). Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J Virol  79, 1666-77.   https://doi.org/10.1128/JVI.79.3.1666-1677.2005




PubMed



        
     
Free Article


 


PubMed ID 15650192
         Pubmed Central ID 544095",https://intramural.nih.gov/search/searchview.taf?ipid=37273
275,BC010505-03,"October 01, 2004 -  September 30, 2005",Retroviral Double Infection and Its Relationship to Recombination,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Vitaly P Boyko



Jianbo  Chen



Mario  Chin



William W Fu



Kazushi  Motomura



Olga A Nikolaitchik","Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Derya  Unutmaz
(Vanderbilt University)","John Miller Coffin; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, Powell D, Hu WS (2005). Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol  79, 4140-9.   https://doi.org/10.1128/JVI.79.7.4140-4149.2005




PubMed



        
     
Free Article


 


PubMed ID 15767415
         Pubmed Central ID 1061529 


 



2.
Dang Q, Chen J, Unutmaz D, Coffin JM, Pathak VK, Powell D, KewalRamani VN, Maldarelli F, Hu WS (2004). Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A  101, 632-7.   https://doi.org/10.1073/pnas.0307636100




PubMed



        
     
Free Article


 


PubMed ID 14707263
         Pubmed Central ID 327199",https://intramural.nih.gov/search/searchview.taf?ipid=37274
276,BC010506-03,"October 01, 2004 -  September 30, 2005","Mechanisms of Virus Assembly, RNA Packaging, and Replication","Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Vitaly P Boyko



Jianbo  Chen



Mario  Chin



William W Fu



Kazushi  Motomura



Olga A Nikolaitchik",NULL,"Louis E. Henderson; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee SK, Nagashima K, Hu WS (2005). Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication. J Virol  79, 4159-69.   https://doi.org/10.1128/JVI.79.7.4159-4169.2005




PubMed



        
     
Free Article


 


PubMed ID 15767417
         Pubmed Central ID 1061564 


 



2.
Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK (2004). Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem  279, 35822-8.   https://doi.org/10.1074/jbc.M405761200




PubMed


 


PubMed ID 15210704",https://intramural.nih.gov/search/searchview.taf?ipid=37272
277,BC010510-03,"October 01, 2004 -  September 30, 2005",Trageted therapy of mesothelin expressing cancers using the anti-mesothelin immu,"Raffit  Hassan



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Karen  Bergeron



Linda  Ellison-Dejewski



Jingli  Zhang","Daniel  Brackett





Michael  Henry-Amar
(Comprehensive Cancer Center Francois Baclesse, France)




Alan T Remaley; MD, PhD
(CC)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hassan R, Bera T, Pastan I (2004). Mesothelin: a new target for immunotherapy. Clin Cancer Res  10, 3937-42.   https://doi.org/10.1158/1078-0432.CCR-03-0801




PubMed


 


PubMed ID 15217923
    
     


 



2.
Hassan R, Gupta M, Kern W, Ozer H (2004). Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. Leuk Lymphoma  45, 2149-52.   https://doi.org/10.1080/10428190410001714070




PubMed


 


PubMed ID 15370263
    
     


 



3.
Hassan R, Kreitman RJ, Pastan I, Willingham MC (2005). Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol  13, 243-7.   https://doi.org/10.1097/01.pai.00000141545.36485.d6




PubMed


 


PubMed ID 16082249
    
     


 



4.
Hassan R, Lerner M, Raffeld M, Postier R, Brackett D   (2005) Mesothelin is overexpressed din pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.  Am J Clin Path, in press.




 



5.
Hassan R, Williams-Gould J, Watson T, Pai-Scherf L, Pastan I (2004). Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1. Clin Cancer Res  10, 16-8.   https://doi.org/10.1158/1078-0432.ccr-1160-3




PubMed


 


PubMed ID 14734446
    
     


 



6.
Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I (2005). Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Clin Cancer Res  11, 3814-20.   https://doi.org/10.1158/1078-0432.CCR-04-2304




PubMed


 


PubMed ID 15897581
    
     


 



7.
Li Q, Verschraegen CF, Mendoza J, Hassan R (2004). Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas. Anticancer Res  24, 1327-35.




PubMed


 


PubMed ID 15274292
    
     


 



8.
Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA (2005). Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein. J Nucl Med  46, 1201-9.




PubMed


 


PubMed ID 16000290",https://intramural.nih.gov/search/searchview.taf?ipid=37270
278,BC010511-03,"October 01, 2004 -  September 30, 2005",Retrovirus Assembly and Maturation,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Rachael M Crist



Siddhartha  Datta; PhD



Demetria P Harvin



Shilpa  Kulkarni



Jane  Mirro



Samuel J Rulli



Show all 8","Susan  Krueger
(Center for Neutron Research)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Delphine  Muriaux
(National Institute of Standards and Technology, Unité de Virologie Humaine)




Martha  Simon; PhD
(Dept of Biology, Brookhaven National Laboratory)




Saraswati  Sukumar





Mark  Yeager



Show all 7",Sergey G Tarasov (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Baumann JG, Unutmaz D, Miller MD, Breun SK, Grill SM, Mirro J, Littman DR, Rein A, KewalRamani VN (2004). Murine T cells potently restrict human immunodeficiency virus infection. J Virol  78, 12537-47.   https://doi.org/10.1128/JVI.78.22.12537-12547.2004




PubMed



        
     
Free Article


 


PubMed ID 15507641
         Pubmed Central ID 525105 


 



2.
Mura M, Murcia P, Caporale M, Spencer TE, Nagashima K, Rein A, Palmarini M (2004). Late viral interference induced by transdominant Gag of an endogenous retrovirus. Proc Natl Acad Sci U S A  101, 11117-22.   https://doi.org/10.1073/pnas.0402877101




PubMed



        
     
Free Article


 


PubMed ID 15263098
         Pubmed Central ID 503749 


 



3.
Muriaux D, Costes S, Nagashima K, Mirro J, Cho E, Lockett S, Rein A (2004). Role of murine leukemia virus nucleocapsid protein in virus assembly. J Virol  78, 12378-85.   https://doi.org/10.1128/JVI.78.22.12378-12385.2004




PubMed



        
     
Free Article


 


PubMed ID 15507624
         Pubmed Central ID 525092 


 



4.
Oshima M, Muriaux D, Mirro J, Nagashima K, Dryden K, Yeager M, Rein A (2004). Effects of blocking individual maturation cleavages in murine leukemia virus gag. J Virol  78, 1411-20.   https://doi.org/10.1128/jvi.78.3.1411-1420.2004




PubMed



        
     
Free Article


 


PubMed ID 14722296
         Pubmed Central ID 321369 


 



5.
Yang QE, Stephen AG, Adelsberger JW, Roberts PE, Zhu W, Currens MJ, Feng Y, Crise BJ, Gorelick RJ, Rein AR, Fisher RJ, Shoemaker RH, Sei S (2005). Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4. J Virol  79, 6122-33.   https://doi.org/10.1128/JVI.79.10.6122-6133.2005




PubMed



        
     
Free Article


 


PubMed ID 15857997
         Pubmed Central ID 1091715",https://intramural.nih.gov/search/searchview.taf?ipid=37299
279,BC010512-03,"October 01, 2004 -  September 30, 2005",Interactions of Retroviral Proteins with Nucleic Acids,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Rachael M Crist



Siddhartha  Datta; PhD



Demetria P Harvin



Shilpa  Kulkarni



Jane  Mirro



Samuel J Rulli



Show all 8","Delphine  Muriaux
(National Institute of Standards and Technology, Unité de Virologie Humaine)




Karin  Musier-Forsyth
(University of Minnesota)




Thoru  Pederson





Shizuko  Sei
(Laboratory of Antiviral Drug Mechanisms, SAIC-Frederick)




Mark  Williams; PhD
(Department of Immunology, American Red Cross)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hibbert CS, Rein A (2005). Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus. J Virol  79, 8142-8.   https://doi.org/10.1128/JVI.79.13.8142-8148.2005




PubMed



        
     
Free Article


 


PubMed ID 15956559
         Pubmed Central ID 1143758 


 



2.
Muriaux D, Costes S, Nagashima K, Mirro J, Cho E, Lockett S, Rein A (2004). Role of murine leukemia virus nucleocapsid protein in virus assembly. J Virol  78, 12378-85.   https://doi.org/10.1128/JVI.78.22.12378-12385.2004




PubMed



        
     
Free Article


 


PubMed ID 15507624
         Pubmed Central ID 525092 


 



3.
Oshima M, Muriaux D, Mirro J, Nagashima K, Dryden K, Yeager M, Rein A (2004). Effects of blocking individual maturation cleavages in murine leukemia virus gag. J Virol  78, 1411-20.   https://doi.org/10.1128/jvi.78.3.1411-1420.2004




PubMed



        
     
Free Article


 


PubMed ID 14722296
         Pubmed Central ID 321369 


 



4.
Rein A   (2004) Take two.  Nat Struct Mol Biol 11:1034-5.




PubMed


 


PubMed ID 15523477",https://intramural.nih.gov/search/searchview.taf?ipid=37300
280,BC010516-03,"October 01, 2004 -  September 30, 2005",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,James B Mitchell; PhD,"Radiation Oncology Branch, NCI","Barbara Chin Arora



Frank S Harrington



George  Li



Holly  Ning



Hu-Chen  Xie","Paul  Falkenstien
(Optical Sciences Division, Naval Research Lab (NRL))




Alan  Huston
(Optical Sciences Division, Naval Research Lab (NRL))




Brian  Justus
(Optical Sciences Division, Naval Research Lab (NRL))",Norman Norman Coleman; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Miller R, Falkenstein P, Huston A, Plazas M, Ning H   (2005) Elimination of Cerenkov Interference in a Fiber-Optic-Coupled Radiation Dosimeter.  Radiation Protection Dosimetry, in press.




 



2.
Miller R, Falkentsein P, Huston A, Plazas M, Ning H   (2004) Gated Fibe-Coupled Detector for In-Vivo Real-Time Radiation Dosimetry.  Applied Optics  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37308
281,BC010517-03,"October 01, 2004 -  September 30, 2005",Large Databases of Small Molecules - Drug Development Tool and Public Resource,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Megan L Peach



Markus  Sitzmann","Wolf-Dietrich  Ihlenfeldt
(Xemistry)




Vladimir  Poroikov
(Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37311
282,BC010518-03,"October 01, 2004 -  September 30, 2005",Role of BMP and FGF signaling during limb development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Cindy  Elder



Catherine P Wilson","Yuji  Mishina; PhD
(University of Michigan)




Xin  Sun
(Genetics, University of Wisconsin)",NULL,NULL,"Ordered by publication type and then author name.



1.
Verheyden JM, Lewandoski M, Deng C, Harfe BD, Sun X (2005). Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning. Development  132, 4235-45.   https://doi.org/10.1242/dev.02001




PubMed


 


PubMed ID 16120640",https://intramural.nih.gov/search/searchview.taf?ipid=37317
283,BC010519-03,"October 01, 2004 -  September 30, 2005",Development of Novel Therapeutic Strategies for Thoracic Malignancies by Targeti,"Dao M Nguyen; MD, MS",NULL,"Surgery Branch, NCI","Annette M Alleva



Susan Maryam Shamimi-Noori



Wen-Shuz  Yeow



Jingtong  Zuo","Avi  Ashkenazi
(Genentech, Inc.)




Bing Liang  Fang
(Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center)




Jean-Pierre  Rosat
(Apoxis, SA)




John  Stewart, IV
(Wake Forest University)




Jurg  Tschopp
(Apoxis, SA)","Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cole GW, Alleva AM, Reddy RM, Maxhimer JB, Zuo J, Schrump DS, Nguyen DM (2005). The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro. J Thorac Cardiovasc Surg  129, 1010-7.   https://doi.org/10.1016/j.jtcvs.2004.10.040




PubMed


 


PubMed ID 15867774
    
     


 



2.
Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS (2005). Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res  65, 7763-74.   https://doi.org/10.1158/0008-5472.CAN-05-0823




PubMed


 


PubMed ID 16140944
    
     


 



3.
Maxhimer JB, Reddy RM, Zuo J, Cole GW, Schrump DS, Nguyen DM (2005). Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). J Thorac Cardiovasc Surg  129, 53-63.   https://doi.org/10.1016/j.jtcvs.2004.07.051




PubMed


 


PubMed ID 15632825
    
     


 



4.
Steiner FA, Hong JA, Fischette MR, Beer DG, Guo ZS, Chen GA, Weiser TS, Kassis ES, Nguyen DM, Lee S, Trepel JB, Schrump DS (2005). Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells. Oncogene  24, 2386-97.   https://doi.org/10.1038/sj.onc.1208376




PubMed


 


PubMed ID 15735751",https://intramural.nih.gov/search/searchview.taf?ipid=37309
284,BC010520-03,"October 01, 2004 -  September 30, 2005","Characterization of PBIP1, a novel polo-box-interacting protein at the kinetocho","Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,Toru  Miki; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37292
285,BC010521-03,"October 01, 2004 -  September 30, 2005",Regulation of G2M transition in budding yeast,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Asano S, Park JE, Sakchaisri K, Yu LR, Song S, Supavilai P, Veenstra TD, Lee KS (2005). Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeast. EMBO J  24, 2194-204.   https://doi.org/10.1038/sj.emboj.7600683




PubMed



        
     
Free Article


 


PubMed ID 15920482
         Pubmed Central ID 1150880 


 



2.
Lee K, J-E P, Sakchaisri K, Erikson R   (2005) Monitoring the cell cycle by multi-kinase-dependent regulation of Swe1/Wee1 in budding yeast.  Cell Cycle, in press.




 



3.
Sakchaisri K, Asano S, Yu LR, Shulewitz MJ, Park CJ, Park JE, Cho YW, Veenstra TD, Thorner J, Lee KS (2004). Coupling morphogenesis to mitotic entry. Proc Natl Acad Sci U S A  101, 4124-9.   https://doi.org/10.1073/pnas.0400641101




PubMed



        
     
Free Article


 


PubMed ID 15037762
         Pubmed Central ID 384705",https://intramural.nih.gov/search/searchview.taf?ipid=37293
286,BC010523-02,"October 01, 2004 -  September 30, 2005",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,"Shivinder Singh Grewal



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Hugh P Cam



Ee Sin  Chen



Xi  Chen; MD



Songtao  Jia



Estelle  Nicolas



Rie  Sugiyama



Show all 10","David  Allis
(University of Virginia)




Amikam  Cohen
(Hebrew University)




Danesh  Moazed
(Harvard Medical School)




Brian  Strahl
(University of North Carolina)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cam HP, Sugiyama T, Chen ES, Chen X, FitzGerald PC, Grewal SI (2005). Comprehensive analysis of heterochromatin- and RNAi-mediated epigenetic control of the fission yeast genome. Nat Genet  37, 809-19.   https://doi.org/10.1038/ng1602




PubMed


 


PubMed ID 15976807
    
     


 



2.
Grewal SI, Rice JC (2004). Regulation of heterochromatin by histone methylation and small RNAs. Curr Opin Cell Biol  16, 230-8.   https://doi.org/10.1016/j.ceb.2004.04.002




PubMed


 


PubMed ID 15145346
    
     


 



3.
Jia S, Noma K, Grewal SI (2004). RNAi-independent heterochromatin nucleation by the stress-activated ATF/CREB family proteins. Science  304, 1971-6.   https://doi.org/10.1126/science.1099035




PubMed


 


PubMed ID 15218150
    
     


 



4.
Jia S, Yamada T, Grewal SI (2004). Heterochromatin regulates cell type-specific long-range chromatin interactions essential for directed recombination. Cell  119, 469-80.   https://doi.org/10.1016/j.cell.2004.10.020




PubMed


 


PubMed ID 15537537
    
     


 



5.
Lee BS, Grewal SI, Klar AJ (2004). Biochemical interactions between proteins and mat1 cis-acting sequences required for imprinting in fission yeast. Mol Cell Biol  24, 9813-22.   https://doi.org/10.1128/MCB.24.22.9813-9822.2004




PubMed



        
     
Free Article


 


PubMed ID 15509785
         Pubmed Central ID 525487 


 



6.
Noma K, Sugiyama T, Cam H, Verdel A, Zofall M, Jia S, Moazed D, Grewal SI (2004). RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing. Nat Genet  36, 1174-80.   https://doi.org/10.1038/ng1452




PubMed


 


PubMed ID 15475954
    
     


 



7.
Sugiyama T, Cam H, Verdel A, Moazed D, Grewal SI (2005). RNA-dependent RNA polymerase is an essential component of a self-enforcing loop coupling heterochromatin assembly to siRNA production. Proc Natl Acad Sci U S A  102, 152-7.   https://doi.org/10.1073/pnas.0407641102




PubMed



        
     
Free Article


 


PubMed ID 15615848
         Pubmed Central ID 544066 


 



8.
Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, Grewal SI, Moazed D (2004). RNAi-mediated targeting of heterochromatin by the RITS complex. Science  303, 672-6.   https://doi.org/10.1126/science.1093686




PubMed



        
     
Free Article


 


PubMed ID 14704433
         Pubmed Central ID 3244756",https://intramural.nih.gov/search/searchview.taf?ipid=36965
287,BC010524-03,"October 01, 2004 -  September 30, 2005",HIV Integrase Modeling and Computer-Aided Inhibitor Development,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,NULL,"Yves  Pommier; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37310
288,BC010525-03,"October 01, 2004 -  September 30, 2005",Immune Reconstitution,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Catherine Virginia Bare



Yu-Waye (Wayne)  Chu



Francis  Flomerfelt; PhD



James N Kochenderfer



Philip J Lucas; PhD



Sarfraz A Memon","Greg  Hadley
(University of Maryland)




Mark  Hellerstein
(Nutrition, UCSF)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R (2004). Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol  22, 3886-92.   https://doi.org/10.1200/JCO.2004.01.127




PubMed


 


PubMed ID 15314059
    
     


 



2.
Chu YW, Memon SA, Sharrow SO, Hakim FT, Eckhaus M, Lucas PJ, Gress RE (2004). Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood  104, 1110-9.   https://doi.org/10.1182/blood-2003-10-3635




PubMed


 


PubMed ID 15130942
    
     


 



3.
El Kassar N, Lucas PJ, Klug DB, Zamisch M, Merchant M, Bare CV, Choudhury B, Sharrow SO, Richie E, Mackall CL, Gress RE (2004). A dose effect of IL-7 on thymocyte development. Blood  104, 1419-27.   https://doi.org/10.1182/blood-2004-01-0201




PubMed


 


PubMed ID 15155461
    
     


 



4.
Fellowes VS, Husebekk A, Gress RE, Vance BA (2004). Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR. Int J Oncol  24, 861-7.




PubMed


 


PubMed ID 15010823
    
     


 



5.
Fowler DH, Foley J, Whit-Shan Hou J, Odom J, Castro K, Steinberg SM, Gea-Banacloche J, Kasten-Sportes C, Gress RE, Bishop MR (2004). Clinical ""cytokine storm"" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin Gastroenterol Hepatol  2, 237-45.   https://doi.org/10.1016/s1542-3565(04)00011-4




PubMed


 


PubMed ID 15017608
    
     


 



6.
Fry TJ, Sinha M, Milliron M, Chu YW, Kapoor V, Gress RE, Thomas E, Mackall CL (2004). Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood  104, 2794-800.   https://doi.org/10.1182/blood-2003-11-3789




PubMed


 


PubMed ID 15226184
    
     


 



7.
Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE (2004). Aging, immunity and cancer. Curr Opin Immunol  16, 151-6.   https://doi.org/10.1016/j.coi.2004.01.009




PubMed


 


PubMed ID 15023406
    
     


 



8.
Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T, Gress RE (2004). Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res  64, 6524-9.   https://doi.org/10.1158/0008-5472.CAN-04-0896




PubMed


 


PubMed ID 15374963
    
     


 



9.
Saif MW, Leitman SF, Cusack G, Horne M, Freifeld A, Venzon D, PremKumar A, Cowan KH, Gress RE, Zujewski J, Kasten-Sportes C (2004). Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer. Ann Oncol  15, 1366-72.   https://doi.org/10.1093/annonc/mdh347




PubMed


 


PubMed ID 15319243
    
     


 



10.
Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL, June CH, Serody JS, Blazar BR (2004). L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood  104, 3804-12.   https://doi.org/10.1182/blood-2004-05-1850




PubMed


 


PubMed ID 15292057
    
     


 



11.
Wang D, Yuan R, Feng Y, El-Asady R, Farber DL, Gress RE, Lucas PJ, Hadley GA (2004). Regulation of CD103 expression by CD8+ T cells responding to renal allografts. J Immunol  172, 214-21.   https://doi.org/10.4049/jimmunol.172.1.214




PubMed


 


PubMed ID 14688328",https://intramural.nih.gov/search/searchview.taf?ipid=37267
289,BC010526-03,"October 01, 2004 -  September 30, 2005",Investigation of the Nature of Persistent Viremia (50 copiesml) in Patients on C,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"Dale  Kempf





David M Margolis





John W Mellors





Scott  Wegner
(Henry M. Jackson Foundation)","Shyam  Kottilil (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)",H. Clifford  Lane; MD (NIAID),"Ordered by publication type and then author name.



1.
Dybul M, Nies-Kraske E, Dewar R, Maldarelli F, Hallahan CW, Daucher M, Piscitelli SC, Ehler L, Weigand A, Palmer S, Metcalf JA, Davey RT, Rock Kress DM, Powers A, Beck I, Frenkel L, Baseler M, Coffin J, Fauci AS (2004). A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. J Infect Dis  189, 1974-82.   https://doi.org/10.1086/386344




PubMed


 


PubMed ID 15143462
    
     


 



2.
Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM (2005). Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet  366, 549-55.   https://doi.org/10.1016/S0140-6736(05)67098-5




PubMed



        
     
Free Article


 


PubMed ID 16099290
         Pubmed Central ID 1894952",https://intramural.nih.gov/search/searchview.taf?ipid=37262
290,BC010527-03,"October 01, 2004 -  September 30, 2005",Characterization of the Genetic Diversity of HIV-1 in Infected Individuals Proto,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"Joseph  Margolick
(School of Public Health, Johns Hopkins University)




James  McIntyre
(Chris Hani Baragwanath Hospital and University of the Witwatersrand)




John W Mellors





Lynn  Morris
(National Institute for Communicable Diseases)




Scott  Wegner
(Henry M. Jackson Foundation)","Wei-Shau  Hu; PhD (National Cancer Institute)



Shyam  Kottilil (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)",H. Clifford  Lane; MD (NIAID),"Ordered by publication type and then author name.



1.
Achaz G, Palmer S, Kearney M, Maldarelli F, Mellors JW, Coffin JM, Wakeley J (2004). A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol  21, 1902-12.   https://doi.org/10.1093/molbev/msh196




PubMed


 


PubMed ID 15215321
    
     


 



2.
Dang Q, Chen J, Unutmaz D, Coffin JM, Pathak VK, Powell D, KewalRamani VN, Maldarelli F, Hu WS (2004). Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A  101, 632-7.   https://doi.org/10.1073/pnas.0307636100




PubMed



        
     
Free Article


 


PubMed ID 14707263
         Pubmed Central ID 327199 


 



3.
Nikolenko GN, Palmer S, Maldarelli F, Mellors JW, Coffin JM, Pathak VK (2005). Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Natl Acad Sci U S A  102, 2093-8.   https://doi.org/10.1073/pnas.0409823102




PubMed



        
     
Free Article


 


PubMed ID 15684061
         Pubmed Central ID 548555 


 



4.
Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM (2005). Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol  43, 406-13.   https://doi.org/10.1128/JCM.43.1.406-413.2005




PubMed



        
     
Free Article


 


PubMed ID 15635002
         Pubmed Central ID 540111 


 



5.
Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR (2004). Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol  11, 435-42.   https://doi.org/10.1038/nsmb758




PubMed


 


PubMed ID 15098018",https://intramural.nih.gov/search/searchview.taf?ipid=37263
291,BC010528-03,"October 01, 2004 -  September 30, 2005",In Vivo Assessment of Residual Drug Activity in Patients with Genotypic and Phen,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,NULL,"Shyam  Kottilil (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)",H. Clifford  Lane; MD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37261
292,BC010529-03,"October 01, 2004 -  September 30, 2005",Regulated proteolysis in developmental signaling,Mark E Fortini,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Nikolaos  Tountas



Casper  Groth



Ritu  Kanwar



Goran  Periz



Glen  Seidner","Thomas  Jongens
(Genetics, University of Pennsylvania)




Gunter  Merdes
(Molecular Biology, University of Heidelberg)




Yalin  Wang
(Cold Spring Harbor Laboratories)",NULL,NULL,"Ordered by publication type and then author name.



1.
Fortini ME (2004). PAR-1 for the course of neurodegeneration. Cell  116, 631-2.   https://doi.org/10.1016/s0092-8674(04)00207-7




PubMed


 


PubMed ID 15006343
    
     


 



2.
Kanwar R, Fortini ME (2004). Notch signaling: a different sort makes the cut. Curr Biol  14, R1043-5.   https://doi.org/10.1016/j.cub.2004.11.041




PubMed


 


PubMed ID 15620635
    
     


 



3.
Periz G, Fortini ME (2004). Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2. J Neurosci Res  77, 309-22.   https://doi.org/10.1002/jnr.20203




PubMed


 


PubMed ID 15248287",https://intramural.nih.gov/search/searchview.taf?ipid=37265
293,BC010530-03,"October 01, 2004 -  September 30, 2005",Molecular Therapeutics for HIVAIDS,"Dean H. Hamer; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI",Tao  Wang,"Mario  Roederer; PhD





Michael  Root
(Center for Human Virology, Thomas Jefferson Medical School)




Jerome  Zack
(Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, UCLA)","Peter  Blumberg; PhD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)","Edward Alan Berger; PhD (NIAID) 



Daniel C Douek; MD (NIAID) 



Srinivas S Rao (NIAID)","Ordered by publication type and then author name.



1.
Hamer DH (2004). Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it. Curr HIV Res  2, 99-111.   https://doi.org/10.2174/1570162043484915




PubMed


 


PubMed ID 15078175
    
     


 



2.
Kulkosky J, Sullivan J, Xu Y, Souder E, Hamer DH, Pomerantz RJ (2004). Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents. AIDS Res Hum Retroviruses  20, 497-505.   https://doi.org/10.1089/088922204323087741




PubMed


 


PubMed ID 15186524
    
     


 



3.
Lueders KK, De Rosa SC, Valentin A, Pavlakis GN, Roederer M, Hamer DH (2004). A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types. AIDS Res Hum Retroviruses  20, 145-50.   https://doi.org/10.1089/088922204773004851




PubMed


 


PubMed ID 15018701
    
     


 



4.
Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, Fekete RA, Kar S, Adhya S, Hamer DH (2005). Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci U S A  102, 11993-8.   https://doi.org/10.1073/pnas.0504881102




PubMed



        
     
Free Article


 


PubMed ID 16040799
         Pubmed Central ID 1189328",https://intramural.nih.gov/search/searchview.taf?ipid=37269
294,BC010532-03,"October 01, 2004 -  September 30, 2005","Mechanisms of Reverse Transcriptase Template Switching, Role of RNase H in Antiv","Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Rebekah A Thorick



Yeshitila  Friew



Patricia A Henry; PhD



Jean L Mbisa



Galina  Nikolenko



Hongzhan  Xu



Show all 8","Jeffery  Anderson
(University of North Carolina, Chapel Hill)




John W Mellors





Deborah  Persaud
(Johns Hopkins University)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Ronald I Swanstrom





Derya  Unutmaz
(Vanderbilt University)","Wei-Shau  Hu; PhD (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, Powell D, Hu WS (2005). Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol  79, 4140-9.   https://doi.org/10.1128/JVI.79.7.4140-4149.2005




PubMed



        
     
Free Article


 


PubMed ID 15767415
         Pubmed Central ID 1061529 


 



2.
Dang Q, Chen J, Unutmaz D, Coffin JM, Pathak VK, Powell D, KewalRamani VN, Maldarelli F, Hu WS (2004). Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A  101, 632-7.   https://doi.org/10.1073/pnas.0307636100




PubMed



        
     
Free Article


 


PubMed ID 14707263
         Pubmed Central ID 327199 


 



3.
Nikolenko GN, Palmer S, Maldarelli F, Mellors JW, Coffin JM, Pathak VK (2005). Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Natl Acad Sci U S A  102, 2093-8.   https://doi.org/10.1073/pnas.0409823102




PubMed



        
     
Free Article


 


PubMed ID 15684061
         Pubmed Central ID 548555 


 



4.
Pathak V, Svarovskaia E, Delviks K   (2004) Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template switching frequency.  J Virol  pp.




 



5.
Voronin YA, Pathak VK (2004). Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes. J Virol  78, 5402-13.   https://doi.org/10.1128/jvi.78.10.5402-5413.2004




PubMed



        
     
Free Article


 


PubMed ID 15113919
         Pubmed Central ID 400373",https://intramural.nih.gov/search/searchview.taf?ipid=37314
295,BC010533-03,"October 01, 2004 -  September 30, 2005",Identification of Structural Determinants of Reverse Transcriptase That Influenc,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Rebekah A Thorick



Yeshitila  Friew



Patricia A Henry; PhD



Jean L Mbisa



Galina  Nikolenko



Hongzhan  Xu



Show all 8",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37315
296,BC010534-03,"October 01, 2004 -  September 30, 2005",Development of Antiviral Drugs That Target HIV-1 Integrase and Characterization,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Rebekah A Thorick



Yeshitila  Friew



Patricia A Henry; PhD



Jean L Mbisa



Galina  Nikolenko



Hongzhan  Xu



Show all 7","Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Vladimir  Poroikov
(Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)","Terrence R Burke; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Svarovskaia ES, Barr R, Zhang X, Pais GC, Marchand C, Pommier Y, Burke TR, Pathak VK (2004). Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol  78, 3210-22.   https://doi.org/10.1128/jvi.78.7.3210-3222.2004




PubMed



        
     
Free Article


 


PubMed ID 15016842
         Pubmed Central ID 371038 


 



2.
Williams KL, Zhang Y, Shkriabai N, Karki RG, Nicklaus MC, Kotrikadze N, Hess S, Le Grice SF, Craigie R, Pathak VK, Kvaratskhelia M (2005). Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J Biol Chem  280, 7949-55.   https://doi.org/10.1074/jbc.M413579200




PubMed


 


PubMed ID 15615720",https://intramural.nih.gov/search/searchview.taf?ipid=37316
297,BC010537-03,"October 01, 2004 -  September 30, 2005",Molecular and Genetic Characterization of Mammalian MHC,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Thomas  Beck



Lisa  Maslan



Naoya  Yuhki; MD



Emily L Howe



Katherine M Kelley



Nicholas  Pinkin



Show all 8","Kersten  Lindblad-Toh
(Michigan, Broad Institute)




William J. Murphy
(NCI-FCRDC, NCI)




Claire  Waa
(Michigan, Broad Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, Kim J, Johnson W, van J, Martenson J, Yuhki N, Miquelle D, Uphyrkina O, Goodrich J, Quigley H, Tilson R, Brady G, Martelli P, Subramaniam V, McDougal C, Hean S, Huang S, Pan W, Karanth U, Sunquist M, Smith J   (2004) Phylogeography and genetic ancestry of tigers (Panthera tigris).  PLoS Biology  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=37312
298,BC010538-03,"October 01, 2004 -  September 30, 2005",Molecular Analysis of Breast Cancer Metastasis to the Brain,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Julie L Mason



Diane  Palmieri",NULL,"Sean Richard Davis; MD, PhD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Steeg P, Palmieri D, Bronder J, Stark A   (2005) Breast cancer metastasis to the central nervous system.  Am. J. Pathol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37305
299,BC010539-03,"October 01, 2004 -  September 30, 2005",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Krishan  Kumar,"Karl  Broman
(University of Michigan)




C. Dahlem  Smith
(SAIC-Frederick)




Shirley  Tsang
(LMT, SAIC-Frederick)",NULL,NULL,"Ordered by publication type and then author name.



1.
Reilly KM (2004). The importance of genome architecture in cancer susceptibility: location, location, location. Cell Cycle  3, 1378-82.   https://doi.org/10.4161/cc.3.11.1253




PubMed


 


PubMed ID 15492507
    
     


 



2.
Reilly KM, Broman KW, Bronson RT, Tsang S, Loisel DA, Christy ES, Sun Z, Diehl J, Munroe DJ, Tuskan RG (2006). An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model. Cancer Res  66, 62-8.   https://doi.org/10.1158/0008-5472.CAN-05-1480




PubMed



        
     
Free Article


 


PubMed ID 16397217
         Pubmed Central ID 1401492 


 



3.
Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T (2004). Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci U S A  101, 13008-13.   https://doi.org/10.1073/pnas.0401236101




PubMed



        
     
Free Article


 


PubMed ID 15319471
         Pubmed Central ID 516509",https://intramural.nih.gov/search/searchview.taf?ipid=37297
300,BC010540-03,"October 01, 2004 -  September 30, 2005",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Demirkan B Gursel



Krishan  Kumar","Stephen  Lockett
(SAIC-Frederick)




Nancy  Ratner
(Division of Experimental Hematology, Children's Hospital Medical Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37298
301,BC010541-03,"October 01, 2004 -  September 30, 2005",Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental T,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Demirkan B Gursel,"Carlos  Garcia
(Cytorex Biosciences, Inc.)




Eric  Holland
(CCR, Memorial Sloan Kettering)",Melinda  Hollingshead (National Cancer Institute),"Herman D Morris (NINDS) 



Jeeva P Munasinghe (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37296
302,BC010542-03,"October 01, 2004 -  September 30, 2005",Biology of Keratinocyte and Cancer Stem Cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Manabu  Ohyama



Girish  Patel



Atsushi  Terunuma



Lexa Rae Turner



Carole L Yee",NULL,"John N Brady; PhD (National Cancer Institute)



Christoph  Rader; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blonder J, Conrads TP, Yu LR, Terunuma A, Janini GM, Issaq HJ, Vogel JC, Veenstra TD (2004). A detergent- and cyanogen bromide-free method for integral membrane proteomics: application to Halobacterium purple membranes and the human epidermal membrane proteome. Proteomics  4, 31-45.   https://doi.org/10.1002/pmic.200300543




PubMed


 


PubMed ID 14730670
    
     


 



2.
Blonder J, Terunuma A, Conrads TP, Chan KC, Yee C, Lucas DA, Schaefer CF, Yu LR, Issaq HJ, Veenstra TD, Vogel JC (2004). A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry. J Invest Dermatol  123, 691-9.   https://doi.org/10.1111/j.0022-202X.2004.23421.x




PubMed


 


PubMed ID 15373774
    
     


 



3.
Terunuma A, Shaya MB, Udey MC, Vogel JC (2004). An in vivo competitive repopulation assay system to evaluate human keratinocyte stem cells. J Invest Dermatol  123, 993-5.   https://doi.org/10.1111/j.0022-202X.2004.23456.x




PubMed


 


PubMed ID 15482490",https://intramural.nih.gov/search/searchview.taf?ipid=37294
303,BC010543-02,"October 01, 2004 -  September 30, 2005",HSP90 as a Molecular Target for Ionizing Radiation,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lei  Huang



Anita Marie Mahone



Lunching  Sun",NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lagunas L, Bradbury CM, Laszlo A, Hunt CR, Gius D (2004). Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun  313, 863-70.   https://doi.org/10.1016/j.bbrc.2003.12.018




PubMed


 


PubMed ID 14706622
    
     


 



2.
Li G, Xie H, Ning H, Capala J, Arora BC, Coleman CN, Camphausen K, Miller RW   (2005) A novel 3D volumetric voxel registration technique for volume-view-guided image registration of multiple imaging modalities.  Int J Radiat Oncol Biol Phys, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36962
304,BC010544-02,"October 01, 2004 -  September 30, 2005",Epigenetic regulation of of Gene Expression and multi-modality resistance in tum,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lei  Huang



Anita Marie Mahone



Lunching  Sun",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gius D, Cui H, Bradbury CM, Cook J, Smart DK, Zhao S, Young L, Brandenburg SA, Hu Y, Bisht KS, Ho AS, Mattson D, Sun L, Munson PJ, Chuang EY, Mitchell JB, Feinberg AP (2004). Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell  6, 361-71.   https://doi.org/10.1016/j.ccr.2004.08.029




PubMed


 


PubMed ID 15488759
    
     


 



2.
Lagunas L, Bradbury CM, Laszlo A, Hunt CR, Gius D (2004). Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun  313, 863-70.   https://doi.org/10.1016/j.bbrc.2003.12.018




PubMed


 


PubMed ID 14706622
    
     


 



3.
Wang T, Hu YC, Dong S, Fan M, Tamae D, Ozeki M, Gao Q, Gius D, Li JJ (2005). Co-activation of ERK, NF-kappaB, and GADD45beta in response to ionizing radiation. J Biol Chem  280, 12593-601.   https://doi.org/10.1074/jbc.M410982200




PubMed



        
     
Free Article


 


PubMed ID 15642734
         Pubmed Central ID 4130153",https://intramural.nih.gov/search/searchview.taf?ipid=36963
305,BC010545-02,"October 01, 2004 -  September 30, 2005",Sulfhydryl switches and free-radical scavenger involvement in tumor cell oxidati,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lei  Huang



Anita Marie Mahone



Lunching  Sun",NULL,James B Mitchell; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB (2004). Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol  14, 259-66.   https://doi.org/10.1016/j.semradonc.2004.04.001




PubMed


 


PubMed ID 15254869
    
     


 



2.
Nguyen P, Awwad RT, Smart DD, Spitz DR, Gius D (2006). Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Lett  236, 164-74.   https://doi.org/10.1016/j.canlet.2005.04.028




PubMed


 


PubMed ID 15955621
    
     


 



3.
Smart DK, Ortiz KL, Mattson D, Bradbury CM, Bisht KS, Sieck LK, Brechbiel MW, Gius D (2004). Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res  64, 6716-24.   https://doi.org/10.1158/0008-5472.CAN-03-3990




PubMed


 


PubMed ID 15374989
    
     


 



4.
Spitz DR, Azzam EI, Li JJ, Gius D (2004). Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev  23, 311-22.   https://doi.org/10.1023/B:CANC.0000031769.14728.bc




PubMed


 


PubMed ID 15197331",https://intramural.nih.gov/search/searchview.taf?ipid=36964
306,BC010547-03,"October 01, 2004 -  September 30, 2005",Development of Drugs That Target Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Haiqing  Li



Matthew G Permenter



Douglas K Price



Nicola F Smith",NULL,Bill  Dahut (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37264
307,BC010549-02,"October 01, 2004 -  September 30, 2005",Zebrafish models of human leukemia and sarcoma,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Mizuki  Azuma



Lisa J Embree



Hatem E Sabaawy",NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI) 



Brant M Weinstein; PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36966
308,BC010550-02,"October 01, 2004 -  September 30, 2005",Isolation and Characterisation of Transcription Factories from E. coli and the y,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Vitaly  Chasov,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36967
309,BC010555-03,"October 01, 2004 -  September 30, 2005",Generation of T-cell responses by dendritic cell presentation of tumor cells,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,Nicholas Phillip Restifo; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Yang J, Hanada K, Perry-Lalley D, Bettinotti M, Karpova T   (2005) Generating renal cancer-reactive T-cells using dendritic cells (DCs) to present autologous tumor.  J of Immunother, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37295
310,BC010556-03,"October 01, 2004 -  September 30, 2005",Of Mice and Men: Using Mutations to Characterize Disease Processes,Nancy  Jenkins-Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Adam J Dupuy



Michael B Mann



Lydia  Matesic



Rivka A Rachel; MD, PhD","David  Largaespada
(Univ. Minnesota Cancer Center)




Eirkur  Steingrimsson
(Dept. Lab. Medicine & Pathology, University of Iceland)","Heinz  Arnheiter; MD (National Cancer Institute)



Allan M Weissman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA (2005). Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature  436, 221-6.   https://doi.org/10.1038/nature03691




PubMed


 


PubMed ID 16015321
    
     


 



2.
Goti D, Katzen SM, Mez J, Kurtis N, Kiluk J, Ben-Haïem L, Jenkins NA, Copeland NG, Kakizuka A, Sharp AH, Ross CA, Mouton PR, Colomer V (2004). A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci  24, 10266-79.   https://doi.org/10.1523/JNEUROSCI.2734-04.2004




PubMed


 


PubMed ID 15537899
    
     


 



3.
Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR   (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.  Hum Mol Genet 13:159-70.




PubMed


 


PubMed ID 14645205
    
     


 



4.
Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR   (2004) APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.  Neurobiol Aging 25:885-92.




PubMed


 


PubMed ID 15212842
    
     


 



5.
Jenkins-Copeland N, Slunt H, Gonzales V, Wen J, Copeland N, Younkin L, Younkin S, Borchelt D   (2005) Persistent amyoloidosis following suppression of AB production in a transgenic model of Alzheimer's disease.  PLoS Med, in press.




 



6.
Keng VW, Yae K, Hayakawa T, Mizuno S, Uno Y, Yusa K, Kokubu C, Kinoshita T, Akagi K, Jenkins NA, Copeland NG, Horie K, Takeda J   (2005) Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system.  Nat Methods 2:763-9.




PubMed


 


PubMed ID 16179923
    
     


 



7.
Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM, Poirier M, Gale A, Chan N, Gonzales V, Slunt HH, Coonfield ML, Jenkins NA, Copeland NG, Ross CA, Borchelt DR   (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntingtons disease-like phenotypes in transgenic mice.  Hum Mol Genet 13:1599-610.




PubMed


 


PubMed ID 15190011
    
     


 



8.
Steingrímsson E, Copeland NG, Jenkins NA (2004). Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet  38, 365-411.   https://doi.org/10.1146/annurev.genet.38.072902.092717




PubMed


 


PubMed ID 15568981
    
     


 



9.
Steingrímsson E, Copeland NG, Jenkins NA (2005). Melanocyte stem cell maintenance and hair graying. Cell  121, 9-12.   https://doi.org/10.1016/j.cell.2005.03.021




PubMed


 


PubMed ID 15820674
    
     


 



10.
Tanaka Y, Igarashi S, Nakamura M, Gafni J, Torcassi C, Schilling G, Crippen D, Wood JD, Sawa A, Jenkins NA, Copeland NG, Borchelt DR, Ross CA, Ellerby LM   (2006) Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.  Neurobiol Dis 21:381-91.




PubMed


 


PubMed ID 16150600
    
     


 



11.
Wang J, Xu G, Li H, Gonzales V, Fromholt D, Karch C, Copeland NG, Jenkins NA, Borchelt DR   (2005) Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation.  Hum Mol Genet 14:2335-47.




PubMed


 


PubMed ID 16000321
    
     


 



12.
Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR   (2005) Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.  Neurobiol Dis 20:943-52.




PubMed


 


PubMed ID 16046140",https://intramural.nih.gov/search/searchview.taf?ipid=37280
311,BC010558-02,"October 01, 2004 -  September 30, 2005",The Maintenance of Plasmids in Pathogenic Organisms,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Alena V Dabrazhynetskaya



Brenda L Youngren",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Dabrazhynetskaya A, Sergueev K, Austin S (2005). Species and incompatibility determination within the P1par family of plasmid partition elements. J Bacteriol  187, 5977-83.   https://doi.org/10.1128/JB.187.17.5977-5983.2005




PubMed



        
     
Free Article


 


PubMed ID 16109939
         Pubmed Central ID 1196149 


 



2.
Sergueev K, Dabrazhynetskaya A, Austin S (2005). Plasmid partition system of the P1par family from the pWR100 virulence plasmid of Shigella flexneri. J Bacteriol  187, 3369-73.   https://doi.org/10.1128/JB.187.10.3369-3373.2005




PubMed



        
     
Free Article


 


PubMed ID 15866921
         Pubmed Central ID 1112009",https://intramural.nih.gov/search/searchview.taf?ipid=41933
312,BC010559-02,"October 01, 2004 -  September 30, 2005",Identification of Non-BRCA12 Susceptibility Genes in Special Populations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",Marbin A Pineda,NULL,"Jo Anne N Zujewski (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)



Samir N. Khleif; MD (National Cancer Institute)



Sheila Ann Prindiville (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Mateus Pereira LH, Sigurdson AJ, Doody MM, Pineda MA, Alexander BH, Greene MH, Struewing JP (2004). CHEK2:1100delC and female breast cancer in the United States. Int J Cancer  112, 541-3.   https://doi.org/10.1002/ijc.20439




PubMed


 


PubMed ID 15382084
    
     


 



2.
Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer  4, 9.   https://doi.org/10.1186/1471-2407-4-9




PubMed



        
     
Free Article


 


PubMed ID 15113441
         Pubmed Central ID 408462 


 



3.
Struewing JP, Pineda MA, Sherman ME, Lissowska J, Brinton LA, Peplonska B, Bardin-Mikolajczak A, Garcia-Closas M (2006). Skewed X chromosome inactivation and early-onset breast cancer. J Med Genet  43, 48-53.   https://doi.org/10.1136/jmg.2005.033134




PubMed



        
     
Free Article


 


PubMed ID 15923273
         Pubmed Central ID 1876702",https://intramural.nih.gov/search/searchview.taf?ipid=37318
313,BC010560-02,"October 01, 2004 -  September 30, 2005",Adjuvant Therapy of Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",Fatou G Hughes,"Charles  Geyer
(NSABP)




Norman  Wolmark
(National Surgical Adjuvant Breast and Bowel Project)",NULL,NULL,"Ordered by publication type and then author name.



1.
Swain S   (2005) Concepts and clinical trials of dose-dense chemotherapy for breast cancer.  Clin Breast Cancer, in press.




 



2.
Swain S, Perez E, Bryant J, Suman V, Geyer C, Davidson N, Tan-Chiu E, Martino S, Paik S, Kaufman P, Pickansky T, Fehrenbacher L, Kutten L, Vogel V, Visscher D, Yothers G, Jenkins R, Brown A, Dakhil S, Mamounas T, Lingle W, Abrams J, Ingle J, Wolmark N   (2005) Adjuvant chemotherapy with or without trastuzumab for HER2-positive breast cancer: combined analysis of NSABP B-31 and NCCTG N9831.  N Engl J Med, in press.




 



3.
Swain S, Romond B, Geyer E, Keefe S, Brown F, Vogel S, Rastogi M, Wolmark N   (2005) Cardiac safety analysis of the first stage of SNABP B-31, a randomized trial comparing doxorubicin plus cyclophosphamide (AC) followed by paclitaxel to AC followed by paclitaxel plus trastuzumab as adjuvant therapy for patients with node-positive, HER-2-overexpressing breast cancer.  J Clin Oncol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37320
314,BC010561-02,"October 01, 2004 -  September 30, 2005",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI","Tatiana  Karpova



Florian  Mueller



Hillary  Mueller



Diana  Stavreva","David  Auble
(Univ. Virginia)




Keiko  Ozato; PhD
(NICHHD)




Robert  Pego
(Mathematics, Carnegie Mellon)




Corentin  Spriet
(Pasteur Institute)",Peter Montague Bungay; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Karpova TS, Chen TY, Sprague BL, McNally JG (2004). Dynamic interactions of a transcription factor with DNA are accelerated by a chromatin remodeller. EMBO Rep  5, 1064-70.   https://doi.org/10.1038/sj.embor.7400281




PubMed



        
     
Free Article


 


PubMed ID 15514679
         Pubmed Central ID 1299176 


 



2.
McNally J, Chen T, Sprague B   (2004) Dynamic interactions of a transcription factor with DNA are accelerated by a chromatin remodeler.  EMBO Rep. .




 



3.
Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J  23, 1739-48.   https://doi.org/10.1038/sj.emboj.7600136




PubMed



        
     
Free Article


 


PubMed ID 15057284
         Pubmed Central ID 394229 


 



4.
Sprague BL, McNally JG (2005). FRAP analysis of binding: proper and fitting. Trends Cell Biol  15, 84-91.   https://doi.org/10.1016/j.tcb.2004.12.001




PubMed


 


PubMed ID 15695095
    
     


 



5.
Sprague BL, Pego RL, Stavreva DA, McNally JG (2004). Analysis of binding reactions by fluorescence recovery after photobleaching. Biophys J  86, 3473-95.   https://doi.org/10.1529/biophysj.103.026765




PubMed



        
     
Free Article


 


PubMed ID 15189848
         Pubmed Central ID 1304253 


 



6.
Stavreva DA, Müller WG, Hager GL, Smith CL, McNally JG (2004). Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol  24, 2682-97.   https://doi.org/10.1128/mcb.24.7.2682-2697.2004




PubMed



        
     
Free Article


 


PubMed ID 15024059
         Pubmed Central ID 371101",https://intramural.nih.gov/search/searchview.taf?ipid=37367
315,BC010562-02,"October 01, 2004 -  September 30, 2005",Molecular Interaction Maps and Analysis of Bioregulatory Networks,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Haiqing  Fu



Tsutomu  Shimura



Chiimei (Cindy) L Tseng



Lixin  Wang",NULL,"Yves  Pommier; PhD (National Cancer Institute)



John N.  Weinstein (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37334
316,BC010563-02,"October 01, 2004 -  September 30, 2005",Modulating T cell tolerance to elicit tumor immunity and autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Michael J Anderson



Fran  Dorsey



Vinod  Singh



Jami D Willette brown



Thomas Y Wuest","Vincenzo  Bronte





Eugene  Kwon
(Androgen Ablation to Elicit Prostate Cancer Immunity, Mayo Clinic)




Stephen  Schoenberger
(Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology)




Protul  Shrikant
(Department of Immunology, Roswell Park Cancer Institute)




Andrew  Weinberg
(Robert W. Franz Cancer Research Center, Earle Chiles Cancer Institute)","Joost J Oppenheim; MD (National Cancer Institute)



Scott K Durum; PhD (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen X, Murakami T, Oppenheim JJ, Howard OM (2005). Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood  106, 2409-16.   https://doi.org/10.1182/blood-2005-03-0854




PubMed



        
     
Free Article


 


PubMed ID 15956285
         Pubmed Central ID 1569904 


 



2.
Hurwitz A   (2005) Provision of GM-CSF converts an autoimmune response to a self antigen into an anti-tumor response.  J. Immunol, in press.




 



3.
Hurwitz AA, Ji Q (2004). Autoimmune depigmentation following sensitization to melanoma antigens. Methods Mol Med  102, 421-7.   https://doi.org/10.1385/1-59259-805-6:421




PubMed


 


PubMed ID 15286398
    
     


 



4.
Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED (2004). Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol  173, 6098-108.   https://doi.org/10.4049/jimmunol.173.10.6098




PubMed


 


PubMed ID 15528346",https://intramural.nih.gov/search/searchview.taf?ipid=37353
317,BC010564-02,"October 01, 2004 -  September 30, 2005",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI","Tatiana  Karpova



Hillary  Mueller","Gerd  Schneider
(BESSY)




Zlatko  Trajanoski
(Bioinformatics, Graz University of Technology)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37368
318,BC010565-02,"October 01, 2004 -  September 30, 2005",Determinants of Melanocyte Transformation and Melanoma Progression and Signal Tr,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Nancy M Chung



Ganesh  Diwakar



Shunlin  Jiang



Laura I Longo



Deming  Zhang",NULL,"Leonard  Neckers; PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37350
319,BC010566-02,"October 01, 2004 -  September 30, 2005",Tumor and Metastasis Biology,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI","Jessica  Cassavaugh



Sung-Hyeok  Hong



Rachel  Nguyen



Ling  Ren","John A Beutler
(NCI)




Richard  Gorlick
(Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)




Javed  Khan; MD
(NCI)




Genie  Kleinerman
(Molecular Targets Development Program, MD Anderson)




Andrea  McClatchey
(POB, Harvard/MGH)




Stuart H Yuspa; MD
(NCI)","Lee Jay Helman; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Nancy H Colburn; PhD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Khanna C   (2005) The Biology of Childhood Cancer, in Principles and Practice of Pediatric Oncology. Pizzo P, ed.,  Lippincot, in press.




 



2.
Hansen K, Khanna C (2004). Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer  40, 858-80.   https://doi.org/10.1016/j.ejca.2003.11.031




PubMed


 


PubMed ID 15120042
    
     


 



3.
Khanna C   (2005) Molecular Approaches in Pediatric Oncology.  Annual Reviews, in press.




 



4.
Khanna C, Helman L   (2005) The biology of metastasis: current understanding and recent advances.  Cancer Journal, in press.




 



5.
Khanna C, Hunter K (2005). Modeling metastasis in vivo. Carcinogenesis  26, 513-23.   https://doi.org/10.1093/carcin/bgh261




PubMed


 


PubMed ID 15358632
    
     


 



6.
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med  10, 182-6.   https://doi.org/10.1038/nm982




PubMed


 


PubMed ID 14704791
    
     


 



7.
Wan X, Mendoza A, Khanna C, Helman LJ (2005). Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res  65, 2406-11.   https://doi.org/10.1158/0008-5472.CAN-04-3135




PubMed


 


PubMed ID 15781656
    
     


 



8.
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med  10, 175-81.   https://doi.org/10.1038/nm966




PubMed


 


PubMed ID 14704789",https://intramural.nih.gov/search/searchview.taf?ipid=37363
320,BC010567-02,"October 01, 2004 -  September 30, 2005",Malignant Progression in Human Melanoma,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Ezinma  Achebe



Nancy M Chung



Shunlin  Jiang



Laura I Longo",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37351
321,BC010568-02,"October 01, 2004 -  September 30, 2005",Studies of the anti-tumor mechanisms of the inflammatory cytokines tumor necrosi,"H Richard Alexander; MD, PhD",NULL,"Surgery Branch, NCI","Cynthia B Helsabeck



Susan E Ohl



James F Pingpank



Romi K Sawhney



Geoffrey D Seidel



Ewa M Turner",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005). Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol  12, 138-44.   https://doi.org/10.1245/ASO.2005.05.003




PubMed


 


PubMed ID 15827794
    
     


 



2.
Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR (2005). Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol  23, 3465-74.   https://doi.org/10.1200/JCO.2005.00.927




PubMed



        
     
Free Article


 


PubMed ID 15908655
         Pubmed Central ID 2374756",https://intramural.nih.gov/search/searchview.taf?ipid=37335
322,BC010569-02,"October 01, 2004 -  September 30, 2005",Comparative Oncology Program,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI","Christina  Mazcko



Melissa C Paoloni","Lisa  Barber
(Veterinary Medicine, Tufts University)




Philip  Bergman
(Veterinary Medicine, The Animal Medical Center)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Ruthanne  Chun
(Veterinary Medicine, University of Wisconsin)




Tim  Fan
(Veterinary Medicine, University of Illinois)




Carolyn  Henry
(Veterinary Medicine, University of Missouri)


Show all 19",Kent W Hunter; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Hansen K, Khanna C (2004). Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer  40, 858-80.   https://doi.org/10.1016/j.ejca.2003.11.031




PubMed


 


PubMed ID 15120042
    
     


 



2.
Khanna C, Hunter K (2005). Modeling metastasis in vivo. Carcinogenesis  26, 513-23.   https://doi.org/10.1093/carcin/bgh261




PubMed


 


PubMed ID 15358632",https://intramural.nih.gov/search/searchview.taf?ipid=37364
323,BC010570-02,"October 01, 2004 -  September 30, 2005",Characterization of Proteins in the Tumor Microenvironment That Influence Tumor,"H Richard Alexander; MD, PhD",NULL,"Surgery Branch, NCI","Derrick D Cox; MD



Cynthia B Helsabeck



Susan E Ohl



James F Pingpank



Romi K Sawhney



Geoffrey D Seidel



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Feldman JL, Neverova NV, Saywell SA   (2005) Modulation of hypoglossal motoneuron excitability by intracellular signal transduction cascades.  Respir Physiol Neurobiol 147:131-43.




PubMed


 


PubMed ID 15893504
    
     


 



2.
Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK (2005). Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine  30, 347-58.   https://doi.org/10.1016/j.cyto.2005.01.020




PubMed


 


PubMed ID 15935955",https://intramural.nih.gov/search/searchview.taf?ipid=37336
324,BC010571-02,"October 01, 2004 -  September 30, 2005",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,"Anita B Roberts; PhD (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Carter  Van Waes; MD, PhD (National Cancer Institute)



James Chung-Yin Yang; MD, PhD (National Cancer Institute)","Mary C Dasso; BA, PhD (NICHD)","Ordered by publication type and then author name.



1.
Arnaoutov A, Azuma Y, Ribbeck K, Joseph J, Boyarchuk Y, Karpova T, McNally J, Dasso M (2005). Crm1 is a mitotic effector of Ran-GTP in somatic cells. Nat Cell Biol  7, 626-32.   https://doi.org/10.1038/ncb1263




PubMed


 


PubMed ID 15908946
    
     


 



2.
Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, Bos E, Peters PJ, Henkart PA (2004). Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity  20, 219-30.   https://doi.org/10.1016/s1074-7613(04)00027-5




PubMed


 


PubMed ID 14975243
    
     


 



3.
Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ (2004). Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol  24, 2251-62.   https://doi.org/10.1128/mcb.24.6.2251-2262.2004




PubMed



        
     
Free Article


 


PubMed ID 14993265
         Pubmed Central ID 355855 


 



4.
Ling Y, Sankpal UT, Robertson AK, McNally JG, Karpova T, Robertson KD (2004). Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res  32, 598-610.   https://doi.org/10.1093/nar/gkh195




PubMed



        
     
Free Article


 


PubMed ID 14752048
         Pubmed Central ID 373322 


 



5.
Park JE, Park CJ, Sakchaisri K, Karpova T, Asano S, McNally J, Sunwoo Y, Leem SH, Lee KS (2004). Novel functional dissection of the localization-specific roles of budding yeast polo kinase Cdc5p. Mol Cell Biol  24, 9873-86.   https://doi.org/10.1128/MCB.24.22.9873-9886.2004




PubMed



        
     
Free Article


 


PubMed ID 15509790
         Pubmed Central ID 525480 


 



6.
Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J  23, 1739-48.   https://doi.org/10.1038/sj.emboj.7600136




PubMed



        
     
Free Article


 


PubMed ID 15057284
         Pubmed Central ID 394229 


 



7.
Wong K, Zhang J, Awasthi S, Sharma A, Rogers L, Matlock EF, Van Lint C, Karpova T, McNally J, Harrod R (2004). Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J Biol Chem  279, 55667-74.   https://doi.org/10.1074/jbc.M408174200




PubMed


 


PubMed ID 15496412",https://intramural.nih.gov/search/searchview.taf?ipid=37366
325,BC010572-02,"October 01, 2004 -  September 30, 2005",Thyroid NodulesCancer and Radiation,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Elisha E Peterson



Marbin A Pineda",NULL,"Alice  Sigurdson; PhD (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37319
326,BC010575-02,"October 01, 2004 -  September 30, 2005",In Search of New Molecular Markers in the Diagnosis of Ovarian and  Endometrial,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37369
327,BC010577-02,"October 01, 2004 -  September 30, 2005",Specificity Analysis of Carbohydrate Binding Antibodies and Lectins,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Joseph C Manimala,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Manimala JC, Roach TA, Li Z, Gildersleeve JC (2006). High-throughput carbohydrate microarray analysis of 24 lectins. Angew Chem Int Ed Engl  45, 3607-10.   https://doi.org/10.1002/anie.200600591




PubMed


 


PubMed ID 16639753",https://intramural.nih.gov/search/searchview.taf?ipid=37348
328,BC010578-02,"October 01, 2004 -  September 30, 2005",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Jill M Dunty



Steven  Seaman",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36974
329,BC010579-02,"October 01, 2004 -  September 30, 2005",Papillomavirus Virion Proteins and Vaccines,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,NULL,John  Schiller; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004). Efficient intracellular assembly of papillomaviral vectors. J Virol  78, 751-7.   https://doi.org/10.1128/jvi.78.2.751-757.2004




PubMed



        
     
Free Article


 


PubMed ID 14694107
         Pubmed Central ID 368835 


 



2.
Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005). Maturation of papillomavirus capsids. J Virol  79, 2839-46.   https://doi.org/10.1128/JVI.79.5.2839-2846.2005




PubMed



        
     
Free Article


 


PubMed ID 15709003
         Pubmed Central ID 548454 


 



3.
Chackerian B, Briglio L, Albert PS, Lowy DR, Schiller JT (2004). Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J Virol  78, 4037-47.   https://doi.org/10.1128/jvi.78.8.4037-4047.2004




PubMed



        
     
Free Article


 


PubMed ID 15047820
         Pubmed Central ID 374281 


 



4.
Day PM, Baker CC, Lowy DR, Schiller JT (2004). Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A  101, 14252-7.   https://doi.org/10.1073/pnas.0404229101




PubMed



        
     
Free Article


 


PubMed ID 15383670
         Pubmed Central ID 521143 


 



5.
Gillison ML, Lowy DR (2004). A causal role for human papillomavirus in head and neck cancer. Lancet  363, 1488-9.   https://doi.org/10.1016/S0140-6736(04)16194-1




PubMed


 


PubMed ID 15135592
    
     


 



6.
Lenz P, Lowy DR, Schiller JT (2005). Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells. Eur J Immunol  35, 1548-56.   https://doi.org/10.1002/eji.200425547




PubMed


 


PubMed ID 15832296
    
     


 



7.
Nardelli-Haefliger D, Lurati F, Wirthner D, Spertini F, Schiller JT, Lowy DR, Ponci F, De Grandi P (2005). Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Vaccine  23, 3634-41.   https://doi.org/10.1016/j.vaccine.2005.02.019




PubMed


 


PubMed ID 15882523
    
     


 



8.
Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Krüger Kjaer S, Lowy DR, Schiller JT (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology  321, 205-16.   https://doi.org/10.1016/j.virol.2003.12.027




PubMed


 


PubMed ID 15051381
    
     


 



9.
Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, Culp TD, Christensen ND, Lowy DR, Schiller JT, Roden RB (2005). Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology  337, 365-72.   https://doi.org/10.1016/j.virol.2005.04.011




PubMed


 


PubMed ID 15885736
    
     


 



10.
Pinto LA, Castle PE, Roden RB, Harro CD, Lowy DR, Schiller JT, Wallace D, Williams M, Kopp W, Frazer IH, Berzofsky JA, Hildesheim A (2005). HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine  23, 3555-64.   https://doi.org/10.1016/j.vaccine.2005.01.146




PubMed


 


PubMed ID 15855014
    
     


 



11.
Schiller J, Gambhira R, Lowy D, Pastrana D, Roden R (submitted in 2005) Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies. Patents issued: 200680011079 (CN in 2013); 2006210792 (AU in 2013); 5224821 (JP in 2013); 8,404,244 (US in 2013); 263255 (IN in 2015); 9,388,221 (US in 2016); 2,596,698 (CA in 2017); 1853307 (DE in 2017); 1853307 (EP in 2017); 1853307 (FR in 2017); 1853307 (GB in 2017). Patent pending: PI0607097-3 (BR application).",https://intramural.nih.gov/search/searchview.taf?ipid=37365
330,BC010580-02,"October 01, 2004 -  September 30, 2005",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,NULL,"Howard A Fine; MD, PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)","John Anthony Butman; MD, PhD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37328
331,BC010581-02,"October 01, 2004 -  September 30, 2005",1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,Pamela  Wolters (National Cancer Institute),"Joseph A Frank; MD, MS (CC) 



Bobbi K Lewis (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37329
332,BC010582-02,"October 01, 2004 -  September 30, 2005",A Comparative Study of Pediatric CNS Tumor Activity as Assessed by18F-- FDG PET,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,Paul Stuart Albert (National Cancer Institute),"Nicholas  Patronas; MD (CC) 



John Anthony Butman; MD, PhD (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37330
333,BC010583-02,"October 01, 2004 -  September 30, 2005",Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,"Brigitte  Widemann; MD (National Cancer Institute)



Madeline R Libucha (National Cancer Institute)



Frank M Balis; MD, PhD (National Cancer Institute)",Alberta A Aikin (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37327
334,BC010584-02,"October 01, 2004 -  September 30, 2005",A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatri,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,"Frank M Balis; MD, PhD (National Cancer Institute)","Joseph A Frank; MD, MS (CC) 



Bobbi K Lewis (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41938
335,BC010585-02,"October 01, 2004 -  September 30, 2005",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson","Susan  Blaney
(Pediatric Oncology, Texas Children's Cancer Center)




Henry  Friedman
(Oncology, Duke University Medical Center)




J. Russell  Geyer
(Pediatric Oncology, Children's Hospital & Regional Medical Center)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Mark  Kieran
(Pediatric Oncology, Dana Farber Cancer Institute)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)


Show all 10","Howard A Fine; MD, PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41937
336,BC010586-02,"October 01, 2004 -  September 30, 2005",Evaluation of the Natural History of Patients with Tumors of the Central Nervous,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,"Howard A Fine; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37326
337,BC010589-02,"October 01, 2004 -  September 30, 2005",Imaging characteristics of Diffuse Pontine Gliomas after Radiation Therapy,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,NULL,NULL,"John Anthony Butman; MD, PhD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37324
338,BC010590-02,"October 01, 2004 -  September 30, 2005",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,"Frank M Balis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37325
339,BC010591-02,"October 01, 2004 -  September 30, 2005",Characterization of Xenograft Models of Childhood Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Sven  Bilke



Braden T Greer



Craig C Whiteford",NULL,"Jon Marc Wigginton; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37361
340,BC010592-02,"October 01, 2004 -  September 30, 2005",Comparative Genomic Hybridization of Neuroblastoma,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Sven  Bilke



Qingrong  Chen



Braden T Greer","Frank  Berthold
(Department of Pediatrics, Klinik fr Kinderheilkunde der Universitt zu Kln)




Daniel  Catchpoole
(Tumor Bank, The Children's Hospital at Westmead)




Manfred  Schwab
(Department of Tumour Genetics, German Cancer Research Center)




Frank  Westermann
(Department of Tumour Genetics, German Cancer Research Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bilke S, Chen QR, Whiteford CC, Khan J (2005). Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays. Bioinformatics  21, 1138-45.   https://doi.org/10.1093/bioinformatics/bti133




PubMed


 


PubMed ID 15539449
    
     


 



2.
Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J (2004). cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics  5, 70.   https://doi.org/10.1186/1471-2164-5-70




PubMed



        
     
Free Article


 


PubMed ID 15380028
         Pubmed Central ID 520814",https://intramural.nih.gov/search/searchview.taf?ipid=37362
341,BC010593-02,"October 01, 2004 -  September 30, 2005",Gene Expression Profiling of Normal Tissues,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Sven  Bilke



Braden T Greer



Jun S Wei



Craig C Whiteford",NULL,Carol J Thiele (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Son CG, Bilke S, Davis S, Greer BT, Wei JS, Whiteford CC, Chen QR, Cenacchi N, Khan J (2005). Database of mRNA gene expression profiles of multiple human organs. Genome Res  15, 443-50.   https://doi.org/10.1101/gr.3124505




PubMed



        
     
Free Article


 


PubMed ID 15741514
         Pubmed Central ID 551571",https://intramural.nih.gov/search/searchview.taf?ipid=37359
342,BC010594-02,"October 01, 2004 -  September 30, 2005",Molecular Mechanisms of Drugs Using cDNA Microarrays,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Craig C Whiteford",NULL,Carol J Thiele (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Wei JS, Whiteford CC, Cenacchi N, Son CG, Khan J (2005). BBC3 mediates fenretinide-induced cell death in neuroblastoma. Oncogene  24, 7976-83.   https://doi.org/10.1038/sj.onc.1208947




PubMed



        
     
Free Article


 


PubMed ID 16091745
         Pubmed Central ID 1317264",https://intramural.nih.gov/search/searchview.taf?ipid=37360
343,BC010595-02,"October 01, 2004 -  September 30, 2005","Host Genes That Influence HIV-1 Replication: APOBEC3G Structure and Function, Ef","Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Rebekah A Thorick



Yeshitila  Friew



Patricia A Henry; PhD



Jean L Mbisa



Galina  Nikolenko



Hongzhan  Xu



Show all 8","Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Joseph  Sodroski
(Harvard University)




Joseph  Wedekind
(University of Rochester Medical Center)","Eric O Freed; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)



William  Gillette; PhD (National Cancer Institute)",Klaus  Strebel; PhD (NIAID),"Ordered by publication type and then author name.



1.
Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK (2004). Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem  279, 35822-8.   https://doi.org/10.1074/jbc.M405761200




PubMed


 


PubMed ID 15210704
    
     


 



2.
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK (2004). A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc Natl Acad Sci U S A  101, 5652-7.   https://doi.org/10.1073/pnas.0400830101




PubMed



        
     
Free Article


 


PubMed ID 15054139
         Pubmed Central ID 397464",https://intramural.nih.gov/search/searchview.taf?ipid=37373
344,BC010596-02,"October 01, 2004 -  September 30, 2005",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Paula K Layton



Barbara V Wise



Cynthia P Love",NULL,"Steven  Pavletic; MD, MS (National Cancer Institute)



Terry J Fry (National Cancer Institute)



Susan  Leitman; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37331
345,BC010597-02,"October 01, 2004 -  September 30, 2005",Vaccine Clinical Trials,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Philip M Arlen; MD



James L Gulley; MD, PhD","Paul  Eder
(CLINICAL ONCOLOGY, Dana-Farber Cancer Center)




H. KIM  Lyerly
(Duke University Medical Center)




John  Marshall","William Laurence Dahut; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Claude  Sportes (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL, Todd N, Lieberman R, Steinberg SM, Morin S, Bastian A, Marte J, Tsang KY, Beetham P, Grosenbach DW, Schlom J, Dahut W (2005). Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer. J Urol  174, 539-46.   https://doi.org/10.1097/01.ju.0000165159.33772.5b




PubMed


 


PubMed ID 16006888
    
     


 



2.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



3.
Kaufman HL, Wang W, Manola J, DiPaola RS, Ko YJ, Sweeney C, Whiteside TL, Schlom J, Wilding G, Weiner LM (2004). Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol  22, 2122-32.   https://doi.org/10.1200/JCO.2004.08.083




PubMed


 


PubMed ID 15169798
    
     


 



4.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J (2005). Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol  23, 720-31.   https://doi.org/10.1200/JCO.2005.10.206




PubMed


 


PubMed ID 15613691
    
     


 



5.
Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK (2005). Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res  11, 3017-24.   https://doi.org/10.1158/1078-0432.CCR-04-2172




PubMed


 


PubMed ID 15837756",https://intramural.nih.gov/search/searchview.taf?ipid=36969
346,BC010598-02,"October 01, 2004 -  September 30, 2005",Development of Novel Vaccine Strategies,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Mala  Chakraborty; PhD



Romaine Ingrid Fernando



Charlese T Garnett



Douglas  Grosenbach



James W Hodge; PhD



Mary T Litzinger



Show all 11","Alicia  Gomez-Yafal
(Therion Biologics)




Linda  Gritz
(Therion Biologics)","Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Schlom J, Abrams S   (2005) Vaccines and Immunostimulants, in Holland - Frei Cancer Medicine. BC Decker Inc. (Hamilton, Ontario), in press.




 



2.
Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J (2005). Multiple costimulatory modalities enhance CTL avidity. J Immunol  174, 5994-6004.   https://doi.org/10.4049/jimmunol.174.10.5994




PubMed



        
     
Free Article


 


PubMed ID 15879092
         Pubmed Central ID 1924685 


 



3.
Kudo-Saito C, Schlom J, Hodge JW (2005). Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses. Clin Cancer Res  11, 2416-26.   https://doi.org/10.1158/1078-0432.CCR-04-1380




PubMed


 


PubMed ID 15788693
    
     


 



4.
Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H (2005). Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood  105, 2862-8.   https://doi.org/10.1182/blood-2004-06-2410




PubMed


 


PubMed ID 15591121
    
     


 



5.
Schlom J, Greiner J, Tsang K, Kudo-Saito C, Grosenbach D, Chakraborty M, Gulley J, ARlen P, Hodge J   (2005) TRICOM vector-based cancer vaccines.  Curr. Pharm. Des, in press.




 



6.
Schlom J, Hodge J, Grosenbach D   (2005) Vaccines with Enhanced Costimulation Maintain High Avidity Memory CTL.  J. Immunol, in press.




 



7.
Zhou J, Tagaya Y, Tolouei-Semnani R, Schlom J, Sabzevari H (2005). Physiological relevance of antigen presentasome (APS), an acquired MHC/costimulatory complex, in the sustained activation of CD4+ T cells in the absence of APCs. Blood  105, 3238-46.   https://doi.org/10.1182/blood-2004-08-3236




PubMed


 


PubMed ID 15637136
    
     


 



8.
Panicali DL, Gritz LL, Hodge JL, Mazzara GL, Schlom JL, Tsang KL (submitted in 2005) System For Treating And Preventing Breast Cancer. Patents issued: 2004289340 (AU in 2011); 4995575 (JP in 2012); 1694364 (BE in 2014); 1694364 (CH in 2014); 1694364 (DE in 2014); 1694364 (AT in 2014); 1694364 (DK in 2014); 1694364 (EP in 2014); 1694364 (ES in 2014); 1694364 (FR in 2014); 1694364 (GB in 2014); 1694364 (IT in 2014); 1694364 (NL in 2014); 1694364 (SE in 2014); 8,933,041 (US in 2015); 2545164 (CA in 2017). Patents pending: 11009923.1 (EP application); 07101411.2 (HK application); 2011-179768 (JP application); PCT/US2004/037810 (PC application).




 



9.
Schlom J, Gritz L, Hodge J, Mazzara G, Panicali D, Tsang K (submitted in 2005) Custom Vectors For Treating And Preventing Pancreatic Cancer. Patents issued: 2004289368 (AU in 2011); 5285855 (JP in 2013); 8,901,093 (US in 2015); 1687322 (BE in 2017); 2545183 (CA in 2017); 1687322 (CH in 2017); 1687322 (DE in 2017); 1687322 (DK in 2017); 1687322 (EP in 2017); 1687322 (ES in 2017); 1687322 (FR in 2017); 1687322 (GB in 2017); 1687322 (IT in 2017); 1687322 (NL in 2017); 1687322 (SE in 2017); 1687322 (AT in 2017). Patents pending: PCT/US2004/38643 (PC application); 14/556,897 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36970
347,BC010599-02,"October 01, 2004 -  September 30, 2005",Mechanisms of Transcriptional Repression by Histone Deacetylase Inhibitors,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anne  Gussow



Sang  Lee



Angeliki  Magklara",NULL,Carol J Thiele (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36971
348,BC010600-02,"October 01, 2004 -  September 30, 2005",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Dongyang  Li",NULL,Michael  Maurizi; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Maurizi MR, Xia D (2004). Protein binding and disruption by Clp/Hsp100 chaperones. Structure  12, 175-83.   https://doi.org/10.1016/j.str.2004.01.021




PubMed


 


PubMed ID 14962378
    
     


 



2.
Xia D, Esser L, Singh SK, Guo F, Maurizi MR (2004). Crystallographic investigation of peptide binding sites in the N-domain of the ClpA chaperone. J Struct Biol  146, 166-79.   https://doi.org/10.1016/j.jsb.2003.11.025




PubMed


 


PubMed ID 15037248",https://intramural.nih.gov/search/searchview.taf?ipid=37333
349,BC010601-02,"October 01, 2004 -  September 30, 2005","Physiological role of TNF and Lymphotoxin in host defense, autoimmunity and canc","Sergei A. Nedospasov; PhD, DSc",NULL,"Basic Research Laboratory, NCI","Ludmila  Drutskaya



Sergei I Grivennikov



Dmitry  Liepinsh","Andrei  Gudkov
(Cleveland Clinic Foundation)




Dmitry  Kuprash
(Molecular Biology, Engelhardt Institute of Molecular Biology)




Bernhard  Ryffel
(Oncoimmunology, CNRS, Institute Transgenose)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cataisson C, Pearson AJ, Torgerson S, Nedospasov SA, Yuspa SH (2005). Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo. J Immunol  174, 1686-92.   https://doi.org/10.4049/jimmunol.174.3.1686




PubMed


 


PubMed ID 15661932
    
     


 



2.
Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Förster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA (2005). Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity  22, 93-104.   https://doi.org/10.1016/j.immuni.2004.11.016




PubMed


 


PubMed ID 15664162
    
     


 



3.
Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E, Gudkov AV (2005). p53 is a suppressor of inflammatory response in mice. FASEB J  19, 1030-2.   https://doi.org/10.1096/fj.04-3213fje




PubMed


 


PubMed ID 15811878",https://intramural.nih.gov/search/searchview.taf?ipid=37370
350,BC010602-02,"October 01, 2004 -  September 30, 2005",Characterization of human cancer antigens defined by serology,"Sergei A. Nedospasov; PhD, DSc",NULL,"Basic Research Laboratory, NCI",Yuriy  Shebzukhov,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nedospasov S, Koroleva E, Khlgatian S, Lagarkova M, Meshcheryakov A, Lichinitser M, Karbach J, Jager E, Kuprash D   (2005) Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy.  Immunology Lett, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37371
351,BC010603-02,"October 01, 2004 -  September 30, 2005",Receptor -directed therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Wendy W Gao



Leslie S Moses



Diana  O'Hagan



Arlethia J Spencer



Neelam  Gulati



Cathryn C Lee



Show all 8",NULL,John N Brady; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ahmad E, Kingma DW, Jaffe ES, Schrager JA, Janik J, Wilson W, Stetler-Stevenson M (2005). Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow. Cytometry B Clin Cytom  67, 6-12.   https://doi.org/10.1002/cyto.b.20063




PubMed


 


PubMed ID 15973700
    
     


 



2.
Dunleavy K, Hakim F, Kim HK, Janik JE, Grant N, Nakayama T, White T, Wright G, Kwak L, Gress R, Tosato G, Wilson WH (2005). B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood  106, 795-802.   https://doi.org/10.1182/blood-2004-08-3198




PubMed



        
     
Free Article


 


PubMed ID 15718416
         Pubmed Central ID 1895166 


 



3.
Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005). High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood  105, 496-502.   https://doi.org/10.1182/blood-2004-05-1982




PubMed


 


PubMed ID 15358629
    
     


 



4.
Janik JE, Morris JC, Pittaluga S, McDonald K, Raffeld M, Jaffe ES, Grant N, Gutierrez M, Waldmann TA, Wilson WH (2004). Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. Blood  104, 3355-7.   https://doi.org/10.1182/blood-2003-11-3922




PubMed


 


PubMed ID 15205267
    
     


 



5.
Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M, Jaffe ES, Steinberg SM, Gress R, Hakim F, Wilson WH (2005). Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med  11, 986-91.   https://doi.org/10.1038/nm1290




PubMed


 


PubMed ID 16116429
    
     


 



6.
Patsalides AD, Atac G, Hedge U, Janik J, Grant N, Jaffe ES, Dwyer A, Patronas NJ, Wilson WH (2005). Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology  237, 265-73.   https://doi.org/10.1148/radiol.2371041087




PubMed


 


PubMed ID 16100084
    
     


 



7.
Zhang M, Zhang Z, Goldman CK, Janik J, Waldmann TA (2005). Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody. Blood  105, 1231-6.   https://doi.org/10.1182/blood-2004-05-1709




PubMed


 


PubMed ID 15383455",https://intramural.nih.gov/search/searchview.taf?ipid=37354
352,BC010604-02,"October 01, 2004 -  September 30, 2005",Epigenetic Studies of Gastro-Intestinal Cancers,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)



Sanford Martin Dawsey; MD (National Cancer Institute)



Mark J Roth (National Cancer Institute)



Christian Cormac Abnet; PhD, MPH (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37332
353,BC010607-02,"October 01, 2004 -  September 30, 2005",Ras-mediated signals in human epithelial cell transformation and metastasis,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Michael David Oberst



Claire  Pollock



Kathleen E Romero



Kirsten  Tracy



Ivy (Juan Juan)  Yin",NULL,NULL,Alan Paul Koretsky; PhD (NINDS),"Ordered by publication type and then author name.



1.
Kelly K   (2005) The RGK family: A regulatory tail of small GTP binding proteins.  Trends in Cell Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=37358
354,BC010608-01,"October 01, 2004 -  September 30, 2005",CCR RNAi initiative overview,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Konrad  Huppi; MD, PhD



Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41494
355,BC010609-01,"October 01, 2004 -  September 30, 2005",RNAi analysis of the ATP-binding cassette (ABC) family of proteins,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Tamara L Jones



Scott E Martin",NULL,Michael Marc Gottesman; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Huppi K, Martin SE, Caplen NJ (2005). Defining and assaying RNAi in mammalian cells. Mol Cell  17, 1-10.   https://doi.org/10.1016/j.molcel.2004.12.017




PubMed


 


PubMed ID 15629712
    
     


 



2.
Kimchi-Sarfaty C, Brittain S, Garfield S, Caplen NJ, Tang Q, Gottesman MM (2005). Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions. Hum Gene Ther  16, 1110-5.   https://doi.org/10.1089/hum.2005.16.1110




PubMed



        
     
Free Article


 


PubMed ID 16149909
         Pubmed Central ID 1618762",https://intramural.nih.gov/search/searchview.taf?ipid=41495
356,BC010610-01,"October 01, 2004 -  September 30, 2005",RNAi analysis of metastasis-associated genes,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Tamara L Jones



Dac Anh Nguyen",NULL,Kent W Hunter; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41496
357,BC010611-01,"October 01, 2004 -  September 30, 2005",RNAi analysis of the IGF pathway,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,"Barry R O'Keefe (National Cancer Institute)



James  McMahon; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41497
358,BC010612-01,"October 01, 2004 -  September 30, 2005",The role of microRNAs in the regulation of gene expression,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Konrad  Huppi; MD, PhD



Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,"Robert H Stephens (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41498
359,BC010613-01,"October 01, 2004 -  September 30, 2005",CCR RNAi initiative: High through put validation of siRNAs against cancer associ,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41499
360,BC010614-01,"October 01, 2004 -  September 30, 2005",CCR RNAi initiative: Establishment of shRNA RNAi library screens,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Konrad  Huppi; MD, PhD



Tamara L Jones",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41500
361,BC010615-01,"October 01, 2004 -  September 30, 2005",CCR RNAi initiative: Technology and assay development,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,Paul  Goldsmith; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Dombroski D, Houghtling RA, Labno CM, Precht P, Takesono A, Caplen NJ, Billadeau DD, Wange RL, Burkhardt JK, Schwartzberg PL (2005). Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton. J Immunol  174, 1385-92.   https://doi.org/10.4049/jimmunol.174.3.1385




PubMed


 


PubMed ID 15661896
    
     


 



2.
Huppi K, Martin SE, Caplen NJ (2005). Defining and assaying RNAi in mammalian cells. Mol Cell  17, 1-10.   https://doi.org/10.1016/j.molcel.2004.12.017




PubMed


 


PubMed ID 15629712",https://intramural.nih.gov/search/searchview.taf?ipid=41501
362,BC010618-01,"October 01, 2004 -  September 30, 2005",RNAi for the identification of Hypoxia responsive genes,"Natasha  Caplen



IRP Faculty Profile",NULL,"Office of the Director, NCI","Konrad  Huppi; MD, PhD



Tamara L Jones



Scott E Martin



Dac Anh Nguyen",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41502
363,BC010619-02,"October 01, 2004 -  September 30, 2005",Assembly and Release of HIV-1 and Other Retroviruses,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Anjali  Joshi



Vinita  Puri



Catherine  Adamson



Karine  Gousset



Benjamin G Luttge","Ronald  Montelaro; MD
(Molecular Genetics and Biochemistry, University of Pittsburg School of Medicine)




Tsutomu  Murakami
(Nishihara, University of the Ryukyus)




Carl  Wild
(Panacos Pharmaceuticals)",NULL,NULL,"Ordered by publication type and then author name.



1.
Freed E   (2005) Role of lipid rafts in virus replication.  Adv. Virus Res  pp.




 



2.
Sklar PA, Masur H, Grubb JR, Voell J, Witek J, Ono A, Freed EO, Maldarelli F (2005). Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy. AIDS  19, 1109-11.   https://doi.org/10.1097/01.aids.0000174461.31794.50




PubMed


 


PubMed ID 15958846",https://intramural.nih.gov/search/searchview.taf?ipid=37347
364,BC010620-02,"October 01, 2004 -  September 30, 2005",Clinical Studies of Multidrug Resistance Reversal,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan",NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)",Clara Chi Chen; MD (CC),"Ordered by publication type and then author name.



1.
Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T (2004). A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res  10, 4724-33.   https://doi.org/10.1158/1078-0432.CCR-0829-03




PubMed


 


PubMed ID 15269145
    
     


 



2.
Mertins SD, Myers TG, Holbeck SL, Medina-Perez W, Wang E, Kohlhagen G, Pommier Y, Bates SE (2004). In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity. Mol Cancer Ther  3, 849-60.




PubMed


 


PubMed ID 15252146",https://intramural.nih.gov/search/searchview.taf?ipid=37339
365,BC010621-02,"October 01, 2004 -  September 30, 2005",II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipe,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Esther  Ihezie,NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)



John J Wright (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)","Douglas R Rosing; MD (NHLBI) 



George J Grimes (CC)","Ordered by publication type and then author name.



1.
Blagosklonny MV, Trostel S, Kayastha G, Demidenko ZN, Vassilev LT, Romanova LY, Bates S, Fojo T (2005). Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. Cancer Res  65, 7386-92.   https://doi.org/10.1158/0008-5472.CAN-04-3433




PubMed


 


PubMed ID 16103091
    
     


 



2.
Hwang K, Piekarz RL, Bates SE, Figg WD, Sparreboom A (2004). Determination of the cyclic depsipeptide FK228, a histone deacetylase inhibitor, by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  809, 81-6.   https://doi.org/10.1016/j.jchromb.2004.06.007




PubMed


 


PubMed ID 15282096
    
     


 



3.
Piekarz RL, Robey RW, Zhan Z, Kayastha G, Sayah A, Abdeldaim AH, Torrico S, Bates SE (2004). T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance. Blood  103, 4636-43.   https://doi.org/10.1182/blood-2003-09-3068




PubMed


 


PubMed ID 14996704
    
     


 



4.
Shizukuda Y, Piekarz RL, Bates SE, Sachdev V, Finkel T, Rosing DR (2005). Effect of a histone deacetylase inhibitor on human cardiac mass. Cardiovasc Drugs Ther  19, 89-90.   https://doi.org/10.1007/s10557-005-6901-7




PubMed


 


PubMed ID 15883760",https://intramural.nih.gov/search/searchview.taf?ipid=37337
366,BC010622-02,"October 01, 2004 -  September 30, 2005",III. Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","John F Deeken



Kin Wah  To","Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)




Thomas  Litman
(Bioinformatics Centre, University of Copenhagen)




Douglas  Ross
(Medicine Department, University of Maryland Greenebaum Cancer Center)




Balazs  Sarkadi
(Dept Cell Metabolism, National Insitute of Hematology and Immunology)","Michael  Dean; PhD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Nadya I Tarasova; PhD (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmed-Belkacem A, Pozza A, Muñoz-Martínez F, Bates SE, Castanys S, Gamarro F, Di Pietro A, Pérez-Victoria JM (2005). Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res  65, 4852-60.   https://doi.org/10.1158/0008-5472.CAN-04-1817




PubMed


 


PubMed ID 15930306
    
     


 



2.
Alqawi O, Bates S, Georges E (2004). Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding. Biochem J  382, 711-6.   https://doi.org/10.1042/BJ20040355




PubMed



        
     
Free Article


 


PubMed ID 15139851
         Pubmed Central ID 1133829 


 



3.
Bates SE, Medina-Pérez WY, Kohlhagen G, Antony S, Nadjem T, Robey RW, Pommier Y (2004). ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins. J Pharmacol Exp Ther  310, 836-42.   https://doi.org/10.1124/jpet.103.063149




PubMed


 


PubMed ID 15075385
    
     


 



4.
Dean M, Fojo T, Bates S (2005). Tumour stem cells and drug resistance. Nat Rev Cancer  5, 275-84.   https://doi.org/10.1038/nrc1590




PubMed


 


PubMed ID 15803154
    
     


 



5.
Dong D, Ko B, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB, Bates SE, Lee AS (2005). Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res  65, 5785-91.   https://doi.org/10.1158/0008-5472.CAN-05-0754




PubMed


 


PubMed ID 15994954
    
     


 



6.
Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, Mittal K, Bates SE (2006). Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett  235, 84-92.   https://doi.org/10.1016/j.canlet.2005.04.024




PubMed


 


PubMed ID 15990223
    
     


 



7.
Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ (2004). Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol  265, 262-75.   https://doi.org/10.1016/j.ydbio.2003.09.028




PubMed


 


PubMed ID 14697368
    
     


 



8.
Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, Bates SE (2005). Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol  56, 161-72.   https://doi.org/10.1007/s00280-004-0931-x




PubMed


 


PubMed ID 15838659
    
     


 



9.
Polgar O, Bates SE (2005). ABC transporters in the balance: is there a role in multidrug resistance? Biochem Soc Trans  33, 241-5.   https://doi.org/10.1042/BST0330241




PubMed


 


PubMed ID 15667317
    
     


 



10.
Polgar O, Robey RW, Morisaki K, Dean M, Michejda C, Sauna ZE, Ambudkar SV, Tarasova N, Bates SE (2004). Mutational analysis of ABCG2: role of the GXXXG motif. Biochemistry  43, 9448-56.   https://doi.org/10.1021/bi0497953




PubMed


 


PubMed ID 15260487
    
     


 



11.
Rao VK, Wangsa D, Robey RW, Huff L, Honjo Y, Hung J, Knutsen T, Ried T, Bates SE (2005). Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells. Cancer Genet Cytogenet  160, 126-33.   https://doi.org/10.1016/j.cancergencyto.2004.12.013




PubMed


 


PubMed ID 15993268
    
     


 



12.
Robey RW, Steadman K, Polgar O, Bates SE (2005). ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy. Cancer Biol Ther  4, 187-94.




PubMed


 


PubMed ID 15684613
    
     


 



13.
Robey RW, Steadman K, Polgar O, Morisaki K, Blayney M, Mistry P, Bates SE (2004). Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res  64, 1242-6.   https://doi.org/10.1158/0008-5472.can-03-3298




PubMed


 


PubMed ID 14973080
    
     


 



14.
Shafran A, Ifergan I, Bram E, Jansen G, Kathmann I, Peters GJ, Robey RW, Bates SE, Assaraf YG (2005). ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates. Cancer Res  65, 8414-22.   https://doi.org/10.1158/0008-5472.CAN-04-4547




PubMed


 


PubMed ID 16166320
    
     


 



15.
Shizukuda Y, Piekarz RL, Bates SE, Sachdev V, Finkel T, Rosing DR (2005). Effect of a histone deacetylase inhibitor on human cardiac mass. Cardiovasc Drugs Ther  19, 89-90.   https://doi.org/10.1007/s10557-005-6901-7




PubMed


 


PubMed ID 15883760
    
     


 



16.
Xu J, Liu Y, Yang Y, Bates S, Zhang JT (2004). Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem  279, 19781-9.   https://doi.org/10.1074/jbc.M310785200




PubMed


 


PubMed ID 15001581",https://intramural.nih.gov/search/searchview.taf?ipid=37338
367,BC010623-02,"October 01, 2004 -  September 30, 2005",The molecular recognition of proteins by antibodies: A model for rational design,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI","Mauro  Acchione



Suja R Joseph



Claudia A Lipschultz



Michihiro  Nakamura



Jian  Xu","Peter  Hinterdorfer
(University of Linz)




Roy  Mariuzza
(CARB, University of MD)




Neeti  Sinha",Robert Andrew Byrd (National Cancer Institute),Vozken A. Parsegian; PhD (NICHD),"Ordered by publication type and then author name.



1.
Li Y, Huang Y, Swaminathan CP, Smith-Gill SJ, Mariuzza RA (2005). Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces. Structure  13, 297-307.   https://doi.org/10.1016/j.str.2004.12.012




PubMed


 


PubMed ID 15698573
    
     


 



2.
Sinha N, Smith-Gill SJ (2005). Molecular dynamics simulation of a high-affinity antibody-protein complex: the binding site is a mosaic of locally flexible and preorganized rigid regions. Cell Biochem Biophys  43, 253-73.   https://doi.org/10.1385/CBB:43:2:253




PubMed


 


PubMed ID 16049350
    
     


 



3.
Stroh CM, Ebner A, Geretschläger M, Freudenthaler G, Kienberger F, Kamruzzahan AS, Smith-Gill SJ, Gruber HJ, Hinterdorfer P (2004). Simultaneous topography and recognition imaging using force microscopy. Biophys J  87, 1981-90.   https://doi.org/10.1529/biophysj.104.043331




PubMed



        
     
Free Article


 


PubMed ID 15345574
         Pubmed Central ID 1304601",https://intramural.nih.gov/search/searchview.taf?ipid=36972
368,BC010624-01,"October 01, 2004 -  September 30, 2005",The Molecular Profile of Prostate Tumors in African-American Men,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Robyn  Prueitt","Carlo M Croce





Dong  Lee
(Pathology and Laboratory Medicine, Baltimore Veteran Affairs Hospital)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41473
369,BC010625-02,"October 01, 2004 -  September 30, 2005",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Masaki  Okada,"Robert  Kramer
(Bristol Myers Squibb Pharmaceutical Research Institute)




Francis  Lee
(Bristol Myers Squibb Pharmaceutical Research Institute)




Eva  Nogales
(Lawrence Berkeley National Laboratory, and Molecular and Cell Biology Department, UC Berkeley)",Susan  Bates; MD (National Cancer Institute),Danny L Sackett; PhD (NICHD),"Ordered by publication type and then author name.



1.
Demidenko ZN, Fojo T, Blagosklonny MV   (2005) Complementation of two mutant p53: implications for loss of heterozygosity in cancer.  FEBS Lett 579:2231-5.




PubMed


 


PubMed ID 15811347
    
     


 



2.
Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM (2005). Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer. J Clin Oncol  23, 2726-34.   https://doi.org/10.1200/JCO.2005.10.024




PubMed


 


PubMed ID 15837987
    
     


 



3.
Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T (2005). The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res  583, 105-19.   https://doi.org/10.1016/j.mrgentox.2005.01.013




PubMed


 


PubMed ID 15927870
    
     


 



4.
Zhuang SH, Agrawal M, Edgerly M, Bakke S, Kotz H, Thambi P, Rutt A, Balis FM, Bates S, Fojo T (2005). A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days. Cancer  103, 1932-8.   https://doi.org/10.1002/cncr.20977




PubMed


 


PubMed ID 15800893",https://intramural.nih.gov/search/searchview.taf?ipid=37342
370,BC010627-02,"October 01, 2004 -  September 30, 2005",Clinical Pharmacology,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Haiqing  Li



Matthew G Permenter



Douglas K Price



Nicola F Smith",NULL,"William Laurence Dahut; MD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Figg W, Acharya M, Desai N, Sparreboom A   (2005) Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel.  Cancer Biol Ther, in press.




 



2.
Figg WD, Price DD, Sissung TD, Sparreboom AD (submitted in 2005) Cyp1b1 Genotype. Patents issued: 1943358 (FR in 2015); 1943358 (GB in 2015); 1943358 (DE in 2015); 1943358 (EP in 2015). Patents pending: PCT/US2006/034769 (PC application); 11/991,878 (US application). Tracking number: E-307-2005-0-EP-05 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=37341
371,BC010628-02,"October 01, 2004 -  September 30, 2005",Epigenetic control of mammalian retrotransposons,David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Jef D. Boeke
(Department of Molecular Biology and Genetics, Johns Hopkins University)




Gerald  Schumann
(Federal Agency for Sera and Vaccines, Paul Ehrlich Institute)",Karl Thomas Ried; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37321
372,BC010629-02,"October 01, 2004 -  September 30, 2005",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI","Aamir  Ahmad



Wentao  Liao



Qi  Xiao","Wafik  El-Deiry
(Department of Medicine, University of Pennsylvania)




Yigong  Shi
(Department of Molecular Biology, Princeton University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chao Y, Shiozaki EN, Srinivasula SM, Rigotti DJ, Fairman R, Shi Y (2005). Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation. PLoS Biol  3, e183.   https://doi.org/10.1371/journal.pbio.0030183




PubMed



        
     
Free Article


 


PubMed ID 15941357
         Pubmed Central ID 1088972 


 



2.
Gupta S, Singh R, Datta P, Zhang Z, Orr C, Lu Z, Dubois G, Zervos AS, Meisler MH, Srinivasula SM, Fernandes-Alnemri T, Alnemri ES   (2004) The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity.  J Biol Chem 279:45844-54.




PubMed


 


PubMed ID 15294909
    
     


 



3.
Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW (2004). Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ  11, 143-53.   https://doi.org/10.1038/sj.cdd.4401320




PubMed


 


PubMed ID 14576767
    
     


 



4.
Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW (2004). Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature  429, 75-9.   https://doi.org/10.1038/nature02451




PubMed


 


PubMed ID 15129283
    
     


 



5.
Yanamandra N, Kondraganti S, Srinivasula SM, Gujrati M, Olivero WC, Dinh DH, Rao JS (2004). Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells. Oncogene  23, 2339-46.   https://doi.org/10.1038/sj.onc.1207406




PubMed


 


PubMed ID 14767475",https://intramural.nih.gov/search/searchview.taf?ipid=36973
373,BC010630-02,"October 01, 2004 -  September 30, 2005",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Wendy W Gao



Neelam  Gulati



Leslie S Moses



Diana  O'Hagan



Kamal  Sharma



Arlethia J Spencer",NULL,"Jon Marc Wigginton; MD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37355
374,BC010631-02,"October 01, 2004 -  September 30, 2005",Characterization of candidate histone methyltransferases,David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",Elizabeth K Flynn,NULL,Lino  Tessarollo (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37322
375,BC010632-02,"October 01, 2004 -  September 30, 2005",Tancription Machinery and  Regulation in E. coli,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Julio E Cabrera



Anne-Marie  Hansen



Huijun  Zhi",NULL,Xinhua  Ji; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Hansen AM, Gu Y, Li M, Andrykovitch M, Waugh DS, Jin DJ, Ji X (2005). Structural basis for the function of stringent starvation protein a as a transcription factor. J Biol Chem  280, 17380-91.   https://doi.org/10.1074/jbc.M501444200




PubMed


 


PubMed ID 15735307
    
     


 



2.
Hansen AM, Qiu Y, Yeh N, Blattner FR, Durfee T, Jin DJ (2005). SspA is required for acid resistance in stationary phase by downregulation of H-NS in Escherichia coli. Mol Microbiol  56, 719-34.   https://doi.org/10.1111/j.1365-2958.2005.04567.x




PubMed


 


PubMed ID 15819627
    
     


 



3.
Liu M, Durfee T, Cabrera JE, Zhao K, Jin DJ, Blattner FR (2005). Global transcriptional programs reveal a carbon source foraging strategy by Escherichia coli. J Biol Chem  280, 15921-7.   https://doi.org/10.1074/jbc.M414050200




PubMed


 


PubMed ID 15705577
    
     


 



4.
Xu M, Zhou YN, Goldstein BP, Jin DJ (2005). Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics. J Bacteriol  187, 2783-92.   https://doi.org/10.1128/JB.187.8.2783-2792.2005




PubMed



        
     
Free Article


 


PubMed ID 15805525
         Pubmed Central ID 1070395",https://intramural.nih.gov/search/searchview.taf?ipid=37356
376,BC010633-02,"October 01, 2004 -  September 30, 2005",Transcription Regulation and Pathogenesis in H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Yi  Yang,NULL,"William  Coleman, Jr (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37357
377,BC010634-02,"October 01, 2004 -  September 30, 2005",Pubertal study of offspring of preeclamptics and normotensives,Michele  Forman; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",NULL,"Lisa  Colbert
(University of Wisconsin)




Lars  Vatten
(Epidemiology, University of Trondheim)","Barry Ira Graubard; PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Katherine Ann McGlynn; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37346
378,BC010635-02,"October 01, 2004 -  September 30, 2005",Childhood Cancer Pooling Project,Michele  Forman; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",NULL,"Eve  Roman
(University of York)




Joachim  Schuez
(University of Mainz)




Xiao  Shu
(Vanderbilt)","Martha S Linet; PhD (National Cancer Institute)



Barry Ira Graubard; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37343
379,BC010636-02,"October 01, 2004 -  September 30, 2005","Cervical Cancer in Shanxi Province, China",Michele  Forman; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",NULL,"Jerome  Belinson
(Cleveland Clinic)




You-lin  Qiao
(CICAMS)




Fanghui  Zhao","Barry Ira Graubard; PhD (National Cancer Institute)



Arti C Patel (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37344
380,BC010637-02,"October 01, 2004 -  September 30, 2005","Early puberty, higher obesity, and lower energy expenditure in African American",Michele  Forman; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",NULL,"Fred  Kadlubar
(Molecular Epidemiology, FDA)




Paul  Kaplowitz
(Pediatric Endocrinology, Children's National Medical Center)","Paul Stuart Albert (National Cancer Institute)



Marie  Cantwell (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=37345
381,BC010638-02,"October 01, 2004 -  September 30, 2005",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Cedric  Coulouarn



Joe W Grisham



Jeonghoon  Heo



Tanya N Hoang



Show all 11",NULL,Valentina  Factor (Cellular and Molecular Biology Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37323
382,BC010639-02,"October 01, 2004 -  September 30, 2005",In Silico Screening for Cancer Targets,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Megan L Peach,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37372
383,BC010641-02,"October 01, 2004 -  September 30, 2005",Molecular Oncology,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI","Maria  Zajac-Kaye; PhD



Carolyn  Best",NULL,"Kent W Hunter; PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Martin  Gutierrez (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36975
384,BC010642-02,"October 01, 2004 -  September 30, 2005",Chemistry,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Richard  Cysyk; PhD,NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41934
385,BC010643-02,"October 01, 2004 -  September 30, 2005",Molecular Technologies,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI","Satoshi  Nishizuka



Carolyn  Best",NULL,Martin  Gutierrez (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36976
386,BC010644-02,"October 01, 2004 -  September 30, 2005",Preclinical Models Strategy Team,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Lyuba  Varticovski,NULL,Glenn  Merlino; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41935
387,BC010645-02,"October 01, 2004 -  September 30, 2005",Signal Transduction Pathways That Regulate Male Germline Stem-Cell Fate and Anim,"Steven X Hou



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Grace Zhiyu  Zheng,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hou X   (2005) The JNK signal transduction pathway in Drosophila, in The JNK Signaling Pathway. Lin A, ed., Landes Bioscience (Georgetown TX), pp. 50-62.",https://intramural.nih.gov/search/searchview.taf?ipid=37352
388,BC010646-02,"October 01, 2004 -  September 30, 2005",Chromatin Remodeling Proteins,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sam  John



Ronit  Salomon",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=37349
389,BC010647-01,"October 01, 2004 -  September 30, 2005","Design, engineering, and evolution of monoclonal antibodies for therapy and diag",Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Thomas  Hofer



Ka Yin  Kwong",NULL,Terrence R Burke; PhD (National Cancer Institute),Rose G Mage; PhD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41574
390,BC010648-01,"October 01, 2004 -  September 30, 2005","Discovery of drugs, targets, and target strategies for immunotherapy of chronic",Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Thomas  Hofer",NULL,"Steven  Pavletic; MD, MS (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)","Richard  Childs; MD (NHLBI) 



Gerald Ernest Marti (OD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41575
391,BC010649-01,"October 01, 2004 -  September 30, 2005",Development of Immunotherapy Strategies for Gastrointestinal Cancers with focus,Udai S Kammula,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Emily  Drennan



Monica I Gonzales



Gerald J Gracia",NULL,"Nicholas Phillip Restifo; MD (National Cancer Institute)



Richard Eldon Royal (National Cancer Institute)



Richard  Sherry; MD (National Cancer Institute)



Suzanne L. Topalian; MD (National Cancer Institute)



James Chung-Yin Yang; MD, PhD (National Cancer Institute)



Mark E Dudley (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



2.
Kammula US, Ghossein R, Bhattacharya S, Coit DG (2004). Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients. J Clin Oncol  22, 3989-96.   https://doi.org/10.1200/JCO.2004.03.052




PubMed


 


PubMed ID 15459222",https://intramural.nih.gov/search/searchview.taf?ipid=41536
392,BC010651-01,"October 01, 2004 -  September 30, 2005",Robo4: Function and Signaling Mechanisms in Vascular Development,Ramani I Ramchandran,Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",Victoria  Bedell,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41576
393,BC010652-01,"October 01, 2004 -  September 30, 2005",Lipid-Based Nanocapsules and Nano Fusion Machines,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Catherine M Finnegan



Himanshu  Garg



Amy L Jacobs



Benitra T Johnson



Anu  Puri; PhD



Mathias  Viard","Esther H Chang





Roy  Duncan
(Department of Microbiology and Immunology Faculty of Medicine, Dalhousie University)




Mark  Kester
(Pharmacology, Penn State College of Medicine)




Cara-Lynne  Schengrund
(Biochemistry and Molecular Biology, Penn State College of Medicine)




Alok  Singh
(Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)","Jacek  Capala; PhD (National Cancer Institute)



Arindam  Dhar (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41478
394,BC010653-01,"October 01, 2004 -  September 30, 2005",Inflammation and Prostatic Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Jami D Willette brown,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41533
395,BC010654-01,"October 01, 2004 -  September 30, 2005",Lymphatic Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Hisataka  Kobayashi



Charlene  Shaw",NULL,"Sam  Hwang; MD, PhD (National Cancer Institute)



Vladimir  Talanov (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choyke PL (2005). Contrast agents for imaging tumor angiogenesis: is bigger better? Radiology  235, 1-2.   https://doi.org/10.1148/radiol.2351041773




PubMed


 


PubMed ID 15798159
    
     


 



2.
Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA (2004). Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Reson Imaging  20, 512-8.   https://doi.org/10.1002/jmri.20147




PubMed


 


PubMed ID 15332261
    
     


 



3.
Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst  96, 703-8.   https://doi.org/10.1093/jnci/djh124




PubMed


 


PubMed ID 15126607",https://intramural.nih.gov/search/searchview.taf?ipid=41507
396,BC010655-01,"October 01, 2004 -  September 30, 2005",Prostate Cancer Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",Marcelino  Bernardo,NULL,"Peter A Pinto; MD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choyke PL (2005). Contrast agents for imaging tumor angiogenesis: is bigger better? Radiology  235, 1-2.   https://doi.org/10.1148/radiol.2351041773




PubMed


 


PubMed ID 15798159
    
     


 



2.
Ménard C, Susil RC, Choyke P, Gustafson GS, Kammerer W, Ning H, Miller RW, Ullman KL, Sears Crouse N, Smith S, Lessard E, Pouliot J, Wright V, McVeigh E, Coleman CN, Camphausen K (2004). MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys  59, 1414-23.   https://doi.org/10.1016/j.ijrobp.2004.01.016




PubMed



        
     
Free Article


 


PubMed ID 15275727
         Pubmed Central ID 2396328 


 



3.
Susil RC, Camphausen K, Choyke P, McVeigh ER, Gustafson GS, Ning H, Miller RW, Atalar E, Coleman CN, Ménard C (2004). System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med  52, 683-7.   https://doi.org/10.1002/mrm.20138




PubMed



        
     
Free Article


 


PubMed ID 15334592
         Pubmed Central ID 2396258",https://intramural.nih.gov/search/searchview.taf?ipid=41508
397,BC010656-01,"October 01, 2004 -  September 30, 2005",Growth Factor Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Jamie M Bishop



Hisataka  Kobayashi



Charlene  Shaw



Karen J Wong",NULL,"Jacek  Capala; PhD (National Cancer Institute)



David M Thomasson; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choyke PL (2005). Contrast agents for imaging tumor angiogenesis: is bigger better? Radiology  235, 1-2.   https://doi.org/10.1148/radiol.2351041773




PubMed


 


PubMed ID 15798159
    
     


 



2.
Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA (2004). Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Reson Imaging  20, 512-8.   https://doi.org/10.1002/jmri.20147




PubMed


 


PubMed ID 15332261
    
     


 



3.
Zhang Y, Choyke PL, Lu H, Takahashi H, Mannon RB, Zhang X, Marcos H, Li KC, Kopp JB (2005). Detection and localization of proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325. J Am Soc Nephrol  16, 1752-7.   https://doi.org/10.1681/ASN.2004110981




PubMed


 


PubMed ID 15872075",https://intramural.nih.gov/search/searchview.taf?ipid=41509
398,BC010657-01,"October 01, 2004 -  September 30, 2005",Intracellular In vivo Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Hisataka  Kobayashi



Charlene  Shaw



Karen J Wong",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41510
399,BC010658-01,"October 01, 2004 -  September 30, 2005",Combination of radiation with multi-target molecular therapy for cancer,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Sang  Lee



Dnyanesh  Tipre","Jorgen  Carlsson
( Biomedical Radiation Sciences, Uppsala University)




Fredrik  Nilsson
(Affibody AB)","Peter L Choyke; MD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Martin W Brechbiel; PhD (National Cancer Institute)



Amir Hossein Gandjbakhche; PhD (National Cancer Institute)



Martin  Meier-Schellersheim; PhD (National Cancer Institute)



Lyuba  Varticovski (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41493
400,BC010659-01,"October 01, 2004 -  September 30, 2005",p53 and its cancer-causing mutants,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI","Hangiao  Feng



Ngoc-Diep  Vu



Zheng  Zhou",NULL,Xinhua  Ji; PhD (National Cancer Institute),Daniel  Appella; PhD (NIDDK),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41413
401,BC010660-01,"October 01, 2004 -  September 30, 2005",The Molecular Profile of Prostate Tumors in Smokers,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Robyn  Prueitt","Carlo M Croce





Dong  Lee
(Pathology and Laboratory Medicine, Baltimore Veteran Affairs Hospital)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41474
402,BC010661-01,"October 01, 2004 -  September 30, 2005",The Use of Cancer Vaccines and Combination Therapies,"James W Hodge; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Mala  Chakraborty; PhD



Charlese T Garnett



Elizabeth K Wansley",NULL,"Norman Norman Coleman; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW (2004). External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res  64, 4328-37.   https://doi.org/10.1158/0008-5472.CAN-04-0073




PubMed


 


PubMed ID 15205348
    
     


 



2.
Garnett CT, Palena C, Chakraborty M, Chakarborty M, Tsang KY, Schlom J, Hodge JW (2004). Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res  64, 7985-94.   https://doi.org/10.1158/0008-5472.CAN-04-1525




PubMed


 


PubMed ID 15520206
    
     


 



3.
Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW (2005). The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin Cancer Res  11, 4533-44.   https://doi.org/10.1158/1078-0432.CCR-04-2237




PubMed


 


PubMed ID 15958639
    
     


 



4.
Schlom J, Palena C, Greiner JW, Tsang KY, Grosenbach DW, Sabzevari H, Gulley JL, Arlen PM, Kass E, Hodge JW (2004). Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation. Dev Biol (Basel)  116, 27-47.




PubMed


 


PubMed ID 15603182
    
     


 



5.
Schlom J, Gritz L, Hodge J, Mazzara G, Panicali D, Tsang K (submitted in 2005) Custom Vectors For Treating And Preventing Pancreatic Cancer. Patents issued: 2004289368 (AU in 2011); 5285855 (JP in 2013); 8,901,093 (US in 2015); 1687322 (BE in 2017); 2545183 (CA in 2017); 1687322 (CH in 2017); 1687322 (DE in 2017); 1687322 (DK in 2017); 1687322 (EP in 2017); 1687322 (ES in 2017); 1687322 (FR in 2017); 1687322 (GB in 2017); 1687322 (IT in 2017); 1687322 (NL in 2017); 1687322 (SE in 2017); 1687322 (AT in 2017). Patents pending: PCT/US2004/38643 (PC application); 14/556,897 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=41673
403,BC010662-01,"October 01, 2004 -  September 30, 2005",Vaccine Clinical Trials,Philip M Arlen; MD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Theresa A Ferrara



James L Gulley; MD, PhD



Mary P Pazdur



Myrna B Rauckhorst



Lisa M Skarupa","Paul  Eder
(CLINICAL ONCOLOGY, Dana-Farber Cancer Center)




H. KIM  Lyerly
(Duke University Medical Center)




John  Marshall","Michael R Bishop; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Claude  Sportes (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arlen P   (2005) Hematopoietic growth factors, in Bethesda Handbook of Clinical Oncology. Abraham J, Allegra C, Gulley J, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 475-480.




 



2.
Arlen P   (2004) Therapeutic vaccines for colorectal cancer: a review of clinical data.  Am J Cancer  pp.




 



3.
Arlen P   (2005) Docetaxel-based regimens, the standard of care for metastatic androgen insensitive prostate cancer.  Future Medicine: Oncology  pp.




 



4.
Arlen P, Gulley J, Trout A, Parnes H, Wright J, Lee M, Chung E, Trepel J, Sparreboom A, Chen C, Jones E, Steinberg S, Daniels A, Figg W, Dahut W   (2005) A phase II study of perifosine in androgen independent prostate cancer.  Cancer Biol Ther, in press.




 



5.
Arlen PM, Gulley JL, Dahut W (2004). Vaccine therapy for a patient with androgen-insensitive prostate cancer without evidence of measurable disease on scans. Am J Ther  11, 238-41.   https://doi.org/10.1097/00045391-200405000-00015




PubMed


 


PubMed ID 15133542
    
     


 



6.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



7.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J (2005). Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol  23, 720-31.   https://doi.org/10.1200/JCO.2005.10.206




PubMed


 


PubMed ID 15613691
    
     


 



8.
Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK (2005). Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res  11, 3017-24.   https://doi.org/10.1158/1078-0432.CCR-04-2172




PubMed


 


PubMed ID 15837756",https://intramural.nih.gov/search/searchview.taf?ipid=41373
404,BC010663-01,"October 01, 2004 -  September 30, 2005",The role of junctional adhesion molecule-C (JAM-C)  in adhesive interactions of,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Kaimei  Song; MD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chavakis T, Keiper T, Matz-Westphal R, Hersemeyer K, Sachs UJ, Nawroth PP, Preissner KT, Santoso S (2004). The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem  279, 55602-8.   https://doi.org/10.1074/jbc.M404676200




PubMed


 


PubMed ID 15485832
    
     


 



2.
Keiper T, Santoso S, Nawroth PP, Orlova V, Chavakis T (2005). The role of junctional adhesion molecules in cell-cell interactions. Histol Histopathol  20, 197-203.   https://doi.org/10.14670/HH-20.197




PubMed


 


PubMed ID 15578438",https://intramural.nih.gov/search/searchview.taf?ipid=41504
405,BC010664-01,"October 01, 2004 -  September 30, 2005",Crosstalk between inflammation and angiogenesis,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Kaimei  Song; MD","Khalil  Bdeir
(Pathology and Laboratory Medicine, University of Pennsylvania)




D.B.  Cines
(Pathology and Laboratory Medicine, University of Pennsylvania)




Klaus  Preissner
(Biochemistry, University Giessen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, El Makhfi N, Urbich C, Peters T, Scharffetter-Kochanek K, Zeiher AM, Chavakis T, Dimmeler S (2005). Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med  201, 63-72.   https://doi.org/10.1084/jem.20041402




PubMed



        
     
Free Article


 


PubMed ID 15623573
         Pubmed Central ID 2212777 


 



2.
Chavakis T, Athanasopoulos A, Rhee JS, Orlova V, Schmidt-Wöll T, Bierhaus A, May AE, Celik I, Nawroth PP, Preissner KT (2005). Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood  105, 1036-43.   https://doi.org/10.1182/blood-2004-01-0166




PubMed


 


PubMed ID 15383457
    
     


 



3.
Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K (2004). Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J  18, 1306-8.   https://doi.org/10.1096/fj.03-1009fje




PubMed


 


PubMed ID 15208269",https://intramural.nih.gov/search/searchview.taf?ipid=41505
406,BC010666-01,"October 01, 2004 -  September 30, 2005",Vaccine Clinical Trials,"James L Gulley; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Philip M Arlen; MD



Theresa A Ferrara



Mary P Pazdur



Myrna B Rauckhorst



Lisa M Skarupa","Paul  Eder
(CLINICAL ONCOLOGY, Dana-Farber Cancer Center)




H. KIM  Lyerly
(Duke University Medical Center)




John  Marshall","Michael R Bishop; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Claude  Sportes (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gulley J   (2005) Prostate cancer, in Bethesda Handbook of Clinical Oncology. Abraham J, Allegra C, Gulley J, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 185-202.




 



2.
Gulley J   (2005) Targeted therapies, in Bethesda Handbook of Clinical Oncology. Abraham J, Allegra C, Gulley J, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 555-562.




 



3.
Gulley J, Takimoto C   (2005) Pancreatic cancer, in Bethesda Handbook of Clinical Oncology. Abraham J, Allegra C, Gulley J, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 123-130.




 



4.
Arlen PM, Gulley JL (2005). Therapeutic vaccines for prostate cancer: a review of clinical data. Curr Opin Investig Drugs  6, 592-6.




PubMed


 


PubMed ID 15988910
    
     


 



5.
Arlen PM, Gulley JL, Dahut W (2004). Vaccine therapy for a patient with androgen-insensitive prostate cancer without evidence of measurable disease on scans. Am J Ther  11, 238-41.   https://doi.org/10.1097/00045391-200405000-00015




PubMed


 


PubMed ID 15133542
    
     


 



6.
Arlen PM, Gulley JL, Todd N, Lieberman R, Steinberg SM, Morin S, Bastian A, Marte J, Tsang KY, Beetham P, Grosenbach DW, Schlom J, Dahut W (2005). Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer. J Urol  174, 539-46.   https://doi.org/10.1097/01.ju.0000165159.33772.5b




PubMed


 


PubMed ID 16006888
    
     


 



7.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



8.
Figg WD, Liu Y, Arlen P, Gulley J, Steinberg SM, Liewehr DJ, Cox MC, Zhai S, Cremers S, Parr A, Yang X, Chen CC, Jones E, Dahut WL (2005). A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. J Urol  173, 790-6.   https://doi.org/10.1097/01.ju.0000147013.09157.8e




PubMed


 


PubMed ID 15711271
    
     


 



9.
Gulley J, Arlen P, Trout A, Parnes H, Wright J, Lee M, Chung E, Trepel J, Sparreboom A, Chen C, Jones E, Steinberg S, Daniels A, Figg W, Dahut W   (2005) A phase II study of perifosine in androgen independent prostate cancer.  Cancer Biol. Ther, in press.




 



10.
Gulley J, Dahut W, Steinberg S, Tarassoff C, Arlen P, Figg W   (2005) A retrospective study of time to clinical endpoints for advanced prostate cancer.  B J Urol, in press.




 



11.
Gulley J, Dahut WL (2005). Clodronate in the prevention and treatment of skeletal metastasis. Expert Rev Anticancer Ther  5, 221-30.   https://doi.org/10.1586/14737140.5.2.221




PubMed


 


PubMed ID 15877520
    
     


 



12.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



13.
Gulley JL, Figg WD, Steinberg SM, Carter J, Sartor O, Higano CS, Petrylak DP, Chatta G, Hussain MH, Dahut WL (2005). A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. J Urol  173, 1567-71.   https://doi.org/10.1097/01.ju.0000154780.72631.85




PubMed


 


PubMed ID 15821487
    
     


 



14.
Kaufman HL, Wang W, Manola J, DiPaola RS, Ko YJ, Sweeney C, Whiteside TL, Schlom J, Wilding G, Weiner LM (2004). Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol  22, 2122-32.   https://doi.org/10.1200/JCO.2004.08.083




PubMed


 


PubMed ID 15169798
    
     


 



15.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J (2005). Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol  23, 720-31.   https://doi.org/10.1200/JCO.2005.10.206




PubMed


 


PubMed ID 15613691
    
     


 



16.
Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK (2005). Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res  11, 3017-24.   https://doi.org/10.1158/1078-0432.CCR-04-2172




PubMed


 


PubMed ID 15837756
    
     


 



17.
Retter AS, Gulley JL, Dahut WL (2004). Novel therapeutic strategies in prostate cancer. Cancer Biol Ther  3, 371-6.   https://doi.org/10.4161/cbt.3.4.725




PubMed


 


PubMed ID 14726702
    
     


 



18.
Sharifi N, Gulley JL, Dahut WL (2005). Androgen deprivation therapy for prostate cancer. JAMA  294, 238-44.   https://doi.org/10.1001/jama.294.2.238




PubMed


 


PubMed ID 16014598
    
     


 



19.
Todd NF, Lieberman R, Gulley JL, Dahut W, Arlen PM (2005). Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapy. Am J Ther  12, 172-4.   https://doi.org/10.1097/01.mjt.0000144497.85706.e6




PubMed


 


PubMed ID 15767834
    
     


 



20.
Tohnya TM, Ng SS, Dahut WL, Wright JJ, Arlen PM, Gulley JL, Parker C, Zeldis J, Figg WD (2004). A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer. Clin Prostate Cancer  2, 241-3.   https://doi.org/10.3816/cgc.2004.n.006




PubMed


 


PubMed ID 15072608",https://intramural.nih.gov/search/searchview.taf?ipid=41653
407,BC010667-01,"October 01, 2004 -  September 30, 2005",Clinical Cancer Genetics Program,Sheila Ann Prindiville,"Walter M Kuehl; MD, PhD","Cancer Genetics Branch, NCI","Kathy  Calzone



Michelle  Nehrebecky



Luz  Rodriguez",NULL,Ilan  Kirsch; MD (National Cancer Institute),Donald  Hadley; MS (NHGRI),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41573
408,BC010668-01,"October 01, 2004 -  September 30, 2005",Instrumentation for microSPECT and microPET imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",Jurgen  Seidel; PhD,NULL,"Martin W Brechbiel; PhD (National Cancer Institute)



James L Tatum (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41506
409,BC010669-01,"October 01, 2004 -  September 30, 2005",Role of Gene Methylation in Tumor Microenvironment,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",Elyse  Walk,NULL,"Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41613
410,BC010670-01,"October 01, 2004 -  September 30, 2005",Molecular-targeted Radiation Therapy,"Norman Norman Coleman; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Sanjeewani T Palayoor,NULL,"James B Mitchell; PhD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)



Harold P Freeman (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41434
411,BC010671-01,"October 01, 2004 -  September 30, 2005",Genetic analysis of T-cell differentiation,"Remy J Bosselut; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Tara C Blake



Guangping  Sun



Linhua  Tian



Lie  Wang



Kathryn F Wildt",NULL,Lionel  Feigenbaum (Office Of The Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41414
412,BC010672-01,"October 01, 2004 -  September 30, 2005",KIR gene polymorphism and its role in HIV-1 pathogenesis,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Megan E Boon



Yalun  Liu



Darlene M Marti



Amy E Poisson",NULL,Daniel  McVicar; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Andersen H, Rossio JL, Coalter V, Poore B, Martin MP, Carrington M, Lifson JD (2004). Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level. Cell Immunol  231, 85-95.   https://doi.org/10.1016/j.cellimm.2004.12.004




PubMed


 


PubMed ID 15919373
    
     


 



2.
Carrington M (2005). Antiviral synergism. Nat Genet  37, 565-6.   https://doi.org/10.1038/ng0605-565




PubMed


 


PubMed ID 15920514",https://intramural.nih.gov/search/searchview.taf?ipid=41503
413,BC010673-01,"October 01, 2004 -  September 30, 2005",Regulation of Metastasis and Angiogenesis by Autotaxin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Russell William Bandle



Malgorzata  Ptaszynska



Elliott  Schiffman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Clair T, Koh E, Ptaszynska M, Bandle RW, Liotta LA, Schiffmann E, Stracke ML   (2005) L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.  Lipids Health Dis 4:5.




PubMed



        
     
Free Article


 


PubMed ID 15737239
         Pubmed Central ID 554093 


 



2.
Geho DH, Bandle RW, Clair T, Liotta LA   (2005) Physiological mechanisms of tumor-cell invasion and migration.  Physiology (Bethesda) 20:194-200.




PubMed


 


PubMed ID 15888576
    
     


 



3.
Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, Veenstra TD, Conrads TP, Goldsmith P, Fishman D, Petricoin EF, Liotta LA   (2005) Analysis of albumin-associated peptides and proteins from ovarian cancer patients.  Clin Chem 51:1933-45.




PubMed


 


PubMed ID 16099937",https://intramural.nih.gov/search/searchview.taf?ipid=41577
414,BC010674-01,"October 01, 2004 -  September 30, 2005",Preclinical Pharmacology,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",William D Figg; PharmD,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41593
415,BC010675-01,"October 01, 2004 -  September 30, 2005",Development of a Carbohydrate Microarray,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Zhitao  Li



Joseph C Manimala","Amit  Jain





Sharan  VedBrat
(KamTek Inc.)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41516
416,BC010676-01,"October 01, 2004 -  September 30, 2005",Clinical Proteomics and Laser Capture Microdissection,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Mark  Raffeld; MD



Joy A Aquino



Andrew L Feldman; MD



Mary  Winters",NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



H Richard Alexander; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gulmann C, Espina V, Petricoin E, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL (2005). Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res  11, 5847-55.   https://doi.org/10.1158/1078-0432.CCR-05-0637




PubMed


 


PubMed ID 16115925
    
     


 



2.
Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E, Liotta LA, Jaffe ES (2004). Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest  84, 235-44.   https://doi.org/10.1038/labinvest.3700051




PubMed


 


PubMed ID 14767488",https://intramural.nih.gov/search/searchview.taf?ipid=41534
417,BC010677-01,"October 01, 2004 -  September 30, 2005",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH (2004). Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res  64, 962-8.   https://doi.org/10.1158/0008-5472.can-03-2272




PubMed


 


PubMed ID 14871826",https://intramural.nih.gov/search/searchview.taf?ipid=41515
418,BC010678-01,"October 01, 2004 -  September 30, 2005",Keratinocyte Growth Factor:  Epithelial Homeostatic Factor with Clinical Applica,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41713
419,BC010679-01,"October 01, 2004 -  September 30, 2005",Characterization of novel substrates of budding yeast polo kinase Cdc5,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Park CJ, Song S, Giddings TH, Ro HS, Sakchaisri K, Park JE, Seong YS, Winey M, Lee KS (2004). Requirement for Bbp1p in the proper mitotic functions of Cdc5p in Saccharomyces cerevisiae. Mol Biol Cell  15, 1711-23.   https://doi.org/10.1091/mbc.e03-07-0461




PubMed



        
     
Free Article


 


PubMed ID 14767068
         Pubmed Central ID 379269 


 



2.
Park JE, Park CJ, Sakchaisri K, Karpova T, Asano S, McNally J, Sunwoo Y, Leem SH, Lee KS (2004). Novel functional dissection of the localization-specific roles of budding yeast polo kinase Cdc5p. Mol Cell Biol  24, 9873-86.   https://doi.org/10.1128/MCB.24.22.9873-9886.2004




PubMed



        
     
Free Article


 


PubMed ID 15509790
         Pubmed Central ID 525480",https://intramural.nih.gov/search/searchview.taf?ipid=41540
420,BC010680-01,"October 01, 2004 -  September 30, 2005",Characterization of the hCenexin-Plk1 interaction at the centrosomes of cultured,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41541
421,BC010681-01,"October 01, 2004 -  September 30, 2005",Development of anti-polo-box therapeutic agents,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41542
422,BC010683-01,"October 01, 2004 -  September 30, 2005",Role of FH loss in development of HLRCC heriditary kidney cancer,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",NULL,"Yuen-LI  Chung
(Biomedical Magnetic Resonance Research Group, St. George's Hospital Medical School)




David  Mole
(Molecular Physiology, Oxford University)




Peter  Ratcliffe
(Herny Wellcome Building of Genomic Medicine, Oxford University)","William Marston Linehan; MD (National Cancer Institute)



Carlos A Torres-cabala (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Berton K Zbar; PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)



Jorge R Toro (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell  8, 143-53.   https://doi.org/10.1016/j.ccr.2005.06.017




PubMed


 


PubMed ID 16098467
    
     


 



2.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499",https://intramural.nih.gov/search/searchview.taf?ipid=41555
423,BC010684-01,"October 01, 2004 -  September 30, 2005",Anatomic Pathology Residency Program,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Andrea  Abati; BS, MD



Frances  Manosca



Kant  Matsuda



Maria  Merino; PhD



George  Miles



Kevin L Nellis



Show all 31","Darryl  Carter





Jere  Stern",NULL,NULL,"Ordered by publication type and then author name.



1.
Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES (2004). Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol  11, 227-38.   https://doi.org/10.1097/01.pap.0000138144.11635.f8




PubMed


 


PubMed ID 15322489
    
     


 



2.
Feldman AL, Berthold F, Arceci RJ, Abramowsky C, Shehata BM, Mann KP, Lauer SJ, Pritchard J, Raffeld M, Jaffe ES (2005). Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol  6, 435-7.   https://doi.org/10.1016/S1470-2045(05)70211-4




PubMed


 


PubMed ID 15925822
    
     


 



3.
Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES (2004). Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol  5, 248-50.   https://doi.org/10.1016/S1470-2045(04)01428-7




PubMed


 


PubMed ID 15050956
    
     


 



4.
Maric I, Bryant R, Abu-Asab M, Cohen JI, Vivero A, Jaffe ES, Raffeld M, Tsokos M, Banks PM, Pittaluga S (2004). Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol  17, 1427-33.   https://doi.org/10.1038/modpathol.3800179




PubMed



        
     
Free Article


 


PubMed ID 15494709
         Pubmed Central ID 2288737 


 



5.
Nava VE, Jaffe ES (2005). The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol  12, 27-34.   https://doi.org/10.1097/01.pap.0000151318.34752.80




PubMed


 


PubMed ID 15614162
    
     


 



6.
Schrager JA, Pittaluga S, Raffeld M, Jaffe ES (2005). Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. Am J Surg Pathol  29, 1115-6.




PubMed


 


PubMed ID 16006809",https://intramural.nih.gov/search/searchview.taf?ipid=41535
424,BC010685-01,"October 01, 2004 -  September 30, 2005",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Sedric V Cade



David  Levens; PhD



Susan  Mackem; MD



Martha Maria Nicacio Quezado; MD



James C Rainey



Victoria H Wise



Show all 7",NULL,"William G Stetler-Stevenson; MD, PhD (National Cancer Institute)",Alexander Oliver Vortmeyer; MD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41537
425,BC010686-01,"October 01, 2004 -  September 30, 2005",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Earle J Barnes



Kevin L Nellis



Jesse T White



Fidelia  Acevedo



Martha Maria Nicacio Quezado; MD



Victoria H Wise",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41538
426,BC010687-01,"October 01, 2004 -  September 30, 2005",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Magaly  Rojas



Helen G Lynch



Martha A Pruden



Langston  Lim",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41539
427,BC010688-01,"October 01, 2004 -  September 30, 2005",Dermatology Consultation Clinic and Clinical Research,Maria L Turner; MD,NULL,"Dermatology Branch, NCI","Susan L Booher



Edward W Cowen



Rachel T Fitten



Heidi H Kong



Jatin Raj Matta",NULL,"Sam  Hwang; MD, PhD (National Cancer Institute)



Jonathan  Vogel; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41433
428,BC010692-01,"October 01, 2004 -  September 30, 2005",Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fa,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Alison E Director-Myska; PhD



Shannon I Skarshaug",NULL,Blanche P Alter (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41475
429,BC010693-01,"October 01, 2004 -  September 30, 2005",Legume Inflammation Study,Elaine L Lanza,NULL,"Laboratory of Cancer Prevention, NCI",NULL,"Robert  Chapkin
(Texas A&M)




Terry  Hartman
(Nutrition, PSU)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41693
430,BC010694-01,"October 01, 2004 -  September 30, 2005",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Alison E Director-Myska; PhD



Jack  Hicks



Shannon I Skarshaug",NULL,"Blanche P Alter (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)",Gerald Ernest Marti (OD),"Ordered by publication type and then author name.



1.
Arthur D, Bettinotti M, Director-Myska A, Stroncek D   (2005) The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q1331.  Transfusion, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=41476
431,BC010695-01,"October 01, 2004 -  September 30, 2005",Prostate stem cells and cancer stem cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Jianjun  Zhou



Carole L Yee","Jason  Engel
(Transgenic Core, George Washington Univ)




Jan  Orenstein
(George Washington Univ)




Johng  Rhim
(Pathology, CPDR, USUHS)




Shiv  Srivastava
(Urology, CPDR, USUHS)




Rocky S Tuan; PhD
(NIAMS)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



William G Telford (National Cancer Institute)












Lionel  Feigenbaum  (Office Of The Director)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41733
432,BC010696-01,"October 01, 2004 -  September 30, 2005",Study of Hereditary Renal Syndromes,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,"William Marston Linehan; MD (National Cancer Institute)



Peter A Pinto; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41554
433,BC010697-01,"October 01, 2004 -  September 30, 2005",Idiotype Vaccines,Barry  Gause; PhD,Lee Jay Helman; MD,"Medical Oncology Branch, NCI","Miriam  Ferraro



Thelma M Watson","Jon  Gockerman
(Oncology, Duke University)




Franco  Muggia
(Oncology, New York University)




Daniel  Nikcevich
(Oncology, Duluth Health Systems)




Stephen  Schuster
(Oncology, University of Pennsylvania)




Eduardo  Sotomayer
(Malignant Hematology, Moffitt Cancer Center)




Jane  Winter
(Oncology, Northwestern University)","Sandeep S Dave (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW (2004). Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen. Clin Cancer Res  10, 8309-17.   https://doi.org/10.1158/1078-0432.CCR-04-1071




PubMed


 


PubMed ID 15623607
    
     


 



2.
Neelapu SS, Gause BL, Nikcevich DA, Schuster SJ, Winter J, Gockerman JP, Loughran T, Takeshita K, Inghirami G, McGaughey D, Watson TM, Snow S, Kubovic P, Ferraro M, Jones E, Jaffe ES, Schwartzentruber DJ, Danforth D, Sherry R, Kass E, Van Waes C, Reynolds CW, Kwak LJ (2005). Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. Clin Lymphoma  6, 61-4.   https://doi.org/10.3816/clm.2005.n.031




PubMed


 


PubMed ID 15989711",https://intramural.nih.gov/search/searchview.taf?ipid=41633
434,BC010698-01,"October 01, 2004 -  September 30, 2005",Development of Immunoablative Conditioning Regimens for the Engraftment of Allog,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Janine R Daub



Ladan  Foruraghi



Nancy M Hardy



Michael Charles Krumlauf



Catherine L Simmons",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH (2004). Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. Br J Haematol  126, 837-43.   https://doi.org/10.1111/j.1365-2141.2004.05133.x




PubMed


 


PubMed ID 15352988
    
     


 



2.
Fowler DH, Bishop MR, Gress RE (2004). Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells. Semin Oncol  31, 56-67.   https://doi.org/10.1053/j.seminoncol.2003.11.003




PubMed


 


PubMed ID 14970938
    
     


 



3.
Sportès C, McCarthy NJ, Hakim F, Steinberg SM, Liewehr DJ, Weng D, Kummar S, Gea-Banacloche J, Chow CK, Dean RM, Castro KM, Marchigiani D, Bishop MR, Fowler DH, Gress RE (2005). Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. Biol Blood Marrow Transplant  11, 472-83.   https://doi.org/10.1016/j.bbmt.2005.03.010




PubMed


 


PubMed ID 15931636
    
     


 



4.
Walshe J, Bishop MR (2004). Factors affecting engraftment of allogeneic hematopoietic stem cells after reduced-intensity conditioning. Cytotherapy  6, 589-2.   https://doi.org/10.1080/14653240410005285-1




PubMed


 


PubMed ID 15773022",https://intramural.nih.gov/search/searchview.taf?ipid=41477
435,CP000101-01,"October 01, 2004 -  September 30, 2005",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"David  Baer
(BHNRC, USDA)




Beverly  Clevidence
(BHNRC, USDA)




Jerry  Combs
(USDA)




Joanne  Dorgan; PhD
(NCI)




Terryl  Hartman
(DCEG, NCI, NIH)




Joseph  Judd
(BHNRC, USDA)


Show all 7",Blossom  Patterson (Biometry Research Group),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41855
436,CP000112-01,"October 01, 2004 -  September 30, 2005",Nutrition Intervention Trials in Linxian China,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu,"William J Blot





Zhi-Wei  Dong
(CICAMS)




You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Guo-Qing  Wang
(CICAMS)




Wen-Qiang  Wei
(EPIDEMIOLOGY, CICAMS)




Chung  Yang
(Rutgers State University)","Farin  Kamangar (Nutritional Epidemiology Branch)



Mark J Roth (Nutritional Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41853
437,CP000150-01,"October 01, 2004 -  September 30, 2005",UGI Cancer Genetic Studies,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Nan  Hu



Chaoyu C Wang",NULL,"Maxwell P Lee; PhD (Laboratory of Population Genetics)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41854
438,CP000176-01,"October 01, 2004 -  September 30, 2005",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41856
439,CP000185-01,"October 01, 2004 -  September 30, 2005",Upper Gastrointestinal Cancer Studies,"Sanford Martin Dawsey; MD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI","Christian Cormac Abnet; PhD, MPH



Mark J Roth



Farin  Kamangar",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Nan  Hu (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, Yoonessi A, Semnani S, Islami F, Sotoudeh M, Fahimi S, Sadjadi AR, Nasrollahzadeh D, Aghcheli K, Kamangar F, Abnet CC, Saidi F, Sewram V, Strickland PT, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R (2005). Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer  92, 176-81.   https://doi.org/10.1038/sj.bjc.6602249




PubMed



        
     
Free Article


 


PubMed ID 15597107
         Pubmed Central ID 2361742 


 



2.
Roth MJ, Huppi KJ (submitted in 2005) Method Of Diagnosing And Treating Cancer Using B-catenin Splice Variants. Patents issued: 5031587 (JP in 2012); 8,110,352 (US in 2012); 2006213610 (AU in 2012); 1851340 (CH in 2013); 1851340 (DE in 2013); 1851340 (DK in 2013); 1851340 (EP in 2013); 1851340 (FR in 2013); 1851340 (GB in 2013); 1115165 (HK in 2013); 1851340 (LI in 2013); 1851340 (BE in 2013); 2596845 (CA in 2017). Patents pending: PCT/US06/05032 (PC application); 13/342,877 (US application). Tracking numbers: E-018-2005-2-EP-07 (EP application); E-018-2005-2-EP-08 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=41859
440,CP004410-29,"October 01, 2004 -  September 30, 2005",Family Studies,"Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Gladys M. Glenn; MD, PhD



Mary C Fraser



Mary Louise McMaster; MD



Dilys  Parry; PhD



Kimberly F Kerstann



David  Ng; AB, MD



Show all 8","Janis  Beach
(Information Management Systems)




Giovanna  Bianchi-Scarra
(University of Genova)




Tim  Bishop
(Institute for Cancer Research)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




David  Elder
(University of Pennsylvania School of Medicine, Philadelphia, PA)


Show all 11","June  Peters (Clinical Genetics Branch)



Nancy E Weissman (Clinical Genetics Branch)



Jeffery P Struewing; MS, MD (Laboratory of Population Genetics)",NULL,"Ordered by publication type and then author name.



1.
Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG (2005). The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet  42, 540-6.   https://doi.org/10.1136/jmg.2004.029504




PubMed



        
     
Free Article


 


PubMed ID 15994874
         Pubmed Central ID 1736092 


 



2.
Goldin LR, McMaster ML, Ter-Minassian M, Saddlemire S, Harmsen B, Lalonde G, Tucker MA (2005). A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet  42, 595-601.   https://doi.org/10.1136/jmg.2004.027433




PubMed



        
     
Free Article


 


PubMed ID 15994882
         Pubmed Central ID 1736088 


 



3.
Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA (2005). Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev  14, 2208-12.   https://doi.org/10.1158/1055-9965.EPI-05-0321




PubMed


 


PubMed ID 16172233
    
     


 



4.
Harland M, Taylor CF, Chambers PA, Kukalizch K, Randerson-Moor JA, Gruis NA, de Snoo FA, ter Huurne JA, Goldstein AM, Tucker MA, Bishop DT, Bishop JA (2005). A mutation hotspot at the p14ARF splice site. Oncogene  24, 4604-8.   https://doi.org/10.1038/sj.onc.1208678




PubMed


 


PubMed ID 15856016
    
     


 



5.
McMaster ML, Giambarresi T, Vasquez L, Goldstein AM, Tucker MA (2005). Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition. Clin Lymphoma  5, 230-4.   https://doi.org/10.3816/clm.2005.n.005




PubMed


 


PubMed ID 15794854
    
     


 



6.
Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM (2005). Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol  173, 1482-6.   https://doi.org/10.1097/01.ju.0000154629.45832.30




PubMed


 


PubMed ID 15821464
    
     


 



7.
Strouse JJ, Fears TR, Tucker MA, Wayne AS (2005). Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol  23, 4735-41.   https://doi.org/10.1200/JCO.2005.02.899




PubMed


 


PubMed ID 16034049
    
     


 



8.
Yang X', Beerman M, Bergen AW, Parry DM, Sheridan E, Liebsch NJ, Kelley MJ, Chanock S, Goldstein AM (2005). Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs). Int J Cancer  116, 487-91.   https://doi.org/10.1002/ijc.21006




PubMed


 


PubMed ID 15818627",https://intramural.nih.gov/search/searchview.taf?ipid=36919
441,CP005779-11,"October 01, 2004 -  September 30, 2005",Epidemiology and Natural History of Human Immunodeficiency Viruses,Robert  Biggar; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","James Jerome Goedert; MD



Michie  Hisada; MD, MPH, ScD","Francis  Black
(Yale University School of Public Health)




N.  Kumwenda
(University of Malawi)




Stephen  Wiktor
(Centers of Disease Control and Prevention)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36917
442,CP005781-11,"October 01, 2004 -  September 30, 2005",HIV and AIDS-Associated Cancers,"Charles  Rabkin



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI","James Jerome Goedert; MD



Robert  Biggar; MD



Sam  Mbulaiteye



Eric Andrew Engels; PhD","Emad  El-Omar
(University of Aberdeen)




Shou-Jiang  Gao
(University of Texas)




Lisa  Jacobson
(Johns Hopkins University School of Public Health)




Evelyene  Lennette
(Virolab, Inc.)




Richard  Miller
(Medical Followup Agency)




Debbie  van Baarle
(University of Amsterdam)


Show all 7",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36915
443,CP005782-11,"October 01, 2004 -  September 30, 2005",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36916
444,CP005803-11,"October 01, 2004 -  September 30, 2005",Genetic Epidemiology,"Alisa  Goldstein; PhD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Neil Edward Caporaso; MS, MD



Mary C Fraser



Gladys M. Glenn; MD, PhD



Lynn Rachel Goldin; PhD



Naoko  Ishibe; ScD



Maria Teresa Pia Landi; MD, PhD



Show all 13","Tim  Bishop
(Institute for Cancer Research)




Julianne  Byrne
(Washington Children's hospital)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)




David  Hogg
(University of Toronto)


Show all 9","Martha S Linet; PhD (Radiation Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Thomas  Fears; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Daugherty SE, Pfeiffer RM, Mellemkjaer L, Hemminki K, Goldin LR (2005). No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiol Biomarkers Prev  14, 1245-50.   https://doi.org/10.1158/1055-9965.EPI-04-0783




PubMed


 


PubMed ID 15894680
    
     


 



2.
Kim HJ, Butman JA, Brewer C, Zalewski C, Vortmeyer AO, Glenn G, Oldfield EH, Lonser RR (2005). Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg  102, 503-12.   https://doi.org/10.3171/jns.2005.102.3.0503




PubMed


 


PubMed ID 15796386
    
     


 



3.
Landgren O, Kerstann KF, Gridley G, Mellemkjaer L, Hemminki K, Linet MS, Goldin LR (2005). Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst  97, 543-4; author reply 544-5.   https://doi.org/10.1093/jnci/dji092




PubMed


 


PubMed ID 15812083
    
     


 



4.
Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM (2005). MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst  97, 998-1007.   https://doi.org/10.1093/jnci/dji176




PubMed


 


PubMed ID 15998953
    
     


 



5.
Ng D, Stavrou T, Liu L, Taylor MD, Gold B, Dean M, Kelley MJ, Dubovsky EC, Vezina G, Nicholson HS, Byrne J, Rutka JT, Hogg D, Reaman GH, Goldstein AM (2005). Retrospective family study of childhood medulloblastoma. Am J Med Genet A  134, 399-403.   https://doi.org/10.1002/ajmg.a.30653




PubMed


 


PubMed ID 15759260
    
     


 



6.
Rutter JL, Bromley CM, Goldstein AM, Elder DE, Holly EA, Guerry D, Hartge P, Struewing JP, Hogg D, Halpern A, Sagebiel RW, Tucker MA (2004). Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer  101, 2809-16.   https://doi.org/10.1002/cncr.20669




PubMed


 


PubMed ID 15529312",https://intramural.nih.gov/search/searchview.taf?ipid=36914
445,CP005804-11,"October 01, 2004 -  September 30, 2005",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Alisa  Goldstein; PhD



Lynn Rachel Goldin; PhD



Naoko  Ishibe; ScD



Maria Teresa Pia Landi; MD, PhD



Margaret Anne Tucker","Janis  Beach
(Information Management Systems)




Yvonne  Reid
(American Type Culture Collection)",NULL,NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Pfeiffer R, Consonni D, Pesatori AC, Bonzini M, Patterson DG, Bertazzi PA, Landi MT (2005). Handling of dioxin measurement data in the presence of non-detectable values: overview of available methods and their application in the Seveso chloracne study. Chemosphere  60, 898-906.   https://doi.org/10.1016/j.chemosphere.2005.01.055




PubMed


 


PubMed ID 15992596",https://intramural.nih.gov/search/searchview.taf?ipid=36913
446,CP010119-10,"October 01, 2004 -  September 30, 2005",Studies of Occupational Cancer (Pesticides),Michael  Alavanja; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Debra  Silverman; ScD, ScM



Mustafa  Dosemeci; PhD



Kenneth  Cantor; PhD



Show all 9","Lisbeth  Lopez-Carrillo
(Mexican National Institute of Public Health)




Andrew  Olshan
(University of North Carolina)




Sandra  Petralia
(Roche Laboratories)




Dennis  Weisenburger
(University of Nebraska Medical Center)","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Alavanja MC, Bonner MR (2005). Pesticides and human cancers. Cancer Invest  23, 700-11.   https://doi.org/10.1080/07357900500360008




PubMed


 


PubMed ID 16377589
    
     


 



2.
Coble J, Arbuckle T, Lee W, Alavanja M, Dosemeci M (2005). The validation of a pesticide exposure algorithm using biological monitoring results. J Occup Environ Hyg  2, 194-201.   https://doi.org/10.1080/15459620590923343




PubMed


 


PubMed ID 15764542
    
     


 



3.
De Roos AJ, Blair A, Rusiecki JA, Hoppin JA, Svec M, Dosemeci M, Sandler DP, Alavanja MC (2005). Cancer incidence among glyphosate-exposed pesticide applicators in the Agricultural Health Study. Environ Health Perspect  113, 49-54.   https://doi.org/10.1289/ehp.7340




PubMed



        
     
Free Article


 


PubMed ID 15626647
         Pubmed Central ID 1253709 


 



4.
Poole C, Cullen M, Irons R, Acquavella J (2005) Re: Cancer incidence among pesticide applicators exposed to alachlor in the agricultural health study. Am J Epidemiol 161:101-2; author reply 102-3




PubMed


 


PubMed ID 15615921",https://intramural.nih.gov/search/searchview.taf?ipid=36907
447,CP010120-10,"October 01, 2004 -  September 30, 2005",Studies of Occupational Cancer,"Aaron E Blair; PhD, MPH",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Bu Tian  Ji



Mary Helen Ward; MS, PhD



Roel  Vermeulen



Joseph B Coble



Show all 25","Olufemi  Adegoke
(Meharry Medical College, Nashville, TN)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Leon  Burmeister
(University of Iowa)




Brian  Chiu
(Northwestern University)




Larwence  Figgs
(St. Louis University)


Show all 14","Jay  Lubin; PhD (Biostatistics Branch)



Michael  Hauptmann; PhD (Biostatistics Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Laura Elizabeth Beane Freeman (Office of Preventive Oncology)",NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Tretiakova M, Gorbanev S, Lomtev A, Klimkina I, Tchibissov V, Averkina O, Dosemeci M (2005). Occupation and lung cancer risk in Leningrad Province, Russia. Med Lav  96, 142-54.




PubMed


 


PubMed ID 16001514
    
     


 



2.
Blair A (2005). Occupational medicine: at a turning point or an expansion. Occup Environ Med  62, 285; discussion 287.   https://doi.org/10.1136/oem.2004.018382




PubMed



        
     
Free Article


 


PubMed ID 15837845
         Pubmed Central ID 1741021 


 



3.
Blair A, Sandler D, Thomas K, Hoppin JA, Kamel F, Coble J, Lee WJ, Rusiecki J, Knott C, Dosemeci M, Lynch CF, Lubin J, Alavanja M (2005). Disease and injury among participants in the Agricultural Health Study. J Agric Saf Health  11, 141-50.   https://doi.org/10.13031/2013.18180




PubMed



        
     
Free Article


 


PubMed ID 15931940
         Pubmed Central ID 1237013 


 



4.
Cocco P, Fadda D, Billai B, D'Atri M, Melis M, Blair A (2005). Cancer mortality among men occupationally exposed to dichlorodiphenyltrichloroethane. Cancer Res  65, 9588-94.   https://doi.org/10.1158/0008-5472.CAN-05-1487




PubMed



        
     
Free Article


 


PubMed ID 16230425
         Pubmed Central ID 1403737 


 



5.
De Vocht F, Straif K, Szeszenia-Dabrowska N, Hagmar L, Sorahan T, Burstyn I, Vermeulen R, Kromhout H (2005). A database of exposures in the rubber manufacturing industry: design and quality control. Ann Occup Hyg  49, 691-701.   https://doi.org/10.1093/annhyg/mei035




PubMed


 


PubMed ID 16126766
    
     


 



6.
Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, Chow WH (2006). Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer  42, 84-90.   https://doi.org/10.1016/j.ejca.2005.09.014




PubMed



        
     
Free Article


 


PubMed ID 16321519
         Pubmed Central ID 1513640 


 



7.
Hou L, Lee WJ, Rusiecki J, Hoppin JA, Blair A, Bonner MR, Lubin JH, Samanic C, Sandler DP, Dosemeci M, Alavanja MC (2006). Pendimethalin exposure and cancer incidence among pesticide applicators. Epidemiology  17, 302-7.   https://doi.org/10.1097/01.ede.0000201398.82658.50




PubMed



        
     
Free Article


 


PubMed ID 16452832
         Pubmed Central ID 1513643 


 



8.
Keohavong P, Lan Q, Gao WM, Zheng KC, Mady HH, Melhem MF, Mumford JL (2005). Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China. Carcinogenesis  26, 303-8.   https://doi.org/10.1093/carcin/bgh328




PubMed


 


PubMed ID 15564291
    
     


 



9.
Lee WJ, Purdue MP, Stewart P, Schenk M, De Roos AJ, Cerhan JR, Severson RK, Cozen W, Hartge P, Blair A (2006). Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma. Int J Cancer  118, 3174-6.   https://doi.org/10.1002/ijc.21755




PubMed



        
     
Free Article


 


PubMed ID 16395708
         Pubmed Central ID 1578637 


 



10.
Lynch SM, Rusiecki JA, Blair A, Dosemeci M, Lubin J, Sandler D, Hoppin JA, Lynch CF, Alavanja MC (2006). Cancer incidence among pesticide applicators exposed to cyanazine in the agricultural health study. Environ Health Perspect  114, 1248-52.   https://doi.org/10.1289/ehp.8997




PubMed



        
     
Free Article


 


PubMed ID 16882534
         Pubmed Central ID 1552023 


 



11.
Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, Touchstone JA, Dosemeci M (2005). Potential occupational risks for neurodegenerative diseases. Am J Ind Med  48, 63-77.   https://doi.org/10.1002/ajim.20178




PubMed


 


PubMed ID 15940722
    
     


 



12.
Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, Bonner MR, Tian L, Yeager M, Welch R, Chanock S, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer  116, 768-73.   https://doi.org/10.1002/ijc.21117




PubMed


 


PubMed ID 15849729
    
     


 



13.
Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res  25, 537-42.




PubMed


 


PubMed ID 15816625
    
     


 



14.
Shen M, Rothman N, Berndt SI, He X, Yeager M, Welch R, Chanock S, Caporaso N, Lan Q (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer  49, 299-309.   https://doi.org/10.1016/j.lungcan.2005.04.002




PubMed


 


PubMed ID 15922487
    
     


 



15.
Svec MA, Ward MH, Dosemeci M, Checkoway H, De Roos AJ (2005). Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public. Occup Environ Med  62, 726-35.   https://doi.org/10.1136/oem.2005.021550




PubMed



        
     
Free Article


 


PubMed ID 16169919
         Pubmed Central ID 1740863 


 



16.
Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, Blair A (2005). Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control  16, 389-97.   https://doi.org/10.1007/s10552-004-5026-9




PubMed



        
     
Free Article


 


PubMed ID 15953981
         Pubmed Central ID 1255936 


 



17.
Vermeulen R, Jönsson BA, Lindh CH, Kromhout H (2005). Biological monitoring of carbon disulphide and phthalate exposure in the contemporary rubber industry. Int Arch Occup Environ Health  78, 663-9.   https://doi.org/10.1007/s00420-005-0017-z




PubMed


 


PubMed ID 16041606
    
     


 



18.
Vermeulen R, Kromhout H (2005). Historical limitations of determinant based exposure groupings in the rubber manufacturing industry. Occup Environ Med  62, 793-9.   https://doi.org/10.1136/oem.2004.016329




PubMed



        
     
Free Article


 


PubMed ID 16234406
         Pubmed Central ID 1740896 


 



19.
Zhang Y, Cantor KP, Lynch CF, Zhu Y, Zheng T (2005). Occupation and risk of pancreatic cancer: a population-based case-control study in iowa. J Occup Environ Med  47, 392-8.   https://doi.org/10.1097/01.jom.0000158707.88801.f5




PubMed


 


PubMed ID 15824631",https://intramural.nih.gov/search/searchview.taf?ipid=36909
448,CP010121-10,"October 01, 2004 -  September 30, 2005",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Nathaniel C Rothman; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Mary Helen Ward; MS, PhD



Mustafa  Dosemeci; PhD



Michael  Alavanja; PhD



Kenneth  Cantor; PhD



Aaron E Blair; PhD, MPH



Show all 14","Robert  Branch
(University of Pittsburgh)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




David  DeMarini
(United States Environmental Protection Agency)




Manolis  Kogevinas





NÃºria  Malats
(Institut Municipal dÂInvestigaciÃ³ MÃ¨dica)




Stephen  Rappaport
(University of North Carolina)


Show all 12","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Laura Elizabeth Beane Freeman (Office of Preventive Oncology)",NULL,"Ordered by publication type and then author name.



1.
Bonassi S, Ugolini D, Kirsch-Volders M, Strömberg U, Vermeulen R, Tucker JD (2005). Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ Mol Mutagen  45, 258-70.   https://doi.org/10.1002/em.20115




PubMed


 


PubMed ID 15688363
    
     


 



2.
Bonner MR, Rothman N, Mumford JL, He X, Shen M, Welch R, Yeager M, Chanock S, Caporaso N, Lan Q (2005). Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat Res  582, 53-60.   https://doi.org/10.1016/j.mrgentox.2004.12.008




PubMed


 


PubMed ID 15781210
    
     


 



3.
Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Zhao X, Li G, Wu YY, Shen M, Yin S, Chanock SJ, Rothman N, Smith MT (2005). Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect  113, 801-7.   https://doi.org/10.1289/ehp.7635




PubMed



        
     
Free Article


 


PubMed ID 15929907
         Pubmed Central ID 1257610 


 



4.
García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N (2005). NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet  366, 649-59.   https://doi.org/10.1016/S0140-6736(05)67137-1




PubMed



        
     
Free Article


 


PubMed ID 16112301
         Pubmed Central ID 1459966 


 



5.
Keohavong P, Lan Q, Gao WM, Zheng KC, Mady HH, Melhem MF, Mumford JL (2005). Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China. Carcinogenesis  26, 303-8.   https://doi.org/10.1093/carcin/bgh328




PubMed


 


PubMed ID 15564291
    
     


 



6.
Lan Q, Zhang L, Hakim F, Shen M, Memon S, Li G, Vermeulen R, Smith MT, Rappaport SM, Hayes R, Linet M, Yin S, Rothman N, Rabkin CS (2005). Lymphocyte toxicity and T cell receptor excision circles in workers exposed to benzene. Chem Biol Interact  153-154, 111-5.   https://doi.org/10.1016/j.cbi.2005.03.015




PubMed


 


PubMed ID 15935806
    
     


 



7.
Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004). Hematotoxicity in workers exposed to low levels of benzene. Science  306, 1774-6.   https://doi.org/10.1126/science.1102443




PubMed



        
     
Free Article


 


PubMed ID 15576619
         Pubmed Central ID 1256034 


 



8.
Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, Bonner MR, Tian L, Yeager M, Welch R, Chanock S, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer  116, 768-73.   https://doi.org/10.1002/ijc.21117




PubMed


 


PubMed ID 15849729
    
     


 



9.
Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res  25, 537-42.




PubMed


 


PubMed ID 15816625
    
     


 



10.
Shen M, Rothman N, Berndt SI, He X, Yeager M, Welch R, Chanock S, Caporaso N, Lan Q (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer  49, 299-309.   https://doi.org/10.1016/j.lungcan.2005.04.002




PubMed


 


PubMed ID 15922487
    
     


 



11.
Smith MT, Vermeulen R, Li G, Zhang L, Lan Q, Hubbard AE, Forrest MS, McHale C, Zhao X, Gunn L, Shen M, Rappaport SM, Yin S, Chanock S, Rothman N (2005). Use of 'Omic' technologies to study humans exposed to benzene. Chem Biol Interact  153-154, 123-7.   https://doi.org/10.1016/j.cbi.2005.03.017




PubMed


 


PubMed ID 15935808
    
     


 



12.
Zhang L, Lan Q, Guo W, Li G, Yang W, Hubbard AE, Vermeulen R, Rappaport SM, Yin S, Rothman N, Smith MT (2005). Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzene-exposed workers. Chem Biol Interact  153-154, 117-22.   https://doi.org/10.1016/j.cbi.2005.03.016




PubMed


 


PubMed ID 15935807
    
     


 



13.
Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, Gao B, Hou LF, Zhu GS (2005). A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett  229, 77-83.   https://doi.org/10.1016/j.canlet.2005.04.014




PubMed


 


PubMed ID 15979781",https://intramural.nih.gov/search/searchview.taf?ipid=36910
449,CP010122-10,"October 01, 2004 -  September 30, 2005",Occupational Exposure Assessment,Patricia S Stewart; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Berit  Bakke



Joseph B Coble



Mustafa  Dosemeci; PhD



Roel  Vermeulen



Michael  Alavanja; PhD



Dalsu  Baris



Show all 21","Olufemi  Adegoke
(Meharry Medical College, Nashville, TN)




Wolfgang  Ahrens
(University of Bremen)




Ruth  Allen
(Environmental Protection Agency, Washington, DC)




Tye  Arbuckle
(Health Canada)




Michael  Attfield
(National Institute for Occupational Safety and Health, Morgantown, WV)




Berit  Bakke
(National Institute of Occupational Health)


Show all 52","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Nilanjan  Chatterjee (Biostatistics Branch)



Abhijit  Das Gupta (Biostatistics Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Michael  Hauptmann; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman D, Karagas M (2004). Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control  15, 759-69.   https://doi.org/10.1023/B:CACO.0000043426.28741.a2




PubMed


 


PubMed ID 15456989
    
     


 



2.
Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ (2005). Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax  60, 645-51.   https://doi.org/10.1136/thx.2004.035170




PubMed



        
     
Free Article


 


PubMed ID 16061705
         Pubmed Central ID 1747486",https://intramural.nih.gov/search/searchview.taf?ipid=36908
450,CP010123-10,"October 01, 2004 -  September 30, 2005",Studies of Occupational Cancer among Women and Minorities,Wong H Chow,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD



Dalsu  Baris



Aaron E Blair; PhD, MPH



Kenneth  Cantor; PhD



Mustafa  Dosemeci; PhD



Richard  Hayes; PhD



Show all 12","Hans-Olov  Adami
(Karolinska Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




S.  Cooper
(The University of Texas)




Yu-Tang  Gao
(Shanghai Cancer Institute)




N.  Heyer
(University of Washington)




L.  Hoffman-Goetz
(University of Waterloo)


Show all 19","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Gloria L Gridley (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)



Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36911
451,CP010124-10,"October 01, 2004 -  September 30, 2005",Cervical cancer and human papillomavirus (HPV) infection,"Mark  Schiffman; MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Joseph  Carreon



Jose A Jeronimo



Allan  Hildesheim; PhD



James V Lacey; MPH, PhD



Lori C Sakoda



Mark E Sherman; MD



Show all 7","Concepcion  Bratti
(Costa Rican Social Security)




Robert  Burk
(Albert Einstein College of Medicine)




Michael  Gold, MD
(University of Oklahoma Health Sciences Center)




Patti  Gravitt
(Johns Hopkins Blumberg School of Public Health)




Sharon  Hillier
(University of Pittsburgh)




Martha  Hutchinson
(Brown University)


Show all 13","Abhijit  Das Gupta (Biostatistics Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)



Kenneth  Chu (Integrated Networks Branch)



Aimee Rebecca Kreimer (Office of Preventive Oncology)",NULL,"Ordered by publication type and then author name.



1.
Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A (2005). Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med  201, 1069-75.   https://doi.org/10.1084/jem.20042158




PubMed



        
     
Free Article


 


PubMed ID 15809352
         Pubmed Central ID 2213116 


 



2.
Ferris DG, Litaker M, ALTS Group (2005) Interobserver agreement for colposcopy quality control using digitized colposcopic images during the ALTS trial. J Low Genit Tract Dis 9:29-35.




PubMed


 


PubMed ID 15870519
    
     


 



3.
Ferris DG, Litaker MS, ASCUSLSIL Triage Study (ALTS) Group (2004) Colposcopy quality control by remote review of digitized colposcopic images. Am J Obstet Gynecol 191:1934-41




PubMed


 


PubMed ID 15592275
    
     


 



4.
Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD (2005). Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis  191, 1796-807.   https://doi.org/10.1086/428850




PubMed


 


PubMed ID 15871111
    
     


 



5.
Jeronimo J, Khan MJ, Schiffman M, Solomon D, ALTS Group (2005). Does the interval between papanicolaou tests influence the quality of cytology? Cancer  105, 133-8.   https://doi.org/10.1002/cncr.21065




PubMed


 


PubMed ID 15822121
    
     


 



6.
Khan MJ, Partridge EE, Wang SS, Schiffman M (2005). Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer  104, 61-70.   https://doi.org/10.1002/cncr.21129




PubMed


 


PubMed ID 15889450
    
     


 



7.
McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS Group (2005). Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev  14, 1165-70.   https://doi.org/10.1158/1055-9965.EPI-04-0918




PubMed


 


PubMed ID 15894667
    
     


 



8.
Wang S, Sherman M, Rader MD J, Carreon J, Schiffman M, Baker C (2005) Towards improved biomarker studies of cervical neoplasia: Effects of precolposcopic procedures on gene expression patterns. Diagnostic Molecular Pathology 2005:59-64




 



9.
Wang SS, Dasgupta A, Sherman ME, Walker JL, Gold MA, Zuna R, Sakoda L, Wacholder S, Schiffman M, Baker CC (2005). Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol  14, 59-64.   https://doi.org/10.1097/01.pas.0000162754.45908.d4




PubMed


 


PubMed ID 15905687
    
     


 



10.
Wang SS, Schiffman M (2005). Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities. Cancer Epidemiol Biomarkers Prev  14, 542-5.   https://doi.org/10.1158/1055-9965.EPI-04-0642




PubMed


 


PubMed ID 15734987
    
     


 



11.
Wang SS, Walker JL, Schiffman M, Solomon D (2005). Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. Cancer Epidemiol Biomarkers Prev  14, 2665-8.   https://doi.org/10.1158/1055-9965.EPI-05-0151




PubMed


 


PubMed ID 16284394
    
     


 



12.
Zuna RE, Wang SS, Rosenthal DL, Jeronimo J, Schiffman M, Solomon D, ALTS Group (2005). Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer  105, 253-62.   https://doi.org/10.1002/cncr.21232




PubMed


 


PubMed ID 15991244",https://intramural.nih.gov/search/searchview.taf?ipid=36900
452,CP010125-10,"October 01, 2004 -  September 30, 2005",Cancer Risk and Environmental Exposures,Kenneth  Cantor; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Claudine M Samanic



Debra  Silverman; ScD, ScM



Michael  Alavanja; PhD



Show all 14","John W Brock
(CDC)




James  Cerhan
(Mayo Clinic)




R. William  Field
(University of Iowa, Iowa City, IO)




Margaret  Karagas
(Dartmouth University, Lebanon, NH)




Manolis  Kogevinas





Michele  Lynberg
(Centers for Disease Control and Prevention)


Show all 16","Daryl  Freedman (Radiation Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)



Jay  Lubin; PhD (Biostatistics Branch)



Rashmi P Sinha; PhD (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Zhang Y, Cantor KP, Lynch CF, Zhu Y, Zheng T (2005). Occupation and risk of pancreatic cancer: a population-based case-control study in iowa. J Occup Environ Med  47, 392-8.   https://doi.org/10.1097/01.jom.0000158707.88801.f5




PubMed


 


PubMed ID 15824631",https://intramural.nih.gov/search/searchview.taf?ipid=36920
453,CP010126-10,"October 01, 2004 -  September 30, 2005",Hormone-Related Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Patricia  Madigan



Mark E Sherman; MD



Roni T Falk



Allan  Hildesheim; PhD



Lori C Sakoda","David  Alberts
(University of Arizona Cancer Center)




Douglas  Bauer
(University of California at San Francisco)




Ralph  Coates
(Centers for Disease Control and Prevention)




Joanne  Dorgan; PhD
(NCI)




R. Loren  Erickson
(Department of Defense)




Jolanta  Lissowsaka
(Maria Sklodowsak-Curie Memorial Cancer Center)


Show all 10","Barry Ira Graubard; PhD (Biostatistics Branch)



Jeffery P Struewing; MS, MD (Laboratory of Population Genetics)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Liu E, Sakoda LC, Gao YT, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni JF, Hsing AW (2005). Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev  14, 1315-8.   https://doi.org/10.1158/1055-9965.EPI-05-0032




PubMed


 


PubMed ID 15894693",https://intramural.nih.gov/search/searchview.taf?ipid=36921
454,CP010127-10,"October 01, 2004 -  September 30, 2005",Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein



Rashmi P Sinha; PhD



Michael Fred Leitzmann



Rachael Zoe Solomon



Margaret E Wright



Amanda  Cross



Show all 13","Henry  Appelman
(University of Michigan)




Colin  Begg
(Memorial Sloan-Kettering Cancer Center)




Sheila  Bingham
(University of Cambridge)




M. Robert  Cooper
(Wake Forest University School of Medicine)




Stanley  Hamilton
(M.D. Anderson Cancer Center)




Frank  Iber
(Edward Hines Jr. Veterans Administration Hospital)


Show all 15","Demetrius  Albanes; MD (Office of the Director)



Amy F Subar (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Douglas N Midthune (Biometry Research Group)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)",NULL,"Ordered by publication type and then author name.



1.
Anderson KE, Kadlubar FF, Kulldorff M, Harnack L, Gross M, Lang NP, Barber C, Rothman N, Sinha R (2005). Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev  14, 2261-5.   https://doi.org/10.1158/1055-9965.EPI-04-0514




PubMed


 


PubMed ID 16172241
    
     


 



2.
Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, Rodriguez C, Sinha R, Calle EE (2005). Meat consumption and risk of colorectal cancer. JAMA  293, 172-82.   https://doi.org/10.1001/jama.293.2.172




PubMed


 


PubMed ID 15644544
    
     


 



3.
Schatzkin A, Peters U (2004). Advancing the calcium-colorectal cancer hypothesis. J Natl Cancer Inst  96, 893-4.   https://doi.org/10.1093/jnci/djh190




PubMed


 


PubMed ID 15199101
    
     


 



4.
Sinha R, Cross A, Curtin J, Zimmerman T, McNutt S, Risch A, Holden J (2005). Development of a food frequency questionnaire module and databases for compounds in cooked and processed meats. Mol Nutr Food Res  49, 648-55.   https://doi.org/10.1002/mnfr.200500018




PubMed


 


PubMed ID 15986387
    
     


 



5.
Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N (2005). Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev  14, 2030-4.   https://doi.org/10.1158/1055-9965.EPI-04-0854




PubMed


 


PubMed ID 16103456
    
     


 



6.
Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, Rothman N, Hayes RB (2005). Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res  65, 8034-41.   https://doi.org/10.1158/0008-5472.CAN-04-3429




PubMed


 


PubMed ID 16140978
    
     


 



7.
Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J, Albanes D (2005). Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst  97, 396-9.   https://doi.org/10.1093/jnci/dji045




PubMed


 


PubMed ID 15741576
    
     


 



8.
Wright ME, Michaud DS, Pietinen P, Taylor PR, Virtamo J, Albanes D (2005). Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland). Cancer Causes Control  16, 1117-23.   https://doi.org/10.1007/s10552-005-0348-9




PubMed


 


PubMed ID 16184478",https://intramural.nih.gov/search/searchview.taf?ipid=36954
455,CP010128-10,"October 01, 2004 -  September 30, 2005",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Allan  Hildesheim; PhD



Mark E Sherman; MD","Douglas  Bauer
(University of California at San Francisco)




Lenore  Buckley
(Virginia Commonwealth University)




Theodore  Colton
(Boston University School of Public Health)




Olga  Dvorkina
(SUNY Health Sciences Center)




Susanne  Kruger-Kjaer
(Danish Cancer Registry)




Emmet  Lamb
(Stanford University)


Show all 8","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Catherine G Schairer (Biostatistics Branch)



Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)



Michael Fred Leitzmann (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA (2005). Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol  161, 607-15.   https://doi.org/10.1093/aje/kwi084




PubMed


 


PubMed ID 15781949
    
     


 



2.
Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA (2005) Melanoma, thyroid, cervical and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193:668-674




 



3.
Brinton L (2005) Response to ""Do drugs that stimulate ovulation increase the risk for endometrial stromal sarcoma?"". Hum Reproduction 20:1112-1116




 



4.
Brinton LA (2005). Do breast implants after a mastectomy affect subsequent prognosis and survival? Breast Cancer Res  7, 61-3.   https://doi.org/10.1186/bcr1003




PubMed



        
     
Free Article


 


PubMed ID 15743512
         Pubmed Central ID 1064123 


 



5.
Brinton LA, Moghissi KS, Scoccia B, Westhoff CL, Lamb EJ (2005). Ovulation induction and cancer risk. Fertil Steril  83, 261-74; quiz 525-6.   https://doi.org/10.1016/j.fertnstert.2004.09.016




PubMed


 


PubMed ID 15705362
    
     


 



6.
Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ (2004). Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod  19, 2005-13.   https://doi.org/10.1093/humrep/deh371




PubMed


 


PubMed ID 15217997
    
     


 



7.
Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, Moghissi KS (2005). Causes of infertility as predictors of subsequent cancer risk. Epidemiology  16, 500-7.   https://doi.org/10.1097/01.ede.0000164812.02181.d5




PubMed


 


PubMed ID 15951668",https://intramural.nih.gov/search/searchview.taf?ipid=36922
456,CP010131-10,"October 01, 2004 -  September 30, 2005",Studies of Medical Radiation and Other Therapeutic Agents,Elaine  Ron; PhD,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis



Ruth Anne Kleinerman; MPH



Michele M Doody; MS



Peter D Inskip; ScD



Lois B Travis; PhD



Alice  Sigurdson; PhD



Show all 15","David  Abramson
(New York Presbyterian Hospital)




Michael  Andersson
(Danish Cancer Society)




Anneliese  Borresen
(The Norwegian Radium Hospital, Oslo, Norway)




Bengt  Glimelius
(Uppsala University)




Mary  Gospodarowicz
(Princess Margaret Hospital)




Deirdre A Hill



Show all 19",Margaret Anne Tucker (Genetic Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF (2005). The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer  103, 2391-6.   https://doi.org/10.1002/cncr.21040




PubMed


 


PubMed ID 15852362
    
     


 



2.
Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ (2005). Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood  105, 3802-11.   https://doi.org/10.1182/blood-2004-09-3411




PubMed



        
     
Free Article


 


PubMed ID 15687239
         Pubmed Central ID 1895092 


 



3.
Freedman DM, Travis LB, Gridley G, Kuncl RW (2005). Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors. Neuroepidemiology  25, 176-80.   https://doi.org/10.1159/000087447




PubMed


 


PubMed ID 16103728
    
     


 



4.
Kleinerman RA, Stovall M, Tarone RE, Tucker MA (2005). Gene environment interactions in a cohort of irradiated retinoblastoma patients. Radiat Res  163, 701-2.




PubMed


 


PubMed ID 16044502
    
     


 



5.
Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF (2005). Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol  23, 2272-9.   https://doi.org/10.1200/JCO.2005.05.054




PubMed


 


PubMed ID 15800318
    
     


 



6.
Olsen JH, Hahnemann JM, Børresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarström L, Robsahm TE, Kääriäinen H, Bregård A, Brøndum-Nielsen K, Yuen J, Tucker M (2005). Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br J Cancer  93, 260-5.   https://doi.org/10.1038/sj.bjc.6602658




PubMed



        
     
Free Article


 


PubMed ID 15942625
         Pubmed Central ID 2361547 


 



7.
Ronckers CM, Land CE, Neglia JP, Meadows AT (2005). Breast cancer. Lancet  366, 1605-6; author reply 1606.   https://doi.org/10.1016/S0140-6736(05)67657-X




PubMed


 


PubMed ID 16271638",https://intramural.nih.gov/search/searchview.taf?ipid=36923
457,CP010132-10,"October 01, 2004 -  September 30, 2005",Studies of Populations Exposed to Environmental Sources of Radiation,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Ethel S Gilbert



Ruth Anne Kleinerman; MPH



Andre  Bouville



Nickolas  Luckyanov



Ihor  Masnyk



Elaine  Ron; PhD



Show all 12","Bruce  Alexander
(University of Minnesota)




Aaron  Brill
(Vanderbilt University)




Daniel  Fink
(Columbia University)




Ellen  Greenebaum
(Columbia University)




Boris  Gusev
(Kazakh Institute for Radiation Medicine and Ecology)




Terry  Hartman
(Pennsylvania State University)


Show all 15",Jay  Lubin; PhD (Biostatistics Branch),NULL,"Ordered by publication type and then author name.



1.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, et al. [11 more authors] (2005). Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst  97, 724-32.   https://doi.org/10.1093/jnci/dji129




PubMed


 


PubMed ID 15900042
    
     


 



2.
Stezhko VA, Buglova EE, Danilova LI, Drozd VM, Krysenko NA, Lesnikova NR, Minenko VF, Ostapenko VA, Petrenko SV, Polyanskaya ON, Rzheutski VA, Tronko MD, Bobylyova OO, Bogdanova TI, Ephstein OV, Kairo IA, Kostin OV, Likhtarev IA, Markov VV, Oliynik VA, Shpak VM, Tereshchenko VP, Zamotayeva GA, Beebe GW, Bouville AC, Chornobyl Thyroid Diseases Study Group of Belarus, Chornobyl Thyroid Diseases Study Group of Ukraine, Chornobyl Thyroid Diseases Study Group of the USA, et al. [12 more authors] (2004). A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res  161, 481-92.   https://doi.org/10.1667/3148




PubMed


 


PubMed ID 15038762",https://intramural.nih.gov/search/searchview.taf?ipid=36901
458,CP010133-10,"October 01, 2004 -  September 30, 2005",Studies of Populations Exposed to Occupational Sources of Radiation,Alice  Sigurdson; PhD,NULL,"Radiation Epidemiology Branch, NCI","Andre  Bouville



Michele M Doody; MS



Daryl  Freedman



Maureen Cusack Hatch; MD



Peter D Inskip; ScD



Elaine  Ron; PhD



Show all 10","Bruce  Alexander
(University of Minnesota)




Anssi P Auvinen





William  Bigbee
(University of Pittsburgh)




Timo  Hakulinen
(Finnish Cancer Registry)




Terry  Hartman
(Pennsylvania State University)




Geoffrey  Howe
(Columbia University)


Show all 17",NULL,NULL,"Ordered by publication type and then author name.



1.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, et al. [11 more authors] (2005). Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst  97, 724-32.   https://doi.org/10.1093/jnci/dji129




PubMed


 


PubMed ID 15900042
    
     


 



2.
Sigurdson AJ, Hauptmann M, Alexander BH, Doody MM, Thomas CB, Struewing JP, Jones IM (2005). DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res  586, 173-88.   https://doi.org/10.1016/j.mrgentox.2005.07.001




PubMed


 


PubMed ID 16099702",https://intramural.nih.gov/search/searchview.taf?ipid=36924
459,CP010134-10,"October 01, 2003 -  September 30, 2004",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI",NULL,"Suminori  Akiba
(Kagoshima University)




Michinori  Kabuto
(National Institute for Environmental Studies)




Tim  Key
(Oxford University)




Kazunori  Kodama
(Radiation Effects Research Foundation, Japan)




Dale  Preston
(Radiation Effects Research Foundation)




Richard  Stevens
(University of Connecticut Health Center)


Show all 8","Kiyohiko  Mabuchi; MD, DPhil (National Cancer Institute)



Martha S Linet; PhD (National Cancer Institute)



Cecile M Ronckers (National Cancer Institute)



Elaine  Ron; PhD (National Cancer Institute)



Alina V Brenner (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41939
460,CP010135-10,"October 01, 2004 -  September 30, 2005",Studies of Non-Ionizing Radiation-Related Cancer,Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI","Ruth Anne Kleinerman; MPH



Alina V Brenner



Preetha  Rajaraman



Steven L Simon



Daryl  Freedman



Gabriel  Chodick","Bruce  Alexander
(University of Minnesota)




Peter  Black
(Brigham and Women's Hospital & Dana Farber Cancer Center)




W.  Bleyer
(Children's Cancer Group)




Anneclaire  De Roos
(University of Washington, Seattle, WA)




Howard  Fine
(Brigham and Women's Hospital)




Elizabeth  Hatch
(Boston University)


Show all 9","Joseph B Coble (Occupational and Environmental Epidemiology Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)



Patricia S Stewart; PhD (Occupational and Environmental Epidemiology Branch)



Thomas  Fears; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Tarone RE, Inskip PD (2005). Mobile phone use and acoustic neuromas. Epidemiology  16, 414; author reply 417-8.   https://doi.org/10.1097/01.ede.0000158818.96464.2f




PubMed


 


PubMed ID 15824562",https://intramural.nih.gov/search/searchview.taf?ipid=36925
461,CP010136-10,"October 01, 2004 -  September 30, 2005",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Joseph B Coble



Claudine M Samanic



Show all 12",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mark  Schiffman; MD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Colt JS, Wacholder S, Schwartz K, Davis F, Graubard B, Chow WH (2005). Response rates in a case-control study: effect of disclosure of biologic sample collection in the initial contact letter. Ann Epidemiol  15, 700-4.   https://doi.org/10.1016/j.annepidem.2004.12.002




PubMed


 


PubMed ID 16157256
    
     


 



2.
Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, Zatonski W, Hayes RB (2005). Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis  26, 1354-9.   https://doi.org/10.1093/carcin/bgi084




PubMed


 


PubMed ID 15802298
    
     


 



3.
Nilsson M, Chow WH, Lindblad M, Ye W (2005). No association between gastroesophageal reflux and cancers of the larynx and pharynx. Cancer Epidemiol Biomarkers Prev  14, 1194-7.   https://doi.org/10.1158/1055-9965.EPI-04-0697




PubMed


 


PubMed ID 15894671",https://intramural.nih.gov/search/searchview.taf?ipid=36926
462,CP010138-08,"October 01, 2004 -  September 30, 2005",Genetic Epidemiology of BRCA12,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Elisha E Peterson



Marbin A Pineda



Denise L Stredrick","Georgia  Chenevix-Trench





Doug  Easton





Nathan  Ellis





Kenneth  Offit","Mark H Greene; MD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)



Sholom  Wacholder; PhD (National Cancer Institute)","Barbara B Biesecker; PhD, MS, CGC (NHGRI)","Ordered by publication type and then author name.



1.
McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP (2004). BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet A  130A, 221-7.   https://doi.org/10.1002/ajmg.a.30265




PubMed


 


PubMed ID 15378542
    
     


 



2.
Struewing JP, Hartge P, Wacholder S, Tucker MA, Greene MH (2004). BRCA1 and sex ratio. Eur J Hum Genet  12, 663-7.   https://doi.org/10.1038/sj.ejhg.5201210




PubMed


 


PubMed ID 15114373
    
     


 



3.
Wacholder S, Struewing JP, Hartge P, Greene MH, Tucker MA (2004). Breast cancer risks for BRCA1/2 carriers. Science  306, 2187-91; author reply 2187-91.




PubMed


 


PubMed ID 15622558",https://intramural.nih.gov/search/searchview.taf?ipid=36927
463,CP010139-08,"October 01, 2004 -  September 30, 2005",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Jenny M Kelley



Ying  Hu; PhD



Titia  Scherpbier



Hongen  Zhang",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36928
464,CP010140-08,"October 01, 2004 -  September 30, 2005",Molecular Genetic Epidemiology of leading  U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Daoud M Meerzaman



Michael A Gandolph","David  Flockhart
(DEPARTMENT OF MEDICINE, Indiana University-Purdue University Indianapolis)




N. NEELY  Kazerouni
(NATIONAL CENTER FOR ENVIRONMENTAL HEALTH, Center for Disease Control)","Mark H Greene; MD (National Cancer Institute)



Philip Samuel Rosenberg; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36929
465,CP010141-08,"October 01, 2004 -  September 30, 2005",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Robert  Clifford



Jenny M Kelley



Cu  Nguyen



Titia  Scherpbier



Hongen  Zhang",NULL,"Carl F Schaefer (National Cancer Institute)



Denise M Hise (National Cancer Institute)



Kotien  Wu (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36953
466,CP010142-07,"October 01, 2004 -  September 30, 2005",Pharmacogenetic Determinants of Outcomes Following Treatment for Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",NULL,"John  Bryant
(National Surgical Adjuvant Breast and Bowel Project)




Joseph  Constantino
(National Surgical Adjuvant Breast & Bowel Project Statistical Center)




Howard  McLeod
(Washington University)




Gareth  Morgan
(University of Leeds)




Michael  Pollak
(McGill University)




Larry  Wickerham
(NSABP Group Headquarters)


Show all 7","Philip Samuel Rosenberg; PhD (Biostatistics Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Barry Ira Graubard; PhD (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)



Kenneth  Buetow; PhD (Laboratory of Population Genetics)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Savage SA, Stewart BJ, Liao JS, Helman LJ, Chanock SJ (2005) Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet 160:79-81",https://intramural.nih.gov/search/searchview.taf?ipid=36930
467,CP010144-07,"October 01, 2004 -  September 30, 2005",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Neelam K Giri; MD



Jennifer T Loud



June  Peters



Nancy E Weissman","David  Alberts
(University of Arizona Cancer Center)




Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)




Tim  Bishop
(Institute for Cancer Research)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




George  Dover
(Johns Hopkins University School of Medicine)


Show all 62","Thomas  Fears; PhD (Biostatistics Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)



Philip Samuel Rosenberg; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Kramer J   (2005) Chapter 32B - Epidemiology of Testicular Cancer: Hereditary Testicular Cancer., in Comprehensive Textbook of Genitourinary Oncology, 3rd Edition., pp. 558-562.




 



2.
Kramer J, Greene M (2005) Chapter 24 - Epidemiology of Testicular Cancer, A Clinical Perspective: Hereditary Testicular Cancer, in Genitourinary Cancers: Controversies in Management 3rd Edition (NJ Vogelzang, WU Shipley, PT Scardino, FMJ DeBruyne,., pp. 558-562.




 



3.
Alter B (2005) Diamond-Blackfan Anemia: A ""Cultural"" Diagnosis. Blood 105:435-436




 



4.
Alter B, Joenje H, Oostra A, Pals G (2005) Fanconi Anemia: Adult Head and Neck Cancer and Hematopoietic Mosaicism. Arch Otolaryngol 131:635-639




 



5.
Alter B, Lipton J (2005) Anemia, Fanconi. eMedicine Journal [serial online], 2005 update of 2002 publication, http:www emedicine compedtopic3022 htm n/a:n/a




 



6.
Alter BP (2004). Growth hormone and the risk of malignancy. Pediatr Blood Cancer  43, 534-5.   https://doi.org/10.1002/pbc.20110




PubMed


 


PubMed ID 15382267
    
     


 



7.
Alter BP (2005). Bone marrow failure: a child is not just a small adult (but an adult can have a childhood disease). Hematology Am Soc Hematol Educ Program   96-103  https://doi.org/10.1182/asheducation-2005.1.96




PubMed


 


PubMed ID 16304365
    
     


 



8.
Brewer MA, Ranger-Moore J, Baruche A, Alberts DS, Greene M, Thompson D, Liu Y, Davis J, Bartels PH (2005). Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev  14, 299-305.   https://doi.org/10.1158/1055-9965.EPI-04-0212




PubMed


 


PubMed ID 15734950
    
     


 



9.
Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, Hartge P, Fagerstrom RM, Ragard LR, Chia D, Izmirlian G, Fouad M, Johnson CC, Gohagan JK, PLCO Project Team (2005). Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol  193, 1630-9.   https://doi.org/10.1016/j.ajog.2005.05.005




PubMed


 


PubMed ID 16260202
    
     


 



10.
Green MJ, Peterson SK, Baker MW, Friedman LC, Harper GR, Rubinstein WS, Peters JA, Mauger DT (2005). Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med  7, 221-9.   https://doi.org/10.1097/01.gim.0000159905.13125.86




PubMed



        
     
Free Article


 


PubMed ID 15834239
         Pubmed Central ID 1201432 


 



11.
Kate N, Kanetsky P, Hawes R, Letrero R, Dudakia D, Vaughn D, Johnson L, Robertson K, Tucker K, Friedlander M, Phillips K, Hogg D, Jewett M, Lohynska R, Daugaard G, Richard S, BonaitiPellie C, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston W, Daly P, Looijenga L, Guilford P, et al. [26 more authors] (2005) The Y Deletion grgr and the Risk of Testicular Germ Cell Tumor. American Journal of Human Genetics 77:1034-1043




 



12.
Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH (2005). Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol  23, 8629-35.   https://doi.org/10.1200/JCO.2005.02.9199




PubMed


 


PubMed ID 16314625
    
     


 



13.
Rosenberg PS, Alter BP, SociÃ© G, Gluckman E (2005) Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 11:672-679




 



14.
Rosenberg PS, Socié G, Alter BP, Gluckman E (2005). Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood  105, 67-73.   https://doi.org/10.1182/blood-2004-04-1652




PubMed


 


PubMed ID 15331448
    
     


 



15.
Wacholder S, Struewing JP, Hartge P, Greene MH, Tucker MA (2004). Breast cancer risks for BRCA1/2 carriers. Science  306, 2187-91; author reply 2187-91.




PubMed


 


PubMed ID 15622558
    
     


 



16.
Wideroff L, Vadaparampil S, Greene M, Taplin S, Olson L, Freedman A (2005) Hereditary BreastOvarian and Colorectal Cancer Genetics Knowledge in a National Sample of US Physicians. Journal of Medical Genetics 42:749-755",https://intramural.nih.gov/search/searchview.taf?ipid=36931
468,CP010145-06,"October 01, 2004 -  September 30, 2005",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Neelam K Giri; MD



Ruthann  Giusti



Jennifer T Loud



Christine M Mueller



Larissa A Korde","David  Alberts
(University of Arizona Cancer Center)




Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)




Molly  Brewer
(Arizona Cancer Center)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




M.  Constenino
(BioTech Laboratories)


Show all 17","Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Alisa  Goldstein; PhD (Genetic Epidemiology Branch)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Margaret Anne Tucker (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brewer MA, Ranger-Moore J, Baruche A, Alberts DS, Greene M, Thompson D, Liu Y, Davis J, Bartels PH (2005). Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev  14, 299-305.   https://doi.org/10.1158/1055-9965.EPI-04-0212




PubMed


 


PubMed ID 15734950",https://intramural.nih.gov/search/searchview.taf?ipid=36932
469,CP010146-06,"October 01, 2004 -  September 30, 2005",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Population Genetics, NCI","Nigel P Crawford; MB ChB, PhD



Luanne M Lukes



Haiyan  Yang","Daniel  Pomp
(UNC)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)




Danny  Welch
(Department of Pathology, University of Alabama, Birmingham)




Robert  Williams
(Center for Genomics and Bioinformatics, University of Tennessee, Memphis)","Kenneth  Buetow; PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



Natasha  Caplen (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
David T, Kent H, Fei Z, Kenneth M   (2004) Cancer Modifiers: Detection, Localization, and Identification, in Mouse Models of Human Cancer. Holland E, ed., John Wiley and Sons (New York), pp. 263-291.




 



2.
Hunter K (2004). Genetic, genomic, and bioinformatic tools for studying breast cancer progression. Breast Dis  19, 83-91.   https://doi.org/10.3233/bd-2004-19110




PubMed


 


PubMed ID 15687700
    
     


 



3.
Hunter KW (2004). Ezrin, a key component in tumor metastasis. Trends Mol Med  10, 201-4.   https://doi.org/10.1016/j.molmed.2004.03.001




PubMed


 


PubMed ID 15121044
    
     


 



4.
Hunter KW (2004). Host genetics and tumour metastasis. Br J Cancer  90, 752-5.   https://doi.org/10.1038/sj.bjc.6601590




PubMed



        
     
Free Article


 


PubMed ID 14970848
         Pubmed Central ID 2410172 


 



5.
Khanna C, Hunter K (2005). Modeling metastasis in vivo. Carcinogenesis  26, 513-23.   https://doi.org/10.1093/carcin/bgh261




PubMed


 


PubMed ID 15358632
    
     


 



6.
Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET (2004). Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res  64, 5973-81.   https://doi.org/10.1158/0008-5472.CAN-04-0242




PubMed


 


PubMed ID 15342376
    
     


 



7.
Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW (2005). Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis  22, 593-603.   https://doi.org/10.1007/s10585-005-6244-6




PubMed



        
     
Free Article


 


PubMed ID 16475030
         Pubmed Central ID 2048974",https://intramural.nih.gov/search/searchview.taf?ipid=36905
470,CP010147-06,"October 01, 2004 -  September 30, 2005",Genetic Predisposition to Aflatoxin-Induced Hepatocellular Carcinoma,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,Kenneth  Buetow; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36933
471,CP010149-06,"October 01, 2004 -  September 30, 2005",Epidemiology and Natural History of HTLV-I,"Michie  Hisada; MD, MPH, ScD",NULL,"Infection & Immunoepidemiology Branch, NCI","James Jerome Goedert; MD



Robert  Biggar; MD



Hong-Chuan  Li



Elizabeth E Brown



Anil Kumar Chaturvedi","Brenda  Birmann
(na)




Elizabeth  Breen
(UCLA)




Joseph  Giam
(USUHS)




Barrie  Hanchard
(University of the West Indies)




Annika  Linde
(Karolinska Institute)




Otto  Martinez-Maza
(UCLA AIDS Center)


Show all 12","Nilanjan  Chatterjee (Biostatistics Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Sophia S Wang; PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Barcellos NT, Kreitchmann R, Fuchs SC   (2005) Comments on the brief report Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I.  J Infect Dis 191:1780; author reply 1781.




PubMed


 


PubMed ID 15838809
    
     


 



2.
Hisada M, Miley WJ, Biggar RJ (2005). Provirus load is lower in human T lymphotropic virus (HTLV)-II carriers than in HTLV-I carriers: a key difference in viral pathogenesis? J Infect Dis  191, 1383-5; author reply 1385-6.   https://doi.org/10.1086/429094




PubMed


 


PubMed ID 15776392
    
     


 



3.
Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE (2004). Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis  190, 1605-9.   https://doi.org/10.1086/424598




PubMed


 


PubMed ID 15478065",https://intramural.nih.gov/search/searchview.taf?ipid=36958
472,CP010150-06,"October 01, 2004 -  September 30, 2005","HIV, human herpesvirus 8, and cancer","Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI","James Jerome Goedert; MD



Robert  Biggar; MD



Charles  Rabkin



Sam  Mbulaiteye","Malcolm  Brock; MD
(Surgery, Johns Hopkins Medical Institutions)




Ethel  Cesarman
( Weill Medical College of Cornell University, New York, New York)




Amy  Chadburn
( Weill Medical College of Cornell University, New York, New York)




Richard  Moore
(Johns Hopkins Hospital)","Denise  Whitby (Epidemiology and Biostatistics Program)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Elaine S Jaffe; MD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, Virgo P, Pfeiffer RM (2005). Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr  39, 293-9.   https://doi.org/10.1097/01.qai.0000164033.02947.e3




PubMed


 


PubMed ID 15980688
    
     


 



2.
Engels EA, Goedert JJ (2005). Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst  97, 407-9.   https://doi.org/10.1093/jnci/dji085




PubMed


 


PubMed ID 15769998
    
     


 



3.
Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006). Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer  118, 985-90.   https://doi.org/10.1002/ijc.21443




PubMed


 


PubMed ID 16106415",https://intramural.nih.gov/search/searchview.taf?ipid=36934
473,CP010151-06,"October 01, 2004 -  September 30, 2005",KSHV and other oncogenic viruses,Denise  Whitby,NULL,"Office of the Director, NCI",NULL,"Bruce  Armstrong
(University of Sydney, Sydney, Australia)




Nikolaus  Becker
(German Cancer Research Center, Heidelberg, Germany)




Francis  Black
(Yale University School of Public Health)




Paolo  Boffeta
(International Agency for Research on Cancer, Lyon, France)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)


Show all 30","James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)



Robert  Biggar; MD (Infection & Immunoepidemiology Branch)



Thomas R O'Brien; BA, MPH, MD (Hormonal and Reproductive Epidemiology Branch)



Charles  Rabkin (Infection & Immunoepidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Michie  Hisada; MD, MPH, ScD (Infection & Immunoepidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36935
474,CP010152-06,"October 01, 2004 -  September 30, 2005",Etiologic Studies in the PLCO Trial,Richard  Hayes; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Wen-Yi  Huang



Bu Tian  Ji","Gerry  Andriole
(Washington University)




Thomas  Beck
(NCI)




Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Timothy R. Church; PhD
(Environ & Occup Health, University of Minnesota School of Public Health)




David T Crawford





Mona  Fouad
(University of Alabama, Birmingham)


Show all 11","Jimmie B Vaught (Office of the Director)



Christine Dorothy Berg (Early Detection Research Group)",NULL,"Ordered by publication type and then author name.



1.
Hayes RB, Husgafvel-Pursiainen K, Vainio H (2005). Molecular epidemiology: convergence between toxicology and epidemiology. Mutat Res  592, 1-2.   https://doi.org/10.1016/j.mrfmmm.2005.05.009




PubMed


 


PubMed ID 15993432
    
     


 



2.
Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB (2005). GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev  14, 1823-7.   https://doi.org/10.1158/1055-9965.EPI-05-0037




PubMed


 


PubMed ID 16030123",https://intramural.nih.gov/search/searchview.taf?ipid=36936
475,CP010153-06,"October 01, 2004 -  September 30, 2005","Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C","Mary Helen Ward; MS, PhD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Debra  Silverman; ScD, ScM



Kenneth  Cantor; PhD



Patricia S Stewart; PhD","Patricia  Buffler
(Univerity of California at Berkeley)




David  Camann
(Southwest Research Institute)




James  Cerhan
(Mayo Clinic)




Anneclair  DeRoos
(University of Washington)




James  Giglierano
(Iowa Department of Natural Resources)




Martin  Kulldorf
(University of Connecticut)


Show all 12","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)



Michael  Hauptmann; PhD (Biostatistics Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36959
476,CP010154-06,"October 01, 2004 -  September 30, 2005",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Natacha  Diaz-Meyer



Sheryl A Gere



Mitsutaka  Kadota",NULL,"Kenneth  Buetow; PhD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, Han XY, Goldstein AM, Emmert-Buck MR, Buetow KH, Taylor PR, Lee MP (2005). Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res  65, 2542-6.   https://doi.org/10.1158/0008-5472.CAN-04-3247




PubMed


 


PubMed ID 15805246
    
     


 



2.
Lee MP (2005). Genome-wide analysis of allele-specific gene expression using oligo microarrays. Methods Mol Biol  311, 39-47.   https://doi.org/10.1385/1-59259-957-5:039




PubMed


 


PubMed ID 16100398
    
     


 



3.
Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS (2005). ATG deserts define a novel core promoter subclass. Genome Res  15, 1189-97.   https://doi.org/10.1101/gr.3873705




PubMed



        
     
Free Article


 


PubMed ID 16109972
         Pubmed Central ID 1199533 


 



4.
Lin W, Yang HH, Lee MP (2005). Allelic variation in gene expression identified through computational analysis of the dbEST database. Genomics  86, 518-27.   https://doi.org/10.1016/j.ygeno.2005.05.004




PubMed


 


PubMed ID 15993562
    
     


 



5.
Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP (2004). Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics  83, 395-401.   https://doi.org/10.1016/j.ygeno.2003.09.007




PubMed


 


PubMed ID 14962665
    
     


 



6.
Yang HH, Hu Y, Buetow KH, Lee MP (2004). A computational approach to measuring coherence of gene expression in pathways. Genomics  84, 211-7.   https://doi.org/10.1016/j.ygeno.2004.01.007




PubMed


 


PubMed ID 15203219
    
     


 



7.
Yang HH, Lee MP (2004). Application of bioinformatics in cancer epigenetics. Ann N Y Acad Sci  1020, 67-76.   https://doi.org/10.1196/annals.1310.008




PubMed


 


PubMed ID 15208184",https://intramural.nih.gov/search/searchview.taf?ipid=36937
477,CP010155-06,"October 01, 2004 -  September 30, 2005",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Howard H Yang,NULL,"Dinah  Singer; PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Thomas  Howcroft; PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, Han XY, Goldstein AM, Emmert-Buck MR, Buetow KH, Taylor PR, Lee MP (2005). Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res  65, 2542-6.   https://doi.org/10.1158/0008-5472.CAN-04-3247




PubMed


 


PubMed ID 15805246
    
     


 



2.
Lee MP (2005). Genome-wide analysis of allele-specific gene expression using oligo microarrays. Methods Mol Biol  311, 39-47.   https://doi.org/10.1385/1-59259-957-5:039




PubMed


 


PubMed ID 16100398
    
     


 



3.
Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS (2005). ATG deserts define a novel core promoter subclass. Genome Res  15, 1189-97.   https://doi.org/10.1101/gr.3873705




PubMed



        
     
Free Article


 


PubMed ID 16109972
         Pubmed Central ID 1199533 


 



4.
Lin W, Yang HH, Lee MP (2005). Allelic variation in gene expression identified through computational analysis of the dbEST database. Genomics  86, 518-27.   https://doi.org/10.1016/j.ygeno.2005.05.004




PubMed


 


PubMed ID 15993562
    
     


 



5.
Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP (2004). Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics  83, 395-401.   https://doi.org/10.1016/j.ygeno.2003.09.007




PubMed


 


PubMed ID 14962665
    
     


 



6.
Yang HH, Hu Y, Buetow KH, Lee MP (2004). A computational approach to measuring coherence of gene expression in pathways. Genomics  84, 211-7.   https://doi.org/10.1016/j.ygeno.2004.01.007




PubMed


 


PubMed ID 15203219
    
     


 



7.
Yang HH, Lee MP (2004). Application of bioinformatics in cancer epigenetics. Ann N Y Acad Sci  1020, 67-76.   https://doi.org/10.1196/annals.1310.008




PubMed


 


PubMed ID 15208184",https://intramural.nih.gov/search/searchview.taf?ipid=36938
478,CP010156-05,"October 01, 2004 -  September 30, 2005",Genetic Studies in Melanoma,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",Marbin A Pineda,NULL,"Margaret Anne Tucker (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Calista D, Minghetti P, Marinelli B, Albetti B, Tseng T, Hedayati M, Grossman L, Landi G, Struewing JP, Landi MT (2004). XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer  90, 497-502.   https://doi.org/10.1038/sj.bjc.6601385




PubMed



        
     
Free Article


 


PubMed ID 14735199
         Pubmed Central ID 2409542 


 



2.
Rutter JL, Bromley CM, Goldstein AM, Elder DE, Holly EA, Guerry D, Hartge P, Struewing JP, Hogg D, Halpern A, Sagebiel RW, Tucker MA (2004). Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer  101, 2809-16.   https://doi.org/10.1002/cncr.20669




PubMed


 


PubMed ID 15529312",https://intramural.nih.gov/search/searchview.taf?ipid=36906
479,CP010157-05,"October 01, 2004 -  September 30, 2005","Genetic, Epidemiologic, and Biochemical Studies of DNA Damage Repair","Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Marbin A Pineda



Denise L Stredrick","Irene  Jones
(Lawrence Livermore)




Polly  Newcomb
(Comprehensive Cancer Center, University of Wisconsin)




Linda  Titua-Ernstoff
(Department of Epidemiology, Dartmouth University)","Alice  Sigurdson; PhD (National Cancer Institute)



Montserrat  Garcia-Closas; MD, PhD (National Cancer Institute)



Michael  Hauptmann; PhD (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Sigurdson AJ, Hauptmann M, Alexander BH, Doody MM, Thomas CB, Struewing JP, Jones IM (2005). DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res  586, 173-88.   https://doi.org/10.1016/j.mrgentox.2005.07.001




PubMed


 


PubMed ID 16099702
    
     


 



2.
Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer  4, 9.   https://doi.org/10.1186/1471-2407-4-9




PubMed



        
     
Free Article


 


PubMed ID 15113441
         Pubmed Central ID 408462 


 



3.
Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ (2006). The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat  27, 538-44.   https://doi.org/10.1002/humu.20323




PubMed



        
     
Free Article


 


PubMed ID 16652348
         Pubmed Central ID 1850333",https://intramural.nih.gov/search/searchview.taf?ipid=36904
480,CP010158-05,"October 01, 2004 -  September 30, 2005",Studies of Rare Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Lori C Sakoda



Gabriella  Andreotti



Kelly Jen-Yi Yu","Streamson  Chua
(Columbia University)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




James  Dick
(Johns Hopkins Univeristy)




James  Fox
(MIT)




Yu-Tang  Gao
(Shanghai Cancer Institute)




Evelyene  Lennette
(Virolab, Inc.)


Show all 12","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Liu E, Sakoda LC, Gao YT, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni JF, Hsing AW (2005). Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev  14, 1315-8.   https://doi.org/10.1158/1055-9965.EPI-05-0032




PubMed


 


PubMed ID 15894693
    
     


 



2.
Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM, McGlynn KA (2005). Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer  115, 618-24.   https://doi.org/10.1002/ijc.20937




PubMed


 


PubMed ID 15704105",https://intramural.nih.gov/search/searchview.taf?ipid=36939
481,CP010162-05,"October 01, 2004 -  September 30, 2005",Gene expression profiles in lung cancer using cDNA arrays,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Megan  Hames



Sei Hoon  Yang



Hyo-Sung  Jeon",NULL,"Joanna H Shih (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC (2004). Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol  35, 1196-209.   https://doi.org/10.1016/j.humpath.2004.06.014




PubMed


 


PubMed ID 15492986
    
     


 



2.
Yang SH, Mechanic LE, Yang P, Landi MT, Bowman ED, Wampfler J, Meerzaman D, Hong KM, Mann F, Dracheva T, Fukuoka J, Travis W, Caporaso NE, Harris CC, Jen J (2005). Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res  11, 2106-10.   https://doi.org/10.1158/1078-0432.CCR-04-1853




PubMed


 


PubMed ID 15788655",https://intramural.nih.gov/search/searchview.taf?ipid=36940
482,CP010163-05,"October 01, 2004 -  September 30, 2005",Genetic analysis in early age of onset lung cancer patients,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Megan  Hames



Hyo-Sung  Jeon



Sei Hoon  Yang",NULL,"Joanna H Shih (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Jonathan S Wiest; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hong KM, Yang SH, Guo M, Herman JG, Jen J (2005). Semiautomatic detection of DNA methylation at CpG islands. Biotechniques  38, 354, 356, 358.   https://doi.org/10.2144/05383BM02




PubMed


 


PubMed ID 15786801
    
     


 



2.
Yang SH, Mechanic LE, Yang P, Landi MT, Bowman ED, Wampfler J, Meerzaman D, Hong KM, Mann F, Dracheva T, Fukuoka J, Travis W, Caporaso NE, Harris CC, Jen J (2005). Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res  11, 2106-10.   https://doi.org/10.1158/1078-0432.CCR-04-1853




PubMed


 


PubMed ID 15788655",https://intramural.nih.gov/search/searchview.taf?ipid=36941
483,CP010164-05,"October 01, 2004 -  September 30, 2005",Development of non-small cell lung cancer tissue microarray for systematic analy,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Sei Hoon  Yang



Megan  Hames



Hyo-Sung  Jeon",NULL,"Joanna H Shih (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res  10, 4314-24.   https://doi.org/10.1158/1078-0432.CCR-03-0489




PubMed


 


PubMed ID 15240517
    
     


 



2.
He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC (2004). Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol  35, 1196-209.   https://doi.org/10.1016/j.humpath.2004.06.014




PubMed


 


PubMed ID 15492986
    
     


 



3.
Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K (2004). Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res  2, 489-94.




PubMed


 


PubMed ID 15383627",https://intramural.nih.gov/search/searchview.taf?ipid=36942
484,CP010165-05,"October 01, 2004 -  September 30, 2005",Mechanisms of gene expression changes in lung cancer,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Megan  Hames



Hyo-Sung  Jeon



Sei Hoon  Yang",NULL,"Kent W Hunter; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



Ilona  Linnoila; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC (2004). Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol  35, 1196-209.   https://doi.org/10.1016/j.humpath.2004.06.014




PubMed


 


PubMed ID 15492986
    
     


 



2.
Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K (2004). Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res  2, 489-94.




PubMed


 


PubMed ID 15383627
    
     


 



3.
Monitto CL, Dong SM, Jen J, Sidransky D (2004). Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia. Clin Cancer Res  10, 5862-9.   https://doi.org/10.1158/1078-0432.CCR-04-0435




PubMed


 


PubMed ID 15355918",https://intramural.nih.gov/search/searchview.taf?ipid=36943
485,CP010167-05,"October 01, 2004 -  September 30, 2005",General Studies of Epidemiology,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Rebecca  Troisi



Patricia  Hartge; ScD","Clark  Anderson
(University of Kansas School of Medicine)




Chester  Douglass
(Harvard School of Dentistry)




Sheila  McGuire
(Harvard School of Dentistry)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36944
486,CP010168-05,"October 01, 2004 -  September 30, 2005",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Rebecca  Troisi



Nancy K Carter","Ervin  Adam
(Baylor College of Medicine)




Elizabeth  Hatch
(Boston University)




Arthur  Herbst
(University of Chicago)




Chung  Hsieh
(University of Massachuetts)




Michele  Lauria
(Dartmouth Hitchcock Medical Center)




Kenneth  Noller
(New England Medical Center)


Show all 15",NULL,NULL,"Ordered by publication type and then author name.



1.
Nilsen TI, Romundstad PR, Troisi R, Potischman N, Vatten LJ (2005). Birth size and colorectal cancer risk: a prospective population based study. Gut  54, 1728-32.   https://doi.org/10.1136/gut.2004.060475




PubMed



        
     
Free Article


 


PubMed ID 15843419
         Pubmed Central ID 1774802 


 



2.
Nilsen TI, Romundstad PR, Troisi R, Vatten LJ (2005). Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer  113, 1002-4.   https://doi.org/10.1002/ijc.20674




PubMed


 


PubMed ID 15514943
    
     


 



3.
Palmer JR, Wise LA, Robboy SJ, Titus-Ernstoff L, Noller KL, Herbst AL, Troisi R, Hoover RN (2005). Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology  16, 583-6.   https://doi.org/10.1097/01.ede.0000164789.59728.6d




PubMed


 


PubMed ID 15951681
    
     


 



4.
Strohsnitter WC, Noller KL, Titus-Ernstoff L, Troisi R, Hatch EE, Poole C, Glynn RJ, Hsieh CC (2005). Breast cancer incidence in women prenatally exposed to maternal cigarette smoke. Epidemiology  16, 342-5.   https://doi.org/10.1097/01.ede.0000158741.07645.9b




PubMed


 


PubMed ID 15824550",https://intramural.nih.gov/search/searchview.taf?ipid=36945
487,CP010169-04,"October 01, 2004 -  September 30, 2005","Nutrition, Metabolism, and Cancer","Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Patricia  Hartge; ScD,"Ray  Greenberg
(University of South Carolina)




Rudolf  Kaaks
(International Agency for Research on Cancer)




Lawrence  Kolonel
(University of Hawaii)




Abraham  Nomura
(School of Public Health, University of Hawaii)




Emanuel  Petricoin, III
(Food and Drug Administration)




Malcolm  Pike
(University of Southern California)


Show all 11","Demetrius  Albanes; MD (Office of the Director)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Gloria L Gridley (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Falk RT, Fears TR, Xu X, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Sepkovic DW, Bradlow HL, Ziegler RG (2005). Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev  14, 221-6.




PubMed


 


PubMed ID 15668498
    
     


 



2.
Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005). Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr  81, 1147-54.   https://doi.org/10.1093/ajcn/81.5.1147




PubMed


 


PubMed ID 15883441
    
     


 



3.
Xu X, Keefer LK, Waterhouse DJ, Saavedra JE, Veenstra TD, Ziegler RG (2004). Measuring seven endogenous ketolic estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem  76, 5829-36.   https://doi.org/10.1021/ac049405i




PubMed


 


PubMed ID 15456304",https://intramural.nih.gov/search/searchview.taf?ipid=36951
488,CP010170-05,"October 01, 2004 -  September 30, 2005",Multidisciplinary Studies of Lymphoma,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Wendy  Cozen
(Norris Comprehensive Cancer Center)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




Anneclaire  De Roos
(University of Washington, Seattle, WA)




Maryjean  Schenk
(Barbara Karmanos Cancer Institute)




Richard  Severson
(Barbara Karmanos Cancer Institute)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Hartge P, Colt JS, Severson RK, Cerhan JR, Cozen W, Camann D, Zahm SH, Davis S (2005). Residential herbicide use and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  14, 934-7.   https://doi.org/10.1158/1055-9965.EPI-04-0730




PubMed


 


PubMed ID 15824166
    
     


 



2.
Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C, Hughes AM, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Zheng T (2005). Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev  14, 925-33.   https://doi.org/10.1158/1055-9965.EPI-04-0693




PubMed


 


PubMed ID 15824165
    
     


 



3.
Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D, Chang ET, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Hartge P, InterLymph Consortium (2005). Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol  6, 469-76.   https://doi.org/10.1016/S1470-2045(05)70214-X




PubMed


 


PubMed ID 15992695",https://intramural.nih.gov/search/searchview.taf?ipid=36946
489,CP010171-05,"October 01, 2004 -  September 30, 2005",Assessing the Risk of Breast and Ovarian Cancer,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI","Robert  Hoover; MD, ScD","Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Doug  Reding
(Marshfield Clinic Research Foundation)","Sholom  Wacholder; PhD (Biostatistics Branch)



James V Lacey; MPH, PhD (Hormonal and Reproductive Epidemiology Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)



Christine Dorothy Berg (Early Detection Research Group)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36947
490,CP010172-05,"October 01, 2003 -  September 30, 2004",Simian Virus 40 (SV40),"Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Morten  Frisch
(Danish Serum Institute)




Denise  Galloway
(Fred Hutchinson Cancer Center)




Robert  Garcea
(University of Colorado Health Sciences Center)




Mark A. Klebanoff; MD, MPH
(NICHHD)




David  Malkin
(University of Toronto Hospital for Sick Children)




Keerti  Shah
(Johns Hopkins University)


Show all 7","James Jerome Goedert; MD (National Cancer Institute)



Philip Samuel Rosenberg; PhD (National Cancer Institute)



Nilanjan  Chatterjee (National Cancer Institute)



Jinbo  Chen (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Engels EA (2005). Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research. Expert Rev Vaccines  4, 197-206.   https://doi.org/10.1586/14760584.4.2.197




PubMed


 


PubMed ID 15889993
    
     


 



2.
Engels EA (2005). Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence. Cancer Invest  23, 529-36.   https://doi.org/10.1080/07357900500202820




PubMed


 


PubMed ID 16203661
    
     


 



3.
Engels EA, Rollison DE, Hartge P, Baris D, Cerhan JR, Severson RK, Cozen W, Davis S, Biggar RJ, Goedert JJ, Viscidi RP (2005). Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer  117, 1013-9.   https://doi.org/10.1002/ijc.21277




PubMed


 


PubMed ID 15986438",https://intramural.nih.gov/search/searchview.taf?ipid=41940
491,CP010175-05,"October 01, 2004 -  September 30, 2005",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Daoud M Meerzaman



Phillip D Wise



Robert  Clifford",NULL,Leslie  Derr (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36948
492,CP010176-05,"October 01, 2004 -  September 30, 2005",Epidemiology and Natural History of Cancer-Associated Viruses,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD



Eric Andrew Engels; PhD



Michie  Hisada; MD, MPH, ScD



Charles  Rabkin



Sam  Mbulaiteye","M. Elaine  Eyster
(Pennsylvania State University)




Angelos  Hatzakis
(University of Athens Medical School)




Michael  Lederman; MD
(Case Western Reserve University)




Nino  Romano
(University of Palermo)




Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)




David  Thomas
(Johns Hopkins University)


Show all 7","Philip Samuel Rosenberg; PhD (Biostatistics Branch)



Thomas R O'Brien; BA, MPH, MD (Hormonal and Reproductive Epidemiology Branch)



Denise  Whitby (Epidemiology and Biostatistics Program)



Barry Ira Graubard; PhD (Biostatistics Branch)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Allan JM, Rabkin CS (2005). Genetic susceptibility to iatrogenic malignancy. Pharmacogenomics  6, 615-28.   https://doi.org/10.2217/14622416.6.6.615




PubMed


 


PubMed ID 16143001
    
     


 



2.
Biggar RJ (2005). Vaginal cleansing and the gold standard. J Womens Health (Larchmt)  14, 531-3.   https://doi.org/10.1089/jwh.2005.14.531




PubMed


 


PubMed ID 16115008
    
     


 



3.
Brown EE, Fallin MD, Goedert JJ, Chen R, Whitby D, Foster CB, Lauria C, Alberg AJ, Messina A, Montella M, Rezza G, Vitale F, Chanock SJ, Kaposi Sarcoma Genetics Working Group (2005). A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev  14, 633-7.   https://doi.org/10.1158/1055-9965.EPI-04-0598




PubMed


 


PubMed ID 15767342
    
     


 



4.
Goedert JJ (2005). Preventing infection-associated cancer: from bench to hillside. J Natl Cancer Inst  97, 245-6.   https://doi.org/10.1093/jnci/dji059




PubMed


 


PubMed ID 15713953
    
     


 



5.
Goedert JJ, Second Multicenter Hemophilia Cohort Study (2005). Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia  11, 516-28.   https://doi.org/10.1111/j.1365-2516.2005.01138.x




PubMed


 


PubMed ID 16128897
    
     


 



6.
Hisada M, Chatterjee N, Kalaylioglu Z, Battjes RJ, Goedert JJ (2005). Hepatitis C virus load and survival among injection drug users in the United States. Hepatology  42, 1446-52.   https://doi.org/10.1002/hep.20938




PubMed


 


PubMed ID 16317675
    
     


 



7.
Kirk GD, Lesi OA, Mendy M, Szymañska K, Whittle H, Goedert JJ, Hainaut P, Montesano R (2005). 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene  24, 5858-67.   https://doi.org/10.1038/sj.onc.1208732




PubMed


 


PubMed ID 16007211
    
     


 



8.
Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE, Multicenter Hemophilia Cohort Study Group (2005). HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood  105, 533-41.   https://doi.org/10.1182/blood-2004-04-1452




PubMed


 


PubMed ID 15374882
    
     


 



9.
Semmes OJ, Cazares LH, Ward MD, Qi L, Moody M, Maloney E, Morris J, Trosset MW, Hisada M, Gygi S, Jacobson S (2005). Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease. Leukemia  19, 1229-38.   https://doi.org/10.1038/sj.leu.2403781




PubMed


 


PubMed ID 15889159",https://intramural.nih.gov/search/searchview.taf?ipid=36949
493,CP010177-05,"October 01, 2004 -  September 30, 2005",HPV Vaccine Trials,"Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,"Concepcion  Bratti
(Costa Rican Social Security)




Clayton  Harro
(Johns Hopkins School of Medicine)




Rolando  Herrero
(Ministry of Health)




Ana Cecilia  Rodriguez
(Costa Rican Social Security)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



John  Schiller; PhD (Laboratory of Cellular Oncology)



Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36950
494,CP010178-04,"October 01, 2004 -  September 30, 2005",Core Genotyping Facility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bergen AW, Haque KA, Qi Y, Beerman MB, Garcia-Closas M, Rothman N, Chanock SJ (2005). Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources. Hum Mutat  26, 262-70.   https://doi.org/10.1002/humu.20213




PubMed


 


PubMed ID 16086324
    
     


 



2.
Bergen AW, Qi Y, Haque KA, Welch RA, Chanock SJ (2005). Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance. BMC Biotechnol  5, 24.   https://doi.org/10.1186/1472-6750-5-24




PubMed



        
     
Free Article


 


PubMed ID 16168060
         Pubmed Central ID 1249558 


 



3.
Hughes AL, Packer B, Welch R, Bergen AW, Chanock SJ, Yeager M (2005) Effects of natural selection on interpopulation divergence at polymorphic sites in human protein-coding loci. Genetics 170:1181-1187",https://intramural.nih.gov/search/searchview.taf?ipid=36952
495,CP010180-04,"October 01, 2003 -  September 30, 2004",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Peter  Carroll
(UCSF)




Chawnshang  Chang
(University of Rochester)




Chu  Chen
(University of Washington)




Streamson  Chua
(Columbia University)




Angelo  DeMarzo
(Johns Hopkins U)




Yu-Tang  Gao
(Shanghai Cancer Institute)


Show all 13","Richard  Hayes; PhD (National Cancer Institute)



Lori C Sakoda (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, Stanczyk FZ, Hsing AW (2005). Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev  14, 1703-9.   https://doi.org/10.1158/1055-9965.EPI-04-0809




PubMed


 


PubMed ID 16030105",https://intramural.nih.gov/search/searchview.taf?ipid=41941
496,CP010181-03,"October 01, 2004 -  September 30, 2005",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Thomas  Fears; PhD



Nilanjan  Chatterjee



Joseph L Gastwirth



Michael  Hauptmann; PhD



Hormuzdiar Aspandiar Katki; MS



Philip Samuel Rosenberg; PhD



Show all 12","Jacques  Benichou
(University of Rouen Medical School)




Efstathia  Bura
(The George Washington University, Washington, DC)




Celia  Byrne
(George Washington University)




Raymond  Carroll
(Texas A&M University)




Sarah  Daugherty
(Johns Hopkins University)




Laure  El Ghormli
(GW Biostat)


Show all 15","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Lynn Rachel Goldin; PhD (Genetic Epidemiology Branch)



Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)



Mark H Greene; MD (Clinical Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Pfeiffer RM, Castle PE (2005). With or without a gold standard. Epidemiology  16, 595-7.   https://doi.org/10.1097/01.ede.0000173328.31497.ec




PubMed


 


PubMed ID 16135933
    
     


 



2.
Pfeiffer RM, Ryan L, Litonjua A, Pee D (2005). A case-cohort design for assessing covariate effects in longitudinal studies. Biometrics  61, 982-91.   https://doi.org/10.1111/j.1541-0420.2005.00364.x




PubMed


 


PubMed ID 16401271
    
     


 



3.
Spinka C, Carroll RJ, Chatterjee N (2005). Analysis of case-control studies of genetic and environmental factors with missing genetic information and haplotype-phase ambiguity. Genet Epidemiol  29, 108-27.   https://doi.org/10.1002/gepi.20085




PubMed



        
     
Free Article


 


PubMed ID 16080203
         Pubmed Central ID 2585318",https://intramural.nih.gov/search/searchview.taf?ipid=36903
497,CP010182-03,"October 01, 2004 -  September 30, 2005",Epidemiologic Field Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil



Nilanjan  Chatterjee



Ruth  Pfeiffer; PhD



Catherine G Schairer



Thomas  Fears; PhD



Michael  Hauptmann; PhD



Show all 8","Joe  Ayotte
(US Geological Survey)




Farhat  Ben Ayed
(Institute Salah Azaiz, Tunis)




Tetyana  Bogdanova
(Institute of Endocrinology & Metabolism)




John  Boice, Jr.
(International Epidemiology Institute)




Aaron  Brill
(Vanderbilt University)




Raymond  Carroll
(Texas A&M University)


Show all 78","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Mark H Greene; MD (Clinical Genetics Branch)



Joseph  Fraumeni; MD (Office of the Director)



Ruth Anne Kleinerman; MPH (Radiation Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)



Elaine  Ron; PhD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Fears TR, Tucker MA (2005). Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst  97, 1789-90; author reply 1791.   https://doi.org/10.1093/jnci/dji410




PubMed


 


PubMed ID 16333038
    
     


 



2.
Lacey JV, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2005). Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev  14, 1724-31.   https://doi.org/10.1158/1055-9965.EPI-05-0111




PubMed


 


PubMed ID 16030108
    
     


 



3.
Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME (2005). Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women. Cancer Epidemiol Biomarkers Prev  14, 1660-5.   https://doi.org/10.1158/1055-9965.EPI-05-0017




PubMed


 


PubMed ID 16030098
    
     


 



4.
You WC, Hong JY, Zhang L, Pan KF, Pee D, Li JY, Ma JL, Rothman N, Caporaso N, Fraumeni JF, Xu GW, Gail MH (2005). Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol Biomarkers Prev  14, 451-8.   https://doi.org/10.1158/1055-9965.EPI-04-0311




PubMed


 


PubMed ID 15734972",https://intramural.nih.gov/search/searchview.taf?ipid=36955
498,CP010183-03,"October 01, 2004 -  September 30, 2005",Descriptive Studies and Record Linkage,Susan Shaw Devesa,NULL,"Biostatistics Branch, NCI","Gloria L Gridley



Linda M Brown; MPH, DPhil



Mitchell Henry Gail; PhD, MD



Catherine G Schairer



Ruth  Pfeiffer; PhD



Jay  Lubin; PhD



Show all 9","Hans-Olov  Adami
(Karolinska Institute)




Johan  Askling
(Karolinska Institute)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paige  Bracci
(UCSF)




Leslie  Carroll
(IMS)




Anand  Chokkalingam
(Celera Diagnostics, Alameda, CA)


Show all 34","Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Joseph  Fraumeni; MD (Office of the Director)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005). International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer  117, 294-9.   https://doi.org/10.1002/ijc.21183




PubMed


 


PubMed ID 15900604",https://intramural.nih.gov/search/searchview.taf?ipid=36902
499,CP010184-03,"October 01, 2004 -  September 30, 2005",Consultation and Collaboration,Jay  Lubin; PhD,NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil



Nilanjan  Chatterjee



Mitchell Henry Gail; PhD, MD



Barry Ira Graubard; PhD



Gloria L Gridley



Michael  Hauptmann; PhD



Show all 9","Paul M.  Bakaki
(Makerere University Medical School and Mulago Hospital, Kampala, Uganda)




A.  Barrett
(National Heart, Lung, and Blood Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




David  Brenner
(Columbia University)




Robert  Burk
(Albert Einstein College of Medicine)




Julianne  Byrne
(Washington Children's hospital)


Show all 82","Michael  Alavanja; PhD (Occupational and Environmental Epidemiology Branch)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Robert  Biggar; MD (Infection & Immunoepidemiology Branch)



Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Wong H Chow (Occupational and Environmental Epidemiology Branch)



Joseph B Coble (Occupational and Environmental Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36957
500,CP010185-03,"October 01, 2004 -  September 30, 2005",Bioterrorism Studies,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Maureen Cusack Hatch; MD



Nickolas  Luckyanov



Elaine  Ron; PhD



Charles E. Land; PhD



Kiyohiko  Mabuchi; MD, DPhil



Ethel S Gilbert



Show all 9",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36956
501,CP010186-01,"October 01, 2004 -  September 30, 2005",Radiation-Induced Stomach Cancer,Lois B Travis; PhD,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis



Ethel S Gilbert



Kiyohiko  Mabuchi; MD, DPhil



Regan A Howard","James  Allan
(University of Leeds)




Aage  Andersen
(Norwegian Cancer Registry)




Sophie  Fossa





Eric  Hall
(Columbia University, New York, NY)




Eric  Holowaty
(Cancer Care Ontario)




Charles  Lynch
(University of Iowa)


Show all 10","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mary Louise McMaster; MD (Genetic Epidemiology Branch)



Michael  Hauptmann; PhD (Biostatistics Branch)



Catherine G Schairer (Biostatistics Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41858
502,CP010187-01,"October 01, 2004 -  September 30, 2005",CGEMS,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41860
503,CP010188-01,"October 01, 2004 -  September 30, 2005",Risk prediction methods,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Lois B Travis; PhD (Radiation Epidemiology Branch)



Demetrius  Albanes; MD (Office of the Director)



Andrew  Freedman (Risk Factor Monitoring and Methods Branch)



Graham  Colditz (Epidemiology and Genetics Research Program)



Kathleen A Cronin (Statistical Research and Applications Branch)",NULL,"Ordered by publication type and then author name.



1.
Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME (2005). Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women. Cancer Epidemiol Biomarkers Prev  14, 1660-5.   https://doi.org/10.1158/1055-9965.EPI-05-0017




PubMed


 


PubMed ID 16030098",https://intramural.nih.gov/search/searchview.taf?ipid=41773
504,CP010189-01,"October 01, 2004 -  September 30, 2005",Barretts esophagus,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu,NULL,"Sanford Martin Dawsey; MD (Nutritional Epidemiology Branch)



Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)



Mark J Roth (Nutritional Epidemiology Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=41857
505,SC000164-14,"October 01, 2004 -  September 30, 2005",The Molecular Mechanisms of Oncogene Action,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Aaron B Bell



Tomas A Bonome



Howard  Donninger



Liewei  Xu



Fumihiro  Hommura



Virna D Leaner



Show all 9",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36781
506,SC000165-14,"October 01, 2004 -  September 30, 2005",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Aaron B Bell



Tomas A Bonome



Howard  Donninger



Fumihiro  Hommura



Virna D Leaner



Haihao  Sun



Show all 9",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36782
507,SC000166-14,"October 01, 2004 -  September 30, 2005",Transforming Growth Factor-beta in Lung Cancer and Carcinogenesis,Sonia B Jakowlew; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Lana  Kandalaft



Mi Jung  Lim



Laurent L Ozbun



Jyotsna  Pandey",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ozbun LL, Martínez A, Jakowlew SB (2005). Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear and cytoplasmic localization and increases TGF-beta1-responsive transcription in primates. Biochim Biophys Acta  1728, 163-80.   https://doi.org/10.1016/j.bbaexp.2005.02.010




PubMed


 


PubMed ID 15823505",https://intramural.nih.gov/search/searchview.taf?ipid=36783
508,SC000167-14,"October 01, 2004 -  September 30, 2005",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Sandra  Jensen-Taubman



Heungnam  Kim



Kemi  Tomobi



Xiaoyang  Wang","Doug  Ball
(Oncology, Johns Hopkins University)




Franco  DeMayo
(Cell Biology, Baylor Medical College)




H. Leighton  Grimes
(Institute for Cellular Therapeutics, University of Louisville)




Ralph  Meuwissen
(Molecular Genetics, Netherlands Cancer Institute)




Steven H.  Reynolds
(NIOSH, CDC)","Seth M Steinberg; PhD (National Cancer Institute)



Thomas  Reid; MD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Jin  Jen (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Linnoila I, Meuwissen R, Berns A, DeMayo F   (2004) Mouse lung neuroendocrine carcinomas: Distinct morphologies, same transcription factors.  Experimental Lung Research .




 



2.
Linnoila I, Philburn R, Patterson A, Velasco-miguel S, Friedberg E, Fornace A   (2005) Deletion of XPC leads to lung tumors in mice and is associated with erly events in human carcinogenesis.  Proc. Natl. Acad. Sci, in press.




 



3.
Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF (2004). Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res  10, 1565-73.   https://doi.org/10.1158/1078-0432.ccr-1020-3




PubMed


 


PubMed ID 15014005
    
     


 



4.
Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, Rehm S, Rozengurt N, Schuller HM, Shmidt EN, Travis WD, Ward JM, Jacks T (2004). Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res  64, 2307-16.   https://doi.org/10.1158/0008-5472.can-03-3376




PubMed


 


PubMed ID 15059877
    
     


 



5.
West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA (2004). Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res  64, 446-51.   https://doi.org/10.1158/0008-5472.can-03-3241




PubMed


 


PubMed ID 14744754
    
     


 



6.
West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA (2004). Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo. Chest  125, 101S-2S.   https://doi.org/10.1378/chest.125.5_suppl.101s




PubMed


 


PubMed ID 15136436
    
     


 



7.
Yang Y, Zhang Z, Mukherjee AB, Linnoila RI (2004). Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke. J Biol Chem  279, 29336-40.   https://doi.org/10.1074/jbc.C400162200




PubMed


 


PubMed ID 15148323",https://intramural.nih.gov/search/searchview.taf?ipid=36784
509,SC000173-14,"October 01, 2004 -  September 30, 2005",Identification of Peptide Growth Factors That Regulate Human Tumor Proliferation,Frank  Cuttitta; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Alfredo  Martinez; PhD



Sergio  Portal



Elizabeth  Warner","John  Chirgwin
(Internal Medicine, University of Virginia Health System)




Vundavalli  Murty
(Pathology, College of Physicians & Surgeons of Columbia University)","William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Laurent L Ozbun (National Cancer Institute)



Sonia B Jakowlew; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Michael  Birrer (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cuttitta F, Falco C, Garayoa M, Pío R, Montuenga L, Julián M, Martinez A, Zudaire E   (2006) Adrenomedullin: An Esoteric Juggernaut of Human Cancers, in Handbook of Biologically Active Peptides. Abba K, ed., Elsevier (San Diego), in press.




 



2.
Ajona D, Castaño Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R (2004). Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res  64, 6310-8.   https://doi.org/10.1158/0008-5472.CAN-03-2328




PubMed


 


PubMed ID 15342420
    
     


 



3.
Cuesta N, Martínez A, Cuttitta F, Zudaire E (2005). Identification of adrenomedullin in avian type II pneumocytes: increased expression after exposure to air pollutants. J Histochem Cytochem  53, 773-80.   https://doi.org/10.1369/jhc.4A6498.2005




PubMed


 


PubMed ID 15928326
    
     


 



4.
Cuttitta F, Martínez A, Garayoa M, Pío R, Kaur G, Woolhiser M, Metcalfe D, Hook W, Siraganian R, Guise T, Chirgwin J   (2005) Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis.  American Journal of Pathology, in press.




 



5.
Julián M, Cacho M, García MA, Martín-Santamaría S, de Pascual-Teresa B, Ramos A, Martínez A, Cuttitta F (2005). Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur J Med Chem  40, 737-50.   https://doi.org/10.1016/j.ejmech.2004.10.016




PubMed


 


PubMed ID 15927308
    
     


 



6.
Martínez A, Julián M, Bregonzio C, Notari L, Moody TW, Cuttitta F (2004). Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology  145, 3858-65.   https://doi.org/10.1210/en.2003-1251




PubMed


 


PubMed ID 15107357
    
     


 



7.
Martínez A, Oh HR, Unsworth EJ, Bregonzio C, Saavedra JM, Stetler-Stevenson WG, Cuttitta F (2004). Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J  383, 413-8.   https://doi.org/10.1042/BJ20040920




PubMed



        
     
Free Article


 


PubMed ID 15307819
         Pubmed Central ID 1133733 


 



8.
Martínez A, Zudaire E, Julián M, Moody TW, Cuttitta F (2005). Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo. Oncogene  24, 4106-13.   https://doi.org/10.1038/sj.onc.1208581




PubMed


 


PubMed ID 15750618
    
     


 



9.
Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F (2004). Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res  64, 6489-94.   https://doi.org/10.1158/0008-5472.CAN-04-0103




PubMed


 


PubMed ID 15374959
    
     


 



10.
Zudaire E, Cuesta N, Martínez A, Cuttitta F (2005). Characterization of adrenomedullin in birds. Gen Comp Endocrinol  143, 10-20.   https://doi.org/10.1016/j.ygcen.2005.02.014




PubMed


 


PubMed ID 15993100
    
     


 



11.
Zudaire E, Martínez A, Ozbun LL, Cuttitta F (2004). Characterization of adrenomedullin in non-human primates. Biochem Biophys Res Commun  321, 859-69.   https://doi.org/10.1016/j.bbrc.2004.07.032




PubMed


 


PubMed ID 15358106",https://intramural.nih.gov/search/searchview.taf?ipid=36787
510,SC000181-13,"October 01, 2004 -  September 30, 2005",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Aaron B Bell



Tomas A Bonome



Howard  Donninger



Fumihiro  Hommura



Virna D Leaner



Haihao  Sun



Show all 9",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36788
511,SC000192-12,"October 01, 2004 -  September 30, 2005",Growth of Human Tumor Cell Lines in Protein-freeHormone-Free Media,Frank  Cuttitta; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Alfredo  Martinez; PhD



Sergio  Portal



Elizabeth  Warner","John  Chirgwin
(Internal Medicine, University of Virginia Health System)




Vundavalli  Murty
(Pathology, College of Physicians & Surgeons of Columbia University)","William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)



Sonia B Jakowlew; PhD (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cuttitta F, Falco C, Garayoa M, Pío R, Montuenga L, Julián M, Martinez A, Zudaire E   (2006) Adrenomedullin: An Esoteric Juggernaut of Human Cancers, in Handbook of Biologically Active Peptides. Abba K, ed., Elsevier (San Diego), in press.




 



2.
Ajona D, Castaño Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R (2004). Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res  64, 6310-8.   https://doi.org/10.1158/0008-5472.CAN-03-2328




PubMed


 


PubMed ID 15342420
    
     


 



3.
Cuttitta F, Martínez A, Garayoa M, Pío R, Kaur G, Woolhiser M, Metcalfe D, Hook W, Siraganian R, Guise T, Chirgwin J   (2005) Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis.  American Journal of Pathology, in press.




 



4.
Julián M, Cacho M, García MA, Martín-Santamaría S, de Pascual-Teresa B, Ramos A, Martínez A, Cuttitta F (2005). Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur J Med Chem  40, 737-50.   https://doi.org/10.1016/j.ejmech.2004.10.016




PubMed


 


PubMed ID 15927308
    
     


 



5.
Martínez A, Julián M, Bregonzio C, Notari L, Moody TW, Cuttitta F (2004). Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology  145, 3858-65.   https://doi.org/10.1210/en.2003-1251




PubMed


 


PubMed ID 15107357
    
     


 



6.
Martínez A, Oh HR, Unsworth EJ, Bregonzio C, Saavedra JM, Stetler-Stevenson WG, Cuttitta F (2004). Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J  383, 413-8.   https://doi.org/10.1042/BJ20040920




PubMed



        
     
Free Article


 


PubMed ID 15307819
         Pubmed Central ID 1133733 


 



7.
Martínez A, Zudaire E, Julián M, Moody TW, Cuttitta F (2005). Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo. Oncogene  24, 4106-13.   https://doi.org/10.1038/sj.onc.1208581




PubMed


 


PubMed ID 15750618
    
     


 



8.
Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F (2004). Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res  64, 6489-94.   https://doi.org/10.1158/0008-5472.CAN-04-0103




PubMed


 


PubMed ID 15374959",https://intramural.nih.gov/search/searchview.taf?ipid=36789
512,SC000550-25,"October 01, 2004 -  September 30, 2005",Lymphoma Disease Discovery and Defintion,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jacquelyn E Grays



Mark  Raffeld; MD



Jeffrey Andrew Schrager; MD



Wayne W Chen



Andrew L Feldman; MD



Paul C Herrmann



Show all 8",NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (National Cancer Institute)",Stephen E Straus; MD (NIAID),"Ordered by publication type and then author name.



1.
Colomo L, Loong F, Rives S, Pittaluga S, Martínez A, López-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E (2004). Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol  28, 736-47.   https://doi.org/10.1097/01.pas.0000126781.87158.e3




PubMed


 


PubMed ID 15166665
    
     


 



2.
Feldman AL, Berthold F, Arceci RJ, Abramowsky C, Shehata BM, Mann KP, Lauer SJ, Pritchard J, Raffeld M, Jaffe ES (2005). Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol  6, 435-7.   https://doi.org/10.1016/S1470-2045(05)70211-4




PubMed


 


PubMed ID 15925822
    
     


 



3.
Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES (2004). Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol  5, 248-50.   https://doi.org/10.1016/S1470-2045(04)01428-7




PubMed


 


PubMed ID 15050956
    
     


 



4.
Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC, Lymphoma/Leukemia Molecular Profiling Project (2005). Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood  106, 4315-21.   https://doi.org/10.1182/blood-2005-04-1753




PubMed



        
     
Free Article


 


PubMed ID 16123218
         Pubmed Central ID 1895253 


 



5.
Gulmann C, Espina V, Petricoin E, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL (2005). Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res  11, 5847-55.   https://doi.org/10.1158/1078-0432.CCR-05-0637




PubMed


 


PubMed ID 16115925
    
     


 



6.
Hornick JL, Jaffe ES, Fletcher CD (2004). Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol  28, 1133-44.   https://doi.org/10.1097/01.pas.0000131541.95394.23




PubMed


 


PubMed ID 15316312
    
     


 



7.
Jaffe E, Pittaluga S, Gaulard P, Sorbara L, Alonso M, Raffeld M   (2005) Mediastinal Grey Zone Lymphoma: The missing link between classical Hodgkins lymphoma and mediastinal large B cell lymphoma.  Am J Surg Pathol, in press.




 



8.
Jaffe ES (2004). Mature T-cell and NK-cell lymphomas in the pediatric age group. Am J Clin Pathol  122 Suppl, S110-21.   https://doi.org/10.1309/0DJW8GX2EKF7U1UG




PubMed


 


PubMed ID 15690647
    
     


 



9.
Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW (2004). Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. Blood  104, 2007-9.   https://doi.org/10.1182/blood-2004-04-1431




PubMed


 


PubMed ID 15205266
    
     


 



10.
Kumar S, Pittaluga S, Raffeld M, Guerrera M, Seibel NL, Jaffe ES (2005). Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol  8, 52-60.   https://doi.org/10.1007/s10024-004-8087-6




PubMed


 


PubMed ID 15719203
    
     


 



11.
Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani PL, Pozzobon M, Pulford K, Falini B, Jaffe ES, Müller-Hermelink HK, Mason DY, Pileri SA (2004). Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Haematologica  89, 957-64.




PubMed


 


PubMed ID 15339679
    
     


 



12.
Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES (2005). Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol  29, 903-11.   https://doi.org/10.1097/01.pas.0000157997.61177.08




PubMed


 


PubMed ID 15958855
    
     


 



13.
Nava VE, Jaffe ES (2005). The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol  12, 27-34.   https://doi.org/10.1097/01.pap.0000151318.34752.80




PubMed


 


PubMed ID 15614162
    
     


 



14.
Ozdemirli M, Cheson B, Jaffe ES (2004). What is anaplastic large cell lymphoma? Am J Surg Pathol  28, 1664-5; author reply 1665-7.   https://doi.org/10.1097/00000478-200412000-00019




PubMed


 


PubMed ID 15577690
    
     


 



15.
Patsalides AD, Atac G, Hedge U, Janik J, Grant N, Jaffe ES, Dwyer A, Patronas NJ, Wilson WH (2005). Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology  237, 265-73.   https://doi.org/10.1148/radiol.2371041087




PubMed


 


PubMed ID 16100084
    
     


 



16.
Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM (2004). Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood  103, 4251-8.   https://doi.org/10.1182/blood-2003-07-2365




PubMed


 


PubMed ID 14976040
    
     


 



17.
Schrager JA, Pittaluga S, Raffeld M, Jaffe ES (2005). Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. Am J Surg Pathol  29, 1115-6.




PubMed


 


PubMed ID 16006809
    
     


 



18.
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005). WHO-EORTC classification for cutaneous lymphomas. Blood  105, 3768-85.   https://doi.org/10.1182/blood-2004-09-3502




PubMed


 


PubMed ID 15692063
    
     


 



19.
Zu Y, Steinberg SM, Campo E, Hans CP, Weisenburger DD, Braziel RM, Delabie J, Gascoyne RD, Muller-Hermlink K, Pittaluga S, Raffeld M, Chan WC, Jaffe ES, Pathology Panel of the Lymphoma/Leukemia Molecular Profiling Project (2005). Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma. Leuk Lymphoma  46, 693-701.   https://doi.org/10.1080/10428190500051844




PubMed


 


PubMed ID 16019506",https://intramural.nih.gov/search/searchview.taf?ipid=36790
513,SC000853-52,"October 01, 2004 -  September 30, 2005",Surgical Pathology,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Martha Maria Nicacio Quezado; MD



Sedric V Cade



David Erwin Kleiner; MD, PhD",NULL,"William Marston Linehan; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Celeste Rita Riley (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36792
514,SC000891-22,"October 01, 2004 -  September 30, 2005",Stimulated Motility in Tumor Cells,"Lance A Liotta; MD, PhD",NULL,"Laboratory of Pathology, NCI",Elliott  Schiffman,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36793
515,SC000892-22,"October 01, 2004 -  September 30, 2005",Molecular Biology of the Metastatic Phenotype,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Douglas O Halverson



Diane  Palmieri



Christine E Horak



Jong Heun Lee",NULL,"William D Figg; PharmD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



David A Berrigan (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Stephen D Hursting; PhD, MPH (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Steeg P   (2004) Control of Invasion and Metastasis, in Diseases of the Breast, Third Edition. Harris J, Lippman M, Morrow M, Osborne C, eds., Lippencott and Wilkens (New York), pp. 459-472.




 



2.
Horak CE, Steeg PS (2005). Metastasis gets site specific. Cancer Cell  8, 93-5.   https://doi.org/10.1016/j.ccr.2005.07.013




PubMed


 


PubMed ID 16098461
    
     


 



3.
Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS (2005). Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst  97, 632-42.   https://doi.org/10.1093/jnci/dji111




PubMed


 


PubMed ID 15870434
    
     


 



4.
Salerno M, Palmieri D, Bouadis A, Halverson D, Steeg PS (2005). Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol  25, 1379-88.   https://doi.org/10.1128/MCB.25.4.1379-1388.2005




PubMed



        
     
Free Article


 


PubMed ID 15684389
         Pubmed Central ID 548014 


 



5.
Steeg PS (2004). Perspectives on classic article: metastasis suppressor genes. J Natl Cancer Inst  96, E4.   https://doi.org/10.1093/jnci/djh107




PubMed


 


PubMed ID 15026478
    
     


 



6.
Steeg PS (2005). New insights into the tumor metastatic process revealed by gene expression profiling. Am J Pathol  166, 1291-4.   https://doi.org/10.1016/S0002-9440(10)62348-6




PubMed



        
     
Free Article


 


PubMed ID 15855631
         Pubmed Central ID 1606385",https://intramural.nih.gov/search/searchview.taf?ipid=36794
516,SC003657-31,"October 01, 2004 -  September 30, 2005",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI","Jina  Lewis



Jay T Linton



Fumi  Miyagawa



Zalika S Murray



Kristine  Nograles",NULL,"Mark  Udey; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Katz S   (2005) Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells.  Blood, in press.




 



2.
Takeuchi S, Katz SI (2006). Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells. Blood  107, 184-6.   https://doi.org/10.1182/blood-2005-02-0647




PubMed



        
     
Free Article


 


PubMed ID 16166595
         Pubmed Central ID 1351012",https://intramural.nih.gov/search/searchview.taf?ipid=36796
517,SC003669-16,"October 01, 2004 -  September 30, 2005",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Matthew C Baker



Xu  Feng; PhD



Wolfgang W Leitner; MS, PhD



Keisuke  Nagao



Melanie  Neutzner



Miklos  Sardy



Show all 7","Erika  Crouch
(Pathology, Washington University School of Medicine)




Robert  Modlin
(Medicine/Dermatology, UCLA School of Medicine)




Peter  Sieling
(Medicine/Dermatology, UCLA School of Medicine)




Esther  von Stebut
(Dermatology, University of Mainz)","Lance A Liotta; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nadiminti H, Ehrlich A, Udey MC (2005). Oral erosions as a manifestation of allergic contact sensitivity to cinnamon mints. Contact Dermatitis  52, 46-7.   https://doi.org/10.1111/j.0105-1873.2005.0483c.x




PubMed


 


PubMed ID 15701132
    
     


 



2.
Riedl E, Tada Y, Udey MC (2004). Identification and characterization of an alternatively spliced isoform of mouse Langerin/CD207. J Invest Dermatol  123, 78-86.   https://doi.org/10.1111/j.0022-202X.2004.22718.x




PubMed


 


PubMed ID 15191546
    
     


 



3.
Terunuma A, Shaya MB, Udey MC, Vogel JC (2004). An in vivo competitive repopulation assay system to evaluate human keratinocyte stem cells. J Invest Dermatol  123, 993-5.   https://doi.org/10.1111/j.0022-202X.2004.23456.x




PubMed


 


PubMed ID 15482490
    
     


 



4.
Udey MC (2004). Skin dendritic cells in immunity and autoimmunity. J Investig Dermatol Symp Proc  9, 15-7.   https://doi.org/10.1111/j.1087-0024.2004.00838.x




PubMed


 


PubMed ID 14870979
    
     


 



5.
Udey MC (2005). Gone fishin' in 2005-insights into the inner workings of dendritic cells. J Invest Dermatol  124, vi-vii.   https://doi.org/10.1111/j.0022-202X.2005.23666.x




PubMed


 


PubMed ID 15816821
    
     


 



6.
Udey MC, Hornyak TJ (2004). In this issue--oncogenes, tumor suppressor genes and melanocytic lesions. J Invest Dermatol  122, VII-VIII.   https://doi.org/10.1111/j.0022-202X.2004.22539.x




PubMed


 


PubMed ID 15140248
    
     


 



7.
von Stebut E, Udey MC (2004). Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect  6, 1102-9.   https://doi.org/10.1016/j.micinf.2004.05.024




PubMed


 


PubMed ID 15380780",https://intramural.nih.gov/search/searchview.taf?ipid=36797
518,SC003670-13,"October 01, 2004 -  September 30, 2005",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Atsushi  Terunuma



Jean-Philippe  Therrien



Carole L Yee","Cynthia E Dunbar; MD
(NHLBI)




Wolfgang  Pfutzner
(Dermatology, University of Munich)




Lorne  Taichman
(SUNY - Stony Brook)","Mark  Udey; MD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)



William G Telford (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Vogel J, Emmert S, Kahn S, Kraemer K   (2004) Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.  Gene Therapy  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36798
519,SC003800-35,"October 01, 2004 -  September 30, 2005",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","H Richard Alexander; MD, PhD



David  Danforth



Mary Elizabeth Hughes; PhD



Udai S Kammula



Steven  Libutti; MD



Dao M Nguyen; MD, MS



Show all 11",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Rosenberg SA (2005). TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J Immunol  174, 5215-23.   https://doi.org/10.4049/jimmunol.174.9.5215




PubMed



        
     
Free Article


 


PubMed ID 15843517
         Pubmed Central ID 2562293 


 



2.
Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005). Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol  23, 6043-53.   https://doi.org/10.1200/JCO.2005.06.205




PubMed



        
     
Free Article


 


PubMed ID 16087944
         Pubmed Central ID 1473965 


 



3.
Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA (2005). Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res  65, 2001-8.   https://doi.org/10.1158/0008-5472.CAN-04-2006




PubMed



        
     
Free Article


 


PubMed ID 15753400
         Pubmed Central ID 2174600 


 



4.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



5.
Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP (2005). Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest  115, 1616-26.   https://doi.org/10.1172/JCI24480




PubMed



        
     
Free Article


 


PubMed ID 15931392
         Pubmed Central ID 1137001 


 



6.
Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, Rosenberg SA, Robbins PF (2005). Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother  28, 258-67.   https://doi.org/10.1097/01.cji.0000158855.92792.7a




PubMed



        
     
Free Article


 


PubMed ID 15838383
         Pubmed Central ID 2174599 


 



7.
Hughes MS, Yu YY, Dudley ME, Zheng Z, Robbins PF, Li Y, Wunderlich J, Hawley RG, Moayeri M, Rosenberg SA, Morgan RA (2005). Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther  16, 457-72.   https://doi.org/10.1089/hum.2005.16.457




PubMed



        
     
Free Article


 


PubMed ID 15871677
         Pubmed Central ID 1476695 


 



8.
Khong HT, Wang QJ, Rosenberg SA (2004). Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother  27, 184-90.   https://doi.org/10.1097/00002371-200405000-00002




PubMed



        
     
Free Article


 


PubMed ID 15076135
         Pubmed Central ID 2275330 


 



9.
Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A  101, 1969-74.   https://doi.org/10.1073/pnas.0307298101




PubMed



        
     
Free Article


 


PubMed ID 14762166
         Pubmed Central ID 357036 


 



10.
Parkhurst MR, Riley JP, Robbins PF, Rosenberg SA (2004). Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein. J Immunother  27, 79-91.   https://doi.org/10.1097/00002371-200403000-00001




PubMed



        
     
Free Article


 


PubMed ID 14770079
         Pubmed Central ID 2275328 


 



11.
Powell DJ, Parker LL, Rosenberg SA (2005). Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J Immunother  28, 403-11.   https://doi.org/10.1097/01.cji.0000170363.22585.5a




PubMed



        
     
Free Article


 


PubMed ID 16000960
         Pubmed Central ID 1473966 


 



12.
Powell DJ, Rosenberg SA (2004). Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination. J Immunother  27, 36-47.   https://doi.org/10.1097/00002371-200401000-00004




PubMed



        
     
Free Article


 


PubMed ID 14676632
         Pubmed Central ID 1472182 


 



13.
Rosenberg S, El-Gamil M, Dudley M, Robbins S   (2004) T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppresor gene locus and a mutated HLA class I gene product.  J Immunol  pp.




 



14.
Rosenberg S, Heimann D, Klebanoff C, Antony P, Gattinoni L, Hinrichs C, Hwang L, Palmer D, Spiess P, Surman D, Wrzesiniski C, Restifo S   (2004) Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer.  J Leukoc Biol  pp.




 



15.
Rosenberg S, Riley J, Igarashi T, Robbins Y   (2004) Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumor endogenously expressing telomerase.  Clin Cancer Res  pp.




 



16.
Rosenberg SA (2004). Shedding light on immunotherapy for cancer. N Engl J Med  350, 1461-3.   https://doi.org/10.1056/NEJMcibr045001




PubMed



        
     
Free Article


 


PubMed ID 15070799
         Pubmed Central ID 2275326 


 



17.
Rosenberg SA (2005). The emergence of modern cancer immunotherapy. Ann Surg Oncol  12, 344-6.   https://doi.org/10.1245/ASO.2005.01.904




PubMed



        
     
Free Article


 


PubMed ID 15843873
         Pubmed Central ID 2154347 


 



18.
Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006). High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther  13, 151-9.   https://doi.org/10.1016/j.ymthe.2005.07.688




PubMed



        
     
Free Article


 


PubMed ID 16140584
         Pubmed Central ID 1473967 


 



19.
Zhou J, Dudley ME, Rosenberg SA, Robbins PF (2005). Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother  28, 53-62.   https://doi.org/10.1097/00002371-200501000-00007




PubMed



        
     
Free Article


 


PubMed ID 15614045
         Pubmed Central ID 2175172",https://intramural.nih.gov/search/searchview.taf?ipid=36799
520,SC003811-31,"October 01, 2004 -  September 30, 2005",The Immunotherapy of Animal and Human Cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Mojgan  Ahmadzadeh



Keith William Kerstann



Ajay V Maker



Daniel J Powell",NULL,"Nicholas Phillip Restifo; MD (National Cancer Institute)



Marybeth S Hughes (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



Richard Eldon Royal (National Cancer Institute)



Richard  Sherry; MD (National Cancer Institute)



Suzanne L. Topalian; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Rosenberg SA (2005). TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J Immunol  174, 5215-23.   https://doi.org/10.4049/jimmunol.174.9.5215




PubMed



        
     
Free Article


 


PubMed ID 15843517
         Pubmed Central ID 2562293 


 



2.
Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA (2005). Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother  28, 582-92.   https://doi.org/10.1097/01.cji.0000175468.19742.10




PubMed



        
     
Free Article


 


PubMed ID 16224276
         Pubmed Central ID 1533764 


 



3.
Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005). Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol  23, 6043-53.   https://doi.org/10.1200/JCO.2005.06.205




PubMed



        
     
Free Article


 


PubMed ID 16087944
         Pubmed Central ID 1473965 


 



4.
Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA (2006). Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J Immunother  29, 208-14.   https://doi.org/10.1097/01.cji.0000187959.45803.0c




PubMed



        
     
Free Article


 


PubMed ID 16531821
         Pubmed Central ID 1473974 


 



5.
Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA (2005). Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res  65, 2001-8.   https://doi.org/10.1158/0008-5472.CAN-04-2006




PubMed



        
     
Free Article


 


PubMed ID 15753400
         Pubmed Central ID 2174600 


 



6.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



7.
Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP (2005). Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest  115, 1616-26.   https://doi.org/10.1172/JCI24480




PubMed



        
     
Free Article


 


PubMed ID 15931392
         Pubmed Central ID 1137001 


 



8.
Hsu C, Hughes MS, Zheng Z, Bray RB, Rosenberg SA, Morgan RA (2005). Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine. J Immunol  175, 7226-34.   https://doi.org/10.4049/jimmunol.175.11.7226




PubMed



        
     
Free Article


 


PubMed ID 16301627
         Pubmed Central ID 1473971 


 



9.
Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, Rosenberg SA, Robbins PF (2005). Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother  28, 258-67.   https://doi.org/10.1097/01.cji.0000158855.92792.7a




PubMed



        
     
Free Article


 


PubMed ID 15838383
         Pubmed Central ID 2174599 


 



10.
Hughes MS, Yu YY, Dudley ME, Zheng Z, Robbins PF, Li Y, Wunderlich J, Hawley RG, Moayeri M, Rosenberg SA, Morgan RA (2005). Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther  16, 457-72.   https://doi.org/10.1089/hum.2005.16.457




PubMed



        
     
Free Article


 


PubMed ID 15871677
         Pubmed Central ID 1476695 


 



11.
Khong HT, Wang QJ, Rosenberg SA (2004). Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother  27, 184-90.   https://doi.org/10.1097/00002371-200405000-00002




PubMed



        
     
Free Article


 


PubMed ID 15076135
         Pubmed Central ID 2275330 


 



12.
Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A  101, 1969-74.   https://doi.org/10.1073/pnas.0307298101




PubMed



        
     
Free Article


 


PubMed ID 14762166
         Pubmed Central ID 357036 


 



13.
Parkhurst MR, Riley JP, Robbins PF, Rosenberg SA (2004). Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein. J Immunother  27, 79-91.   https://doi.org/10.1097/00002371-200403000-00001




PubMed



        
     
Free Article


 


PubMed ID 14770079
         Pubmed Central ID 2275328 


 



14.
Powell DJ, Parker LL, Rosenberg SA (2005). Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J Immunother  28, 403-11.   https://doi.org/10.1097/01.cji.0000170363.22585.5a




PubMed



        
     
Free Article


 


PubMed ID 16000960
         Pubmed Central ID 1473966 


 



15.
Powell DJ, Rosenberg SA (2004). Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination. J Immunother  27, 36-47.   https://doi.org/10.1097/00002371-200401000-00004




PubMed



        
     
Free Article


 


PubMed ID 14676632
         Pubmed Central ID 1472182 


 



16.
Rosenberg SA (2004). Development of effective immunotherapy for the treatment of patients with cancer. J Am Coll Surg  198, 685-96.   https://doi.org/10.1016/j.jamcollsurg.2004.01.025




PubMed



        
     
Free Article


 


PubMed ID 15110801
         Pubmed Central ID 1471995 


 



17.
Rosenberg SA (2004). Shedding light on immunotherapy for cancer. N Engl J Med  350, 1461-3.   https://doi.org/10.1056/NEJMcibr045001




PubMed



        
     
Free Article


 


PubMed ID 15070799
         Pubmed Central ID 2275326 


 



18.
Rosenberg SA (2005). The emergence of modern cancer immunotherapy. Ann Surg Oncol  12, 344-6.   https://doi.org/10.1245/ASO.2005.01.904




PubMed



        
     
Free Article


 


PubMed ID 15843873
         Pubmed Central ID 2154347 


 



19.
Rosenberg SA, Sherry RM, Morton KE, Yang JC, Topalian SL, Royal RE, Kammula US, Restifo NP, Hughes MS, Schwarz SL, Ngo LT, Mavroukakis SA, White DE (2006). Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. J Immunother  29, 224-31.   https://doi.org/10.1097/01.cji.0000190399.98802.10




PubMed



        
     
Free Article


 


PubMed ID 16531823
         Pubmed Central ID 1473975 


 



20.
Rosenberg SA, Sportès C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler-Stevenson M, Morton KE, Mavroukakis SA, Morre M, Buffet R, Mackall CL, Gress RE (2006). IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother  29, 313-9.   https://doi.org/10.1097/01.cji.0000210386.55951.c2




PubMed



        
     
Free Article


 


PubMed ID 16699374
         Pubmed Central ID 1473976 


 



21.
Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006). High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther  13, 151-9.   https://doi.org/10.1016/j.ymthe.2005.07.688




PubMed



        
     
Free Article


 


PubMed ID 16140584
         Pubmed Central ID 1473967 


 



22.
Zhao Y, Zheng Z, Khong HT, Rosenberg SA, Morgan RA (2006). Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes. J Immunother  29, 398-406.   https://doi.org/10.1097/01.cji.0000203082.20365.7f




PubMed



        
     
Free Article


 


PubMed ID 16799335
         Pubmed Central ID 1510955 


 



23.
Zhou J, Dudley ME, Rosenberg SA, Robbins PF (2005). Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother  28, 53-62.   https://doi.org/10.1097/00002371-200501000-00007




PubMed



        
     
Free Article


 


PubMed ID 15614045
         Pubmed Central ID 2175172",https://intramural.nih.gov/search/searchview.taf?ipid=36800
521,SC004002-36,"October 01, 2004 -  September 30, 2005",Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Barbara  Beck



Jean  Decker



Sigrid Priscilla Dubois



Kayhan  Garmestani; PhD



Carolyn  Goldman



Jurgen  Muller



Show all 14","Steven J Jacobson; PhD
(NINDS)




Gillian  Warfe
(University of the West Indies)",Martin W Brechbiel; PhD (National Cancer Institute),"Jorge A Carrasquillo; MD (CC) 



Robert B. Nussenblatt; MD (NEI) 



Henry F McFarland; MD (NINDS)","Ordered by publication type and then author name.



1.
Waldmann T, Burke D, Berzofsky J   (2005) IL-15/IL-15alpha-mediated antigen-independent avidity maturation of memory CD8+ T cells.  Proceeding National Academy of Science USA .




 



2.
Waldmann T, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones A, Finkelstein S, Palmer D, Antony P, Hwang S, Rosenberg S, Restifo N   (2005) Central memory self/tumor-reactive CD8(+) T cells confer superior anti-tumor immunity compared with effector memory T cells.  Proc. Natl. Acad. Sci. USA  pp.




 



3.
Waldmann T, Robinson T, Chattergoon M, Choo D, Choo A, Choe Y, Ramanathan M, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim J, Pavlakis G, Felber B, Boyer J, Weiner D   (2005) Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.  J. Immunol.  pp.




 



4.
Waldmann T, Szollosi J, Szentesi G, Damjanovich L, Gaspar R, Damjanovich S   (2005) Detection of receptor trimers on the cell surface by flow cytometric fluorescence energy homotransfer measurements.  Biochimica Et Biophysica Acta-Molecular Cell Research  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36801
522,SC004017-27,"October 01, 2004 -  September 30, 2005",Biology of the Immune Response,"David  Nelson; MD, PhD",NULL,"Lymphoid Malignancies Branch, NCI","Haiying  Qin



Donn M Stewart; MD



Musafumi  Yamada","Tadashi  Ariga
(Pediatrics, Hokkaido University)




Tim  Behrens
(Rheumatology, U. Minnesota)




Gary S. Gilkeson; MD
(Medical University of South Carolina)




Lennart  Hammarstrom
(Immunology, Karolinska Institute)




David  Hilbert
(HGSI, Inc.)




Don B. Kohn; MD
(Division of Research Immunology, Children's Hospital of Los Angeles)


Show all 9",NULL,"Ashish K Jain; BA, MD (NIAID) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Jin Y, Mazza C, Christie R   (2004) Mutations of the Wiskott-Aldrich syndrome protein (WASP): hot spots, effect on transcription and translation and phenotype/genotype correlation.  Blood  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36803
523,SC004020-28,"October 01, 2004 -  September 30, 2005","Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Elena  Ambrosino



Igor M. Belyakov; MD, PhD



Amiran  Dzutsev; PhD



Dmitry V Isakov



Michael G Lemon



Sangkon  Oh



Show all 12","Donald  Burke
(Ctr Immunization Research, Johns Hopkins Sch Publ Health)




David  Carbone
(Dept. of Medicine, Vanderbilt University)




John  Clements
(Tulane University)




Anne  DeGroot
(Dept. of Medicine, Brown University Sch. of Med.)




Debra  Donaldson; PhD
(Immunology, Wyeth-Genetics Institute)




Stephen  Feinstone
(Ctr Immunization Research, CBER, FDA)


Show all 19","Lee Jay Helman; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



Liyanage P Perera; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bukreyev A, Belyakov IM, Prince GA, Yim KC, Harris KK, Berzofsky JA, Collins PL (2005). Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J Virol  79, 9515-26.   https://doi.org/10.1128/JVI.79.15.9515-9526.2005




PubMed



        
     
Free Article


 


PubMed ID 16014914
         Pubmed Central ID 1181599 


 



2.
Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA (2005). Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J Clin Oncol  23, 5099-107.   https://doi.org/10.1200/JCO.2005.03.158




PubMed


 


PubMed ID 15983396
    
     


 



3.
Park JM, Terabe M, Sakai Y, Munasinghe J, Forni G, Morris JC, Berzofsky JA (2005). Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas. J Immunol  174, 4228-36.   https://doi.org/10.4049/jimmunol.174.7.4228




PubMed


 


PubMed ID 15778385
    
     


 



4.
Park JM, Terabe M, van den Broeke LT, Donaldson DD, Berzofsky JA (2005). Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. Int J Cancer  114, 80-7.   https://doi.org/10.1002/ijc.20669




PubMed


 


PubMed ID 15523692
    
     


 



5.
Pinto LA, Trivett MT, Wallace D, Higgins J, Baseler M, Terabe M, Belyakov IM, Berzofsky JA, Hildesheim A (2005). Fixation and cryopreservation of whole blood and isolated mononuclear cells: Influence of different procedures on lymphocyte subset analysis by flow cytometry. Cytometry B Clin Cytom  63, 47-55.   https://doi.org/10.1002/cyto.b.20038




PubMed


 


PubMed ID 15624203
    
     


 



6.
Berzofsky JA, Helman LA, Mackall CA, Van Den Broeke LA (submitted in 2005) Immunogenic Peptides And Methods Of Use For Treating And Preventing Cancer. Patent issued: 8,614,304 (US in 2014). Patents pending: 14/958,114 (US application); PCT/US2006/041462 (PC application).




 



7.
Khleif SN, Berzofsky JN, Qian JN (submitted in 2005) Methods And Compositions For Producing An Enhanced Immune Response To A Human Papillomavirus Immunogen. Patents issued: 7,691,579 (US in 2010); 2006236905 (AU in 2010); 1877087 (CH in 2013); 1877087 (DE in 2013); 1877087 (EP in 2013); 1877087 (FR in 2013); 1877087 (GB in 2013); 1877087 (IE in 2013). Patent pending: 2604909 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=36804
524,SC004024-18,"October 01, 2004 -  September 30, 2005",Molecular Biology of Human Lymphoid Malignancies,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Christina M Annunziata



Richard E Davis



Laurence  Lamy



Lam  Lloyd



Vu  Ngo



Dave  Sandeep



Show all 10","Elias  Campo
(Univ. of Barcelona, Spain)




John  Chan
(Univ. of Nebraska Medical Center)




Richard  Fisher
(Southwest Oncology Group)




Randy  Gascoyne
(British Columbia Cancer Center)




T. Andrew  Lister
(St. Bartholomew Hospital)




Konrad  Muller-Hermelink
(Univ. of Wuerzburg)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Lymphoma/Leukemia Molecular Profiling Project, et al. [8 more authors] (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood  106, 3183-90.   https://doi.org/10.1182/blood-2005-04-1399




PubMed



        
     
Free Article


 


PubMed ID 16046532
         Pubmed Central ID 1895326 


 



2.
Lam LT, Davis RE, Pierce J, Hepperle M, Xu Y, Hottelet M, Nong Y, Wen D, Adams J, Dang L, Staudt LM (2005). Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res  11, 28-40.




PubMed


 


PubMed ID 15671525
    
     


 



3.
Staudt LM, Dave S (2005). The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol  87, 163-208.   https://doi.org/10.1016/S0065-2776(05)87005-1




PubMed



        
     
Free Article


 


PubMed ID 16102574
         Pubmed Central ID 1351148",https://intramural.nih.gov/search/searchview.taf?ipid=36805
525,SC006321-26,"October 01, 2004 -  September 30, 2005",Modulation of Therapeutic Response,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Rajani  Choudhuri



Deborah O Coffin



John Andrew Cook; PhD



William  Degraff



Janet W Gamson



Kelly J Grimes



Show all 9",NULL,"Kathleen C Flanders; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Matsumoto K, Okajo A, Kobayashi T, Mitchell JB, Krishna MC, Endo K (2005). Estimation of free radical formation by beta-ray irradiation in rat liver. J Biochem Biophys Methods  63, 79-90.   https://doi.org/10.1016/j.jbbm.2005.03.004




PubMed


 


PubMed ID 15896849
    
     


 



2.
Matsumoto S, Utsumi H, Aravalluvan T, Matsumoto K, Matsumoto A, Devasahayam N, Sowers AL, Mitchell JB, Subramanian S, Krishna MC (2005). Influence of proton T1 on oxymetry using Overhauser enhanced magnetic resonance imaging. Magn Reson Med  54, 213-7.   https://doi.org/10.1002/mrm.20564




PubMed


 


PubMed ID 15968662
    
     


 



3.
Tsai MH, Yan H, Chen X, Chandramouli GV, Zhao S, Coffin D, Coleman CN, Mitchell JB, Chuang EY (2005). Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays. Mol Biotechnol  29, 221-4.   https://doi.org/10.1385/MB:29:3:221




PubMed


 


PubMed ID 15767699
    
     


 



4.
Subramanian S, Devasahayam N, Koscielniak J, Krishna M, Mitchell J, Pohida T, Pursley R, Salem G (submitted in 2005) Fast Electron Paramagnetic Resonance Imaging (epri) In The Cw Epr Mode Using Rapid-scan In The Presence Of Rotating Gradients And Direct Detection With Transmit/receive & Data Processing In A Digital Signal Processing Platform. Patent issued: 8,242,778 (US in 2012). Patent pending: 12/564,006 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36806
526,SC006329-24,"October 01, 2004 -  September 30, 2005",Clinical Radiation Physics Service,Robert W Miller,James B Mitchell; PhD,"Radiation Oncology Branch, NCI","Barbara Chin Arora



Frank S Harrington



George  Li



Holly  Ning



Hu-Chen  Xie",NULL,"Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)



Anurag  Singh (National Cancer Institute)



Deborah E Citrin (National Cancer Institute)



Jacek  Capala; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Miller R, Camphausen K, Choyke P, McVeigh E, Gustafson G, Ning H, Atalar C, Coleman C, Menard C   (2004) MRI-Guided Transperineal Prostate Interventions in a Standard 15 Magnet.  Magnetic Resonance in Medicine .




 



2.
Miller R, Ning H, Guion P, Susil G, Lessard R, Pouliot E, Huchen J, Capala X, Coleman J, Camphausen C, Menard K   (2005) Inverse Treatment Planning Based on MRI for HDR Prostate Brachytherapy.  International Journal of radiation Oncology, Biology and Physics  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36772
527,SC006330-24,"October 01, 2004 -  September 30, 2005",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,James B Mitchell; PhD,"Radiation Oncology Branch, NCI","Barbara Chin Arora



George  Li



Holly  Ning



Hu-Chen  Xie",NULL,"Norman Norman Coleman; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Miller R, Ning H, Capala H, Arora J, Coleman B, Camphausen C   (2005) A Novel 3D Volumetric Voxel Registration Technique for Volume-View-Guided Image Registration of Multiple Imaging Modalities.  International Journal of Radiation Oncology, Biology and Physics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36773
528,SC006353-23,"October 01, 2004 -  September 30, 2005",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Erik D Brady



Thomas  Clifford



Diane E Milenic



Celeste A Regino



Vladimir  Talanov



Vincent Joseph Venditto","Greg  Adams
(Fox Chase Cancer Center)




David  Scheinberg
(Memorial Sloan-Kettering)




Andrew  Scott
(Ludwig Institute)




George  Sgouros
(Johs Hopkins)","Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Regino CA, Torti SV, Ma R, Yap GP, Kreisel KA, Torti FM, Planalp RP, Brechbiel MW (2005). N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. J Med Chem  48, 7993-9.   https://doi.org/10.1021/jm050724r




PubMed



        
     
Free Article


 


PubMed ID 16335923
         Pubmed Central ID 2597376",https://intramural.nih.gov/search/searchview.taf?ipid=36807
529,SC006358-22,"October 01, 2004 -  September 30, 2005","Radiolysis, Photolysis, Sonolysis and Sonoprotection of Cells and their Constitu",Peter  Riesz; PhD,NULL,"Radiation Biology Branch, NCI","Jason Yulin Cheng; PhD



Joe  Sostaric","Takashi  Kondo
(Department of Radiological Sciences, Toyama Medical and Pharmaceutical University)




Norio  Miyoshi
(Department of Pathology, Fukui Medical University)




Ionel  Rosenthal
(Dept of Food Science, The Volcani Center/Agricultural Organization)","James B Mitchell; PhD (National Cancer Institute)



William  Degraff (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Feril LB, Kondo T, Takaya K, Riesz P (2004). Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol  80, 165-75.   https://doi.org/10.1080/09553000310001654684




PubMed


 


PubMed ID 15164798
    
     


 



2.
Feril LB, Tsuda Y, Kondo T, Zhao QL, Ogawa R, Cui ZG, Tsukada K, Riesz P (2004). Ultrasound-induced killing of monocytic U937 cells enhanced by 2,2'-azobis(2-amidinopropane) dihydrochloride. Cancer Sci  95, 181-5.   https://doi.org/10.1111/j.1349-7006.2004.tb03201.x




PubMed


 


PubMed ID 14965370
    
     


 



3.
Riesz P, Sostaric J   (2004) Enlightened Sonochemistry - A review.  Research in Chemical Intermediates - Sonochemistry-Special Issue  pp.




 



4.
Rosenthal I, Sostaric JZ, Riesz P (2004). Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem  11, 349-63.   https://doi.org/10.1016/j.ultsonch.2004.03.004




PubMed


 


PubMed ID 15302020
    
     


 



5.
Sostaric JZ, Miyoshi N, Riesz P, DeGraff WG, Mitchell JB (2005). n-Alkyl glucopyranosides completely inhibit ultrasound-induced cytolysis. Free Radic Biol Med  39, 1539-48.   https://doi.org/10.1016/j.freeradbiomed.2005.07.020




PubMed


 


PubMed ID 16298679",https://intramural.nih.gov/search/searchview.taf?ipid=36808
530,SC006387-18,"October 01, 2004 -  September 30, 2005",Nitroxides as Protectors Against Oxidative Stress,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Rajani  Choudhuri



Deborah O Coffin



John Andrew Cook; PhD



William  Degraff



Janet W Gamson



Kelly J Grimes



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, Wynshaw-Boris A (2005). Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet  14, 1699-708.   https://doi.org/10.1093/hmg/ddi181




PubMed


 


PubMed ID 15888486
    
     


 



2.
Mitchell JB, Yamada K, Devasahayam N, Cook JA, Subramanian S, Krishna MC (2004). Novel functional imaging for tissue oxygen concentration and redox status. J Nutr  134, 3210S.   https://doi.org/10.1093/jn/134.11.3210S




PubMed


 


PubMed ID 15514310
    
     


 



3.
Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U (2005). Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer  103, 1302-13.   https://doi.org/10.1002/cncr.20898




PubMed


 


PubMed ID 15685617",https://intramural.nih.gov/search/searchview.taf?ipid=36809
531,SC006538-12,"October 01, 2004 -  September 30, 2005",Development of Angiogenesis Inhibitors,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Haiqing  Li



Matthew G Permenter



Douglas K Price



Nicola F Smith","Kurt  Eger
(Pharmacuetical Institute, University of Leipzig)




Frederick  Luzzio
(Department of Chemistry, University of Louisville)",Bill  Dahut (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Figg W, Macpherson G, Price D, Schimmel D   (2005) Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.  Oncol Report, in press.




 



2.
Kumar S, Raje N, Hideshima T, Ishitsuka K, Roccaro A, Shiraishi N, Hamasaki M, Yasui H, Munshi NC, Richardson P, Figg WD, Anderson KC (2005). Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs. Leukemia  19, 1253-61.   https://doi.org/10.1038/sj.leu.2403776




PubMed


 


PubMed ID 15858615
    
     


 



3.
Singh AS, Figg WD (2005). In vivo models of prostate cancer metastasis to bone. J Urol  174, 820-6.   https://doi.org/10.1097/01.ju.0000169133.82167.aa




PubMed


 


PubMed ID 16093963",https://intramural.nih.gov/search/searchview.taf?ipid=36810
532,SC006581-22,"October 01, 2004 -  September 30, 2005",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Leslie Ann Brents



Constance M Cultraro



Ana  Gabrea



Benjamin  Ristau","Leif  Bergsagel
(Division of Hematology, Cornell Medical School)




Rafael  Fonseca
(Division of Hematology, Mayo Clinic)




John  Shaughnessy
(Lambert Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J (2005). Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood  106, 296-303.   https://doi.org/10.1182/blood-2005-01-0034




PubMed



        
     
Free Article


 


PubMed ID 15755896
         Pubmed Central ID 1895118 


 



2.
Knutsen T, Vakulchuk A, Mosijcczuk A, Gabrea A, Ried T, Tretyak N   (2005) Novel complex rearrangements involving der(8;20) and der(14)t(8;14)t(11;14), CCND1, and duplication of constant region in acute plasmablastic leukemia.  Cancer Genetics and Cytogenetics, in press.




 



3.
Kuehl W   (2005) Early genetic events provide the basis for a clinical classification of multiple myeloma.  Hematology 2005 ASH Education Book, in press.




 



4.
Kuehl W   (2005) Molecular pathogenesis and a consequent classification of multiple myeloma.  J Clin Oncology, in press.




 



5.
Rasmussen T, Kuehl M, Lodahl M, Johnsen HE, Dahl IM   (2005) Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.  Blood 105:317-23.




PubMed


 


PubMed ID 15339850",https://intramural.nih.gov/search/searchview.taf?ipid=36812
533,SC006659-23,"October 01, 2004 -  September 30, 2005",Molecular Genetics of Kidney Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Donald P Bottaro; PhD



Jonathan A Coleman



James R Vasselli



Cathy  Vocke; PhD



Youfeng  Yang



Sang-Min Justing Lee



Show all 9",NULL,"Berton K Zbar; PhD (National Cancer Institute)



Jorge R Toro (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36814
534,SC006660-21,"October 01, 2004 -  September 30, 2005",Defining the T-cell response to human renal cancer,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Craig A Mckinney



Qiong J Wang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36774
535,SC006663-16,"October 01, 2004 -  September 30, 2005",Characterization and Regulation of High Risk and Malignant Breast Epithelium,David  Danforth,NULL,"Surgery Branch, NCI",Joan E Harris,NULL,"Jo Anne N Zujewski (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



David Erwin Kleiner; MD, PhD (National Cancer Institute)



Richard  Simon (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Danforth D   (2005) Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.  Breast Cancer Research and Treatment, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36815
536,SC006664-16,"October 01, 2004 -  September 30, 2005",Specific Immune Recognition of Tumor-Associated Antigens by Human T Cells,Suzanne L. Topalian; MD,NULL,"Surgery Branch, NCI","Deborah Marie Stewart



Lisa  Goldfeder



Sinae T Park



Marisa  Shiina



Nadrian F Teclar



Susan  Tsai","Lieping  Chen
(Dermatology, Johns Hopkins University School of Medicine)




Roy  Mariuzza
(Dermatology, U. Maryland)




Drew  Pardoll
(Johns Hopkins University School of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Topalian S, Gonzales M   (2004) Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.  Human Gene Therapy  pp.




 



2.
Topalian S, Gonzales M   (2004) Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR.  BioTechniques  pp.




 



3.
Topalian S, Lizee G, Gonzales M, Patel S   (2004) CD4+ T cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation.  Cancer Research  pp.




 



4.
Topalian S, Yang J, Sherry R, Mavroukakis S, White D, Rosenberg S   (2004) Immunization of HLA-A*0201 and/or HLA-DPB1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen.  J. Immunother.  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36816
537,SC006670-13,"October 01, 2004 -  September 30, 2005",Molecular Approaches to the Development of Novel Tumor Immunotherapies,"Nicholas Phillip Restifo; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Paul A Antony



Luca  Gattinoni



Douglas  Palmer



Chrystal  Paulos



Nadrian F Teclar



Claudia  Wrzesinski



Show all 7",NULL,"Christopher Austin Klebanoff (Surgery Branch)



Suzanne L. Topalian; MD (National Cancer Institute)



Sam  Hwang; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Heinrichs C, Klebanoff CA, Tagaya Y, Restifo NP (2006). Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol  176, 5255-66.   https://doi.org/10.4049/jimmunol.176.9.5255




PubMed



        
     
Free Article


 


PubMed ID 16621991
         Pubmed Central ID 1473163 


 



2.
Antony PA, Restifo NP (2005). CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother  28, 120-8.   https://doi.org/10.1097/01.cji.0000155049.26787.45




PubMed



        
     
Free Article


 


PubMed ID 15725955
         Pubmed Central ID 1242172 


 



3.
Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005). Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol  23, 6043-53.   https://doi.org/10.1200/JCO.2005.06.205




PubMed



        
     
Free Article


 


PubMed ID 16087944
         Pubmed Central ID 1473965 


 



4.
Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM (2005). Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol  174, 4812-20.   https://doi.org/10.4049/jimmunol.174.8.4812




PubMed



        
     
Free Article


 


PubMed ID 15814707
         Pubmed Central ID 2241749 


 



5.
Chang CC, Campoli M, Restifo NP, Wang X, Ferrone S (2005). Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol  174, 1462-71.   https://doi.org/10.4049/jimmunol.174.3.1462




PubMed



        
     
Free Article


 


PubMed ID 15661905
         Pubmed Central ID 2245899 


 



6.
Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA (2005). Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res  65, 2001-8.   https://doi.org/10.1158/0008-5472.CAN-04-2006




PubMed



        
     
Free Article


 


PubMed ID 15753400
         Pubmed Central ID 2174600 


 



7.
Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN   (2006) Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.  Cancer Res 66:4904-12.




PubMed



        
     
Free Article


 


PubMed ID 16651447
         Pubmed Central ID 2242844 


 



8.
Donohue KB, Grant JM, Tewalt EF, Palmer DC, Theoret MR, Restifo NP, Norbury CC (2006). Cross-priming utilizes antigen not available to the direct presentation pathway. Immunology  119, 63-73.   https://doi.org/10.1111/j.1365-2567.2006.02406.x




PubMed



        
     
Free Article


 


PubMed ID 16764686
         Pubmed Central ID 1782342 


 



9.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



10.
Finkelstein SE, Heimann DM, Klebanoff CA, Antony PA, Gattinoni L, Hinrichs CS, Hwang LN, Palmer DC, Spiess PJ, Surman DR, Wrzesiniski C, Yu Z, Rosenberg SA, Restifo NP (2004). Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol  76, 333-7.   https://doi.org/10.1189/jlb.0304120




PubMed



        
     
Free Article


 


PubMed ID 15155774
         Pubmed Central ID 1484508 


 



11.
Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med  202, 907-12.   https://doi.org/10.1084/jem.20050732




PubMed



        
     
Free Article


 


PubMed ID 16203864
         Pubmed Central ID 1397916 


 



12.
Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP (2005). Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest  115, 1616-26.   https://doi.org/10.1172/JCI24480




PubMed



        
     
Free Article


 


PubMed ID 15931392
         Pubmed Central ID 1137001 


 



13.
Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006). Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol  6, 383-93.   https://doi.org/10.1038/nri1842




PubMed



        
     
Free Article


 


PubMed ID 16622476
         Pubmed Central ID 1473162 


 



14.
Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS (2006). De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res  66, 1105-13.   https://doi.org/10.1158/0008-5472.CAN-05-3020




PubMed



        
     
Free Article


 


PubMed ID 16424047
         Pubmed Central ID 2242843 


 



15.
Hinrichs CS, Gattinoni L, Restifo NP (2006). Programming CD8+ T cells for effective immunotherapy. Curr Opin Immunol  18, 363-70.   https://doi.org/10.1016/j.coi.2006.03.009




PubMed



        
     
Free Article


 


PubMed ID 16616471
         Pubmed Central ID 1540013 


 



16.
Hwang LN, Yu Z, Palmer DC, Restifo NP (2006). The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor. Cancer Res  66, 1132-8.   https://doi.org/10.1158/0008-5472.CAN-05-1679




PubMed



        
     
Free Article


 


PubMed ID 16424050
         Pubmed Central ID 1550975 


 



17.
Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A  101, 1969-74.   https://doi.org/10.1073/pnas.0307298101




PubMed



        
     
Free Article


 


PubMed ID 14762166
         Pubmed Central ID 357036 


 



18.
Klebanoff CA, Gattinoni L, Restifo NP (2006). CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev  211, 214-24.   https://doi.org/10.1111/j.0105-2896.2006.00391.x




PubMed



        
     
Free Article


 


PubMed ID 16824130
         Pubmed Central ID 1501075 


 



19.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



20.
Klebanoff CA, Khong HT, Antony PA, Palmer DC, Restifo NP (2005). Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol  26, 111-7.   https://doi.org/10.1016/j.it.2004.12.003




PubMed



        
     
Free Article


 


PubMed ID 15668127
         Pubmed Central ID 1388277 


 



21.
Lee CH, Kakinuma T, Wang J, Zhang H, Palmer DC, Restifo NP, Hwang ST (2006). Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol Cancer Ther  5, 2592-9.   https://doi.org/10.1158/1535-7163.MCT-06-0310




PubMed



        
     
Free Article


 


PubMed ID 17041104
         Pubmed Central ID 2228334 


 



22.
Leitner WW, Bergmann-Leitner ES, Hwang LN, Restifo NP (2006). Type I Interferons are essential for the efficacy of replicase-based DNA vaccines. Vaccine  24, 5110-8.   https://doi.org/10.1016/j.vaccine.2006.04.059




PubMed



        
     
Free Article


 


PubMed ID 16725231
         Pubmed Central ID 1484849 


 



23.
Leitner WW, Hwang LN, Bergmann-Leitner ES, Finkelstein SE, Frank S, Restifo NP (2004). Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine  22, 1537-44.   https://doi.org/10.1016/j.vaccine.2003.10.013




PubMed



        
     
Free Article


 


PubMed ID 15063579
         Pubmed Central ID 1484509 


 



24.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



25.
Lou Y, Wang G, Lizée G, Kim GJ, Finkelstein SE, Feng C, Restifo NP, Hwu P (2004). Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo. Cancer Res  64, 6783-90.   https://doi.org/10.1158/0008-5472.CAN-04-1621




PubMed



        
     
Free Article


 


PubMed ID 15374997
         Pubmed Central ID 2241750 


 



26.
Manjili MH, Kmieciak M, Keeler J (2006) Comment on Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol 176:4511; author reply 4511-2.




PubMed



        
     
Free Article


 


PubMed ID 16585536
         Pubmed Central ID 1458368 


 



27.
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science  314, 126-9.   https://doi.org/10.1126/science.1129003




PubMed



        
     
Free Article


 


PubMed ID 16946036
         Pubmed Central ID 2267026 


 



28.
Overwijk WW, de Visser KE, Tirion FH, de Jong LA, Pols TW, van der Velden YU, van den Boorn JG, Keller AM, Buurman WA, Theoret MR, Blom B, Restifo NP, Kruisbeek AM, Kastelein RA, Haanen JB (2006). Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol  176, 5213-22.   https://doi.org/10.4049/jimmunol.176.9.5213




PubMed



        
     
Free Article


 


PubMed ID 16621986
         Pubmed Central ID 2242845 


 



29.
Palmer DC, Balasubramaniam S, Hanada K, Wrzesinski C, Yu Z, Farid S, Theoret MR, Hwang LN, Klebanoff CA, Gattinoni L, Goldstein AL, Yang JC, Restifo NP (2004). Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction. J Immunol  173, 7209-16.   https://doi.org/10.4049/jimmunol.173.12.7209




PubMed



        
     
Free Article


 


PubMed ID 15585842
         Pubmed Central ID 2241746 


 



30.
Restifo NP, Rosenberg SA (2005). Use of standard criteria for assessment of cancer vaccines. Lancet Oncol  6, 3-4.   https://doi.org/10.1016/S1470-2045(04)01693-6




PubMed



        
     
Free Article


 


PubMed ID 15629270
         Pubmed Central ID 1484507 


 



31.
Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM (2005). Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol  175, 6169-76.   https://doi.org/10.4049/jimmunol.175.9.6169




PubMed


 


PubMed ID 16237114
    
     


 



32.
Rosenberg SA, Yang JC, Restifo NP (2004). Cancer immunotherapy: moving beyond current vaccines. Nat Med  10, 909-15.   https://doi.org/10.1038/nm1100




PubMed



        
     
Free Article


 


PubMed ID 15340416
         Pubmed Central ID 1435696 


 



33.
Wang LX, Li R, Yang G, Lim M, O'Hara A, Chu Y, Fox BA, Restifo NP, Urba WJ, Hu HM (2005). Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing. Cancer Res  65, 10569-77.   https://doi.org/10.1158/0008-5472.CAN-05-2117




PubMed



        
     
Free Article


 


PubMed ID 16288050
         Pubmed Central ID 2241747 


 



34.
Wrzesinski C, Restifo NP (2005). Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy. Curr Opin Immunol  17, 195-201.   https://doi.org/10.1016/j.coi.2005.02.002




PubMed



        
     
Free Article


 


PubMed ID 15766681
         Pubmed Central ID 2254579 


 



35.
Yu Z, Theoret MR, Touloukian CE, Surman DR, Garman SC, Feigenbaum L, Baxter TK, Baker BM, Restifo NP (2004). Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. J Clin Invest  114, 551-9.   https://doi.org/10.1172/JCI21695




PubMed



        
     
Free Article


 


PubMed ID 15314692
         Pubmed Central ID 503773 


 



36.
Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ (2005). Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med  201, 139-48.   https://doi.org/10.1084/jem.20041057




PubMed



        
     
Free Article


 


PubMed ID 15630141
         Pubmed Central ID 2212766 


 



37.
Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006). High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther  13, 151-9.   https://doi.org/10.1016/j.ymthe.2005.07.688




PubMed



        
     
Free Article


 


PubMed ID 16140584
         Pubmed Central ID 1473967",https://intramural.nih.gov/search/searchview.taf?ipid=36817
538,SC006732-17,"October 01, 2004 -  September 30, 2005",Multidrug resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn  Mickley Huff,NULL,"Susan  Bates; MD (National Cancer Institute)



Francis W Ruscetti; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dean M, Fojo T, Bates S (2005). Tumour stem cells and drug resistance. Nat Rev Cancer  5, 275-84.   https://doi.org/10.1038/nrc1590




PubMed


 


PubMed ID 15803154
    
     


 



2.
Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T (2005). The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res  583, 105-19.   https://doi.org/10.1016/j.mrgentox.2005.01.013




PubMed


 


PubMed ID 15927870",https://intramural.nih.gov/search/searchview.taf?ipid=36819
539,SC006737-14,"October 01, 2004 -  September 30, 2005",Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman



David A Davis; MD



Muzammel  Haque



Richard  Little; MD, PhD



Kathleen  Singer



Victoria Y Wang



Show all 8","Jean  Chmielewski
(Purdue University)




Amir Hossein Gandjbakhche; PhD





Rodney L.  Levine
(Laboratory of Biochemistry, NHLBI)




John J. Mieyal; PhD
(Department of Pharmacology, Case Western Reserve University)","Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Giovanna  Tosato; PhD (National Cancer Institute)



Denise  Whitby (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)","Henry M. Fales; PhD (NHLBI) 



Paul T Wingfield; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Yarchoan R, Chernomordik V, Vogel A, Hattery D, Gannot I, Gandjibakhche A   (2006) Infrared imaging for tissue characterization and function, in The Biomedical Engineering Handbook, Third Edition.  CRC and IEEE Press, in press.




 



2.
Yarchoan R, Little R   (2006) Epstein-Barr virus-related and Kaposi's sarcoma associated herpesvirus-related neoplasms, in Clinical Hematology. Young N, Gerson S, High A, eds., Elsevier (Philadelphia, PA), pp. 610-624.




 



3.
Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM, Yarchoan R, Tosato G (2005). Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood  105, 4561-8.   https://doi.org/10.1182/blood-2004-12-4618




PubMed



        
     
Free Article


 


PubMed ID 15718415
         Pubmed Central ID 1895000 


 



4.
De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G (2004). Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood  103, 2452-9.   https://doi.org/10.1182/blood-2003-08-2857




PubMed


 


PubMed ID 14525775
    
     


 



5.
Hassan M, Little RF, Vogel A, Aleman K, Wyvill K, Yarchoan R, Gandjbakhche AH (2004). Quantitative assessment of tumor vasculature and response to therapy in kaposi's sarcoma using functional noninvasive imaging. Technol Cancer Res Treat  3, 451-7.   https://doi.org/10.1177/153303460400300506




PubMed


 


PubMed ID 15453810
    
     


 



6.
Wang V, Davis DA, Haque M, Huang LE, Yarchoan R (2005). Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res  65, 3299-306.   https://doi.org/10.1158/0008-5472.CAN-04-4130




PubMed


 


PubMed ID 15833863
    
     


 



7.
Yarchoan R, Tosato G, Little RF (2005). Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol  2, 406-15; quiz 423.   https://doi.org/10.1038/ncponc0253




PubMed


 


PubMed ID 16130937",https://intramural.nih.gov/search/searchview.taf?ipid=36820
540,SC006738-13,"October 01, 2004 -  September 30, 2005",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Shigeyoshi  Harada



Kenji  Maeda



Sadahiro  Tamiya



Kiyoto  Tsuchiya","Edward  Arnold
(BIOCHEMISTRY, Rutgers University)




Arun  Ghosh





Yoshio  Koyanagi





Masao  Matsuoka





Toshikazu  Miyakawa





Shinichi  Oka



Show all 8",Seth M Steinberg; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Depboylu C, Reinhart TA, Takikawa O, Imai Y, Maeda H, Mitsuya H, Rausch D, Eiden LE, Weihe E (2004). Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2',3'-dideoxyguanosine. Eur J Neurosci  19, 2997-3005.   https://doi.org/10.1111/j.0953-816X.2004.03404.x




PubMed


 


PubMed ID 15182307
    
     


 



2.
Ghosh AK, Swanson LM, Cho H, Leshchenko S, Hussain KA, Kay S, Walters DE, Koh Y, Mitsuya H (2005). Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. J Med Chem  48, 3576-85.   https://doi.org/10.1021/jm050019i




PubMed


 


PubMed ID 15887965
    
     


 



3.
Hachiya A, Gatanaga H, Kodama E, Ikeuchi M, Matsuoka M, Harada S, Mitsuya H, Kimura S, Oka S (2004). Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients. Virology  327, 215-24.   https://doi.org/10.1016/j.virol.2004.07.001




PubMed


 


PubMed ID 15351209
    
     


 



4.
Hayakawa H, Kohgo S, Kitano K, Ashida N, Kodama E, Mitsuya H, Ohrui H (2004). Potential of 4'-C-substituted nucleosides for the treatment of HIV-1. Antivir Chem Chemother  15, 169-87.   https://doi.org/10.1177/095632020401500401




PubMed


 


PubMed ID 15457679
    
     


 



5.
Kitano K, Kohgo S, Yamada K, Sakata S, Ashida N, Hayakawa H, Nameki D, Kodama E, Matsuoka M, Mitsuya H, Ohrui H (2004). Attempt to reduce cytotoxicity by synthesizing the L-enantiomer of 4'-C-ethynyl-2'-deoxypurine nucleosides as antiviral agents against HIV and HBV. Antivir Chem Chemother  15, 161-7.   https://doi.org/10.1177/095632020401500306




PubMed


 


PubMed ID 15266898
    
     


 



6.
Kohgo S, Yamada K, Kitano K, Iwai Y, Sakata S, Ashida N, Hayakawa H, Nameki D, Kodama E, Matsuoka M, Mitsuya H, Ohrui H (2004). Design, efficient synthesis, and anti-HIV activity of 4'-C-cyano- and 4'-C-ethynyl-2'-deoxy purine nucleosides. Nucleosides Nucleotides Nucleic Acids  23, 671-90.   https://doi.org/10.1081/NCN-120037508




PubMed


 


PubMed ID 15200030
    
     


 



7.
Maeda K, Nakata H, Koh Y, Miyakawa T, Ogata H, Takaoka Y, Shibayama S, Sagawa K, Fukushima D, Moravek J, Koyanagi Y, Mitsuya H (2004). Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. J Virol  78, 8654-62.   https://doi.org/10.1128/JVI.78.16.8654-8662.2004




PubMed



        
     
Free Article


 


PubMed ID 15280474
         Pubmed Central ID 479103 


 



8.
Maeda K, Nakata H, Ogata H, Koh Y, Miyakawa T, Mitsuya H (2004). The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection. Curr Opin Pharmacol  4, 447-52.   https://doi.org/10.1016/j.coph.2004.07.004




PubMed


 


PubMed ID 15351348
    
     


 



9.
Matsuno N, Hoshino K, Nanri T, Kawakita T, Mitsuya H, Asou N (2004). Transcriptional repression of the p15 gene predicts the clinical outcome of acute myeloblastic leukemia with intermediate and adverse cytogenetics. Leukemia  18, 1146-8.   https://doi.org/10.1038/sj.leu.2403362




PubMed


 


PubMed ID 15085158
    
     


 



10.
Matsuno N, Hoshino K, Nanri T, Kawakita T, Suzushima H, Kawano F, Mitsuya H, Asou N (2005). p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia. Leuk Res  29, 557-64.   https://doi.org/10.1016/j.leukres.2004.11.003




PubMed


 


PubMed ID 15755508
    
     


 



11.
Matsuno N, Nanri T, Kawakita T, Mitsuya H, Asou N (2005). A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia. Leukemia  19, 480-1.   https://doi.org/10.1038/sj.leu.2403630




PubMed


 


PubMed ID 15625552
    
     


 



12.
Matsushita S, Yoshimura K, Kimura T, Kamihira A, Takano M, Eto K, Shirasaka T, Mitsuya H, Oka S (2005). Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir containing regimen. J Clin Virol  33, 188-93.   https://doi.org/10.1016/j.jcv.2004.11.002




PubMed


 


PubMed ID 15911439
    
     


 



13.
Nakata H, Maeda K, Miyakawa T, Shibayama S, Matsuo M, Takaoka Y, Ito M, Koyanagi Y, Mitsuya H (2005). Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model. J Virol  79, 2087-96.   https://doi.org/10.1128/JVI.79.4.2087-2096.2005




PubMed



        
     
Free Article


 


PubMed ID 15681411
         Pubmed Central ID 546550 


 



14.
Nanri T, Matsuno N, Kawakita T, Suzushima H, Kawano F, Mitsuya H, Asou N (2005). Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). Leukemia  19, 1361-6.   https://doi.org/10.1038/sj.leu.2403803




PubMed


 


PubMed ID 15902284
    
     


 



15.
Siddiqui MA, Hughes SH, Boyer PL, Mitsuya H, Van QN, George C, Sarafinanos SG, Marquez VE (2004). A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides. J Med Chem  47, 5041-8.   https://doi.org/10.1021/jm049550o




PubMed


 


PubMed ID 15456247
    
     


 



16.
Tamiya S, Mardy S, Kavlick MF, Yoshimura K, Mistuya H   (2004) Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors.  J Virol 78:12030-40.




PubMed



        
     
Free Article


 


PubMed ID 15479842
         Pubmed Central ID 523239 


 



17.
Yasunaga J, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, Sakai T, Mitsuya H, Matsuoka M (2004). Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res  64, 6002-9.   https://doi.org/10.1158/0008-5472.CAN-04-1422




PubMed


 


PubMed ID 15342380
    
     


 



18.
Zhou S, Kern ER, Gullen E, Cheng YC, Drach JC, Matsumi S, Mitsuya H, Zemlicka J (2004). (Z)- and (E)-[2-Fluoro-2-(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines, a new class of methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity. J Med Chem  47, 6964-72.   https://doi.org/10.1021/jm040093l




PubMed


 


PubMed ID 15615545",https://intramural.nih.gov/search/searchview.taf?ipid=36775
541,SC006741-12,"October 01, 2004 -  September 30, 2005",Lymphoma Studies,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



John  Janik; MD (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36776
542,SC006743-12,"October 01, 2004 -  September 30, 2005",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Lee Jay Helman; MD,"Medical Oncology Branch, NCI",Sunmin T Lee,"Charles  Erlichman
(Medicine, Mayo Clinic)




Julio  Herrera
(Dept. Biochem., Mol Biol., Biophys., University of Minnesota)




Patricia  LoRusso
(Medicine, Karmanos Cancer Institute)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Seong-Jin  Kim; PhD (National Cancer Institute)



J. Frederic Mushinski; MD (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=41936
543,SC006813-23,"October 01, 2004 -  September 30, 2005",Cell and Molecular Genetic Analysis of Pediatric Tumors,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Zhi-Jie  Li



Katsuya  Nakamura



Xuezhong  Yang



Amy E Mckee



Jennifer  Jackson



Fei  Tan","David A Kaplan





Javed  Khan; MD
(NCI)




Martin  Wojotowicz
(Physiology, U. of Toronto)","Maria  Tsokos; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Khanna C, Thiele C   (2005) Biology of Pediatric Tumors, in Principles and Practive of Pediatric Oncology, in press.




 



2.
Thiele C, Reynolds C   (2005) Differentiation and Retinoids, in Neuroblastoma. Nai-Kong C, Susan C, eds., Springer (Berlin), pp. 243-256.




 



3.
Barenboim-Stapleton L, Yang X, Tsokos M, Wigginton JM, Padilla-Nash H, Ried T, Thiele CJ (2005). Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line. Cancer Genet Cytogenet  157, 109-17.   https://doi.org/10.1016/j.cancergencyto.2004.05.017




PubMed


 


PubMed ID 15721631
    
     


 



4.
Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ (2005). Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Res  65, 4775-81.   https://doi.org/10.1158/0008-5472.CAN-04-3332




PubMed


 


PubMed ID 15930297
    
     


 



5.
Choi YL, Kim CJ, Matsuo T, Gaetano C, Falconi R, Suh YL, Kim SH, Shin YK, Park SH, Chi JG, Thiele CJ   (2005) HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors.  J Neurooncol 73:19-27.




PubMed


 


PubMed ID 15933812
    
     


 



6.
Lavoie JF, Lesauteur L, Kohn J, Wong J, Furtoss O, Thiele CJ, Miller FD, Kaplan DR   (2005) TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism.  J Biol Chem 280:29199-207.




PubMed


 


PubMed ID 15961390
    
     


 



7.
Li Z, Jaboin J, Dennis PA, Thiele CJ (2005). Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res  65, 2070-5.   https://doi.org/10.1158/0008-5472.CAN-04-3606




PubMed


 


PubMed ID 15781614",https://intramural.nih.gov/search/searchview.taf?ipid=36821
544,SC006830-35,"October 01, 2004 -  September 30, 2005","Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic",Thomas J. Walsh; MD,NULL,"Pediatric Oncology Branch, NCI","Miki B Kasai



Caron A Lyman



Joanne S Peter



Robert L Schaufele







Emmanuel  Roilides",NULL,"Stephen J Chanock; MD, PhD (National Cancer Institute)



Juan Carlos Gea-Banacloche; MD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)","Anthony F Suffredini; MD (CC) 



Richard  Childs; MD (NHLBI) 



John D. Bacher; BS, DVM, MS (OD)","Ordered by publication type and then author name.



1.
Antachopoulos C, Walsh TJ (2005). New agents for invasive mycoses in children. Curr Opin Pediatr  17, 78-87.   https://doi.org/10.1097/01.mop.0000150630.83442.e1




PubMed


 


PubMed ID 15659969
    
     


 



2.
Choi EH, Taylor JG, Foster CB, Walsh TJ, Anttila VJ, Ruutu T, Palotie A, Chanock SJ (2005). Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients. Med Mycol  43, 349-53.   https://doi.org/10.1080/13693780412331282322




PubMed


 


PubMed ID 16110781
    
     


 



3.
Cortez KJ, Groll AH, Walsh TJ (2005). Resources for medical mycology on the World Wide Web. Clin Infect Dis  40, 437-50.   https://doi.org/10.1086/427218




PubMed


 


PubMed ID 15668869
    
     


 



4.
El Saleeby CM, Allison KJ, Knapp KM, Walsh TJ, Hayden RT (2005). Discordant rise in galactomannan antigenemia in a patient with resolving Aspergillosis, renal failure, and ongoing hemodialysis. J Clin Microbiol  43, 3560-3.   https://doi.org/10.1128/JCM.43.7.3560-3563.2005




PubMed



        
     
Free Article


 


PubMed ID 16000507
         Pubmed Central ID 1169100 


 



5.
Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ (2005). Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis  191, 1180-7.   https://doi.org/10.1086/428503




PubMed


 


PubMed ID 15747255
    
     


 



6.
Gil-Lamaignere C, Winn RM, Simitsopoulou M, Maloukou A, Walsh TJ, Roilides E (2005). Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. Med Mycol  43, 253-60.   https://doi.org/10.1080/13693780412331271072




PubMed


 


PubMed ID 16010852
    
     


 



7.
Groll AH, Stergiopoulou T, Roilides E, Walsh TJ (2005). Micafungin: pharmacology, experimental therapeutics and clinical applications. Expert Opin Investig Drugs  14, 489-509.   https://doi.org/10.1517/13543784.14.4.489




PubMed


 


PubMed ID 15882123
    
     


 



8.
Groll AH, Walsh TJ (2005). Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Rev Anti Infect Ther  3, 467-87.   https://doi.org/10.1586/14787210.3.4.467




PubMed


 


PubMed ID 16107193
    
     


 



9.
Hope WW, Walsh TJ, Denning DW (2005). The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol  43 Suppl 1, S207-38.   https://doi.org/10.1080/13693780400025179




PubMed


 


PubMed ID 16110814
    
     


 



10.
Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, Greer BT, Chanock S, Lyman CA, Walsh TJ (2005). Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun  73, 3714-24.   https://doi.org/10.1128/IAI.73.6.3714-3724.2005




PubMed



        
     
Free Article


 


PubMed ID 15908401
         Pubmed Central ID 1111842 


 



11.
Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II   (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.  J Infect Dis 191:1350-60.




PubMed


 


PubMed ID 15776383
    
     


 



12.
Kurtzman CP, Robnett CJ, Ward JM, Brayton C, Gorelick P, Walsh TJ (2005). Multigene phylogenetic analysis of pathogenic candida species in the Kazachstania (Arxiozyma) telluris complex and description of their ascosporic states as Kazachstania bovina sp. nov, K. heterogenica sp. nov, K. pintolopesii sp. nov, and K. slooffiae sp. nov. J Clin Microbiol  43, 101-11.   https://doi.org/10.1128/JCM.43.1.101-111.2005




PubMed



        
     
Free Article


 


PubMed ID 15634957
         Pubmed Central ID 540161 


 



13.
Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW (2005). Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol  43 Suppl 1, S49-58.   https://doi.org/10.1080/13693780400020113




PubMed


 


PubMed ID 16110792
    
     


 



14.
Peter J, Armstrong D, Lyman CA, Walsh TJ (2005). Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. J Clin Microbiol  43, 3788-92.   https://doi.org/10.1128/JCM.43.8.3788-3792.2005




PubMed



        
     
Free Article


 


PubMed ID 16081911
         Pubmed Central ID 1233965 


 



15.
Petraitiene R, Petraitis V, Kelaher AM, Sarafandi AA, Mickiene D, Groll AH, Sein T, Bacher J, Walsh TJ (2005). Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits. Antimicrob Agents Chemother  49, 2084-92.   https://doi.org/10.1128/AAC.49.5.2084-2092.2005




PubMed



        
     
Free Article


 


PubMed ID 15855534
         Pubmed Central ID 1087633 


 



16.
Petraitis V, Petraitiene R, Lin P, Calis K, Kelaher AM, Muray HA, Mya-San C, Mickiene D, Bacher J, Walsh TJ (2005). Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis. Antimicrob Agents Chemother  49, 1642-5.   https://doi.org/10.1128/AAC.49.4.1642-1645.2005




PubMed



        
     
Free Article


 


PubMed ID 15793161
         Pubmed Central ID 1068600 


 



17.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ (2005). Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis  41, 634-53.   https://doi.org/10.1086/432579




PubMed


 


PubMed ID 16080086
    
     


 



18.
Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM (2005). Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis  40, 1684-8.   https://doi.org/10.1086/430068




PubMed


 


PubMed ID 15889369
    
     


 



19.
Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ (2005). Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother  49, 3317-24.   https://doi.org/10.1128/AAC.49.8.3317-3324.2005




PubMed



        
     
Free Article


 


PubMed ID 16048942
         Pubmed Central ID 1196271 


 



20.
Shaukat A, Bakri F, Young P, Hahn T, Ball D, Baer MR, Wetzler M, Slack JL, Loud P, Czuczman M, McCarthy PL, Walsh TJ, Segal BH (2005). Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia  159, 181-8.   https://doi.org/10.1007/s11046-004-5495-0




PubMed


 


PubMed ID 15770441
    
     


 



21.
Simitsopoulou M, Roilides E, Dotis J, Dalakiouridou M, Dudkova F, Andreadou E, Walsh TJ (2005). Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob Agents Chemother  49, 1397-403.   https://doi.org/10.1128/AAC.49.4.1397-1403.2005




PubMed



        
     
Free Article


 


PubMed ID 15793118
         Pubmed Central ID 1068615 


 



22.
Walsh TJ, Roilides E, Cortez K, Kottilil S, Bailey J, Lyman CA (2005). Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med Mycol  43 Suppl 1, S165-72.   https://doi.org/10.1080/13693780500064672




PubMed


 


PubMed ID 16114132
    
     


 



23.
Walsh TJ, van Burik JA (2005). Reply to Cornely et al. Clin Infect Dis  40, 1699-1701.




PubMed


 


PubMed ID 15889373
    
     


 



24.
Wiley JM, Seibel NL, Walsh TJ (2005). Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J  24, 167-74.   https://doi.org/10.1097/01.inf.0000153183.51258.b8




PubMed


 


PubMed ID 15702047
    
     


 



25.
Winn RM, Gil-Lamaignere C, Roilides E, Simitsopoulou M, Lyman CA, Maloukou A, Walsh TJ (2005). Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp. Cytokine  31, 1-8.   https://doi.org/10.1016/j.cyto.2004.07.016




PubMed


 


PubMed ID 15935692
    
     


 



26.
Yamagishi H, Fitzgerald DH, Sein T, Walsh TJ, O'Connell BC (2005). Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans. FEMS Microbiol Lett  244, 207-12.   https://doi.org/10.1016/j.femsle.2005.01.045




PubMed


 


PubMed ID 15727842
    
     


 



27.
Zaoutis TE, Coffin SE, Chu JH, Heydon K, Zhao H, Greves HM, Walsh TJ (2005). Risk factors for mortality in children with candidemia. Pediatr Infect Dis J  24, 736-9.   https://doi.org/10.1097/01.inf.0000172938.76561.8e




PubMed


 


PubMed ID 16094234
    
     


 



28.
Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD (2005). Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis  52, 295-8.   https://doi.org/10.1016/j.diagmicrobio.2005.03.002




PubMed


 


PubMed ID 15922535",https://intramural.nih.gov/search/searchview.taf?ipid=36822
545,SC006880-28,"October 01, 2004 -  September 30, 2005",Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Can,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI","Alberta A Aikin



Elena  Byrley



Diane  Cole



Elizabeth  Fox; MD



Wendy J Goodspeed



Anne D Goodwin



Show all 11","Peter Charles Adamson; MD





Kristin  Baird
(NHGRI)




Stacey  Berg
(Pediatric Oncology, Baylor Univ.)




Susan  Blaney
(Pediatric Oncology, Baylor Univ.)




Merrill  Egorin
(Medical Oncology, Univ. of Pittsburgh)




Neil  Gibson
(OSI Pharmaceuticals)


Show all 12","Antonio  Fojo; MD, PhD (National Cancer Institute)



Katherine Elizabeth Warren; MD (National Cancer Institute)



Robert C Moschel; PhD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Mark  Raffeld; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)","John D. Bacher; BS, DVM, MS (OD)","Ordered by publication type and then author name.



1.
Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM (2005). Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res  11, 1669-74.   https://doi.org/10.1158/1078-0432.CCR-04-1807




PubMed


 


PubMed ID 15746072
    
     


 



2.
Zhuang SH, Agrawal M, Edgerly M, Bakke S, Kotz H, Thambi P, Rutt A, Balis FM, Bates S, Fojo T (2005). A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days. Cancer  103, 1932-8.   https://doi.org/10.1002/cncr.20977




PubMed


 


PubMed ID 15800893",https://intramural.nih.gov/search/searchview.taf?ipid=36823
546,SC006891-17,"October 01, 2004 -  September 30, 2005",Solid Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Donna B Bernstein



Lauren M Long","Larry  Baker
(Medical Oncology, Univ. of Michagan)




Ching  Lau
(Ped Heme/Onc, Texas Children's Hospital)",Crystal L. Mackall; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36824
547,SC006892-17,"October 01, 2004 -  September 30, 2005",Molecular Biology of Pediatric Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Patrick  Grohar,NULL,"Derkek  Leroith (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Capponcelli S, Pedrini E, Cerone MA, Corti V, Fontanesi S, Alessio M, Bachi A, Soddu S, Ribatti D, Picci P, Helman LJ, Cantelli-Forti G, Sangiorgi L (2005). Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat  26, 94-103.   https://doi.org/10.1002/humu.20192




PubMed


 


PubMed ID 15977174
    
     


 



2.
Savage SA, Stewart BJ, Liao JS, Helman LJ, Chanock SJ (2005). Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet  160, 79-81.   https://doi.org/10.1016/j.cancergencyto.2004.12.004




PubMed


 


PubMed ID 15949576
    
     


 



3.
Wan X, Mendoza A, Khanna C, Helman LJ (2005). Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res  65, 2406-11.   https://doi.org/10.1158/0008-5472.CAN-04-3135




PubMed


 


PubMed ID 15781656",https://intramural.nih.gov/search/searchview.taf?ipid=36825
548,SC007202-21,"October 01, 2004 -  September 30, 2005",Biostatistics and Data Management Section,"Seth M Steinberg; PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI","David J Liewehr



David J Venzon; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bennett LM, Montgomery JL, Steinberg SM, Kulp KS (2004). Flor-Essence herbal tonic does not inhibit mammary tumor development in Sprague Dawley rats. Breast Cancer Res Treat  88, 87-93.   https://doi.org/10.1007/s10549-004-1203-5




PubMed


 


PubMed ID 15538049
    
     


 



2.
Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R (2004). Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol  22, 3886-92.   https://doi.org/10.1200/JCO.2004.01.127




PubMed


 


PubMed ID 15314059
    
     


 



3.
Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH (2004). Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. Br J Haematol  126, 837-43.   https://doi.org/10.1111/j.1365-2141.2004.05133.x




PubMed


 


PubMed ID 15352988
    
     


 



4.
Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M (2005). Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol  174, 2185-9.   https://doi.org/10.4049/jimmunol.174.4.2185




PubMed


 


PubMed ID 15699150
    
     


 



5.
Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005). High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood  105, 496-502.   https://doi.org/10.1182/blood-2004-05-1982




PubMed


 


PubMed ID 15358629
    
     


 



6.
Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J (2005). A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. Clin Cancer Res  11, 1247-52.




PubMed


 


PubMed ID 15709195
    
     


 



7.
Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM (2004). Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol  22, 4067-74.   https://doi.org/10.1200/JCO.2004.04.068




PubMed


 


PubMed ID 15483018
    
     


 



8.
Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM (2005). Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer. J Clin Oncol  23, 2726-34.   https://doi.org/10.1200/JCO.2005.10.024




PubMed


 


PubMed ID 15837987
    
     


 



9.
Macpherson GR, Singh AS, Bennett CL, Venzon DJ, Liewehr DJ, Franks ME, Dahut WL, Kantoff PW, Price DK, Figg WD (2004). Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther  3, 1298-303.   https://doi.org/10.4161/cbt.3.12.1453




PubMed


 


PubMed ID 15662127
    
     


 



10.
Nacsa J, Edghill-Smith Y, Tsai WP, Venzon D, Tryniszewska E, Hryniewicz A, Moniuszko M, Kinter A, Smith KA, Franchini G (2005). Contrasting effects of low-dose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251. J Immunol  174, 1913-21.   https://doi.org/10.4049/jimmunol.174.4.1913




PubMed


 


PubMed ID 15699118
    
     


 



11.
Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS (2005). Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst  97, 632-42.   https://doi.org/10.1093/jnci/dji111




PubMed


 


PubMed ID 15870434
    
     


 



12.
Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S (2004). Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics  114, e235-42.   https://doi.org/10.1542/peds.114.2.e235




PubMed


 


PubMed ID 15286262
    
     


 



13.
Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D, Berthold F, Schwab M, Khan J (2004). Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res  64, 6883-91.   https://doi.org/10.1158/0008-5472.CAN-04-0695




PubMed



        
     
Free Article


 


PubMed ID 15466177
         Pubmed Central ID 1298184",https://intramural.nih.gov/search/searchview.taf?ipid=36768
549,SC007256-17,"October 01, 2004 -  September 30, 2005",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI","Amy B Coxon



Sanjay R Modi



Yoon Soo  Park","Adel  El-Naggar
(MD Anderson Cancer Center)




Priscilla  Furth
(Georgetown University)




William  Sellers
(Dana-Farber Cancer Institute)",Ilan  Kirsch; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kaye F   (2004) For Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastomas Survivors.  J Natl Cancer Inst  pp.




 



2.
Kaye F, Rozenblum E, Park Y, Joshi N, Tsuratani J, Dennis P, Kirsch I   (2005) Mect1-Mam12 fusion oncogene linked to the aberrant activation of cAMP/CREB regulated genes.  Cancer Research, in press.




 



3.
Kaye FJ (2005). A curious link between epidermal growth factor receptor amplification and survival: effect of ""allele dilution"" on gefitinib sensitivity? J Natl Cancer Inst  97, 621-3.   https://doi.org/10.1093/jnci/dji127




PubMed


 


PubMed ID 15870427
    
     


 



4.
Martins a   (2004) A study of Mect1-Maml2 in mucoepidermoid carcinoma and Warthins tumor of salivary glands.  J Mol Diag .




 



5.
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science  304, 1497-500.   https://doi.org/10.1126/science.1099314




PubMed


 


PubMed ID 15118125
    
     


 



6.
Rahman a   (2004) Evolutionary conservation of a 2 kilobase intronic sequence flanking a tissue-specific alternative exon in the human nPTB gene.  Genomics  pp.




 



7.
Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, Kaye FJ, Zajac-Kaye M (2004). Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell  5, 341-51.   https://doi.org/10.1016/s1535-6108(04)00080-7




PubMed


 


PubMed ID 15093541
    
     


 



8.
Tonon a   (2004) Multiple reciprocal translocations in salivary gland mucoepidermoid carcinoma.  Cancer Genetics Cytogenetics .",https://intramural.nih.gov/search/searchview.taf?ipid=36826
550,SC007263-13,"October 01, 2004 -  September 30, 2005","Molecular Control of Growth, Differentiation, and Death in Epithelial Cancer Cel","Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Gareth E Davies



Jeremy  Karlin



Marion M Nau



Monzur  Rahman



Philip  Ryan","David  Louis
(Neuropathology, Massachusetts General Hosp - East)




Josef  Penninger
(Institute of Molecular Biotechnology)




Allan M Weissman; MD
(NCI)","Maria  Zajac-Kaye; PhD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Dao M Nguyen; MD, MS (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Toshiyuki E Mori (National Cancer Institute)



Xiaowei  Yang (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, Liewehr DJ, Steinberg SM, Soballe PW, Lipkowitz S, Klein P, Kirsch IR (2005). Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. J Clin Oncol  23, 3455-64.   https://doi.org/10.1200/JCO.2005.04.050




PubMed


 


PubMed ID 15908654
    
     


 



2.
Davies GC, Ettenberg SA, Coats AO, Mussante M, Ravichandran S, Collins J, Nau MM, Lipkowitz S (2004). Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene  23, 7104-15.   https://doi.org/10.1038/sj.onc.1207952




PubMed


 


PubMed ID 15273720
    
     


 



3.
Lipkowitz S, Coats A, Ettenberg S, Gardner G, Nau M, Liu J, Birrer M   (2004) N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines Cell Death and Differentiation.  Cell Death and Differentiation  pp.




 



4.
Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M (2004). A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem  279, 29565-71.   https://doi.org/10.1074/jbc.M403954200




PubMed


 


PubMed ID 15123609
    
     


 



5.
Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, Kaye FJ, Zajac-Kaye M (2004). Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell  5, 341-51.   https://doi.org/10.1016/s1535-6108(04)00080-7




PubMed


 


PubMed ID 15093541
    
     


 



6.
Tan AR, Yang X, Hewitt SM, Berman A, Lepper ER, Sparreboom A, Parr AL, Figg WD, Chow C, Steinberg SM, Bacharach SL, Whatley M, Carrasquillo JA, Brahim JS, Ettenberg SA, Lipkowitz S, Swain SM (2004). Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Clin Oncol  22, 3080-90.   https://doi.org/10.1200/JCO.2004.08.189




PubMed


 


PubMed ID 15284258
    
     


 



7.
Zeng S, Xu Z, Lipkowitz S, Longley JB (2005). Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood  105, 226-32.   https://doi.org/10.1182/blood-2004-05-1768




PubMed


 


PubMed ID 15315962",https://intramural.nih.gov/search/searchview.taf?ipid=36827
551,SC007264-10,"October 01, 2004 -  September 30, 2005",Medical Oncology Fellowship Office,Barry  Gause; PhD,Lee Jay Helman; MD,"Medical Oncology Branch, NCI","Clarisse Nichole Brooks



Kathleen G Hilburn



Richard J Moon",NULL,"Martin  Gutierrez (National Cancer Institute)



Dennis D Hickstein (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Jennifer  Eng Wong (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=29215
552,SC007265-11,"October 01, 2004 -  September 30, 2005",Cancer Genetics,Ilan  Kirsch; MD,NULL,"Cancer Genetics Branch, NCI","Kathy  Calzone



Kristie  Gehlhaus



Oleg K Glebov



Geula  Klorin



Ken  Nakahara



Michelle  Nehrebecky



Show all 9",NULL,"David  Covell (National Cancer Institute)



Robert  Shoemaker (National Cancer Institute)



Karen  Woodson (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Jennifer  Eng Wong (National Cancer Institute)","Catherine K Chow; MD (CC) 



Donald  Hadley; MS (NHGRI)","Ordered by publication type and then author name.



1.
Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, Liewehr DJ, Steinberg SM, Soballe PW, Lipkowitz S, Klein P, Kirsch IR (2005). Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. J Clin Oncol  23, 3455-64.   https://doi.org/10.1200/JCO.2005.04.050




PubMed


 


PubMed ID 15908654
    
     


 



2.
Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol  22, 39-44.   https://doi.org/10.1200/JCO.2004.06.128




PubMed


 


PubMed ID 14701766
    
     


 



3.
Roschke AV, Lababidi S, Tonon G, Gehlhaus KS, Bussey K, Weinstein JN, Kirsch IR (2005). Karyotypic ""state"" as a potential determinant for anticancer drug discovery. Proc Natl Acad Sci U S A  102, 2964-9.   https://doi.org/10.1073/pnas.0405578102




PubMed



        
     
Free Article


 


PubMed ID 15703300
         Pubmed Central ID 549443",https://intramural.nih.gov/search/searchview.taf?ipid=36828
553,SC007281-12,"October 01, 2004 -  September 30, 2005",Nitric Oxide as a Modifier of Oxidative Stress,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Sonia  Donzelli



Irfan M Elahi



Michael G Espey; MT, PhD



Daniele  Mancardi



Lisa Ann Ridnour



Douglas D Thomas



Show all 7","Peter  Ford
(Univ. of Calif, Santa Barbara)




Jon  Fukuto
(UCLA)




Ken  Houk
(UCLA)




Dave  Kass
(Univ. of Torino, Italy)




Katrina  Miranda
(Chemistry Dept, Univ. of Arizona)




Nazarreano  Paoloci
(Johns Hopkins University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB (2004). Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol  14, 259-66.   https://doi.org/10.1016/j.semradonc.2004.04.001




PubMed


 


PubMed ID 15254869
    
     


 



2.
Fukuto JM, Switzer CH, Miranda KM, Wink DA (2005). Nitroxyl (HNO): chemistry, biochemistry, and pharmacology. Annu Rev Pharmacol Toxicol  45, 335-55.   https://doi.org/10.1146/annurev.pharmtox.45.120403.095959




PubMed


 


PubMed ID 15822180
    
     


 



3.
Hamelink C, Hampson A, Wink DA, Eiden LE, Eskay RL (2005). Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity. J Pharmacol Exp Ther  314, 780-8.   https://doi.org/10.1124/jpet.105.085779




PubMed



        
     
Free Article


 


PubMed ID 15878999
         Pubmed Central ID 4183207 


 



4.
Mancardi D, Ridnour LA, Thomas DD, Katori T, Tocchetti CG, Espey MG, Miranda KM, Paolocci N, Wink DA (2004). The chemical dynamics of NO and reactive nitrogen oxides: a practical guide. Curr Mol Med  4, 723-40.   https://doi.org/10.2174/1566524043359854




PubMed


 


PubMed ID 15579020
    
     


 



5.
Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, Espey MG, Houk KN, Fukuto JM, Wink DA (2005). Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc  127, 722-31.   https://doi.org/10.1021/ja045480z




PubMed


 


PubMed ID 15643898
    
     


 



6.
Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, Feelisch M, Fukuto J, Wink DA (2004). The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem  385, 1-10.   https://doi.org/10.1515/BC.2004.001




PubMed


 


PubMed ID 14977040
    
     


 



7.
Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, Wink DA (2004). Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A  101, 8894-9.   https://doi.org/10.1073/pnas.0400453101




PubMed



        
     
Free Article


 


PubMed ID 15178764
         Pubmed Central ID 428443 


 



8.
Wink D, Isenberg J, Espey M, Thomas D, Roberts D   (2005) Nitric Oxide regulates angiogenesis through a functional switch involving Thrombospondin-1.  Proc. Natl. Acad. Sci, in press.




 



9.
Wink D, Katori T, Torres C, Thomas L, Ridnour L, McLendon W, Cologna A, Champion H, Mancardi D, Tocchetti C, Saavedra J, Keefer L, Houk K, Fukuto J, Kass D, Paolocci N   (2005) Comparisons of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo.  J. Med. Chem, in press.




 



10.
Wink D, Ridnour L, Espey M, Katori T, Tocchetti C, Citrin D, Thomas D, Mancardi D, Ferlito M, Donzelli S, Fukuto J, Paolocci N   (2004) Comparison of the Chemical Biology of NO and HNO: An Inorganic Perspective.  Progress Inorg. Chem .




 



11.
Wink D, Ridnour L, Espey M, Roberts D   (2005) Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-Dependent Manner.  Proc. Natl. Acad. Sci, in press.




 



12.
Wink D, Switzer C, Miranda K   (2004) Nitroxyl (HNO): Chemistry, Biochemistry and Pharmacology.  Annual Reviews of Pharm. .




 



13.
Wink D, Thomas D, Mancardi D, Donzelli S, Paolocci N, Pagliaro P, Miranda K, Krishna M, Fukuto J, Grisham M, Mitchell J, Espey M   (2004) Antioxidant properties of nitric oxide in cellular physiological and pathophysiological mechanisms The implications of biological balance between NO and oxidative stress.  Med. Chem .




 



14.
Xu Q, Wink DA, Colton CA (2004). Nitric oxide production and regulation of neuronal NOS in tyrosine hydroxylase containing neurons. Exp Neurol  188, 341-50.   https://doi.org/10.1016/j.expneurol.2004.04.016




PubMed


 


PubMed ID 15246834",https://intramural.nih.gov/search/searchview.taf?ipid=36829
554,SC009144-21,"October 01, 2004 -  September 30, 2005",Mechanisms of transcription factor integration at the c-myc promoter,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Larry  Benjamin



Hye-Jung  Chung



Fedor Edmundovich Kouzine



Juhong  Liu



Suzanne Laurie Sanford



James  Soh



Show all 7",NULL,"Lino  Tessarollo (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)","G. Marius  Clore; PhD, MD (NIDDK)","Ordered by publication type and then author name.



1.
Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, Braddock DT, Muchmore SW, Comess KM, Fesik SW, Clore GM, Levens D, Hajduk PJ (2004). NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem  47, 4851-7.   https://doi.org/10.1021/jm0497803




PubMed


 


PubMed ID 15369388
    
     


 



2.
Kouzine F, Liu J, Sanford S, Chung H   (2004) The dynamic response of upstream DNA to transcription generated torsional stress.  Nature Structural and Molecular Biology .




 



3.
Weber A, Liu J, Collins I, Levens D (2005). TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol  25, 147-61.   https://doi.org/10.1128/MCB.25.1.147-161.2005




PubMed



        
     
Free Article


 


PubMed ID 15601838
         Pubmed Central ID 538784",https://intramural.nih.gov/search/searchview.taf?ipid=36830
555,SC009163-18,"October 01, 2004 -  September 30, 2005",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Nick  Devoogdt



Jeremiah Benjamin Frueauf



Jareer Nabeel Kassis



Shu-Fen  Mai



Nabila  Rasool



Fiona A Simpkins



Show all 8","Andrew  Bateman
(McGill University)




Monica  Brown Jones
(Mayo Clinic)




Ben  Davidson
(Norwegian Radium Hospital)




Howard  Doong
(U-Maryland)




arturo  leone
(Univ. Salerno)




Lance A Liotta; MD, PhD
(NCI)


Show all 10","David R Gius; MD, PhD (National Cancer Institute)



David Jay Goldstein (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004). Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer  100, 2139-47.   https://doi.org/10.1002/cncr.20219




PubMed


 


PubMed ID 15139056
    
     


 



2.
Kamrava M, Simpkins F, Alejandro E, Michener C, Meltzer E, Kohn EC (2005). Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. Oncogene  24, 7084-93.   https://doi.org/10.1038/sj.onc.1208857




PubMed


 


PubMed ID 16044162
    
     


 



3.
Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Müller SC, Kohn EC (2005). Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model. Anticancer Res  25, 725-9.




PubMed


 


PubMed ID 15868902
    
     


 



4.
Perabo FG, Wirger A, Kamp S, Lindner H, Schmidt DH, Müller SC, Kohn EC (2004). Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. Anticancer Res  24, 2869-77.




PubMed


 


PubMed ID 15517890
    
     


 



5.
Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA (2005). Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res  65, 3853-60.   https://doi.org/10.1158/0008-5472.CAN-04-1989




PubMed


 


PubMed ID 15867384",https://intramural.nih.gov/search/searchview.taf?ipid=36831
556,SC009170-18,"October 01, 2004 -  September 30, 2005",Genes regulating pattern formation during embryonic development,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Yuting  Chen



Hai  Huang



Minh-Thanh T. Nguyen; PhD



Junming  Yang



Jianjian  Zhu","Richard R. Behringer
(Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center)




Denis  Duboule
(Zoology and Animal Biology, Univ. of Geneva)




Gerard  Evan
(UCSF)




Lance  Liotta; MD, PhD
(George Mason University)",NULL,Alexandra L Joyner (NHGRI),"Ordered by publication type and then author name.



1.
Mackem S   (2005) Limb Development, in Cell signaling and growth factors in development: from molecules to organogenesis. Unsicker K, Krieglstein K, eds., Wiley-VCH Verlag GmbH and Co. (Weinheim), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36832
557,SC009172-17,"October 01, 2004 -  September 30, 2005",Cellular Interactions with Thrombospondin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jo A Cashel



Jeffrey S Isenberg



Yifeng  Jia



Svetlana A Kuznetsova



Gema  Martin-Manso



Elizabeth M Perruccio



Show all 7","William  Frazier
(Biochemistry, Washington University)




Jack  Lawler
(Beth Israel, Harvard)




Deane  Mosher
(Medicine, University of Wisconsin)",David Anderson Wink (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Calzada MJ, Annis DS, Zeng B, Marcinkiewicz C, Banas B, Lawler J, Mosher DF, Roberts DD (2004). Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J Biol Chem  279, 41734-43.   https://doi.org/10.1074/jbc.M406267200




PubMed


 


PubMed ID 15292271
    
     


 



2.
Isenberg JS, Calzada MJ, Zhou L, Guo N, Lawler J, Wang XQ, Frazier WA, Roberts DD (2005). Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. Matrix Biol  24, 110-23.   https://doi.org/10.1016/j.matbio.2005.01.002




PubMed


 


PubMed ID 15890262
    
     


 



3.
Isenberg JS, Ridnour LA, Espey MG, Wink DA, Roberts DD (2005). Nitric oxide in wound-healing. Microsurgery  25, 442-51.   https://doi.org/10.1002/micr.20168




PubMed


 


PubMed ID 16044466
    
     


 



4.
Kuznetsova SA, Day AJ, Mahoney DJ, Rugg MS, Mosher DF, Roberts DD (2005). The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J Biol Chem  280, 30899-908.   https://doi.org/10.1074/jbc.M500701200




PubMed



        
     
Free Article


 


PubMed ID 16006654
         Pubmed Central ID 1351260 


 



5.
Roberts D   (2005) Novel integrin antagonists derived from thrombospondins.  Curr. Pharm. Des.  pp.




 



6.
Roberts D, Isenberg J, Cao Z   (2005) Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.  Oncogene, in press.




 



7.
Roberts D, Isenberg J, Espey M, Thomas D, Cashel J, Wink D   (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.  Proc. Natl. Acad. Sci. USA, in press.




 



8.
Roberts D, Ridnour L, Espey M, Wink D   (2005) Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.  Proc. Natl. Acad. Sci. USA, in press.




 



9.
Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK (2005). Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine  30, 347-58.   https://doi.org/10.1016/j.cyto.2005.01.020




PubMed


 


PubMed ID 15935955",https://intramural.nih.gov/search/searchview.taf?ipid=36770
558,SC009173-17,"October 01, 2004 -  September 30, 2005",Host Colonization and Vascular Dissemination of ICandida albicansI,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jo A Cashel



Mike  Pendrak



Alexander W Peterson



John M Sipes",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36771
559,SC009174-17,"October 01, 2004 -  September 30, 2005",Role of Glycoconjugates in Tumor Biology,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jo A Cashel



Svetlana A Kuznetsova



John M Sipes",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kuznetsova SA, Day AJ, Mahoney DJ, Rugg MS, Mosher DF, Roberts DD (2005). The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J Biol Chem  280, 30899-908.   https://doi.org/10.1074/jbc.M500701200




PubMed



        
     
Free Article


 


PubMed ID 16006654
         Pubmed Central ID 1351260 


 



2.
Roberts D, Sharrow S, Lawler J   (2004) CD44 Expression in Immune Cells is Dysregulated in Thrombospondin-1 Null Mice.  Hyaluronan 2003 Conference Proceedings .",https://intramural.nih.gov/search/searchview.taf?ipid=36769
560,SC009179-17,"October 01, 2004 -  September 30, 2005",Tissue Inhibitors of Metalloproteinases: Regulation of Cell Growth and Different,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Seo-Jin  Lee



Hongmei  Li



Renuka  Sivendran



Beiyang  Wei","Steven  Libutti; MD
(Office Of The Director)




Maryalice  Stetler-Stevenson; MD, PhD
(NCI)",NULL,NULL,"Ordered by publication type and then author name.



1.
Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA (2004). Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke  35, e159-62.   https://doi.org/10.1161/01.STR.0000127420.10990.76




PubMed


 


PubMed ID 15105518
    
     


 



2.
Feldman AL, Stetler-Stevenson WG, Costouros NG, Knezevic V, Baibakov G, Alexander HR, Lorang D, Hewitt SM, Seo DW, Miller MS, O'Connor S, Libutti SK (2004). Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism. Cancer Res  64, 4481-6.   https://doi.org/10.1158/0008-5472.CAN-03-2929




PubMed


 


PubMed ID 15231657
    
     


 



3.
Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler-Stevenson M, Raffeld M, Stetler-Stevenson WG (2005). Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood  105, 1660-8.   https://doi.org/10.1182/blood-2004-04-1385




PubMed


 


PubMed ID 15479729
    
     


 



4.
Haviernik P, Lahoda C, Bradley HL, Hawley TS, Ramezani A, Hawley RG, Stetler-Stevenson M, Stetler-Stevenson WG, Bunting KD (2004). Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Oncogene  23, 9212-9.   https://doi.org/10.1038/sj.onc.1208096




PubMed


 


PubMed ID 15516987
    
     


 



5.
Larsen MB, Stephens RW, Brünner N, Nielsen HJ, Engelholm LH, Christensen IJ, Stetler-Stevenson WG, Høyer-Hansen G (2005). Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients. Scand J Immunol  61, 449-60.   https://doi.org/10.1111/j.1365-3083.2005.01585.x




PubMed


 


PubMed ID 15882437
    
     


 



6.
Martínez A, Oh HR, Unsworth EJ, Bregonzio C, Saavedra JM, Stetler-Stevenson WG, Cuttitta F (2004). Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J  383, 413-8.   https://doi.org/10.1042/BJ20040920




PubMed



        
     
Free Article


 


PubMed ID 15307819
         Pubmed Central ID 1133733 


 



7.
Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F (2004). Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res  64, 6489-94.   https://doi.org/10.1158/0008-5472.CAN-04-0103




PubMed


 


PubMed ID 15374959
    
     


 



8.
Oh J, Seo DW, Diaz T, Wei B, Ward Y, Ray JM, Morioka Y, Shi S, Kitayama H, Takahashi C, Noda M, Stetler-Stevenson WG (2004). Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res  64, 9062-9.   https://doi.org/10.1158/0008-5472.CAN-04-1981




PubMed


 


PubMed ID 15604273
    
     


 



9.
Stetler-Stevenson WG, Seo DW (2005). TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med  11, 97-103.   https://doi.org/10.1016/j.molmed.2005.01.007




PubMed


 


PubMed ID 15760767
    
     


 



10.
Stuelten CH, DaCosta Byfield S, Arany PR, Karpova TS, Stetler-Stevenson WG, Roberts AB (2005). Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci  118, 2143-53.   https://doi.org/10.1242/jcs.02334




PubMed


 


PubMed ID 15855236
    
     


 



11.
Tester AM, Waltham M, Oh SJ, Bae SN, Bills MM, Walker EC, Kern FG, Stetler-Stevenson WG, Lippman ME, Thompson EW (2004). Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Res  64, 652-8.   https://doi.org/10.1158/0008-5472.can-0384-2




PubMed


 


PubMed ID 14744781
    
     


 



12.
Wang T, Ward Y, Tian L, Lake R, Guedez L, Stetler-Stevenson WG, Kelly K (2005). CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Blood  105, 2836-44.   https://doi.org/10.1182/blood-2004-07-2878




PubMed


 


PubMed ID 15576472",https://intramural.nih.gov/search/searchview.taf?ipid=36833
561,SC009372-13,"October 01, 2004 -  September 30, 2005",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Catharine S Mccoy



Linda Shonk Weaver",NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmad E, Kingma DW, Jaffe ES, Schrager JA, Janik J, Wilson W, Stetler-Stevenson M (2005). Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow. Cytometry B Clin Cytom  67, 6-12.   https://doi.org/10.1002/cyto.b.20063




PubMed


 


PubMed ID 15973700
    
     


 



2.
Fogarty PF, Stetler-Stevenson M, Pereira A, Dunbar CE (2005). Large granular lymphocytic proliferation-associated cyclic thrombocytopenia. Am J Hematol  79, 334-6.   https://doi.org/10.1002/ajh.20375




PubMed


 


PubMed ID 16044437
    
     


 



3.
Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005). High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood  105, 496-502.   https://doi.org/10.1182/blood-2004-05-1982




PubMed


 


PubMed ID 15358629
    
     


 



4.
Lamb LS, Neuberg R, Welsh J, Best R, Stetler-Stevenson M, Sorrell A (2005). T-cell lymphoblastic leukemia/lymphoma syndrome with eosinophilia and acute myeloid leukemia. Cytometry B Clin Cytom  65, 37-41.   https://doi.org/10.1002/cyto.b.20033




PubMed


 


PubMed ID 15786509",https://intramural.nih.gov/search/searchview.taf?ipid=36777
562,SC009373-13,"October 01, 2004 -  September 30, 2005",Thr Role of TIMP1 in B Cell Differentiation and Survival,"Maryalice  Stetler-Stevenson; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",Yueqin  Liu,NULL,"William G Stetler-Stevenson; MD, PhD (National Cancer Institute)","Randy T Fischer (NIAMS) 



Amrie C Grammer; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler-Stevenson M, Raffeld M, Stetler-Stevenson WG (2005). Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood  105, 1660-8.   https://doi.org/10.1182/blood-2004-04-1385




PubMed


 


PubMed ID 15479729
    
     


 



2.
Haviernik P, Lahoda C, Bradley HL, Hawley TS, Ramezani A, Hawley RG, Stetler-Stevenson M, Stetler-Stevenson WG, Bunting KD (2004). Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Oncogene  23, 9212-9.   https://doi.org/10.1038/sj.onc.1208096




PubMed


 


PubMed ID 15516987",https://intramural.nih.gov/search/searchview.taf?ipid=36778
563,SC009374-14,"October 01, 2004 -  September 30, 2005",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Jeremiah Benjamin Frueauf



Jareer Nabeel Kassis



Victoria M Virador



Nana E Tchabo



Ebony  Boyce



Edwin M Posadas","Riccardo  Alessandro
(Univ. Palermo)




Ben  Davidson
(Norwegian Radium, Hospital)




Alan  Franklin
(U-Tenn)




Steven  Libutti; MD
(Office Of The Director)




Lance A Liotta; MD, PhD
(NCI)","Stephen M Hewitt; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Franklin AJ, Jetton TL, Kuchemann CL, Russell SR, Kohn EC (2004). CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy. Invest Ophthalmol Vis Sci  45, 3756-66.   https://doi.org/10.1167/iovs.03-1126




PubMed


 


PubMed ID 15452087
    
     


 



2.
Hoffmann S, He S, Jin ML, Masiero L, Wiedemann P, Ryan SJ, Kohn EC (2005). Carboxyamido-triazole modulates retinal pigment epithelial and choroidal endothelial cell attachment, migration, proliferation, and MMP-2 secretion of choroidal endothelial cells. Curr Eye Res  30, 103-13.   https://doi.org/10.1080/02713680490894595




PubMed


 


PubMed ID 15814468
    
     


 



3.
Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Müller SC, Kohn EC (2005). Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model. Anticancer Res  25, 725-9.




PubMed


 


PubMed ID 15868902
    
     


 



4.
Perabo FG, Wirger A, Kamp S, Lindner H, Schmidt DH, Müller SC, Kohn EC (2004). Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. Anticancer Res  24, 2869-77.




PubMed


 


PubMed ID 15517890
    
     


 



5.
Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA (2005). Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res  65, 3853-60.   https://doi.org/10.1158/0008-5472.CAN-04-1989




PubMed


 


PubMed ID 15867384",https://intramural.nih.gov/search/searchview.taf?ipid=36836
564,SC009375-13,"October 01, 2004 -  September 30, 2005",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Jeremiah Benjamin Frueauf



Vernelle Victoria Grays



Nana E Tchabo



Ebony  Boyce



Meghan S Liel



Edwin M Posadas","Riccardo  Alessandro
(Univ. Palermo)




Peter L Choyke; MD
(CC)




William D Figg; PharmD
(NCI)




Alan  Franklin
(U-TENN)




Steven  Libutti; MD
(Office Of The Director)




Lance A Liotta; MD, PhD
(NCI)


Show all 9",NULL,NULL,"Ordered by publication type and then author name.



1.
Alessandro R, Belluco C, Kohn EC (2005). Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clin Colorectal Cancer  4, 396-402.   https://doi.org/10.3816/ccc.2005.n.012




PubMed


 


PubMed ID 15807933
    
     


 



2.
Bell DA, Longacre TA, Prat J, Kohn EC, Soslow RA, Ellenson LH, Malpica A, Stoler MH, Kurman RJ (2004). Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol  35, 934-48.   https://doi.org/10.1016/j.humpath.2004.03.005




PubMed


 


PubMed ID 15297961
    
     


 



3.
Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF, Veenstra TD (2004). High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer  11, 163-78.   https://doi.org/10.1677/erc.0.0110163




PubMed


 


PubMed ID 15163296
    
     


 



4.
Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004). Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer  100, 2139-47.   https://doi.org/10.1002/cncr.20219




PubMed


 


PubMed ID 15139056
    
     


 



5.
Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB (2004). Molecular therapeutics: promise and challenges. Semin Oncol  31, 39-53.   https://doi.org/10.1053/j.seminoncol.2004.01.009




PubMed


 


PubMed ID 15052542
    
     


 



6.
Posadas EM, Davidson B, Kohn EC (2004). Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Curr Opin Oncol  16, 478-84.   https://doi.org/10.1097/00001622-200409000-00012




PubMed


 


PubMed ID 15314519
    
     


 



7.
Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC (2005). Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? Ann Oncol  16, 16-22.   https://doi.org/10.1093/annonc/mdi004




PubMed


 


PubMed ID 15598930
    
     


 



8.
Stevens EV, Posadas EM, Davidson B, Kohn EC (2004). Proteomics in cancer. Ann Oncol  15 Suppl 4, iv167-71.   https://doi.org/10.1093/annonc/mdh922




PubMed


 


PubMed ID 15477302
    
     


 



9.
Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B (2005). Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma. Cancer  103, 2313-9.   https://doi.org/10.1002/cncr.21031




PubMed


 


PubMed ID 15844177
    
     


 



10.
Tchabo NE, Liel MS, Kohn EC (2005). Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer. Am J Pharmacogenomics  5, 141-8.   https://doi.org/10.2165/00129785-200505030-00001




PubMed


 


PubMed ID 15952868",https://intramural.nih.gov/search/searchview.taf?ipid=36837
565,SC009377-13,"October 01, 2004 -  September 30, 2005",Molecular Alterations in Premalignant and In-Situ Breast Lesions,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Douglas O Halverson



Diane  Palmieri",NULL,Maria  Merino; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36838
566,SC009389-12,"October 01, 2004 -  September 30, 2005",A Mitogen-induced G Protein-coupled Receptor,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ross G Lake



Yvona  Ward; PhD",NULL,NULL,"Alan  Sher; PhD (NIAID) 



Ulrich K Siebenlist; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36839
567,SC009392-12,"October 01, 2004 -  September 30, 2005",Proteomic Analysis of Microdissected Benign and Malignant Kidney Tissues: A Tool,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,William Marston Linehan; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36840
568,SC009394-12,"October 01, 2004 -  September 30, 2005",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Mones  Abu-Asab



Celeste Rita Riley",NULL,Martha Maria Nicacio Quezado; MD (National Cancer Institute),"Constantine Argyrios Stratakis; MD, DSc (NICHD)","Ordered by publication type and then author name.



1.
Bossis I, Voutetakis A, Matyakhina L, Pack S, Abu-Asab M, Bourdeau I, Griffin KJ, Courcoutsakis N, Stergiopoulos S, Batista D, Tsokos M, Stratakis CA (2004). A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J Med Genet  41, 596-600.   https://doi.org/10.1136/jmg.2004.020214




PubMed



        
     
Free Article


 


PubMed ID 15286154
         Pubmed Central ID 1735874 


 



2.
Cassarino DS, Santi M, Arruda A, Patrocinio R, Tsokos M, Ghatak N, Quezado M (2004). Spinal adrenal cortical adenoma with oncocytic features: report of the first intramedullary case and review of the literature. Int J Surg Pathol  12, 259-64.   https://doi.org/10.1177/106689690401200309




PubMed


 


PubMed ID 15306940
    
     


 



3.
Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA (2004). Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab  89, 3173-82.   https://doi.org/10.1210/jc.2003-032247




PubMed


 


PubMed ID 15240590
    
     


 



4.
Maric I, Bryant R, Abu-Asab M, Cohen JI, Vivero A, Jaffe ES, Raffeld M, Tsokos M, Banks PM, Pittaluga S (2004). Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol  17, 1427-33.   https://doi.org/10.1038/modpathol.3800179




PubMed



        
     
Free Article


 


PubMed ID 15494709
         Pubmed Central ID 2288737 


 



5.
Stergiopoulos SG, Abu-Asab MS, Tsokos M, Stratakis CA (2004). Pituitary pathology in Carney complex patients. Pituitary  7, 73-82.   https://doi.org/10.1007/s11102-005-5348-y




PubMed



        
     
Free Article


 


PubMed ID 15761655
         Pubmed Central ID 2366887 


 



6.
Tsokos M, Rapkiewicz A, Abu-Asab M, Ries M, Askari H   (2005) Pathological findings in a patient with Fabry disease who died after 26 years of enzyme replacement.  Virch. Archiv, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36841
569,SC009431-11,"October 01, 2004 -  September 30, 2005",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Celeste Rita Riley,NULL,"Crystal L. Mackall; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Barenboim-Stapleton L, Yang X, Tsokos M, Wigginton JM, Padilla-Nash H, Ried T, Thiele CJ (2005). Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line. Cancer Genet Cytogenet  157, 109-17.   https://doi.org/10.1016/j.cancergencyto.2004.05.017




PubMed


 


PubMed ID 15721631
    
     


 



2.
Nathan PC, Tsokos M, Long L, Bernstein D, Wexler LH, Mackall CL, Helman LJ (2005). Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer  44, 449-54.   https://doi.org/10.1002/pbc.20262




PubMed


 


PubMed ID 15547929",https://intramural.nih.gov/search/searchview.taf?ipid=36842
570,SC010051-10,"October 01, 2004 -  September 30, 2005",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Erik D Brady



Thomas  Clifford



Diane E Milenic



Celeste A Regino



Vladimir  Talanov



Vincent Joseph Venditto",NULL,James B Mitchell; PhD (National Cancer Institute),"Robert  Star; MD (NIEHS) 



Peter L Choyke; MD (CC)","Ordered by publication type and then author name.



1.
Regino CA, Torti SV, Ma R, Yap GP, Kreisel KA, Torti FM, Planalp RP, Brechbiel MW (2005). N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. J Med Chem  48, 7993-9.   https://doi.org/10.1021/jm050724r




PubMed



        
     
Free Article


 


PubMed ID 16335923
         Pubmed Central ID 2597376",https://intramural.nih.gov/search/searchview.taf?ipid=36843
571,SC010056-10,"October 01, 2004 -  September 30, 2005",Mechanisms of Transcriptional Regulation in Activated T-cells,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Wenwu  Cui



Yun  Ge



Cynthia  Haggerty



Gila  Idelman



Gabriella  Rustici",NULL,"Ernest S Kawasaki (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)



James G McNally; PhD (National Cancer Institute)","Sharon H Jackson; MD (NIAID) 



Dennis D Taub; PhD (NIA)","Ordered by publication type and then author name.



1.
Cannons JL, Yu LJ, Hill B, Mijares LA, Dombroski D, Nichols KE, Antonellis A, Koretzky GA, Gardner K, Schwartzberg PL (2004). SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity  21, 693-706.   https://doi.org/10.1016/j.immuni.2004.09.012




PubMed


 


PubMed ID 15539155
    
     


 



2.
Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, Graham A, Chandramouli GV, Stewart DH, Biebuyck HA, Taub DD, Gardner K (2005). Pharmacologic profiling of transcriptional targets deciphers promoter logic. Pharmacogenomics J  5, 305-23.   https://doi.org/10.1038/sj.tpj.6500325




PubMed


 


PubMed ID 16044165
    
     


 



3.
Galperin MM, Traicoff JL, Ramesh A, Freebern WJ, Haggerty CM, Hartmann DP, Emmert-Buck MR, Gardner K, Knezevic V (2004). Multimembrane dot-blotting: a cost-effective tool for proteome analysis. Biotechniques  36, 1046-51.   https://doi.org/10.2144/04366PF01




PubMed


 


PubMed ID 15211757
    
     


 



4.
Gardner K, Tongbai R, Cui W, Collins I, Freebern W, Montano I, Haggerty C, Chandramouli G   (2005) Human Promoter Genomic Composition Demonstrates Non-Random Groupings that Reflect General Cellular Function.  BMC Bioinformatics, in press.




 



5.
Smith JL, Freebern WJ, Collins I, De Siervi A, Montano I, Haggerty CM, McNutt MC, Butscher WG, Dzekunova I, Petersen DW, Kawasaki E, Merchant JL, Gardner K (2004). Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proc Natl Acad Sci U S A  101, 11554-9.   https://doi.org/10.1073/pnas.0402156101




PubMed



        
     
Free Article


 


PubMed ID 15286281
         Pubmed Central ID 511019 


 



6.
Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, Gardner K, Rade JJ (2005). Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood  105, 3910-7.   https://doi.org/10.1182/blood-2004-03-0928




PubMed


 


PubMed ID 15677570
    
     


 



7.
Traicoff JL, Galperin MM, Ramesh A, Freebern WJ, Haggerty CM, Gardner K, Knezevic V (2004). Profiling the expression of mitogen-induced T-cell proteins by using multi-membrane dot-blotting. Biochem Biophys Res Commun  323, 355-60.   https://doi.org/10.1016/j.bbrc.2004.08.093




PubMed


 


PubMed ID 15351744",https://intramural.nih.gov/search/searchview.taf?ipid=36845
572,SC010058-10,"October 01, 2004 -  September 30, 2005",Regulation of apoptosis in Ewings sarcoma and neuroblastoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Susana Beatriz Galli



Yan  Ren",NULL,"Crystal L. Mackall; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tsokos M, Tsokos M   (2005) Apoptosis in tissue injury, in Forensic Pathology Reviews. Tsokos M, ed., Humana Press (Totowa, NJ), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36846
573,SC010074-10,"October 01, 2004 -  September 30, 2005",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Edward G Mimnaugh



Ivo A Wortman



Wanping  Xu



Elizabeth P Cartwright



Tomohiro  Kajiguchi



Fumitaka  Koga



Show all 7","Merritt  Andrus





Yair  Argon
(Pathology, University of Pennsylvania)




Brian  Blagg
(Chemistry, University of Kansas)




Charles  Erlichman
(Medicine, Mayo Clinic)




Linda  Hendershot
(Cell Biology, St. Jude's Childrens Hospital)




Daniel  Jay
(Physiology, Tufts Universityq)


Show all 11",David  Schrump; MD (National Cancer Institute),Yong Sok  Lee; PhD (CIT),"Ordered by publication type and then author name.



1.
Gotlib J, Berubé C, Growney JD, Chen CC, George TI, Williams C, Kajiguchi T, Ruan J, Lilleberg SL, Durocher JA, Lichy JH, Wang Y, Cohen PS, Arber DA, Heinrich MC, Neckers L, Galli SJ, Gilliland DG, Coutré SE (2005). Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood  106, 2865-70.   https://doi.org/10.1182/blood-2005-04-1568




PubMed



        
     
Free Article


 


PubMed ID 15972446
         Pubmed Central ID 1895309 


 



2.
Grem JL, Morrison G, Guo XD, Agnew E, Takimoto CH, Thomas R, Szabo E, Grochow L, Grollman F, Hamilton JM, Neckers L, Wilson RH (2005). Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. J Clin Oncol  23, 1885-93.   https://doi.org/10.1200/JCO.2005.12.085




PubMed


 


PubMed ID 15774780
    
     


 



3.
Xu W, Yuan X, Xiang Z, Mimnaugh E, Marcu M, Neckers L (2005). Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex. Nat Struct Mol Biol  12, 120-6.   https://doi.org/10.1038/nsmb885




PubMed


 


PubMed ID 15643424
    
     


 



4.
Blagg B, Han H, Neckers L, Yu X (submitted in 2005) Novobiocin Analogues As Anticancer Agents. Patents issued: 7,608,594 (US in 2010); 7,811,998 (US in 2011). Patents pending: 05824355.1 (EP application); PCT/US2005/039990 (PC application); 2005301957 (AU application); 2585091 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=36848
574,SC010083-09,"October 01, 2004 -  September 30, 2005",Molecular Basis for Augmentation of Host Response and Understanding Genetic Risk,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Renee A Chen,"Anne-Lise  Borresen-Dale
(Radium Hospital, Oslo)




John  Curnutte
(DNAX)




Charles  Foster
(Johns Hopkins University)




David  Hunter
(Harvard)




Gritta  Janka-Schaub
(University Hamburg)




T.J.W.  Kuijpers
(AMC, Amsterdam)


Show all 10","Nathaniel C Rothman; MD (National Cancer Institute)



Sholom  Wacholder; PhD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Harry  Maelch (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Joseph  Fraumeni; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bergen AW, Haque KA, Qi Y, Beerman MB, Garcia-Closas M, Rothman N, Chanock SJ (2005). Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources. Hum Mutat  26, 262-70.   https://doi.org/10.1002/humu.20213




PubMed


 


PubMed ID 16086324
    
     


 



2.
Bergen AW, Qi Y, Haque KA, Welch RA, Garcia-Closas M, Chanock SJ, Vaught J, Castle PE (2005). Effects of electron-beam irradiation on whole genome amplification. Cancer Epidemiol Biomarkers Prev  14, 1016-9.   https://doi.org/10.1158/1055-9965.EPI-04-0686




PubMed


 


PubMed ID 15824182
    
     


 



3.
Bonner MR, Rothman N, Mumford JL, He X, Shen M, Welch R, Yeager M, Chanock S, Caporaso N, Lan Q (2005). Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat Res  582, 53-60.   https://doi.org/10.1016/j.mrgentox.2004.12.008




PubMed


 


PubMed ID 15781210
    
     


 



4.
Brown EE, Fallin MD, Goedert JJ, Chen R, Whitby D, Foster CB, Lauria C, Alberg AJ, Messina A, Montella M, Rezza G, Vitale F, Chanock SJ, Kaposi Sarcoma Genetics Working Group (2005). A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev  14, 633-7.   https://doi.org/10.1158/1055-9965.EPI-04-0598




PubMed


 


PubMed ID 15767342
    
     


 



5.
Choi EH, Taylor JG, Foster CB, Walsh TJ, Anttila VJ, Ruutu T, Palotie A, Chanock SJ (2005). Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients. Med Mycol  43, 349-53.   https://doi.org/10.1080/13693780412331282322




PubMed


 


PubMed ID 16110781
    
     


 



6.
Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF (2005). Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology  16, 469-77.   https://doi.org/10.1097/01.ede.0000164539.09250.31




PubMed


 


PubMed ID 15951664
    
     


 



7.
Engel SA, Olshan AF, Savitz DA, Thorp J, Erichsen HC, Chanock SJ (2005). Risk of small-for-gestational age is associated with common anti-inflammatory cytokine polymorphisms. Epidemiology  16, 478-86.   https://doi.org/10.1097/01.ede.0000164535.36412.6b




PubMed


 


PubMed ID 15951665
    
     


 



8.
Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Zhao X, Li G, Wu YY, Shen M, Yin S, Chanock SJ, Rothman N, Smith MT (2005). Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect  113, 801-7.   https://doi.org/10.1289/ehp.7635




PubMed



        
     
Free Article


 


PubMed ID 15929907
         Pubmed Central ID 1257610 


 



9.
García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N (2005). NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet  366, 649-59.   https://doi.org/10.1016/S0140-6736(05)67137-1




PubMed



        
     
Free Article


 


PubMed ID 16112301
         Pubmed Central ID 1459966 


 



10.
Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, Bresalier RS, Chanock SJ, Caporaso NE, Ji BT, Weissfeld JL, Hayes RB (2005). CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis  26, 1122-8.   https://doi.org/10.1093/carcin/bgi054




PubMed


 


PubMed ID 15731166
    
     


 



11.
Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, Hou LF, Berndt SI, Yadavalli S, Johnson CC, Hayes RB (2005). Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev  14, 152-7.




PubMed


 


PubMed ID 15668489
    
     


 



12.
Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, Chanock SJ, Fraumeni JF, Hayes RB (2005). Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev  14, 1747-53.   https://doi.org/10.1158/1055-9965.EPI-05-0162




PubMed


 


PubMed ID 16030112
    
     


 



13.
Hughes AL, Packer B, Welch R, Bergen AW, Chanock SJ, Yeager M (2005). Effects of natural selection on interpopulation divergence at polymorphic sites in human protein-coding Loci. Genetics  170, 1181-7.   https://doi.org/10.1534/genetics.104.037077




PubMed



        
     
Free Article


 


PubMed ID 15911586
         Pubmed Central ID 1242184 


 



14.
Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, Greer BT, Chanock S, Lyman CA, Walsh TJ (2005). Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun  73, 3714-24.   https://doi.org/10.1128/IAI.73.6.3714-3724.2005




PubMed



        
     
Free Article


 


PubMed ID 15908401
         Pubmed Central ID 1111842 


 



15.
Lan Q, Shen M, Berndt SI, Bonner MR, He X, Yeager M, Welch R, Keohavong P, Donahue M, Hainaut P, Chanock S (2005). Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer  49, 317-23.   https://doi.org/10.1016/j.lungcan.2005.04.004




PubMed


 


PubMed ID 15921821
    
     


 



16.
Lehrnbecher T, Bernig T, Hanisch M, Koehl U, Behl M, Reinhardt D, Creutzig U, Klingebiel T, Chanock SJ, Schwabe D (2005). Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia  19, 1745-50.   https://doi.org/10.1038/sj.leu.2403922




PubMed


 


PubMed ID 16107886
    
     


 



17.
McGlynn KA, Sakoda LC, Hu Y, Schoen RE, Bresalier RS, Yeager M, Chanock S, Hayes RB, Buetow KH (2005). Hemochromatosis gene mutations and distal adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev  14, 158-63.




PubMed


 


PubMed ID 15668490
    
     


 



18.
Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC (2005). Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis  26, 597-604.   https://doi.org/10.1093/carcin/bgh344




PubMed


 


PubMed ID 15564288
    
     


 



19.
Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB (2005). GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev  14, 1823-7.   https://doi.org/10.1158/1055-9965.EPI-05-0037




PubMed


 


PubMed ID 16030123
    
     


 



20.
Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, Weissfeld JL, Schatzkin A, Hayes RB (2004). Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev  13, 2181-6.




PubMed


 


PubMed ID 15598778
    
     


 



21.
Savage SA, Chanock SJ (2004). Using germ-line genetic variation to investigate and treat cancer. Drug Discov Today  9, 610-8.   https://doi.org/10.1016/S1359-6446(04)03179-4




PubMed


 


PubMed ID 15239980
    
     


 



22.
Savage SA, Stewart BJ, Eckert A, Kiley M, Liao JS, Chanock SJ (2005). Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Hum Mutat  26, 343-50.   https://doi.org/10.1002/humu.20226




PubMed


 


PubMed ID 16110488
    
     


 



23.
Savage SA, Stewart BJ, Liao JS, Helman LJ, Chanock SJ (2005). Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet  160, 79-81.   https://doi.org/10.1016/j.cancergencyto.2004.12.004




PubMed


 


PubMed ID 15949576
    
     


 



24.
Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, Bonner MR, Tian L, Yeager M, Welch R, Chanock S, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer  116, 768-73.   https://doi.org/10.1002/ijc.21117




PubMed


 


PubMed ID 15849729
    
     


 



25.
Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, Zheng T, Caporaso N, Lan Q (2005). Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res  25, 537-42.




PubMed


 


PubMed ID 15816625
    
     


 



26.
Shen M, Rothman N, Berndt SI, He X, Yeager M, Welch R, Chanock S, Caporaso N, Lan Q (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer  49, 299-309.   https://doi.org/10.1016/j.lungcan.2005.04.002




PubMed


 


PubMed ID 15922487
    
     


 



27.
Smith MT, Vermeulen R, Li G, Zhang L, Lan Q, Hubbard AE, Forrest MS, McHale C, Zhao X, Gunn L, Shen M, Rappaport SM, Yin S, Chanock S, Rothman N (2005). Use of 'Omic' technologies to study humans exposed to benzene. Chem Biol Interact  153-154, 123-7.   https://doi.org/10.1016/j.cbi.2005.03.017




PubMed


 


PubMed ID 15935808
    
     


 



28.
Staats B, Qi L, Beerman M, Sicotte H, Burdett LA, Packer B, Chanock SJ, Yeager M (2005). Genewindow: an interactive tool for visualization of genomic variation. Nat Genet  37, 109-10.   https://doi.org/10.1038/ng0205-109




PubMed


 


PubMed ID 15678133
    
     


 



29.
Toraason M, Albertini R, Bayard S, Bigbee W, Blair A, Boffetta P, Bonassi S, Chanock S, Christiani D, Eastmond D, Hanash S, Henry C, Kadlubar F, Mirer F, Nebert D, Rapport S, Rest K, Rothman N, Ruder A, Savage R, Schulte P, Siemiatycki J, Shields P, Smith M, Tolbert P, et al. [6 more authors] (2004). Applying new biotechnologies to the study of occupational cancer--a workshop summary. Environ Health Perspect  112, 413-6.   https://doi.org/10.1289/ehp.6343




PubMed



        
     
Free Article


 


PubMed ID 15033588
         Pubmed Central ID 1241892 


 



30.
Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM (2004). Mutation of GATA3 in human breast tumors. Oncogene  23, 7669-78.   https://doi.org/10.1038/sj.onc.1207966




PubMed


 


PubMed ID 15361840
    
     


 



31.
Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS (2005). Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med  352, 1413-24.   https://doi.org/10.1056/NEJMoa042980




PubMed


 


PubMed ID 15814878
    
     


 



32.
Yang X', Beerman M, Bergen AW, Parry DM, Sheridan E, Liebsch NJ, Kelley MJ, Chanock S, Goldstein AM (2005). Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs). Int J Cancer  116, 487-91.   https://doi.org/10.1002/ijc.21006




PubMed


 


PubMed ID 15818627",https://intramural.nih.gov/search/searchview.taf?ipid=36851
575,SC010084-34,"October 01, 2004 -  September 30, 2005",Pediatric HIVAIDS Clinical Research,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Alexandra  Freeman



Rohan  Hazra



Lori  Wiener; PhD, LCSW-C



Steven Leonard Zeichner; MD, PhD","Nilo Alonso Avila; MD
(CC)




Michael  Bates





Andrew  Bonwit





Andrew  Cheng





Josephine  Cox





Boro  Dropulic



Show all 13","Frank M Balis; MD, PhD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Zhi Ming  Zheng; MD, PhD (National Cancer Institute)","Richard A Koup; MD (NIAID) 



Daniel C Douek; MD (NIAID) 



Chad  Womack; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36852
576,SC010087-09,"October 01, 2004 -  September 30, 2005",HIV Molecular Virology and Pathogenesis,"Steven Leonard Zeichner; MD, PhD",NULL,"HIV and AIDS Malignancy Branch, NCI","Vyjayanthi  Krishnan



Michael C Lu



Naoto  Yoshizuka","Christian  Brander
(AIDS Research Center, Massachusetts General Hospital)




Gary  Hayward
(Department of Oncology, Johns Hopkins Medical School)




Jae  Jung
(New England Regional Primate Center, Harvard University)




Hsing-Jien  Kung
(Department of Biological Chemistry, University of California, Davis)




David  Lukac
(UMDNJ)




John  Nicholas
(Deparment of Oncology, Johns Hopkins Medical School)


Show all 7","Eric Y Chuang (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)","Richard A Koup; MD (NIAID) 



Barney S Graham; MD, PhD (NIAID) 



Kuan-Teh  Jeang; PhD, MD (NIAID)","Ordered by publication type and then author name.



1.
Yoshizuka N, Yoshizuka-Chadani Y, Krishnan V, Zeichner SL (2005). Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. J Virol  79, 11366-81.   https://doi.org/10.1128/JVI.79.17.11366-11381.2005




PubMed



        
     
Free Article


 


PubMed ID 16103188
         Pubmed Central ID 1193619 


 



2.
Zeichner S, Gafni R, Maldarelli F, Balis F, Tullio A, DeCarlo E, Worrell C, Steinberg S, Flaherty J, Yale K, Kearney B   (2005) Tenofovir disoproxil fumarate and an optimized background regimen of antiretrovirals as salvage therapy for pediatric HIV infection.  Pediatrics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36853
577,SC010090-09,"October 01, 2004 -  September 30, 2005",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Mary  Hawkins,"Lesley  Davenport
(Biochemistry, Brooklyn College)




Basil  Hanss
(Chemistry, Mt. Sinai University)




Wei  Kong





Ishita  Mukerji
(Biochemistry, Wesleyan University)




Tom  Norlund
(University of Alabama, Birmingham)




Wolfgang  Pfleiderer
(Organic Chemistry, Konstanz GE)


Show all 7",NULL,Jay Robert Knutson; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Sanabia J, Goldner L, Lacaze P, Hawkins M   (2004) On the feasibility of single-molecule detection of the guanosine analogue 3-MI.  J Physical Chem  pp.




 



2.
Stanley R, Hou Z, Yang A, Hawkins M   (2005) The two photon excitation cross section of 6MAP, a fluorescent adenine analog.  J Physical Chem  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36854
578,SC010093-08,"October 01, 2004 -  September 30, 2005",Targeting the Epigenome for the Treatment and Prevention of Thoracic Malignancie,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Aaron  Chen



Ana R Hancox



Julie A Hong



Yang  Kang



Tricia  Kunst



Ming  Zhao



Show all 7","Nasser  Altorki
(Thoracic Surgery, Cornell University Medical Center)




J. Carl  Barrett
(Novartis)




David  Beer
(Thoracic Surgery, University of Michigan)




Andrew  Dannenberg
(Gastroenterology, Cornell University Medical Center)","Dao M Nguyen; MD, MS (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)",Victor  Lobanenkov (NIAID),"Ordered by publication type and then author name.



1.
Cole GW, Alleva AM, Reddy RM, Maxhimer JB, Zuo J, Schrump DS, Nguyen DM (2005). The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro. J Thorac Cardiovasc Surg  129, 1010-7.   https://doi.org/10.1016/j.jtcvs.2004.10.040




PubMed


 


PubMed ID 15867774
    
     


 



2.
Maxhimer JB, Reddy RM, Zuo J, Cole GW, Schrump DS, Nguyen DM (2005). Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). J Thorac Cardiovasc Surg  129, 53-63.   https://doi.org/10.1016/j.jtcvs.2004.07.051




PubMed


 


PubMed ID 15632825
    
     


 



3.
Schrump D   (2005) Novel molecular targeted therapy for esophageal cancer.  Seminars Surg Oncol, in press.




 



4.
Schrump D   (2005) Targeting the epigenome for the treatment and prevention of lung cancer.  Seminars Oncol, in press.




 



5.
Schrump D, Abdulaev Z, Pack S, Flanagan P, Custer M, Loukinov D, Pugacheva E, Hong J, Morse H, Risinger J, Barrett J, Lobanenkov V (2005) Ectopic expression of CTCF-paralogous transcription factor BORIS in normal cells results in demethylation and de-repression of MAGE A1, and reactivation of other cancer-testis genes. Cancer Res.




 



6.
Schrump D, Chandramouli G, Maxwell L, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Berchuck A, Lobanenkov V, Barrett J   (2005) Global expression analysis of cancer-testis genes in uterine cancers reveals a high incidence of BORIS expression.  Mol Cancer Res, in press.




 



7.
Schrump D, Hong J, Irvine K, Chen G, Spiess P, Liu Y, Zeng G, Wunderlich J, Nguyen D, Restifo N   (2005) Adoptive immunotherapy targeting a cancer-testis antigen induced by 5-aza 2deoxycytidine diminishes pulmonary metastases in a syngeneic murine tumor model.  Cancer Res, in press.




 



8.
Schrump D, Kang Y, Abdullaev Z, Flanagan P, Pack S, Fischette M, Adnani M, Loukinov D, Vatolin S, Risinger J, Custer M, Chen G, Zhao M, Nguyen D, Barrett J, Lobanenkov V   (2005) Reciprocal binding of CTCF and BORIS (Brother of the Regulator of Imprinted Sites) to the NY-ESO-1 promoter coincides with de-repression of this cancer-testis gene in lung cancer cells.  Cancer Res, in press.




 



9.
Schrump D, Zhao M, Chen G, Hong J, Nguyen D   (2005) Depletion of DNA methyltransferase(DNMT) 1 and/or 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.  J Thorac Cardiovasc Surg, in press.




 



10.
Srinivasan R, Filie A, Reynolds J, Chang R, Chow C, Schrump DS, Takahashi Y, Suffredini AF, Childs RW (2005). Positron emission tomography for lymphoma staging: tissue remains the issue. J Natl Cancer Inst  97, 611-3.   https://doi.org/10.1093/jnci/dji110




PubMed


 


PubMed ID 15840888
    
     


 



11.
Steiner FA, Hong JA, Fischette MR, Beer DG, Guo ZS, Chen GA, Weiser TS, Kassis ES, Nguyen DM, Lee S, Trepel JB, Schrump DS (2005). Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells. Oncogene  24, 2386-97.   https://doi.org/10.1038/sj.onc.1208376




PubMed


 


PubMed ID 15735751",https://intramural.nih.gov/search/searchview.taf?ipid=36779
579,SC010097-06,"October 01, 2004 -  September 30, 2005",Inflammatory Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI","Sherry M Yang



Diana A Nguyen",NULL,"Suparna B Wedam (National Cancer Institute)



James C Lee (National Cancer Institute)



Xiaowei  Yang (National Cancer Institute)



Neelima  Denduluri (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



Janice Maria Walshe (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Swain S   (2005) Indications for neoadjuvant therapy in breast cancer.  Seminars in Breast Disease: radiologic, pathologic and surgical considerations, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36856
580,SC010100-06,"October 01, 2004 -  September 30, 2005",Developmental Therapeutics for Improved Treatment of Tumors of the Central Nervo,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Jeongwu  Lee



Ai-Min  Hui



Lyndon J Kim



Cheryl L Royce



Benjamin W Purow



Dan  Xi; PhD



Show all 7","Michael  Prados
(Neurological Surgery, UCSF)
















Ken  Adalpe
(Pathology, M.D. Anderson Cancer Center)




Mitchel  Berger
(Neurosurgery, University of California)




Oliver  Bogler
(Hermelin Brain Tumor Center, Henry Ford Hospital)




Steven  Brem
(Neurosurgery, H. Lee Moffitt Cancer Center)




Timothy  Cloughesy
(University of California, Los Angeles)


Show all 20",Paul Stuart Albert (National Cancer Institute),"John Keenam Park (NINDS) 



Joseph A Frank; MD, MS (CC) 



Edward H. Oldfield; MD (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36857
581,SC010277-08,"October 01, 2004 -  September 30, 2005",Chemokines in Skin Immune Cell Trafficking & Cancer Progression,"Sam  Hwang; MD, PhD",NULL,"Dermatology Branch, NCI","Lei  Fang



Takashi  Kakinuma



Chih-Hung  Lee



Bradford A Perez



Hong G Zhang; PhD



Adela R Cardones



Show all 7",NULL,"Nicholas Phillip Restifo; MD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



John R Wunderlich (National Cancer Institute)



Steven Frank Goldberg (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)



Nadya I Tarasova; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hwang ST (2004). Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J Invest Dermatol  122, xiv-xv.   https://doi.org/10.1111/j.0022-202X.2004.22346.x




PubMed


 


PubMed ID 15086589
    
     


 



2.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



3.
Murakami T, Cardones AR, Hwang ST (2004). Chemokine receptors and melanoma metastasis. J Dermatol Sci  36, 71-8.   https://doi.org/10.1016/j.jdermsci.2004.03.002




PubMed


 


PubMed ID 15519136",https://intramural.nih.gov/search/searchview.taf?ipid=36858
582,SC010278-08,"October 01, 2004 -  September 30, 2005",Waldenstroms Macroglobulinemia,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents,NULL,Mary Louise McMaster; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kuehl W   (2005) Early genetic events provide the basis for a clinical classification of multiple myeloma.  Hematology 2005 ASH Education Book, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36859
583,SC010279-08,"October 01, 2004 -  September 30, 2005",Mechanisms of effector activation by the RAS oncogene,Geoffrey J Clark; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Nadia  Allen



Kristin  Eckfeld



Candice A Elam



Kristopher A Lofgren",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmed-Choudhury J, Agathanggelou A, Fenton SL, Ricketts C, Clark GJ, Maher ER, Latif F (2005). Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res  65, 2690-7.   https://doi.org/10.1158/0008-5472.CAN-04-3593




PubMed


 


PubMed ID 15805267
    
     


 



2.
Armesilla AL, Williams JC, Buch MH, Pickard A, Emerson M, Cartwright EJ, Oceandy D, Vos MD, Gillies S, Clark GJ, Neyses L (2004). Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem  279, 31318-28.   https://doi.org/10.1074/jbc.M307557200




PubMed


 


PubMed ID 15145946
    
     


 



3.
Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD, Clark GJ, Downward J, Maher ER, Latif F (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res  64, 4112-6.   https://doi.org/10.1158/0008-5472.CAN-04-0267




PubMed


 


PubMed ID 15205320
    
     


 



4.
Leaner VD, Donninger H, Ellis CA, Clark GJ, Birrer MJ (2005). p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol Cell Biol  25, 3324-37.   https://doi.org/10.1128/MCB.25.8.3324-3337.2005




PubMed



        
     
Free Article


 


PubMed ID 15798216
         Pubmed Central ID 1069594",https://intramural.nih.gov/search/searchview.taf?ipid=36860
584,SC010280-08,"October 01, 2004 -  September 30, 2005",The role of Ras-related proteins in transformation,Geoffrey J Clark; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Nadia  Allen



Kristin  Eckfeld



Candice A Elam



Kristopher A Lofgren","Nicholas  Nassar
(Biochemistry, SUNY)




lawrence  quilliam
(Biochemistry, university of Indianna)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36861
585,SC010281-08,"October 01, 2004 -  September 30, 2005",Biology and Therapy of T Cell Depletion,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Kevin  Chua



Terry J Fry



Martin  Guimond



Sarah G Herby



Aviva  Krauss



Kristen M Snyder



Show all 7","Warren J Leonard; MD
(NHLBI)




Michel  Morre
(CYTHERIS, INC)","John J Letterio; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)","Daniel C Douek; MD (NIAID) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Mackall C   (2005) Promising Gamma-c Cytokines for Cancer Immunotherapy: IL7, IL15 and IL21 as Vaccine Adjuvants, Growth Factors and Immunorestoratives, in Immunotherapy of Cancer. Disis N, ed.,  Human Press, in press.




 



2.
Fry TJ, Mackall CL (2005). Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future. Bone Marrow Transplant  35 Suppl 1, S53-7.   https://doi.org/10.1038/sj.bmt.1704848




PubMed


 


PubMed ID 15812532
    
     


 



3.
Guimond M, Fry TJ, Mackall CL (2005). Cytokine signals in T-cell homeostasis. J Immunother  28, 289-94.   https://doi.org/10.1097/01.cji.0000165356.03924.e7




PubMed


 


PubMed ID 16000945
    
     


 



4.
Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, Gress RE (2005). Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest  115, 930-9.   https://doi.org/10.1172/JCI22492




PubMed



        
     
Free Article


 


PubMed ID 15776111
         Pubmed Central ID 1064981 


 



5.
Karl JC, Mackall CL (2005). Cancer therapy-induced immune modulation. Cancer Chemother Biol Response Modif  22, 325-41.




PubMed


 


PubMed ID 16110619
    
     


 



6.
Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL (2005). Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest  115, 1177-87.   https://doi.org/10.1172/JCI23134




PubMed



        
     
Free Article


 


PubMed ID 15841203
         Pubmed Central ID 1074679",https://intramural.nih.gov/search/searchview.taf?ipid=36862
586,SC010282-08,"October 01, 2004 -  September 30, 2005",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Alison E Director-Myska; PhD



Shannon I Skarshaug",NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36863
587,SC010288-08,"October 01, 2004 -  September 30, 2005",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Babak  Behbahani



Todd R Borenstein



J  Foley



Jacopo  Mariotti","Carl  June
(Abramson Family Cancer Research Center, University of Pennsylvania)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)




Jeff  Medin
(Dept. of Molecular Therapy, University of Toronto Cancer Institute)","Michael R Bishop; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)",Elizabeth J Read; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36864
588,SC010289-07,"October 01, 2004 -  September 30, 2005",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Kevin  Chua



Varun  Khanna



Aviva  Krauss



Melinda S Merchant



Kristen M Snyder



Hua  Zhang","Avi  Ashkenazi
(Genentech, Inc.)




Nai-Kong  Cheung
(Memorial Sloan Kettering Cancer Center)




Norma Lynn  Fox
(Human Genome Sciences, Inc.)




Carl  June
(ABRAMSON CANCER CENTER, University of Pennsylvania)




H. Udo  Kontny
(University of Freiburg, Germany)




Robert  Vonderheide
(UNIVERSITY OF PENNSYLVANIA)","Lee Jay Helman; MD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)



Christoph  Rader; PhD (National Cancer Institute)",Elizabeth J Read; MD (CC),"Ordered by publication type and then author name.



1.
Mackall C   (2005) Tumor Immunology and Pediatric Cancer, in Principles and Practice of Pediatric Oncology. Pizzo P, Poplack D, eds., Lippincott Raven (Philadelphia), in press.




 



2.
Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ (2004). Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst  96, 46-55.   https://doi.org/10.1093/jnci/djh004




PubMed


 


PubMed ID 14709738
    
     


 



3.
Melchionda F, McKirdy MK, Medeiros F, Fry TJ, Mackall CL (2004). Escape from immune surveillance does not result in tolerance to tumor-associated antigens. J Immunother  27, 329-38.   https://doi.org/10.1097/00002371-200409000-00001




PubMed


 


PubMed ID 15314541
    
     


 



4.
Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL (2004). Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res  64, 8349-56.   https://doi.org/10.1158/0008-5472.CAN-04-1705




PubMed


 


PubMed ID 15548704
    
     


 



5.
Nathan PC, Tsokos M, Long L, Bernstein D, Wexler LH, Mackall CL, Helman LJ (2005). Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer  44, 449-54.   https://doi.org/10.1002/pbc.20262




PubMed


 


PubMed ID 15547929",https://intramural.nih.gov/search/searchview.taf?ipid=36865
589,SC010292-07,"October 01, 2004 -  September 30, 2005",Identification and regulation of signal transduction pathways that promote survi,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Courtney A Granville



Wei  Han



Jaminelli J Liwanag



Junji  Tsurutani



Noel Andrew Warfel



Chunyu  Zhang",NULL,"Curtis  Harris; MD (National Cancer Institute)



Ilona  Linnoila; MD (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carón RW, Yacoub A, Li M, Zhu X, Mitchell C, Hong Y, Hawkins W, Sasazuki T, Shirasawa S, Kozikowski AP, Dennis PA, Hagan MP, Grant S, Dent P (2005). Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Mol Cancer Ther  4, 257-70.




PubMed


 


PubMed ID 15713897
    
     


 



2.
Dennis P, Granville C   (2004) Targetting aberrant signal transduction pathways in lung cancer.  Cancer Biology and Therapy  pp.




 



3.
Dennis P, Linnoila I, Belinsky S, Harris C   (2004) Tobacco carcinogen-induced cellular transformation increases activation of the phosphatinylinositol 3'-kinase/Akt pathway in vitro and in vivo.  Cancer Research  pp.




 



4.
Fiala ES, Sohn OS, Wang CX, Seibert E, Tsurutani J, Dennis PA, El-Bayoumy K, Sodum RS, Desai D, Reinhardt J, Aliaga C (2005). Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E. Carcinogenesis  26, 605-12.   https://doi.org/10.1093/carcin/bgh341




PubMed


 


PubMed ID 15579485
    
     


 



5.
Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA (2005). Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis  26, 1182-95.   https://doi.org/10.1093/carcin/bgi072




PubMed


 


PubMed ID 15790591
    
     


 



6.
West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA (2004). Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo. Chest  125, 101S-2S.   https://doi.org/10.1378/chest.125.5_suppl.101s




PubMed


 


PubMed ID 15136436",https://intramural.nih.gov/search/searchview.taf?ipid=36866
590,SC010294-07,"October 01, 2004 -  September 30, 2005",Approaches to Enhance Cancer Gene Therapy,John Charles Morris; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",Jason C Steel,"Salvatore  Alesci
(CLINICAL AND BIOLOGICAL SCIENCES, National Institute of Mental Health)




Guido  Forni
(Clinical and Biological Sciences, University of Turin)




Pacak  Karel
(CLINICAL NEUROENDOCRINOLOGY BRANCH, National Institute of Child Health and Human Development)




Charles  Link
(NewLink Genetics, Inc.)




Gregory  Prince
(REPRODUCTIVE BIOLOGY AND MEDICINE BRANCH, VIRION SYSTEMS, INC.)




Oliver  Wilder
(Ruhr-Universitat Bochum)","Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Park JM, Terabe M, Sakai Y, Munasinghe J, Forni G, Morris JC, Berzofsky JA (2005). Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas. J Immunol  174, 4228-36.   https://doi.org/10.4049/jimmunol.174.7.4228




PubMed


 


PubMed ID 15778385",https://intramural.nih.gov/search/searchview.taf?ipid=36867
591,SC010298-07,"October 01, 2004 -  September 30, 2005",Identification of patterns and mechanisms of chromosomal aberrations in hematolo,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Michael John Difilippantonio; PhD



Amanda  Hummon



Nicole E Mcneil



Hesed M Padilla Nash



Kundan  Sengupta; MS, PhD



Linda I Stapleton



Show all 7","Andrew  Arnold; MD
(Center for Molecular Medicine, University of Connecticut Health Center)




Hans-Peter  Bruch





Martin  Carroll
(Institute of Signal Processing, University of Pennsylvania)




Bijan  Ghadimi
(Biomedical Sciences, University of Connecticut)




Raju  Kucherlapati





Paul  Lambert
(McArdle Laboratory for Cancer Research, University of Wisconsin Medical School)","Kerstin  Heselmeyer (Cancer Genetics Branch)



Glenn  Merlino; PhD (National Cancer Institute)



Jeff  Green (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)



Siegfried  Janz; MD, DSc (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)","Karl  Sirotkin (NLM) 



Vemulkonda Koneti Rao; MD, FRCPA (NIAID)","Ordered by publication type and then author name.



1.
Barenboim-Stapleton L, Yang X, Tsokos M, Wigginton JM, Padilla-Nash H, Ried T, Thiele CJ (2005). Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line. Cancer Genet Cytogenet  157, 109-17.   https://doi.org/10.1016/j.cancergencyto.2004.05.017




PubMed


 


PubMed ID 15721631
    
     


 



2.
Dorritie K, Montagna C, Difilippantonio MJ, Ried T (2004). Advanced molecular cytogenetics in human and mouse. Expert Rev Mol Diagn  4, 663-76.   https://doi.org/10.1586/14737159.4.5.663




PubMed



        
     
Free Article


 


PubMed ID 15347260
         Pubmed Central ID 4729310 


 



3.
Janicki SM, Tsukamoto T, Salghetti SE, Tansey WP, Sachidanandam R, Prasanth KV, Ried T, Shav-Tal Y, Bertrand E, Singer RH, Spector DL (2004). From silencing to gene expression: real-time analysis in single cells. Cell  116, 683-98.   https://doi.org/10.1016/s0092-8674(04)00171-0




PubMed



        
     
Free Article


 


PubMed ID 15006351
         Pubmed Central ID 4942132 


 



4.
Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T, Gress RE (2004). Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res  64, 6524-9.   https://doi.org/10.1158/0008-5472.CAN-04-0896




PubMed


 


PubMed ID 15374963
    
     


 



5.
McNeil N, Kim JS, Ried T, Janz S (2005). Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation. Genes Chromosomes Cancer  43, 137-46.   https://doi.org/10.1002/gcc.20172




PubMed


 


PubMed ID 15751044
    
     


 



6.
Musio A, Mariani T, Montagna C, Zambroni D, Ascoli C, Ried T, Vezzoni P (2004). Recapitulation of the Roberts syndrome cellular phenotype by inhibition of INCENP, ZWINT-1 and ZW10 genes. Gene  331, 33-40.   https://doi.org/10.1016/j.gene.2004.01.028




PubMed


 


PubMed ID 15094189
    
     


 



7.
Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S (2005). Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res  65, 1306-15.   https://doi.org/10.1158/0008-5472.CAN-04-0268




PubMed


 


PubMed ID 15735016
    
     


 



8.
Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T (2005). The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res  583, 105-19.   https://doi.org/10.1016/j.mrgentox.2005.01.013




PubMed


 


PubMed ID 15927870
    
     


 



9.
Schaeffer AJ, Nguyen M, Liem A, Lee D, Montagna C, Lambert PF, Ried T, Difilippantonio MJ (2004). E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res  64, 538-46.   https://doi.org/10.1158/0008-5472.can-03-0124




PubMed


 


PubMed ID 14744767
    
     


 



10.
Ried KT, Andersson ST, Auer GT, Heselmeyer-haddad KT, Larsson CT, Steinberg WT (submitted in 2005) Methods For Detecting Progression Of Low Grade Cervical Dysplasia. Patents issued: 1853735 (CH in 2011); 1853735 (DE in 2011); 1853735 (DK in 2011); 1853735 (EP in 2011); 1853735 (ES in 2011); 1853735 (FI in 2011); 1853735 (FR in 2011); 1853735 (GB in 2011); HK1115166 (HK in 2011); 1853735 (IT in 2011); 1853735 (NL in 2011); 1853735 (SE in 2011); 2006213996 (AU in 2012); 8,409,808 (US in 2013); 5053867 (JP in 2013); 2333117 (DE in 2014); 2333117 (EP in 2014); 2333117 (FR in 2014); 2333117 (GB in 2014); 2333117 (SE in 2014). Patents pending: 13/854,764 (US application); 2598179 (CA application); PCT/US2006/006116 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=36868
592,SC010299-07,"October 01, 2004 -  September 30, 2005",Consequences of chromosomal aneuploidy on the cancer transcriptome,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sandra  Becker



Buddy  Chen



Michael John Difilippantonio; PhD



Patrick  Hoermann



Amanda  Hummon



Nicole E Mcneil



Show all 7","Martin  Carroll
(Institute of Signal Processing, University of Pennsylvania)




Thomas  Cremer
(Istituto di Tecnologie Biomediche, University of Munich)




Sampsa  Hautaniemi





Paolo  Vezzoni","James Carl Barrett; PhD (National Cancer Institute)



Lisa  Mcshane (National Cancer Institute)



ED  Korn (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)



Richard  Simon (National Cancer Institute)



Gilbert  Smith; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Guda K, Upender MB, Belinsky G, Flynn C, Nakanishi M, Marino JN, Ried T, Rosenberg DW (2004). Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene  23, 3813-21.   https://doi.org/10.1038/sj.onc.1207489




PubMed


 


PubMed ID 15021908
    
     


 



2.
Pack SD, Alper OM, Stromberg K, Augustus M, Ozdemirli M, Miermont AM, Klus G, Rusin M, Slack R, Hacker NF, Ried T, Szallasi Z, Alper O (2004). Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line. Cancer Res  64, 789-94.   https://doi.org/10.1158/0008-5472.can-03-1982




PubMed


 


PubMed ID 14871800
    
     


 



3.
Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T (2005). The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res  583, 105-19.   https://doi.org/10.1016/j.mrgentox.2005.01.013




PubMed


 


PubMed ID 15927870
    
     


 



4.
Ried T, Dorritie K, Weaver Z, Wangsa D, Difilippantonio MJ, Montagna C (2004). Molecular cytogenetics of mouse models of breast cancer. Breast Dis  19, 59-67.   https://doi.org/10.3233/bd-2004-19108




PubMed



        
     
Free Article


 


PubMed ID 15687698
         Pubmed Central ID 4729361 


 



5.
Schaeffer AJ, Nguyen M, Liem A, Lee D, Montagna C, Lambert PF, Ried T, Difilippantonio MJ (2004). E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res  64, 538-46.   https://doi.org/10.1158/0008-5472.can-03-0124




PubMed


 


PubMed ID 14744767
    
     


 



6.
Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, Ried T (2004). Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res  64, 6941-9.   https://doi.org/10.1158/0008-5472.CAN-04-0474




PubMed



               Available in future as a Free Article 


 


PubMed ID 15466185
         Pubmed Central ID 4772432",https://intramural.nih.gov/search/searchview.taf?ipid=36869
593,SC010300-07,"October 01, 2004 -  September 30, 2005",Translational genomics,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Starsha N Valentine



Buddy  Chen



Michael John Difilippantonio; PhD



Linda I Stapleton",NULL,"Kerstin  Heselmeyer (Cancer Genetics Branch)



David  Danforth (National Cancer Institute)",Alejandro Alberto Schaffer; PhD (NLM),"Ordered by publication type and then author name.



1.
Barenboim-Stapleton L, Yang X, Tsokos M, Wigginton JM, Padilla-Nash H, Ried T, Thiele CJ (2005). Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line. Cancer Genet Cytogenet  157, 109-17.   https://doi.org/10.1016/j.cancergencyto.2004.05.017




PubMed


 


PubMed ID 15721631
    
     


 



2.
Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Füzesi L, Langer C, Becker H, Liersch T, Ried T (2005). Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol  23, 1826-38.   https://doi.org/10.1200/JCO.2005.00.406




PubMed



        
     
Free Article


 


PubMed ID 15774776
         Pubmed Central ID 4721601 


 



3.
Habermann JK, Hellman K, Freitag S, Heselmeyer-Haddad K, Hellström AC, Shah K, Auer G, Ried T (2004). A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina. Cancer Genet Cytogenet  148, 7-13.   https://doi.org/10.1016/s0165-4608(03)00245-0




PubMed


 


PubMed ID 14697635
    
     


 



4.
Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T (2005). Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol  166, 1229-38.   https://doi.org/10.1016/S0002-9440(10)62341-3




PubMed



        
     
Free Article


 


PubMed ID 15793301
         Pubmed Central ID 1602397 


 



5.
Maranchie JK, Afonso A, Albert PS, Kalyandrug S, Phillips JL, Zhou S, Peterson J, Ghadimi BM, Hurley K, Riss J, Vasselli JR, Ried T, Zbar B, Choyke P, Walther MM, Klausner RD, Linehan WM (2004). Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat  23, 40-6.   https://doi.org/10.1002/humu.10302




PubMed


 


PubMed ID 14695531
    
     


 



6.
Roblick UJ, Hirschberg D, Habermann JK, Palmberg C, Becker S, Krüger S, Gustafsson M, Bruch HP, Franzén B, Ried T, Bergmann T, Auer G, Jörnvall H (2004). Sequential proteome alterations during genesis and progression of colon cancer. Cell Mol Life Sci  61, 1246-55.   https://doi.org/10.1007/s00018-004-4049-4




PubMed


 


PubMed ID 15141310
    
     


 



7.
Stoltzfus P, Heselmeyer-Haddad K, Castro J, White N, Silfverswärd C, Sjövall K, Einhorn N, Tryggvason K, Auer G, Ried T, Nordström B (2005). Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva. Int J Gynecol Cancer  15, 120-6.   https://doi.org/10.1111/j.1048-891X.2005.15012.x




PubMed


 


PubMed ID 15670306",https://intramural.nih.gov/search/searchview.taf?ipid=36870
594,SC010353-06,"October 01, 2004 -  September 30, 2005",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Paula K Layton



Cynthia P Love",NULL,"Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)","Austin John Barrett; MD (NHLBI) 



Stephen E Straus; MD (NIAID) 



Roger  Kurlander; MD (CC) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Wayne A, Yau Y, Cullis H, Horwitz M, Mackall C, Barrett A, Malech H, Rehak N, Leitman S   (2004) Pediatric large volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.  Transfusion  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36871
595,SC010354-06,"October 01, 2004 -  September 30, 2005",Clinical Development of Novel Drugs for Children with Cancer and Neurofibromatos,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Tatiana  Petrosyan



Eva  Dombi","Peter Charles Adamson; MD





Robert  Arceci
(Genetics, Johns Hopkins)




Dusica  Babovic-Vuksanovic
(Genetics, Mayo Clinic)




Lawrence  Baker
(SARC)




Susan  Blaney
(Pediatrics, Texas Children's Cancer Center)




Jan  Friedman
(University of British Columbia)


Show all 15","Frank M Balis; MD, PhD (National Cancer Institute)



Jo Anne N Zujewski (National Cancer Institute)



Elizabeth  Fox; MD (National Cancer Institute)



Katherine Elizabeth Warren; MD (National Cancer Institute)



Karlyne M Reilly; BS, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Adamson PC, Blaney SM, Widemann BC, Kitchen B, Murphy RF, Hannah AL, Cropp GF, Patel M, Gillespie AF, Whitcomb PG, Balis FM (2004). Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother Pharmacol  53, 482-8.   https://doi.org/10.1007/s00280-004-0769-2




PubMed


 


PubMed ID 14999430
    
     


 



2.
Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J (2005). A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. Clin Cancer Res  11, 1247-52.




PubMed


 


PubMed ID 15709195
    
     


 



3.
Solomon J, Warren K, Dombi E, Patronas N, Widemann B (2004). Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Comput Med Imaging Graph  28, 257-65.   https://doi.org/10.1016/j.compmedimag.2004.03.002




PubMed


 


PubMed ID 15249071
    
     


 



4.
Stephens MC, Baldassano RN, York A, Widemann B, Pitney AC, Jayaprakash N, Adamson PC (2005). The bioavailability of oral methotrexate in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr  40, 445-9.   https://doi.org/10.1097/01.mpg.0000157588.27125.50




PubMed


 


PubMed ID 15795592
    
     


 



5.
Widemann BC (2004). Merlin PAKs a punch. Cancer J  10, 8-11.   https://doi.org/10.1097/00130404-200401000-00002




PubMed


 


PubMed ID 15000489
    
     


 



6.
Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC (2004). High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer  100, 2222-32.   https://doi.org/10.1002/cncr.20255




PubMed


 


PubMed ID 15139068
    
     


 



7.
Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC (2004). Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst  96, 1557-9.   https://doi.org/10.1093/jnci/djh270




PubMed


 


PubMed ID 15494606",https://intramural.nih.gov/search/searchview.taf?ipid=36872
596,SC010355-06,"October 01, 2004 -  September 30, 2005",Angiogenesis and Tumor Growth,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","Cassin Elizabeth Kimmel; BS



Bernhard  Lange-Asschenfeldt



Takayuki  Nakayama



Masashi  Narazaki",NULL,"Sam  Hwang; MD, PhD (National Cancer Institute)



David A Davis; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36873
597,SC010356-06,"October 01, 2004 -  September 30, 2005",A Role for KSHV (Kaposis Sarcoma-associated Herpesvirus) in the Pathogenesis of,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","Yoshiyasu  Aoki



Cassin Elizabeth Kimmel; BS



Maria N Labo



Takayuki  Nakayama",NULL,"Stefania  Pittaluga (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36874
598,SC010357-06,"October 01, 2004 -  September 30, 2005",Gene expression and post-transcriptional regulation of oncogenic DNA tumor virus,"Zhi Ming  Zheng; MD, PhD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Sohrab  Bodaghi



Rong  Jia



Vladimir  Majerciak



Shuang  Tang



Mingfang  Tao



Koji  Yamanegi","Elliot  Androphy
(Medicine, University of Massachusetts Medical School)




Shou-Jiang  Gao
(University of Texas)




Craig  Meyers
(Microbiology and Immunology, Penn State University College of Medicine)","Michael John Kruhlak; PhD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)",John Philip McCoy (NHLBI),"Ordered by publication type and then author name.



1.
Zheng ZM, Tang S, Tao M (2005). Development of resistance to RNAi in mammalian cells. Ann N Y Acad Sci  1058, 105-18.   https://doi.org/10.1196/annals.1359.019




PubMed



        
     
Free Article


 


PubMed ID 16394130
         Pubmed Central ID 1462965",https://intramural.nih.gov/search/searchview.taf?ipid=36875
599,SC010359-07,"October 01, 2004 -  September 30, 2005",The Role of Nore1 Class Effectors in Ras-Mediated Transformation,Geoffrey J Clark; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Nadia  Allen



Kristin  Eckfeld



Candice A Elam



Kristopher A Lofgren","Farida  Latif
(University of Birmingham, U.K.)




Bin  Teh
(Van Andel Res. Inst.)




Michael  White
(Biochemistry, UTSouthwestern)",NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmed-Choudhury J, Agathanggelou A, Fenton SL, Ricketts C, Clark GJ, Maher ER, Latif F (2005). Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res  65, 2690-7.   https://doi.org/10.1158/0008-5472.CAN-04-3593




PubMed


 


PubMed ID 15805267
    
     


 



2.
Armesilla AL, Williams JC, Buch MH, Pickard A, Emerson M, Cartwright EJ, Oceandy D, Vos MD, Gillies S, Clark GJ, Neyses L (2004). Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem  279, 31318-28.   https://doi.org/10.1074/jbc.M307557200




PubMed


 


PubMed ID 15145946
    
     


 



3.
Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD, Clark GJ, Downward J, Maher ER, Latif F (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res  64, 4112-6.   https://doi.org/10.1158/0008-5472.CAN-04-0267




PubMed


 


PubMed ID 15205320
    
     


 



4.
Eckfeld K, Hesson L, Vos MD, Bieche I, Latif F, Clark GJ (2004). RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res  64, 8688-93.   https://doi.org/10.1158/0008-5472.CAN-04-2065




PubMed


 


PubMed ID 15574778
    
     


 



5.
Elam C, Hesson L, Vos MD, Eckfeld K, Ellis CA, Bell A, Krex D, Birrer MJ, Latif F, Clark GJ (2005). RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. Cancer Res  65, 3117-25.   https://doi.org/10.1158/0008-5472.CAN-04-0749




PubMed


 


PubMed ID 15833841
    
     


 



6.
Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F, Clark GJ (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res  64, 4244-50.   https://doi.org/10.1158/0008-5472.CAN-04-0339




PubMed


 


PubMed ID 15205337",https://intramural.nih.gov/search/searchview.taf?ipid=36876
600,SC010360-07,"October 01, 2004 -  September 30, 2005",Molecular Determinants of Faithful Chromosome Transmission and Cell Cycle Regula,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ayca  Akal-strader



Wei-Chun  Au



Lauren  Kitchen



Suveena  Sharma; PhD","Jef  Boeke
(Molecular Biology and Genetics, Johns Hopkins School of Medicine)




Ron  Davis
(Biochemistry and Genome Technology Center, Stanford University)




Grant  Hartzog
(MCD Biology, Univ. of California, Santa Cruz)




Michael  Snyder
(Molecular, Cellular and Developmental Biology, Yale University)




Forrest  Spencer
(Molecular Biology and Genetics, Johns Hopkins School of Medicine)




Richard  Wozniak
(Dept. of Cell Biology, Univ. of Alberta)",Michael Joseph Lichten; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Brannon AR, Maresca JA, Boeke JD, Basrai MA, McBride AA (2005). Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein. Proc Natl Acad Sci U S A  102, 2998-3003.   https://doi.org/10.1073/pnas.0407818102




PubMed



        
     
Free Article


 


PubMed ID 15710895
         Pubmed Central ID 549465 


 



2.
Kastenmayer JP, Lee MS, Hong AL, Spencer FA, Basrai MA (2005). The C-terminal half of Saccharomyces cerevisiae Mad1p mediates spindle checkpoint function, chromosome transmission fidelity and CEN association. Genetics  170, 509-17.   https://doi.org/10.1534/genetics.105.041426




PubMed



        
     
Free Article


 


PubMed ID 15802513
         Pubmed Central ID 1450390",https://intramural.nih.gov/search/searchview.taf?ipid=36877
601,SC010362-06,"October 01, 2004 -  September 30, 2005",Maternal cohort study of the Nurses Health Studies,Michele  Forman; PhD,NULL,"Laboratory of Biosystems and Cancer, NCI",NULL,"Lisa  Colbert
(University of Wisconsin)




Graham  Coldizt
(Brigham Womens Hospital, Harvard University)




Karin  Michels
(Brigham Womens Hospital, Harvard University)




Janet  Rich Edwards
(Brigham Womens Hospital, Harvard University)","James Carl Barrett; PhD (National Cancer Institute)



Barry Ira Graubard; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Forman M, Umar A, Barrett J   (2004) Nutrition and Cancer Prevention: A multidisciplinary Perspective on Human Trials.  Annu Rev Nutr  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36879
602,SC010364-05,"October 01, 2004 -  September 30, 2005",Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Stephen M Hewitt; MD, PhD



Kimberly  Tuttle",NULL,"Mark  Raffeld; MD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)",Ira W Levin; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Braunschweig T, Chung JY, Hewitt SM (2004). Perspectives in tissue microarrays. Comb Chem High Throughput Screen  7, 575-85.   https://doi.org/10.2174/1386207043328445




PubMed


 


PubMed ID 15379629
    
     


 



2.
Erez A, Perelman M, Hewitt SM, Cojacaru G, Goldberg I, Shahar I, Yaron P, Muler I, Campaner S, Amariglio N, Rechavi G, Kirsch IR, Krupsky M, Kaminski N, Izraeli S (2004). Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene  23, 5371-7.   https://doi.org/10.1038/sj.onc.1207685




PubMed


 


PubMed ID 15107824
    
     


 



3.
Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME (2004). Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev  13, 667-72.




PubMed


 


PubMed ID 15066936
    
     


 



4.
Fernandez DC, Bhargava R, Hewitt SM, Levin IW (2005). Infrared spectroscopic imaging for histopathologic recognition. Nat Biotechnol  23, 469-74.   https://doi.org/10.1038/nbt1080




PubMed


 


PubMed ID 15793574
    
     


 



5.
Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res  10, 4314-24.   https://doi.org/10.1158/1078-0432.CCR-03-0489




PubMed


 


PubMed ID 15240517
    
     


 



6.
Goodman MT, Hernandez BY, Hewitt S, Lynch CF, Coté TR, Frierson HF, Moskaluk CA, Killeen JL, Cozen W, Key CR, Clegg L, Reichman M, Hankey BF, Edwards B (2005). Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol  36, 812-20.   https://doi.org/10.1016/j.humpath.2005.03.010




PubMed


 


PubMed ID 16084952
    
     


 



7.
Mobasheri A, Airley R, Hewitt SM, Marples D (2005). Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. Int J Oncol  26, 1149-58.




PubMed


 


PubMed ID 15809704",https://intramural.nih.gov/search/searchview.taf?ipid=36780
603,SC010365-06,"October 01, 2004 -  September 30, 2005",Optimization of the Graft-Versus-Tumor Effect in Allogeneic Hematopoietic Stem C,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Janine R Daub



Ladan  Foruraghi



Nancy M Hardy



Michael Charles Krumlauf



Catherine L Simmons","Sergio  Giralt
(M.D. ANDERSON CANCER CENTER)




Carl  June
(UNIVERSITY OF PENNSYLVANIA)




Larry  Kwak
(NCI)




Sattva  Neelapu
(M.D. ANDERSON CANCER CENTER)","Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bishop MR (2004). Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer. Haematologica  89, 599-605.




PubMed


 


PubMed ID 15136224
    
     


 



2.
Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R (2004). Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol  22, 3886-92.   https://doi.org/10.1200/JCO.2004.01.127




PubMed


 


PubMed ID 15314059
    
     


 



3.
Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH (2004). Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. Br J Haematol  126, 837-43.   https://doi.org/10.1111/j.1365-2141.2004.05133.x




PubMed


 


PubMed ID 15352988
    
     


 



4.
Dean RM, Bishop MR (2004). Allogeneic hematopoietic stem cell transplantation for lymphoma. Clin Lymphoma  4, 238-49.   https://doi.org/10.3816/clm.2004.n.004




PubMed


 


PubMed ID 15072616
    
     


 



5.
Dean RM, Fowler DH, Wilson WH, Odom J, Steinberg SM, Chow C, Kasten-Sportes C, Gress RE, Bishop MR (2005). Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma. Biol Blood Marrow Transplant  11, 593-9.   https://doi.org/10.1016/j.bbmt.2005.04.005




PubMed


 


PubMed ID 16041309
    
     


 



6.
Fowler DH, Bishop MR, Gress RE (2004). Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells. Semin Oncol  31, 56-67.   https://doi.org/10.1053/j.seminoncol.2003.11.003




PubMed


 


PubMed ID 14970938
    
     


 



7.
Fowler DH, Foley J, Whit-Shan Hou J, Odom J, Castro K, Steinberg SM, Gea-Banacloche J, Kasten-Sportes C, Gress RE, Bishop MR (2004). Clinical ""cytokine storm"" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin Gastroenterol Hepatol  2, 237-45.   https://doi.org/10.1016/s1542-3565(04)00011-4




PubMed


 


PubMed ID 15017608
    
     


 



8.
Kwak LW, Neelapu SS, Bishop MR (2004). Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion. Semin Oncol  31, 37-46.   https://doi.org/10.1053/j.seminoncol.2003.11.001




PubMed


 


PubMed ID 14970936
    
     


 



9.
Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringdén O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C (2005). Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research. J Clin Oncol  23, 5788-94.   https://doi.org/10.1200/JCO.2005.03.962




PubMed


 


PubMed ID 16043827
    
     


 



10.
Sportès C, McCarthy NJ, Hakim F, Steinberg SM, Liewehr DJ, Weng D, Kummar S, Gea-Banacloche J, Chow CK, Dean RM, Castro KM, Marchigiani D, Bishop MR, Fowler DH, Gress RE (2005). Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. Biol Blood Marrow Transplant  11, 472-83.   https://doi.org/10.1016/j.bbmt.2005.03.010




PubMed


 


PubMed ID 15931636",https://intramural.nih.gov/search/searchview.taf?ipid=36880
604,SC010366-05,"October 01, 2004 -  September 30, 2005",Identification of Genes for Predicting Prognosis in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Sven  Bilke



Qingrong  Chen



Braden T Greer



Jun S Wei","Frank  Berthold
(Department of Pediatrics, Klinik fr Kinderheilkunde der Universitt zu Kln)




Daniel  Catchpoole
(Tumor Bank, The Children's Hospital at Westmead)




Manfred  Schwab
(Department of Tumour Genetics, German Cancer Research Center)




Frank  Westermann
(Department of Tumour Genetics, German Cancer Research Center)",Seth M Steinberg; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Krasnoselsky AL, Whiteford CC, Wei JS, Bilke S, Westermann F, Chen QR, Khan J (2005). Altered expression of cell cycle genes distinguishes aggressive neuroblastoma. Oncogene  24, 1533-41.   https://doi.org/10.1038/sj.onc.1208341




PubMed


 


PubMed ID 15592497
    
     


 



2.
Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D, Berthold F, Schwab M, Khan J (2004). Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res  64, 6883-91.   https://doi.org/10.1158/0008-5472.CAN-04-0695




PubMed



        
     
Free Article


 


PubMed ID 15466177
         Pubmed Central ID 1298184",https://intramural.nih.gov/search/searchview.taf?ipid=36881
605,SC010367-05,"October 01, 2004 -  September 30, 2005",Regulation of the cell cycle by cyclin-dependent kinases,Philipp  Kaldis; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Eiman  Aleem



Cyril  Berthet



Kristy L Mcdowell","Joe  Baldassare
(Molecular Pharmacology and Physiology, Saint Louis University Medical School)




Dean  Felsher
(Division of Oncology, Stanford University School of Medicine)




Vittorio  Gallo; PhD
(NICHHD)




Hiroaki  Kiyokawa
(Molecular Pharmacology and Biological Chemistry, Northwestern University The Feinberg School of Medicine)




Neil  Segil
(Cell and Molecular Biology, House Ear Institute)","Ilan  Kirsch; MD (National Cancer Institute)



Remy J Bosselut; MD, PhD (National Cancer Institute)



Peter F Johnson; PhD (National Cancer Institute)



Jonathan  Keller; PhD (National Cancer Institute)



Andrew  Blauvelt; MD (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aleem E, Berthet C, Kaldis P (2004). Cdk2 as a master of S phase entry: fact or fake? Cell Cycle  3, 35-7.




PubMed


 


PubMed ID 14657662
    
     


 



2.
Aleem E, Kiyokawa H, Kaldis P (2005). Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol  7, 831-6.   https://doi.org/10.1038/ncb1284




PubMed


 


PubMed ID 16007079
    
     


 



3.
Campaner S, Kaldis P, Izraeli S, Kirsch IR (2005). Sil phosphorylation in a Pin1 binding domain affects the duration of the spindle checkpoint. Mol Cell Biol  25, 6660-72.   https://doi.org/10.1128/MCB.25.15.6660-6672.2005




PubMed



        
     
Free Article


 


PubMed ID 16024801
         Pubmed Central ID 1190358 


 



4.
Fu Z, Schroeder MJ, Shabanowitz J, Kaldis P, Togawa K, Rustgi AK, Hunt DF, Sturgill TW (2005). Activation of a nuclear Cdc2-related kinase within a mitogen-activated protein kinase-like TDY motif by autophosphorylation and cyclin-dependent protein kinase-activating kinase. Mol Cell Biol  25, 6047-64.   https://doi.org/10.1128/MCB.25.14.6047-6064.2005




PubMed



        
     
Free Article


 


PubMed ID 15988018
         Pubmed Central ID 1168834 


 



5.
Kaldis P (2005). The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity. J Biol Chem  280, 11165-74.   https://doi.org/10.1074/jbc.M408887200




PubMed


 


PubMed ID 15664993
    
     


 



6.
Shuman JD, Sebastian T, Kaldis P, Copeland TD, Zhu S, Smart RC, Johnson PF (2004). Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Mol Cell Biol  24, 7380-91.   https://doi.org/10.1128/MCB.24.17.7380-7391.2004




PubMed



        
     
Free Article


 


PubMed ID 15314150
         Pubmed Central ID 507001 


 



7.
Sugaya M, Watanabe T, Yang A, Starost MF, Kobayashi H, Atkins AM, Borris DL, Hanan EA, Schimel D, Bryant MA, Roberts N, Skobe M, Staskus KA, Kaldis P, Blauvelt A (2005). Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood  105, 2356-63.   https://doi.org/10.1182/blood-2004-08-3364




PubMed


 


PubMed ID 15536152",https://intramural.nih.gov/search/searchview.taf?ipid=36882
606,SC010368-05,"October 01, 2004 -  September 30, 2005",Targeting the Tumor Vasculature to Treat Cancer,Steven  Libutti; MD,NULL,"Surgery Branch, NCI","Sarah  Greer



Kerry  Holtz



Victoria  Keck



Mijung  Kwon



David P Mangiameli



Shane Young Morita



Show all 15","Raghu  Kalluri
(Medicine, Beth Israel Hospital)




Renata  Pasqualini
(Urology, MD Anderson)




Martha  Zeiger
(Surgery, Johns Hopkins)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



William G Stetler-Stevenson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ (2005). Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res  37, 369-74.   https://doi.org/10.1055/s-2005-870139




PubMed


 


PubMed ID 16001329
    
     


 



2.
Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB, Mullendore ME, Whitten I, Skarulis MC, Simonds WF, Mateo C, Crabtree JS, Scacheri PC, Ji Y, Novotny EA, Garrett-Beal L, Ward JM, Libutti SK, Richard Alexander H, Cerrato A, Parisi MJ, Santa Anna-A S, Oliver B, Chandrasekharappa SC, Collins FS, et al. [2 more authors] (2004). Molecular pathology of the MEN1 gene. Ann N Y Acad Sci  1014, 189-98.   https://doi.org/10.1196/annals.1294.020




PubMed


 


PubMed ID 15153434
    
     


 



3.
Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005). Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol  12, 138-44.   https://doi.org/10.1245/ASO.2005.05.003




PubMed


 


PubMed ID 15827794
    
     


 



4.
Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA (2004). Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene  23, 1575-85.   https://doi.org/10.1038/sj.onc.1207277




PubMed


 


PubMed ID 14767469
    
     


 



5.
Feldman AL, Stetler-Stevenson WG, Costouros NG, Knezevic V, Baibakov G, Alexander HR, Lorang D, Hewitt SM, Seo DW, Miller MS, O'Connor S, Libutti SK (2004). Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism. Cancer Res  64, 4481-6.   https://doi.org/10.1158/0008-5472.CAN-03-2929




PubMed


 


PubMed ID 15231657
    
     


 



6.
Feldman ED, Wu PC, Beresneva T, Helsabeck C, Rodriguez M, Bartlett DL, Libutti SK, Pingpank JF, Alexander HR (2004). Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. J Gastrointest Surg  8, 200-7.   https://doi.org/10.1016/j.gassur.2003.11.005




PubMed


 


PubMed ID 15036196
    
     


 



7.
Friedman M, Mikityansky I, Kam A, Libutti SK, Walther MM, Neeman Z, Locklin JK, Wood BJ (2004). Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol  27, 427-34.   https://doi.org/10.1007/s00270-004-0062-0




PubMed



        
     
Free Article


 


PubMed ID 15383844
         Pubmed Central ID 2408956 


 



8.
Grover AC, Libutti SK, Pingpank JF, Helsabeck C, Beresnev T, Alexander HR (2004). Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. Surgery  136, 1176-82.   https://doi.org/10.1016/j.surg.2004.06.044




PubMed


 


PubMed ID 15657573
    
     


 



9.
Hirshberg B, Cochran C, Skarulis MC, Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE, Gorden P (2005). Malignant insulinoma: spectrum of unusual clinical features. Cancer  104, 264-72.   https://doi.org/10.1002/cncr.21179




PubMed



        
     
Free Article


 


PubMed ID 15937909
         Pubmed Central ID 4136659 


 



10.
Libutti SK (2004). Do angiogenesis inhibitors perform a physiologic gatekeeper role in cancer prevention? Cancer J  10, 12-4.   https://doi.org/10.1097/00130404-200401000-00003




PubMed


 


PubMed ID 15000490
    
     


 



11.
Libutti SK (2005). Understanding the role of gender in the incidence of thyroid cancer. Cancer J  11, 104-5.   https://doi.org/10.1097/00130404-200503000-00003




PubMed


 


PubMed ID 15969983
    
     


 



12.
Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F (2004). Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res  64, 6489-94.   https://doi.org/10.1158/0008-5472.CAN-04-0103




PubMed


 


PubMed ID 15374959
    
     


 



13.
Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK, Costourous N (2004). Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res  64, 2898-903.   https://doi.org/10.1158/0008-5472.can-03-3811




PubMed


 


PubMed ID 15087409
    
     


 



14.
Mazzanti CM, Tandle A, Lorang D, Costouros N, Roberts D, Bevilacqua G, Libutti SK (2004). Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. Genome Res  14, 1585-93.   https://doi.org/10.1101/gr.2552804




PubMed



        
     
Free Article


 


PubMed ID 15289477
         Pubmed Central ID 509267 


 



15.
McCart JA, Mehta N, Scollard D, Reilly RM, Carrasquillo JA, Tang N, Deng H, Miller M, Xu H, Libutti SK, Alexander HR, Bartlett DL (2004). Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide. Mol Ther  10, 553-61.   https://doi.org/10.1016/j.ymthe.2004.06.158




PubMed


 


PubMed ID 15336655
    
     


 



16.
McDonald DM, Teicher BA, Stetler-Stevenson W, Ng SS, Figg WD, Folkman J, Hanahan D, Auerbach R, O'Reilly M, Herbst R, Cheresh D, Gordon M, Eggermont A, Libutti SK (2004). Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring. J Immunother  27, 161-75.   https://doi.org/10.1097/00002371-200403000-00010




PubMed


 


PubMed ID 14770088
    
     


 



17.
Miller WJ, Kayton ML, Patton A, O'Connor S, He M, Vu H, Baibakov G, Lorang D, Knezevic V, Kohn E, Alexander HR, Stirling D, Payvandi F, Muller GW, Libutti SK (2004). A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay. J Transl Med  2, 4.   https://doi.org/10.1186/1479-5876-2-4




PubMed



        
     
Free Article


 


PubMed ID 14754458
         Pubmed Central ID 373457 


 



18.
Minn AH, Kayton M, Lorang D, Hoffmann SC, Harlan DM, Libutti SK, Shalev A (2004). Insulinomas and expression of an insulin splice variant. Lancet  363, 363-7.   https://doi.org/10.1016/S0140-6736(04)15438-X




PubMed


 


PubMed ID 15070567
    
     


 



19.
Sundaram SK, Freedman NM, Carrasquillo JA, Carson JM, Whatley M, Libutti SK, Sellers D, Bacharach SL (2004). Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach. J Nucl Med  45, 1328-33.




PubMed


 


PubMed ID 15299057
    
     


 



20.
Tandle A, Blazer DG, Libutti SK (2004). Antiangiogenic gene therapy of cancer: recent developments. J Transl Med  2, 22.   https://doi.org/10.1186/1479-5876-2-22




PubMed



        
     
Free Article


 


PubMed ID 15219236
         Pubmed Central ID 455695 


 



21.
Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK (2005). Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine  30, 347-58.   https://doi.org/10.1016/j.cyto.2005.01.020




PubMed


 


PubMed ID 15935955",https://intramural.nih.gov/search/searchview.taf?ipid=36883
607,SC010370-05,"October 01, 2004 -  September 30, 2005",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Elizabeth  Lybarger



Jill  Slattery



Carrie  Mccracken



Walter  Knott



Joan  Pontius","Scott  Cram
(Los Alamos National Lab, Life Science Division)




Vanessa  King
(Genomic Medicine, The Center for the Advancement of Genomics)




Jonathan  Longmire
(Los Alamos National Lab)




Doug  Smith
(Agencourt BioSciences Corp.)",NULL,NULL,"Ordered by publication type and then author name.



1.
King V, Pearks A, Goodfellow P, OBrien S, Pecon-Slattery J   (2005) Evolution of SRY in Felidae.  Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36884
608,SC010371-05,"October 01, 2004 -  September 30, 2005",Mechanisms of Tumor Escape and Metastatic Development in Mouse Models of Experim,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Jenny  Bai



Kristy M Greeneltch



Monika  Schneider



Trina J Stewart",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Abrams SI (2004). Regulation of tumor progression by anti-neoplastic T cell responses. Cancer Biol Ther  3, 140-6.   https://doi.org/10.4161/cbt.3.2.758




PubMed


 


PubMed ID 14739786
    
     


 



2.
Abrams SI (2005). Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response. Front Biosci  10, 809-21.   https://doi.org/10.2741/1575




PubMed


 


PubMed ID 15569621
    
     


 



3.
Liu K, Caldwell SA, Abrams SI (2005). Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency. Cancer Res  65, 1045-54.




PubMed


 


PubMed ID 15705906
    
     


 



4.
Liu K, Caldwell SA, Abrams SI (2005). Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression. Cancer Res  65, 4376-88.   https://doi.org/10.1158/0008-5472.CAN-04-4269




PubMed


 


PubMed ID 15899830",https://intramural.nih.gov/search/searchview.taf?ipid=36885
609,SC010372-05,"October 01, 2004 -  September 30, 2005",Molecular profiling of patients undergoing radiotherapy,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Tamalee  Scott



Mary T Sproull",NULL,Cynthia  Menard (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36886
610,SC010373-05,"October 01, 2004 -  September 30, 2005",The synergy between radiotherapy and molecularly targeted agents,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Tamalee  Scott



Mary T Sproull",NULL,"Philip Jeffrey Tofilon (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Jeffrey  Schlom; PhD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



James W Hodge; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36887
611,SC010375-05,"October 01, 2004 -  September 30, 2005",Regulation of TAFI Activity by TAF7,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Helit  Cohen



Aparna  Kotekar



Jocelyn D Weissman",NULL,John N Brady; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36888
612,SC010376-05,"October 01, 2004 -  September 30, 2005",Molecular mechanism of TNF signaling and apoptosis,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Chung  Park,NULL,"Sergei A. Nedospasov; PhD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bender LM, Morgan MJ, Thomas LR, Liu ZG, Thorburn A (2005). The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ  12, 473-81.   https://doi.org/10.1038/sj.cdd.4401578




PubMed


 


PubMed ID 15761471
    
     


 



2.
Kim YS, Nedospasov SA, Liu ZG (2005). TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling. Mol Cell Biol  25, 2130-7.   https://doi.org/10.1128/MCB.25.6.2130-2137.2005




PubMed



        
     
Free Article


 


PubMed ID 15743811
         Pubmed Central ID 1061604 


 



3.
Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem  279, 10822-8.   https://doi.org/10.1074/jbc.M313141200




PubMed


 


PubMed ID 14701813
    
     


 



4.
Liu ZG (2005). Molecular mechanism of TNF signaling and beyond. Cell Res  15, 24-7.   https://doi.org/10.1038/sj.cr.7290259




PubMed


 


PubMed ID 15686622
    
     


 



5.
Shen HM, Lin Y, Choksi S, Tran J, Jin T, Chang L, Karin M, Zhang J, Liu ZG (2004). Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol  24, 5914-22.   https://doi.org/10.1128/MCB.24.13.5914-5922.2004




PubMed



        
     
Free Article


 


PubMed ID 15199146
         Pubmed Central ID 480890 


 



6.
Wan J, Sun L, Mendoza JW, Chui YL, Huang DP, Chen ZJ, Suzuki N, Suzuki S, Yeh WC, Akira S, Matsumoto K, Liu ZG, Wu Z (2004). Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1. Mol Cell Biol  24, 192-9.   https://doi.org/10.1128/mcb.24.1.192-199.2004




PubMed



        
     
Free Article


 


PubMed ID 14673155
         Pubmed Central ID 303354",https://intramural.nih.gov/search/searchview.taf?ipid=36889
613,SC010378-05,"October 01, 2004 -  September 30, 2005",Activation of Proto-Oncogenes by Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","David L Caudell



Yue  Cheng



Ying-Wei  Lin



Christopher  Slape



Zhenhua  Zhang","Kenneth  Gross
(RPCI)




Trang  Hoang
(CRIM)




Keith  Humphries
(Terry Fox Labs)","Lino  Tessarollo (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)



Linda  Wolff; PhD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Aplan PD (2005). ""You break it, you fix it."". Blood  105, 1843-4.   https://doi.org/10.1182/blood-2004-12-4760




PubMed


 


PubMed ID 15747400
    
     


 



2.
Lin YW, Aplan PD (2004). Leukemic transformation. Cancer Biol Ther  3, 13-20.   https://doi.org/10.4161/cbt.3.1.537




PubMed


 


PubMed ID 14726677
    
     


 



3.
Lin YW, Deveney R, Barbara M, Iscove NN, Nimer SD, Slape C, Aplan PD (2005). OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Cancer Res  65, 7151-8.   https://doi.org/10.1158/0008-5472.CAN-05-1400




PubMed



        
     
Free Article


 


PubMed ID 16103065
         Pubmed Central ID 1681523 


 



4.
Lin YW, Slape C, Zhang Z, Aplan PD (2005). NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood  106, 287-95.   https://doi.org/10.1182/blood-2004-12-4794




PubMed



        
     
Free Article


 


PubMed ID 15755899
         Pubmed Central ID 1201424 


 



5.
Slape C, Aplan PD (2004). The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma  45, 1341-50.   https://doi.org/10.1080/10428190310001659325




PubMed


 


PubMed ID 15359631",https://intramural.nih.gov/search/searchview.taf?ipid=36890
614,SC010379-05,"October 01, 2004 -  September 30, 2005",Mechanisms of Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Yue  Cheng



Ying-Wei  Lin



Tamas  Varga



Zhenhua  Zhang","Pieter  deJong
(CHORI)




Carolyn  Felix
(CHOP)




Linda  Resar
(Johns Hopkins)




Martin  Stanulla
(University of Hannover)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36891
615,SC010381-05,"October 01, 2004 -  September 30, 2005",Non-cytotoxic functions of lymphoycte granule exocytosis,Pierre A. Henkart; PhD,NULL,"Experimental Immunology Branch, NCI",Marta Liliana Catalfamo; PhD,NULL,"Wei  Xiao (Lymphocyte Cytotoxicity Section)



Tatiana  Karpova (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, Bos E, Peters PJ, Henkart PA (2004). Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity  20, 219-30.   https://doi.org/10.1016/s1074-7613(04)00027-5




PubMed


 


PubMed ID 14975243
    
     


 



2.
Henkart PA, Catalfamo M (2004). CD8+ effector cells. Adv Immunol  83, 233-52.   https://doi.org/10.1016/S0065-2776(04)83007-4




PubMed


 


PubMed ID 15135633",https://intramural.nih.gov/search/searchview.taf?ipid=36892
616,SC010382-05,"October 01, 2004 -  September 30, 2005",Biological Therapy and Modulation of the Tumor Microenvironment: New Strategies,Jon Marc Wigginton; MD,Robert  Wiltrout; PhD,"Pediatric Oncology Branch, NCI",NULL,"Jocelyn  Holash
(Regeneron Pharmaceuticals)




Zdenka  Jonak
(Department of Oncology, Glaxo-Smithkline Pharmaceuticals)




Robert  Kastelein
(Department of Immunology, DNAX Research Institute)




Robert  Seeger
(Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)




Paul  Sondel
(Pediatric Hematology-Oncology, University of Wisconsin Comprehensive Cancer Center)","John  Janik; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Thomas Joseph Sayers; PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)","Peter L Choyke; MD (CC) 












William T Murphy (OD)","Ordered by publication type and then author name.



1.
Wigginton J   (2005) Translational research and oncology drug development: opportunities and obstacles.  European Biopharmaceutical Review  pp.




 



2.
Wigginton J, Hixon J, Stauffer J, Lincoln E, Back T   (2005) IL-12 inhibits AKT activity and induces BID activation in conjunction with complete regression of orthotopic murine neuroblastoma tumors.  Journal of the National Cancer Institute, in press.




 



3.
Wigginton J, Stauffer J, Lincoln E, Hixon J, Kastelein R   (2004) IL-27 mediates complete regression of orthotopic primary and/or metastatic murine.  Journal of Immunology  pp.




 



4.
Wigginton J, Yang X, Tsokos M, Padilla-Nash H, Reid T, Thiele C   (2005) Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line.  Cancer Genetics and Cytogenetics  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=36893
617,SC010384-05,"October 01, 2004 -  September 30, 2005",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Thomas R Bauer



Yuchen  Gu



Laura M Tuschong



Mizuki  Azuma



Lisa J Embree



Mehreen  Hai



Show all 8","Mark  Haskins; VMD, PhD
(Veterinary School, Dept. Pathology, University of Pennsylvania)




David W Russell",NULL,"Robert E Donahue; VMD, MS (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36894
618,SC010385-06,"October 01, 2004 -  September 30, 2005",Molecular Classification of Human and Mouse Hepatocellular Carcinoma by Gene Exp,"Snorri S. Thorgeirsson; MD, PhD",Robert  Wiltrout; PhD,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Cedric  Coulouarn



Joe W Grisham



Jeonghoon  Heo



Pal  Kaposi-Novak



Show all 9","Antony  Demetris
(Dept. Pathology, University of Pittsburg)




Jozsef  Horti
(Dept. Chemotherapy, National Oncology Institute)




Janardan  Reddy
(Dept. of Pathology, Northwestern University)




Lewis  Roberts
(Gastroenterology, Mayo Clinic)




Tania  Roskams
(Dpt. Pathology, K.U.Leuven University)




Zongtang  Sun
(Chinese Academy of Medical Sciences)","Valentina  Factor (Cellular and Molecular Biology Section)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)



Elizabeth  Snyderwine; PhD (National Cancer Institute)



John R Ortaldo; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thorgeirsson SS (2005). Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol  42, 842-9.   https://doi.org/10.1016/j.jhep.2005.01.029




PubMed


 


PubMed ID 15885355",https://intramural.nih.gov/search/searchview.taf?ipid=36895
619,SC010386-04,"October 01, 2004 -  September 30, 2005","Crystallographic Studies of Chemokines, Chemokine Receptors, and Related Protein",Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI","Cyril  Barinka



Marzena E Pazgier



James L Gattis","Douglas  Cines
(Dept. Pathology and Laboratory medicine, University of Pennsylvania)




Wolfgang  Lockau
(Biochemistry, Humbolt-University)




Wuyuan  Lu
(Institute of Virology, University of Maryland)




Andrew  Mazar
(Bio-tech company, Attenuon, L.L.C.)",Joost J Oppenheim; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T (2005). Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood  106, 3831-8.   https://doi.org/10.1182/blood-2005-03-0889




PubMed



        
     
Free Article


 


PubMed ID 16123222
         Pubmed Central ID 1895098 


 



2.
Szyk A, Lu W, Xu C, Lubkowski J (2004). Structure of the scorpion toxin BmBKTtx1 solved from single wavelength anomalous scattering of sulfur. J Struct Biol  145, 289-94.   https://doi.org/10.1016/j.jsb.2003.11.012




PubMed


 


PubMed ID 14960379
    
     


 



3.
Wu Z, Alexandratos J, Ericksen B, Lubkowski J, Gallo RC, Lu W (2004). Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci U S A  101, 11587-92.   https://doi.org/10.1073/pnas.0404649101




PubMed



        
     
Free Article


 


PubMed ID 15280532
         Pubmed Central ID 511025 


 



4.
Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, Devico A, Lehrer RI, Lu W (2005). Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett  579, 162-6.   https://doi.org/10.1016/j.febslet.2004.11.062




PubMed


 


PubMed ID 15620707
    
     


 



5.
Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W (2004). Synthesis and characterization of human alpha-defensins 4-6. J Pept Res  64, 118-25.   https://doi.org/10.1111/j.1399-3011.2004.00179.x




PubMed


 


PubMed ID 15317502
    
     


 



6.
Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, Li X, Lu WY, Lubkowski J, Lu W (2005). Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem  280, 32921-9.   https://doi.org/10.1074/jbc.M503084200




PubMed


 


PubMed ID 15894545
    
     


 



7.
Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004). Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol  22, 181-215.   https://doi.org/10.1146/annurev.immunol.22.012703.104603




PubMed


 


PubMed ID 15032578",https://intramural.nih.gov/search/searchview.taf?ipid=36897
620,SC010387-05,"October 01, 2004 -  September 30, 2005",HIV Molecular Biology and DNA Vaccine Approaches Against AIDS,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Cristina  Bergamaschi



Susan L Lindtner



Margherita  Rosati



Hiroaki  Uranishi



Antonio L Valentin



Agneta S Von Gegerfelt","M  Egan
(Wyeth)




J  Eldridge
(Wyeth)




S  Lockett
(SAIC)




Ralf  Schneider
(GSF-National Research Center for Environment and Health)




D  Weiner
(U Penn)","Neal G Copeland; PhD (National Cancer Institute)



Marjorie  Robert-Guroff; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Boyer JD, Robinson TM, Maciag PC, Peng X, Johnson RS, Pavlakis G, Lewis MG, Shen A, Siliciano R, Brown CR, Weiner DB, Paterson Y (2005). DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology  333, 88-101.   https://doi.org/10.1016/j.virol.2004.12.026




PubMed


 


PubMed ID 15708595
    
     


 



2.
Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S (2004). Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J  86, 3993-4003.   https://doi.org/10.1529/biophysj.103.038422




PubMed



        
     
Free Article


 


PubMed ID 15189895
         Pubmed Central ID 1304300 


 



3.
Daelemans D, Costes SV, Cho EH, Erwin-Cohen RA, Lockett S, Pavlakis GN (2004). In vivo HIV-1 Rev multimerization in the nucleolus and cytoplasm identified by fluorescence resonance energy transfer. J Biol Chem  279, 50167-75.   https://doi.org/10.1074/jbc.M407713200




PubMed


 


PubMed ID 15294891
    
     


 



4.
Daelemans D, Costes SV, Lockett S, Pavlakis GN (2005). Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol Cell Biol  25, 728-39.   https://doi.org/10.1128/MCB.25.2.728-739.2005




PubMed



        
     
Free Article


 


PubMed ID 15632073
         Pubmed Central ID 543413 


 



5.
Daelemans D, Pannecouque C, Pavlakis GN, Tabarrini O, De Clercq E (2005). A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. Mol Pharmacol  67, 1574-80.   https://doi.org/10.1124/mol.104.010249




PubMed


 


PubMed ID 15728798
    
     


 



6.
Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, Eldridge JH (2005). Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses  21, 629-43.   https://doi.org/10.1089/aid.2005.21.629




PubMed


 


PubMed ID 16060834
    
     


 



7.
Egan MA, Megati S, Roopchand V, Garcia-Hand D, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Eldridge JH, Sidhu MK (2006). Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine  24, 4510-23.   https://doi.org/10.1016/j.vaccine.2005.08.024




PubMed


 


PubMed ID 16140439
    
     


 



8.
Kaur A, Sanford HB, Garry D, Lang S, Klumpp SA, Watanabe D, Bronson RT, Lifson JD, Rosati M, Pavlakis GN, Felber BK, Knipe DM, Desrosiers RC (2007). Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology  357, 199-214.   https://doi.org/10.1016/j.virol.2006.08.007




PubMed



        
     
Free Article


 


PubMed ID 16962628
         Pubmed Central ID 1819472 


 



9.
Kumar S, Yan J, Muthumani K, Ramanathan MP, Yoon H, Pavlakis GN, Felber BK, Sidhu M, Boyer JD, Weiner DB (2006). Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol  25, 383-92.   https://doi.org/10.1089/dna.2006.25.383




PubMed


 


PubMed ID 16848679
    
     


 



10.
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB (2005). Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol  175, 112-23.   https://doi.org/10.4049/jimmunol.175.1.112




PubMed


 


PubMed ID 15972637
    
     


 



11.
Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB (2004). Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model. Vaccine  22, 1782-90.   https://doi.org/10.1016/j.vaccine.2004.01.037




PubMed


 


PubMed ID 15068862
    
     


 



12.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN (2005). DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol  79, 8480-92.   https://doi.org/10.1128/JVI.79.13.8480-8492.2005




PubMed



        
     
Free Article


 


PubMed ID 15956591
         Pubmed Central ID 1143718 


 



13.
Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, Quiroz J, Boyer JD, Felber BK, Pavlakis GN, Weiner DB, Eldridge JH, Israel ZR (2006). A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine  24, 4677-87.   https://doi.org/10.1016/j.vaccine.2005.10.035




PubMed


 


PubMed ID 16288822
    
     


 



14.
Smulevitch S, Michalowski D, Zolotukhin AS, Schneider R, Bear J, Roth P, Pavlakis GN, Felber BK (2005). Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome. J Virol  79, 2356-65.   https://doi.org/10.1128/JVI.79.4.2356-2365.2005




PubMed



        
     
Free Article


 


PubMed ID 15681436
         Pubmed Central ID 546579 


 



15.
von Gegerfelt AS, Alicea C, Valentin A, Morrow M, van Rompay KK, Ayash-Rashkovsky M, Markham P, Else JG, Marthas ML, Pavlakis GN, Ruprecht RM, Felber BK (2006). Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses  22, 516-28.   https://doi.org/10.1089/aid.2006.22.516




PubMed


 


PubMed ID 16796527
    
     


 



16.
Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM (2007). Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector. Virology  357, 186-98.   https://doi.org/10.1016/j.virol.2006.08.015




PubMed


 


PubMed ID 16996101
    
     


 



17.
Yuste E, Johnson W, Pavlakis GN, Desrosiers RC (2005). Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus. J Virol  79, 12455-63.   https://doi.org/10.1128/JVI.79.19.12455-12463.2005




PubMed



        
     
Free Article


 


PubMed ID 16160173
         Pubmed Central ID 1211544 


 



18.
Felber BK, Pavlakis GK (submitted in 2005) Codon Optimized Il-15 And Il-15r-alpha Gene Expression In Mammalian Cells. Patents issued: 200780003101 (CN in 2012); 295870 (MX in 2012); 569541 (NZ in 2012); 192730 (IL in 2013); 596494 (NZ in 2014); 2007207785 (AU in 2014); 5709356 (JP in 2015); ZL 201210119 (CN in 2016); 9,303,080 (US in 2016); 2013203171 (AU in 2016); 221384 (IL in 2017); 28163 (IN in 2017); 9,725,492 (US in 2017); 6289099 (JP in 2018); 9,790,261 (US in 2018). Patents pending: 2016216577 (AU application); PI0707106-0 (BR application); 2636111 (CA application); 07716564.5 (EP application); 11154217.1 (EP application); MX/A/2012/001670 (MX application); 15/728,455 (US application).




 



19.
Felber BK, Pavlakis GK, Rosati MK (submitted in 2005) Improved Il-12 For Expression In Mammalian Cells. Patent issued: 7,833,754 (US in 2011).",https://intramural.nih.gov/search/searchview.taf?ipid=36896
621,SC010437-05,"October 01, 2004 -  September 30, 2005",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI","Rodrigo F Chuaqui



Heidi S Erickson



Gallya  Gannot



Michael  Tangrea",NULL,"William Marston Linehan; MD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)","Francis S Collins; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF (2005). Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res  11, 6823-34.   https://doi.org/10.1158/1078-0432.CCR-05-0585




PubMed



        
     
Free Article


 


PubMed ID 16203770
         Pubmed Central ID 1432092",https://intramural.nih.gov/search/searchview.taf?ipid=36898
